data_1q9f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1q9f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 t -151.05 158.14 43.71 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.384 1.074 . . . . 0.0 108.601 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.05 114.93 17.71 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 124.045 1.879 . . . . 0.0 109.038 168.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m -89.06 103.54 16.15 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -92.31 100.13 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 p -126.26 160.95 28.9 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.51 0.671 . . . . 0.0 111.15 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.95 178.41 48.16 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.51 -151.57 23.31 Favored Glycine 0 C--O 1.24 0.529 0 CA-C-N 118.741 1.27 . . . . 0.0 111.698 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.86 157.83 20.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.959 0.903 . . . . 0.0 109.151 -177.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.08 154.33 47.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.096 1.359 . . . . 0.0 108.355 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.49 ' NE2' ' HE1' ' A' ' 140' ' ' TRP . 2.3 mp0 -124.98 104.19 8.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 167.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.2 t -84.87 115.02 22.53 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 159.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.83 155.11 49.56 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.576 1.15 . . . . 0.0 108.482 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -143.12 163.93 31.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 110.058 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 60.17 9.51 1.91 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.924 1.689 . . . . 0.0 114.023 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.72 94.72 0.35 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -45.38 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.29 2.236 . . . . 0.0 111.588 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -148.82 -2.44 0.47 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -118.48 113.01 20.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 122.884 1.326 . . . . 0.0 114.316 -162.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -66.68 96.12 0.38 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 161.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.5 mtt -133.14 103.95 6.26 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 167.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.46 -170.95 23.73 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 128.335 2.874 . . . . 0.0 106.545 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.15 -84.25 0.05 OUTLIER Glycine 0 C--N 1.328 0.108 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 -169.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.82 174.17 10.78 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.348 1.459 . . . . 0.0 108.17 163.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -138.59 152.32 48.05 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.824 1.249 . . . . 0.0 107.746 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.68 131.06 19.72 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.664 1.986 . . . . 0.0 106.035 166.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -122.54 133.8 54.56 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -156.45 108.62 2.53 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -171.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -142.04 163.06 33.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.973 0.892 . . . . 0.0 111.127 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -99.66 157.47 16.45 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.164 1.385 . . . . 0.0 108.369 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.24 147.95 50.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -172.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -75.89 166.34 23.65 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.617 1.567 . . . . 0.0 111.67 -159.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -112.66 40.95 2.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.551 1.167 . . . . 0.0 108.565 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -167.59 -75.42 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.32 162.42 66.5 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.016 0.926 . . . . 0.0 109.601 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.91 62.6 8.48 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.669 2.913 . . . . 0.0 108.99 165.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.8 tp -112.01 123.79 51.0 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.182 1.393 . . . . 0.0 107.539 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.39 176.88 16.26 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.2 t -126.03 155.88 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 tt -132.94 121.03 43.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.35 108.85 2.08 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 m -80.49 142.11 34.54 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.163 0.982 . . . . 0.0 109.19 161.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -143.29 125.76 15.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 167.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.6 t -118.17 150.92 38.59 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.995 0.816 . . . . 0.0 109.5 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -142.99 123.72 14.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.0 p -114.17 121.56 44.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.59 29.41 0.93 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.899 0.772 . . . . 0.0 110.275 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -103.85 147.1 27.7 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.701 2.001 . . . . 0.0 108.528 177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 m -122.6 154.95 37.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.811 1.645 . . . . 0.0 108.19 168.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.449 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.333 0 CA-C-N 118.14 0.427 . . . . 0.0 110.618 -171.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 122.479 1.133 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -51.94 93.11 0.01 OUTLIER 'General case' 0 C--O 1.237 0.433 0 C-N-CA 128.221 2.609 . . . . 0.0 113.655 -167.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.02 168.35 16.02 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.522 -0.736 . . . . 0.0 109.632 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t30 61.58 176.9 0.12 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.774 1.23 . . . . 0.0 110.591 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -129.23 154.31 46.92 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 166.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.36 159.12 24.45 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -141.16 135.35 30.74 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.11 116.65 0.86 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -167.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.28 110.1 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.3 m -128.34 144.04 51.08 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.757 1.623 . . . . 0.0 107.848 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.96 167.61 24.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.285 1.034 . . . . 0.0 110.754 -172.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.42 174.0 34.57 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 128.137 2.78 . . . . 0.0 110.795 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -85.75 -179.75 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.961 3.774 . . . . 0.0 110.8 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.97 135.1 35.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.856 1.662 . . . . 0.0 107.367 164.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -150.14 154.87 38.78 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.065 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -87.97 148.45 24.55 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.061 1.3 . . . . 0.0 111.145 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.91 -57.02 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -132.43 -75.9 0.5 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -165.55 74.98 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -130.89 -60.28 0.97 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.318 1.447 . . . . 0.0 109.175 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.84 164.6 32.34 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.653 1.181 . . . . 0.0 109.304 -174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 p -125.44 109.46 12.75 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.054 1.341 . . . . 0.0 107.637 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.26 151.7 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -150.11 165.73 31.92 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.117 0.872 . . . . 0.0 110.86 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.37 139.18 21.44 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.58 152.21 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.43 1.115 . . . . 0.0 109.149 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.66 150.81 15.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.885 0.874 . . . . 0.0 109.193 -167.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.52 -165.7 27.31 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 123.306 0.479 . . . . 0.0 112.614 -168.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.53 150.33 18.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.73 1.212 . . . . 0.0 107.747 171.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.57 130.85 7.63 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.835 1.683 . . . . 0.0 109.159 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -127.57 117.51 22.18 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.246 1.418 . . . . 0.0 110.022 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.57 142.61 11.42 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 170.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.078 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.7 t . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -159.71 174.79 14.01 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 165.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -124.02 159.8 29.05 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.906 1.683 . . . . 0.0 107.737 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.11 137.49 9.41 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -75.78 102.21 5.37 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -67.39 135.03 52.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -148.12 171.47 15.83 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 121.929 -0.482 . . . . 0.0 110.047 168.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.18 -149.63 20.89 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.09 148.16 48.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.335 1.054 . . . . 0.0 109.602 174.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.23 124.11 7.68 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.03 139.42 49.88 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -170.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -138.48 129.9 27.48 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -92.83 171.59 8.88 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.149 0.5 . . . . 0.0 110.112 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -66.2 117.0 38.9 Favored Pre-proline 0 C--O 1.241 0.608 0 C-N-CA 123.95 0.9 . . . . 0.0 108.579 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.97 176.54 9.34 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.234 2.623 . . . . 0.0 112.0 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.14 -176.38 4.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.458 2.303 . . . . 0.0 107.49 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -91.14 -7.95 50.07 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.008 2.123 . . . . 0.0 110.121 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.72 12.18 0.25 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.99 1.716 . . . . 0.0 110.511 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.4 t -136.91 137.84 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.03 -1.669 . . . . 0.0 108.844 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -136.18 155.21 50.48 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -139.29 115.07 10.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.84 141.69 48.58 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 126.425 1.89 . . . . 0.0 106.646 -172.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -135.2 142.69 46.1 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 p -127.16 149.2 50.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 158.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.15 119.64 14.91 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 169.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -127.72 138.18 52.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -129.83 139.39 51.23 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.5 m -130.72 159.98 35.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.806 2.043 . . . . 0.0 107.186 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -132.33 145.62 51.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.19 95.95 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 75.27 -74.88 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.742 2.417 . . . . 0.0 111.512 165.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.7 m -148.75 27.05 0.9 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.432 1.493 . . . . 0.0 109.646 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.75 120.53 61.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 166.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.38 152.58 34.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.67 137.43 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 164.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.22 140.96 14.41 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 168.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.1 m -140.67 120.34 13.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.49 ' HE1' ' NE2' ' A' ' 11' ' ' GLN . 3.2 p-90 -105.03 153.16 21.83 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 166.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.7 mt -136.68 131.56 47.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.97 129.86 35.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -113.37 96.54 0.81 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.8 t -116.54 152.09 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 157.28 -143.01 9.1 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 106.429 -2.668 . . . . 0.0 106.429 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -121.76 176.87 5.51 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.604 1.962 . . . . 0.0 110.068 -166.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 129.95 13.44 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.283 171.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.5 p90 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 124.469 1.108 . . . . 0.0 108.37 175.231 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -92.4 151.09 20.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -143.46 107.09 4.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 162.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 t -138.83 150.91 46.56 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.089 0.947 . . . . 0.0 108.894 167.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.53 137.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 111.521 -2.581 . . . . 0.0 106.468 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.7 m -152.78 144.01 23.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.79 -178.55 44.75 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.74 -172.37 25.03 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.99 158.37 17.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.12 170.03 9.55 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.798 0.332 . . . . 0.0 110.722 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -140.99 113.04 7.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 156.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.5 t -84.75 151.3 24.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.062 0.934 . . . . 0.0 108.967 164.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -136.76 170.82 15.45 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.776 2.43 . . . . 0.0 107.863 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.19 159.5 42.1 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 161.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -75.63 64.77 1.73 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.707 1.203 . . . . 0.0 109.536 174.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 160.01 -37.95 0.46 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 126.855 2.169 . . . . 0.0 110.686 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -129.72 96.51 4.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.074 0.937 . . . . 0.0 109.758 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.5 mtt -78.3 58.15 2.04 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.637 0.732 . . . . 0.0 109.338 166.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.99 93.86 1.8 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 164.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HD3' ' H ' ' A' ' 20' ' ' LYS . 0.5 OUTLIER -58.74 106.12 0.37 Allowed 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 81.9 mtp -136.06 109.69 8.03 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -169.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.07 -178.5 37.65 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.19 -128.67 0.96 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 104.86 -3.296 . . . . 0.0 104.86 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.89 150.25 37.36 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -122.04 162.77 20.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.62 1.968 . . . . 0.0 107.529 173.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -147.6 167.84 23.52 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -138.11 159.99 40.56 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.245 1.018 . . . . 0.0 108.894 170.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -136.19 141.57 44.04 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.517 2.327 . . . . 0.0 106.377 164.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.71 160.33 23.55 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 160.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -131.96 156.45 46.16 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.394 1.478 . . . . 0.0 107.328 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -98.25 140.16 32.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.667 0.746 . . . . 0.0 109.258 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.05 156.96 23.17 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 127.008 2.123 . . . . 0.0 107.19 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -133.26 71.66 1.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.96 -37.97 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.823 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -162.41 153.95 15.36 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 124.36 1.064 . . . . 0.0 109.207 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.56 88.42 1.42 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.376 2.717 . . . . 0.0 109.21 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.9 tp -143.74 156.94 44.68 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 128.314 2.645 . . . . 0.0 105.791 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.89 175.89 21.55 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 91.1 t -124.61 157.21 32.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 118.189 0.994 . . . . 0.0 111.198 -168.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.75 141.53 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 126.779 2.032 . . . . 0.0 106.86 161.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.81 108.95 0.39 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 p -124.87 154.22 41.38 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.276 1.03 . . . . 0.0 110.613 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -131.66 122.45 25.98 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -170.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.8 p -95.47 146.8 24.15 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -171.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.98 154.95 50.92 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.623 1.169 . . . . 0.0 109.411 -178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.1 m -132.43 130.51 40.67 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.863 1.211 . . . . 0.0 112.564 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -110.95 -14.18 13.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.639 1.176 . . . . 0.0 112.856 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -66.42 145.73 55.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.813 0.845 . . . . 0.0 110.585 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 p -74.92 144.36 43.32 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.922 0.783 . . . . 0.0 109.405 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 . . . . . 0 N--CA 1.444 -0.755 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 158.693 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.49 -60.19 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.922 0.889 . . . . 0.0 110.216 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.46 133.07 48.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 122.0 -0.437 . . . . 0.0 110.543 -159.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -146.46 19.25 1.35 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -166.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -110.21 128.15 55.34 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 120.986 1.721 . . . . 0.0 107.855 -158.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -152.5 119.98 5.99 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.02 116.86 29.13 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.06 131.53 10.82 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 158.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.3 mt -119.68 109.54 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 167.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -120.01 147.59 44.61 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.554 2.342 . . . . 0.0 108.166 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.28 172.76 15.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.492 1.517 . . . . 0.0 109.188 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.44 175.59 43.92 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 161.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -74.33 175.75 10.57 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.471 2.114 . . . . 0.0 110.235 160.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.39 109.21 8.08 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.619 1.967 . . . . 0.0 108.085 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.37 130.25 35.25 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -111.38 118.45 35.87 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 170.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.06 -65.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -167.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -135.72 -79.31 0.42 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 161.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -158.69 80.52 0.8 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.049 1.295 . . . . 0.0 110.996 167.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -129.55 -40.51 1.41 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.28 1.432 . . . . 0.0 109.783 164.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.37 174.0 13.86 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.472 1.109 . . . . 0.0 109.733 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 t -148.87 105.26 3.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.11 156.5 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.795 0.838 . . . . 0.0 110.794 -172.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -151.18 173.34 14.52 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.024 1.329 . . . . 0.0 111.624 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.71 114.93 4.94 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.969 1.747 . . . . 0.0 108.759 170.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -110.36 161.08 9.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.224 1.409 . . . . 0.0 110.917 -164.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.39 165.36 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 C-N-CA 124.249 1.02 . . . . 0.0 110.578 -169.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.11 -164.71 30.23 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 p -148.55 137.88 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 169.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.97 108.92 2.24 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 127.575 2.512 . . . . 0.0 109.623 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.58 140.29 31.42 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.417 1.087 . . . . 0.0 108.594 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.3 160.36 27.84 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 118.446 0.566 . . . . 0.0 112.424 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 C--O 1.236 0.362 0 C-N-CA 127.146 2.178 . . . . 0.0 106.502 173.273 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -129.14 129.01 44.61 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -92.65 160.03 15.19 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 166.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.98 131.47 5.12 Favored Glycine 0 C--N 1.33 0.248 0 N-CA-C 107.959 -2.057 . . . . 0.0 107.959 170.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.49 126.38 30.9 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 m -92.58 131.25 37.85 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -146.22 133.02 20.03 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.05 -172.09 34.67 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.153 1.359 . . . . 0.0 111.144 -160.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.31 158.29 44.74 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.864 0.866 . . . . 0.0 110.555 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -134.21 104.75 0.53 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.074 1.321 . . . . 0.0 111.345 -168.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.4 148.3 37.9 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.62 1.568 . . . . 0.0 107.243 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.38 159.4 34.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.436 1.095 . . . . 0.0 108.816 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -133.91 159.19 41.44 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 126.461 1.904 . . . . 0.0 107.023 -171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -56.38 114.75 8.31 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 123.779 0.832 . . . . 0.0 110.351 -158.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.43 171.61 11.0 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.281 3.321 . . . . 0.0 113.514 -168.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.9 mtm -145.85 177.68 8.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.175 2.19 . . . . 0.0 108.916 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -93.01 18.22 9.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.556 1.942 . . . . 0.0 112.995 -166.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -174.68 -7.92 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.035 2.134 . . . . 0.0 111.643 -168.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.41 140.9 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 128.646 2.778 . . . . 0.0 103.551 -170.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.62 159.62 42.17 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -137.63 117.15 12.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.73 150.7 40.57 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 168.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -140.93 123.45 15.97 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.1 m -122.49 136.16 54.82 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -126.23 122.23 34.98 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.412 1.885 . . . . 0.0 106.98 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.83 157.05 42.6 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.662 1.185 . . . . 0.0 110.212 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -132.26 152.97 51.1 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.287 1.035 . . . . 0.0 108.479 172.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.3 t -141.17 160.51 39.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 127.402 2.281 . . . . 0.0 107.349 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -128.87 107.09 9.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.6 pt -137.04 151.78 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.809 1.244 . . . . 0.0 108.152 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.45 18.89 6.0 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.784 1.634 . . . . 0.0 112.292 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.9 m 53.48 34.54 18.53 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.887 1.221 . . . . 0.0 112.03 -164.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.39 149.31 23.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 122.019 0.914 . . . . 0.0 108.842 161.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.8 140.13 53.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 168.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -136.26 98.64 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.32 151.34 32.86 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -141.65 154.2 45.21 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 146.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -139.21 155.23 47.95 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 168.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.4 pt -121.3 140.24 45.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -173.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.04 135.07 33.58 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -113.44 121.77 5.59 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 106.509 -2.636 . . . . 0.0 106.509 170.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.81 148.16 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 129.387 3.075 . . . . 0.0 103.988 169.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.72 -125.46 1.37 Allowed Glycine 0 C--O 1.227 -0.322 0 CA-C-O 118.014 -1.437 . . . . 0.0 109.904 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.84 143.04 22.44 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 127.287 2.235 . . . . 0.0 106.625 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -136.68 96.29 3.3 Favored 'General case' 0 CA--C 1.518 -0.279 0 O-C-N 120.863 -1.148 . . . . 0.0 108.298 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 115.13 -2.367 . . . . 0.0 112.379 159.757 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.9 m -137.29 152.93 50.31 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 171.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -142.07 133.89 27.14 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 122.311 1.053 . . . . 0.0 108.66 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -152.44 145.46 24.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.69 132.09 64.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.8 p -137.82 130.41 29.62 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.75 159.13 23.13 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.84 -152.39 19.28 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 107.346 -2.302 . . . . 0.0 107.346 -164.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -99.85 153.27 19.28 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.357 0.579 . . . . 0.0 110.353 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.93 142.01 50.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 170.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.9 149.58 50.31 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.795 1.238 . . . . 0.0 108.514 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.7 m -137.27 121.53 18.05 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.396 1.079 . . . . 0.0 109.802 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -103.61 162.16 13.29 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.58 146.02 51.42 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 118.295 0.498 . . . . 0.0 110.854 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 61.6 -60.09 0.1 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 130.253 3.421 . . . . 0.0 112.018 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.83 -66.16 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 105.892 -2.883 . . . . 0.0 105.892 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.86 96.81 4.75 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.027 1.331 . . . . 0.0 109.231 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.5 ttt -152.91 -69.02 0.15 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.299 0.639 . . . . 0.0 109.553 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.83 146.6 19.34 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.971 0.908 . . . . 0.0 110.243 -172.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -120.33 154.54 34.88 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 124.99 1.316 . . . . 0.0 108.912 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.4 ptp -131.24 159.17 38.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.09 175.45 23.19 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.696 1.141 . . . . 0.0 111.064 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.8 -177.32 47.55 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 118.064 0.932 . . . . 0.0 111.29 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -99.83 147.87 25.04 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.413 HD22 ' HB2' ' A' ' 42' ' ' SER . 24.5 t-20 -137.91 150.73 47.33 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.921 1.688 . . . . 0.0 109.673 -176.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mt -139.22 161.68 36.84 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 128.039 2.536 . . . . 0.0 108.619 171.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.49 176.43 12.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.27 1.828 . . . . 0.0 107.954 157.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -144.86 114.61 7.28 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 120.877 -1.139 . . . . 0.0 108.478 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 109.15 20.78 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -99.86 158.86 15.5 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.792 1.637 . . . . 0.0 109.224 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -115.2 152.31 32.87 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -121.28 166.76 13.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.021 1.329 . . . . 0.0 110.42 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -125.4 56.72 1.35 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.79 1.236 . . . . 0.0 108.071 -163.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.21 -47.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.181 1.392 . . . . 0.0 109.092 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.5 m -134.96 152.02 76.54 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.907 1.683 . . . . 0.0 107.899 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.84 13.2 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.939 3.759 . . . . 0.0 114.929 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 tp -87.24 118.91 26.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.157 1.783 . . . . 0.0 110.222 -165.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.22 177.27 49.0 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.1 t -133.87 145.27 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.172 1.389 . . . . 0.0 109.293 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 mp -139.68 131.91 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.469 1.908 . . . . 0.0 107.13 168.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.17 148.93 18.75 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 142.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.413 ' HB2' HD22 ' A' ' 25' ' ' ASN . 4.9 p -125.0 154.34 41.4 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.326 1.051 . . . . 0.0 110.515 165.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -112.77 148.97 33.67 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.318 1.047 . . . . 0.0 108.746 169.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 m -93.93 146.61 23.79 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.68 0.792 . . . . 0.0 109.218 165.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.417 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 48.5 m-85 -117.62 153.74 32.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.563 1.545 . . . . 0.0 108.593 166.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.85 143.21 34.31 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.008 0.822 . . . . 0.0 111.293 168.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.78 -11.49 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.012 2.525 . . . . 0.0 112.076 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.82 147.06 30.61 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.074 -1.641 . . . . 0.0 110.39 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.2 p -111.14 155.88 22.21 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.417 1.487 . . . . 0.0 109.132 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 162.804 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 C--O 1.239 0.546 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.2 128.63 36.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.14 -0.975 . . . . 0.0 108.666 171.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -144.63 172.65 12.69 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 84.92 -177.69 0.03 OUTLIER 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.843 2.057 . . . . 0.0 109.018 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.83 169.84 14.08 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.657 1.583 . . . . 0.0 107.919 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.417 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 25.2 p90 -73.73 139.22 45.14 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 159.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -140.39 117.54 11.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 157.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.52 121.69 1.05 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.46 150.46 34.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.1 p -140.48 157.36 45.63 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.23 140.53 21.36 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.041 0.837 . . . . 0.0 111.158 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.02 160.19 28.05 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 156.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.19 -179.81 5.8 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.14 1.893 . . . . 0.0 111.668 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.56 146.02 41.26 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.208 1.403 . . . . 0.0 108.251 164.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -128.85 130.03 46.36 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -67.18 111.93 4.2 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.838 1.655 . . . . 0.0 109.301 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 tt -73.75 171.38 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.026 0.441 . . . . 0.0 109.875 -176.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -88.73 37.48 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.102 1.761 . . . . 0.0 110.091 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -149.51 -119.98 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.591 1.957 . . . . 0.0 105.73 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -128.67 66.25 1.41 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.506 1.922 . . . . 0.0 109.441 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.1 176.02 13.04 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.657 -1.277 . . . . 0.0 110.766 168.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 m -137.94 112.95 9.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 164.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.71 147.21 23.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -150.4 164.88 34.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 119.665 1.12 . . . . 0.0 110.564 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.69 129.99 9.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.92 -176.52 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 124.374 1.07 . . . . 0.0 111.166 -176.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.86 165.56 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.677 1.991 . . . . 0.0 107.874 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.88 -172.26 31.14 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 162.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.51 138.97 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.47 139.13 10.72 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -132.66 116.98 17.31 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.583 1.953 . . . . 0.0 106.935 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.14 125.9 0.79 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? . . . . . 0 C--O 1.238 0.488 0 CA-C-N 118.06 0.93 . . . . 0.0 109.523 165.705 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 C--O 1.237 0.441 0 CA-C-O 121.319 0.58 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -144.22 164.83 29.6 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 127.214 2.205 . . . . 0.0 108.33 172.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -68.54 123.61 21.32 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -104.88 123.15 7.55 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 170.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -81.2 151.29 28.26 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.5 p -146.11 151.64 38.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -141.73 167.72 21.46 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.729 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 166.81 -172.7 42.04 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.8 149.55 31.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.628 0.714 . . . . 0.0 110.548 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.21 122.23 6.64 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 170.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -115.69 139.9 49.7 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -121.14 159.38 25.93 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.693 0.759 . . . . 0.0 109.886 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.5 170.54 8.0 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.825 1.65 . . . . 0.0 106.623 158.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -60.43 110.71 3.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.138 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.55 120.67 7.91 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.44 2.093 . . . . 0.0 108.805 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -177.06 164.7 2.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.932 1.242 . . . . 0.0 108.878 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 103.89 27.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.898 2.479 . . . . 0.0 109.051 154.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.94 15.91 10.22 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.689 1.595 . . . . 0.0 110.961 -169.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.73 171.33 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.7 159.65 39.03 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.375 1.87 . . . . 0.0 105.956 163.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -125.22 114.95 19.64 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 161.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -136.17 133.96 37.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 174.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -139.73 142.81 36.81 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 -172.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.8 m -146.53 165.26 29.99 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.592 -0.693 . . . . 0.0 111.318 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -140.0 129.26 23.88 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.727 2.411 . . . . 0.0 105.332 -171.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -137.81 108.2 6.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -99.22 111.61 23.95 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.1 m -76.82 150.88 36.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.452 0.701 . . . . 0.0 110.56 171.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.7 ptt85 -140.72 96.54 3.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.763 1.625 . . . . 0.0 106.91 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.2 mt -100.79 81.37 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 -175.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 56.75 -64.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 129.728 3.211 . . . . 0.0 113.575 -171.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 p -145.8 26.76 1.23 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.685 1.994 . . . . 0.0 110.107 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.8 t -123.27 103.4 12.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -82.3 131.99 35.23 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.7 101.18 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.73 115.43 4.34 Favored Glycine 0 C--O 1.242 0.604 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -174.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 57.4 m -107.85 142.29 38.14 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -141.72 141.3 33.27 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.0 pt -135.95 151.3 29.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.49 148.92 47.4 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.706 1.203 . . . . 0.0 108.57 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.36 94.53 0.2 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 124.924 1.249 . . . . 0.0 110.415 -169.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.25 171.87 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.552 1.941 . . . . 0.0 107.586 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.99 -116.12 0.7 Allowed Glycine 0 C--O 1.221 -0.666 0 O-C-N 119.913 -1.742 . . . . 0.0 108.87 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -163.81 163.42 23.9 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.958 1.879 . . . . 0.0 110.079 171.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -90.07 147.47 23.62 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.868 161.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 115.432 -2.223 . . . . 0.0 107.489 174.735 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.8 m -139.47 149.66 44.26 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m -106.73 107.09 17.93 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.435 1.494 . . . . 0.0 107.841 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.1 m -131.12 127.13 37.46 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.38 133.1 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 127.011 2.124 . . . . 0.0 105.915 -163.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.9 t -157.15 146.6 20.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.96 164.08 37.58 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.859 -1.697 . . . . 0.0 108.859 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.55 -154.72 23.54 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.77 159.33 41.67 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 109.142 -160.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.34 168.92 11.87 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.337 1.065 . . . . 0.0 113.767 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -125.0 117.49 24.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.407 1.483 . . . . 0.0 107.205 155.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.6 t -84.0 145.63 28.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 160.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -138.63 158.13 44.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.194 1.798 . . . . 0.0 107.944 -165.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.77 158.19 43.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 120.979 1.718 . . . . 0.0 111.31 159.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -78.76 56.76 1.94 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.685 0.755 . . . . 0.0 110.921 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.98 -39.13 0.2 Allowed Glycine 0 CA--C 1.519 0.282 0 O-C-N 120.06 -1.65 . . . . 0.0 110.434 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.55 96.36 2.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.681 0.753 . . . . 0.0 109.414 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.1 mtm -74.9 64.5 1.3 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.834 2.454 . . . . 0.0 108.195 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -66.33 102.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -64.17 98.04 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.881 1.272 . . . . 0.0 108.539 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 52.0 mtp -133.98 129.7 36.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.49 -145.47 4.13 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 170.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.04 -127.23 1.48 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 119.691 1.745 . . . . 0.0 110.668 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -132.58 121.17 22.83 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.983 1.313 . . . . 0.0 108.953 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -96.15 160.96 14.17 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.426 1.49 . . . . 0.0 110.107 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.95 139.86 29.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 162.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HZ2' ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -135.33 149.81 49.82 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 118.775 0.716 . . . . 0.0 109.875 165.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -149.45 110.08 4.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.58 119.64 33.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.99 157.12 16.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -130.09 153.19 48.73 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.837 0.855 . . . . 0.0 109.481 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.43 172.24 9.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.704 0.801 . . . . 0.0 110.538 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -101.99 -26.31 13.45 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.752 -1.218 . . . . 0.0 109.719 161.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.65 -25.29 53.61 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.3 m -152.17 157.23 34.07 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.739 1.215 . . . . 0.0 109.508 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.42 21.4 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.354 3.369 . . . . 0.0 113.515 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.6 tp -91.45 136.53 33.05 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.153 -0.967 . . . . 0.0 109.248 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.12 -168.61 12.48 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.816 1.198 . . . . 0.0 111.299 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.95 148.14 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.437 1.095 . . . . 0.0 110.657 -172.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.3 mm -119.3 119.76 61.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 127.077 2.151 . . . . 0.0 107.936 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.04 119.9 1.05 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 106.759 -2.536 . . . . 0.0 106.759 164.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.82 149.75 42.89 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.421 1.888 . . . . 0.0 106.584 175.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -144.13 128.41 17.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.9 m -126.51 132.07 51.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 168.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -91.44 150.17 21.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.4 p -98.1 138.34 35.55 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.01 163.95 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.176 1.39 . . . . 0.0 109.65 163.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.451 ' HB2' HD21 ' A' ' 58' ' ' ASN . 0.0 OUTLIER -152.27 113.79 4.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -170.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 m -115.73 103.75 10.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.382 1.087 . . . . 0.0 110.502 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 . . . . . 0 N--CA 1.444 -0.77 0 C-N-CA 129.344 3.057 . . . . 0.0 108.89 177.42 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 . . . . . 0 C--O 1.236 0.349 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.451 HD21 ' HB2' ' A' ' 48' ' ' LYS . 2.3 t30 -81.2 92.11 6.26 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -160.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -155.77 116.35 3.79 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.071 0.948 . . . . 0.0 108.961 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.425 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -149.66 -160.88 1.23 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 160.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.425 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 10.2 pt20 -126.86 128.8 47.08 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 164.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -97.31 114.04 25.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.67 117.84 29.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.88 96.68 0.96 Allowed Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.0 141.31 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 t -133.65 157.39 45.88 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 171.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.28 138.98 20.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.588 -0.695 . . . . 0.0 111.411 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.86 166.15 32.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.753 1.644 . . . . 0.0 109.314 160.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.428 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 66.7 Cg_endo -73.88 -177.96 3.5 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.734 2.289 . . . . 0.0 112.538 171.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.55 128.77 44.92 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.708 2.003 . . . . 0.0 108.032 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.1 130.29 28.84 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 ttp-105 -80.4 89.93 5.6 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.8 pp -93.29 1.57 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.244 1.018 . . . . 0.0 112.054 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -128.49 -178.28 4.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.941 1.696 . . . . 0.0 107.244 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -52.0 -67.53 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.72 2.008 . . . . 0.0 109.255 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.42 42.83 2.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.965 2.106 . . . . 0.0 110.559 -169.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.31 151.71 33.35 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.68 141.53 49.6 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.384 1.074 . . . . 0.0 109.422 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.48 154.82 6.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.234 1.413 . . . . 0.0 107.391 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.428 ' CE2' ' HD2' ' A' ' 69' ' ' PRO . 36.0 t80 -149.81 150.68 32.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.166 1.386 . . . . 0.0 107.857 169.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.26 109.84 3.35 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.2 m -103.76 161.8 4.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.967 0.907 . . . . 0.0 109.876 -167.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 t -109.08 131.07 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -116.34 159.88 13.68 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.53 150.84 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 170.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.97 158.3 21.4 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.946 1.736 . . . . 0.0 109.774 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -140.91 127.7 20.4 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.26 -171.66 16.64 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.0 pttt . . . . . 0 N--CA 1.483 1.181 0 C-N-CA 127.709 2.403 . . . . 0.0 112.919 160.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -94.91 151.76 18.93 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 164.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -95.1 110.6 22.52 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.155 1.382 . . . . 0.0 107.819 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.13 98.44 0.56 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.22 133.78 42.7 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.391 1.096 . . . . 0.0 108.296 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 p -133.06 173.62 11.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.351 1.072 . . . . 0.0 111.659 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -161.78 163.69 29.34 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.254 1.822 . . . . 0.0 106.353 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 177.18 -162.28 30.31 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -140.88 130.55 24.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 167.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.6 142.19 15.97 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 172.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.35 140.52 51.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.39 1.876 . . . . 0.0 108.539 -168.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.68 159.82 35.26 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.816 1.246 . . . . 0.0 110.769 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -91.87 171.09 9.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 168.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -56.92 154.21 19.88 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.793 168.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.98 109.91 0.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.254 0 N-CA-C 107.647 -1.713 . . . . 0.0 107.647 162.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.1 mmt -81.08 -174.97 5.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.974 2.11 . . . . 0.0 107.095 153.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -117.69 -4.24 11.21 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.359 -1.463 . . . . 0.0 110.736 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -137.45 0.14 2.25 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 124.561 1.144 . . . . 0.0 111.316 166.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.77 147.08 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 120.363 -1.461 . . . . 0.0 107.69 -162.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -143.62 153.06 42.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.456 1.903 . . . . 0.0 106.846 167.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -133.78 130.46 38.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 172.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.412 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS . 3.2 t70 -146.59 129.79 16.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 119.211 0.914 . . . . 0.0 109.176 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -149.65 151.9 34.5 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.512 0.596 . . . . 0.0 110.479 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.9 t -145.48 166.61 25.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.564 0.746 . . . . 0.0 110.338 173.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -143.57 106.13 4.45 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.595 1.958 . . . . 0.0 106.178 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -131.38 114.72 15.31 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -99.3 107.84 20.22 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -169.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.0 t -81.73 157.55 24.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.771 0.829 . . . . 0.0 108.833 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -130.0 129.07 43.26 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.0 mm -118.19 91.4 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -166.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.39 -82.71 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 126.156 1.782 . . . . 0.0 108.585 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.74 23.96 3.11 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.395 1.078 . . . . 0.0 112.551 171.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.94 148.79 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 119.413 1.006 . . . . 0.0 108.574 171.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.08 129.27 39.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.605 1.562 . . . . 0.0 107.652 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 79.6 t -136.82 92.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.866 1.666 . . . . 0.0 109.531 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.4 152.49 41.28 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.524 -0.735 . . . . 0.0 111.557 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.85 143.92 49.85 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 155.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -130.8 119.74 22.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.7 133.02 70.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.95 138.39 26.83 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -153.1 167.86 31.82 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 124.286 0.946 . . . . 0.0 110.926 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 m -140.3 168.33 17.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.084 1.353 . . . . 0.0 107.841 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -166.76 -103.85 0.17 Allowed Glycine 0 C--N 1.334 0.438 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.632 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -164.11 176.47 9.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.206 1.802 . . . . 0.0 109.511 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.11 145.05 35.26 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 168.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.0 p90 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 117.869 -1.062 . . . . 0.0 109.651 -179.233 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.477 0.18 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -141.7 141.31 33.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 121.414 -0.804 . . . . 0.0 108.987 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.07 107.01 11.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -95.75 139.74 31.55 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.431 HG13 ' H ' ' A' ' 146' ' ' TYR . 2.4 p -142.78 128.94 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.897 1.679 . . . . 0.0 107.524 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.6 p -138.51 163.56 31.68 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.453 0.569 . . . . 0.0 110.653 168.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.77 155.52 26.79 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.47 -165.43 37.95 Favored Glycine 0 C--O 1.236 0.272 0 O-C-N 121.793 -0.828 . . . . 0.0 112.75 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.74 157.58 16.39 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.246 1.018 . . . . 0.0 110.087 -169.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.79 162.89 34.05 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.921 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -143.73 154.34 43.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.331 1.053 . . . . 0.0 108.222 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 t -115.12 151.13 34.88 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 162.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.33 170.75 12.15 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.272 2.229 . . . . 0.0 105.296 160.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.91 164.49 28.19 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.5 -0.75 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -74.04 85.35 1.8 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 159.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.83 90.41 0.45 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.48 94.74 0.29 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 122.302 1.048 . . . . 0.0 109.74 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -151.21 -58.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.208 1.803 . . . . 0.0 108.03 170.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -63.69 103.92 0.61 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.168 1.387 . . . . 0.0 109.266 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -129.81 75.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 161.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -81.47 161.32 23.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.739 1.616 . . . . 0.0 109.282 164.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.93 179.88 40.93 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 108.209 -1.957 . . . . 0.0 108.209 171.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.74 -163.63 30.26 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 118.285 1.043 . . . . 0.0 111.858 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -99.62 153.97 18.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.24 1.416 . . . . 0.0 108.747 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -137.93 153.26 49.51 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.873 1.669 . . . . 0.0 107.648 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.6 mt -133.41 148.29 51.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 162.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -125.92 127.22 45.65 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 164.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -155.64 108.43 2.69 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -169.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -141.18 165.93 26.18 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.845 1.258 . . . . 0.0 108.707 -171.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -111.35 157.2 20.48 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -107.71 149.57 27.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 168.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.54 151.27 41.89 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 170.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.54 2.85 55.67 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.342 -0.849 . . . . 0.0 110.886 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -141.44 -70.32 0.36 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.47 1.508 . . . . 0.0 109.277 -153.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.1 t -72.67 122.83 88.58 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 167.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.47 68.28 6.94 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.629 2.22 . . . . 0.0 111.229 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 tp -142.35 121.61 13.06 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.932 1.293 . . . . 0.0 109.234 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -103.84 178.48 24.9 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -127.74 157.41 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.3 mm -124.94 151.62 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.93 1.692 . . . . 0.0 107.399 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.94 108.68 0.37 Allowed Glycine 0 C--N 1.336 0.563 0 O-C-N 120.136 -1.603 . . . . 0.0 111.372 159.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -67.46 151.65 47.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 166.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -136.51 103.04 5.12 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -92.99 150.84 20.27 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -172.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.2 157.76 40.92 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.413 1.085 . . . . 0.0 109.757 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 m -99.81 130.47 46.01 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 160.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -135.63 -56.59 0.79 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.544 1.938 . . . . 0.0 106.619 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.68 113.73 5.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.325 1.45 . . . . 0.0 107.508 174.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -101.6 155.59 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.059 2.143 . . . . 0.0 109.435 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.502 ' H ' ' HB2' ' A' ' 58' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 164.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.235 0.336 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.502 ' HB2' ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -124.77 98.92 5.92 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 170.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -115.12 147.65 39.97 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 72.86 -177.84 0.19 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.59 2.356 . . . . 0.0 110.838 -168.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -124.99 163.74 21.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.078 1.751 . . . . 0.0 108.403 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.69 142.35 29.1 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -130.41 118.52 21.32 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.57 166.26 19.43 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 122.43 1.017 . . . . 0.0 112.235 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.7 142.83 42.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 167.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.9 m -139.79 130.95 26.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.88 164.55 31.61 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.617 0.767 . . . . 0.0 110.09 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.14 162.53 10.76 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 126.667 2.08 . . . . 0.0 107.993 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.05 156.62 38.44 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.576 1.517 . . . . 0.0 111.745 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.59 104.06 16.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 157.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -103.14 117.55 34.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -66.94 146.95 53.85 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.82 0.448 . . . . 0.0 110.469 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 pt -141.99 164.05 18.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.8 0.81 . . . . 0.0 111.168 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 t30 65.49 -74.87 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 130.448 3.499 . . . . 0.0 113.072 164.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -132.02 -56.48 0.98 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 117.074 -1.441 . . . . 0.0 109.372 165.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -151.67 27.02 0.65 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.117 1.767 . . . . 0.0 111.037 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.65 172.2 8.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.365 1.466 . . . . 0.0 110.263 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -127.83 168.98 14.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.724 1.609 . . . . 0.0 110.773 -173.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.31 162.1 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.67 1.188 . . . . 0.0 110.77 -172.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -104.65 124.72 49.84 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 127.731 2.412 . . . . 0.0 108.564 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.69 42.76 0.08 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.7 m -104.95 164.34 3.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.74 140.04 28.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -161.32 172.81 37.63 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-O 121.612 0.562 . . . . 0.0 112.789 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.69 149.09 16.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.63 145.15 18.56 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 166.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -135.04 152.15 51.44 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.635 1.574 . . . . 0.0 108.316 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.97 -156.43 12.83 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt . . . . . 0 C--O 1.235 0.336 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.789 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.236 0.371 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -85.69 138.72 31.93 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.061 0.944 . . . . 0.0 109.212 -173.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.97 126.7 49.16 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.054 1.341 . . . . 0.0 107.903 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.66 83.41 0.28 Allowed Glycine 0 CA--C 1.522 0.483 0 CA-C-N 119.078 0.853 . . . . 0.0 111.624 -173.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -74.35 141.16 45.19 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.76 1.224 . . . . 0.0 109.364 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.66 -150.31 0.15 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.984 0.811 . . . . 0.0 110.622 154.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -128.18 162.49 26.83 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.321 1.848 . . . . 0.0 110.001 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.71 -176.2 15.12 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.755 0.693 . . . . 0.0 112.461 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.22 174.22 6.64 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.944 1.698 . . . . 0.0 111.232 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -157.86 84.37 0.13 Allowed Glycine 0 C--N 1.342 0.865 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.643 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.13 139.61 49.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.178 0.989 . . . . 0.0 108.746 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -137.43 159.37 42.12 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.091 1.356 . . . . 0.0 107.674 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -92.85 170.71 9.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 119.619 1.1 . . . . 0.0 108.38 171.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -61.27 104.49 0.47 Allowed Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.439 1.096 . . . . 0.0 110.524 -170.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.15 106.64 2.31 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.642 2.228 . . . . 0.0 109.908 -166.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.7 ptm -164.68 169.77 16.47 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.406 0.548 . . . . 0.0 110.774 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 63.69 35.65 11.29 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.601 1.16 . . . . 0.0 108.67 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 60.01 14.11 4.16 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.864 1.266 . . . . 0.0 113.318 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.26 110.43 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 123.734 1.73 . . . . 0.0 109.309 171.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -113.9 110.25 19.79 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.229 2.612 . . . . 0.0 106.395 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.37 131.66 34.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.78 148.76 42.68 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.727 0.694 . . . . 0.0 110.594 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -143.35 150.7 39.52 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.99 1.316 . . . . 0.0 108.51 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 p -144.08 152.99 41.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.657 0.741 . . . . 0.0 111.367 152.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -108.18 125.09 51.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.144 2.177 . . . . 0.0 105.733 168.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -136.61 145.24 44.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.238 1.815 . . . . 0.0 107.873 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -127.29 161.67 28.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.729 0.775 . . . . 0.0 110.993 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 p -141.22 159.89 41.26 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.831 2.052 . . . . 0.0 108.084 170.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -128.79 114.93 17.18 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 87.2 mt -105.9 98.03 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.18 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 129.179 2.992 . . . . 0.0 109.893 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.5 p -137.78 20.76 2.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.471 1.108 . . . . 0.0 111.245 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.82 115.71 50.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 167.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.29 130.46 40.84 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 168.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.4 t -135.49 112.35 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -172.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.25 144.92 16.94 Favored Glycine 0 C--O 1.238 0.357 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -169.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.3 p -138.0 148.85 45.57 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.436 0.695 . . . . 0.0 110.218 -164.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -121.18 150.27 41.55 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 166.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.45 131.45 65.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.83 131.79 20.3 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.666 0.786 . . . . 0.0 109.045 -171.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -161.97 173.52 38.32 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 114.599 0.6 . . . . 0.0 114.599 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.0 178.06 2.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.951 2.1 . . . . 0.0 108.78 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 167.67 -165.15 38.49 Favored Glycine 0 C--O 1.217 -0.952 0 O-C-N 120.545 -1.347 . . . . 0.0 110.367 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.431 ' H ' HG13 ' A' ' 5' ' ' VAL . 51.4 m-85 -104.92 175.45 5.49 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -166.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.87 130.32 19.98 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 120.813 -1.18 . . . . 0.0 108.13 170.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.191 1.396 . . . . 0.0 107.848 -179.112 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.6 p -132.79 157.17 45.64 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 149.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.85 106.71 4.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.133 0.973 . . . . 0.0 108.822 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -134.35 125.55 27.83 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.985 -1.072 . . . . 0.0 109.095 -168.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.38 112.85 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.468 1.107 . . . . 0.0 108.663 -168.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.5 p -149.15 123.58 9.67 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.927 0.891 . . . . 0.0 109.14 -166.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.34 158.53 27.71 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.794 1.187 . . . . 0.0 111.463 176.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.25 -139.35 5.09 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -167.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -150.33 154.93 38.69 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 117.668 0.734 . . . . 0.0 110.97 -166.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.93 160.19 39.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.461 1.105 . . . . 0.0 111.03 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -132.73 114.12 13.77 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -84.96 144.35 28.38 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.866 0.866 . . . . 0.0 109.004 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -138.39 119.31 14.29 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.34 1.856 . . . . 0.0 109.357 -173.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.03 166.45 19.76 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.499 1.12 . . . . 0.0 110.765 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -39.27 -20.33 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.275 2.63 . . . . 0.0 115.948 169.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.26 -108.7 0.56 Allowed Glycine 0 C--N 1.338 0.659 0 CA-C-N 120.192 1.36 . . . . 0.0 110.584 167.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -141.14 101.81 4.11 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.719 1.26 . . . . 0.0 109.311 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 58.2 mtp -130.32 -75.09 0.54 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.17 99.28 3.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -78.61 132.06 36.96 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 ptp -133.99 149.16 51.2 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.07 177.46 47.69 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.73 -162.41 28.19 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -171.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.06 110.16 22.46 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -170.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -95.69 150.81 19.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.049 -1.464 . . . . 0.0 107.049 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.33 145.03 20.12 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -170.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -132.87 150.11 52.19 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.68 139.62 50.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 170.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -129.53 109.0 10.67 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -115.9 132.5 56.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.59 153.12 45.96 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.777 1.631 . . . . 0.0 107.532 172.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -141.64 155.57 45.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -69.46 -19.97 63.76 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.538 -0.726 . . . . 0.0 110.146 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -21.05 65.98 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 125.548 1.539 . . . . 0.0 112.83 173.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -152.12 90.16 3.85 Favored Pre-proline 0 C--O 1.238 0.448 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.61 64.73 4.73 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.226 2.618 . . . . 0.0 112.012 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.86 125.58 10.4 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 167.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.05 174.19 54.59 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 118.555 0.616 . . . . 0.0 111.859 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.0 t -132.39 148.37 31.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.938 1.695 . . . . 0.0 107.659 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.33 120.74 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 126.592 1.957 . . . . 0.0 106.231 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.78 127.59 4.13 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 168.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 t -125.98 154.9 42.23 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.618 1.167 . . . . 0.0 110.729 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -112.68 140.3 47.56 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.905 0.882 . . . . 0.0 109.01 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.7 m -118.3 116.04 25.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.038 1.335 . . . . 0.0 107.973 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -112.9 149.68 32.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.232 1.413 . . . . 0.0 109.353 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -123.95 122.43 37.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -136.73 88.93 2.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -174.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -150.7 134.58 16.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.402 1.081 . . . . 0.0 109.288 -161.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.8 p -131.24 122.56 26.72 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.654 1.182 . . . . 0.0 112.155 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 . . . . . 0 C--O 1.224 -0.251 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 162.251 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -81.24 66.53 6.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.391 0.615 . . . . 0.0 109.401 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -134.49 115.72 14.27 Favored 'General case' 0 CA--C 1.523 -0.06 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -158.93 161.78 36.79 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.692 1.997 . . . . 0.0 106.514 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -112.7 128.16 56.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 168.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -107.96 138.32 44.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 170.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -141.39 163.89 31.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.21 169.97 34.35 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.68 143.96 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 t -141.19 127.84 20.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.84 139.1 48.74 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.428 0.558 . . . . 0.0 110.978 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -172.97 167.16 39.92 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 163.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.22 177.79 8.16 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.589 2.193 . . . . 0.0 110.163 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.18 107.31 6.04 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.839 1.256 . . . . 0.0 107.63 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.19 148.66 22.21 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -91.34 142.76 27.35 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 122.074 -0.391 . . . . 0.0 110.308 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.3 mt -83.51 -102.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -129.76 12.04 5.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.487 1.515 . . . . 0.0 109.919 172.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -157.75 -178.41 7.3 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.851 -1.156 . . . . 0.0 112.865 -158.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -69.82 16.56 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.534 2.334 . . . . 0.0 114.292 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.97 141.0 48.7 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.6 1.16 . . . . 0.0 108.537 167.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 p -146.66 120.17 9.09 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.1 149.97 23.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -150.32 171.96 16.14 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.05 0.94 . . . . 0.0 108.922 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.28 150.16 38.33 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 164.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.72 165.49 28.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.284 1.034 . . . . 0.0 108.954 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.62 131.33 73.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.12 156.68 21.34 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.55 150.09 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.51 154.4 20.37 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -132.53 140.24 48.23 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.612 1.965 . . . . 0.0 108.434 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.39 171.67 32.12 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -174.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.397 0 C-N-CA 127.286 2.234 . . . . 0.0 107.657 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.466 0.333 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -149.59 151.66 34.17 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.55 0.691 . . . . 0.0 110.722 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -105.18 125.4 50.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 129.082 2.953 . . . . 0.0 106.991 -165.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.21 105.64 3.31 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.99 139.19 42.76 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.8 m -133.82 177.16 7.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.178 0.991 . . . . 0.0 109.401 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -168.12 167.8 12.18 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.937 2.095 . . . . 0.0 107.464 159.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.73 -166.33 35.19 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.08 158.49 44.28 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.77 1.228 . . . . 0.0 108.681 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.3 113.63 3.32 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.85 140.57 49.75 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.516 1.158 . . . . 0.0 109.35 -166.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -117.42 134.78 54.45 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.553 0.741 . . . . 0.0 109.957 -171.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.45 171.07 9.14 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -57.08 118.17 22.41 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.936 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.82 170.09 15.85 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.022 2.481 . . . . 0.0 112.612 170.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 46.3 mtt -152.98 162.95 40.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 130.03 3.332 . . . . 0.0 106.684 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.55 -4.84 1.5 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 129.178 2.991 . . . . 0.0 114.413 -171.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -145.21 8.89 1.23 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.087 0.955 . . . . 0.0 111.51 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.24 139.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 120.221 1.373 . . . . 0.0 108.842 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.9 154.1 38.97 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 119.907 -1.746 . . . . 0.0 107.566 161.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 132.88 46.13 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -140.98 130.69 24.17 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -129.31 151.25 50.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.48 1.112 . . . . 0.0 108.409 -173.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.96 162.42 37.85 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.636 0.732 . . . . 0.0 109.722 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -130.93 136.64 48.76 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -136.72 132.46 34.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 103.944 -2.614 . . . . 0.0 103.944 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -99.41 154.61 18.08 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 170.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 72.2 m -135.42 149.04 49.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -137.8 118.82 14.36 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 61.3 mt -123.38 105.5 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.68 50.89 17.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.076 1.35 . . . . 0.0 113.28 169.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.7 10.13 3.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.207 1.403 . . . . 0.0 111.518 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.63 119.5 43.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 166.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -71.67 133.14 45.46 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.9 t -133.25 157.06 42.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.25 152.19 23.11 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -140.26 153.9 46.66 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 167.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -136.35 118.74 15.73 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.7 mt -99.75 136.13 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.004 1.722 . . . . 0.0 107.35 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.32 139.62 35.47 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.32 163.05 36.61 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.9 m -139.08 173.54 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.001 1.32 . . . . 0.0 109.426 -172.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 180.0 -99.6 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-O 118.337 -1.257 . . . . 0.0 109.989 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -152.51 173.85 14.64 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.308 1.443 . . . . 0.0 110.513 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.2 tpt85 -133.3 150.97 51.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 162.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.6 p90 . . . . . 0 C--O 1.254 1.301 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 165.113 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.687 0.279 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.95 146.66 26.41 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 174.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.42 ' C ' ' HG1' ' A' ' 4' ' ' THR . 14.6 m -93.07 145.9 24.05 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.725 0.774 . . . . 0.0 109.113 165.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.42 ' HG1' ' C ' ' A' ' 3' ' ' SER . 18.1 m -153.72 125.71 7.84 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 119.565 -1.959 . . . . 0.0 110.041 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.71 127.61 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.688 0.795 . . . . 0.0 110.958 -170.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 p -139.18 119.99 14.3 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.402 1.081 . . . . 0.0 109.293 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.31 164.13 31.83 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.022 1.296 . . . . 0.0 110.49 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.17 -117.39 0.62 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -168.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -149.68 158.92 44.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.857 0.863 . . . . 0.0 109.735 -169.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.22 152.97 34.67 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.949 1.3 . . . . 0.0 107.802 168.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -142.37 154.37 44.58 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.291 0.636 . . . . 0.0 109.602 162.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 p -139.4 147.06 40.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 128.186 2.594 . . . . 0.0 107.46 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -126.82 113.37 16.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.595 0.712 . . . . 0.0 110.561 -155.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.62 106.14 1.39 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.337 1.055 . . . . 0.0 112.906 -156.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 64.44 8.46 4.3 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.922 1.689 . . . . 0.0 113.391 162.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.18 -101.32 0.23 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 104.178 -3.569 . . . . 0.0 104.178 -169.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -141.08 130.69 24.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 160.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.8 ttp -157.75 -34.91 0.07 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.383 0.427 . . . . 0.0 110.481 155.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -129.17 152.8 48.36 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 126.414 1.886 . . . . 0.0 106.424 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -123.51 80.93 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 171.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -67.61 129.4 39.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.89 176.04 29.6 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.79 -156.36 12.63 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 -171.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -98.55 156.16 16.93 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.391 1.096 . . . . 0.0 109.476 -169.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.77 144.43 41.6 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 124.278 1.031 . . . . 0.0 109.223 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -161.54 126.57 3.52 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -121.96 151.74 40.43 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 109.492 170.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -120.87 139.71 52.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -133.92 157.68 45.4 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 122.888 0.475 . . . . 0.0 110.064 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.71 157.67 38.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 173.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -108.89 125.1 51.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 154.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.76 173.04 3.75 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -117.06 37.68 3.76 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 169.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -148.72 -78.98 0.14 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 m -65.12 143.39 98.84 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.75 29.48 0.38 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.825 3.684 . . . . 0.0 110.972 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 tp -117.34 155.86 28.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.362 1.865 . . . . 0.0 108.791 -168.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.78 -172.99 13.83 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 168.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.1 t -139.56 142.33 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.91 152.91 38.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 163.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.0 136.08 4.2 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 105.021 -3.232 . . . . 0.0 105.021 165.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 t -124.56 142.89 51.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 117.922 0.861 . . . . 0.0 108.874 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -92.35 140.11 29.93 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.282 0.633 . . . . 0.0 110.211 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.89 130.02 37.74 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 167.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -116.84 156.43 27.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 156.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.7 m -138.3 122.2 17.74 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.68 42.26 2.18 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.528 1.931 . . . . 0.0 108.951 -164.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.412 ' H ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -65.3 138.54 58.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.003 1.321 . . . . 0.0 107.92 -175.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.5 p -130.39 155.06 47.03 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.196 0.522 . . . . 0.0 111.871 -169.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 C-N-CA 124.861 1.264 . . . . 0.0 111.887 -175.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.1 t80 . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -56.29 140.19 45.74 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -116.65 168.48 10.15 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.573 0.701 . . . . 0.0 110.936 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 8.2 t30 45.0 -165.44 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 130.081 3.352 . . . . 0.0 113.526 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.481 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 12.3 pt20 -135.53 149.11 49.37 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.715 1.206 . . . . 0.0 108.759 -169.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -103.84 140.01 38.25 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 169.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -140.46 118.13 11.64 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.87 139.34 15.05 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.35 117.08 38.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.8 p -105.02 159.4 15.85 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.263 1.025 . . . . 0.0 109.629 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.18 144.02 28.64 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.027 -1.046 . . . . 0.0 109.703 164.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.76 121.07 1.36 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.66 127.64 21.22 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 N-CA-C 106.471 -2.165 . . . . 0.0 106.471 157.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.58 103.65 16.22 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.25 155.01 20.26 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 164.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -106.1 150.78 25.47 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.696 1.598 . . . . 0.0 106.801 161.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.1 mm -77.92 -104.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -129.54 7.29 5.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.986 1.267 . . . . 0.0 112.207 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -136.52 10.19 3.18 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.688 2.395 . . . . 0.0 111.894 -155.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 66.8 m95 51.03 70.58 0.51 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.507 1.523 . . . . 0.0 110.013 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.07 -169.03 1.89 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.435 1.894 . . . . 0.0 109.162 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 t -126.57 169.7 12.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.131 2.172 . . . . 0.0 106.365 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 tp -134.16 157.78 41.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.705 1.602 . . . . 0.0 108.494 -171.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -103.0 176.08 5.26 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 128.064 2.546 . . . . 0.0 109.097 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.16 53.23 2.87 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.71 160.66 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 m -95.45 154.43 3.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 121.561 -0.712 . . . . 0.0 109.676 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.67 134.63 4.82 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.89 129.17 68.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -118.71 115.09 3.0 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -168.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -121.15 123.71 42.96 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.064 0.932 . . . . 0.0 110.294 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.5 161.65 8.79 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.1 tttt . . . . . 0 C--O 1.233 0.211 0 C-N-CA 126.275 1.83 . . . . 0.0 106.899 -170.378 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.2 135.24 38.96 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -145.87 157.1 43.92 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.647 1.979 . . . . 0.0 108.016 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.32 160.56 33.2 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.371 0.986 . . . . 0.0 110.642 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -138.33 151.95 48.02 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 128.632 2.773 . . . . 0.0 109.111 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 m -170.31 -146.83 0.05 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.949 2.499 . . . . 0.0 108.748 159.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -136.94 177.51 7.8 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.942 1.697 . . . . 0.0 109.376 -171.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.38 177.19 37.79 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 121.285 -0.885 . . . . 0.0 113.657 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.63 161.89 14.17 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.008 0.923 . . . . 0.0 111.341 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.33 84.81 0.15 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.03 159.93 20.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.828 0.851 . . . . 0.0 109.767 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.04 154.97 43.07 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.067 1.347 . . . . 0.0 108.424 170.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -92.54 170.07 10.03 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -56.05 130.82 74.03 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.84 127.17 18.05 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -87.64 -175.19 5.1 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 152.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -109.97 -25.6 10.18 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 126.932 2.093 . . . . 0.0 108.458 -173.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.97 5.56 10.4 Favored 'General case' 0 C--O 1.225 -0.188 0 O-C-N 121.067 -1.021 . . . . 0.0 109.357 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.1 t -137.45 144.54 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.51 153.26 51.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.156 1.382 . . . . 0.0 108.56 164.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -143.98 115.86 8.29 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.908 1.683 . . . . 0.0 108.696 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.32 148.04 44.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.951 2.1 . . . . 0.0 109.405 173.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -137.32 122.99 19.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.84 1.256 . . . . 0.0 109.123 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 t -139.54 151.77 46.37 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.516 1.126 . . . . 0.0 108.219 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -149.81 145.17 26.45 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -137.8 165.22 26.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.971 1.709 . . . . 0.0 108.772 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -119.9 159.55 24.44 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.216 -1.553 . . . . 0.0 110.633 169.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 t -140.43 159.82 41.36 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 170.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -141.11 97.85 3.26 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.69 83.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 54.62 48.97 19.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.263 1.025 . . . . 0.0 111.73 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 m 62.4 5.14 1.49 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.534 1.534 . . . . 0.0 114.876 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.7 t -82.2 148.74 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 121.169 1.804 . . . . 0.0 107.232 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 t70 78.02 -59.27 0.44 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.56 2.744 . . . . 0.0 113.032 171.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.4 t 68.82 -72.83 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 127.868 2.467 . . . . 0.0 113.089 165.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.15 116.18 1.09 Allowed Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.2 t -106.11 150.71 25.54 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.954 0.883 . . . . 0.0 109.466 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -134.9 133.28 39.46 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.5 pt -130.41 159.57 42.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.98 150.01 50.58 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.526 1.53 . . . . 0.0 109.27 -171.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -153.85 106.62 0.3 Allowed Glycine 0 C--O 1.22 -0.775 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.85 167.13 24.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 118.848 1.324 . . . . 0.0 109.213 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.59 -122.29 1.06 Allowed Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -163.14 177.21 9.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.445 1.898 . . . . 0.0 109.556 -167.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -121.54 163.12 19.38 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.211 -0.931 . . . . 0.0 111.239 171.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . 0.258 0.0 OUTLIER . . . . . 0 C--O 1.251 1.173 0 CA-C-O 116.521 -1.704 . . . . 0.0 107.475 160.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 115.829 -2.034 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -139.14 152.04 47.12 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 123.335 2.788 . . . . 0.0 109.928 -163.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m -143.53 160.04 41.35 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 161.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -142.93 105.11 4.42 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 119.689 -1.882 . . . . 0.0 107.939 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 m -92.69 138.2 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.524 1.529 . . . . 0.0 107.273 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 m -148.92 143.72 26.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 168.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.47 164.19 32.41 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.44 -111.9 0.47 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -173.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -124.87 158.38 33.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.373 1.087 . . . . 0.0 111.018 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.51 133.26 34.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 128.517 2.727 . . . . 0.0 104.03 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -140.0 131.89 27.65 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 164.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -85.27 151.2 24.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 161.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.74 169.96 16.86 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.121 1.368 . . . . 0.0 107.693 160.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.92 40.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.345 1.43 . . . . 0.0 109.603 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -70.75 97.62 1.4 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.038 0.923 . . . . 0.0 110.821 -168.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.48 -26.06 3.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 127.592 2.52 . . . . 0.0 109.419 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -146.79 96.07 2.69 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.481 1.512 . . . . 0.0 107.059 -170.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -76.82 61.01 1.83 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.307 1.043 . . . . 0.0 109.187 172.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -70.74 99.11 1.64 Allowed 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 124.995 1.318 . . . . 0.0 107.538 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -70.47 108.51 4.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -136.75 130.95 32.75 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.26 -173.5 44.53 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -161.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.88 -94.24 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -149.64 137.95 20.63 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -101.19 148.84 24.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.673 1.589 . . . . 0.0 109.487 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.86 136.65 27.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.733 1.213 . . . . 0.0 107.881 163.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.07 150.81 50.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.44 1.096 . . . . 0.0 108.274 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -135.88 122.28 20.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -107.69 128.55 54.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -99.06 147.95 24.53 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 167.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -111.54 114.51 27.64 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 156.46 37.11 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.09 -20.54 17.93 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.276 1.031 . . . . 0.0 110.345 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.12 -8.16 59.71 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -170.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.37 163.28 18.61 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.99 -7.92 19.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.082 1.855 . . . . 0.0 112.775 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 tp -81.45 139.53 35.16 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.883 1.219 . . . . 0.0 109.655 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.32 -169.57 13.09 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.881 1.229 . . . . 0.0 110.445 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.47 150.29 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.807 0.843 . . . . 0.0 109.437 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.6 tp -135.8 141.77 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.24 145.53 11.08 Favored Glycine 0 C--O 1.239 0.408 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.6 m -112.08 141.14 46.12 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -170.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -111.95 115.3 28.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.4 m -91.47 150.89 21.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -140.47 142.31 35.35 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 160.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.2 m -143.06 133.59 24.96 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.957 0.903 . . . . 0.0 109.57 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -130.27 171.15 13.22 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 149.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -157.66 146.37 19.43 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 p -79.06 107.07 11.55 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 157.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 167.172 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.71 111.99 24.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -165.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -113.68 130.4 56.42 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -171.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -160.17 165.95 30.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.577 1.551 . . . . 0.0 110.045 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.14 140.79 49.08 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 162.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -107.95 123.34 48.49 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -126.08 135.74 52.09 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 163.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.92 95.05 0.32 Allowed Glycine 0 C--N 1.331 0.278 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -174.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.6 mt -77.45 108.99 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 p -131.35 128.21 39.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.593 1.957 . . . . 0.0 106.637 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.62 174.03 13.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.737 0.415 . . . . 0.0 111.396 -172.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.87 176.57 48.09 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 123.34 0.495 . . . . 0.0 113.072 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.73 129.73 10.17 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.89 3.06 . . . . 0.0 109.421 168.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.74 149.09 22.17 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.629 0.772 . . . . 0.0 110.044 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -141.29 127.43 19.6 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.071 0.948 . . . . 0.0 108.683 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.6 120.32 16.05 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 125.164 1.385 . . . . 0.0 109.625 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mp -67.67 165.99 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.744 1.618 . . . . 0.0 107.161 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -79.03 14.64 1.34 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.524 -1.36 . . . . 0.0 112.313 -174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -139.13 60.87 1.58 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.471 1.508 . . . . 0.0 108.485 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 57.2 m95 58.35 -16.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 129.079 2.951 . . . . 0.0 117.716 170.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.52 161.12 29.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.492 1.117 . . . . 0.0 108.758 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.2 p -142.93 115.98 8.87 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 117.657 -1.163 . . . . 0.0 108.478 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 mp -142.1 151.26 18.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.09 1.356 . . . . 0.0 108.297 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -150.29 173.95 13.4 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.84 1.256 . . . . 0.0 109.1 160.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.21 140.46 27.51 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.34 143.8 37.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.196 0.998 . . . . 0.0 108.731 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.95 165.41 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.062 0.945 . . . . 0.0 109.819 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 177.25 -162.62 30.79 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.884 -166.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.69 139.89 19.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.579 0.751 . . . . 0.0 109.287 173.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.51 146.41 16.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 125.403 1.478 . . . . 0.0 109.466 168.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 3.7 p90 -149.37 166.96 27.47 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 122.095 -0.65 . . . . 0.0 111.926 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.64 -93.96 0.1 OUTLIER Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 149.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.19 0 C-N-CA 128.557 2.743 . . . . 0.0 108.813 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.8 m . . . . . 0 CA--C 1.533 0.317 0 CA-C-O 121.526 0.679 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 45.5 p30 -161.69 176.02 11.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.404 3.082 . . . . 0.0 109.586 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 54.83 17.27 1.71 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.904 2.081 . . . . 0.0 114.959 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.97 104.33 1.31 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.21 148.52 45.48 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.5 p -136.79 161.19 36.66 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.621 0.725 . . . . 0.0 111.518 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.57 157.23 37.96 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.497 1.519 . . . . 0.0 108.957 174.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.02 -168.3 37.91 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.881 1.705 . . . . 0.0 108.987 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.68 152.1 51.8 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.1 116.85 4.08 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -115.64 139.71 49.86 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -166.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.66 145.55 38.59 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 120.916 -1.115 . . . . 0.0 109.4 -172.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -93.15 164.4 13.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -56.86 103.92 0.39 Allowed Pre-proline 0 CA--C 1.528 0.125 0 C-N-CA 125.062 1.345 . . . . 0.0 110.579 -166.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.14 120.26 5.64 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.37 1.38 . . . . 0.0 109.058 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.7 mtm 166.9 153.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 129.917 3.287 . . . . 0.0 105.682 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 113.96 28.2 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 129.767 3.227 . . . . 0.0 107.494 160.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.9 t30 44.08 26.69 0.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.372 1.469 . . . . 0.0 113.727 -153.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.64 169.3 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 108.477 160.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.89 135.89 5.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.016 2.926 . . . . 0.0 103.155 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.22 146.87 46.85 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -172.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -141.16 152.94 45.09 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.243 1.017 . . . . 0.0 109.196 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -150.34 114.76 5.18 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.38 2.272 . . . . 0.0 105.603 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.1 m -118.3 154.23 32.66 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 168.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.49 120.85 11.62 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -136.61 136.11 38.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.234 1.413 . . . . 0.0 108.792 -168.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -100.05 150.68 22.21 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.799 0.84 . . . . 0.0 109.31 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.3 m -133.87 160.05 38.82 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.824 1.65 . . . . 0.0 108.039 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.52 97.79 4.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.907 1.283 . . . . 0.0 111.208 -166.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.4 mt -134.31 89.03 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.093 0.957 . . . . 0.0 108.888 -166.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.22 -161.31 0.18 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.5 m -77.34 58.55 1.68 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.543 1.065 . . . . 0.0 109.438 168.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.65 149.42 33.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 170.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -122.2 80.46 1.72 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.842 0.746 . . . . 0.0 110.766 -174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.9 t -78.99 96.55 2.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.931 1.693 . . . . 0.0 108.887 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.66 144.65 23.27 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 164.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.12 152.83 45.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 172.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -140.87 147.65 39.26 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 164.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.02 150.47 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.64 166.11 26.12 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.681 0.792 . . . . 0.0 108.9 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.18 178.77 47.14 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.642 -0.789 . . . . 0.0 114.107 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.5 163.33 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 127.783 2.433 . . . . 0.0 107.042 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -166.56 -119.25 0.47 Allowed Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -163.17 164.39 25.23 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.579 1.19 . . . . 0.0 110.711 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -91.36 125.93 36.28 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 116.865 -1.54 . . . . 0.0 107.613 164.615 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 t -150.42 142.08 23.62 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 120.728 -1.232 . . . . 0.0 108.937 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -140.71 106.86 5.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.801 0.81 . . . . 0.0 109.419 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.1 p -104.84 129.01 53.24 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 p -91.7 145.28 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 165.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 t -158.14 161.07 37.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.89 173.72 27.66 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.07 -162.06 34.84 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -171.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -91.6 144.5 25.47 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -172.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HB1' ' H ' ' A' ' 23' ' ' GLY . . . -95.57 134.92 37.89 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.5 104.14 5.26 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 127.394 2.278 . . . . 0.0 106.552 -175.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 t -84.66 140.64 31.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.286 1.434 . . . . 0.0 107.393 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -138.78 126.89 22.6 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.059 1.744 . . . . 0.0 106.798 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.85 147.45 43.93 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.778 1.626 . . . . 0.0 107.613 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -63.24 92.58 0.06 Allowed 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 124.052 0.845 . . . . 0.0 108.722 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.84 41.72 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-O 117.434 -1.759 . . . . 0.0 111.922 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -150.76 94.91 2.14 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 157.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.6 mtt -76.73 57.26 1.25 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.882 2.873 . . . . 0.0 109.441 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -71.41 101.57 2.44 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -63.13 102.4 0.37 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.64 159.61 41.3 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.166 1.787 . . . . 0.0 106.983 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.11 -176.37 17.8 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -171.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' H ' ' HB1' ' A' ' 10' ' ' ALA . . . -163.69 -137.4 2.18 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 -164.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.76 157.69 25.1 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.211 1.506 . . . . 0.0 109.469 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -134.57 148.59 50.5 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.894 1.678 . . . . 0.0 107.995 -173.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.95 124.95 19.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -120.55 132.56 55.22 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -155.61 106.52 2.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -166.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 164.91 28.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.999 0.428 . . . . 0.0 110.88 -173.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -125.4 157.74 36.06 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.061 2.144 . . . . 0.0 106.59 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -128.79 159.94 34.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 168.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -136.12 125.84 25.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -67.41 1.46 2.24 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.933 1.293 . . . . 0.0 113.203 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -55.73 -27.07 48.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.723 0.809 . . . . 0.0 111.376 159.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.7 m -147.44 107.04 3.82 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 169.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.99 78.01 2.26 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.487 2.791 . . . . 0.0 109.713 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.41 126.31 10.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 128.83 2.852 . . . . 0.0 105.433 173.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.39 176.87 48.58 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.23 146.78 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.1 mm -138.44 116.27 12.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -170.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.09 124.05 1.75 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 107.009 -2.436 . . . . 0.0 107.009 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 p -122.71 153.92 38.79 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.129 1.771 . . . . 0.0 107.557 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -129.49 120.21 25.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -160.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.9 p -119.69 115.15 23.34 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.906 0.776 . . . . 0.0 110.07 -152.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.93 153.85 32.9 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.307 -0.871 . . . . 0.0 110.954 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.5 t -131.58 122.34 25.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.913 0.885 . . . . 0.0 109.035 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -131.59 74.81 1.61 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.04 1.736 . . . . 0.0 106.926 174.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -153.76 146.45 24.24 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.5 t -131.06 155.78 46.32 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.911 2.084 . . . . 0.0 107.925 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 172.116 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.249 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -66.65 112.36 4.13 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.15 0.886 . . . . 0.0 111.931 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -89.31 171.04 10.05 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.893 -1.129 . . . . 0.0 108.093 161.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 66.35 175.67 0.23 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.563 2.345 . . . . 0.0 112.46 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -139.02 155.88 47.63 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.855 1.662 . . . . 0.0 107.321 -167.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -77.57 157.68 30.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -140.97 117.33 10.74 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 154.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.91 106.05 2.32 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 106.882 -2.487 . . . . 0.0 106.882 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.21 108.95 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.3 p -128.96 159.16 36.76 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -137.45 163.5 30.94 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.3 156.32 27.28 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 157.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.02 178.86 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.281 2.654 . . . . 0.0 112.083 145.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.35 144.49 50.8 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.698 1.599 . . . . 0.0 108.191 154.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -133.35 155.87 48.66 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.065 1.346 . . . . 0.0 109.323 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.94 94.99 5.37 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 170.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 33.8 mt -28.09 -70.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 129.832 3.253 . . . . 0.0 110.324 -170.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -170.12 5.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.67 1.588 . . . . 0.0 110.368 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -150.08 -177.1 5.73 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.6 1.16 . . . . 0.0 108.714 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -73.98 63.22 0.92 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.84 2.456 . . . . 0.0 112.936 -166.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.64 175.86 10.06 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.792 1.637 . . . . 0.0 108.648 166.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -143.21 112.28 6.63 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 155.66 18.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.689 0.796 . . . . 0.0 109.71 -173.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.55 162.77 39.51 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 155.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.7 131.77 10.62 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 163.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.33 144.59 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 118.712 1.256 . . . . 0.0 108.446 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 m -145.97 165.13 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.301 0.64 . . . . 0.0 111.423 -174.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.41 -143.62 9.54 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 p -133.38 146.33 32.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -170.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.42 113.4 1.51 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 125.087 1.327 . . . . 0.0 109.831 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -95.57 117.12 29.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.476 1.91 . . . . 0.0 107.202 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.98 77.86 0.38 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.1 tttt . . . . . 0 C--O 1.235 0.315 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.456 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.08 177.12 9.0 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.981 0.913 . . . . 0.0 111.616 -159.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -72.59 123.87 24.1 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.624 0.77 . . . . 0.0 110.079 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.76 165.43 17.7 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 159.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -90.3 135.16 33.85 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.1 m -104.98 131.84 51.99 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -143.05 134.69 26.49 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.83 -162.86 14.29 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 124.55 1.071 . . . . 0.0 110.868 -161.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.54 174.44 11.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.922 1.289 . . . . 0.0 109.503 171.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.01 142.34 13.76 Favored Glycine 0 C--N 1.33 0.249 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 168.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.31 140.23 52.34 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -131.86 149.52 52.43 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -109.62 171.38 7.48 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 126.416 1.886 . . . . 0.0 108.726 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -56.49 111.38 3.19 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.639 1.176 . . . . 0.0 110.834 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.64 114.23 3.98 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.932 3.088 . . . . 0.0 110.795 -169.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 49.1 mtt -80.13 158.07 26.46 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.791 1.281 . . . . 0.0 109.738 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -81.12 90.68 6.05 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 134.59 -20.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 132.414 4.285 . . . . 0.0 112.235 170.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.13 119.06 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 120.17 1.35 . . . . 0.0 108.898 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.26 155.37 34.42 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 120.201 -1.562 . . . . 0.0 107.729 155.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -125.58 114.58 18.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 161.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -155.5 151.67 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -147.84 151.81 36.58 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.47 1.508 . . . . 0.0 108.68 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.4 t -125.18 141.97 51.78 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 161.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -115.5 124.94 52.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -132.43 119.24 20.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.251 1.02 . . . . 0.0 108.734 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -109.57 107.32 17.36 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 170.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 t -85.21 160.37 19.9 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 163.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -136.65 151.71 49.61 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 155.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.89 111.42 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.9 ttt-85 52.86 46.14 27.35 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.309 1.044 . . . . 0.0 111.893 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.1 m 56.1 39.43 30.39 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.272 1.029 . . . . 0.0 113.134 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.59 140.95 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 153.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -101.3 122.07 43.02 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 126.428 1.891 . . . . 0.0 108.376 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.5 t -128.85 93.45 2.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -166.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.74 139.26 17.0 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -141.34 119.48 12.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -123.79 113.74 18.96 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.6 pp -108.29 147.5 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.649 1.113 . . . . 0.0 109.477 -172.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.58 163.45 15.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -147.81 102.83 0.25 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 107.669 -2.172 . . . . 0.0 107.669 -172.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.08 153.3 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.59 -141.93 7.55 Favored Glycine 0 C--O 1.218 -0.87 0 CA-C-O 117.532 -1.705 . . . . 0.0 109.203 -159.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -163.41 167.09 22.1 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 121.609 2.705 . . . . 0.0 111.003 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -89.35 144.92 25.71 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 159.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.781 154.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -150.66 164.72 35.42 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -143.48 159.72 41.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.3 1.84 . . . . 0.0 108.173 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -131.5 146.08 52.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.85 98.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.9 t -148.38 119.81 7.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -159.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.65 171.17 40.03 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.34 -123.08 1.12 Allowed Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 -163.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -146.6 158.3 43.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -159.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.02 156.69 31.62 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.094 0.958 . . . . 0.0 109.725 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -125.47 111.9 15.62 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 167.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.8 m -85.48 140.9 30.31 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 160.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -138.79 172.02 13.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.12 2.568 . . . . 0.0 107.062 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.91 164.49 33.57 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.875 1.216 . . . . 0.0 110.794 162.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.81 86.19 5.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.092 0.949 . . . . 0.0 109.201 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.3 -32.02 1.53 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.576 1.56 . . . . 0.0 109.892 172.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -137.6 99.29 3.9 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.6 mtt -69.3 71.38 0.28 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 160.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -71.98 91.97 1.25 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 166.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -68.12 120.36 14.2 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.0 mtp -137.28 134.4 36.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.46 -179.76 24.66 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 162.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.59 -105.37 0.28 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 104.428 -3.469 . . . . 0.0 104.428 170.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -127.97 153.98 46.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.144 1.378 . . . . 0.0 108.723 167.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -138.81 129.58 26.33 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.123 2.169 . . . . 0.0 109.651 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 tp -135.56 143.17 45.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.937 1.244 . . . . 0.0 109.896 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -127.05 166.27 17.91 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.356 1.863 . . . . 0.0 109.07 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.5 141.24 18.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.899 1.68 . . . . 0.0 106.971 -166.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -116.74 147.62 41.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.089 0.859 . . . . 0.0 109.395 165.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.14 120.0 21.7 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.654 1.582 . . . . 0.0 107.574 166.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -101.59 112.49 25.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.5 101.02 12.8 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.475 1.91 . . . . 0.0 107.896 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 38.04 64.05 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.683 1.993 . . . . 0.0 111.981 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 62.35 40.15 11.51 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.775 2.03 . . . . 0.0 112.394 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.8 p -63.82 122.96 79.98 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.57 -37.39 12.81 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.211 1.941 . . . . 0.0 112.08 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.06 155.3 32.59 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 164.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.59 -167.35 12.18 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 172.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.41 146.17 34.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.23 137.08 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 167.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.28 108.55 0.36 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 165.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 p -125.52 137.59 53.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.444 0.622 . . . . 0.0 110.925 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.65 153.62 20.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.5 m -120.3 132.7 55.42 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 161.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -120.36 153.33 36.64 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.806 2.042 . . . . 0.0 106.109 167.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.9 p -133.19 145.38 50.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.103 0.865 . . . . 0.0 111.741 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -129.77 115.95 18.04 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 163.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -162.66 147.28 11.87 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 m -65.22 155.05 36.32 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 157.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 t80 . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -160.3 172.85 16.61 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.684 0.794 . . . . 0.0 109.705 -167.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -60.33 130.47 46.78 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -154.01 148.86 26.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.695 0.798 . . . . 0.0 108.977 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -152.74 146.42 25.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 164.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -97.95 122.72 41.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 157.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.9 125.55 45.9 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.04 135.49 12.89 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.7 mm -141.89 135.92 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 127.667 2.387 . . . . 0.0 105.603 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 t -140.28 153.61 46.55 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.201 1.4 . . . . 0.0 108.168 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.65 152.97 44.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.871 1.268 . . . . 0.0 108.308 170.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.55 141.43 3.16 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 168.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.88 169.69 18.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 121.71 1.607 . . . . 0.0 110.163 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.86 157.86 16.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.465 1.906 . . . . 0.0 107.34 168.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -145.58 116.55 7.8 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -84.22 134.38 34.55 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.0 mp -77.37 -79.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -171.61 1.94 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.245 0.929 . . . . 0.0 113.374 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -135.15 66.81 1.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -162.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 93.3 m95 53.47 -38.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 131.013 3.725 . . . . 0.0 117.569 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.21 162.9 28.47 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.182 1.793 . . . . 0.0 110.603 -170.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 t -148.45 110.08 4.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.87 145.76 34.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -151.07 164.91 35.35 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.91 0.884 . . . . 0.0 109.333 166.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.62 130.45 20.54 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 170.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 m -119.57 172.17 6.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.298 1.039 . . . . 0.0 108.666 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.1 158.55 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 C-N-CA 125.682 1.593 . . . . 0.0 108.783 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.0 162.64 25.03 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 170.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.2 p -134.54 136.33 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.44 110.92 1.76 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 107.191 -2.363 . . . . 0.0 107.191 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -129.11 156.62 43.58 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.89 174.04 39.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 C--O 1.239 0.52 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 167.476 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.41 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -161.58 176.05 11.44 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.729 0.812 . . . . 0.0 109.223 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -139.62 165.19 27.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.346 1.458 . . . . 0.0 109.032 170.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.29 167.55 38.91 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 165.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -102.85 152.39 21.33 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.323 1.849 . . . . 0.0 110.363 -173.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 p -137.41 168.33 19.86 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.416 1.487 . . . . 0.0 110.101 165.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -146.3 153.12 40.19 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.704 0.802 . . . . 0.0 108.901 168.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.24 -153.94 9.36 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.75 160.28 41.96 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.514 1.125 . . . . 0.0 108.955 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -99.06 121.82 7.35 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 171.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.7 138.94 50.61 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -141.83 155.71 45.56 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.071 -1.018 . . . . 0.0 109.548 -161.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -93.14 163.63 13.56 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -57.02 134.86 80.29 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.336 -0.84 . . . . 0.0 108.759 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.45 104.28 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.444 2.096 . . . . 0.0 110.42 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttt -75.34 -175.02 2.59 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.803 1.241 . . . . 0.0 107.676 167.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -106.08 -13.81 15.34 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.624 1.57 . . . . 0.0 110.438 -159.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.41 25.5 0.35 Allowed 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 125.267 1.427 . . . . 0.0 108.967 166.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.68 137.35 27.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.72 145.2 30.77 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.89 135.68 51.28 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -131.03 145.22 51.96 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.24 1.416 . . . . 0.0 110.362 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -147.5 144.79 28.81 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.487 1.915 . . . . 0.0 108.225 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.2 p -145.82 163.62 34.47 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 151.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -137.27 137.46 39.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -138.21 165.16 27.38 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.021 0.929 . . . . 0.0 109.175 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -127.07 118.24 24.02 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 165.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.6 m -83.24 154.5 24.16 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.833 0.853 . . . . 0.0 109.684 167.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -116.78 102.96 9.85 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.18 93.95 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.631 0.651 . . . . 0.0 110.996 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 88.57 39.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.79 2.836 . . . . 0.0 109.995 164.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m 52.85 43.77 31.13 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.208 1.403 . . . . 0.0 111.564 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.47 130.28 53.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 127.994 2.517 . . . . 0.0 105.075 165.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.75 104.96 15.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.368 0.667 . . . . 0.0 109.724 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.87 92.07 2.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.92 1.288 . . . . 0.0 107.866 -169.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.57 151.81 43.67 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.0 t -138.33 153.49 48.99 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.492 1.117 . . . . 0.0 108.405 165.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -139.36 157.22 46.26 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 152.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.6 pt -120.61 149.03 23.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 168.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.2 123.52 12.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 166.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.02 154.13 25.39 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.84 -179.55 3.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 125.795 1.638 . . . . 0.0 107.963 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 174.78 -96.09 0.11 Allowed Glycine 0 C--O 1.228 -0.281 0 O-C-N 120.29 -1.506 . . . . 0.0 111.58 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -146.63 176.02 10.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.992 1.317 . . . . 0.0 110.522 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -141.31 139.39 33.61 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 10.8 p90 . . . . . 0 C--O 1.252 1.217 0 CA-C-N 119.371 0.987 . . . . 0.0 109.28 176.689 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.3 m -146.36 166.65 25.69 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.688 1.595 . . . . 0.0 106.751 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -122.95 140.61 52.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.102 0.961 . . . . 0.0 109.967 -173.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 t -151.42 173.2 14.83 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.58 120.76 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -139.89 122.25 16.03 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -161.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.38 -159.89 33.14 Favored Glycine 0 C--N 1.332 0.331 0 O-C-N 119.931 -1.731 . . . . 0.0 113.635 -157.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 114.44 -99.83 0.97 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 106.984 -2.447 . . . . 0.0 106.984 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -139.74 157.68 45.34 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.029 1.414 . . . . 0.0 108.753 -163.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.14 132.24 41.41 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.053 1.741 . . . . 0.0 107.703 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -100.04 113.17 25.58 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -85.01 137.72 32.9 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 157.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -138.14 170.65 15.67 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.449 1.1 . . . . 0.0 108.397 171.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -114.23 165.48 12.63 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.264 1.026 . . . . 0.0 111.866 -165.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -46.2 -20.39 0.1 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.28 2.632 . . . . 0.0 113.693 172.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.15 94.71 0.15 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 168.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -42.48 102.94 0.03 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 129.772 3.229 . . . . 0.0 112.408 -173.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.3 ttm -145.83 -36.17 0.28 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.003 1.721 . . . . 0.0 111.056 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.89 103.25 7.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.86 1.264 . . . . 0.0 111.658 173.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 157.34 18.0 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.742 172.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.9 mtm -130.21 159.7 36.07 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.198 0.999 . . . . 0.0 109.785 172.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.26 176.03 38.94 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.026 1.774 . . . . 0.0 110.164 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.91 -84.58 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.53 156.72 41.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 172.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -137.41 150.22 47.49 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 164.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.8 tp -150.73 131.77 14.33 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 168.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -131.02 161.28 32.32 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.896 2.078 . . . . 0.0 110.143 -176.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -145.46 142.33 29.16 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.761 1.624 . . . . 0.0 108.356 -172.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -131.63 115.27 15.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.475 0.71 . . . . 0.0 109.298 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -98.94 156.57 16.83 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.733 0.697 . . . . 0.0 110.01 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -139.91 113.19 8.35 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.943 1.697 . . . . 0.0 108.939 -165.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -64.35 169.06 4.98 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.414 1.486 . . . . 0.0 110.828 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.2 -30.72 12.84 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.749 0.82 . . . . 0.0 109.37 167.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.83 -82.59 0.06 Allowed 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.56 0.744 . . . . 0.0 109.45 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.5 p -89.07 173.45 6.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.772 0.829 . . . . 0.0 110.943 -171.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.46 -3.86 14.51 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.628 2.219 . . . . 0.0 112.44 165.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.5 tp -70.67 155.94 40.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.32 0.964 . . . . 0.0 110.13 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.17 -166.77 28.76 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 t -132.87 151.08 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 118.163 0.981 . . . . 0.0 109.822 -166.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.3 mm -119.88 143.99 29.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 125.74 1.616 . . . . 0.0 107.867 169.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.06 144.37 15.93 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 148.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.0 m -123.51 153.54 40.42 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 127.021 2.128 . . . . 0.0 106.568 168.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -121.15 122.29 39.69 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 m -93.54 116.4 28.92 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -166.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -139.22 125.2 19.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.688 0.395 . . . . 0.0 110.781 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -133.23 130.97 39.75 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -72.25 -177.45 2.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.962 167.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.13 118.87 4.94 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 119.807 -1.808 . . . . 0.0 109.648 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 m -123.48 128.94 50.51 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.835 1.254 . . . . 0.0 108.229 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 164.096 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.405 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.49 116.98 17.68 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -149.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -143.54 170.8 15.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 118.469 0.577 . . . . 0.0 110.758 -169.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 t30 53.53 -177.23 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.859 1.264 . . . . 0.0 109.026 -150.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -113.53 169.34 9.04 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.914 1.286 . . . . 0.0 108.217 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -97.06 103.43 15.36 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -98.12 147.55 24.45 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.17 170.42 36.24 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.82 138.11 46.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.9 m -134.39 127.07 30.87 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.16 149.02 26.62 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.869 0.468 . . . . 0.0 109.775 -172.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.54 -178.28 31.41 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.611 0.624 . . . . 0.0 111.746 176.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -81.29 -177.28 3.57 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.906 3.738 . . . . 0.0 112.141 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.74 146.23 45.56 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.159 -0.963 . . . . 0.0 109.448 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -88.99 101.09 13.74 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -71.83 146.25 48.1 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 162.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.8 mm -97.92 -105.34 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 167.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -155.26 -57.15 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.85 170.57 3.33 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.26 2.224 . . . . 0.0 108.864 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.82 59.47 1.23 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.859 1.264 . . . . 0.0 112.956 -173.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.05 162.9 34.31 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.743 1.617 . . . . 0.0 108.78 158.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -150.05 167.29 27.18 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.755 -1.216 . . . . 0.0 110.342 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.54 146.85 24.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -107.16 148.19 29.16 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.84 83.19 0.16 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -131.13 167.67 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.513 1.125 . . . . 0.0 110.451 -175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.48 131.22 60.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -175.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.68 122.5 3.24 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.74 146.2 28.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.119 0.968 . . . . 0.0 108.834 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.62 145.27 16.29 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 124.04 0.829 . . . . 0.0 111.984 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -126.86 117.7 23.13 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.1 1.36 . . . . 0.0 107.492 165.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.57 133.78 9.06 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 106.003 -2.839 . . . . 0.0 106.003 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm . . . . . 0 C--N 1.331 -0.228 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 168.719 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.235 0.324 0 N-CA-C 111.101 0.037 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -137.7 128.49 27.04 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 109.912 -165.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -90.65 159.51 16.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 163.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.33 136.54 8.67 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 105.775 -2.93 . . . . 0.0 105.775 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -130.39 130.3 44.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -171.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.82 -175.19 3.88 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.072 1.349 . . . . 0.0 109.65 -167.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -135.23 148.71 49.69 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 165.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.46 64.24 1.11 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 125.436 1.493 . . . . 0.0 109.81 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -95.81 64.29 2.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.755 0.822 . . . . 0.0 109.672 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -96.19 165.72 24.13 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.808 1.67 . . . . 0.0 112.645 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -138.03 140.6 40.18 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.369 1.868 . . . . 0.0 108.857 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -113.45 141.01 47.62 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.041 1.337 . . . . 0.0 109.393 -167.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -119.05 171.83 7.99 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.376 1.071 . . . . 0.0 109.171 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -56.15 110.26 2.2 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.96 1.304 . . . . 0.0 110.15 -173.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 125.98 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.389 2.726 . . . . 0.0 111.013 -169.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.4 ttp -90.63 155.6 18.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 122.919 1.342 . . . . 0.0 110.111 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -80.55 30.1 0.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 128.942 2.897 . . . . 0.0 110.025 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.81 -14.3 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.219 1.808 . . . . 0.0 112.021 171.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.9 m -152.16 121.81 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 126.327 1.851 . . . . 0.0 108.058 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.75 165.59 17.02 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 119.996 -1.69 . . . . 0.0 109.64 160.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -139.13 114.58 9.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 165.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -156.83 155.58 31.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -137.84 114.62 10.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.616 1.566 . . . . 0.0 107.248 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 m -113.91 135.24 54.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 165.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -136.84 113.07 9.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 -169.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -121.29 143.47 49.15 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.143 0.977 . . . . 0.0 108.783 -173.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -133.46 125.0 28.06 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.271 1.428 . . . . 0.0 109.461 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 p -139.1 160.34 40.03 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 120.007 1.276 . . . . 0.0 111.516 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -113.73 117.22 30.9 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 44.7 mt -120.75 109.72 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.66 41.23 28.68 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.478 1.111 . . . . 0.0 110.903 172.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 56.6 m 58.66 16.5 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.81 128.89 39.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 160.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.12 131.1 41.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 169.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.3 t -132.7 133.23 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.2 153.42 17.62 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.3 t -132.69 129.91 39.39 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 159.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -102.04 110.07 21.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 169.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.6 mt -93.86 118.38 39.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.63 145.13 24.85 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -124.37 82.75 0.35 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.99 179.59 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 168.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.9 -120.53 1.23 Allowed Glycine 0 N--CA 1.465 0.618 0 CA-C-O 117.477 -1.735 . . . . 0.0 111.287 -169.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -164.23 164.39 22.53 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.578 1.951 . . . . 0.0 109.701 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.77 132.03 36.26 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.133 -1.604 . . . . 0.0 109.252 175.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.852 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.4 p -141.98 165.96 26.02 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 165.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.47 107.69 4.76 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.971 1.308 . . . . 0.0 110.047 -167.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -61.95 142.09 57.64 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 159.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.84 100.23 4.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 171.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -150.67 146.11 26.27 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.086 -1.634 . . . . 0.0 109.231 -165.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.38 170.81 38.91 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 121.452 0.473 . . . . 0.0 112.125 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.81 -127.32 1.4 Allowed Glycine 0 C--O 1.227 -0.309 0 O-C-N 121.164 -1.198 . . . . 0.0 111.748 -170.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -139.7 158.7 43.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.174 0.989 . . . . 0.0 109.982 -166.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.72 125.76 47.34 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.957 1.303 . . . . 0.0 107.738 169.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -101.94 104.48 15.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 163.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.0 m -89.14 141.94 28.07 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 159.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -138.23 165.03 27.71 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.682 1.993 . . . . 0.0 108.399 170.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.76 164.97 21.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 111.35 -170.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -62.07 5.97 0.09 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.24 102.63 0.23 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 104.521 -3.432 . . . . 0.0 104.521 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -65.09 95.92 0.19 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.894 1.278 . . . . 0.0 109.626 -164.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.2 mtt -153.8 10.7 0.41 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.082 2.553 . . . . 0.0 110.596 -176.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -131.78 143.66 50.38 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 120.707 -1.246 . . . . 0.0 109.0 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -137.63 76.99 1.61 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.461 1.904 . . . . 0.0 106.649 164.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.9 mtm -83.45 154.74 23.78 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.78 170.08 12.71 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.294 1.902 . . . . 0.0 111.447 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.37 -141.39 3.22 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -170.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -99.26 123.6 43.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.131 0.966 . . . . 0.0 109.649 -171.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -94.98 151.06 19.5 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.642 1.177 . . . . 0.0 107.846 -172.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.56 148.99 35.08 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.292 1.437 . . . . 0.0 107.923 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -137.63 130.73 30.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.867 1.667 . . . . 0.0 107.63 -167.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.45 138.62 29.42 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -170.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 163.24 33.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.292 1.037 . . . . 0.0 108.608 167.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -120.4 157.87 28.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 161.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -101.94 112.29 24.86 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.8 OUTLIER -77.09 178.81 6.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.401 1.08 . . . . 0.0 110.315 -175.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.401 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 5.2 p-10 -135.37 13.81 3.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.687 1.595 . . . . 0.0 111.504 -156.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -137.44 -28.35 0.92 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.085 0.954 . . . . 0.0 111.503 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 p -120.74 114.71 32.52 Favored Pre-proline 0 CA--C 1.535 0.382 0 O-C-N 120.919 -1.113 . . . . 0.0 111.07 -169.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.75 80.19 2.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.334 2.022 . . . . 0.0 109.227 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.34 156.29 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.111 2.164 . . . . 0.0 106.659 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.75 167.69 28.52 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.6 -1.111 . . . . 0.0 111.56 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.47 139.01 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 119.313 1.556 . . . . 0.0 107.929 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.5 110.46 16.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.65 123.39 5.22 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 107.244 -2.343 . . . . 0.0 107.244 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 m -122.55 154.36 38.01 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.509 1.523 . . . . 0.0 109.605 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -121.12 132.71 55.02 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.407 0.683 . . . . 0.0 110.586 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -127.64 150.53 49.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.271 1.428 . . . . 0.0 108.185 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -138.62 157.11 46.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.222 3.009 . . . . 0.0 106.493 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 t -99.65 132.81 44.75 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -143.74 40.95 1.42 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.982 0.913 . . . . 0.0 109.888 -166.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -148.35 138.21 22.35 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 120.937 -1.102 . . . . 0.0 110.852 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -90.3 144.58 25.7 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.0 mtp85 . . . . . 0 CA--C 1.521 -0.169 0 CA-C-O 117.167 -1.397 . . . . 0.0 108.084 157.831 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 . . . . . 0 N--CA 1.463 0.177 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -39.09 103.9 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.172 2.189 . . . . 0.0 110.906 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -120.87 122.94 41.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.833 1.197 . . . . 0.0 109.579 -166.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 66.28 -166.26 0.22 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.206 1.802 . . . . 0.0 107.67 -165.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -113.79 151.92 31.35 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.051 1.296 . . . . 0.0 110.166 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -75.17 136.65 41.04 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 155.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -122.11 117.59 26.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 174.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.22 124.48 4.54 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.77 157.08 38.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 171.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.8 t -140.61 158.63 43.7 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.14 145.36 24.66 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.024 0.93 . . . . 0.0 108.616 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.65 161.13 33.98 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 151.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.94 154.62 33.66 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.834 1.689 . . . . 0.0 109.398 165.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.15 167.08 13.0 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 161.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -140.69 154.89 46.55 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.772 -0.58 . . . . 0.0 109.933 165.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -111.27 148.56 32.63 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.458 1.103 . . . . 0.0 108.866 -175.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.3 mp -114.74 -58.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.874 1.27 . . . . 0.0 108.343 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 172.37 -41.14 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.877 2.471 . . . . 0.0 107.957 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.33 165.63 3.48 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.435 2.294 . . . . 0.0 110.406 -177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -82.44 46.93 1.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.279 163.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.94 151.59 36.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.516 2.326 . . . . 0.0 106.69 170.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.04 168.45 23.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 163.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.54 148.58 24.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 174.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -150.67 124.33 9.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.353 0.661 . . . . 0.0 110.211 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.27 142.21 47.03 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 163.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.53 176.08 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.042 0.937 . . . . 0.0 108.877 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -127.57 155.2 38.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.64 163.67 26.83 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.82 131.95 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 171.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.44 109.32 0.95 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 107.17 -2.372 . . . . 0.0 107.17 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -128.84 146.3 50.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.41 -175.59 33.28 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 118.225 -1.941 . . . . 0.0 112.56 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.2 mttt . . . . . 0 C--N 1.324 -0.529 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -162.368 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.23 143.5 40.17 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.255 1.822 . . . . 0.0 107.103 -166.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.91 88.08 2.47 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.224 1.009 . . . . 0.0 108.336 -156.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.15 39.71 1.87 Allowed Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.322 1.439 . . . . 0.0 111.804 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -73.99 121.23 20.71 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 t -157.29 -161.83 1.12 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -129.58 174.16 9.93 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 126.719 2.008 . . . . 0.0 108.848 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.11 -173.8 31.23 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.72 105.37 8.93 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.706 1.602 . . . . 0.0 108.244 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.26 141.93 15.89 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -138.15 161.44 36.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.657 1.983 . . . . 0.0 108.2 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -139.46 159.72 41.5 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.116 0.967 . . . . 0.0 108.419 167.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -92.98 171.54 8.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.444 1.498 . . . . 0.0 108.52 165.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -56.48 119.95 32.41 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.411 1.484 . . . . 0.0 109.117 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.12 148.84 70.14 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.166 1.911 . . . . 0.0 110.5 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 95.2 mtp -116.25 -176.52 2.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.322 1.449 . . . . 0.0 108.804 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.88 -15.88 59.56 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.04 1.336 . . . . 0.0 110.139 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -164.59 14.37 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.836 2.455 . . . . 0.0 111.805 -168.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.94 148.16 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -156.94 154.05 29.09 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 164.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.32 115.78 15.33 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.03 109.51 16.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.509 1.523 . . . . 0.0 107.432 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -115.34 143.66 44.94 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.296 1.038 . . . . 0.0 109.251 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 p -145.92 162.58 37.46 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.379 1.072 . . . . 0.0 110.656 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -151.12 105.48 3.23 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.372 1.069 . . . . 0.0 109.219 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -123.28 163.58 20.43 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.609 1.564 . . . . 0.0 109.956 -170.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -118.52 158.19 25.86 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.762 0.825 . . . . 0.0 111.577 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 t -140.93 105.96 4.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.267 1.827 . . . . 0.0 109.246 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -78.6 97.93 5.97 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 120.851 -1.155 . . . . 0.0 110.109 169.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.5 81.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.96 -70.87 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 128.522 2.729 . . . . 0.0 112.831 -171.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.83 3.82 2.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.298 2.639 . . . . 0.0 110.902 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.72 129.53 46.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -83.27 109.02 16.89 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.2 t -118.72 152.97 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.705 1.202 . . . . 0.0 108.368 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -140.2 152.74 22.99 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 128.123 2.773 . . . . 0.0 107.874 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -135.49 136.08 40.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.414 1.107 . . . . 0.0 109.644 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -112.45 110.67 21.01 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.1 mt -113.65 129.5 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.31 162.1 35.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.33 1.062 . . . . 0.0 109.679 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -158.07 164.37 33.26 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 167.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 m -137.65 166.36 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 166.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -174.82 -107.19 0.2 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 106.982 -2.447 . . . . 0.0 106.982 167.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -141.76 176.6 8.79 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.827 2.051 . . . . 0.0 109.335 -170.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.31 151.76 35.94 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.715 -0.616 . . . . 0.0 110.078 171.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 C--O 1.248 1.014 0 C-N-CA 126.303 1.841 . . . . 0.0 107.97 168.922 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.5 p -96.65 138.2 34.58 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.661 -0.649 . . . . 0.0 109.507 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -89.97 159.18 17.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.947 1.299 . . . . 0.0 108.627 162.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -159.92 144.9 15.08 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 167.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.31 100.14 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.572 0.749 . . . . 0.0 109.143 -171.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 m -132.44 141.35 48.8 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 119.977 -1.702 . . . . 0.0 109.022 -170.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.0 -164.9 26.49 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -166.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.07 -114.05 0.86 Allowed Glycine 0 C--O 1.233 0.094 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.82 158.07 45.11 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.363 1.865 . . . . 0.0 109.223 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.44 136.92 51.35 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 160.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -120.07 122.48 41.18 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -131.66 151.05 51.92 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.34 170.69 15.57 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.754 1.622 . . . . 0.0 109.195 -173.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.67 164.89 27.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.391 1.076 . . . . 0.0 111.493 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -58.93 74.82 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.268 2.627 . . . . 0.0 110.27 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.71 82.86 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 107.835 -2.106 . . . . 0.0 107.835 -171.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -46.02 96.02 0.01 OUTLIER 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.923 2.489 . . . . 0.0 110.094 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.18 -12.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.993 2.117 . . . . 0.0 111.09 -176.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -105.25 123.69 48.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.347 1.459 . . . . 0.0 107.283 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -133.56 95.83 3.57 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.33 159.29 34.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.065 0.936 . . . . 0.0 108.736 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.56 156.09 16.8 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.38 -88.7 0.09 OUTLIER Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -165.42 164.62 19.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.221 1.008 . . . . 0.0 109.251 173.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -130.9 142.17 50.35 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.481 2.312 . . . . 0.0 107.068 166.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -150.44 140.13 21.69 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.791 1.236 . . . . 0.0 108.192 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -151.53 168.16 25.79 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.048 0.939 . . . . 0.0 110.945 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -141.31 114.51 8.67 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.778 0.831 . . . . 0.0 109.127 -167.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -93.73 108.32 20.09 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -103.55 118.26 36.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -140.55 143.3 35.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 7.9 tp10 -143.33 147.46 34.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -175.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.89 2.41 20.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.557 1.143 . . . . 0.0 112.184 -175.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.41 ' H ' ' HG3' ' A' ' 32' ' ' GLU . 4.0 m120 -73.93 -39.07 64.06 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.116 1.366 . . . . 0.0 110.335 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 t -153.37 110.58 2.61 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.4 68.23 5.25 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.992 3.128 . . . . 0.0 110.025 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.1 tp -139.05 105.3 5.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.8 -177.53 47.31 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 123.677 0.656 . . . . 0.0 111.669 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.1 t -134.61 139.72 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.8 pt -129.43 109.73 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 163.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.28 146.55 18.48 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 154.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.39 155.47 40.3 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 128.404 2.682 . . . . 0.0 106.348 160.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -115.78 131.1 57.04 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 167.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 m -92.73 147.45 22.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 156.65 45.23 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.104 1.762 . . . . 0.0 107.106 172.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -143.11 162.43 35.56 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.647 -0.658 . . . . 0.0 109.56 157.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.82 134.21 51.74 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.452 1.901 . . . . 0.0 107.898 166.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.62 147.8 1.1 Allowed 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.513 1.525 . . . . 0.0 107.577 -175.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -130.22 119.01 22.24 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 . . . . . 0 CA--C 1.521 -0.149 0 C-N-CA 125.522 1.529 . . . . 0.0 109.388 175.168 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.4 t80 . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 175.79 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 128.286 2.634 . . . . 0.0 105.423 152.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -150.98 157.02 42.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 128.205 2.602 . . . . 0.0 105.913 168.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -133.48 80.33 1.87 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -165.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -113.25 150.17 32.79 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -169.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -141.74 159.34 42.43 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 168.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -128.37 173.26 10.34 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.05 140.9 9.77 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -123.31 107.53 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 170.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -138.11 142.28 40.19 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 128.067 2.547 . . . . 0.0 104.868 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.26 40.06 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 118.562 0.619 . . . . 0.0 110.693 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.7 170.04 30.53 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.959 1.742 . . . . 0.0 109.103 161.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.9 179.79 5.36 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.405 2.07 . . . . 0.0 109.006 164.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.66 144.16 48.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 153.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -141.24 125.91 17.92 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -83.51 93.56 7.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.069 0.849 . . . . 0.0 109.973 -165.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.1 pp -142.52 -168.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.597 1.559 . . . . 0.0 110.354 -174.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 64.38 -95.51 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 128.744 2.818 . . . . 0.0 107.494 -170.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -147.76 115.44 6.37 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 120.55 1.523 . . . . 0.0 108.443 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 12.8 m0 59.81 8.13 1.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.027 2.531 . . . . 0.0 115.27 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.9 179.83 4.24 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.397 0.999 . . . . 0.0 109.218 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -144.99 105.32 4.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.87 152.45 35.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.99 167.2 27.4 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.649 0.38 . . . . 0.0 109.99 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.89 150.44 50.47 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 163.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -131.36 143.78 39.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.2 153.41 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 123.297 0.639 . . . . 0.0 110.643 -177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.96 -170.81 39.15 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 123.624 0.577 . . . . 0.0 113.118 -169.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.09 141.26 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.048 1.339 . . . . 0.0 107.946 172.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.86 143.69 16.04 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 125.658 1.599 . . . . 0.0 109.519 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.9 130.47 35.96 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.208 1.803 . . . . 0.0 107.305 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.86 -145.39 13.09 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.186 1.85 . . . . 0.0 110.091 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.367 0 C-N-CA 127.484 2.313 . . . . 0.0 110.459 -170.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.237 0.421 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.89 162.02 21.7 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 168.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -146.88 144.57 29.37 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -125.81 107.16 0.93 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 124.594 1.092 . . . . 0.0 111.018 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.68 118.3 15.43 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.8 m -98.05 132.82 43.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -144.91 61.43 1.31 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.3 1.04 . . . . 0.0 110.916 -171.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.63 -164.35 40.23 Favored Glycine 0 CA--C 1.52 0.393 0 O-C-N 121.097 -1.002 . . . . 0.0 113.254 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.94 159.18 40.71 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 151.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -122.46 116.25 2.97 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 107.851 -2.099 . . . . 0.0 107.851 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -117.85 155.72 29.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.104 2.561 . . . . 0.0 106.622 -166.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.28 149.45 33.87 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.935 -1.103 . . . . 0.0 112.152 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.11 172.16 8.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.244 1.818 . . . . 0.0 109.817 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -59.15 130.67 87.0 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 119.12 -0.467 . . . . 0.0 110.796 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.3 118.32 5.29 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.682 2.255 . . . . 0.0 110.361 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 ttt -78.18 -176.03 4.42 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 150.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -86.68 -28.34 23.21 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 123.856 0.862 . . . . 0.0 109.827 172.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.68 3.59 4.54 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 110.755 -162.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.5 t -150.54 112.25 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 127.82 2.448 . . . . 0.0 105.69 -170.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.92 134.0 51.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.67 132.76 46.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -172.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -141.27 155.67 45.97 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.385 1.474 . . . . 0.0 109.182 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -138.1 123.09 19.02 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 124.525 1.13 . . . . 0.0 108.92 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.2 m -122.42 144.76 48.84 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 164.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -149.79 114.85 5.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.86 137.39 38.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.777 1.231 . . . . 0.0 108.339 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -99.76 161.64 13.49 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 169.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p -140.14 108.08 5.71 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.407 1.083 . . . . 0.0 109.351 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.8 ttm105 -62.28 123.79 19.16 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 168.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.7 mt -123.43 104.78 14.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.63 50.93 12.61 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.864 1.265 . . . . 0.0 111.713 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 61.4 m 48.87 29.66 2.39 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -174.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.57 138.58 19.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 156.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -86.21 121.0 28.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.98 134.16 31.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.34 146.63 17.78 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.7 p -124.16 136.38 54.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -131.63 157.74 42.89 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 163.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.3 mt -127.03 128.25 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -167.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.06 126.91 35.64 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.36 101.99 0.57 Allowed Glycine 0 C--O 1.224 -0.529 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 -170.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 t -138.41 139.17 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 127.291 2.236 . . . . 0.0 106.306 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -179.27 -129.61 1.34 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -146.83 177.1 9.37 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.77 2.028 . . . . 0.0 110.046 -158.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.23 166.28 24.14 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 166.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 12.6 p90 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.486 -1.721 . . . . 0.0 108.278 174.85 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.912 -0.033 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.3 p -140.52 160.35 40.2 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.423 0.689 . . . . 0.0 109.782 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.6 106.64 10.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.632 0.73 . . . . 0.0 110.291 -173.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.78 159.57 29.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 161.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.03 101.18 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 166.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 t -122.06 143.99 49.18 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.4 160.93 25.95 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.783 1.658 . . . . 0.0 109.043 -175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.75 -172.21 45.25 Favored Glycine 0 CA--C 1.51 -0.277 0 O-C-N 119.406 -2.232 . . . . 0.0 110.732 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -90.78 139.82 30.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.121 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.73 154.8 17.03 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.115 1.366 . . . . 0.0 109.123 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -152.54 118.8 5.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.62 151.12 24.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -138.42 159.94 40.79 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 150.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.63 160.45 37.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.619 0.645 . . . . 0.0 110.948 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.41 77.27 3.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.255 0.55 . . . . 0.0 111.176 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.69 -2.8 7.53 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.253 1.406 . . . . 0.0 112.377 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -150.99 96.39 2.32 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.075 1.437 . . . . 0.0 107.994 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.9 mtt -75.99 65.13 1.99 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.863 2.465 . . . . 0.0 110.344 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -78.89 95.94 5.55 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 108.766 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -76.35 77.9 3.1 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.563 0.697 . . . . 0.0 109.556 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.3 mmm -114.25 159.42 20.17 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.904 1.282 . . . . 0.0 108.273 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.54 163.89 12.73 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -168.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.53 -120.95 1.07 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 104.356 -3.498 . . . . 0.0 104.356 -172.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.33 170.32 8.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.335 1.068 . . . . 0.0 109.948 -171.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -137.22 163.14 31.61 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 128.029 2.532 . . . . 0.0 106.387 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.69 158.77 43.82 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 164.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -139.48 156.59 46.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.53 130.85 33.08 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -105.63 115.07 29.62 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -98.21 118.67 35.37 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 103.625 -2.731 . . . . 0.0 103.625 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -87.78 128.34 35.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -109.15 178.44 4.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.52 16.42 8.21 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.293 1.437 . . . . 0.0 109.922 -167.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.38 -63.58 0.98 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.191 1.396 . . . . 0.0 110.351 172.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.0 m -75.19 133.29 75.26 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 117.921 0.328 . . . . 0.0 110.768 -172.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.42 -9.22 18.76 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.521 2.814 . . . . 0.0 112.995 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -88.92 155.57 19.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.166 0.986 . . . . 0.0 109.811 173.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.72 -172.94 17.16 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 166.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -130.52 143.92 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 pt -140.27 142.01 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.85 1.26 . . . . 0.0 109.165 165.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.28 108.08 0.34 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.568 1.08 . . . . 0.0 110.435 166.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.85 153.87 42.36 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.354 1.062 . . . . 0.0 110.374 173.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -120.62 148.38 43.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 153.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 t -127.38 150.93 49.39 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.452 1.901 . . . . 0.0 105.928 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -142.72 156.97 45.09 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.309 0.504 . . . . 0.0 110.214 171.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.3 t -100.06 143.98 29.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.729 0.812 . . . . 0.0 110.291 -176.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -151.05 29.27 0.66 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.927 2.091 . . . . 0.0 110.572 -172.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -133.68 148.4 51.48 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 118.985 -2.322 . . . . 0.0 111.545 -175.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.2 m -113.17 121.74 45.42 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.939 1.296 . . . . 0.0 107.629 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.5 t80 . . . . . 0 C--O 1.237 0.408 0 CA-C-O 119.368 -0.348 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -114.03 143.4 44.81 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 171.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -149.7 120.61 7.65 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 156.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.516 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 41.7 t30 -157.83 -158.41 0.73 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 155.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.516 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 10.8 mp0 -111.36 165.09 12.25 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 165.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.67 116.17 13.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 174.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -97.04 133.86 41.16 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -173.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.09 104.8 0.35 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.6 tt -126.46 114.37 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.443 1.097 . . . . 0.0 108.762 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 t -122.57 151.84 41.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.75 158.41 39.49 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.067 0.947 . . . . 0.0 109.127 168.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.22 -178.56 42.34 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 168.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.52 142.43 44.57 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.015 1.81 . . . . 0.0 110.377 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.31 103.15 15.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 153.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.7 144.97 33.22 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 167.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -74.06 127.38 32.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mm -50.27 -60.86 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.19 0.996 . . . . 0.0 108.848 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -156.89 -43.53 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 167.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.3 -89.51 0.05 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.034 1.333 . . . . 0.0 107.577 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.34 7.11 0.2 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -166.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.84 167.99 20.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.346 1.43 . . . . 0.0 111.161 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 p -74.0 168.76 18.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.983 0.913 . . . . 0.0 110.166 164.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.74 164.57 32.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -105.08 171.0 7.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.826 2.051 . . . . 0.0 110.971 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.57 70.76 1.16 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.74 168.72 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 117.95 0.875 . . . . 0.0 110.405 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.49 154.12 3.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.76 171.51 36.15 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 118.434 0.561 . . . . 0.0 111.999 163.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.33 126.42 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 170.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.99 104.97 2.02 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 166.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -112.95 135.75 53.38 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.564 1.146 . . . . 0.0 107.974 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.25 -166.54 39.35 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.158 0 C-N-CA 125.924 1.69 . . . . 0.0 110.056 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -151.18 157.95 43.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 167.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -70.89 157.45 38.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 117.894 -1.522 . . . . 0.0 108.729 163.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.3 122.55 6.33 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 105.568 -3.013 . . . . 0.0 105.568 159.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -78.63 117.18 19.55 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 78.7 p -103.02 158.33 16.37 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.306 1.051 . . . . 0.0 112.077 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -105.11 112.84 26.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.13 143.03 16.31 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 118.558 0.617 . . . . 0.0 111.783 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -140.18 160.64 39.5 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.689 1.196 . . . . 0.0 109.504 172.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.59 122.12 0.87 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.08 140.52 51.9 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.109 1.364 . . . . 0.0 107.482 173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -120.22 149.76 41.76 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.189 0.995 . . . . 0.0 108.85 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -92.66 172.27 8.46 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.947 1.299 . . . . 0.0 109.62 -174.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -57.18 154.71 19.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.552 -0.717 . . . . 0.0 110.702 169.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.46 143.47 52.4 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.77 2.314 . . . . 0.0 111.538 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.7 mmt -108.44 -176.73 3.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -92.84 -30.33 15.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 109.404 -170.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -142.34 9.72 1.86 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.248 1.419 . . . . 0.0 110.693 -171.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.261 0.2 OUTLIER -141.31 140.43 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 119.582 1.083 . . . . 0.0 108.551 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.4 153.32 18.66 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -133.39 116.16 15.72 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 162.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -141.09 137.71 33.03 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.864 1.666 . . . . 0.0 107.425 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -133.63 121.81 22.57 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.325 0.966 . . . . 0.0 109.178 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.5 m -127.62 149.94 49.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 140' ' ' TRP . 1.5 t80 -145.01 137.25 25.93 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -127.58 153.87 45.87 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.377 1.071 . . . . 0.0 108.774 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -131.52 154.82 48.39 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 168.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.4 m -136.66 156.77 48.09 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.914 2.086 . . . . 0.0 108.534 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -134.1 97.17 3.79 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.3 90.97 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 60.79 -93.11 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 126.656 1.982 . . . . 0.0 110.573 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.17 1.76 20.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.349 0.977 . . . . 0.0 112.633 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.37 112.81 41.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-N 119.847 1.203 . . . . 0.0 108.599 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.43 136.47 57.92 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 162.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.9 t -125.86 116.85 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 169.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.48 149.84 20.04 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 170.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 87.6 m -141.12 120.42 13.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 164.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.418 ' HB3' ' CE2' ' A' ' 127' ' ' TYR . 5.6 p-90 -90.88 141.89 28.34 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 170.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.96 134.88 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.69 164.39 14.73 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 172.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -146.63 104.09 0.29 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.47 -179.83 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.372 1.869 . . . . 0.0 105.989 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 146.15 -115.12 0.78 Allowed Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 106.883 -2.487 . . . . 0.0 106.883 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -147.75 175.8 10.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.01 1.324 . . . . 0.0 110.679 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -140.28 165.81 26.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 164.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 C--O 1.25 1.101 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 170.203 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.447 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 2.5 p -140.48 141.38 35.41 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 168.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -122.93 158.78 29.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 m -145.78 154.82 42.45 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 166.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.1 98.96 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.1 p -117.47 135.15 54.12 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.928 1.291 . . . . 0.0 107.917 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.12 168.42 38.56 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.44 -169.15 42.1 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.483 -173.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -92.04 157.86 16.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.722 1.209 . . . . 0.0 109.026 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.02 172.91 8.17 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.157 0.983 . . . . 0.0 111.307 -174.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -148.24 104.56 3.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 155.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t -84.39 134.02 34.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 157.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -103.28 171.38 7.4 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.37 158.25 44.02 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 161.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.16 97.45 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 162.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.16 -29.81 2.68 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.778 1.18 . . . . 0.0 110.664 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -151.1 93.88 1.98 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -88.34 69.52 9.06 Favored 'General case' 0 C--N 1.335 -0.065 0 CA-C-O 123.954 1.835 . . . . 0.0 107.005 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.49 -177.77 4.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 128.168 2.587 . . . . 0.0 108.476 -168.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -90.79 96.78 10.81 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 164.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 62.2 mtm -70.57 159.23 34.73 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 138.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.77 -161.91 17.96 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.46 -140.48 5.04 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -160.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.99 154.45 20.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.864 1.266 . . . . 0.0 109.703 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -137.66 153.89 49.78 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.452 2.701 . . . . 0.0 107.634 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -150.25 141.41 23.1 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.787 1.635 . . . . 0.0 107.768 168.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -116.43 146.42 42.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.693 1.997 . . . . 0.0 107.363 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.66 110.91 10.19 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -93.23 157.7 16.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -143.63 158.25 43.81 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.823 0.283 . . . . 0.0 110.553 165.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.447 ' CD ' ' HG1' ' A' ' 2' ' ' THR . 13.3 pt-20 -125.02 112.55 16.69 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.564 0.697 . . . . 0.0 109.147 169.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.0 164.09 21.69 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.81 8.44 41.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.777 1.631 . . . . 0.0 112.912 -169.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -1.27 22.55 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -172.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.06 139.82 8.36 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 126.555 1.942 . . . . 0.0 107.306 166.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.79 81.06 2.45 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.516 2.144 . . . . 0.0 108.301 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 tp -150.65 156.65 41.77 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.202 1.801 . . . . 0.0 107.94 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.18 -177.9 15.26 Favored Glycine 0 C--O 1.226 -0.346 0 O-C-N 121.571 -0.706 . . . . 0.0 111.539 172.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.2 t -143.5 137.37 25.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.367 1.467 . . . . 0.0 108.25 -165.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.6 mm -139.9 141.39 34.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.977 1.311 . . . . 0.0 109.91 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.64 167.89 20.64 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 107.729 -2.149 . . . . 0.0 107.729 144.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.8 t -127.45 155.27 43.95 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.208 -1.76 . . . . 0.0 106.877 143.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -98.48 143.82 28.49 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 165.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -127.7 134.18 49.57 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.858 1.263 . . . . 0.0 108.389 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -141.96 123.87 15.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.593 1.157 . . . . 0.0 108.395 -172.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -99.21 126.85 45.1 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -163.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -139.14 0.48 1.93 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.308 0.575 . . . . 0.0 112.254 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.19 123.49 26.97 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.001 -1.687 . . . . 0.0 109.1 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.9 p -67.06 152.25 46.12 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.396 0.998 . . . . 0.0 110.633 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 157.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.8 t80 . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -62.74 109.2 1.35 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.244 0.929 . . . . 0.0 109.908 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -121.25 170.93 9.11 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.259 1.424 . . . . 0.0 110.968 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.45 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 8.0 t30 58.22 -159.0 0.28 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.71 1.604 . . . . 0.0 111.112 175.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.45 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -128.77 158.64 38.09 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 120.507 -1.371 . . . . 0.0 108.616 174.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -115.73 158.95 22.06 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -127.91 157.14 41.33 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.312 1.845 . . . . 0.0 107.77 -173.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.32 88.82 0.14 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.73 113.47 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.9 m -131.16 128.0 39.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.59 149.28 25.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.373 1.069 . . . . 0.0 108.969 -174.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.13 175.87 31.58 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 166.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.66 175.4 11.15 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.451 2.768 . . . . 0.0 113.036 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.51 138.58 52.34 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.283 1.833 . . . . 0.0 110.712 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -121.02 128.42 52.66 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.08 1.352 . . . . 0.0 108.93 -168.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.53 149.45 24.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.71 0.804 . . . . 0.0 110.223 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.88 179.06 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 163.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -61.32 -52.65 63.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.617 -1.302 . . . . 0.0 110.718 -176.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -159.98 148.52 17.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 149.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 11.6 m0 145.1 -49.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 130.746 3.618 . . . . 0.0 108.87 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.71 168.69 22.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.758 0.823 . . . . 0.0 109.516 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 m -133.48 156.99 46.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 163.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 pt -127.47 167.68 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.84 2.056 . . . . 0.0 108.575 -176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.15 123.96 26.61 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.268 -0.895 . . . . 0.0 108.885 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.43 86.58 0.4 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 106.908 -2.477 . . . . 0.0 106.908 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.66 -176.62 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.336 0.655 . . . . 0.0 109.867 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.4 m -116.33 151.01 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 166.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.77 158.4 20.05 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 167.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.8 p -145.86 121.62 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.05 106.35 3.22 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -108.59 117.4 34.07 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.43 174.1 19.41 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm . . . . . 0 CA--C 1.516 -0.355 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 170.523 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -141.11 159.26 42.58 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 165.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -85.68 165.83 16.65 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.494 -0.754 . . . . 0.0 110.267 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.51 142.31 14.27 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 163.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -118.11 93.2 4.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.572 1.186 . . . . 0.0 109.034 -160.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.7 t -87.21 147.51 25.55 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.976 0.893 . . . . 0.0 110.198 -173.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.12 144.24 51.25 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 128.398 2.679 . . . . 0.0 106.479 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.69 -170.13 14.56 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 -165.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -166.97 -65.53 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.413 1.107 . . . . 0.0 109.203 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 155.11 174.35 24.91 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -167.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.2 mp -145.17 143.84 30.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -104.24 149.51 25.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -173.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.8 171.17 8.82 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -58.75 142.16 84.21 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-O 119.165 -0.445 . . . . 0.0 109.865 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.43 152.55 78.62 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 120.931 1.087 . . . . 0.0 111.007 172.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -109.09 -174.19 2.45 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 130.955 3.702 . . . . 0.0 105.503 162.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -110.93 -11.8 14.3 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.309 1.844 . . . . 0.0 109.294 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -142.01 17.22 2.11 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.176 1.39 . . . . 0.0 111.6 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.82 156.04 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 172.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.41 156.71 42.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.777 0.717 . . . . 0.0 109.166 157.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -136.89 122.36 19.54 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.991 2.117 . . . . 0.0 108.403 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -124.61 160.52 28.28 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.773 2.429 . . . . 0.0 107.64 163.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -140.87 116.69 10.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.23 144.16 51.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.418 0.554 . . . . 0.0 109.939 -168.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -137.29 156.62 48.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -129.79 147.61 51.59 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 155.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -132.84 112.2 11.72 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.8 t -139.56 160.3 40.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.624 1.57 . . . . 0.0 108.228 -157.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.65 145.83 37.11 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.45 110.35 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 171.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 50.17 40.91 23.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.302 1.041 . . . . 0.0 111.97 -173.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 m 47.76 36.84 6.19 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.6 t -81.48 112.79 19.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 143.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.16 137.2 58.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.5 t -139.26 97.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.88 152.4 34.98 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 164.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.8 m -141.0 130.88 24.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 120.775 -1.427 . . . . 0.0 108.047 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -121.23 143.19 49.28 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.8 mt -144.75 132.31 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.805 1.242 . . . . 0.0 107.873 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.61 165.88 14.51 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -154.26 87.36 0.13 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.66 162.61 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 152.81 -119.37 0.95 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -150.59 176.38 11.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.119 1.368 . . . . 0.0 109.564 -158.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 137.9 23.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.039 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 12.0 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-N 119.34 0.973 . . . . 0.0 108.655 167.288 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 p -141.08 136.95 32.49 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 t -127.9 106.81 9.36 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -117.24 118.8 33.3 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.281 5.9 p -110.56 119.41 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 122.006 0.908 . . . . 0.0 111.093 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.32 137.77 23.36 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.728 1.211 . . . . 0.0 108.943 -167.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.5 170.07 40.08 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.59 -152.01 10.02 Favored Glycine 0 C--N 1.319 -0.375 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -172.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -91.87 157.7 16.71 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.47 113.29 11.68 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 169.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.32 148.04 29.52 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.8 t -138.88 115.57 10.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.982 2.113 . . . . 0.0 107.206 -171.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.38 160.69 34.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.068 0.947 . . . . 0.0 109.163 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.72 148.47 52.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.727 0.811 . . . . 0.0 110.986 -167.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 54.65 -70.15 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 128.323 2.649 . . . . 0.0 112.067 -175.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.75 -42.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.7 0 CA-C-N 119.975 1.261 . . . . 0.0 111.04 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -145.21 119.49 9.55 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.438 1.095 . . . . 0.0 108.461 164.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.2 ttm -157.18 -51.75 0.07 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.212 1.005 . . . . 0.0 109.324 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -142.19 158.22 43.98 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.232 1.813 . . . . 0.0 107.733 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -135.76 77.33 1.66 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 170.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.06 138.62 49.06 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 166.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.84 157.22 27.34 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.61 -166.68 38.17 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -170.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -99.89 154.74 18.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.326 0.563 . . . . 0.0 110.402 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -102.43 144.06 31.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.939 1.296 . . . . 0.0 108.271 161.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.0 mt -127.13 150.86 49.3 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 149.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.45 161.09 41.77 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 165.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -144.16 140.41 29.35 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -120.08 114.48 22.05 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.246 0.93 . . . . 0.0 109.357 169.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -99.32 151.92 20.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 163.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -134.69 130.57 36.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -172.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 3.8 tt0 -76.71 163.11 27.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.352 1.072 . . . . 0.0 112.11 -161.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.408 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 5.2 t70 -86.71 27.47 0.98 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.616 1.566 . . . . 0.0 110.885 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -143.1 -65.05 0.39 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.156 1.782 . . . . 0.0 108.983 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.5 p -92.96 127.8 46.03 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.872 1.669 . . . . 0.0 108.921 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -76.92 54.81 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 124.088 3.192 . . . . 0.0 110.252 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.27 106.65 5.81 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.631 2.373 . . . . 0.0 106.73 -159.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.18 178.72 22.07 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.984 1.278 . . . . 0.0 111.082 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.85 144.68 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 124.266 1.026 . . . . 0.0 109.555 -156.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.7 mt -126.54 109.8 21.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.94 1.296 . . . . 0.0 108.083 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.01 148.04 18.35 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 105.862 -2.895 . . . . 0.0 105.862 151.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 p -108.89 144.17 37.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.255 1.027 . . . . 0.0 109.196 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -91.9 145.79 24.27 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 162.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 t -128.91 152.44 48.55 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.061 1.744 . . . . 0.0 108.084 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -136.98 156.65 48.17 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 175.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.4 m -98.35 121.96 40.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 165.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.56 53.45 1.05 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.474 2.31 . . . . 0.0 107.108 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -158.93 146.63 17.75 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 128.524 2.729 . . . . 0.0 108.464 169.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 p -127.7 156.66 42.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.929 2.491 . . . . 0.0 107.599 163.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.862 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -66.06 107.08 1.78 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.396 -171.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -135.8 146.25 47.37 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 118.739 0.699 . . . . 0.0 110.213 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 51.2 -161.69 0.08 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.352 1.861 . . . . 0.0 110.745 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.67 176.13 7.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.154 1.381 . . . . 0.0 111.527 -171.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -89.3 130.87 35.62 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 160.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.63 120.04 41.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 165.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.31 88.67 0.19 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.47 141.07 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 p -126.36 155.79 41.52 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.737 1.615 . . . . 0.0 107.782 171.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.62 150.58 45.14 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.74 0.7 . . . . 0.0 110.284 170.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 173.53 137.35 2.39 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 174.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.22 164.83 34.4 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 CA-C-N 120.405 2.102 . . . . 0.0 110.706 167.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.14 103.98 13.07 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.236 1.414 . . . . 0.0 107.879 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.71 112.24 21.47 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.336 0.516 . . . . 0.0 109.713 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -67.96 136.67 54.3 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 168.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.84 178.67 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 126.91 2.084 . . . . 0.0 105.88 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.8 t30 38.39 -121.37 0.26 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.435 1.494 . . . . 0.0 109.077 -162.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -110.19 104.14 12.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.202 1.801 . . . . 0.0 108.631 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 65.8 m95 60.84 19.46 9.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.381 2.272 . . . . 0.0 114.73 167.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.57 -169.85 0.92 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.293 0.951 . . . . 0.0 110.468 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.1 m -140.95 169.16 18.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.148 1.379 . . . . 0.0 107.726 167.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.8 mm -133.83 158.61 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 122.804 1.288 . . . . 0.0 109.235 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -105.43 175.48 5.48 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 130.048 3.339 . . . . 0.0 109.627 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 54.05 0.88 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.58 173.22 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.35 160.41 10.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 O-C-N 120.525 -1.359 . . . . 0.0 108.26 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -156.42 165.45 32.91 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-O 122.182 0.879 . . . . 0.0 112.936 162.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -115.26 150.51 17.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 127.055 2.142 . . . . 0.0 106.065 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.89 149.78 18.41 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 165.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -150.77 145.47 25.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.042 1.337 . . . . 0.0 108.944 172.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.62 -133.87 12.07 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.3 tttp . . . . . 0 N--CA 1.474 0.77 0 C-N-CA 128.586 2.754 . . . . 0.0 114.709 178.431 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.64 128.74 36.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -171.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -114.68 142.83 45.96 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -102.35 168.5 18.79 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -138.43 151.72 47.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 164.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -169.4 -164.47 0.45 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.775 0.83 . . . . 0.0 110.56 166.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -134.5 160.3 38.44 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.51 1.924 . . . . 0.0 108.446 -176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -153.25 -158.19 8.43 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.771 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -139.83 168.76 19.06 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -167.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.24 86.42 0.1 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mt -130.15 149.85 51.67 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.6 1.16 . . . . 0.0 107.939 -173.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -135.25 158.88 43.24 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.199 0.454 . . . . 0.0 111.602 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -101.01 171.14 7.82 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.711 1.204 . . . . 0.0 107.77 166.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -56.77 107.01 0.76 Allowed Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.619 0.768 . . . . 0.0 110.653 -170.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.89 158.06 34.81 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.963 2.442 . . . . 0.0 109.59 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' H ' ' A' ' 120' ' ' ASN . 49.4 ttm -135.95 159.82 40.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.127 1.371 . . . . 0.0 109.189 -174.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -69.88 25.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 130.873 3.669 . . . . 0.0 110.75 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 118' ' ' MET . 0.4 OUTLIER -155.14 -32.16 0.1 Allowed 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.885 -1.135 . . . . 0.0 113.015 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.5 m -145.78 135.77 18.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -174.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.19 155.32 18.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.098 0.863 . . . . 0.0 109.427 168.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -130.44 114.08 15.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 155.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.01 148.99 45.68 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.415 2.286 . . . . 0.0 105.607 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -149.83 138.98 21.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 120.644 -1.285 . . . . 0.0 109.471 -162.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.7 m -134.45 166.37 23.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 166.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -145.98 137.89 25.14 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -134.4 163.6 29.3 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -122.02 169.81 10.46 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 127.018 2.127 . . . . 0.0 106.48 170.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.7 t -131.82 159.9 37.19 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 163.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -123.82 97.08 5.2 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.3 mt -86.88 81.95 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 65.94 -78.92 0.03 OUTLIER 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.248 2.219 . . . . 0.0 111.11 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -146.15 61.06 1.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.167 1.787 . . . . 0.0 107.102 166.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.9 t -125.08 145.61 32.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 162.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.25 137.17 39.95 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.864 1.666 . . . . 0.0 107.423 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.4 t -138.45 151.52 24.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 126.649 1.98 . . . . 0.0 106.937 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -137.05 143.86 15.27 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -140.48 135.99 32.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -123.83 131.18 53.54 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.5 115.93 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.499 . . . . 0.0 107.504 -166.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.85 152.3 21.34 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.143 0.577 . . . . 0.0 110.055 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.26 82.56 0.29 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.818 1.675 . . . . 0.0 109.719 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.8 t -104.19 158.41 5.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 126.516 1.926 . . . . 0.0 106.704 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.33 -107.25 0.28 Allowed Glycine 0 C--O 1.221 -0.677 0 C-N-CA 118.657 -1.735 . . . . 0.0 112.799 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.5 165.85 23.27 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.046 1.738 . . . . 0.0 106.858 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -148.99 136.24 20.09 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 119.835 -1.79 . . . . 0.0 111.555 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 128.805 2.842 . . . . 0.0 111.252 168.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.6 m -141.2 125.01 16.98 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -98.86 132.63 44.06 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.496 1.119 . . . . 0.0 109.159 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -143.58 118.78 10.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.38 143.82 10.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.4 m -158.35 139.57 13.29 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.971 1.708 . . . . 0.0 107.989 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.48 172.59 31.15 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.81 -160.68 29.0 Favored Glycine 0 N--CA 1.462 0.384 0 CA-C-N 120.33 2.065 . . . . 0.0 110.903 -172.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -91.71 157.34 16.99 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.405 1.102 . . . . 0.0 109.845 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' HB2' HD22 ' A' ' 25' ' ' ASN . . . -119.93 155.07 33.48 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.517 1.527 . . . . 0.0 110.035 -175.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -148.09 118.35 7.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 162.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -83.79 139.63 32.57 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 167.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -116.68 153.86 31.59 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 157.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.1 106.57 3.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.547 1.939 . . . . 0.0 108.524 -171.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 71.38 -54.1 0.67 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.762 2.025 . . . . 0.0 112.63 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.81 -81.38 0.05 OUTLIER Glycine 0 C--N 1.337 0.638 0 CA-C-N 119.469 1.031 . . . . 0.0 114.257 -172.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -152.57 95.87 2.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.279 1.539 . . . . 0.0 108.913 166.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.8 mtt -144.71 -48.87 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.654 0.782 . . . . 0.0 110.314 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -128.37 109.73 11.7 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -169.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -131.41 77.84 1.8 Allowed 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.717 1.207 . . . . 0.0 107.89 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.81 145.23 47.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 169.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.36 -179.93 34.52 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 128.678 3.037 . . . . 0.0 106.747 167.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.81 -90.95 0.08 OUTLIER Glycine 0 CA--C 1.523 0.545 0 CA-C-N 118.998 1.399 . . . . 0.0 110.646 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -164.71 143.09 6.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 168.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.429 HD22 ' HB2' ' A' ' 10' ' ' ALA . 38.9 m-80 -125.32 163.26 22.93 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.133 0.973 . . . . 0.0 110.233 -166.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 mt -142.79 163.1 33.72 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.148 0.979 . . . . 0.0 110.516 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -140.03 161.06 38.51 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.477 2.311 . . . . 0.0 106.538 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -147.81 112.19 5.26 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -105.3 159.42 15.9 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.163 -0.96 . . . . 0.0 108.945 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -142.77 155.84 44.89 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.942 0.897 . . . . 0.0 108.86 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.41 113.06 19.78 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.335 0.654 . . . . 0.0 109.781 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.85 159.2 26.54 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.304 0.574 . . . . 0.0 109.674 167.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -128.83 39.54 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.66 -16.32 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.995 1.318 . . . . 0.0 112.15 -173.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.6 t -155.07 133.48 7.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.854 1.662 . . . . 0.0 108.193 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.84 -5.0 16.39 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.312 3.342 . . . . 0.0 113.867 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -77.5 123.97 27.29 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.105 -0.997 . . . . 0.0 109.025 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.36 -167.39 36.91 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.7 t -127.08 147.78 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.344 1.458 . . . . 0.0 108.675 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 mm -122.48 127.85 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 166.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.17 108.71 0.39 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 107.226 -2.35 . . . . 0.0 107.226 163.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.6 t -88.23 150.72 23.12 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.849 1.66 . . . . 0.0 108.293 167.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -127.72 131.13 49.75 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.394 1.878 . . . . 0.0 107.976 172.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -127.32 117.0 21.39 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.978 1.711 . . . . 0.0 109.073 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -113.52 133.91 54.97 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.284 1.434 . . . . 0.0 107.827 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 p -126.6 130.06 49.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.318 0.58 . . . . 0.0 110.878 -168.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -140.17 93.21 2.61 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.363 1.465 . . . . 0.0 108.155 -170.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -162.75 147.46 11.81 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.879 0.872 . . . . 0.0 109.11 -174.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.1 p -121.63 153.93 37.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.51 -0.564 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 119.646 -0.216 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.21 122.34 6.72 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.758 -0.589 . . . . 0.0 109.843 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -115.26 171.64 7.57 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.892 1.677 . . . . 0.0 108.516 170.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.89 -176.01 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.379 1.072 . . . . 0.0 110.202 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 pm0 -137.1 162.15 34.16 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 160.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -83.87 143.09 30.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.61 117.71 21.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.844 2.057 . . . . 0.0 106.455 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.87 92.98 1.05 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.3 mm -79.71 146.43 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 p -133.66 155.42 49.74 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.02 139.21 21.22 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.22 175.33 34.96 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.176 0.417 . . . . 0.0 112.249 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -79.02 176.04 10.26 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.886 2.391 . . . . 0.0 110.351 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.01 150.48 38.54 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.631 1.173 . . . . 0.0 108.841 162.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.2 124.2 41.93 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.099 0.96 . . . . 0.0 108.571 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -71.8 133.27 45.42 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.012 0.369 . . . . 0.0 110.049 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.8 mt -77.95 -76.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 165.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -83.09 -76.07 0.29 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 170.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -148.09 -62.01 0.26 Allowed 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -104.48 105.95 16.27 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.279 1.037 . . . . 0.0 109.56 172.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.42 -169.02 3.24 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.389 1.876 . . . . 0.0 108.754 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.97 169.67 17.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 157.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mm -143.06 147.3 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -105.4 141.59 36.65 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.425 2.29 . . . . 0.0 107.972 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.82 50.42 0.21 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -161.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.04 176.4 4.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.55 130.22 54.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.55 158.41 15.13 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.01 118.36 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 170.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.63 122.69 7.62 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 107.372 -2.291 . . . . 0.0 107.372 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -132.63 116.93 17.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -169.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.23 101.55 0.22 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt . . . . . 0 C--O 1.234 0.249 0 CA-C-N 117.666 0.733 . . . . 0.0 109.654 165.608 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.67 165.13 35.11 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.997 -1.065 . . . . 0.0 110.894 170.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.17 109.48 18.92 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 166.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.86 93.42 1.89 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -74.52 111.65 9.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.64 1.176 . . . . 0.0 109.704 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 p -105.79 151.06 24.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.33 1.052 . . . . 0.0 111.211 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -136.85 80.84 1.84 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.468 1.907 . . . . 0.0 107.972 -170.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.08 -161.48 11.0 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 126.512 2.005 . . . . 0.0 108.144 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.28 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 153.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.71 170.83 30.19 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -171.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -133.29 150.83 51.88 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.58 1.952 . . . . 0.0 106.836 -177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -132.64 154.2 50.33 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.139 0.971 . . . . 0.0 110.023 -171.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -104.64 174.44 5.88 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 128.044 2.537 . . . . 0.0 109.107 173.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -55.62 114.09 6.75 Favored Pre-proline 0 C--O 1.234 0.269 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.28 103.56 1.7 Allowed 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.044 -1.56 . . . . 0.0 108.044 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.1 ttt -74.64 155.55 37.67 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -54.64 -33.25 60.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 126.787 2.035 . . . . 0.0 110.991 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -104.45 -25.95 12.6 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 117.271 -1.347 . . . . 0.0 113.602 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.93 109.47 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.308 0.958 . . . . 0.0 108.885 -174.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.97 154.17 42.04 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 162.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -132.26 116.35 16.81 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 168.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.84 146.58 37.74 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.913 2.085 . . . . 0.0 107.301 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -129.68 135.61 48.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.3 m -124.23 148.24 47.47 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 171.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -149.86 132.92 16.24 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -136.63 145.22 44.61 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.62 1.568 . . . . 0.0 107.693 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -116.75 129.07 55.89 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 171.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 t -111.11 159.57 17.7 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.188 0.995 . . . . 0.0 108.934 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -136.45 97.4 3.56 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -172.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.57 94.34 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 167.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.3 ttm-85 63.93 58.53 1.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.618 1.167 . . . . 0.0 111.741 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m 53.72 27.89 7.47 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.342 1.057 . . . . 0.0 113.073 171.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.45 149.0 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.392 1.477 . . . . 0.0 108.094 172.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.72 102.4 13.6 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 169.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.3 t -131.85 103.68 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.87 133.17 7.49 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.4 t -125.48 139.89 53.24 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.479 1.512 . . . . 0.0 107.457 -175.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -129.7 151.18 50.57 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 171.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.8 pt -136.23 145.16 31.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.13 158.04 18.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.25 101.95 0.36 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 106.664 -2.574 . . . . 0.0 106.664 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.87 160.44 20.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.06 -149.84 9.45 Favored Glycine 0 C--O 1.221 -0.718 0 C-N-CA 118.688 -1.72 . . . . 0.0 109.799 -172.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -162.66 175.32 11.49 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.937 1.695 . . . . 0.0 106.988 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -102.98 147.67 26.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 C--O 1.249 1.064 0 C-N-CA 126.174 1.789 . . . . 0.0 108.049 170.79 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 p -131.82 137.58 48.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -132.21 106.89 8.23 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.8 t -135.96 127.21 28.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.259 9.7 p -101.93 153.4 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.735 0.779 . . . . 0.0 109.512 -173.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.463 ' HG1' ' HB3' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -158.9 124.08 4.24 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 174.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.39 -172.7 45.67 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 118.594 0.634 . . . . 0.0 113.235 -166.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.31 -116.44 1.54 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.602 1.572 . . . . 0.0 110.818 169.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.35 146.26 45.47 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.617 1.209 . . . . 0.0 108.307 -163.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.39 120.84 24.88 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -169.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -99.65 148.15 24.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 168.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -130.93 131.34 44.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 165.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -119.25 111.17 17.87 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.4 143.04 27.03 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.324 1.049 . . . . 0.0 108.286 -170.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 60.89 -75.48 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.243 1.817 . . . . 0.0 109.537 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.46 -73.35 0.02 OUTLIER Glycine 0 CA--C 1.52 0.405 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -126.12 105.91 9.2 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ttt -148.21 -54.63 0.2 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.206 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -144.62 133.05 21.94 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -167.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -121.15 77.82 1.35 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -170.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -58.08 157.73 7.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.294 1.437 . . . . 0.0 110.31 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.69 155.16 26.25 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.07 -175.4 39.4 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 118.386 1.093 . . . . 0.0 111.688 -173.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.11 146.43 43.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.771 0.785 . . . . 0.0 111.604 -164.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.422 HD22 ' HA ' ' A' ' 44' ' ' THR . 1.0 OUTLIER -139.36 152.52 47.22 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.536 1.935 . . . . 0.0 109.531 176.454 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -156.28 116.11 3.59 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.667 0.787 . . . . 0.0 108.883 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 128.6 38.82 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.513 1.125 . . . . 0.0 109.58 175.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -95.74 141.5 29.14 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.778 2.431 . . . . 0.0 108.095 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 69.7 mtm-85 -128.37 162.85 26.13 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.958 1.254 . . . . 0.0 109.74 166.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.21 138.52 31.53 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -88.09 135.16 33.55 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 171.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -136.48 162.22 33.69 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.768 0.827 . . . . 0.0 110.639 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.68 47.09 2.18 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.247 1.419 . . . . 0.0 108.411 -166.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.51 -48.18 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.708 1.203 . . . . 0.0 109.455 171.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.97 115.07 45.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.602 1.161 . . . . 0.0 108.375 175.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.99 -43.81 6.1 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.809 1.673 . . . . 0.0 109.901 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -73.09 148.33 44.11 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.125 2.17 . . . . 0.0 110.597 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.72 -178.21 36.61 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.677 1.132 . . . . 0.0 110.613 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.5 t -117.95 139.57 44.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.353 1.861 . . . . 0.0 108.519 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 mm -134.04 127.36 51.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 124.502 1.121 . . . . 0.0 108.301 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.02 108.86 0.37 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 172.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 t -126.71 155.01 43.36 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.704 -0.88 . . . . 0.0 108.666 161.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -114.91 147.78 39.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.422 ' HA ' HD22 ' A' ' 25' ' ' ASN . 1.2 p -116.24 115.22 25.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -169.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -142.8 123.76 14.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.3 p -140.83 124.7 17.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -165.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -137.09 90.58 2.54 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -125.79 120.96 31.96 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 p -65.55 155.82 34.54 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.706 2.002 . . . . 0.0 110.457 -170.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 . . . . . 0 N--CA 1.448 -0.54 0 CA-C-O 122.242 1.02 . . . . 0.0 108.694 166.365 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -70.89 62.49 0.28 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.566 1.947 . . . . 0.0 111.551 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -86.28 167.43 14.83 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.643 1.577 . . . . 0.0 110.589 -171.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 m120 50.41 -163.1 0.05 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.076 1.35 . . . . 0.0 110.032 -165.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -147.15 169.02 20.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.69 1.196 . . . . 0.0 109.599 -164.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -78.42 158.58 28.67 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.224 1.01 . . . . 0.0 108.686 159.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -135.87 117.74 15.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 161.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.49 154.1 16.63 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 170.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 tt -142.16 112.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.1 p -128.58 126.85 41.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.38 155.67 43.3 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.12 165.45 38.77 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 171.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.98 168.58 16.88 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 CA-C-N 119.622 1.711 . . . . 0.0 109.572 156.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.01 154.9 19.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 159.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -93.02 154.81 17.91 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 152.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -140.42 96.71 3.08 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.89 -55.5 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 118.039 0.381 . . . . 0.0 110.294 -170.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -79.17 178.53 7.99 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.983 1.313 . . . . 0.0 108.67 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.91 47.48 1.26 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.29 1.036 . . . . 0.0 110.333 172.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 22.2 p-90 -156.16 -57.93 0.09 Allowed 'General case' 0 CA--C 1.529 0.152 0 O-C-N 120.975 -1.078 . . . . 0.0 110.15 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.43 154.02 44.23 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.999 0.92 . . . . 0.0 108.674 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -147.67 168.35 22.27 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.911 0.884 . . . . 0.0 110.609 -176.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -128.15 146.33 33.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -175.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -150.44 158.96 44.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.367 0.667 . . . . 0.0 109.773 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.3 129.87 7.32 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.45 151.89 6.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.17 159.79 13.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 123.843 0.857 . . . . 0.0 109.396 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 157.52 -136.39 4.84 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.55 151.06 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -166.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.89 158.38 22.25 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 161.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -149.45 160.34 43.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.122 1.769 . . . . 0.0 107.777 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.58 172.91 33.55 Favored Glycine 0 C--N 1.331 0.282 0 O-C-N 120.861 -1.149 . . . . 0.0 111.562 175.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? . . . . . 0 CA--C 1.52 -0.173 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 171.48 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.55 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -151.52 171.64 17.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.77 0.714 . . . . 0.0 110.918 166.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -102.94 94.87 5.79 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -83.89 130.95 10.06 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -74.13 150.58 40.4 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.084 0.942 . . . . 0.0 109.162 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.0 m -131.35 135.98 47.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -155.42 95.72 1.72 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -172.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.01 169.57 13.59 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 125.06 1.314 . . . . 0.0 111.293 -169.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.02 156.76 32.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.817 1.247 . . . . 0.0 108.747 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.4 150.34 20.71 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -138.26 139.75 39.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 -169.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -136.66 139.55 42.1 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.954 0.797 . . . . 0.0 110.199 -169.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -118.94 171.19 8.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.334 1.454 . . . . 0.0 108.208 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -59.89 114.6 10.1 Favored Pre-proline 0 N--CA 1.456 -0.152 0 C-N-CA 125.546 1.539 . . . . 0.0 107.912 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -81.48 122.81 4.15 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.468 1.446 . . . . 0.0 109.323 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.1 ttm -170.53 149.68 3.3 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.143 2.177 . . . . 0.0 107.051 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 117.3 12.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 131.23 3.812 . . . . 0.0 109.409 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 62.03 28.81 17.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.098 1.759 . . . . 0.0 111.196 -160.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.09 145.99 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.696 1.198 . . . . 0.0 108.4 156.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.38 163.13 23.06 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 120.183 -1.573 . . . . 0.0 109.927 149.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -118.99 113.56 21.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 158.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.463 ' HB3' ' HG1' ' A' ' 6' ' ' THR . 3.2 t0 -148.36 149.54 31.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 173.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -129.45 151.71 49.78 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.31 0.959 . . . . 0.0 109.997 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.9 m -136.31 145.92 46.03 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.903 0.881 . . . . 0.0 110.729 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -138.76 148.38 43.8 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.671 1.988 . . . . 0.0 107.473 162.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -137.25 147.94 46.09 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 165.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -132.0 129.15 39.75 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 169.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.6 m -140.36 154.34 46.71 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.536 1.134 . . . . 0.0 108.098 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -121.6 98.13 5.82 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 121.449 -0.782 . . . . 0.0 109.388 -171.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.1 mm -66.0 91.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 67.27 -79.67 0.04 OUTLIER 'General case' 0 C--O 1.232 0.146 0 C-N-CA 127.924 2.49 . . . . 0.0 109.144 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.2 p -134.4 -2.16 2.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.12 1.368 . . . . 0.0 111.92 -170.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.17 149.31 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.366 1.066 . . . . 0.0 108.222 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.62 156.52 25.09 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.6 t -142.61 143.45 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 163.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -140.86 128.18 3.67 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -126.08 142.72 51.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -169.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -134.26 119.18 18.41 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 -165.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.1 mp -128.67 136.64 59.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.18 157.95 18.08 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -127.37 65.27 0.57 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.7 m -124.76 -176.35 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.519 1.527 . . . . 0.0 110.652 -164.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.27 -84.14 0.17 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 117.001 1.56 . . . . 0.0 117.001 174.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -163.32 177.41 8.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.699 2.799 . . . . 0.0 107.976 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -132.61 140.53 48.27 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 119.33 -2.106 . . . . 0.0 110.092 161.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 128.509 2.723 . . . . 0.0 113.367 169.05 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 t -142.1 165.75 26.59 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 121.32 -0.863 . . . . 0.0 108.816 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 m -134.06 140.86 46.93 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.3 t -157.75 161.1 38.46 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 120.424 -1.422 . . . . 0.0 107.545 -171.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.75 119.77 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -160.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 p -135.49 155.36 50.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.469 1.128 . . . . 0.0 110.456 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.14 -159.2 30.9 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -164.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.03 -127.06 7.48 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -164.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -134.72 149.15 50.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.682 0.793 . . . . 0.0 109.061 -171.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.28 113.83 21.46 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 105.474 -2.046 . . . . 0.0 105.474 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -124.96 123.52 40.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -162.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.3 t -139.29 140.5 37.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.936 1.295 . . . . 0.0 107.75 -163.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -138.96 157.94 45.11 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.378 1.071 . . . . 0.0 110.746 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.17 165.05 12.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.406 1.082 . . . . 0.0 111.73 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -73.59 61.08 0.7 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.463 1.105 . . . . 0.0 110.318 168.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.65 104.02 0.28 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -53.74 96.32 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.326 2.251 . . . . 0.0 111.357 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 96.7 mtp -149.35 -56.4 0.19 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.906 2.082 . . . . 0.0 107.834 173.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.15 111.94 19.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.148 1.379 . . . . 0.0 109.231 -170.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.57 150.33 41.04 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 45.6 mtt -115.42 143.41 45.34 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.096 1.759 . . . . 0.0 107.01 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.26 168.05 40.62 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 126.601 2.048 . . . . 0.0 108.055 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.83 -85.03 0.1 OUTLIER Glycine 0 C--O 1.225 -0.41 0 N-CA-C 107.916 -2.073 . . . . 0.0 107.916 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -146.36 172.07 14.05 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.635 1.974 . . . . 0.0 108.633 173.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -125.35 152.76 44.32 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 160.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 tp -145.74 140.26 27.07 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.675 0.671 . . . . 0.0 109.358 161.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -138.98 163.21 32.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.167 1.387 . . . . 0.0 107.523 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -143.39 140.24 30.37 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -132.78 144.04 49.98 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -117.27 147.16 42.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 161.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.87 136.69 32.58 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 156.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -86.73 179.13 6.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.28 2.232 . . . . 0.0 111.232 -166.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.81 -22.67 14.32 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.442 -0.786 . . . . 0.0 112.071 165.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.62 5.25 33.54 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.106 1.362 . . . . 0.0 113.209 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -153.44 104.02 2.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.94 1.696 . . . . 0.0 106.81 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.05 78.29 3.22 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.993 2.462 . . . . 0.0 109.463 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 tp -149.78 131.71 15.2 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.084 0.954 . . . . 0.0 109.748 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.16 176.75 18.74 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 168.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 m -137.11 160.48 36.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 125.938 1.695 . . . . 0.0 108.988 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mm -140.17 109.74 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.387 1.475 . . . . 0.0 107.729 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.69 167.06 33.27 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 153.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p -125.5 151.54 46.16 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 118.685 1.242 . . . . 0.0 108.804 146.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.61 148.89 27.77 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.905 1.23 . . . . 0.0 109.206 156.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -94.11 148.97 21.66 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 162.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -143.08 110.08 5.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.289 1.404 . . . . 0.0 108.161 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.8 p -101.97 120.57 40.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 121.191 1.814 . . . . 0.0 111.224 -166.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -162.61 76.75 0.45 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.057 1.343 . . . . 0.0 108.289 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -162.42 114.15 1.61 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 164.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 155.57 39.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.845 1.202 . . . . 0.0 110.225 174.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 123.235 1.493 . . . . 0.0 107.961 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -67.26 105.11 1.64 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.645 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -143.85 114.67 7.73 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.598 1.09 . . . . 0.0 108.669 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 151.56 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.024 2.93 . . . . 0.0 106.482 -164.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.8 170.46 8.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.704 1.602 . . . . 0.0 107.69 -162.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -76.81 143.05 40.04 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.9 -1.125 . . . . 0.0 109.719 166.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -141.63 118.35 11.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.735 1.614 . . . . 0.0 107.018 161.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.89 158.09 28.8 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.454 -1.859 . . . . 0.0 108.454 162.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.39 143.77 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 169.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.5 m -139.67 148.05 41.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 161.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.96 150.03 28.82 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.386 0.674 . . . . 0.0 110.897 -164.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.02 163.52 12.85 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.94 1.733 . . . . 0.0 110.861 166.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.68 172.46 15.73 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.736 2.291 . . . . 0.0 110.526 168.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.62 153.89 47.44 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.484 1.114 . . . . 0.0 109.81 163.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -151.17 151.54 32.06 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -164.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -82.07 149.91 27.8 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.127 0.571 . . . . 0.0 109.634 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.55 -103.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 162.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.02 0.73 1.4 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.218 1.372 . . . . 0.0 112.881 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -113.77 -118.99 0.31 Allowed 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -129.87 -9.31 4.43 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -165.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.53 159.7 30.12 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 121.606 2.003 . . . . 0.0 109.578 164.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.6 m -135.86 125.06 24.56 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -136.84 147.09 27.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.49 174.74 12.17 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.385 1.474 . . . . 0.0 109.413 171.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.16 138.8 14.12 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 168.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.9 m -131.4 159.42 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.214 1.007 . . . . 0.0 110.222 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.28 135.42 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 C-N-CA 125.136 1.374 . . . . 0.0 109.495 -168.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.3 168.05 20.31 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 123.922 0.763 . . . . 0.0 113.137 -169.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.88 150.79 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 127.386 2.274 . . . . 0.0 106.894 170.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.49 158.69 22.23 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 161.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.4 116.86 21.12 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.612 0.765 . . . . 0.0 109.978 173.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.06 112.52 3.6 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 167.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt . . . . . 0 N--CA 1.47 0.532 0 CA-C-N 118.749 1.275 . . . . 0.0 112.093 175.678 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.83 0.824 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -155.83 166.67 32.79 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.489 1.116 . . . . 0.0 108.885 -171.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -78.87 131.35 36.41 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.546 0.738 . . . . 0.0 110.152 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.05 82.52 0.4 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -73.14 151.17 41.67 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 118.585 1.192 . . . . 0.0 108.323 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.9 p -146.44 162.64 37.83 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.962 0.905 . . . . 0.0 110.827 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -141.27 155.11 46.03 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.68 -146.84 7.05 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.47 158.93 43.32 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.853 0.861 . . . . 0.0 110.317 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -136.35 133.68 6.72 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.64 143.47 14.63 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.992 0.396 . . . . 0.0 110.019 -170.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -142.91 145.15 32.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.944 0.878 . . . . 0.0 111.572 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -139.73 111.63 7.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 166.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 117.3 61.2 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.64 -33.78 2.19 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.336 1.358 . . . . 0.0 110.868 172.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.5 mtt -157.89 159.27 36.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.975 0.91 . . . . 0.0 111.124 -165.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -91.65 42.61 1.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 126.09 1.756 . . . . 0.0 109.658 -174.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.521 ' HA ' ' CD2' ' A' ' 146' ' ' TYR . 0.7 OUTLIER -160.7 -14.21 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.623 1.969 . . . . 0.0 111.269 -174.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.93 117.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 165.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.81 163.85 18.52 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 160.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.6 114.74 10.85 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 161.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.35 149.66 47.91 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 127.887 2.475 . . . . 0.0 107.06 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -129.66 151.44 50.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.2 m -145.52 166.32 26.04 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 145.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -143.41 145.75 32.89 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 160.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -138.13 159.86 40.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 119.734 1.152 . . . . 0.0 110.056 160.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -122.83 114.9 21.13 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.758 1.223 . . . . 0.0 109.596 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.5 p -100.88 130.57 46.91 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.779 2.032 . . . . 0.0 112.538 -171.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.81 111.89 24.31 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.44 81.55 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 171.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 53.8 -102.32 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.956 1.702 . . . . 0.0 108.508 -164.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m -105.29 3.52 30.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.27 1.028 . . . . 0.0 112.221 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.2 t -82.66 110.96 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 173.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -92.89 126.85 38.17 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.78 146.75 31.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 171.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.69 150.53 18.7 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 169.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -122.87 146.5 47.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -135.84 123.67 22.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 167.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.8 pt -116.93 139.79 42.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -168.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.22 134.94 33.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -120.27 74.55 0.32 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.43 168.03 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.708 1.203 . . . . 0.0 108.747 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.56 -105.07 0.25 Allowed Glycine 0 C--O 1.227 -0.344 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.521 ' CD2' ' HA ' ' A' ' 120' ' ' ASN . 0.3 OUTLIER -161.39 167.62 25.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.063 2.545 . . . . 0.0 107.624 -170.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -138.78 158.29 44.49 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.362 -1.461 . . . . 0.0 108.853 166.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 126.408 1.883 . . . . 0.0 109.766 -175.337 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.6 m -145.89 157.8 43.89 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 168.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 m -127.16 140.13 52.47 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 167.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 m -148.22 129.72 14.89 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 120.244 -1.535 . . . . 0.0 107.35 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.409 ' CG2' ' HB2' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -108.93 138.41 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.165 1.386 . . . . 0.0 108.505 173.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 p -157.2 117.72 3.55 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.8 2.04 . . . . 0.0 105.581 -169.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -173.18 165.64 37.88 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.39 -127.14 1.39 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -147.7 158.39 43.99 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.335 1.068 . . . . 0.0 110.698 -169.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.15 154.66 48.12 Favored 'General case' 0 C--N 1.335 -0.051 0 C-N-CA 125.129 1.372 . . . . 0.0 110.133 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -113.0 104.84 12.8 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 162.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -85.05 124.54 31.86 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 166.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.97 163.72 12.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.533 1.533 . . . . 0.0 107.412 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.57 161.96 37.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -55.6 81.37 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.911 1.684 . . . . 0.0 113.089 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.67 -15.23 5.21 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.593 1.568 . . . . 0.0 112.458 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -132.95 93.66 3.23 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.68 1.229 . . . . 0.0 108.48 172.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -90.27 60.02 4.6 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 129.437 3.095 . . . . 0.0 109.585 173.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -137.03 -178.47 5.21 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.887 1.275 . . . . 0.0 110.662 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -89.22 84.32 6.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.526 1.93 . . . . 0.0 107.116 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.5 ttm -92.52 147.83 22.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 153.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.9 -160.83 30.31 Favored Glycine 0 C--O 1.228 -0.252 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.21 -155.44 7.57 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 105.646 -2.982 . . . . 0.0 105.646 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.73 145.28 25.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -95.01 135.87 36.02 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 103.671 -2.714 . . . . 0.0 103.671 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.2 tp -145.97 116.71 7.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.16 140.96 48.76 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -137.56 121.41 17.6 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.96 143.08 45.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -118.53 158.14 25.95 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.462 1.905 . . . . 0.0 108.263 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -125.56 143.04 51.19 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.531 -1.356 . . . . 0.0 107.787 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -114.65 159.3 20.65 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.051 0.94 . . . . 0.0 108.78 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -95.19 15.26 19.63 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.123 -0.986 . . . . 0.0 111.701 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.41 0.73 2.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.698 1.199 . . . . 0.0 113.865 -172.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.4 125.3 3.02 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.124 168.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -72.46 79.91 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.547 3.498 . . . . 0.0 109.027 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.1 tp -150.42 155.81 40.27 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.589 1.556 . . . . 0.0 107.39 -160.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.24 -175.84 14.03 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 161.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.15 162.41 39.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 127.749 2.42 . . . . 0.0 106.218 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.8 mm -114.82 120.29 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.33 108.8 1.05 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 105.308 -3.117 . . . . 0.0 105.308 155.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -122.36 153.36 39.11 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 158.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -144.16 122.86 12.57 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.409 1.883 . . . . 0.0 107.098 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.9 m -127.59 125.18 39.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 172.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -91.49 158.41 16.49 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.653 1.981 . . . . 0.0 106.928 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -105.22 130.93 53.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -144.6 141.23 29.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.133 2.173 . . . . 0.0 107.152 166.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -175.54 147.92 0.88 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.601 2.36 . . . . 0.0 105.791 163.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -66.54 105.2 1.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 166.21 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -84.02 124.33 30.96 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.298 -0.876 . . . . 0.0 110.335 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -132.51 168.71 17.73 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.024 0.529 . . . . 0.0 109.776 166.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 m120 49.79 172.14 0.01 OUTLIER 'General case' 0 C--O 1.239 0.532 0 C-N-CA 128.49 2.716 . . . . 0.0 111.75 -155.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -123.5 147.58 47.08 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 120.968 -1.083 . . . . 0.0 110.284 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -76.11 128.37 34.84 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -109.81 117.83 34.88 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.7 89.41 0.29 Allowed Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -161.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.2 pp -109.47 141.55 24.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.762 0.791 . . . . 0.0 110.455 -166.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -111.38 148.45 33.01 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 170.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.95 159.02 43.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.359 0.6 . . . . 0.0 109.55 163.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.13 164.99 10.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.045 1.307 . . . . 0.0 110.626 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.88 144.47 53.51 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.962 2.442 . . . . 0.0 111.553 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.03 122.59 33.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 160.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -79.44 126.99 31.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 167.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -69.78 128.77 37.56 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.7 tt -76.42 -178.85 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.709 0.766 . . . . 0.0 109.954 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -60.9 -0.04 0.26 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.279 2.232 . . . . 0.0 115.963 -170.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -136.21 -87.52 0.33 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 120.2 1.364 . . . . 0.0 110.056 168.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.78 70.21 0.63 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.091 1.314 . . . . 0.0 109.958 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.16 -169.04 3.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.477 1.911 . . . . 0.0 107.296 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 t -122.43 170.16 10.25 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.903 1.681 . . . . 0.0 110.496 -162.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.83 167.99 25.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 121.528 -0.733 . . . . 0.0 111.696 -176.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -104.27 123.98 48.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.903 2.081 . . . . 0.0 109.134 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.17 73.62 0.02 OUTLIER Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.71 171.89 13.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 117.863 0.831 . . . . 0.0 109.66 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.14 130.42 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.37 148.16 18.92 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 170.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.9 132.3 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 165.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.76 152.89 18.72 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 162.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.58 165.2 29.35 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.597 0.759 . . . . 0.0 109.094 163.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.26 -167.95 43.93 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 113.634 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 122.837 1.303 . . . . 0.0 108.01 -163.405 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.29 176.69 9.54 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.971 1.308 . . . . 0.0 108.999 159.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -115.9 166.91 11.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 150.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.17 122.39 1.45 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -73.91 152.32 40.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.635 1.174 . . . . 0.0 109.754 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.5 t -134.44 143.65 47.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.891 0.876 . . . . 0.0 110.293 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -80.48 99.48 8.04 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.82 125.51 7.11 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -175.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.65 145.29 32.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.085 1.754 . . . . 0.0 107.439 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.32 148.63 8.58 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.521 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -139.43 142.63 37.43 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.555 2.342 . . . . 0.0 107.878 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -105.69 160.92 14.84 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.222 1.809 . . . . 0.0 109.82 169.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -91.65 171.69 8.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -57.1 111.43 3.36 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.491 1.116 . . . . 0.0 108.472 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -85.17 162.95 11.47 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.422 2.081 . . . . 0.0 111.971 -168.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 68.3 mtm -154.28 171.47 19.19 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 128.804 2.842 . . . . 0.0 108.649 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -44.12 -55.19 4.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 131.396 3.878 . . . . 0.0 109.77 -164.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER -132.28 37.53 3.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.198 0.523 . . . . 0.0 110.224 171.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.46 110.22 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.81 157.53 40.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 161.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.7 132.25 40.41 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 102.752 -3.055 . . . . 0.0 102.752 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -140.32 128.97 22.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.54 1.064 . . . . 0.0 109.824 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -136.41 145.99 45.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.376 1.07 . . . . 0.0 108.135 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.75 166.74 25.0 Favored 'General case' 0 C--O 1.239 0.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.127 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -142.66 118.39 10.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 169.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.87 108.43 9.4 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -99.5 132.97 44.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.5 p -129.85 159.41 36.65 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.591 1.157 . . . . 0.0 109.951 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 47.8 mtt-85 -122.2 98.0 5.73 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.485 0.659 . . . . 0.0 109.466 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 10.9 mm -82.41 81.12 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.384 1.073 . . . . 0.0 108.165 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 64.14 -55.87 0.24 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.692 2.797 . . . . 0.0 114.08 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.3 t -149.85 -0.94 0.44 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.587 1.555 . . . . 0.0 110.546 169.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.18 135.66 24.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.9 137.17 32.57 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.0 t -139.33 108.0 3.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.039 1.336 . . . . 0.0 108.674 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.08 151.76 35.58 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 167.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 t -140.38 153.31 46.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 146.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -137.86 110.79 7.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 172.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.9 pp -81.72 154.57 4.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.0 166.41 22.47 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 163.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -176.57 167.46 38.96 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.5 m -144.35 148.7 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 173.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -163.16 -145.72 4.46 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.409 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 8.1 m-85 -136.23 158.73 43.72 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.901 2.081 . . . . 0.0 108.395 -163.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.68 112.1 5.81 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.713 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 124.576 1.151 . . . . 0.0 108.367 178.362 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 t -151.05 158.14 43.71 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.384 1.074 . . . . 0.0 108.601 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.05 114.93 17.71 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 124.045 1.879 . . . . 0.0 109.038 168.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m -89.06 103.54 16.15 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -92.31 100.13 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 p -126.26 160.95 28.9 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.51 0.671 . . . . 0.0 111.15 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.95 178.41 48.16 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.51 -151.57 23.31 Favored Glycine 0 C--O 1.24 0.529 0 CA-C-N 118.741 1.27 . . . . 0.0 111.698 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.86 157.83 20.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.959 0.903 . . . . 0.0 109.151 -177.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.08 154.33 47.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.096 1.359 . . . . 0.0 108.355 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.49 ' NE2' ' HE1' ' A' ' 140' ' ' TRP . 2.3 mp0 -124.98 104.19 8.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 167.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.2 t -84.87 115.02 22.53 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 159.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.83 155.11 49.56 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.576 1.15 . . . . 0.0 108.482 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -143.12 163.93 31.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 110.058 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 60.17 9.51 1.91 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.924 1.689 . . . . 0.0 114.023 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.72 94.72 0.35 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -45.38 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.29 2.236 . . . . 0.0 111.588 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -148.82 -2.44 0.47 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -118.48 113.01 20.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 122.884 1.326 . . . . 0.0 114.316 -162.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -66.68 96.12 0.38 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 161.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.5 mtt -133.14 103.95 6.26 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 167.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.46 -170.95 23.73 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 128.335 2.874 . . . . 0.0 106.545 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.15 -84.25 0.05 OUTLIER Glycine 0 C--N 1.328 0.108 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 -169.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.82 174.17 10.78 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.348 1.459 . . . . 0.0 108.17 163.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -138.59 152.32 48.05 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.824 1.249 . . . . 0.0 107.746 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.68 131.06 19.72 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.664 1.986 . . . . 0.0 106.035 166.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -122.54 133.8 54.56 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -156.45 108.62 2.53 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -171.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -142.04 163.06 33.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.973 0.892 . . . . 0.0 111.127 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -99.66 157.47 16.45 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.164 1.385 . . . . 0.0 108.369 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.24 147.95 50.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -172.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -75.89 166.34 23.65 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.617 1.567 . . . . 0.0 111.67 -159.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -112.66 40.95 2.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.551 1.167 . . . . 0.0 108.565 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -167.59 -75.42 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.32 162.42 66.5 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.016 0.926 . . . . 0.0 109.601 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.91 62.6 8.48 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.669 2.913 . . . . 0.0 108.99 165.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.8 tp -112.01 123.79 51.0 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.182 1.393 . . . . 0.0 107.539 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.39 176.88 16.26 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.2 t -126.03 155.88 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 tt -132.94 121.03 43.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.35 108.85 2.08 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 m -80.49 142.11 34.54 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.163 0.982 . . . . 0.0 109.19 161.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -143.29 125.76 15.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 167.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.6 t -118.17 150.92 38.59 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.995 0.816 . . . . 0.0 109.5 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -142.99 123.72 14.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.0 p -114.17 121.56 44.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.59 29.41 0.93 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.899 0.772 . . . . 0.0 110.275 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -103.85 147.1 27.7 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.701 2.001 . . . . 0.0 108.528 177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 m -122.6 154.95 37.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.811 1.645 . . . . 0.0 108.19 168.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.449 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -130.46 96.96 4.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.14 0.427 . . . . 0.0 110.618 -171.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -84.1 174.24 10.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 165.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.44 -86.37 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 128.937 2.895 . . . . 0.0 103.981 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -170.14 78.85 0.09 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 129.013 2.925 . . . . 0.0 104.192 167.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.6 m -162.99 -43.24 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.119 1.768 . . . . 0.0 109.913 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.46 38.06 1.52 Allowed Glycine 0 CA--C 1.535 1.294 0 N-CA-C 114.488 0.555 . . . . 0.0 114.488 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.6 91.73 3.43 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 120.948 -1.325 . . . . 0.0 107.551 171.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -110.89 76.38 0.97 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.479 1.133 . . . . 0.0 110.459 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -51.94 93.11 0.01 OUTLIER 'General case' 0 C--O 1.237 0.433 0 C-N-CA 128.221 2.609 . . . . 0.0 113.655 -167.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.02 168.35 16.02 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.522 -0.736 . . . . 0.0 109.632 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t30 61.58 176.9 0.12 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.774 1.23 . . . . 0.0 110.591 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -129.23 154.31 46.92 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 166.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.36 159.12 24.45 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -141.16 135.35 30.74 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.11 116.65 0.86 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -167.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.28 110.1 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.3 m -128.34 144.04 51.08 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.757 1.623 . . . . 0.0 107.848 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.96 167.61 24.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.285 1.034 . . . . 0.0 110.754 -172.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.42 174.0 34.57 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 128.137 2.78 . . . . 0.0 110.795 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -85.75 -179.75 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.961 3.774 . . . . 0.0 110.8 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.97 135.1 35.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.856 1.662 . . . . 0.0 107.367 164.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -150.14 154.87 38.78 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.065 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -87.97 148.45 24.55 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.061 1.3 . . . . 0.0 111.145 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.91 -57.02 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -132.43 -75.9 0.5 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -165.55 74.98 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -130.89 -60.28 0.97 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.318 1.447 . . . . 0.0 109.175 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.84 164.6 32.34 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.653 1.181 . . . . 0.0 109.304 -174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 p -125.44 109.46 12.75 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.054 1.341 . . . . 0.0 107.637 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.26 151.7 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -150.11 165.73 31.92 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.117 0.872 . . . . 0.0 110.86 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.37 139.18 21.44 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.58 152.21 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.43 1.115 . . . . 0.0 109.149 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.66 150.81 15.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.885 0.874 . . . . 0.0 109.193 -167.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.52 -165.7 27.31 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 123.306 0.479 . . . . 0.0 112.614 -168.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.53 150.33 18.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.73 1.212 . . . . 0.0 107.747 171.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.57 130.85 7.63 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.835 1.683 . . . . 0.0 109.159 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -127.57 117.51 22.18 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.246 1.418 . . . . 0.0 110.022 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.57 142.61 11.42 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 170.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.47 68.95 1.48 Allowed 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -70.16 -179.71 2.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.071 1.348 . . . . 0.0 111.011 -172.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -163.27 143.39 8.92 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.644 1.178 . . . . 0.0 109.15 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p -69.49 117.15 10.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.981 1.712 . . . . 0.0 106.701 171.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 20.9 m -118.13 49.7 1.23 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.424 1.09 . . . . 0.0 109.623 -168.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -148.59 -70.16 0.21 Allowed 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.907 1.683 . . . . 0.0 107.969 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -61.76 150.12 83.02 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 124.046 0.938 . . . . 0.0 110.305 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.99 77.84 1.88 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.898 3.065 . . . . 0.0 110.197 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.3 m -156.24 -28.27 0.1 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.932 2.093 . . . . 0.0 109.075 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 50.57 -150.77 0.23 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.647 1.579 . . . . 0.0 110.528 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -54.72 120.91 7.44 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 120.929 -1.107 . . . . 0.0 108.543 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -80.18 -91.8 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -141.73 24.06 2.06 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.09 1.756 . . . . 0.0 110.843 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 p -70.09 155.3 40.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.055 0.942 . . . . 0.0 112.134 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.7 t 132.67 104.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 1 C-N-CA 131.997 4.119 . . . . 0.0 107.192 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -159.71 174.79 14.01 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 165.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -124.02 159.8 29.05 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.906 1.683 . . . . 0.0 107.737 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.11 137.49 9.41 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -75.78 102.21 5.37 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -67.39 135.03 52.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -148.12 171.47 15.83 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 121.929 -0.482 . . . . 0.0 110.047 168.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.18 -149.63 20.89 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.09 148.16 48.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.335 1.054 . . . . 0.0 109.602 174.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.23 124.11 7.68 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.03 139.42 49.88 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -170.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -138.48 129.9 27.48 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -92.83 171.59 8.88 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.149 0.5 . . . . 0.0 110.112 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -66.2 117.0 38.9 Favored Pre-proline 0 C--O 1.241 0.608 0 C-N-CA 123.95 0.9 . . . . 0.0 108.579 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.97 176.54 9.34 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.234 2.623 . . . . 0.0 112.0 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.14 -176.38 4.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.458 2.303 . . . . 0.0 107.49 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -91.14 -7.95 50.07 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.008 2.123 . . . . 0.0 110.121 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.72 12.18 0.25 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.99 1.716 . . . . 0.0 110.511 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.4 t -136.91 137.84 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.03 -1.669 . . . . 0.0 108.844 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -136.18 155.21 50.48 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -139.29 115.07 10.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.84 141.69 48.58 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 126.425 1.89 . . . . 0.0 106.646 -172.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -135.2 142.69 46.1 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 p -127.16 149.2 50.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 158.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.15 119.64 14.91 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 169.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -127.72 138.18 52.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -129.83 139.39 51.23 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.5 m -130.72 159.98 35.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.806 2.043 . . . . 0.0 107.186 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -132.33 145.62 51.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.19 95.95 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 75.27 -74.88 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.742 2.417 . . . . 0.0 111.512 165.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.7 m -148.75 27.05 0.9 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.432 1.493 . . . . 0.0 109.646 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.75 120.53 61.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 166.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.38 152.58 34.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.67 137.43 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 164.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.22 140.96 14.41 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 168.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.1 m -140.67 120.34 13.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.49 ' HE1' ' NE2' ' A' ' 11' ' ' GLN . 3.2 p-90 -105.03 153.16 21.83 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 166.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.7 mt -136.68 131.56 47.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.97 129.86 35.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -113.37 96.54 0.81 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.8 t -116.54 152.09 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 157.28 -143.01 9.1 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 106.429 -2.668 . . . . 0.0 106.429 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -121.76 176.87 5.51 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.604 1.962 . . . . 0.0 110.068 -166.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 129.95 13.44 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.283 171.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.5 p90 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 124.469 1.108 . . . . 0.0 108.37 175.231 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -92.4 151.09 20.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -143.46 107.09 4.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 162.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 t -138.83 150.91 46.56 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.089 0.947 . . . . 0.0 108.894 167.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.53 137.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 111.521 -2.581 . . . . 0.0 106.468 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.7 m -152.78 144.01 23.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.79 -178.55 44.75 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.74 -172.37 25.03 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.99 158.37 17.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.12 170.03 9.55 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.798 0.332 . . . . 0.0 110.722 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -140.99 113.04 7.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 156.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.5 t -84.75 151.3 24.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.062 0.934 . . . . 0.0 108.967 164.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -136.76 170.82 15.45 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.776 2.43 . . . . 0.0 107.863 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.19 159.5 42.1 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 161.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -75.63 64.77 1.73 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.707 1.203 . . . . 0.0 109.536 174.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 160.01 -37.95 0.46 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 126.855 2.169 . . . . 0.0 110.686 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -129.72 96.51 4.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.074 0.937 . . . . 0.0 109.758 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.5 mtt -78.3 58.15 2.04 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.637 0.732 . . . . 0.0 109.338 166.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.99 93.86 1.8 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 164.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HD3' ' H ' ' A' ' 20' ' ' LYS . 0.5 OUTLIER -58.74 106.12 0.37 Allowed 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 81.9 mtp -136.06 109.69 8.03 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -169.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.07 -178.5 37.65 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.19 -128.67 0.96 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 104.86 -3.296 . . . . 0.0 104.86 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.89 150.25 37.36 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -122.04 162.77 20.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.62 1.968 . . . . 0.0 107.529 173.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -147.6 167.84 23.52 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -138.11 159.99 40.56 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.245 1.018 . . . . 0.0 108.894 170.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -136.19 141.57 44.04 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.517 2.327 . . . . 0.0 106.377 164.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.71 160.33 23.55 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 160.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -131.96 156.45 46.16 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.394 1.478 . . . . 0.0 107.328 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -98.25 140.16 32.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.667 0.746 . . . . 0.0 109.258 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.05 156.96 23.17 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 127.008 2.123 . . . . 0.0 107.19 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -133.26 71.66 1.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.96 -37.97 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.823 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -162.41 153.95 15.36 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 124.36 1.064 . . . . 0.0 109.207 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.56 88.42 1.42 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.376 2.717 . . . . 0.0 109.21 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.9 tp -143.74 156.94 44.68 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 128.314 2.645 . . . . 0.0 105.791 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.89 175.89 21.55 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 91.1 t -124.61 157.21 32.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 118.189 0.994 . . . . 0.0 111.198 -168.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.75 141.53 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 126.779 2.032 . . . . 0.0 106.86 161.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.81 108.95 0.39 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 p -124.87 154.22 41.38 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.276 1.03 . . . . 0.0 110.613 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -131.66 122.45 25.98 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -170.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.8 p -95.47 146.8 24.15 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -171.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.98 154.95 50.92 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.623 1.169 . . . . 0.0 109.411 -178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.1 m -132.43 130.51 40.67 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.863 1.211 . . . . 0.0 112.564 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -110.95 -14.18 13.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.639 1.176 . . . . 0.0 112.856 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -66.42 145.73 55.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.813 0.845 . . . . 0.0 110.585 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 p -74.92 144.36 43.32 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.922 0.783 . . . . 0.0 109.405 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -80.24 141.38 35.63 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 158.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -148.32 118.15 7.12 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 161.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.26 -87.31 0.19 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 t -160.55 79.46 0.65 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 171.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m 57.41 84.85 0.09 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.643 1.177 . . . . 0.0 110.538 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.05 -40.32 0.05 OUTLIER Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.602 159.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -120.13 96.01 4.98 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.603 1.561 . . . . 0.0 107.5 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -131.58 81.1 1.96 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.441 -0.787 . . . . 0.0 109.513 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.49 -60.19 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.922 0.889 . . . . 0.0 110.216 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.46 133.07 48.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 122.0 -0.437 . . . . 0.0 110.543 -159.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -146.46 19.25 1.35 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -166.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -110.21 128.15 55.34 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 120.986 1.721 . . . . 0.0 107.855 -158.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -152.5 119.98 5.99 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.02 116.86 29.13 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.06 131.53 10.82 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 158.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.3 mt -119.68 109.54 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 167.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -120.01 147.59 44.61 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.554 2.342 . . . . 0.0 108.166 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.28 172.76 15.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.492 1.517 . . . . 0.0 109.188 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.44 175.59 43.92 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 161.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -74.33 175.75 10.57 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.471 2.114 . . . . 0.0 110.235 160.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.39 109.21 8.08 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.619 1.967 . . . . 0.0 108.085 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.37 130.25 35.25 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -111.38 118.45 35.87 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 170.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.06 -65.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -167.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -135.72 -79.31 0.42 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 161.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -158.69 80.52 0.8 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.049 1.295 . . . . 0.0 110.996 167.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -129.55 -40.51 1.41 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.28 1.432 . . . . 0.0 109.783 164.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.37 174.0 13.86 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.472 1.109 . . . . 0.0 109.733 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 t -148.87 105.26 3.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.11 156.5 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.795 0.838 . . . . 0.0 110.794 -172.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -151.18 173.34 14.52 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.024 1.329 . . . . 0.0 111.624 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.71 114.93 4.94 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.969 1.747 . . . . 0.0 108.759 170.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -110.36 161.08 9.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.224 1.409 . . . . 0.0 110.917 -164.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.39 165.36 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 C-N-CA 124.249 1.02 . . . . 0.0 110.578 -169.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.11 -164.71 30.23 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 p -148.55 137.88 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 169.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.97 108.92 2.24 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 127.575 2.512 . . . . 0.0 109.623 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.58 140.29 31.42 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.417 1.087 . . . . 0.0 108.594 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.3 160.36 27.84 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 118.446 0.566 . . . . 0.0 112.424 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -131.3 160.25 35.5 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.146 2.178 . . . . 0.0 106.502 173.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -127.94 170.01 13.32 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 159.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -148.52 144.45 27.33 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 173.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.4 m -120.28 132.57 55.38 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -164.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -132.56 32.33 3.9 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 125.39 1.476 . . . . 0.0 109.438 -161.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -150.6 -47.52 0.12 Allowed 'General case' 0 N--CA 1.462 0.165 0 O-C-N 120.939 -1.101 . . . . 0.0 110.111 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -68.38 153.2 95.95 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 121.898 -0.501 . . . . 0.0 110.501 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.09 -7.26 19.34 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.338 2.692 . . . . 0.0 113.129 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -67.53 5.48 0.79 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.985 1.714 . . . . 0.0 113.084 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -24.59 -39.31 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 130.568 3.547 . . . . 0.0 116.755 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.96 65.54 9.28 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.793 -1.192 . . . . 0.0 108.528 169.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -116.02 109.11 17.08 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -114.84 142.76 46.13 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.596 -0.69 . . . . 0.0 110.705 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 81.4 p -138.42 158.08 44.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.769 1.628 . . . . 0.0 107.116 172.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.9 m -145.56 106.18 4.1 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -129.14 129.01 44.61 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -92.65 160.03 15.19 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 166.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.98 131.47 5.12 Favored Glycine 0 C--N 1.33 0.248 0 N-CA-C 107.959 -2.057 . . . . 0.0 107.959 170.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.49 126.38 30.9 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 m -92.58 131.25 37.85 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -146.22 133.02 20.03 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.05 -172.09 34.67 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.153 1.359 . . . . 0.0 111.144 -160.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.31 158.29 44.74 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.864 0.866 . . . . 0.0 110.555 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -134.21 104.75 0.53 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.074 1.321 . . . . 0.0 111.345 -168.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.4 148.3 37.9 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.62 1.568 . . . . 0.0 107.243 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.38 159.4 34.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.436 1.095 . . . . 0.0 108.816 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -133.91 159.19 41.44 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 126.461 1.904 . . . . 0.0 107.023 -171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -56.38 114.75 8.31 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 123.779 0.832 . . . . 0.0 110.351 -158.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.43 171.61 11.0 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.281 3.321 . . . . 0.0 113.514 -168.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.9 mtm -145.85 177.68 8.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.175 2.19 . . . . 0.0 108.916 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -93.01 18.22 9.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.556 1.942 . . . . 0.0 112.995 -166.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -174.68 -7.92 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.035 2.134 . . . . 0.0 111.643 -168.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.41 140.9 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 128.646 2.778 . . . . 0.0 103.551 -170.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.62 159.62 42.17 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -137.63 117.15 12.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.73 150.7 40.57 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 168.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -140.93 123.45 15.97 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.1 m -122.49 136.16 54.82 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -126.23 122.23 34.98 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.412 1.885 . . . . 0.0 106.98 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.83 157.05 42.6 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.662 1.185 . . . . 0.0 110.212 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -132.26 152.97 51.1 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.287 1.035 . . . . 0.0 108.479 172.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.3 t -141.17 160.51 39.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 127.402 2.281 . . . . 0.0 107.349 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -128.87 107.09 9.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.6 pt -137.04 151.78 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.809 1.244 . . . . 0.0 108.152 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.45 18.89 6.0 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.784 1.634 . . . . 0.0 112.292 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.9 m 53.48 34.54 18.53 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.887 1.221 . . . . 0.0 112.03 -164.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.39 149.31 23.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 122.019 0.914 . . . . 0.0 108.842 161.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.8 140.13 53.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 168.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -136.26 98.64 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.32 151.34 32.86 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -141.65 154.2 45.21 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 146.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -139.21 155.23 47.95 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 168.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.4 pt -121.3 140.24 45.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -173.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.04 135.07 33.58 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -113.44 121.77 5.59 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 106.509 -2.636 . . . . 0.0 106.509 170.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.81 148.16 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 129.387 3.075 . . . . 0.0 103.988 169.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.72 -125.46 1.37 Allowed Glycine 0 C--O 1.227 -0.322 0 CA-C-O 118.014 -1.437 . . . . 0.0 109.904 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.84 143.04 22.44 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 127.287 2.235 . . . . 0.0 106.625 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -136.68 96.29 3.3 Favored 'General case' 0 CA--C 1.518 -0.279 0 O-C-N 120.863 -1.148 . . . . 0.0 108.298 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 115.13 -2.367 . . . . 0.0 112.379 159.757 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.9 m -137.29 152.93 50.31 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 171.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -142.07 133.89 27.14 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 122.311 1.053 . . . . 0.0 108.66 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -152.44 145.46 24.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.69 132.09 64.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.8 p -137.82 130.41 29.62 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.75 159.13 23.13 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.84 -152.39 19.28 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 107.346 -2.302 . . . . 0.0 107.346 -164.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -99.85 153.27 19.28 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.357 0.579 . . . . 0.0 110.353 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.93 142.01 50.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 170.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.9 149.58 50.31 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.795 1.238 . . . . 0.0 108.514 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.7 m -137.27 121.53 18.05 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.396 1.079 . . . . 0.0 109.802 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -103.61 162.16 13.29 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.58 146.02 51.42 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 118.295 0.498 . . . . 0.0 110.854 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 61.6 -60.09 0.1 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 130.253 3.421 . . . . 0.0 112.018 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.83 -66.16 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 105.892 -2.883 . . . . 0.0 105.892 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.86 96.81 4.75 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.027 1.331 . . . . 0.0 109.231 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.5 ttt -152.91 -69.02 0.15 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.299 0.639 . . . . 0.0 109.553 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.83 146.6 19.34 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.971 0.908 . . . . 0.0 110.243 -172.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -120.33 154.54 34.88 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 124.99 1.316 . . . . 0.0 108.912 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.4 ptp -131.24 159.17 38.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.09 175.45 23.19 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.696 1.141 . . . . 0.0 111.064 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.8 -177.32 47.55 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 118.064 0.932 . . . . 0.0 111.29 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -99.83 147.87 25.04 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.413 HD22 ' HB2' ' A' ' 42' ' ' SER . 24.5 t-20 -137.91 150.73 47.33 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.921 1.688 . . . . 0.0 109.673 -176.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mt -139.22 161.68 36.84 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 128.039 2.536 . . . . 0.0 108.619 171.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.49 176.43 12.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.27 1.828 . . . . 0.0 107.954 157.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -144.86 114.61 7.28 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 120.877 -1.139 . . . . 0.0 108.478 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 109.15 20.78 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -99.86 158.86 15.5 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.792 1.637 . . . . 0.0 109.224 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -115.2 152.31 32.87 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -121.28 166.76 13.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.021 1.329 . . . . 0.0 110.42 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -125.4 56.72 1.35 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.79 1.236 . . . . 0.0 108.071 -163.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.21 -47.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.181 1.392 . . . . 0.0 109.092 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.5 m -134.96 152.02 76.54 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.907 1.683 . . . . 0.0 107.899 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.84 13.2 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.939 3.759 . . . . 0.0 114.929 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 tp -87.24 118.91 26.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.157 1.783 . . . . 0.0 110.222 -165.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.22 177.27 49.0 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.1 t -133.87 145.27 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.172 1.389 . . . . 0.0 109.293 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 mp -139.68 131.91 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.469 1.908 . . . . 0.0 107.13 168.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.17 148.93 18.75 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 142.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.413 ' HB2' HD22 ' A' ' 25' ' ' ASN . 4.9 p -125.0 154.34 41.4 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.326 1.051 . . . . 0.0 110.515 165.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -112.77 148.97 33.67 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.318 1.047 . . . . 0.0 108.746 169.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 m -93.93 146.61 23.79 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.68 0.792 . . . . 0.0 109.218 165.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.417 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 48.5 m-85 -117.62 153.74 32.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.563 1.545 . . . . 0.0 108.593 166.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.85 143.21 34.31 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.008 0.822 . . . . 0.0 111.293 168.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.78 -11.49 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.012 2.525 . . . . 0.0 112.076 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.82 147.06 30.61 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.074 -1.641 . . . . 0.0 110.39 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.2 p -111.14 155.88 22.21 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.417 1.487 . . . . 0.0 109.132 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -129.96 130.71 45.4 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 162.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t 177.09 89.4 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -168.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.17 -59.64 3.07 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.278 -0.889 . . . . 0.0 109.403 171.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.9 m -148.27 -56.5 0.22 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 125.725 1.61 . . . . 0.0 107.431 169.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -161.99 102.14 1.13 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 102.704 -3.073 . . . . 0.0 102.704 173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.05 -56.68 0.03 OUTLIER Glycine 0 CA--C 1.51 -0.267 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -119.75 115.31 23.64 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 162.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -94.37 152.73 18.41 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.343 1.457 . . . . 0.0 107.937 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.2 128.63 36.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.14 -0.975 . . . . 0.0 108.666 171.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -144.63 172.65 12.69 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 84.92 -177.69 0.03 OUTLIER 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.843 2.057 . . . . 0.0 109.018 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.83 169.84 14.08 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.657 1.583 . . . . 0.0 107.919 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.417 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 25.2 p90 -73.73 139.22 45.14 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 159.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -140.39 117.54 11.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 157.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.52 121.69 1.05 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.46 150.46 34.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.1 p -140.48 157.36 45.63 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.23 140.53 21.36 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.041 0.837 . . . . 0.0 111.158 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.02 160.19 28.05 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 156.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.19 -179.81 5.8 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.14 1.893 . . . . 0.0 111.668 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.56 146.02 41.26 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.208 1.403 . . . . 0.0 108.251 164.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -128.85 130.03 46.36 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -67.18 111.93 4.2 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.838 1.655 . . . . 0.0 109.301 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 tt -73.75 171.38 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.026 0.441 . . . . 0.0 109.875 -176.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -88.73 37.48 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.102 1.761 . . . . 0.0 110.091 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -149.51 -119.98 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.591 1.957 . . . . 0.0 105.73 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -128.67 66.25 1.41 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.506 1.922 . . . . 0.0 109.441 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.1 176.02 13.04 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.657 -1.277 . . . . 0.0 110.766 168.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 m -137.94 112.95 9.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 164.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.71 147.21 23.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -150.4 164.88 34.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 119.665 1.12 . . . . 0.0 110.564 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.69 129.99 9.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.92 -176.52 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 124.374 1.07 . . . . 0.0 111.166 -176.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.86 165.56 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.677 1.991 . . . . 0.0 107.874 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.88 -172.26 31.14 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 162.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.51 138.97 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.47 139.13 10.72 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -132.66 116.98 17.31 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.583 1.953 . . . . 0.0 106.935 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.14 125.9 0.79 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -162.53 165.05 26.57 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 118.06 0.93 . . . . 0.0 109.523 165.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -60.63 161.42 7.77 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.369 1.467 . . . . 0.0 111.612 -175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -98.43 169.22 9.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 164.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.6 115.07 23.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.839 1.656 . . . . 0.0 106.722 172.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -146.79 64.18 1.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 123.03 1.395 . . . . 0.0 108.954 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.69 -32.28 72.82 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 120.818 -1.176 . . . . 0.0 111.377 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.26 155.54 79.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 126.039 1.735 . . . . 0.0 106.447 174.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.45 -13.75 41.4 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.413 2.075 . . . . 0.0 114.149 -170.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 p -76.13 -37.67 57.73 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.856 1.663 . . . . 0.0 111.764 172.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -72.56 114.59 10.85 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -163.03 117.27 1.67 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 171.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -160.66 127.39 4.17 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 155.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.71 125.57 28.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.926 0.89 . . . . 0.0 108.665 165.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.1 m -140.51 111.24 6.89 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.436 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.8 m -144.82 175.71 9.99 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.348 1.459 . . . . 0.0 109.618 161.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -144.22 164.83 29.6 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 127.214 2.205 . . . . 0.0 108.33 172.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -68.54 123.61 21.32 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -104.88 123.15 7.55 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 170.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -81.2 151.29 28.26 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.5 p -146.11 151.64 38.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -141.73 167.72 21.46 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.729 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 166.81 -172.7 42.04 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.8 149.55 31.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.628 0.714 . . . . 0.0 110.548 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.21 122.23 6.64 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 170.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -115.69 139.9 49.7 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -121.14 159.38 25.93 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.693 0.759 . . . . 0.0 109.886 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.5 170.54 8.0 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.825 1.65 . . . . 0.0 106.623 158.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -60.43 110.71 3.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.138 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.55 120.67 7.91 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.44 2.093 . . . . 0.0 108.805 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -177.06 164.7 2.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.932 1.242 . . . . 0.0 108.878 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 103.89 27.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.898 2.479 . . . . 0.0 109.051 154.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.94 15.91 10.22 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.689 1.595 . . . . 0.0 110.961 -169.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.73 171.33 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.7 159.65 39.03 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.375 1.87 . . . . 0.0 105.956 163.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -125.22 114.95 19.64 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 161.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -136.17 133.96 37.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 174.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -139.73 142.81 36.81 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 -172.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.8 m -146.53 165.26 29.99 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.592 -0.693 . . . . 0.0 111.318 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -140.0 129.26 23.88 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.727 2.411 . . . . 0.0 105.332 -171.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -137.81 108.2 6.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -99.22 111.61 23.95 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.1 m -76.82 150.88 36.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.452 0.701 . . . . 0.0 110.56 171.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.7 ptt85 -140.72 96.54 3.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.763 1.625 . . . . 0.0 106.91 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.2 mt -100.79 81.37 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 -175.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 56.75 -64.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 129.728 3.211 . . . . 0.0 113.575 -171.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 p -145.8 26.76 1.23 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.685 1.994 . . . . 0.0 110.107 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.8 t -123.27 103.4 12.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -82.3 131.99 35.23 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.7 101.18 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.73 115.43 4.34 Favored Glycine 0 C--O 1.242 0.604 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -174.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 57.4 m -107.85 142.29 38.14 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -141.72 141.3 33.27 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.0 pt -135.95 151.3 29.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.49 148.92 47.4 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.706 1.203 . . . . 0.0 108.57 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.36 94.53 0.2 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 124.924 1.249 . . . . 0.0 110.415 -169.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.25 171.87 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.552 1.941 . . . . 0.0 107.586 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.99 -116.12 0.7 Allowed Glycine 0 C--O 1.221 -0.666 0 O-C-N 119.913 -1.742 . . . . 0.0 108.87 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -163.81 163.42 23.9 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.958 1.879 . . . . 0.0 110.079 171.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -90.07 147.47 23.62 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.868 161.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 115.432 -2.223 . . . . 0.0 107.489 174.735 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.8 m -139.47 149.66 44.26 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m -106.73 107.09 17.93 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.435 1.494 . . . . 0.0 107.841 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.1 m -131.12 127.13 37.46 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.38 133.1 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 127.011 2.124 . . . . 0.0 105.915 -163.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.9 t -157.15 146.6 20.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.96 164.08 37.58 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.859 -1.697 . . . . 0.0 108.859 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.55 -154.72 23.54 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.77 159.33 41.67 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 109.142 -160.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.34 168.92 11.87 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.337 1.065 . . . . 0.0 113.767 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -125.0 117.49 24.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.407 1.483 . . . . 0.0 107.205 155.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.6 t -84.0 145.63 28.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 160.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -138.63 158.13 44.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.194 1.798 . . . . 0.0 107.944 -165.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.77 158.19 43.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 120.979 1.718 . . . . 0.0 111.31 159.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -78.76 56.76 1.94 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.685 0.755 . . . . 0.0 110.921 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.98 -39.13 0.2 Allowed Glycine 0 CA--C 1.519 0.282 0 O-C-N 120.06 -1.65 . . . . 0.0 110.434 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.55 96.36 2.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.681 0.753 . . . . 0.0 109.414 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.1 mtm -74.9 64.5 1.3 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.834 2.454 . . . . 0.0 108.195 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -66.33 102.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -64.17 98.04 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.881 1.272 . . . . 0.0 108.539 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 52.0 mtp -133.98 129.7 36.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.49 -145.47 4.13 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 170.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.04 -127.23 1.48 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 119.691 1.745 . . . . 0.0 110.668 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -132.58 121.17 22.83 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.983 1.313 . . . . 0.0 108.953 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -96.15 160.96 14.17 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.426 1.49 . . . . 0.0 110.107 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.95 139.86 29.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 162.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HZ2' ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -135.33 149.81 49.82 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 118.775 0.716 . . . . 0.0 109.875 165.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -149.45 110.08 4.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.58 119.64 33.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.99 157.12 16.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -130.09 153.19 48.73 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.837 0.855 . . . . 0.0 109.481 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.43 172.24 9.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.704 0.801 . . . . 0.0 110.538 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -101.99 -26.31 13.45 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.752 -1.218 . . . . 0.0 109.719 161.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.65 -25.29 53.61 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.3 m -152.17 157.23 34.07 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.739 1.215 . . . . 0.0 109.508 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.42 21.4 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.354 3.369 . . . . 0.0 113.515 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.6 tp -91.45 136.53 33.05 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.153 -0.967 . . . . 0.0 109.248 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.12 -168.61 12.48 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.816 1.198 . . . . 0.0 111.299 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.95 148.14 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.437 1.095 . . . . 0.0 110.657 -172.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.3 mm -119.3 119.76 61.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 127.077 2.151 . . . . 0.0 107.936 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.04 119.9 1.05 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 106.759 -2.536 . . . . 0.0 106.759 164.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.82 149.75 42.89 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.421 1.888 . . . . 0.0 106.584 175.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -144.13 128.41 17.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.9 m -126.51 132.07 51.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 168.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -91.44 150.17 21.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.4 p -98.1 138.34 35.55 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.01 163.95 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.176 1.39 . . . . 0.0 109.65 163.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.451 ' HB2' HD21 ' A' ' 58' ' ' ASN . 0.0 OUTLIER -152.27 113.79 4.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -170.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 m -115.73 103.75 10.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.382 1.087 . . . . 0.0 110.502 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -71.51 111.31 6.71 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 129.344 3.057 . . . . 0.0 108.89 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -53.14 -37.45 61.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.679 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 49.85 60.88 3.49 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 125.539 1.536 . . . . 0.0 110.087 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 t -164.36 -88.92 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -59.68 -56.28 23.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.801 -0.619 . . . . 0.0 110.755 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.84 4.8 0.1 OUTLIER Glycine 0 C--N 1.343 0.93 0 CA-C-O 118.259 -1.3 . . . . 0.0 115.814 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -71.03 90.95 0.86 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.122 1.961 . . . . 0.0 108.015 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -82.89 78.56 9.46 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.451 HD21 ' HB2' ' A' ' 48' ' ' LYS . 2.3 t30 -81.2 92.11 6.26 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -160.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -155.77 116.35 3.79 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.071 0.948 . . . . 0.0 108.961 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.425 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -149.66 -160.88 1.23 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 160.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.425 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 10.2 pt20 -126.86 128.8 47.08 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 164.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -97.31 114.04 25.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.67 117.84 29.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.88 96.68 0.96 Allowed Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.0 141.31 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 t -133.65 157.39 45.88 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 171.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.28 138.98 20.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.588 -0.695 . . . . 0.0 111.411 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.86 166.15 32.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.753 1.644 . . . . 0.0 109.314 160.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.428 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 66.7 Cg_endo -73.88 -177.96 3.5 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.734 2.289 . . . . 0.0 112.538 171.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.55 128.77 44.92 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.708 2.003 . . . . 0.0 108.032 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.1 130.29 28.84 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 ttp-105 -80.4 89.93 5.6 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.8 pp -93.29 1.57 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.244 1.018 . . . . 0.0 112.054 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -128.49 -178.28 4.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.941 1.696 . . . . 0.0 107.244 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -52.0 -67.53 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.72 2.008 . . . . 0.0 109.255 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.42 42.83 2.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.965 2.106 . . . . 0.0 110.559 -169.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.31 151.71 33.35 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.68 141.53 49.6 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.384 1.074 . . . . 0.0 109.422 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.48 154.82 6.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.234 1.413 . . . . 0.0 107.391 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.428 ' CE2' ' HD2' ' A' ' 69' ' ' PRO . 36.0 t80 -149.81 150.68 32.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.166 1.386 . . . . 0.0 107.857 169.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.26 109.84 3.35 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.2 m -103.76 161.8 4.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.967 0.907 . . . . 0.0 109.876 -167.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 t -109.08 131.07 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -116.34 159.88 13.68 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.53 150.84 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 170.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.97 158.3 21.4 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.946 1.736 . . . . 0.0 109.774 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -140.91 127.7 20.4 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.26 -171.66 16.64 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.0 pttt 175.28 -2.48 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.709 2.403 . . . . 0.0 112.919 160.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.56 -153.66 0.52 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 80.17 -71.37 0.08 Allowed 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 126.645 1.978 . . . . 0.0 109.897 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 p -74.3 99.88 3.59 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.255 12.1 t -81.76 61.62 5.21 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 175.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.391 12.3 pt-20 59.04 -18.06 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 130.824 3.649 . . . . 0.0 118.078 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -39.95 -72.84 0.1 Allowed Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.608 1.563 . . . . 0.0 114.553 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.3 -54.33 0.86 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 CA-C-N 122.182 1.815 . . . . 0.0 113.669 -173.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.6 m -154.49 65.67 0.69 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.509 1.049 . . . . 0.0 111.761 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 64.86 169.66 0.19 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.53 1.132 . . . . 0.0 110.245 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -62.41 150.01 40.94 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 119.69 -1.881 . . . . 0.0 109.374 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -47.21 -57.85 4.71 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 125.147 1.529 . . . . 0.0 112.777 -170.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -167.01 -174.32 2.64 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.679 1.992 . . . . 0.0 106.448 160.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 p -111.43 92.77 4.17 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.972 -1.08 . . . . 0.0 108.764 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 m 49.5 66.89 0.99 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.106 1.362 . . . . 0.0 112.182 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -94.91 151.76 18.93 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 164.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -95.1 110.6 22.52 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.155 1.382 . . . . 0.0 107.819 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.13 98.44 0.56 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.22 133.78 42.7 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.391 1.096 . . . . 0.0 108.296 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 p -133.06 173.62 11.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.351 1.072 . . . . 0.0 111.659 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -161.78 163.69 29.34 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.254 1.822 . . . . 0.0 106.353 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 177.18 -162.28 30.31 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -140.88 130.55 24.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 167.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.6 142.19 15.97 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 172.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.35 140.52 51.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.39 1.876 . . . . 0.0 108.539 -168.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.68 159.82 35.26 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.816 1.246 . . . . 0.0 110.769 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -91.87 171.09 9.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 168.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -56.92 154.21 19.88 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.793 168.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.98 109.91 0.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.254 0 N-CA-C 107.647 -1.713 . . . . 0.0 107.647 162.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.1 mmt -81.08 -174.97 5.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.974 2.11 . . . . 0.0 107.095 153.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -117.69 -4.24 11.21 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.359 -1.463 . . . . 0.0 110.736 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -137.45 0.14 2.25 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 124.561 1.144 . . . . 0.0 111.316 166.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.77 147.08 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 120.363 -1.461 . . . . 0.0 107.69 -162.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -143.62 153.06 42.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.456 1.903 . . . . 0.0 106.846 167.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -133.78 130.46 38.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 172.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.412 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS . 3.2 t70 -146.59 129.79 16.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 119.211 0.914 . . . . 0.0 109.176 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -149.65 151.9 34.5 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.512 0.596 . . . . 0.0 110.479 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.9 t -145.48 166.61 25.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.564 0.746 . . . . 0.0 110.338 173.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -143.57 106.13 4.45 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.595 1.958 . . . . 0.0 106.178 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -131.38 114.72 15.31 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -99.3 107.84 20.22 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -169.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.0 t -81.73 157.55 24.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.771 0.829 . . . . 0.0 108.833 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -130.0 129.07 43.26 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.0 mm -118.19 91.4 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -166.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.39 -82.71 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 126.156 1.782 . . . . 0.0 108.585 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.74 23.96 3.11 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.395 1.078 . . . . 0.0 112.551 171.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.94 148.79 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 119.413 1.006 . . . . 0.0 108.574 171.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.08 129.27 39.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.605 1.562 . . . . 0.0 107.652 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 79.6 t -136.82 92.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.866 1.666 . . . . 0.0 109.531 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.4 152.49 41.28 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.524 -0.735 . . . . 0.0 111.557 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.85 143.92 49.85 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 155.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -130.8 119.74 22.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.7 133.02 70.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.95 138.39 26.83 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -153.1 167.86 31.82 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 124.286 0.946 . . . . 0.0 110.926 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 m -140.3 168.33 17.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.084 1.353 . . . . 0.0 107.841 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -166.76 -103.85 0.17 Allowed Glycine 0 C--N 1.334 0.438 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.632 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -164.11 176.47 9.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.206 1.802 . . . . 0.0 109.511 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.11 145.05 35.26 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 168.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.0 p90 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 117.869 -1.062 . . . . 0.0 109.651 -179.233 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.477 0.18 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -141.7 141.31 33.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 121.414 -0.804 . . . . 0.0 108.987 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.07 107.01 11.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -95.75 139.74 31.55 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.431 HG13 ' H ' ' A' ' 146' ' ' TYR . 2.4 p -142.78 128.94 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.897 1.679 . . . . 0.0 107.524 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.6 p -138.51 163.56 31.68 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.453 0.569 . . . . 0.0 110.653 168.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.77 155.52 26.79 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.47 -165.43 37.95 Favored Glycine 0 C--O 1.236 0.272 0 O-C-N 121.793 -0.828 . . . . 0.0 112.75 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.74 157.58 16.39 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.246 1.018 . . . . 0.0 110.087 -169.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.79 162.89 34.05 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.921 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -143.73 154.34 43.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.331 1.053 . . . . 0.0 108.222 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 t -115.12 151.13 34.88 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 162.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.33 170.75 12.15 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.272 2.229 . . . . 0.0 105.296 160.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.91 164.49 28.19 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.5 -0.75 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -74.04 85.35 1.8 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 159.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.83 90.41 0.45 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.48 94.74 0.29 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 122.302 1.048 . . . . 0.0 109.74 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -151.21 -58.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.208 1.803 . . . . 0.0 108.03 170.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -63.69 103.92 0.61 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.168 1.387 . . . . 0.0 109.266 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -129.81 75.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 161.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -81.47 161.32 23.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.739 1.616 . . . . 0.0 109.282 164.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.93 179.88 40.93 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 108.209 -1.957 . . . . 0.0 108.209 171.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.74 -163.63 30.26 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 118.285 1.043 . . . . 0.0 111.858 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -99.62 153.97 18.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.24 1.416 . . . . 0.0 108.747 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -137.93 153.26 49.51 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.873 1.669 . . . . 0.0 107.648 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.6 mt -133.41 148.29 51.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 162.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -125.92 127.22 45.65 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 164.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -155.64 108.43 2.69 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -169.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -141.18 165.93 26.18 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.845 1.258 . . . . 0.0 108.707 -171.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -111.35 157.2 20.48 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -107.71 149.57 27.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 168.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.54 151.27 41.89 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 170.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.54 2.85 55.67 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.342 -0.849 . . . . 0.0 110.886 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -141.44 -70.32 0.36 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.47 1.508 . . . . 0.0 109.277 -153.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.1 t -72.67 122.83 88.58 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 167.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.47 68.28 6.94 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.629 2.22 . . . . 0.0 111.229 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 tp -142.35 121.61 13.06 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.932 1.293 . . . . 0.0 109.234 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -103.84 178.48 24.9 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -127.74 157.41 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.3 mm -124.94 151.62 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.93 1.692 . . . . 0.0 107.399 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.94 108.68 0.37 Allowed Glycine 0 C--N 1.336 0.563 0 O-C-N 120.136 -1.603 . . . . 0.0 111.372 159.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -67.46 151.65 47.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 166.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -136.51 103.04 5.12 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -92.99 150.84 20.27 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -172.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.2 157.76 40.92 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.413 1.085 . . . . 0.0 109.757 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 m -99.81 130.47 46.01 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 160.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -135.63 -56.59 0.79 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.544 1.938 . . . . 0.0 106.619 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.68 113.73 5.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.325 1.45 . . . . 0.0 107.508 174.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -101.6 155.59 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.059 2.143 . . . . 0.0 109.435 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.502 ' H ' ' HB2' ' A' ' 58' ' ' ASN . 0.3 OUTLIER -109.28 145.86 35.23 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 164.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t 178.63 149.24 0.22 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 130.353 3.461 . . . . 0.0 104.691 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 46.36 66.69 0.9 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.773 2.029 . . . . 0.0 110.596 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.3 t -162.63 -43.04 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.823 -0.608 . . . . 0.0 111.58 -172.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.72 3.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.859 0.863 . . . . 0.0 112.769 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.4 -0.66 53.97 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 121.192 1.814 . . . . 0.0 111.761 -171.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -71.1 91.28 0.9 Allowed 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.878 2.071 . . . . 0.0 106.408 165.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -72.5 144.45 48.01 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.502 ' HB2' ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -124.77 98.92 5.92 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 170.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -115.12 147.65 39.97 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 72.86 -177.84 0.19 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.59 2.356 . . . . 0.0 110.838 -168.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -124.99 163.74 21.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.078 1.751 . . . . 0.0 108.403 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.69 142.35 29.1 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -130.41 118.52 21.32 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.57 166.26 19.43 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 122.43 1.017 . . . . 0.0 112.235 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.7 142.83 42.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 167.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.9 m -139.79 130.95 26.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.88 164.55 31.61 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.617 0.767 . . . . 0.0 110.09 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.14 162.53 10.76 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 126.667 2.08 . . . . 0.0 107.993 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.05 156.62 38.44 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.576 1.517 . . . . 0.0 111.745 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.59 104.06 16.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 157.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -103.14 117.55 34.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -66.94 146.95 53.85 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.82 0.448 . . . . 0.0 110.469 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 pt -141.99 164.05 18.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.8 0.81 . . . . 0.0 111.168 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 t30 65.49 -74.87 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 130.448 3.499 . . . . 0.0 113.072 164.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -132.02 -56.48 0.98 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 117.074 -1.441 . . . . 0.0 109.372 165.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -151.67 27.02 0.65 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.117 1.767 . . . . 0.0 111.037 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.65 172.2 8.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.365 1.466 . . . . 0.0 110.263 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -127.83 168.98 14.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.724 1.609 . . . . 0.0 110.773 -173.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.31 162.1 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.67 1.188 . . . . 0.0 110.77 -172.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -104.65 124.72 49.84 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 127.731 2.412 . . . . 0.0 108.564 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.69 42.76 0.08 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.7 m -104.95 164.34 3.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.74 140.04 28.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -161.32 172.81 37.63 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-O 121.612 0.562 . . . . 0.0 112.789 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.69 149.09 16.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.63 145.15 18.56 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 166.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -135.04 152.15 51.44 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.635 1.574 . . . . 0.0 108.316 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.97 -156.43 12.83 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -154.4 88.44 1.22 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -65.37 151.55 46.0 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -133.78 151.01 51.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.761 155.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.2 t -137.75 117.6 13.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 163.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.0 p -101.19 -124.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -167.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 75.38 -53.67 0.65 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.544 2.338 . . . . 0.0 113.277 162.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.86 150.59 82.17 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 167.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.03 6.64 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.346 2.698 . . . . 0.0 113.38 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.7 t -142.48 53.39 1.42 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.183 1.393 . . . . 0.0 108.642 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.4 p90 47.88 -124.54 1.7 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.183 1.393 . . . . 0.0 109.625 171.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -161.69 -61.99 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 148.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -161.96 150.0 14.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -150.06 105.46 3.38 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.684 1.193 . . . . 0.0 107.804 -170.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.19 164.4 30.16 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.328 -0.858 . . . . 0.0 110.611 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 p -82.04 115.14 21.05 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 165.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -85.69 138.72 31.93 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.061 0.944 . . . . 0.0 109.212 -173.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.97 126.7 49.16 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.054 1.341 . . . . 0.0 107.903 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.66 83.41 0.28 Allowed Glycine 0 CA--C 1.522 0.483 0 CA-C-N 119.078 0.853 . . . . 0.0 111.624 -173.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -74.35 141.16 45.19 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.76 1.224 . . . . 0.0 109.364 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.66 -150.31 0.15 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.984 0.811 . . . . 0.0 110.622 154.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -128.18 162.49 26.83 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.321 1.848 . . . . 0.0 110.001 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.71 -176.2 15.12 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.755 0.693 . . . . 0.0 112.461 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.22 174.22 6.64 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.944 1.698 . . . . 0.0 111.232 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -157.86 84.37 0.13 Allowed Glycine 0 C--N 1.342 0.865 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.643 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.13 139.61 49.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.178 0.989 . . . . 0.0 108.746 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -137.43 159.37 42.12 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.091 1.356 . . . . 0.0 107.674 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -92.85 170.71 9.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 119.619 1.1 . . . . 0.0 108.38 171.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -61.27 104.49 0.47 Allowed Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.439 1.096 . . . . 0.0 110.524 -170.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.15 106.64 2.31 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.642 2.228 . . . . 0.0 109.908 -166.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.7 ptm -164.68 169.77 16.47 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.406 0.548 . . . . 0.0 110.774 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 63.69 35.65 11.29 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.601 1.16 . . . . 0.0 108.67 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 60.01 14.11 4.16 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.864 1.266 . . . . 0.0 113.318 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.26 110.43 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 123.734 1.73 . . . . 0.0 109.309 171.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -113.9 110.25 19.79 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.229 2.612 . . . . 0.0 106.395 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.37 131.66 34.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.78 148.76 42.68 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.727 0.694 . . . . 0.0 110.594 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -143.35 150.7 39.52 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.99 1.316 . . . . 0.0 108.51 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 p -144.08 152.99 41.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.657 0.741 . . . . 0.0 111.367 152.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -108.18 125.09 51.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.144 2.177 . . . . 0.0 105.733 168.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -136.61 145.24 44.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.238 1.815 . . . . 0.0 107.873 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -127.29 161.67 28.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.729 0.775 . . . . 0.0 110.993 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 p -141.22 159.89 41.26 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.831 2.052 . . . . 0.0 108.084 170.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -128.79 114.93 17.18 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 87.2 mt -105.9 98.03 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.18 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 129.179 2.992 . . . . 0.0 109.893 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.5 p -137.78 20.76 2.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.471 1.108 . . . . 0.0 111.245 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.82 115.71 50.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 167.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.29 130.46 40.84 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 168.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.4 t -135.49 112.35 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -172.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.25 144.92 16.94 Favored Glycine 0 C--O 1.238 0.357 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -169.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.3 p -138.0 148.85 45.57 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.436 0.695 . . . . 0.0 110.218 -164.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -121.18 150.27 41.55 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 166.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.45 131.45 65.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.83 131.79 20.3 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.666 0.786 . . . . 0.0 109.045 -171.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -161.97 173.52 38.32 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 114.599 0.6 . . . . 0.0 114.599 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.0 178.06 2.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.951 2.1 . . . . 0.0 108.78 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 167.67 -165.15 38.49 Favored Glycine 0 C--O 1.217 -0.952 0 O-C-N 120.545 -1.347 . . . . 0.0 110.367 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.431 ' H ' HG13 ' A' ' 5' ' ' VAL . 51.4 m-85 -104.92 175.45 5.49 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -166.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.87 130.32 19.98 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 120.813 -1.18 . . . . 0.0 108.13 170.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.191 1.396 . . . . 0.0 107.848 -179.112 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.6 p -132.79 157.17 45.64 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 149.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.85 106.71 4.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.133 0.973 . . . . 0.0 108.822 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -134.35 125.55 27.83 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.985 -1.072 . . . . 0.0 109.095 -168.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.38 112.85 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.468 1.107 . . . . 0.0 108.663 -168.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.5 p -149.15 123.58 9.67 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.927 0.891 . . . . 0.0 109.14 -166.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.34 158.53 27.71 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.794 1.187 . . . . 0.0 111.463 176.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.25 -139.35 5.09 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -167.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -150.33 154.93 38.69 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 117.668 0.734 . . . . 0.0 110.97 -166.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.93 160.19 39.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.461 1.105 . . . . 0.0 111.03 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -132.73 114.12 13.77 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -84.96 144.35 28.38 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.866 0.866 . . . . 0.0 109.004 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -138.39 119.31 14.29 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.34 1.856 . . . . 0.0 109.357 -173.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.03 166.45 19.76 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.499 1.12 . . . . 0.0 110.765 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -39.27 -20.33 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.275 2.63 . . . . 0.0 115.948 169.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.26 -108.7 0.56 Allowed Glycine 0 C--N 1.338 0.659 0 CA-C-N 120.192 1.36 . . . . 0.0 110.584 167.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -141.14 101.81 4.11 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.719 1.26 . . . . 0.0 109.311 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 58.2 mtp -130.32 -75.09 0.54 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.17 99.28 3.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -78.61 132.06 36.96 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 ptp -133.99 149.16 51.2 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.07 177.46 47.69 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.73 -162.41 28.19 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -171.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.06 110.16 22.46 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -170.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -95.69 150.81 19.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.049 -1.464 . . . . 0.0 107.049 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.33 145.03 20.12 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -170.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -132.87 150.11 52.19 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.68 139.62 50.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 170.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -129.53 109.0 10.67 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -115.9 132.5 56.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.59 153.12 45.96 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.777 1.631 . . . . 0.0 107.532 172.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -141.64 155.57 45.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -69.46 -19.97 63.76 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.538 -0.726 . . . . 0.0 110.146 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -21.05 65.98 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 125.548 1.539 . . . . 0.0 112.83 173.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -152.12 90.16 3.85 Favored Pre-proline 0 C--O 1.238 0.448 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.61 64.73 4.73 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.226 2.618 . . . . 0.0 112.012 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.86 125.58 10.4 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 167.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.05 174.19 54.59 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 118.555 0.616 . . . . 0.0 111.859 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.0 t -132.39 148.37 31.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.938 1.695 . . . . 0.0 107.659 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.33 120.74 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 126.592 1.957 . . . . 0.0 106.231 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.78 127.59 4.13 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 168.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 t -125.98 154.9 42.23 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.618 1.167 . . . . 0.0 110.729 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -112.68 140.3 47.56 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.905 0.882 . . . . 0.0 109.01 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.7 m -118.3 116.04 25.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.038 1.335 . . . . 0.0 107.973 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -112.9 149.68 32.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.232 1.413 . . . . 0.0 109.353 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -123.95 122.43 37.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -136.73 88.93 2.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -174.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -150.7 134.58 16.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.402 1.081 . . . . 0.0 109.288 -161.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.8 p -131.24 122.56 26.72 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.654 1.182 . . . . 0.0 112.155 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -134.66 113.71 11.99 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 162.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.6 t -141.59 136.72 31.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 156.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.33 -102.65 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.3 m -138.83 97.09 3.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.2 m 61.28 51.38 4.3 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.986 161.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.4 -35.02 0.03 OUTLIER Glycine 0 CA--C 1.532 1.14 0 N-CA-C 114.066 0.386 . . . . 0.0 114.066 172.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -119.21 111.67 18.52 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.83 80.59 1.66 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 172.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -81.24 66.53 6.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.391 0.615 . . . . 0.0 109.401 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -134.49 115.72 14.27 Favored 'General case' 0 CA--C 1.523 -0.06 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -158.93 161.78 36.79 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.692 1.997 . . . . 0.0 106.514 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -112.7 128.16 56.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 168.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -107.96 138.32 44.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 170.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -141.39 163.89 31.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.21 169.97 34.35 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.68 143.96 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 t -141.19 127.84 20.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.84 139.1 48.74 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.428 0.558 . . . . 0.0 110.978 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -172.97 167.16 39.92 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 163.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.22 177.79 8.16 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.589 2.193 . . . . 0.0 110.163 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.18 107.31 6.04 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.839 1.256 . . . . 0.0 107.63 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.19 148.66 22.21 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -91.34 142.76 27.35 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 122.074 -0.391 . . . . 0.0 110.308 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.3 mt -83.51 -102.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -129.76 12.04 5.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.487 1.515 . . . . 0.0 109.919 172.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -157.75 -178.41 7.3 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.851 -1.156 . . . . 0.0 112.865 -158.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -69.82 16.56 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.534 2.334 . . . . 0.0 114.292 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.97 141.0 48.7 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.6 1.16 . . . . 0.0 108.537 167.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 p -146.66 120.17 9.09 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.1 149.97 23.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -150.32 171.96 16.14 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.05 0.94 . . . . 0.0 108.922 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.28 150.16 38.33 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 164.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.72 165.49 28.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.284 1.034 . . . . 0.0 108.954 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.62 131.33 73.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.12 156.68 21.34 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.55 150.09 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.51 154.4 20.37 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -132.53 140.24 48.23 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.612 1.965 . . . . 0.0 108.434 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.39 171.67 32.12 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -174.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.21 156.56 0.77 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.286 2.234 . . . . 0.0 107.657 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -49.04 149.47 1.91 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.715 1.206 . . . . 0.0 111.396 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.93 158.58 21.8 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -170.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -136.97 122.17 19.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.789 1.636 . . . . 0.0 108.194 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.7 m -137.85 95.57 3.07 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -76.45 76.65 3.18 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.908 2.483 . . . . 0.0 108.037 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 59.42 -179.82 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 127.35 2.26 . . . . 0.0 112.233 -175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.19 15.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 121.899 1.733 . . . . 0.0 115.091 170.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 t -114.34 -24.2 9.01 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.063 1.302 . . . . 0.0 112.84 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -149.44 175.51 11.41 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 120.682 1.583 . . . . 0.0 110.054 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -164.81 165.74 20.34 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.772 1.629 . . . . 0.0 108.084 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -146.82 111.52 5.28 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -148.85 150.96 33.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 119.01 0.823 . . . . 0.0 108.848 171.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.4 m -140.71 117.7 11.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.065 1.346 . . . . 0.0 108.801 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.5 p -70.02 108.63 4.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.405 1.457 . . . . 0.0 107.532 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -149.59 151.66 34.17 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.55 0.691 . . . . 0.0 110.722 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -105.18 125.4 50.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 129.082 2.953 . . . . 0.0 106.991 -165.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.21 105.64 3.31 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.99 139.19 42.76 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.8 m -133.82 177.16 7.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.178 0.991 . . . . 0.0 109.401 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -168.12 167.8 12.18 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.937 2.095 . . . . 0.0 107.464 159.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.73 -166.33 35.19 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.08 158.49 44.28 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.77 1.228 . . . . 0.0 108.681 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.3 113.63 3.32 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.85 140.57 49.75 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.516 1.158 . . . . 0.0 109.35 -166.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -117.42 134.78 54.45 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.553 0.741 . . . . 0.0 109.957 -171.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.45 171.07 9.14 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -57.08 118.17 22.41 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.936 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.82 170.09 15.85 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.022 2.481 . . . . 0.0 112.612 170.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 46.3 mtt -152.98 162.95 40.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 130.03 3.332 . . . . 0.0 106.684 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.55 -4.84 1.5 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 129.178 2.991 . . . . 0.0 114.413 -171.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -145.21 8.89 1.23 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.087 0.955 . . . . 0.0 111.51 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.24 139.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 120.221 1.373 . . . . 0.0 108.842 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.9 154.1 38.97 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 119.907 -1.746 . . . . 0.0 107.566 161.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 132.88 46.13 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -140.98 130.69 24.17 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -129.31 151.25 50.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.48 1.112 . . . . 0.0 108.409 -173.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.96 162.42 37.85 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.636 0.732 . . . . 0.0 109.722 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -130.93 136.64 48.76 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -136.72 132.46 34.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 103.944 -2.614 . . . . 0.0 103.944 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -99.41 154.61 18.08 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 170.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 72.2 m -135.42 149.04 49.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -137.8 118.82 14.36 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 61.3 mt -123.38 105.5 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.68 50.89 17.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.076 1.35 . . . . 0.0 113.28 169.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.7 10.13 3.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.207 1.403 . . . . 0.0 111.518 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.63 119.5 43.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 166.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -71.67 133.14 45.46 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.9 t -133.25 157.06 42.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.25 152.19 23.11 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -140.26 153.9 46.66 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 167.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -136.35 118.74 15.73 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.7 mt -99.75 136.13 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.004 1.722 . . . . 0.0 107.35 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.32 139.62 35.47 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.32 163.05 36.61 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.9 m -139.08 173.54 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.001 1.32 . . . . 0.0 109.426 -172.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 180.0 -99.6 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-O 118.337 -1.257 . . . . 0.0 109.989 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -152.51 173.85 14.64 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.308 1.443 . . . . 0.0 110.513 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.2 tpt85 -133.3 150.97 51.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 162.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.6 p90 . . . . . 0 C--O 1.254 1.301 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 165.113 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.687 0.279 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.95 146.66 26.41 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 174.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.42 ' C ' ' HG1' ' A' ' 4' ' ' THR . 14.6 m -93.07 145.9 24.05 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.725 0.774 . . . . 0.0 109.113 165.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.42 ' HG1' ' C ' ' A' ' 3' ' ' SER . 18.1 m -153.72 125.71 7.84 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 119.565 -1.959 . . . . 0.0 110.041 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.71 127.61 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.688 0.795 . . . . 0.0 110.958 -170.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 p -139.18 119.99 14.3 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.402 1.081 . . . . 0.0 109.293 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.31 164.13 31.83 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.022 1.296 . . . . 0.0 110.49 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.17 -117.39 0.62 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -168.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -149.68 158.92 44.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.857 0.863 . . . . 0.0 109.735 -169.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.22 152.97 34.67 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.949 1.3 . . . . 0.0 107.802 168.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -142.37 154.37 44.58 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.291 0.636 . . . . 0.0 109.602 162.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 p -139.4 147.06 40.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 128.186 2.594 . . . . 0.0 107.46 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -126.82 113.37 16.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.595 0.712 . . . . 0.0 110.561 -155.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.62 106.14 1.39 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.337 1.055 . . . . 0.0 112.906 -156.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 64.44 8.46 4.3 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.922 1.689 . . . . 0.0 113.391 162.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.18 -101.32 0.23 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 104.178 -3.569 . . . . 0.0 104.178 -169.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -141.08 130.69 24.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 160.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.8 ttp -157.75 -34.91 0.07 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.383 0.427 . . . . 0.0 110.481 155.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -129.17 152.8 48.36 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 126.414 1.886 . . . . 0.0 106.424 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -123.51 80.93 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 171.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -67.61 129.4 39.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.89 176.04 29.6 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.79 -156.36 12.63 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 -171.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -98.55 156.16 16.93 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.391 1.096 . . . . 0.0 109.476 -169.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.77 144.43 41.6 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 124.278 1.031 . . . . 0.0 109.223 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -161.54 126.57 3.52 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -121.96 151.74 40.43 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 109.492 170.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -120.87 139.71 52.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -133.92 157.68 45.4 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 122.888 0.475 . . . . 0.0 110.064 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.71 157.67 38.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 173.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -108.89 125.1 51.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 154.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.76 173.04 3.75 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -117.06 37.68 3.76 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 169.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -148.72 -78.98 0.14 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 m -65.12 143.39 98.84 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.75 29.48 0.38 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.825 3.684 . . . . 0.0 110.972 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 tp -117.34 155.86 28.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.362 1.865 . . . . 0.0 108.791 -168.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.78 -172.99 13.83 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 168.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.1 t -139.56 142.33 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.91 152.91 38.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 163.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.0 136.08 4.2 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 105.021 -3.232 . . . . 0.0 105.021 165.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 t -124.56 142.89 51.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 117.922 0.861 . . . . 0.0 108.874 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -92.35 140.11 29.93 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.282 0.633 . . . . 0.0 110.211 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.89 130.02 37.74 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 167.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -116.84 156.43 27.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 156.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.7 m -138.3 122.2 17.74 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.68 42.26 2.18 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.528 1.931 . . . . 0.0 108.951 -164.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.412 ' H ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -65.3 138.54 58.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.003 1.321 . . . . 0.0 107.92 -175.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.5 p -130.39 155.06 47.03 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.196 0.522 . . . . 0.0 111.871 -169.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.6 99.87 12.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.861 1.264 . . . . 0.0 111.887 -175.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 t -158.4 16.16 0.21 Allowed 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.459 -0.775 . . . . 0.0 112.911 171.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.18 15.26 1.03 Allowed 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.347 -0.846 . . . . 0.0 112.18 -154.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.34 -116.61 0.17 Allowed 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 -173.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.6 m -126.09 13.02 7.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.039 1.336 . . . . 0.0 111.468 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.84 22.84 8.14 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 118.987 0.812 . . . . 0.0 113.838 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -70.68 104.19 2.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -58.44 106.29 0.37 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.435 -1.711 . . . . 0.0 108.176 162.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -56.29 140.19 45.74 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -116.65 168.48 10.15 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.573 0.701 . . . . 0.0 110.936 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 8.2 t30 45.0 -165.44 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 130.081 3.352 . . . . 0.0 113.526 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.481 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 12.3 pt20 -135.53 149.11 49.37 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.715 1.206 . . . . 0.0 108.759 -169.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -103.84 140.01 38.25 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 169.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -140.46 118.13 11.64 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.87 139.34 15.05 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.35 117.08 38.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.8 p -105.02 159.4 15.85 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.263 1.025 . . . . 0.0 109.629 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.18 144.02 28.64 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.027 -1.046 . . . . 0.0 109.703 164.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.76 121.07 1.36 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.66 127.64 21.22 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 N-CA-C 106.471 -2.165 . . . . 0.0 106.471 157.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.58 103.65 16.22 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.25 155.01 20.26 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 164.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -106.1 150.78 25.47 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.696 1.598 . . . . 0.0 106.801 161.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.1 mm -77.92 -104.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -129.54 7.29 5.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.986 1.267 . . . . 0.0 112.207 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -136.52 10.19 3.18 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.688 2.395 . . . . 0.0 111.894 -155.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 66.8 m95 51.03 70.58 0.51 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.507 1.523 . . . . 0.0 110.013 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.07 -169.03 1.89 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.435 1.894 . . . . 0.0 109.162 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 t -126.57 169.7 12.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.131 2.172 . . . . 0.0 106.365 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 tp -134.16 157.78 41.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.705 1.602 . . . . 0.0 108.494 -171.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -103.0 176.08 5.26 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 128.064 2.546 . . . . 0.0 109.097 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.16 53.23 2.87 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.71 160.66 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 m -95.45 154.43 3.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 121.561 -0.712 . . . . 0.0 109.676 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.67 134.63 4.82 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.89 129.17 68.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -118.71 115.09 3.0 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -168.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -121.15 123.71 42.96 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.064 0.932 . . . . 0.0 110.294 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.5 161.65 8.79 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -165.58 128.77 2.17 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.275 1.83 . . . . 0.0 106.899 -170.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -67.29 165.66 15.86 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.694 0.679 . . . . 0.0 111.17 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -122.38 179.9 4.41 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.256 1.422 . . . . 0.0 109.234 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.8 p -136.43 145.27 45.06 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.565 1.075 . . . . 0.0 110.375 158.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.4 m -131.6 25.04 4.75 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.8 0.84 . . . . 0.0 110.747 -155.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.44 -53.09 0.27 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.323 -1.485 . . . . 0.0 112.219 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -59.99 139.12 90.87 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-O 118.215 -0.898 . . . . 0.0 108.643 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.12 84.13 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.959 3.106 . . . . 0.0 110.382 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 m -154.68 -45.44 0.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.973 1.309 . . . . 0.0 108.067 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 37.25 63.43 0.72 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.106 1.762 . . . . 0.0 112.452 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -51.87 -48.66 63.94 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.8 t30 40.17 64.74 0.85 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.441 1.496 . . . . 0.0 110.755 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.78 129.32 9.17 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 127.723 2.409 . . . . 0.0 105.706 -173.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.7 p -132.46 104.69 6.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 123.987 0.804 . . . . 0.0 108.968 168.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -140.59 72.76 1.4 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 160.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.2 135.24 38.96 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -145.87 157.1 43.92 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.647 1.979 . . . . 0.0 108.016 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.32 160.56 33.2 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.371 0.986 . . . . 0.0 110.642 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -138.33 151.95 48.02 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 128.632 2.773 . . . . 0.0 109.111 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 m -170.31 -146.83 0.05 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.949 2.499 . . . . 0.0 108.748 159.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -136.94 177.51 7.8 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.942 1.697 . . . . 0.0 109.376 -171.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.38 177.19 37.79 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 121.285 -0.885 . . . . 0.0 113.657 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.63 161.89 14.17 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.008 0.923 . . . . 0.0 111.341 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.33 84.81 0.15 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.03 159.93 20.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.828 0.851 . . . . 0.0 109.767 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.04 154.97 43.07 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.067 1.347 . . . . 0.0 108.424 170.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -92.54 170.07 10.03 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -56.05 130.82 74.03 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.84 127.17 18.05 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -87.64 -175.19 5.1 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 152.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -109.97 -25.6 10.18 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 126.932 2.093 . . . . 0.0 108.458 -173.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.97 5.56 10.4 Favored 'General case' 0 C--O 1.225 -0.188 0 O-C-N 121.067 -1.021 . . . . 0.0 109.357 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.1 t -137.45 144.54 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.51 153.26 51.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.156 1.382 . . . . 0.0 108.56 164.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -143.98 115.86 8.29 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.908 1.683 . . . . 0.0 108.696 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.32 148.04 44.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.951 2.1 . . . . 0.0 109.405 173.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -137.32 122.99 19.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.84 1.256 . . . . 0.0 109.123 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 t -139.54 151.77 46.37 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.516 1.126 . . . . 0.0 108.219 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -149.81 145.17 26.45 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -137.8 165.22 26.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.971 1.709 . . . . 0.0 108.772 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -119.9 159.55 24.44 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.216 -1.553 . . . . 0.0 110.633 169.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 t -140.43 159.82 41.36 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 170.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -141.11 97.85 3.26 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.69 83.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 54.62 48.97 19.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.263 1.025 . . . . 0.0 111.73 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 m 62.4 5.14 1.49 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.534 1.534 . . . . 0.0 114.876 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.7 t -82.2 148.74 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 121.169 1.804 . . . . 0.0 107.232 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 t70 78.02 -59.27 0.44 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.56 2.744 . . . . 0.0 113.032 171.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.4 t 68.82 -72.83 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 127.868 2.467 . . . . 0.0 113.089 165.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.15 116.18 1.09 Allowed Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.2 t -106.11 150.71 25.54 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.954 0.883 . . . . 0.0 109.466 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -134.9 133.28 39.46 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.5 pt -130.41 159.57 42.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.98 150.01 50.58 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.526 1.53 . . . . 0.0 109.27 -171.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -153.85 106.62 0.3 Allowed Glycine 0 C--O 1.22 -0.775 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.85 167.13 24.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 118.848 1.324 . . . . 0.0 109.213 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.59 -122.29 1.06 Allowed Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -163.14 177.21 9.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.445 1.898 . . . . 0.0 109.556 -167.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -121.54 163.12 19.38 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.211 -0.931 . . . . 0.0 111.239 171.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . 0.258 0.0 OUTLIER . . . . . 0 C--O 1.251 1.173 0 CA-C-O 116.521 -1.704 . . . . 0.0 107.475 160.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 115.829 -2.034 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -139.14 152.04 47.12 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 123.335 2.788 . . . . 0.0 109.928 -163.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m -143.53 160.04 41.35 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 161.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -142.93 105.11 4.42 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 119.689 -1.882 . . . . 0.0 107.939 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 m -92.69 138.2 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.524 1.529 . . . . 0.0 107.273 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 m -148.92 143.72 26.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 168.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.47 164.19 32.41 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.44 -111.9 0.47 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -173.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -124.87 158.38 33.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.373 1.087 . . . . 0.0 111.018 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.51 133.26 34.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 128.517 2.727 . . . . 0.0 104.03 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -140.0 131.89 27.65 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 164.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -85.27 151.2 24.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 161.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -138.74 169.96 16.86 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.121 1.368 . . . . 0.0 107.693 160.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.92 40.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.345 1.43 . . . . 0.0 109.603 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -70.75 97.62 1.4 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.038 0.923 . . . . 0.0 110.821 -168.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.48 -26.06 3.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 127.592 2.52 . . . . 0.0 109.419 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -146.79 96.07 2.69 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.481 1.512 . . . . 0.0 107.059 -170.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -76.82 61.01 1.83 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.307 1.043 . . . . 0.0 109.187 172.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -70.74 99.11 1.64 Allowed 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 124.995 1.318 . . . . 0.0 107.538 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -70.47 108.51 4.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -136.75 130.95 32.75 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.26 -173.5 44.53 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -161.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.88 -94.24 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -149.64 137.95 20.63 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -101.19 148.84 24.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.673 1.589 . . . . 0.0 109.487 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.86 136.65 27.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.733 1.213 . . . . 0.0 107.881 163.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.07 150.81 50.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.44 1.096 . . . . 0.0 108.274 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -135.88 122.28 20.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -107.69 128.55 54.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -99.06 147.95 24.53 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 167.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -111.54 114.51 27.64 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 156.46 37.11 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.09 -20.54 17.93 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.276 1.031 . . . . 0.0 110.345 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.12 -8.16 59.71 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -170.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.37 163.28 18.61 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.99 -7.92 19.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.082 1.855 . . . . 0.0 112.775 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 tp -81.45 139.53 35.16 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.883 1.219 . . . . 0.0 109.655 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.32 -169.57 13.09 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.881 1.229 . . . . 0.0 110.445 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.47 150.29 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.807 0.843 . . . . 0.0 109.437 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.6 tp -135.8 141.77 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.24 145.53 11.08 Favored Glycine 0 C--O 1.239 0.408 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.6 m -112.08 141.14 46.12 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -170.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -111.95 115.3 28.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.4 m -91.47 150.89 21.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -140.47 142.31 35.35 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 160.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.2 m -143.06 133.59 24.96 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.957 0.903 . . . . 0.0 109.57 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -130.27 171.15 13.22 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 149.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -157.66 146.37 19.43 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 p -79.06 107.07 11.55 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 157.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -105.55 105.0 14.83 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 167.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -163.41 179.62 7.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.563 1.145 . . . . 0.0 109.542 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.45 -86.31 0.16 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.856 2.063 . . . . 0.0 105.64 166.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -124.01 -7.77 7.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.164 1.386 . . . . 0.0 114.218 -173.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 m 129.93 70.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 131.682 3.993 . . . . 0.0 109.745 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -134.26 -82.11 0.17 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 169.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -73.35 103.11 3.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.518 2.327 . . . . 0.0 107.651 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -117.77 88.61 2.95 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.71 111.99 24.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -165.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -113.68 130.4 56.42 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -171.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -160.17 165.95 30.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.577 1.551 . . . . 0.0 110.045 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.14 140.79 49.08 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 162.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -107.95 123.34 48.49 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -126.08 135.74 52.09 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 163.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.92 95.05 0.32 Allowed Glycine 0 C--N 1.331 0.278 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -174.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.6 mt -77.45 108.99 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 p -131.35 128.21 39.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.593 1.957 . . . . 0.0 106.637 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.62 174.03 13.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.737 0.415 . . . . 0.0 111.396 -172.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.87 176.57 48.09 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 123.34 0.495 . . . . 0.0 113.072 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.73 129.73 10.17 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.89 3.06 . . . . 0.0 109.421 168.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.74 149.09 22.17 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.629 0.772 . . . . 0.0 110.044 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -141.29 127.43 19.6 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.071 0.948 . . . . 0.0 108.683 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.6 120.32 16.05 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 125.164 1.385 . . . . 0.0 109.625 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mp -67.67 165.99 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.744 1.618 . . . . 0.0 107.161 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -79.03 14.64 1.34 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.524 -1.36 . . . . 0.0 112.313 -174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -139.13 60.87 1.58 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.471 1.508 . . . . 0.0 108.485 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 57.2 m95 58.35 -16.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 129.079 2.951 . . . . 0.0 117.716 170.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.52 161.12 29.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.492 1.117 . . . . 0.0 108.758 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.2 p -142.93 115.98 8.87 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 117.657 -1.163 . . . . 0.0 108.478 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 mp -142.1 151.26 18.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.09 1.356 . . . . 0.0 108.297 -174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -150.29 173.95 13.4 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.84 1.256 . . . . 0.0 109.1 160.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.21 140.46 27.51 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.34 143.8 37.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.196 0.998 . . . . 0.0 108.731 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.95 165.41 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.062 0.945 . . . . 0.0 109.819 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 177.25 -162.62 30.79 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.884 -166.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.69 139.89 19.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.579 0.751 . . . . 0.0 109.287 173.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.51 146.41 16.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 125.403 1.478 . . . . 0.0 109.466 168.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 3.7 p90 -149.37 166.96 27.47 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 122.095 -0.65 . . . . 0.0 111.926 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.64 -93.96 0.1 OUTLIER Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 149.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.89 105.67 0.07 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 128.557 2.743 . . . . 0.0 108.813 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -131.2 -75.83 0.52 Allowed 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.242 0.617 . . . . 0.0 110.659 -167.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -156.64 137.32 13.26 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.0 m -137.3 137.71 39.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 166.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.8 t -133.93 54.9 1.92 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -162.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -79.92 60.71 3.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.4 1.08 . . . . 0.0 111.764 -159.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -39.55 -53.65 4.22 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -166.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.98 9.8 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.915 3.076 . . . . 0.0 114.864 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 m -137.29 -65.9 0.52 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.846 2.058 . . . . 0.0 109.849 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -169.29 -167.41 0.71 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.717 1.207 . . . . 0.0 110.511 -170.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.5 109.6 6.45 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 173.89 155.15 0.12 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 127.097 2.159 . . . . 0.0 105.267 -167.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.92 122.3 14.95 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.071 1.749 . . . . 0.0 109.347 -174.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.0 t -140.59 94.11 2.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.014 0.926 . . . . 0.0 110.202 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.8 m -157.12 88.55 1.03 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.845 -1.159 . . . . 0.0 109.925 164.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 45.5 p30 -161.69 176.02 11.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.404 3.082 . . . . 0.0 109.586 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 54.83 17.27 1.71 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.904 2.081 . . . . 0.0 114.959 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.97 104.33 1.31 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.21 148.52 45.48 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.5 p -136.79 161.19 36.66 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.621 0.725 . . . . 0.0 111.518 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.57 157.23 37.96 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.497 1.519 . . . . 0.0 108.957 174.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.02 -168.3 37.91 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.881 1.705 . . . . 0.0 108.987 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.68 152.1 51.8 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.1 116.85 4.08 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -115.64 139.71 49.86 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -166.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.66 145.55 38.59 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 120.916 -1.115 . . . . 0.0 109.4 -172.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -93.15 164.4 13.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -56.86 103.92 0.39 Allowed Pre-proline 0 CA--C 1.528 0.125 0 C-N-CA 125.062 1.345 . . . . 0.0 110.579 -166.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.14 120.26 5.64 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.37 1.38 . . . . 0.0 109.058 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.7 mtm 166.9 153.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 129.917 3.287 . . . . 0.0 105.682 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 113.96 28.2 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 129.767 3.227 . . . . 0.0 107.494 160.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.9 t30 44.08 26.69 0.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.372 1.469 . . . . 0.0 113.727 -153.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.64 169.3 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 108.477 160.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.89 135.89 5.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.016 2.926 . . . . 0.0 103.155 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.22 146.87 46.85 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -172.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -141.16 152.94 45.09 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.243 1.017 . . . . 0.0 109.196 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -150.34 114.76 5.18 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.38 2.272 . . . . 0.0 105.603 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.1 m -118.3 154.23 32.66 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 168.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.49 120.85 11.62 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -136.61 136.11 38.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.234 1.413 . . . . 0.0 108.792 -168.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -100.05 150.68 22.21 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.799 0.84 . . . . 0.0 109.31 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.3 m -133.87 160.05 38.82 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.824 1.65 . . . . 0.0 108.039 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.52 97.79 4.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.907 1.283 . . . . 0.0 111.208 -166.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.4 mt -134.31 89.03 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.093 0.957 . . . . 0.0 108.888 -166.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.22 -161.31 0.18 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.5 m -77.34 58.55 1.68 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.543 1.065 . . . . 0.0 109.438 168.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.65 149.42 33.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 170.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -122.2 80.46 1.72 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.842 0.746 . . . . 0.0 110.766 -174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.9 t -78.99 96.55 2.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.931 1.693 . . . . 0.0 108.887 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.66 144.65 23.27 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 164.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.12 152.83 45.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 172.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -140.87 147.65 39.26 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 164.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.02 150.47 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.64 166.11 26.12 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.681 0.792 . . . . 0.0 108.9 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.18 178.77 47.14 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.642 -0.789 . . . . 0.0 114.107 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.5 163.33 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 127.783 2.433 . . . . 0.0 107.042 167.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -166.56 -119.25 0.47 Allowed Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -163.17 164.39 25.23 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.579 1.19 . . . . 0.0 110.711 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -91.36 125.93 36.28 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 116.865 -1.54 . . . . 0.0 107.613 164.615 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 t -150.42 142.08 23.62 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 120.728 -1.232 . . . . 0.0 108.937 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -140.71 106.86 5.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.801 0.81 . . . . 0.0 109.419 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.1 p -104.84 129.01 53.24 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 p -91.7 145.28 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 165.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 t -158.14 161.07 37.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.89 173.72 27.66 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.07 -162.06 34.84 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -171.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -91.6 144.5 25.47 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -172.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HB1' ' H ' ' A' ' 23' ' ' GLY . . . -95.57 134.92 37.89 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.5 104.14 5.26 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 127.394 2.278 . . . . 0.0 106.552 -175.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 t -84.66 140.64 31.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.286 1.434 . . . . 0.0 107.393 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -138.78 126.89 22.6 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.059 1.744 . . . . 0.0 106.798 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.85 147.45 43.93 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.778 1.626 . . . . 0.0 107.613 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -63.24 92.58 0.06 Allowed 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 124.052 0.845 . . . . 0.0 108.722 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.84 41.72 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-O 117.434 -1.759 . . . . 0.0 111.922 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -150.76 94.91 2.14 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 157.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.6 mtt -76.73 57.26 1.25 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.882 2.873 . . . . 0.0 109.441 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -71.41 101.57 2.44 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -63.13 102.4 0.37 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.64 159.61 41.3 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.166 1.787 . . . . 0.0 106.983 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.11 -176.37 17.8 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -171.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' H ' ' HB1' ' A' ' 10' ' ' ALA . . . -163.69 -137.4 2.18 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 -164.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.76 157.69 25.1 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.211 1.506 . . . . 0.0 109.469 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -134.57 148.59 50.5 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.894 1.678 . . . . 0.0 107.995 -173.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.95 124.95 19.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -120.55 132.56 55.22 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -155.61 106.52 2.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -166.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 164.91 28.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.999 0.428 . . . . 0.0 110.88 -173.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -125.4 157.74 36.06 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.061 2.144 . . . . 0.0 106.59 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -128.79 159.94 34.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 168.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -136.12 125.84 25.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -67.41 1.46 2.24 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.933 1.293 . . . . 0.0 113.203 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -55.73 -27.07 48.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.723 0.809 . . . . 0.0 111.376 159.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.7 m -147.44 107.04 3.82 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 169.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.99 78.01 2.26 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.487 2.791 . . . . 0.0 109.713 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.41 126.31 10.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 128.83 2.852 . . . . 0.0 105.433 173.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.39 176.87 48.58 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.23 146.78 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.1 mm -138.44 116.27 12.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -170.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.09 124.05 1.75 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 107.009 -2.436 . . . . 0.0 107.009 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 p -122.71 153.92 38.79 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.129 1.771 . . . . 0.0 107.557 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -129.49 120.21 25.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -160.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.9 p -119.69 115.15 23.34 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.906 0.776 . . . . 0.0 110.07 -152.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.93 153.85 32.9 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.307 -0.871 . . . . 0.0 110.954 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.5 t -131.58 122.34 25.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.913 0.885 . . . . 0.0 109.035 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -131.59 74.81 1.61 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.04 1.736 . . . . 0.0 106.926 174.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -153.76 146.45 24.24 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.5 t -131.06 155.78 46.32 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.911 2.084 . . . . 0.0 107.925 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -126.96 101.25 6.49 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 172.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 p -142.04 93.47 2.55 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.96 36.79 2.15 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.971 1.309 . . . . 0.0 111.073 -173.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 m 105.46 44.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 1 C-N-CA 131.878 4.071 . . . . 0.0 111.409 175.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.3 m -126.04 -59.0 1.35 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.098 0.959 . . . . 0.0 108.633 166.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.63 74.91 1.29 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 105.763 -2.935 . . . . 0.0 105.763 -162.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -120.09 91.69 3.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.54 91.94 7.82 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -66.65 112.36 4.13 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.15 0.886 . . . . 0.0 111.931 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -89.31 171.04 10.05 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.893 -1.129 . . . . 0.0 108.093 161.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 66.35 175.67 0.23 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.563 2.345 . . . . 0.0 112.46 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -139.02 155.88 47.63 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.855 1.662 . . . . 0.0 107.321 -167.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -77.57 157.68 30.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -140.97 117.33 10.74 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 154.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.91 106.05 2.32 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 106.882 -2.487 . . . . 0.0 106.882 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.21 108.95 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.3 p -128.96 159.16 36.76 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -137.45 163.5 30.94 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.3 156.32 27.28 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 157.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.02 178.86 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.281 2.654 . . . . 0.0 112.083 145.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.35 144.49 50.8 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.698 1.599 . . . . 0.0 108.191 154.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -133.35 155.87 48.66 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.065 1.346 . . . . 0.0 109.323 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.94 94.99 5.37 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 170.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 33.8 mt -28.09 -70.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 129.832 3.253 . . . . 0.0 110.324 -170.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -170.12 5.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.67 1.588 . . . . 0.0 110.368 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -150.08 -177.1 5.73 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.6 1.16 . . . . 0.0 108.714 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -73.98 63.22 0.92 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.84 2.456 . . . . 0.0 112.936 -166.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.64 175.86 10.06 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.792 1.637 . . . . 0.0 108.648 166.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -143.21 112.28 6.63 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 155.66 18.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.689 0.796 . . . . 0.0 109.71 -173.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.55 162.77 39.51 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 155.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.7 131.77 10.62 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 163.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.33 144.59 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 118.712 1.256 . . . . 0.0 108.446 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 m -145.97 165.13 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.301 0.64 . . . . 0.0 111.423 -174.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.41 -143.62 9.54 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 p -133.38 146.33 32.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -170.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.42 113.4 1.51 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 125.087 1.327 . . . . 0.0 109.831 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -95.57 117.12 29.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.476 1.91 . . . . 0.0 107.202 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.98 77.86 0.38 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -84.59 77.28 10.07 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -67.62 83.01 0.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.573 1.149 . . . . 0.0 110.757 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -63.72 116.7 5.97 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 165.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.3 t -129.46 165.74 21.0 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 157.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.24 -11.25 0.42 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 116.938 -1.506 . . . . 0.0 114.266 -175.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -82.15 -94.14 0.05 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.298 1.408 . . . . 0.0 108.957 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -49.24 94.91 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -162.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.1 -2.89 12.75 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 CA-C-N 122.192 1.819 . . . . 0.0 113.319 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.7 m 57.85 88.28 0.06 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.703 1.201 . . . . 0.0 111.294 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 70.06 -148.35 0.1 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.841 1.656 . . . . 0.0 110.516 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -55.63 113.07 1.31 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.234 1.014 . . . . 0.0 110.539 -171.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -45.35 -45.85 12.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.212 1.405 . . . . 0.0 113.985 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 144.51 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.236 1 C-N-CA 132.276 4.23 . . . . 0.0 111.797 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 t -135.03 110.58 9.16 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.591 -1.318 . . . . 0.0 108.222 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.7 m -156.5 67.55 0.57 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.601 1.56 . . . . 0.0 107.577 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.08 177.12 9.0 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.981 0.913 . . . . 0.0 111.616 -159.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -72.59 123.87 24.1 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.624 0.77 . . . . 0.0 110.079 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.76 165.43 17.7 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 159.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -90.3 135.16 33.85 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.1 m -104.98 131.84 51.99 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -143.05 134.69 26.49 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.83 -162.86 14.29 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 124.55 1.071 . . . . 0.0 110.868 -161.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.54 174.44 11.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.922 1.289 . . . . 0.0 109.503 171.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.01 142.34 13.76 Favored Glycine 0 C--N 1.33 0.249 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 168.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.31 140.23 52.34 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -131.86 149.52 52.43 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -109.62 171.38 7.48 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 126.416 1.886 . . . . 0.0 108.726 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -56.49 111.38 3.19 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.639 1.176 . . . . 0.0 110.834 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.64 114.23 3.98 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.932 3.088 . . . . 0.0 110.795 -169.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 49.1 mtt -80.13 158.07 26.46 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.791 1.281 . . . . 0.0 109.738 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -81.12 90.68 6.05 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 134.59 -20.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 132.414 4.285 . . . . 0.0 112.235 170.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.13 119.06 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 120.17 1.35 . . . . 0.0 108.898 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.26 155.37 34.42 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 120.201 -1.562 . . . . 0.0 107.729 155.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -125.58 114.58 18.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 161.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -155.5 151.67 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -147.84 151.81 36.58 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.47 1.508 . . . . 0.0 108.68 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.4 t -125.18 141.97 51.78 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 161.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -115.5 124.94 52.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -132.43 119.24 20.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.251 1.02 . . . . 0.0 108.734 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -109.57 107.32 17.36 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 170.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 t -85.21 160.37 19.9 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 163.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -136.65 151.71 49.61 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 155.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.89 111.42 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.9 ttt-85 52.86 46.14 27.35 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.309 1.044 . . . . 0.0 111.893 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.1 m 56.1 39.43 30.39 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.272 1.029 . . . . 0.0 113.134 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.59 140.95 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 153.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -101.3 122.07 43.02 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 126.428 1.891 . . . . 0.0 108.376 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.5 t -128.85 93.45 2.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -166.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.74 139.26 17.0 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -141.34 119.48 12.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -123.79 113.74 18.96 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.6 pp -108.29 147.5 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.649 1.113 . . . . 0.0 109.477 -172.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.58 163.45 15.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -147.81 102.83 0.25 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 107.669 -2.172 . . . . 0.0 107.669 -172.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.08 153.3 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.59 -141.93 7.55 Favored Glycine 0 C--O 1.218 -0.87 0 CA-C-O 117.532 -1.705 . . . . 0.0 109.203 -159.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -163.41 167.09 22.1 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 121.609 2.705 . . . . 0.0 111.003 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -89.35 144.92 25.71 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 159.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.781 154.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -150.66 164.72 35.42 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -143.48 159.72 41.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.3 1.84 . . . . 0.0 108.173 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -131.5 146.08 52.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.85 98.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.9 t -148.38 119.81 7.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -159.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.65 171.17 40.03 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.34 -123.08 1.12 Allowed Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 -163.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -146.6 158.3 43.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -159.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.02 156.69 31.62 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.094 0.958 . . . . 0.0 109.725 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -125.47 111.9 15.62 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 167.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.8 m -85.48 140.9 30.31 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 160.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -138.79 172.02 13.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.12 2.568 . . . . 0.0 107.062 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.91 164.49 33.57 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.875 1.216 . . . . 0.0 110.794 162.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.81 86.19 5.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.092 0.949 . . . . 0.0 109.201 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.3 -32.02 1.53 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.576 1.56 . . . . 0.0 109.892 172.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -137.6 99.29 3.9 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.6 mtt -69.3 71.38 0.28 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 160.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -71.98 91.97 1.25 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 166.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -68.12 120.36 14.2 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.0 mtp -137.28 134.4 36.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.46 -179.76 24.66 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 162.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.59 -105.37 0.28 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 104.428 -3.469 . . . . 0.0 104.428 170.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -127.97 153.98 46.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.144 1.378 . . . . 0.0 108.723 167.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -138.81 129.58 26.33 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.123 2.169 . . . . 0.0 109.651 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 tp -135.56 143.17 45.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.937 1.244 . . . . 0.0 109.896 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -127.05 166.27 17.91 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.356 1.863 . . . . 0.0 109.07 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.5 141.24 18.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.899 1.68 . . . . 0.0 106.971 -166.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -116.74 147.62 41.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.089 0.859 . . . . 0.0 109.395 165.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.14 120.0 21.7 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.654 1.582 . . . . 0.0 107.574 166.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -101.59 112.49 25.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.5 101.02 12.8 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.475 1.91 . . . . 0.0 107.896 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 38.04 64.05 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.683 1.993 . . . . 0.0 111.981 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 62.35 40.15 11.51 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.775 2.03 . . . . 0.0 112.394 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.8 p -63.82 122.96 79.98 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.57 -37.39 12.81 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.211 1.941 . . . . 0.0 112.08 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.06 155.3 32.59 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 164.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.59 -167.35 12.18 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 172.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.41 146.17 34.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.23 137.08 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 167.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.28 108.55 0.36 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 165.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 p -125.52 137.59 53.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.444 0.622 . . . . 0.0 110.925 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.65 153.62 20.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.5 m -120.3 132.7 55.42 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 161.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -120.36 153.33 36.64 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.806 2.042 . . . . 0.0 106.109 167.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.9 p -133.19 145.38 50.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.103 0.865 . . . . 0.0 111.741 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -129.77 115.95 18.04 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 163.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -162.66 147.28 11.87 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 m -65.22 155.05 36.32 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.07 137.46 51.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 157.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 t -171.91 110.08 0.27 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.528 1.531 . . . . 0.0 107.342 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.69 1.02 0.13 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 119.915 -1.741 . . . . 0.0 114.51 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.3 t -143.3 87.17 1.94 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 127.229 2.212 . . . . 0.0 106.07 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 m 57.77 38.88 27.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.358 1.063 . . . . 0.0 111.273 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.82 33.08 66.32 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.425 -0.653 . . . . 0.0 113.331 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -70.88 91.35 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.174 2.19 . . . . 0.0 109.371 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -116.13 128.02 55.31 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.456 2.303 . . . . 0.0 106.745 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -160.3 172.85 16.61 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.684 0.794 . . . . 0.0 109.705 -167.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -60.33 130.47 46.78 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -154.01 148.86 26.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.695 0.798 . . . . 0.0 108.977 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -152.74 146.42 25.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 164.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -97.95 122.72 41.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 157.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.9 125.55 45.9 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.04 135.49 12.89 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.7 mm -141.89 135.92 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 127.667 2.387 . . . . 0.0 105.603 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 t -140.28 153.61 46.55 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.201 1.4 . . . . 0.0 108.168 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.65 152.97 44.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.871 1.268 . . . . 0.0 108.308 170.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.55 141.43 3.16 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 168.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.88 169.69 18.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 121.71 1.607 . . . . 0.0 110.163 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.86 157.86 16.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.465 1.906 . . . . 0.0 107.34 168.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -145.58 116.55 7.8 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -84.22 134.38 34.55 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.0 mp -77.37 -79.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -171.61 1.94 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.245 0.929 . . . . 0.0 113.374 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -135.15 66.81 1.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -162.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 93.3 m95 53.47 -38.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 131.013 3.725 . . . . 0.0 117.569 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.21 162.9 28.47 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.182 1.793 . . . . 0.0 110.603 -170.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 t -148.45 110.08 4.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.87 145.76 34.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -151.07 164.91 35.35 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.91 0.884 . . . . 0.0 109.333 166.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.62 130.45 20.54 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 170.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 m -119.57 172.17 6.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.298 1.039 . . . . 0.0 108.666 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.1 158.55 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 C-N-CA 125.682 1.593 . . . . 0.0 108.783 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.0 162.64 25.03 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 170.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.2 p -134.54 136.33 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.44 110.92 1.76 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 107.191 -2.363 . . . . 0.0 107.191 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -129.11 156.62 43.58 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.89 174.04 39.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -127.27 145.61 50.72 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 167.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -162.35 152.04 16.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.746 0.703 . . . . 0.0 110.438 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -111.17 165.29 12.03 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.0 m -136.29 111.62 9.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.332 1.453 . . . . 0.0 107.468 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 95' ' ' TYR 0.301 2.9 m 69.74 -60.61 0.47 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.648 1.979 . . . . 0.0 109.445 -175.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.07 -23.0 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 129.32 3.048 . . . . 0.0 114.299 -171.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.432 ' H ' ' C ' ' A' ' 93' ' ' THR . 22.5 m-85 -57.36 152.79 30.54 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 164.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.94 -9.92 20.91 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.849 2.366 . . . . 0.0 113.818 -172.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -21.97 60.34 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.877 1.671 . . . . 0.0 112.734 174.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -157.24 -38.52 0.07 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.716 1.144 . . . . 0.0 113.432 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 53.6 tttm 35.43 65.18 0.41 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.211 2.204 . . . . 0.0 114.998 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -110.39 102.65 11.26 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.949 0.899 . . . . 0.0 109.729 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.21 143.16 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.63 0.772 . . . . 0.0 109.223 164.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.5 m -140.01 144.74 37.1 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.397 -0.815 . . . . 0.0 110.49 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.97 153.4 48.42 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 154.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -161.58 176.05 11.44 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.729 0.812 . . . . 0.0 109.223 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -139.62 165.19 27.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.346 1.458 . . . . 0.0 109.032 170.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.29 167.55 38.91 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 165.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -102.85 152.39 21.33 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.323 1.849 . . . . 0.0 110.363 -173.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 p -137.41 168.33 19.86 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.416 1.487 . . . . 0.0 110.101 165.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -146.3 153.12 40.19 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.704 0.802 . . . . 0.0 108.901 168.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.24 -153.94 9.36 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.75 160.28 41.96 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.514 1.125 . . . . 0.0 108.955 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -99.06 121.82 7.35 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 171.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.7 138.94 50.61 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -141.83 155.71 45.56 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.071 -1.018 . . . . 0.0 109.548 -161.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -93.14 163.63 13.56 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -57.02 134.86 80.29 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.336 -0.84 . . . . 0.0 108.759 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.45 104.28 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.444 2.096 . . . . 0.0 110.42 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttt -75.34 -175.02 2.59 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.803 1.241 . . . . 0.0 107.676 167.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -106.08 -13.81 15.34 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.624 1.57 . . . . 0.0 110.438 -159.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.41 25.5 0.35 Allowed 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 125.267 1.427 . . . . 0.0 108.967 166.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.68 137.35 27.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.72 145.2 30.77 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.89 135.68 51.28 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -131.03 145.22 51.96 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.24 1.416 . . . . 0.0 110.362 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -147.5 144.79 28.81 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.487 1.915 . . . . 0.0 108.225 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.2 p -145.82 163.62 34.47 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 151.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -137.27 137.46 39.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -138.21 165.16 27.38 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.021 0.929 . . . . 0.0 109.175 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -127.07 118.24 24.02 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 165.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.6 m -83.24 154.5 24.16 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.833 0.853 . . . . 0.0 109.684 167.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -116.78 102.96 9.85 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.18 93.95 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.631 0.651 . . . . 0.0 110.996 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 88.57 39.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.79 2.836 . . . . 0.0 109.995 164.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m 52.85 43.77 31.13 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.208 1.403 . . . . 0.0 111.564 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.47 130.28 53.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 127.994 2.517 . . . . 0.0 105.075 165.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.75 104.96 15.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.368 0.667 . . . . 0.0 109.724 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.87 92.07 2.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.92 1.288 . . . . 0.0 107.866 -169.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.57 151.81 43.67 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.0 t -138.33 153.49 48.99 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.492 1.117 . . . . 0.0 108.405 165.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -139.36 157.22 46.26 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 152.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.6 pt -120.61 149.03 23.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 168.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.2 123.52 12.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 166.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.02 154.13 25.39 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.84 -179.55 3.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 125.795 1.638 . . . . 0.0 107.963 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 174.78 -96.09 0.11 Allowed Glycine 0 C--O 1.228 -0.281 0 O-C-N 120.29 -1.506 . . . . 0.0 111.58 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -146.63 176.02 10.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.992 1.317 . . . . 0.0 110.522 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -141.31 139.39 33.61 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 10.8 p90 . . . . . 0 C--O 1.252 1.217 0 CA-C-N 119.371 0.987 . . . . 0.0 109.28 176.689 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.3 m -146.36 166.65 25.69 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.688 1.595 . . . . 0.0 106.751 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -122.95 140.61 52.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.102 0.961 . . . . 0.0 109.967 -173.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 t -151.42 173.2 14.83 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.58 120.76 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -139.89 122.25 16.03 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -161.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.38 -159.89 33.14 Favored Glycine 0 C--N 1.332 0.331 0 O-C-N 119.931 -1.731 . . . . 0.0 113.635 -157.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 114.44 -99.83 0.97 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 106.984 -2.447 . . . . 0.0 106.984 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -139.74 157.68 45.34 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.029 1.414 . . . . 0.0 108.753 -163.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.14 132.24 41.41 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.053 1.741 . . . . 0.0 107.703 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -100.04 113.17 25.58 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -85.01 137.72 32.9 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 157.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -138.14 170.65 15.67 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.449 1.1 . . . . 0.0 108.397 171.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -114.23 165.48 12.63 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.264 1.026 . . . . 0.0 111.866 -165.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -46.2 -20.39 0.1 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.28 2.632 . . . . 0.0 113.693 172.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.15 94.71 0.15 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 168.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -42.48 102.94 0.03 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 129.772 3.229 . . . . 0.0 112.408 -173.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.3 ttm -145.83 -36.17 0.28 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.003 1.721 . . . . 0.0 111.056 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.89 103.25 7.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.86 1.264 . . . . 0.0 111.658 173.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 157.34 18.0 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.742 172.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.9 mtm -130.21 159.7 36.07 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.198 0.999 . . . . 0.0 109.785 172.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.26 176.03 38.94 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.026 1.774 . . . . 0.0 110.164 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.91 -84.58 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.53 156.72 41.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 172.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -137.41 150.22 47.49 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 164.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.8 tp -150.73 131.77 14.33 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 168.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -131.02 161.28 32.32 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.896 2.078 . . . . 0.0 110.143 -176.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -145.46 142.33 29.16 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.761 1.624 . . . . 0.0 108.356 -172.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -131.63 115.27 15.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.475 0.71 . . . . 0.0 109.298 -175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -98.94 156.57 16.83 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.733 0.697 . . . . 0.0 110.01 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -139.91 113.19 8.35 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.943 1.697 . . . . 0.0 108.939 -165.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -64.35 169.06 4.98 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.414 1.486 . . . . 0.0 110.828 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.2 -30.72 12.84 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.749 0.82 . . . . 0.0 109.37 167.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.83 -82.59 0.06 Allowed 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.56 0.744 . . . . 0.0 109.45 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.5 p -89.07 173.45 6.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.772 0.829 . . . . 0.0 110.943 -171.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.46 -3.86 14.51 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.628 2.219 . . . . 0.0 112.44 165.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.5 tp -70.67 155.94 40.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.32 0.964 . . . . 0.0 110.13 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.17 -166.77 28.76 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 t -132.87 151.08 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 118.163 0.981 . . . . 0.0 109.822 -166.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.3 mm -119.88 143.99 29.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 125.74 1.616 . . . . 0.0 107.867 169.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.06 144.37 15.93 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 148.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.0 m -123.51 153.54 40.42 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 127.021 2.128 . . . . 0.0 106.568 168.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -121.15 122.29 39.69 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 m -93.54 116.4 28.92 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -166.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -139.22 125.2 19.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.688 0.395 . . . . 0.0 110.781 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -133.23 130.97 39.75 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -72.25 -177.45 2.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.962 167.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.13 118.87 4.94 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 119.807 -1.808 . . . . 0.0 109.648 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 m -123.48 128.94 50.51 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.835 1.254 . . . . 0.0 108.229 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -70.0 99.81 1.5 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 164.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t 179.85 95.28 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.537 2.335 . . . . 0.0 105.864 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.48 5.59 7.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.216 2.206 . . . . 0.0 111.214 170.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 88.65 -37.11 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 128.376 2.67 . . . . 0.0 109.624 177.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 p -82.6 -66.15 0.92 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 152.67 82.28 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 107.066 -2.414 . . . . 0.0 107.066 -155.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -119.42 99.22 6.55 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 163.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.93 77.32 3.5 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -167.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.49 116.98 17.68 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -149.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -143.54 170.8 15.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 118.469 0.577 . . . . 0.0 110.758 -169.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 t30 53.53 -177.23 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.859 1.264 . . . . 0.0 109.026 -150.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -113.53 169.34 9.04 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.914 1.286 . . . . 0.0 108.217 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -97.06 103.43 15.36 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -98.12 147.55 24.45 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.17 170.42 36.24 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.82 138.11 46.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.9 m -134.39 127.07 30.87 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.16 149.02 26.62 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.869 0.468 . . . . 0.0 109.775 -172.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.54 -178.28 31.41 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.611 0.624 . . . . 0.0 111.746 176.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -81.29 -177.28 3.57 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.906 3.738 . . . . 0.0 112.141 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.74 146.23 45.56 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.159 -0.963 . . . . 0.0 109.448 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -88.99 101.09 13.74 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -71.83 146.25 48.1 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 162.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.8 mm -97.92 -105.34 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 167.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -155.26 -57.15 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.85 170.57 3.33 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.26 2.224 . . . . 0.0 108.864 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.82 59.47 1.23 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.859 1.264 . . . . 0.0 112.956 -173.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.05 162.9 34.31 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.743 1.617 . . . . 0.0 108.78 158.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -150.05 167.29 27.18 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.755 -1.216 . . . . 0.0 110.342 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.54 146.85 24.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -107.16 148.19 29.16 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.84 83.19 0.16 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -131.13 167.67 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.513 1.125 . . . . 0.0 110.451 -175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.48 131.22 60.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -175.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.68 122.5 3.24 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.74 146.2 28.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.119 0.968 . . . . 0.0 108.834 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.62 145.27 16.29 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 124.04 0.829 . . . . 0.0 111.984 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -126.86 117.7 23.13 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.1 1.36 . . . . 0.0 107.492 165.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.57 133.78 9.06 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 106.003 -2.839 . . . . 0.0 106.003 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -76.36 96.91 4.1 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 168.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -70.04 111.68 5.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -64.84 151.88 44.34 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 167.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.3 141.81 51.59 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 44.1 m -67.51 -6.51 20.09 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.409 1.484 . . . . 0.0 112.706 -171.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 87.12 -28.72 0.06 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.549 2.34 . . . . 0.0 111.709 157.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -37.55 -58.31 1.3 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 128.309 2.644 . . . . 0.0 114.493 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.6 15.12 1.1 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.384 2.056 . . . . 0.0 113.399 -173.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . 0.305 0.6 OUTLIER 65.81 81.34 0.21 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 123.229 1.49 . . . . 0.0 107.922 -169.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.18 -54.25 1.19 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.937 1.295 . . . . 0.0 110.364 -177.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? 41.81 67.26 0.59 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.46 1.904 . . . . 0.0 114.255 171.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.5 t30 42.55 65.55 0.9 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.877 2.471 . . . . 0.0 113.682 167.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.32 -58.32 2.99 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 126.39 1.876 . . . . 0.0 112.517 -165.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.42 157.83 44.93 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.273 -0.892 . . . . 0.0 109.09 164.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -103.2 176.71 5.06 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.71 1.204 . . . . 0.0 111.101 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -137.7 128.49 27.04 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 109.912 -165.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -90.65 159.51 16.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 163.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.33 136.54 8.67 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 105.775 -2.93 . . . . 0.0 105.775 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -130.39 130.3 44.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -171.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.82 -175.19 3.88 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.072 1.349 . . . . 0.0 109.65 -167.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -135.23 148.71 49.69 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 165.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.46 64.24 1.11 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 125.436 1.493 . . . . 0.0 109.81 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -95.81 64.29 2.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.755 0.822 . . . . 0.0 109.672 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -96.19 165.72 24.13 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.808 1.67 . . . . 0.0 112.645 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -138.03 140.6 40.18 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.369 1.868 . . . . 0.0 108.857 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -113.45 141.01 47.62 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.041 1.337 . . . . 0.0 109.393 -167.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -119.05 171.83 7.99 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.376 1.071 . . . . 0.0 109.171 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -56.15 110.26 2.2 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.96 1.304 . . . . 0.0 110.15 -173.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 125.98 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.389 2.726 . . . . 0.0 111.013 -169.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.4 ttp -90.63 155.6 18.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 122.919 1.342 . . . . 0.0 110.111 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -80.55 30.1 0.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 128.942 2.897 . . . . 0.0 110.025 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.81 -14.3 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.219 1.808 . . . . 0.0 112.021 171.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.9 m -152.16 121.81 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 126.327 1.851 . . . . 0.0 108.058 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.75 165.59 17.02 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 119.996 -1.69 . . . . 0.0 109.64 160.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -139.13 114.58 9.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 165.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -156.83 155.58 31.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -137.84 114.62 10.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.616 1.566 . . . . 0.0 107.248 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 m -113.91 135.24 54.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 165.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -136.84 113.07 9.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 -169.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -121.29 143.47 49.15 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.143 0.977 . . . . 0.0 108.783 -173.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -133.46 125.0 28.06 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.271 1.428 . . . . 0.0 109.461 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 p -139.1 160.34 40.03 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 120.007 1.276 . . . . 0.0 111.516 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -113.73 117.22 30.9 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 44.7 mt -120.75 109.72 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.66 41.23 28.68 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.478 1.111 . . . . 0.0 110.903 172.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 56.6 m 58.66 16.5 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.81 128.89 39.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 160.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.12 131.1 41.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 169.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.3 t -132.7 133.23 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.2 153.42 17.62 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.3 t -132.69 129.91 39.39 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 159.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -102.04 110.07 21.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 169.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.6 mt -93.86 118.38 39.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.63 145.13 24.85 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -124.37 82.75 0.35 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.99 179.59 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 168.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.9 -120.53 1.23 Allowed Glycine 0 N--CA 1.465 0.618 0 CA-C-O 117.477 -1.735 . . . . 0.0 111.287 -169.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -164.23 164.39 22.53 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.578 1.951 . . . . 0.0 109.701 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.77 132.03 36.26 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.133 -1.604 . . . . 0.0 109.252 175.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.852 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.4 p -141.98 165.96 26.02 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 165.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.47 107.69 4.76 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.971 1.308 . . . . 0.0 110.047 -167.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -61.95 142.09 57.64 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 159.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.84 100.23 4.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 171.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -150.67 146.11 26.27 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.086 -1.634 . . . . 0.0 109.231 -165.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.38 170.81 38.91 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 121.452 0.473 . . . . 0.0 112.125 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.81 -127.32 1.4 Allowed Glycine 0 C--O 1.227 -0.309 0 O-C-N 121.164 -1.198 . . . . 0.0 111.748 -170.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -139.7 158.7 43.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.174 0.989 . . . . 0.0 109.982 -166.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.72 125.76 47.34 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.957 1.303 . . . . 0.0 107.738 169.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -101.94 104.48 15.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 163.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.0 m -89.14 141.94 28.07 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 159.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -138.23 165.03 27.71 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.682 1.993 . . . . 0.0 108.399 170.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.76 164.97 21.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 111.35 -170.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -62.07 5.97 0.09 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.24 102.63 0.23 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 104.521 -3.432 . . . . 0.0 104.521 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -65.09 95.92 0.19 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.894 1.278 . . . . 0.0 109.626 -164.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.2 mtt -153.8 10.7 0.41 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.082 2.553 . . . . 0.0 110.596 -176.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -131.78 143.66 50.38 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 120.707 -1.246 . . . . 0.0 109.0 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -137.63 76.99 1.61 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.461 1.904 . . . . 0.0 106.649 164.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.9 mtm -83.45 154.74 23.78 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.78 170.08 12.71 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.294 1.902 . . . . 0.0 111.447 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.37 -141.39 3.22 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -170.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -99.26 123.6 43.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.131 0.966 . . . . 0.0 109.649 -171.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -94.98 151.06 19.5 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.642 1.177 . . . . 0.0 107.846 -172.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.56 148.99 35.08 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.292 1.437 . . . . 0.0 107.923 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -137.63 130.73 30.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.867 1.667 . . . . 0.0 107.63 -167.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.45 138.62 29.42 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -170.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 163.24 33.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.292 1.037 . . . . 0.0 108.608 167.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -120.4 157.87 28.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 161.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -101.94 112.29 24.86 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.8 OUTLIER -77.09 178.81 6.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.401 1.08 . . . . 0.0 110.315 -175.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.401 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 5.2 p-10 -135.37 13.81 3.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.687 1.595 . . . . 0.0 111.504 -156.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -137.44 -28.35 0.92 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.085 0.954 . . . . 0.0 111.503 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 p -120.74 114.71 32.52 Favored Pre-proline 0 CA--C 1.535 0.382 0 O-C-N 120.919 -1.113 . . . . 0.0 111.07 -169.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.75 80.19 2.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.334 2.022 . . . . 0.0 109.227 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.34 156.29 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.111 2.164 . . . . 0.0 106.659 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.75 167.69 28.52 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.6 -1.111 . . . . 0.0 111.56 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.47 139.01 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 119.313 1.556 . . . . 0.0 107.929 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.5 110.46 16.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.65 123.39 5.22 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 107.244 -2.343 . . . . 0.0 107.244 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 m -122.55 154.36 38.01 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.509 1.523 . . . . 0.0 109.605 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -121.12 132.71 55.02 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.407 0.683 . . . . 0.0 110.586 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -127.64 150.53 49.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.271 1.428 . . . . 0.0 108.185 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -138.62 157.11 46.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.222 3.009 . . . . 0.0 106.493 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 t -99.65 132.81 44.75 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -143.74 40.95 1.42 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.982 0.913 . . . . 0.0 109.888 -166.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -148.35 138.21 22.35 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 120.937 -1.102 . . . . 0.0 110.852 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -90.3 144.58 25.7 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.0 mtp85 -134.91 118.1 16.56 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 117.167 -1.397 . . . . 0.0 108.084 157.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.5 m -128.67 123.12 32.37 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 120.238 1.381 . . . . 0.0 108.464 172.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.74 89.02 1.87 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.263 0.625 . . . . 0.0 110.705 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m 60.08 16.97 6.35 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.491 1.117 . . . . 0.0 113.097 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 m -135.68 4.83 3.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.929 1.292 . . . . 0.0 111.123 -169.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.89 23.56 63.66 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.078 0.847 . . . . 0.0 113.543 173.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.5 101.8 6.63 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 128.759 2.824 . . . . 0.0 105.819 177.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -121.61 115.98 23.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.113 165.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -39.09 103.9 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.172 2.189 . . . . 0.0 110.906 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -120.87 122.94 41.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.833 1.197 . . . . 0.0 109.579 -166.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 66.28 -166.26 0.22 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.206 1.802 . . . . 0.0 107.67 -165.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -113.79 151.92 31.35 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.051 1.296 . . . . 0.0 110.166 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -75.17 136.65 41.04 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 155.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -122.11 117.59 26.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 174.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.22 124.48 4.54 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.77 157.08 38.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 171.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.8 t -140.61 158.63 43.7 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.14 145.36 24.66 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.024 0.93 . . . . 0.0 108.616 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.65 161.13 33.98 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 151.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.94 154.62 33.66 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.834 1.689 . . . . 0.0 109.398 165.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.15 167.08 13.0 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 161.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -140.69 154.89 46.55 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.772 -0.58 . . . . 0.0 109.933 165.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -111.27 148.56 32.63 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.458 1.103 . . . . 0.0 108.866 -175.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.3 mp -114.74 -58.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.874 1.27 . . . . 0.0 108.343 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 172.37 -41.14 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.877 2.471 . . . . 0.0 107.957 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.33 165.63 3.48 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.435 2.294 . . . . 0.0 110.406 -177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -82.44 46.93 1.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.279 163.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.94 151.59 36.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.516 2.326 . . . . 0.0 106.69 170.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.04 168.45 23.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 163.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.54 148.58 24.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 174.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -150.67 124.33 9.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.353 0.661 . . . . 0.0 110.211 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.27 142.21 47.03 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 163.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.53 176.08 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.042 0.937 . . . . 0.0 108.877 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -127.57 155.2 38.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.64 163.67 26.83 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.82 131.95 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 171.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.44 109.32 0.95 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 107.17 -2.372 . . . . 0.0 107.17 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -128.84 146.3 50.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.41 -175.59 33.28 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 118.225 -1.941 . . . . 0.0 112.56 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -118.16 120.87 39.03 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -162.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -73.53 0.16 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.781 0.832 . . . . 0.0 112.7 -168.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -175.9 44.97 0.01 OUTLIER 'General case' 0 C--O 1.235 0.304 0 C-N-CA 127.716 2.406 . . . . 0.0 111.84 -165.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.2 95.52 1.28 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.254 1.026 . . . . 0.0 109.485 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 p -145.03 28.26 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.277 1.431 . . . . 0.0 108.985 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.48 -56.87 7.83 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.742 0.817 . . . . 0.0 110.504 -170.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 171.28 -62.93 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 128.243 2.617 . . . . 0.0 108.087 -174.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.54 169.66 10.9 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.702 1.601 . . . . 0.0 110.764 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.5 p -71.05 15.0 0.12 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.885 1.674 . . . . 0.0 112.896 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.16 -171.9 3.98 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.361 1.864 . . . . 0.0 107.796 -164.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 133.19 -66.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 131.529 3.932 . . . . 0.0 108.656 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -87.95 -71.78 0.56 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 121.129 1.786 . . . . 0.0 109.423 171.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.2 t0 56.68 -160.36 0.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.496 1.118 . . . . 0.0 110.568 -158.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.9 t -125.38 117.8 24.51 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 126.759 2.024 . . . . 0.0 106.245 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -158.85 38.27 0.22 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.624 1.17 . . . . 0.0 108.132 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.23 143.5 40.17 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.255 1.822 . . . . 0.0 107.103 -166.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.91 88.08 2.47 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.224 1.009 . . . . 0.0 108.336 -156.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.15 39.71 1.87 Allowed Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.322 1.439 . . . . 0.0 111.804 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -73.99 121.23 20.71 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 t -157.29 -161.83 1.12 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -129.58 174.16 9.93 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 126.719 2.008 . . . . 0.0 108.848 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.11 -173.8 31.23 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.72 105.37 8.93 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.706 1.602 . . . . 0.0 108.244 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.26 141.93 15.89 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -138.15 161.44 36.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.657 1.983 . . . . 0.0 108.2 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -139.46 159.72 41.5 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.116 0.967 . . . . 0.0 108.419 167.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -92.98 171.54 8.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.444 1.498 . . . . 0.0 108.52 165.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -56.48 119.95 32.41 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.411 1.484 . . . . 0.0 109.117 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.12 148.84 70.14 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.166 1.911 . . . . 0.0 110.5 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 95.2 mtp -116.25 -176.52 2.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.322 1.449 . . . . 0.0 108.804 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.88 -15.88 59.56 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.04 1.336 . . . . 0.0 110.139 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -164.59 14.37 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.836 2.455 . . . . 0.0 111.805 -168.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.94 148.16 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -156.94 154.05 29.09 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 164.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.32 115.78 15.33 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.03 109.51 16.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.509 1.523 . . . . 0.0 107.432 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -115.34 143.66 44.94 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.296 1.038 . . . . 0.0 109.251 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 p -145.92 162.58 37.46 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.379 1.072 . . . . 0.0 110.656 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -151.12 105.48 3.23 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.372 1.069 . . . . 0.0 109.219 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -123.28 163.58 20.43 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.609 1.564 . . . . 0.0 109.956 -170.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -118.52 158.19 25.86 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.762 0.825 . . . . 0.0 111.577 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 t -140.93 105.96 4.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.267 1.827 . . . . 0.0 109.246 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -78.6 97.93 5.97 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 120.851 -1.155 . . . . 0.0 110.109 169.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.5 81.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.96 -70.87 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 128.522 2.729 . . . . 0.0 112.831 -171.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.83 3.82 2.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.298 2.639 . . . . 0.0 110.902 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.72 129.53 46.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -83.27 109.02 16.89 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.2 t -118.72 152.97 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.705 1.202 . . . . 0.0 108.368 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -140.2 152.74 22.99 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 128.123 2.773 . . . . 0.0 107.874 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -135.49 136.08 40.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.414 1.107 . . . . 0.0 109.644 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -112.45 110.67 21.01 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.1 mt -113.65 129.5 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.31 162.1 35.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.33 1.062 . . . . 0.0 109.679 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -158.07 164.37 33.26 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 167.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 m -137.65 166.36 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 166.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -174.82 -107.19 0.2 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 106.982 -2.447 . . . . 0.0 106.982 167.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -141.76 176.6 8.79 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.827 2.051 . . . . 0.0 109.335 -170.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.31 151.76 35.94 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.715 -0.616 . . . . 0.0 110.078 171.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 C--O 1.248 1.014 0 C-N-CA 126.303 1.841 . . . . 0.0 107.97 168.922 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.5 p -96.65 138.2 34.58 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.661 -0.649 . . . . 0.0 109.507 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -89.97 159.18 17.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.947 1.299 . . . . 0.0 108.627 162.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -159.92 144.9 15.08 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 167.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.31 100.14 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.572 0.749 . . . . 0.0 109.143 -171.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 m -132.44 141.35 48.8 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 119.977 -1.702 . . . . 0.0 109.022 -170.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.0 -164.9 26.49 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -166.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.07 -114.05 0.86 Allowed Glycine 0 C--O 1.233 0.094 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.82 158.07 45.11 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.363 1.865 . . . . 0.0 109.223 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.44 136.92 51.35 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 160.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -120.07 122.48 41.18 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -131.66 151.05 51.92 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.34 170.69 15.57 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.754 1.622 . . . . 0.0 109.195 -173.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.67 164.89 27.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.391 1.076 . . . . 0.0 111.493 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -58.93 74.82 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.268 2.627 . . . . 0.0 110.27 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.71 82.86 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 107.835 -2.106 . . . . 0.0 107.835 -171.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -46.02 96.02 0.01 OUTLIER 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.923 2.489 . . . . 0.0 110.094 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.18 -12.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.993 2.117 . . . . 0.0 111.09 -176.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -105.25 123.69 48.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.347 1.459 . . . . 0.0 107.283 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -133.56 95.83 3.57 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.33 159.29 34.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.065 0.936 . . . . 0.0 108.736 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.56 156.09 16.8 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.38 -88.7 0.09 OUTLIER Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -165.42 164.62 19.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.221 1.008 . . . . 0.0 109.251 173.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -130.9 142.17 50.35 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.481 2.312 . . . . 0.0 107.068 166.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -150.44 140.13 21.69 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.791 1.236 . . . . 0.0 108.192 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -151.53 168.16 25.79 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.048 0.939 . . . . 0.0 110.945 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -141.31 114.51 8.67 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.778 0.831 . . . . 0.0 109.127 -167.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -93.73 108.32 20.09 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -103.55 118.26 36.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -140.55 143.3 35.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 7.9 tp10 -143.33 147.46 34.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -175.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.89 2.41 20.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.557 1.143 . . . . 0.0 112.184 -175.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.41 ' H ' ' HG3' ' A' ' 32' ' ' GLU . 4.0 m120 -73.93 -39.07 64.06 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.116 1.366 . . . . 0.0 110.335 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 t -153.37 110.58 2.61 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.4 68.23 5.25 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.992 3.128 . . . . 0.0 110.025 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.1 tp -139.05 105.3 5.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.8 -177.53 47.31 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 123.677 0.656 . . . . 0.0 111.669 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.1 t -134.61 139.72 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.8 pt -129.43 109.73 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 163.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.28 146.55 18.48 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 154.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.39 155.47 40.3 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 128.404 2.682 . . . . 0.0 106.348 160.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -115.78 131.1 57.04 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 167.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 m -92.73 147.45 22.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 156.65 45.23 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.104 1.762 . . . . 0.0 107.106 172.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -143.11 162.43 35.56 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.647 -0.658 . . . . 0.0 109.56 157.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.82 134.21 51.74 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.452 1.901 . . . . 0.0 107.898 166.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.62 147.8 1.1 Allowed 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.513 1.525 . . . . 0.0 107.577 -175.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -130.22 119.01 22.24 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -134.16 178.31 7.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.522 1.529 . . . . 0.0 109.388 175.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.5 t -154.64 38.07 0.42 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.061 1.745 . . . . 0.0 110.325 -173.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.85 107.44 0.45 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.706 0.802 . . . . 0.0 109.306 -172.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.1 m 149.73 -81.74 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 1 C-N-CA 132.643 4.377 . . . . 0.0 108.408 170.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.7 m -119.3 19.42 12.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.328 1.051 . . . . 0.0 112.312 -171.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.61 -2.2 88.01 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 118.447 -1.196 . . . . 0.0 114.486 160.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -72.37 106.12 4.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 163.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -121.78 108.88 14.01 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 126.055 1.742 . . . . 0.0 108.195 159.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 175.79 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 128.286 2.634 . . . . 0.0 105.423 152.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -150.98 157.02 42.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 128.205 2.602 . . . . 0.0 105.913 168.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -133.48 80.33 1.87 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -165.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -113.25 150.17 32.79 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -169.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -141.74 159.34 42.43 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 168.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -128.37 173.26 10.34 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.05 140.9 9.77 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -123.31 107.53 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 170.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -138.11 142.28 40.19 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 128.067 2.547 . . . . 0.0 104.868 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.26 40.06 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 118.562 0.619 . . . . 0.0 110.693 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.7 170.04 30.53 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.959 1.742 . . . . 0.0 109.103 161.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.9 179.79 5.36 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.405 2.07 . . . . 0.0 109.006 164.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.66 144.16 48.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 153.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -141.24 125.91 17.92 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -83.51 93.56 7.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.069 0.849 . . . . 0.0 109.973 -165.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.1 pp -142.52 -168.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.597 1.559 . . . . 0.0 110.354 -174.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 64.38 -95.51 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 128.744 2.818 . . . . 0.0 107.494 -170.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -147.76 115.44 6.37 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 120.55 1.523 . . . . 0.0 108.443 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 12.8 m0 59.81 8.13 1.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.027 2.531 . . . . 0.0 115.27 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.9 179.83 4.24 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.397 0.999 . . . . 0.0 109.218 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -144.99 105.32 4.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.87 152.45 35.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.99 167.2 27.4 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.649 0.38 . . . . 0.0 109.99 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.89 150.44 50.47 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 163.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -131.36 143.78 39.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.2 153.41 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 123.297 0.639 . . . . 0.0 110.643 -177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.96 -170.81 39.15 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 123.624 0.577 . . . . 0.0 113.118 -169.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.09 141.26 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.048 1.339 . . . . 0.0 107.946 172.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.86 143.69 16.04 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 125.658 1.599 . . . . 0.0 109.519 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.9 130.47 35.96 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.208 1.803 . . . . 0.0 107.305 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.86 -145.39 13.09 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.186 1.85 . . . . 0.0 110.091 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.31 133.62 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.484 2.313 . . . . 0.0 110.459 -170.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -135.32 -66.38 0.58 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 117.665 -1.16 . . . . 0.0 112.086 165.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.79 115.73 14.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 120.108 1.322 . . . . 0.0 108.4 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.58 115.48 16.15 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -166.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 p -138.5 -48.69 0.53 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.399 1.454 . . . . 0.0 111.636 -167.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 49.71 -68.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 131.2 3.8 . . . . 0.0 112.743 -163.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -162.14 -54.37 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 129.073 2.949 . . . . 0.0 109.795 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.58 -2.16 8.77 Favored 'Trans proline' 0 C--N 1.354 0.864 0 CA-C-N 121.892 1.711 . . . . 0.0 113.099 -178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.9 m 68.87 75.82 0.25 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.784 2.034 . . . . 0.0 108.286 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -59.16 -45.48 90.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.397 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.5 pttp 35.07 49.27 0.41 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.382 2.273 . . . . 0.0 112.358 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -163.97 -80.57 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 118.289 -0.863 . . . . 0.0 109.761 -169.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.8 t0 76.36 154.49 0.15 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 130.075 3.35 . . . . 0.0 112.034 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.7 p -63.38 113.3 3.16 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 162.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.9 p -61.89 103.72 0.38 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.89 162.02 21.7 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 168.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -146.88 144.57 29.37 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -125.81 107.16 0.93 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 124.594 1.092 . . . . 0.0 111.018 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.68 118.3 15.43 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.8 m -98.05 132.82 43.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -144.91 61.43 1.31 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.3 1.04 . . . . 0.0 110.916 -171.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.63 -164.35 40.23 Favored Glycine 0 CA--C 1.52 0.393 0 O-C-N 121.097 -1.002 . . . . 0.0 113.254 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.94 159.18 40.71 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 151.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -122.46 116.25 2.97 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 107.851 -2.099 . . . . 0.0 107.851 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -117.85 155.72 29.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.104 2.561 . . . . 0.0 106.622 -166.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.28 149.45 33.87 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.935 -1.103 . . . . 0.0 112.152 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.11 172.16 8.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.244 1.818 . . . . 0.0 109.817 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -59.15 130.67 87.0 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 119.12 -0.467 . . . . 0.0 110.796 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.3 118.32 5.29 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.682 2.255 . . . . 0.0 110.361 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 ttt -78.18 -176.03 4.42 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 150.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -86.68 -28.34 23.21 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 123.856 0.862 . . . . 0.0 109.827 172.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.68 3.59 4.54 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 110.755 -162.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.5 t -150.54 112.25 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 127.82 2.448 . . . . 0.0 105.69 -170.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.92 134.0 51.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.67 132.76 46.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -172.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -141.27 155.67 45.97 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.385 1.474 . . . . 0.0 109.182 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -138.1 123.09 19.02 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 124.525 1.13 . . . . 0.0 108.92 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.2 m -122.42 144.76 48.84 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 164.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -149.79 114.85 5.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.86 137.39 38.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.777 1.231 . . . . 0.0 108.339 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -99.76 161.64 13.49 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 169.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p -140.14 108.08 5.71 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.407 1.083 . . . . 0.0 109.351 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.8 ttm105 -62.28 123.79 19.16 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 168.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.7 mt -123.43 104.78 14.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.63 50.93 12.61 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.864 1.265 . . . . 0.0 111.713 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 61.4 m 48.87 29.66 2.39 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -174.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.57 138.58 19.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 156.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -86.21 121.0 28.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.98 134.16 31.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.34 146.63 17.78 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.7 p -124.16 136.38 54.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -131.63 157.74 42.89 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 163.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.3 mt -127.03 128.25 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -167.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.06 126.91 35.64 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.36 101.99 0.57 Allowed Glycine 0 C--O 1.224 -0.529 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 -170.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 t -138.41 139.17 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 127.291 2.236 . . . . 0.0 106.306 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -179.27 -129.61 1.34 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -146.83 177.1 9.37 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.77 2.028 . . . . 0.0 110.046 -158.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.23 166.28 24.14 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 166.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 12.6 p90 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.486 -1.721 . . . . 0.0 108.278 174.85 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.912 -0.033 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.3 p -140.52 160.35 40.2 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.423 0.689 . . . . 0.0 109.782 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.6 106.64 10.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.632 0.73 . . . . 0.0 110.291 -173.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.78 159.57 29.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 161.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.03 101.18 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 166.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 t -122.06 143.99 49.18 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.4 160.93 25.95 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.783 1.658 . . . . 0.0 109.043 -175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.75 -172.21 45.25 Favored Glycine 0 CA--C 1.51 -0.277 0 O-C-N 119.406 -2.232 . . . . 0.0 110.732 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -90.78 139.82 30.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.121 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.73 154.8 17.03 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.115 1.366 . . . . 0.0 109.123 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -152.54 118.8 5.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.62 151.12 24.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -138.42 159.94 40.79 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 150.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.63 160.45 37.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.619 0.645 . . . . 0.0 110.948 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.41 77.27 3.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.255 0.55 . . . . 0.0 111.176 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.69 -2.8 7.53 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.253 1.406 . . . . 0.0 112.377 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -150.99 96.39 2.32 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.075 1.437 . . . . 0.0 107.994 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.9 mtt -75.99 65.13 1.99 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.863 2.465 . . . . 0.0 110.344 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -78.89 95.94 5.55 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 108.766 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -76.35 77.9 3.1 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.563 0.697 . . . . 0.0 109.556 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.3 mmm -114.25 159.42 20.17 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.904 1.282 . . . . 0.0 108.273 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.54 163.89 12.73 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -168.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.53 -120.95 1.07 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 104.356 -3.498 . . . . 0.0 104.356 -172.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.33 170.32 8.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.335 1.068 . . . . 0.0 109.948 -171.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -137.22 163.14 31.61 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 128.029 2.532 . . . . 0.0 106.387 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.69 158.77 43.82 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 164.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -139.48 156.59 46.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.53 130.85 33.08 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -105.63 115.07 29.62 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -98.21 118.67 35.37 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 103.625 -2.731 . . . . 0.0 103.625 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -87.78 128.34 35.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -109.15 178.44 4.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.52 16.42 8.21 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.293 1.437 . . . . 0.0 109.922 -167.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.38 -63.58 0.98 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.191 1.396 . . . . 0.0 110.351 172.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.0 m -75.19 133.29 75.26 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 117.921 0.328 . . . . 0.0 110.768 -172.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.42 -9.22 18.76 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.521 2.814 . . . . 0.0 112.995 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -88.92 155.57 19.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.166 0.986 . . . . 0.0 109.811 173.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.72 -172.94 17.16 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 166.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -130.52 143.92 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 pt -140.27 142.01 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.85 1.26 . . . . 0.0 109.165 165.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.28 108.08 0.34 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.568 1.08 . . . . 0.0 110.435 166.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.85 153.87 42.36 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.354 1.062 . . . . 0.0 110.374 173.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -120.62 148.38 43.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 153.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 t -127.38 150.93 49.39 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.452 1.901 . . . . 0.0 105.928 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -142.72 156.97 45.09 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.309 0.504 . . . . 0.0 110.214 171.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.3 t -100.06 143.98 29.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.729 0.812 . . . . 0.0 110.291 -176.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -151.05 29.27 0.66 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.927 2.091 . . . . 0.0 110.572 -172.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -133.68 148.4 51.48 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 118.985 -2.322 . . . . 0.0 111.545 -175.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.2 m -113.17 121.74 45.42 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.939 1.296 . . . . 0.0 107.629 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.11 103.5 13.3 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -137.45 166.09 24.68 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 164.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.95 -89.02 0.35 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 166.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.1 m -151.38 62.39 0.89 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.399 -0.813 . . . . 0.0 109.145 172.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 m 64.3 79.2 0.26 Allowed 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.477 1.511 . . . . 0.0 111.349 -177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.4 -74.19 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 103.627 -3.789 . . . . 0.0 103.627 156.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -86.11 115.8 23.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 174.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -130.89 117.86 19.89 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 123.42 0.688 . . . . 0.0 110.139 161.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -114.03 143.4 44.81 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 171.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -149.7 120.61 7.65 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 156.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.516 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 41.7 t30 -157.83 -158.41 0.73 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 155.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.516 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 10.8 mp0 -111.36 165.09 12.25 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 165.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.67 116.17 13.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 174.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -97.04 133.86 41.16 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -173.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.09 104.8 0.35 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.6 tt -126.46 114.37 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.443 1.097 . . . . 0.0 108.762 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 t -122.57 151.84 41.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.75 158.41 39.49 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.067 0.947 . . . . 0.0 109.127 168.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.22 -178.56 42.34 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 168.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.52 142.43 44.57 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.015 1.81 . . . . 0.0 110.377 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.31 103.15 15.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 153.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.7 144.97 33.22 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 167.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -74.06 127.38 32.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mm -50.27 -60.86 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.19 0.996 . . . . 0.0 108.848 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -156.89 -43.53 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 167.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.3 -89.51 0.05 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.034 1.333 . . . . 0.0 107.577 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.34 7.11 0.2 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -166.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.84 167.99 20.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.346 1.43 . . . . 0.0 111.161 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 p -74.0 168.76 18.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.983 0.913 . . . . 0.0 110.166 164.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.74 164.57 32.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -105.08 171.0 7.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.826 2.051 . . . . 0.0 110.971 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.57 70.76 1.16 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.74 168.72 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 117.95 0.875 . . . . 0.0 110.405 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.49 154.12 3.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.76 171.51 36.15 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 118.434 0.561 . . . . 0.0 111.999 163.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.33 126.42 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 170.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.99 104.97 2.02 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 166.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -112.95 135.75 53.38 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.564 1.146 . . . . 0.0 107.974 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.25 -166.54 39.35 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.79 102.6 0.05 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.924 1.69 . . . . 0.0 110.056 -176.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -124.09 -78.49 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 175.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -69.87 142.4 53.03 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.42 -0.8 . . . . 0.0 110.835 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.1 m -136.01 137.06 40.82 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.029 2.132 . . . . 0.0 105.712 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 29.0 m -169.41 101.86 0.34 Allowed 'General case' 0 N--CA 1.444 -0.773 1 N-CA-C 99.653 -4.202 . . . . 0.0 99.653 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -111.01 -36.32 5.68 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.966 1.306 . . . . 0.0 108.038 174.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -160.96 -70.37 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.21 1.404 . . . . 0.0 109.292 160.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.7 -2.03 4.79 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.351 2.701 . . . . 0.0 115.702 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.6 m 66.43 15.21 10.03 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 120.34 1.427 . . . . 0.0 112.728 162.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -56.42 -37.67 70.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.386 1.075 . . . . 0.0 111.649 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt 69.2 158.46 0.16 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.676 2.791 . . . . 0.0 112.139 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.64 -56.57 1.95 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -171.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 55.13 15.12 1.14 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.062 1.745 . . . . 0.0 112.649 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.9 p -67.37 95.2 0.43 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.773 2.029 . . . . 0.0 111.132 -173.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 p -76.48 125.37 29.1 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -151.18 157.95 43.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 167.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -70.89 157.45 38.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 117.894 -1.522 . . . . 0.0 108.729 163.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.3 122.55 6.33 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 105.568 -3.013 . . . . 0.0 105.568 159.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -78.63 117.18 19.55 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 78.7 p -103.02 158.33 16.37 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.306 1.051 . . . . 0.0 112.077 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -105.11 112.84 26.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.13 143.03 16.31 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 118.558 0.617 . . . . 0.0 111.783 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -140.18 160.64 39.5 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.689 1.196 . . . . 0.0 109.504 172.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.59 122.12 0.87 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.08 140.52 51.9 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.109 1.364 . . . . 0.0 107.482 173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -120.22 149.76 41.76 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.189 0.995 . . . . 0.0 108.85 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -92.66 172.27 8.46 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.947 1.299 . . . . 0.0 109.62 -174.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -57.18 154.71 19.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.552 -0.717 . . . . 0.0 110.702 169.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.46 143.47 52.4 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.77 2.314 . . . . 0.0 111.538 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.7 mmt -108.44 -176.73 3.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -92.84 -30.33 15.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 109.404 -170.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -142.34 9.72 1.86 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.248 1.419 . . . . 0.0 110.693 -171.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.261 0.2 OUTLIER -141.31 140.43 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 119.582 1.083 . . . . 0.0 108.551 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.4 153.32 18.66 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -133.39 116.16 15.72 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 162.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -141.09 137.71 33.03 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.864 1.666 . . . . 0.0 107.425 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -133.63 121.81 22.57 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.325 0.966 . . . . 0.0 109.178 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.5 m -127.62 149.94 49.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 140' ' ' TRP . 1.5 t80 -145.01 137.25 25.93 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -127.58 153.87 45.87 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.377 1.071 . . . . 0.0 108.774 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -131.52 154.82 48.39 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 168.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.4 m -136.66 156.77 48.09 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.914 2.086 . . . . 0.0 108.534 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -134.1 97.17 3.79 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.3 90.97 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 60.79 -93.11 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 126.656 1.982 . . . . 0.0 110.573 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.17 1.76 20.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.349 0.977 . . . . 0.0 112.633 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.37 112.81 41.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-N 119.847 1.203 . . . . 0.0 108.599 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.43 136.47 57.92 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 162.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.9 t -125.86 116.85 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 169.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.48 149.84 20.04 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 170.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 87.6 m -141.12 120.42 13.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 164.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.418 ' HB3' ' CE2' ' A' ' 127' ' ' TYR . 5.6 p-90 -90.88 141.89 28.34 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 170.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.96 134.88 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.69 164.39 14.73 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 172.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -146.63 104.09 0.29 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.47 -179.83 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.372 1.869 . . . . 0.0 105.989 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 146.15 -115.12 0.78 Allowed Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 106.883 -2.487 . . . . 0.0 106.883 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -147.75 175.8 10.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.01 1.324 . . . . 0.0 110.679 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -140.28 165.81 26.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 164.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 C--O 1.25 1.101 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 170.203 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.447 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 2.5 p -140.48 141.38 35.41 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 168.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -122.93 158.78 29.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 m -145.78 154.82 42.45 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 166.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.1 98.96 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.1 p -117.47 135.15 54.12 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.928 1.291 . . . . 0.0 107.917 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.12 168.42 38.56 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.44 -169.15 42.1 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.483 -173.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -92.04 157.86 16.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.722 1.209 . . . . 0.0 109.026 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.02 172.91 8.17 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.157 0.983 . . . . 0.0 111.307 -174.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -148.24 104.56 3.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 155.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t -84.39 134.02 34.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 157.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -103.28 171.38 7.4 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.37 158.25 44.02 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 161.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.16 97.45 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 162.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.16 -29.81 2.68 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.778 1.18 . . . . 0.0 110.664 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -151.1 93.88 1.98 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -88.34 69.52 9.06 Favored 'General case' 0 C--N 1.335 -0.065 0 CA-C-O 123.954 1.835 . . . . 0.0 107.005 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.49 -177.77 4.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 128.168 2.587 . . . . 0.0 108.476 -168.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -90.79 96.78 10.81 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 164.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 62.2 mtm -70.57 159.23 34.73 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 138.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.77 -161.91 17.96 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.46 -140.48 5.04 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -160.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.99 154.45 20.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.864 1.266 . . . . 0.0 109.703 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -137.66 153.89 49.78 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.452 2.701 . . . . 0.0 107.634 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -150.25 141.41 23.1 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.787 1.635 . . . . 0.0 107.768 168.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -116.43 146.42 42.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.693 1.997 . . . . 0.0 107.363 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.66 110.91 10.19 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -93.23 157.7 16.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -143.63 158.25 43.81 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.823 0.283 . . . . 0.0 110.553 165.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' CD ' ' HG1' ' A' ' 2' ' ' THR . 13.3 pt-20 -125.02 112.55 16.69 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.564 0.697 . . . . 0.0 109.147 169.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.0 164.09 21.69 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.81 8.44 41.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.777 1.631 . . . . 0.0 112.912 -169.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -1.27 22.55 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -172.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.06 139.82 8.36 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 126.555 1.942 . . . . 0.0 107.306 166.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.79 81.06 2.45 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.516 2.144 . . . . 0.0 108.301 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 tp -150.65 156.65 41.77 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.202 1.801 . . . . 0.0 107.94 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.18 -177.9 15.26 Favored Glycine 0 C--O 1.226 -0.346 0 O-C-N 121.571 -0.706 . . . . 0.0 111.539 172.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.2 t -143.5 137.37 25.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.367 1.467 . . . . 0.0 108.25 -165.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.6 mm -139.9 141.39 34.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.977 1.311 . . . . 0.0 109.91 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.64 167.89 20.64 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 107.729 -2.149 . . . . 0.0 107.729 144.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.8 t -127.45 155.27 43.95 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.208 -1.76 . . . . 0.0 106.877 143.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -98.48 143.82 28.49 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 165.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -127.7 134.18 49.57 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.858 1.263 . . . . 0.0 108.389 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -141.96 123.87 15.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.593 1.157 . . . . 0.0 108.395 -172.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -99.21 126.85 45.1 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -163.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -139.14 0.48 1.93 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.308 0.575 . . . . 0.0 112.254 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.19 123.49 26.97 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.001 -1.687 . . . . 0.0 109.1 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.9 p -67.06 152.25 46.12 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.396 0.998 . . . . 0.0 110.633 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.93 123.22 25.54 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 157.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -157.92 -176.33 5.86 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 161.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.77 -54.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.331 1.452 . . . . 0.0 108.878 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 m -147.93 -43.12 0.16 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.917 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 p 173.18 84.04 0.0 OUTLIER 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.401 1.881 . . . . 0.0 106.027 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.66 -74.89 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 O-C-N 121.849 -0.532 . . . . 0.0 113.261 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -119.28 91.17 3.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.989 0.895 . . . . 0.0 109.806 -166.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -88.74 126.21 35.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.894 0.878 . . . . 0.0 110.284 -162.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -62.74 109.2 1.35 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.244 0.929 . . . . 0.0 109.908 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -121.25 170.93 9.11 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.259 1.424 . . . . 0.0 110.968 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.45 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 8.0 t30 58.22 -159.0 0.28 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.71 1.604 . . . . 0.0 111.112 175.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.45 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -128.77 158.64 38.09 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 120.507 -1.371 . . . . 0.0 108.616 174.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -115.73 158.95 22.06 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -127.91 157.14 41.33 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.312 1.845 . . . . 0.0 107.77 -173.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.32 88.82 0.14 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.73 113.47 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.9 m -131.16 128.0 39.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.59 149.28 25.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.373 1.069 . . . . 0.0 108.969 -174.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.13 175.87 31.58 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 166.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.66 175.4 11.15 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.451 2.768 . . . . 0.0 113.036 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.51 138.58 52.34 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.283 1.833 . . . . 0.0 110.712 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -121.02 128.42 52.66 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.08 1.352 . . . . 0.0 108.93 -168.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.53 149.45 24.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.71 0.804 . . . . 0.0 110.223 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.88 179.06 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 163.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -61.32 -52.65 63.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.617 -1.302 . . . . 0.0 110.718 -176.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -159.98 148.52 17.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 149.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 11.6 m0 145.1 -49.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 130.746 3.618 . . . . 0.0 108.87 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.71 168.69 22.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.758 0.823 . . . . 0.0 109.516 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 m -133.48 156.99 46.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 163.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.3 pt -127.47 167.68 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.84 2.056 . . . . 0.0 108.575 -176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.15 123.96 26.61 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.268 -0.895 . . . . 0.0 108.885 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.43 86.58 0.4 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 106.908 -2.477 . . . . 0.0 106.908 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.66 -176.62 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.336 0.655 . . . . 0.0 109.867 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.4 m -116.33 151.01 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 166.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.77 158.4 20.05 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 167.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.8 p -145.86 121.62 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.05 106.35 3.22 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -108.59 117.4 34.07 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.43 174.1 19.41 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -154.46 98.92 2.15 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 170.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -70.64 152.63 43.68 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 157.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -148.76 104.64 3.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.536 0.684 . . . . 0.0 109.694 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -66.55 123.32 19.72 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 127.23 2.212 . . . . 0.0 106.977 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -126.27 4.5 7.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.46 -163.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -126.5 -61.2 1.21 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.682 1.193 . . . . 0.0 109.054 -164.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -60.02 153.53 55.13 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 167.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.79 81.83 1.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.693 2.929 . . . . 0.0 109.354 171.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.7 m -138.5 -46.75 0.5 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.484 1.514 . . . . 0.0 109.384 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 68.6 -68.04 0.19 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.026 2.13 . . . . 0.0 112.851 169.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.47 93.8 4.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -70.2 -47.61 60.72 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -176.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.88 176.53 10.07 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.789 1.236 . . . . 0.0 107.786 166.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.4 m -85.17 156.7 20.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 166.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 p -69.68 155.57 40.31 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 175.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -141.11 159.26 42.58 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 165.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -85.68 165.83 16.65 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.494 -0.754 . . . . 0.0 110.267 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.51 142.31 14.27 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 163.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -118.11 93.2 4.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.572 1.186 . . . . 0.0 109.034 -160.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.7 t -87.21 147.51 25.55 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.976 0.893 . . . . 0.0 110.198 -173.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.12 144.24 51.25 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 128.398 2.679 . . . . 0.0 106.479 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.69 -170.13 14.56 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 -165.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -166.97 -65.53 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.413 1.107 . . . . 0.0 109.203 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 155.11 174.35 24.91 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -167.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.2 mp -145.17 143.84 30.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -104.24 149.51 25.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -173.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.8 171.17 8.82 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -58.75 142.16 84.21 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-O 119.165 -0.445 . . . . 0.0 109.865 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.43 152.55 78.62 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 120.931 1.087 . . . . 0.0 111.007 172.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -109.09 -174.19 2.45 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 130.955 3.702 . . . . 0.0 105.503 162.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -110.93 -11.8 14.3 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.309 1.844 . . . . 0.0 109.294 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -142.01 17.22 2.11 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.176 1.39 . . . . 0.0 111.6 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.82 156.04 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 172.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.41 156.71 42.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.777 0.717 . . . . 0.0 109.166 157.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -136.89 122.36 19.54 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.991 2.117 . . . . 0.0 108.403 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -124.61 160.52 28.28 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.773 2.429 . . . . 0.0 107.64 163.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -140.87 116.69 10.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.23 144.16 51.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.418 0.554 . . . . 0.0 109.939 -168.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -137.29 156.62 48.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -129.79 147.61 51.59 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 155.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -132.84 112.2 11.72 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.8 t -139.56 160.3 40.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.624 1.57 . . . . 0.0 108.228 -157.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.65 145.83 37.11 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.45 110.35 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 171.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 50.17 40.91 23.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.302 1.041 . . . . 0.0 111.97 -173.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 m 47.76 36.84 6.19 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.6 t -81.48 112.79 19.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 143.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.16 137.2 58.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.5 t -139.26 97.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.88 152.4 34.98 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 164.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.8 m -141.0 130.88 24.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 120.775 -1.427 . . . . 0.0 108.047 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -121.23 143.19 49.28 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.8 mt -144.75 132.31 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.805 1.242 . . . . 0.0 107.873 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.61 165.88 14.51 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -154.26 87.36 0.13 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.66 162.61 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 152.81 -119.37 0.95 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -150.59 176.38 11.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.119 1.368 . . . . 0.0 109.564 -158.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 137.9 23.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.039 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 12.0 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-N 119.34 0.973 . . . . 0.0 108.655 167.288 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 p -141.08 136.95 32.49 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 t -127.9 106.81 9.36 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -117.24 118.8 33.3 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.281 5.9 p -110.56 119.41 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 122.006 0.908 . . . . 0.0 111.093 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.32 137.77 23.36 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.728 1.211 . . . . 0.0 108.943 -167.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.5 170.07 40.08 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.59 -152.01 10.02 Favored Glycine 0 C--N 1.319 -0.375 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -172.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -91.87 157.7 16.71 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.47 113.29 11.68 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 169.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.32 148.04 29.52 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.8 t -138.88 115.57 10.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.982 2.113 . . . . 0.0 107.206 -171.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.38 160.69 34.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.068 0.947 . . . . 0.0 109.163 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.72 148.47 52.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.727 0.811 . . . . 0.0 110.986 -167.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 54.65 -70.15 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 128.323 2.649 . . . . 0.0 112.067 -175.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.75 -42.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.7 0 CA-C-N 119.975 1.261 . . . . 0.0 111.04 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -145.21 119.49 9.55 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.438 1.095 . . . . 0.0 108.461 164.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.2 ttm -157.18 -51.75 0.07 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.212 1.005 . . . . 0.0 109.324 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -142.19 158.22 43.98 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.232 1.813 . . . . 0.0 107.733 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -135.76 77.33 1.66 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 170.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.06 138.62 49.06 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 166.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.84 157.22 27.34 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.61 -166.68 38.17 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -170.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -99.89 154.74 18.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.326 0.563 . . . . 0.0 110.402 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -102.43 144.06 31.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.939 1.296 . . . . 0.0 108.271 161.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.0 mt -127.13 150.86 49.3 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 149.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.45 161.09 41.77 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 165.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -144.16 140.41 29.35 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -120.08 114.48 22.05 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.246 0.93 . . . . 0.0 109.357 169.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -99.32 151.92 20.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 163.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -134.69 130.57 36.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -172.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 3.8 tt0 -76.71 163.11 27.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.352 1.072 . . . . 0.0 112.11 -161.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.408 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 5.2 t70 -86.71 27.47 0.98 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.616 1.566 . . . . 0.0 110.885 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -143.1 -65.05 0.39 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.156 1.782 . . . . 0.0 108.983 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.5 p -92.96 127.8 46.03 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.872 1.669 . . . . 0.0 108.921 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -76.92 54.81 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 124.088 3.192 . . . . 0.0 110.252 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.27 106.65 5.81 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.631 2.373 . . . . 0.0 106.73 -159.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.18 178.72 22.07 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.984 1.278 . . . . 0.0 111.082 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.85 144.68 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 124.266 1.026 . . . . 0.0 109.555 -156.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.7 mt -126.54 109.8 21.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.94 1.296 . . . . 0.0 108.083 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.01 148.04 18.35 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 105.862 -2.895 . . . . 0.0 105.862 151.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 p -108.89 144.17 37.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.255 1.027 . . . . 0.0 109.196 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -91.9 145.79 24.27 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 162.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 t -128.91 152.44 48.55 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.061 1.744 . . . . 0.0 108.084 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -136.98 156.65 48.17 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 175.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.4 m -98.35 121.96 40.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 165.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.56 53.45 1.05 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.474 2.31 . . . . 0.0 107.108 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -158.93 146.63 17.75 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 128.524 2.729 . . . . 0.0 108.464 169.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 p -127.7 156.66 42.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.929 2.491 . . . . 0.0 107.599 163.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 -133.74 146.19 50.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -145.75 147.73 32.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 54.81 52.8 11.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.555 1.542 . . . . 0.0 111.935 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t -142.34 -49.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.213 1.405 . . . . 0.0 107.879 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.1 m -136.68 -43.4 0.6 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.649 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.02 8.15 15.78 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 118.977 0.808 . . . . 0.0 112.684 -170.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -72.02 91.01 1.2 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.833 1.653 . . . . 0.0 106.963 170.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 94' ' ' GLU . 1.1 m-85 -71.75 96.62 1.64 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.847 2.059 . . . . 0.0 107.861 178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -66.06 107.08 1.78 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.396 -171.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -135.8 146.25 47.37 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 118.739 0.699 . . . . 0.0 110.213 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 51.2 -161.69 0.08 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.352 1.861 . . . . 0.0 110.745 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.67 176.13 7.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.154 1.381 . . . . 0.0 111.527 -171.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -89.3 130.87 35.62 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 160.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.63 120.04 41.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 165.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.31 88.67 0.19 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.47 141.07 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 p -126.36 155.79 41.52 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.737 1.615 . . . . 0.0 107.782 171.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.62 150.58 45.14 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.74 0.7 . . . . 0.0 110.284 170.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 173.53 137.35 2.39 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 174.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.22 164.83 34.4 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 CA-C-N 120.405 2.102 . . . . 0.0 110.706 167.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.14 103.98 13.07 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.236 1.414 . . . . 0.0 107.879 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.71 112.24 21.47 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.336 0.516 . . . . 0.0 109.713 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -67.96 136.67 54.3 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 168.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.84 178.67 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 126.91 2.084 . . . . 0.0 105.88 172.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.8 t30 38.39 -121.37 0.26 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.435 1.494 . . . . 0.0 109.077 -162.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -110.19 104.14 12.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.202 1.801 . . . . 0.0 108.631 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 65.8 m95 60.84 19.46 9.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.381 2.272 . . . . 0.0 114.73 167.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.57 -169.85 0.92 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.293 0.951 . . . . 0.0 110.468 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.1 m -140.95 169.16 18.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.148 1.379 . . . . 0.0 107.726 167.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.8 mm -133.83 158.61 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 122.804 1.288 . . . . 0.0 109.235 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -105.43 175.48 5.48 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 130.048 3.339 . . . . 0.0 109.627 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 54.05 0.88 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.58 173.22 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.35 160.41 10.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 O-C-N 120.525 -1.359 . . . . 0.0 108.26 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -156.42 165.45 32.91 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-O 122.182 0.879 . . . . 0.0 112.936 162.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -115.26 150.51 17.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 127.055 2.142 . . . . 0.0 106.065 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.89 149.78 18.41 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 165.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -150.77 145.47 25.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.042 1.337 . . . . 0.0 108.944 172.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.62 -133.87 12.07 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.3 tttp 32.6 82.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.586 2.754 . . . . 0.0 114.709 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.52 -45.71 0.82 Allowed 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.594 -0.691 . . . . 0.0 112.603 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 56.84 27.51 13.04 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -176.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 p -94.39 97.49 10.23 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.09 1.356 . . . . 0.0 109.201 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 52.1 m -138.61 -65.38 0.5 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 171.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.411 ' HA ' ' CD1' ' A' ' 57' ' ' TYR 0.294 7.7 tt0 26.32 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.933 2.493 . . . . 0.0 111.666 -150.477 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -138.51 -69.06 0.02 OUTLIER Pre-proline 0 C--O 1.235 0.294 0 CA-C-O 117.342 -1.313 . . . . 0.0 111.369 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.26 -34.12 36.93 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.198 1.464 . . . . 0.0 112.837 -170.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.7 m -65.79 -55.09 19.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.299 0.954 . . . . 0.0 109.588 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.5 t80 43.92 34.76 0.97 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.774 1.63 . . . . 0.0 113.176 -174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -64.36 -45.16 88.96 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.612 -1.305 . . . . 0.0 108.692 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 72.07 -74.17 0.09 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 127.315 2.246 . . . . 0.0 108.876 167.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -133.82 146.38 50.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.394 1.877 . . . . 0.0 108.853 170.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 t -139.09 148.21 43.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.69 1.596 . . . . 0.0 106.94 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 t -79.34 24.67 0.34 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.747 1.619 . . . . 0.0 111.353 -175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.64 128.74 36.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -171.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -114.68 142.83 45.96 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -102.35 168.5 18.79 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -138.43 151.72 47.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 164.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -169.4 -164.47 0.45 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.775 0.83 . . . . 0.0 110.56 166.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -134.5 160.3 38.44 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.51 1.924 . . . . 0.0 108.446 -176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -153.25 -158.19 8.43 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.771 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -139.83 168.76 19.06 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -167.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.24 86.42 0.1 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mt -130.15 149.85 51.67 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.6 1.16 . . . . 0.0 107.939 -173.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -135.25 158.88 43.24 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.199 0.454 . . . . 0.0 111.602 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -101.01 171.14 7.82 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.711 1.204 . . . . 0.0 107.77 166.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -56.77 107.01 0.76 Allowed Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.619 0.768 . . . . 0.0 110.653 -170.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.89 158.06 34.81 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.963 2.442 . . . . 0.0 109.59 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' H ' ' A' ' 120' ' ' ASN . 49.4 ttm -135.95 159.82 40.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.127 1.371 . . . . 0.0 109.189 -174.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -69.88 25.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 130.873 3.669 . . . . 0.0 110.75 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 118' ' ' MET . 0.4 OUTLIER -155.14 -32.16 0.1 Allowed 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.885 -1.135 . . . . 0.0 113.015 178.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.5 m -145.78 135.77 18.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -174.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.19 155.32 18.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.098 0.863 . . . . 0.0 109.427 168.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -130.44 114.08 15.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 155.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.01 148.99 45.68 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.415 2.286 . . . . 0.0 105.607 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -149.83 138.98 21.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 120.644 -1.285 . . . . 0.0 109.471 -162.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.7 m -134.45 166.37 23.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 166.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -145.98 137.89 25.14 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -134.4 163.6 29.3 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -122.02 169.81 10.46 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 127.018 2.127 . . . . 0.0 106.48 170.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.7 t -131.82 159.9 37.19 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 163.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -123.82 97.08 5.2 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.3 mt -86.88 81.95 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 65.94 -78.92 0.03 OUTLIER 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.248 2.219 . . . . 0.0 111.11 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -146.15 61.06 1.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.167 1.787 . . . . 0.0 107.102 166.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.9 t -125.08 145.61 32.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 162.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.25 137.17 39.95 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.864 1.666 . . . . 0.0 107.423 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.4 t -138.45 151.52 24.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 126.649 1.98 . . . . 0.0 106.937 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -137.05 143.86 15.27 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -140.48 135.99 32.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -123.83 131.18 53.54 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.5 115.93 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.499 . . . . 0.0 107.504 -166.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.85 152.3 21.34 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.143 0.577 . . . . 0.0 110.055 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.26 82.56 0.29 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.818 1.675 . . . . 0.0 109.719 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.8 t -104.19 158.41 5.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 126.516 1.926 . . . . 0.0 106.704 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.33 -107.25 0.28 Allowed Glycine 0 C--O 1.221 -0.677 0 C-N-CA 118.657 -1.735 . . . . 0.0 112.799 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.5 165.85 23.27 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.046 1.738 . . . . 0.0 106.858 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -148.99 136.24 20.09 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 119.835 -1.79 . . . . 0.0 111.555 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 128.805 2.842 . . . . 0.0 111.252 168.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.6 m -141.2 125.01 16.98 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -98.86 132.63 44.06 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.496 1.119 . . . . 0.0 109.159 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -143.58 118.78 10.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.38 143.82 10.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.4 m -158.35 139.57 13.29 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.971 1.708 . . . . 0.0 107.989 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.48 172.59 31.15 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.81 -160.68 29.0 Favored Glycine 0 N--CA 1.462 0.384 0 CA-C-N 120.33 2.065 . . . . 0.0 110.903 -172.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -91.71 157.34 16.99 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.405 1.102 . . . . 0.0 109.845 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' HB2' HD22 ' A' ' 25' ' ' ASN . . . -119.93 155.07 33.48 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.517 1.527 . . . . 0.0 110.035 -175.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -148.09 118.35 7.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 162.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -83.79 139.63 32.57 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 167.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -116.68 153.86 31.59 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 157.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.1 106.57 3.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.547 1.939 . . . . 0.0 108.524 -171.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 71.38 -54.1 0.67 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.762 2.025 . . . . 0.0 112.63 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.81 -81.38 0.05 OUTLIER Glycine 0 C--N 1.337 0.638 0 CA-C-N 119.469 1.031 . . . . 0.0 114.257 -172.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -152.57 95.87 2.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.279 1.539 . . . . 0.0 108.913 166.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.8 mtt -144.71 -48.87 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.654 0.782 . . . . 0.0 110.314 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -128.37 109.73 11.7 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -169.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -131.41 77.84 1.8 Allowed 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.717 1.207 . . . . 0.0 107.89 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.81 145.23 47.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 169.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.36 -179.93 34.52 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 128.678 3.037 . . . . 0.0 106.747 167.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.81 -90.95 0.08 OUTLIER Glycine 0 CA--C 1.523 0.545 0 CA-C-N 118.998 1.399 . . . . 0.0 110.646 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -164.71 143.09 6.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 168.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.429 HD22 ' HB2' ' A' ' 10' ' ' ALA . 38.9 m-80 -125.32 163.26 22.93 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.133 0.973 . . . . 0.0 110.233 -166.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 mt -142.79 163.1 33.72 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.148 0.979 . . . . 0.0 110.516 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -140.03 161.06 38.51 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.477 2.311 . . . . 0.0 106.538 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -147.81 112.19 5.26 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -105.3 159.42 15.9 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.163 -0.96 . . . . 0.0 108.945 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -142.77 155.84 44.89 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.942 0.897 . . . . 0.0 108.86 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.41 113.06 19.78 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.335 0.654 . . . . 0.0 109.781 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.85 159.2 26.54 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.304 0.574 . . . . 0.0 109.674 167.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -128.83 39.54 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.66 -16.32 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.995 1.318 . . . . 0.0 112.15 -173.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.6 t -155.07 133.48 7.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.854 1.662 . . . . 0.0 108.193 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.84 -5.0 16.39 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.312 3.342 . . . . 0.0 113.867 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -77.5 123.97 27.29 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.105 -0.997 . . . . 0.0 109.025 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.36 -167.39 36.91 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.7 t -127.08 147.78 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.344 1.458 . . . . 0.0 108.675 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 mm -122.48 127.85 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 166.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.17 108.71 0.39 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 107.226 -2.35 . . . . 0.0 107.226 163.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.6 t -88.23 150.72 23.12 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.849 1.66 . . . . 0.0 108.293 167.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -127.72 131.13 49.75 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.394 1.878 . . . . 0.0 107.976 172.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -127.32 117.0 21.39 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.978 1.711 . . . . 0.0 109.073 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -113.52 133.91 54.97 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.284 1.434 . . . . 0.0 107.827 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 p -126.6 130.06 49.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.318 0.58 . . . . 0.0 110.878 -168.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -140.17 93.21 2.61 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.363 1.465 . . . . 0.0 108.155 -170.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -162.75 147.46 11.81 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.879 0.872 . . . . 0.0 109.11 -174.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.1 p -121.63 153.93 37.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.07 100.4 6.95 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 t -159.21 99.88 1.51 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -166.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.98 81.45 1.27 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.2 t 58.2 67.53 0.94 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 122.702 1.239 . . . . 0.0 107.697 -174.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.38 -32.01 0.39 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.533 173.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.96 47.02 68.0 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.36 104.62 10.18 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.959 2.103 . . . . 0.0 105.73 -175.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -90.8 98.27 11.68 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.475 -1.39 . . . . 0.0 110.446 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.21 122.34 6.72 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.758 -0.589 . . . . 0.0 109.843 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -115.26 171.64 7.57 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.892 1.677 . . . . 0.0 108.516 170.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.89 -176.01 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.379 1.072 . . . . 0.0 110.202 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 pm0 -137.1 162.15 34.16 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 160.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -83.87 143.09 30.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.61 117.71 21.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.844 2.057 . . . . 0.0 106.455 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.87 92.98 1.05 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.3 mm -79.71 146.43 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 p -133.66 155.42 49.74 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.02 139.21 21.22 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.22 175.33 34.96 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.176 0.417 . . . . 0.0 112.249 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -79.02 176.04 10.26 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.886 2.391 . . . . 0.0 110.351 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.01 150.48 38.54 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.631 1.173 . . . . 0.0 108.841 162.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.2 124.2 41.93 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.099 0.96 . . . . 0.0 108.571 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -71.8 133.27 45.42 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.012 0.369 . . . . 0.0 110.049 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.8 mt -77.95 -76.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 165.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -83.09 -76.07 0.29 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 170.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -148.09 -62.01 0.26 Allowed 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -104.48 105.95 16.27 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.279 1.037 . . . . 0.0 109.56 172.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.42 -169.02 3.24 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.389 1.876 . . . . 0.0 108.754 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.97 169.67 17.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 157.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mm -143.06 147.3 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -105.4 141.59 36.65 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.425 2.29 . . . . 0.0 107.972 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.82 50.42 0.21 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -161.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.04 176.4 4.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.55 130.22 54.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.55 158.41 15.13 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.01 118.36 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 170.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.63 122.69 7.62 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 107.372 -2.291 . . . . 0.0 107.372 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -132.63 116.93 17.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -169.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.23 101.55 0.22 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -56.67 161.5 2.74 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.666 0.733 . . . . 0.0 109.654 165.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -129.78 171.44 12.68 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 126.182 1.793 . . . . 0.0 106.493 167.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -143.52 135.32 26.5 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 120.92 -1.113 . . . . 0.0 108.592 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.3 p -105.84 108.11 19.46 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -170.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.4 m 50.64 -87.01 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.888 1.675 . . . . 0.0 109.62 -158.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -158.41 11.21 0.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.233 1.013 . . . . 0.0 110.831 -176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -140.69 155.79 69.28 Favored Pre-proline 0 C--O 1.236 0.358 0 O-C-N 120.415 -1.428 . . . . 0.0 110.795 -173.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.9 -34.71 47.55 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.51 1.473 . . . . 0.0 109.85 170.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.4 m -52.38 -37.31 56.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 128.447 2.699 . . . . 0.0 112.953 -173.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -62.48 -53.54 53.25 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.618 0.644 . . . . 0.0 111.742 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.48 -60.45 0.11 Allowed 'General case' 0 C--O 1.226 -0.174 0 CA-C-O 117.158 -1.401 . . . . 0.0 109.078 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 32.97 89.57 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.644 2.378 . . . . 0.0 110.979 -165.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -66.21 164.07 16.5 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.992 -1.068 . . . . 0.0 109.489 160.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.7 p -67.76 150.26 48.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.53 -0.731 . . . . 0.0 110.11 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 p -71.75 177.48 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 161.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.67 165.13 35.11 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.997 -1.065 . . . . 0.0 110.894 170.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.17 109.48 18.92 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 166.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.86 93.42 1.89 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -74.52 111.65 9.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.64 1.176 . . . . 0.0 109.704 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 p -105.79 151.06 24.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.33 1.052 . . . . 0.0 111.211 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -136.85 80.84 1.84 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.468 1.907 . . . . 0.0 107.972 -170.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.08 -161.48 11.0 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 126.512 2.005 . . . . 0.0 108.144 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.28 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 153.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.71 170.83 30.19 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -171.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -133.29 150.83 51.88 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.58 1.952 . . . . 0.0 106.836 -177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -132.64 154.2 50.33 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.139 0.971 . . . . 0.0 110.023 -171.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -104.64 174.44 5.88 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 128.044 2.537 . . . . 0.0 109.107 173.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -55.62 114.09 6.75 Favored Pre-proline 0 C--O 1.234 0.269 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.28 103.56 1.7 Allowed 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.044 -1.56 . . . . 0.0 108.044 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.1 ttt -74.64 155.55 37.67 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -54.64 -33.25 60.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 126.787 2.035 . . . . 0.0 110.991 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -104.45 -25.95 12.6 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 117.271 -1.347 . . . . 0.0 113.602 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.93 109.47 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.308 0.958 . . . . 0.0 108.885 -174.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.97 154.17 42.04 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 162.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -132.26 116.35 16.81 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 168.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.84 146.58 37.74 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.913 2.085 . . . . 0.0 107.301 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -129.68 135.61 48.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.3 m -124.23 148.24 47.47 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 171.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -149.86 132.92 16.24 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -136.63 145.22 44.61 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.62 1.568 . . . . 0.0 107.693 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -116.75 129.07 55.89 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 171.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 t -111.11 159.57 17.7 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.188 0.995 . . . . 0.0 108.934 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -136.45 97.4 3.56 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -172.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.57 94.34 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 167.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.3 ttm-85 63.93 58.53 1.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.618 1.167 . . . . 0.0 111.741 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m 53.72 27.89 7.47 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.342 1.057 . . . . 0.0 113.073 171.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.45 149.0 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.392 1.477 . . . . 0.0 108.094 172.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.72 102.4 13.6 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 169.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.3 t -131.85 103.68 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.87 133.17 7.49 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.4 t -125.48 139.89 53.24 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.479 1.512 . . . . 0.0 107.457 -175.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -129.7 151.18 50.57 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 171.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.8 pt -136.23 145.16 31.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.13 158.04 18.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.25 101.95 0.36 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 106.664 -2.574 . . . . 0.0 106.664 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.87 160.44 20.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.06 -149.84 9.45 Favored Glycine 0 C--O 1.221 -0.718 0 C-N-CA 118.688 -1.72 . . . . 0.0 109.799 -172.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -162.66 175.32 11.49 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.937 1.695 . . . . 0.0 106.988 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -102.98 147.67 26.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 C--O 1.249 1.064 0 C-N-CA 126.174 1.789 . . . . 0.0 108.049 170.79 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 p -131.82 137.58 48.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -132.21 106.89 8.23 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.8 t -135.96 127.21 28.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.259 9.7 p -101.93 153.4 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.735 0.779 . . . . 0.0 109.512 -173.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.463 ' HG1' ' HB3' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -158.9 124.08 4.24 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 174.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.39 -172.7 45.67 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 118.594 0.634 . . . . 0.0 113.235 -166.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.31 -116.44 1.54 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.602 1.572 . . . . 0.0 110.818 169.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.35 146.26 45.47 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.617 1.209 . . . . 0.0 108.307 -163.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.39 120.84 24.88 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -169.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -99.65 148.15 24.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 168.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -130.93 131.34 44.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 165.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -119.25 111.17 17.87 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.4 143.04 27.03 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.324 1.049 . . . . 0.0 108.286 -170.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 60.89 -75.48 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.243 1.817 . . . . 0.0 109.537 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.46 -73.35 0.02 OUTLIER Glycine 0 CA--C 1.52 0.405 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -126.12 105.91 9.2 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ttt -148.21 -54.63 0.2 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.206 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -144.62 133.05 21.94 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -167.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -121.15 77.82 1.35 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -170.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -58.08 157.73 7.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.294 1.437 . . . . 0.0 110.31 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.69 155.16 26.25 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.07 -175.4 39.4 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 118.386 1.093 . . . . 0.0 111.688 -173.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.11 146.43 43.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.771 0.785 . . . . 0.0 111.604 -164.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.422 HD22 ' HA ' ' A' ' 44' ' ' THR . 1.0 OUTLIER -139.36 152.52 47.22 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.536 1.935 . . . . 0.0 109.531 176.454 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -156.28 116.11 3.59 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.667 0.787 . . . . 0.0 108.883 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 128.6 38.82 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.513 1.125 . . . . 0.0 109.58 175.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -95.74 141.5 29.14 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.778 2.431 . . . . 0.0 108.095 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 69.7 mtm-85 -128.37 162.85 26.13 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.958 1.254 . . . . 0.0 109.74 166.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.21 138.52 31.53 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -88.09 135.16 33.55 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 171.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -136.48 162.22 33.69 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.768 0.827 . . . . 0.0 110.639 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.68 47.09 2.18 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.247 1.419 . . . . 0.0 108.411 -166.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.51 -48.18 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.708 1.203 . . . . 0.0 109.455 171.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.97 115.07 45.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.602 1.161 . . . . 0.0 108.375 175.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.99 -43.81 6.1 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.809 1.673 . . . . 0.0 109.901 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -73.09 148.33 44.11 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.125 2.17 . . . . 0.0 110.597 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.72 -178.21 36.61 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.677 1.132 . . . . 0.0 110.613 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.5 t -117.95 139.57 44.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.353 1.861 . . . . 0.0 108.519 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 mm -134.04 127.36 51.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 124.502 1.121 . . . . 0.0 108.301 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.02 108.86 0.37 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 172.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 t -126.71 155.01 43.36 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.704 -0.88 . . . . 0.0 108.666 161.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -114.91 147.78 39.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.422 ' HA ' HD22 ' A' ' 25' ' ' ASN . 1.2 p -116.24 115.22 25.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -169.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -142.8 123.76 14.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.3 p -140.83 124.7 17.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -165.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -137.09 90.58 2.54 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -125.79 120.96 31.96 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 p -65.55 155.82 34.54 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.706 2.002 . . . . 0.0 110.457 -170.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -128.22 154.12 46.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 122.242 1.02 . . . . 0.0 108.694 166.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -162.71 103.51 1.04 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 101.35 -3.574 . . . . 0.0 101.35 163.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.0 -98.37 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 166.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -153.74 73.95 0.97 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 172.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.0 t -166.7 -62.34 0.03 OUTLIER 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.01 2.124 . . . . 0.0 105.898 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.96 60.31 0.34 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -85.4 91.38 8.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -75.81 88.88 2.85 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.122 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -70.89 62.49 0.28 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.566 1.947 . . . . 0.0 111.551 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -86.28 167.43 14.83 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.643 1.577 . . . . 0.0 110.589 -171.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 m120 50.41 -163.1 0.05 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.076 1.35 . . . . 0.0 110.032 -165.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -147.15 169.02 20.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.69 1.196 . . . . 0.0 109.599 -164.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -78.42 158.58 28.67 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.224 1.01 . . . . 0.0 108.686 159.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -135.87 117.74 15.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 161.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.49 154.1 16.63 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 170.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 tt -142.16 112.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.1 p -128.58 126.85 41.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.38 155.67 43.3 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.12 165.45 38.77 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 171.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.98 168.58 16.88 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 CA-C-N 119.622 1.711 . . . . 0.0 109.572 156.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.01 154.9 19.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 159.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -93.02 154.81 17.91 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 152.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -140.42 96.71 3.08 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.89 -55.5 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 118.039 0.381 . . . . 0.0 110.294 -170.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -79.17 178.53 7.99 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.983 1.313 . . . . 0.0 108.67 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.91 47.48 1.26 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.29 1.036 . . . . 0.0 110.333 172.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 22.2 p-90 -156.16 -57.93 0.09 Allowed 'General case' 0 CA--C 1.529 0.152 0 O-C-N 120.975 -1.078 . . . . 0.0 110.15 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.43 154.02 44.23 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.999 0.92 . . . . 0.0 108.674 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -147.67 168.35 22.27 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.911 0.884 . . . . 0.0 110.609 -176.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -128.15 146.33 33.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -175.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -150.44 158.96 44.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.367 0.667 . . . . 0.0 109.773 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.3 129.87 7.32 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.45 151.89 6.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.17 159.79 13.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 123.843 0.857 . . . . 0.0 109.396 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 157.52 -136.39 4.84 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.55 151.06 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -166.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.89 158.38 22.25 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 161.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -149.45 160.34 43.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.122 1.769 . . . . 0.0 107.777 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.58 172.91 33.55 Favored Glycine 0 C--N 1.331 0.282 0 O-C-N 120.861 -1.149 . . . . 0.0 111.562 175.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -148.33 98.37 2.9 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 171.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -142.6 100.71 3.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -161.98 -78.93 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -132.04 128.97 39.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.8 m -154.6 84.1 1.11 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -151.44 -70.93 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.1 -67.19 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 116.671 -1.633 . . . . 0.0 109.885 169.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -62.34 149.41 90.85 Favored 'Trans proline' 0 C--N 1.352 0.726 0 CA-C-N 121.877 1.706 . . . . 0.0 111.082 -173.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m 66.86 -14.28 0.17 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.777 2.031 . . . . 0.0 113.303 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 46.98 -143.76 0.33 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.428 1.891 . . . . 0.0 111.551 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -69.83 98.4 1.23 Allowed 'General case' 0 C--O 1.234 0.249 0 O-C-N 119.877 -1.764 . . . . 0.0 106.657 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -69.79 -73.35 0.16 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.863 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.21 124.28 20.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.678 1.191 . . . . 0.0 109.932 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.0 m -82.89 160.22 22.18 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.32 1.448 . . . . 0.0 110.335 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.32 117.05 9.61 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.964 1.706 . . . . 0.0 108.946 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -151.52 171.64 17.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.77 0.714 . . . . 0.0 110.918 166.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -102.94 94.87 5.79 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -83.89 130.95 10.06 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -74.13 150.58 40.4 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.084 0.942 . . . . 0.0 109.162 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.0 m -131.35 135.98 47.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -155.42 95.72 1.72 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -172.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.01 169.57 13.59 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 125.06 1.314 . . . . 0.0 111.293 -169.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.02 156.76 32.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.817 1.247 . . . . 0.0 108.747 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.4 150.34 20.71 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -138.26 139.75 39.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 -169.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -136.66 139.55 42.1 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.954 0.797 . . . . 0.0 110.199 -169.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -118.94 171.19 8.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.334 1.454 . . . . 0.0 108.208 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -59.89 114.6 10.1 Favored Pre-proline 0 N--CA 1.456 -0.152 0 C-N-CA 125.546 1.539 . . . . 0.0 107.912 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -81.48 122.81 4.15 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.468 1.446 . . . . 0.0 109.323 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.1 ttm -170.53 149.68 3.3 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.143 2.177 . . . . 0.0 107.051 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 117.3 12.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 131.23 3.812 . . . . 0.0 109.409 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 62.03 28.81 17.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.098 1.759 . . . . 0.0 111.196 -160.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.09 145.99 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.696 1.198 . . . . 0.0 108.4 156.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.38 163.13 23.06 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 120.183 -1.573 . . . . 0.0 109.927 149.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -118.99 113.56 21.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 158.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.463 ' HB3' ' HG1' ' A' ' 6' ' ' THR . 3.2 t0 -148.36 149.54 31.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 173.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -129.45 151.71 49.78 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.31 0.959 . . . . 0.0 109.997 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.9 m -136.31 145.92 46.03 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.903 0.881 . . . . 0.0 110.729 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -138.76 148.38 43.8 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.671 1.988 . . . . 0.0 107.473 162.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -137.25 147.94 46.09 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 165.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -132.0 129.15 39.75 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 169.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.6 m -140.36 154.34 46.71 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.536 1.134 . . . . 0.0 108.098 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -121.6 98.13 5.82 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 121.449 -0.782 . . . . 0.0 109.388 -171.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.1 mm -66.0 91.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 67.27 -79.67 0.04 OUTLIER 'General case' 0 C--O 1.232 0.146 0 C-N-CA 127.924 2.49 . . . . 0.0 109.144 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.2 p -134.4 -2.16 2.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.12 1.368 . . . . 0.0 111.92 -170.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.17 149.31 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.366 1.066 . . . . 0.0 108.222 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.62 156.52 25.09 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.6 t -142.61 143.45 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 163.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -140.86 128.18 3.67 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -126.08 142.72 51.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -169.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -134.26 119.18 18.41 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 -165.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.1 mp -128.67 136.64 59.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.18 157.95 18.08 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -127.37 65.27 0.57 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.7 m -124.76 -176.35 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.519 1.527 . . . . 0.0 110.652 -164.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.27 -84.14 0.17 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 117.001 1.56 . . . . 0.0 117.001 174.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -163.32 177.41 8.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.699 2.799 . . . . 0.0 107.976 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -132.61 140.53 48.27 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 119.33 -2.106 . . . . 0.0 110.092 161.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 128.509 2.723 . . . . 0.0 113.367 169.05 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 t -142.1 165.75 26.59 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 121.32 -0.863 . . . . 0.0 108.816 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 m -134.06 140.86 46.93 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.3 t -157.75 161.1 38.46 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 120.424 -1.422 . . . . 0.0 107.545 -171.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.75 119.77 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -160.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 p -135.49 155.36 50.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.469 1.128 . . . . 0.0 110.456 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.14 -159.2 30.9 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -164.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.03 -127.06 7.48 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -164.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -134.72 149.15 50.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.682 0.793 . . . . 0.0 109.061 -171.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.28 113.83 21.46 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 105.474 -2.046 . . . . 0.0 105.474 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -124.96 123.52 40.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -162.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.3 t -139.29 140.5 37.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.936 1.295 . . . . 0.0 107.75 -163.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -138.96 157.94 45.11 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.378 1.071 . . . . 0.0 110.746 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.17 165.05 12.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.406 1.082 . . . . 0.0 111.73 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -73.59 61.08 0.7 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.463 1.105 . . . . 0.0 110.318 168.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.65 104.02 0.28 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -53.74 96.32 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.326 2.251 . . . . 0.0 111.357 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 96.7 mtp -149.35 -56.4 0.19 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.906 2.082 . . . . 0.0 107.834 173.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.15 111.94 19.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.148 1.379 . . . . 0.0 109.231 -170.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.57 150.33 41.04 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 45.6 mtt -115.42 143.41 45.34 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.096 1.759 . . . . 0.0 107.01 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.26 168.05 40.62 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 126.601 2.048 . . . . 0.0 108.055 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.83 -85.03 0.1 OUTLIER Glycine 0 C--O 1.225 -0.41 0 N-CA-C 107.916 -2.073 . . . . 0.0 107.916 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -146.36 172.07 14.05 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.635 1.974 . . . . 0.0 108.633 173.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -125.35 152.76 44.32 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 160.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 tp -145.74 140.26 27.07 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.675 0.671 . . . . 0.0 109.358 161.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -138.98 163.21 32.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.167 1.387 . . . . 0.0 107.523 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -143.39 140.24 30.37 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -132.78 144.04 49.98 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -117.27 147.16 42.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 161.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.87 136.69 32.58 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 156.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -86.73 179.13 6.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.28 2.232 . . . . 0.0 111.232 -166.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.81 -22.67 14.32 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.442 -0.786 . . . . 0.0 112.071 165.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.62 5.25 33.54 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.106 1.362 . . . . 0.0 113.209 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -153.44 104.02 2.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.94 1.696 . . . . 0.0 106.81 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.05 78.29 3.22 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.993 2.462 . . . . 0.0 109.463 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 tp -149.78 131.71 15.2 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.084 0.954 . . . . 0.0 109.748 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.16 176.75 18.74 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 168.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 m -137.11 160.48 36.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 125.938 1.695 . . . . 0.0 108.988 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mm -140.17 109.74 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.387 1.475 . . . . 0.0 107.729 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.69 167.06 33.27 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 153.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p -125.5 151.54 46.16 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 118.685 1.242 . . . . 0.0 108.804 146.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.61 148.89 27.77 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.905 1.23 . . . . 0.0 109.206 156.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -94.11 148.97 21.66 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 162.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -143.08 110.08 5.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.289 1.404 . . . . 0.0 108.161 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.8 p -101.97 120.57 40.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 121.191 1.814 . . . . 0.0 111.224 -166.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -162.61 76.75 0.45 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.057 1.343 . . . . 0.0 108.289 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -162.42 114.15 1.61 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 164.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 155.57 39.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.845 1.202 . . . . 0.0 110.225 174.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.35 102.45 5.55 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 175.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.9 m -148.17 76.24 1.36 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -169.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.15 19.36 1.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.893 1.677 . . . . 0.0 110.763 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -145.58 -105.98 0.1 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -46.51 59.52 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 121.144 1.793 . . . . 0.0 110.169 167.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.89 74.28 0.27 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.66 90.42 1.81 Allowed 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.0 77.88 10.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 123.235 1.493 . . . . 0.0 107.961 -176.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -67.26 105.11 1.64 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.645 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -143.85 114.67 7.73 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.598 1.09 . . . . 0.0 108.669 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 151.56 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.024 2.93 . . . . 0.0 106.482 -164.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.8 170.46 8.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.704 1.602 . . . . 0.0 107.69 -162.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -76.81 143.05 40.04 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.9 -1.125 . . . . 0.0 109.719 166.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -141.63 118.35 11.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.735 1.614 . . . . 0.0 107.018 161.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.89 158.09 28.8 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.454 -1.859 . . . . 0.0 108.454 162.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.39 143.77 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 169.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.5 m -139.67 148.05 41.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 161.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.96 150.03 28.82 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.386 0.674 . . . . 0.0 110.897 -164.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.02 163.52 12.85 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.94 1.733 . . . . 0.0 110.861 166.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.68 172.46 15.73 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.736 2.291 . . . . 0.0 110.526 168.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.62 153.89 47.44 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.484 1.114 . . . . 0.0 109.81 163.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -151.17 151.54 32.06 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -164.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -82.07 149.91 27.8 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.127 0.571 . . . . 0.0 109.634 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.55 -103.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 162.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.02 0.73 1.4 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.218 1.372 . . . . 0.0 112.881 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -113.77 -118.99 0.31 Allowed 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -129.87 -9.31 4.43 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -165.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.53 159.7 30.12 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 121.606 2.003 . . . . 0.0 109.578 164.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.6 m -135.86 125.06 24.56 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -136.84 147.09 27.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.49 174.74 12.17 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.385 1.474 . . . . 0.0 109.413 171.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.16 138.8 14.12 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 168.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.9 m -131.4 159.42 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.214 1.007 . . . . 0.0 110.222 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.28 135.42 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 C-N-CA 125.136 1.374 . . . . 0.0 109.495 -168.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.3 168.05 20.31 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 123.922 0.763 . . . . 0.0 113.137 -169.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.88 150.79 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 127.386 2.274 . . . . 0.0 106.894 170.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.49 158.69 22.23 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 161.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.4 116.86 21.12 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.612 0.765 . . . . 0.0 109.978 173.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.06 112.52 3.6 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 167.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -54.12 -59.15 5.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.749 1.275 . . . . 0.0 112.093 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -147.32 -63.55 0.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.503 1.521 . . . . 0.0 107.053 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 73.13 -56.2 0.66 Allowed 'General case' 0 C--N 1.346 0.449 0 C-N-CA 124.706 1.202 . . . . 0.0 109.29 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -67.08 113.54 5.13 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 165.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.3 p -119.8 74.44 1.02 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 167.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 55.1 19.2 2.68 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.373 1.869 . . . . 0.0 114.592 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.93 -56.68 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.791 2.036 . . . . 0.0 111.399 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -82.64 52.76 4.18 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 CA-C-N 121.962 1.737 . . . . 0.0 112.744 -172.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p 47.14 69.55 0.49 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.101 2.16 . . . . 0.0 112.108 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 30.52 61.8 0.2 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.903 2.481 . . . . 0.0 113.045 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -77.55 -47.15 20.19 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.761 -159.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -152.25 65.8 0.83 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.94 0.896 . . . . 0.0 110.731 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -68.23 -59.99 2.8 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.049 1.34 . . . . 0.0 109.804 -171.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -68.12 97.03 0.67 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.345 1.858 . . . . 0.0 108.889 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.4 p -66.39 155.98 35.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.83 0.824 . . . . 0.0 111.165 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -155.83 166.67 32.79 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.489 1.116 . . . . 0.0 108.885 -171.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -78.87 131.35 36.41 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.546 0.738 . . . . 0.0 110.152 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.05 82.52 0.4 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -73.14 151.17 41.67 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 118.585 1.192 . . . . 0.0 108.323 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.9 p -146.44 162.64 37.83 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.962 0.905 . . . . 0.0 110.827 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -141.27 155.11 46.03 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.68 -146.84 7.05 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.47 158.93 43.32 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.853 0.861 . . . . 0.0 110.317 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -136.35 133.68 6.72 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.64 143.47 14.63 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.992 0.396 . . . . 0.0 110.019 -170.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -142.91 145.15 32.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.944 0.878 . . . . 0.0 111.572 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -139.73 111.63 7.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 166.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 117.3 61.2 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.64 -33.78 2.19 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.336 1.358 . . . . 0.0 110.868 172.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.5 mtt -157.89 159.27 36.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.975 0.91 . . . . 0.0 111.124 -165.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -91.65 42.61 1.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 126.09 1.756 . . . . 0.0 109.658 -174.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.521 ' HA ' ' CD2' ' A' ' 146' ' ' TYR . 0.7 OUTLIER -160.7 -14.21 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.623 1.969 . . . . 0.0 111.269 -174.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.93 117.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 165.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.81 163.85 18.52 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 160.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.6 114.74 10.85 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 161.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.35 149.66 47.91 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 127.887 2.475 . . . . 0.0 107.06 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -129.66 151.44 50.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.2 m -145.52 166.32 26.04 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 145.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -143.41 145.75 32.89 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 160.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -138.13 159.86 40.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 119.734 1.152 . . . . 0.0 110.056 160.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -122.83 114.9 21.13 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.758 1.223 . . . . 0.0 109.596 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.5 p -100.88 130.57 46.91 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.779 2.032 . . . . 0.0 112.538 -171.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.81 111.89 24.31 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.44 81.55 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 171.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 53.8 -102.32 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.956 1.702 . . . . 0.0 108.508 -164.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m -105.29 3.52 30.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.27 1.028 . . . . 0.0 112.221 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.2 t -82.66 110.96 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 173.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -92.89 126.85 38.17 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.78 146.75 31.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 171.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.69 150.53 18.7 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 169.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -122.87 146.5 47.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -135.84 123.67 22.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 167.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.8 pt -116.93 139.79 42.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -168.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.22 134.94 33.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -120.27 74.55 0.32 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.43 168.03 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.708 1.203 . . . . 0.0 108.747 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.56 -105.07 0.25 Allowed Glycine 0 C--O 1.227 -0.344 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.521 ' CD2' ' HA ' ' A' ' 120' ' ' ASN . 0.3 OUTLIER -161.39 167.62 25.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.063 2.545 . . . . 0.0 107.624 -170.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -138.78 158.29 44.49 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.362 -1.461 . . . . 0.0 108.853 166.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 126.408 1.883 . . . . 0.0 109.766 -175.337 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.6 m -145.89 157.8 43.89 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 168.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 m -127.16 140.13 52.47 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 167.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 m -148.22 129.72 14.89 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 120.244 -1.535 . . . . 0.0 107.35 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.409 ' CG2' ' HB2' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -108.93 138.41 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.165 1.386 . . . . 0.0 108.505 173.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 p -157.2 117.72 3.55 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.8 2.04 . . . . 0.0 105.581 -169.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -173.18 165.64 37.88 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.39 -127.14 1.39 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -147.7 158.39 43.99 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.335 1.068 . . . . 0.0 110.698 -169.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.15 154.66 48.12 Favored 'General case' 0 C--N 1.335 -0.051 0 C-N-CA 125.129 1.372 . . . . 0.0 110.133 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -113.0 104.84 12.8 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 162.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -85.05 124.54 31.86 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 166.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.97 163.72 12.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.533 1.533 . . . . 0.0 107.412 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.57 161.96 37.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -55.6 81.37 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.911 1.684 . . . . 0.0 113.089 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.67 -15.23 5.21 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.593 1.568 . . . . 0.0 112.458 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -132.95 93.66 3.23 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.68 1.229 . . . . 0.0 108.48 172.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -90.27 60.02 4.6 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 129.437 3.095 . . . . 0.0 109.585 173.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -137.03 -178.47 5.21 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.887 1.275 . . . . 0.0 110.662 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -89.22 84.32 6.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.526 1.93 . . . . 0.0 107.116 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.5 ttm -92.52 147.83 22.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 153.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.9 -160.83 30.31 Favored Glycine 0 C--O 1.228 -0.252 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.21 -155.44 7.57 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 105.646 -2.982 . . . . 0.0 105.646 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.73 145.28 25.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -95.01 135.87 36.02 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 103.671 -2.714 . . . . 0.0 103.671 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.2 tp -145.97 116.71 7.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.16 140.96 48.76 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -137.56 121.41 17.6 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.96 143.08 45.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -118.53 158.14 25.95 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.462 1.905 . . . . 0.0 108.263 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -125.56 143.04 51.19 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.531 -1.356 . . . . 0.0 107.787 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -114.65 159.3 20.65 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.051 0.94 . . . . 0.0 108.78 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -95.19 15.26 19.63 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.123 -0.986 . . . . 0.0 111.701 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.41 0.73 2.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.698 1.199 . . . . 0.0 113.865 -172.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.4 125.3 3.02 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.124 168.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -72.46 79.91 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.547 3.498 . . . . 0.0 109.027 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.1 tp -150.42 155.81 40.27 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.589 1.556 . . . . 0.0 107.39 -160.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.24 -175.84 14.03 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 161.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.15 162.41 39.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 127.749 2.42 . . . . 0.0 106.218 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.8 mm -114.82 120.29 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.33 108.8 1.05 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 105.308 -3.117 . . . . 0.0 105.308 155.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -122.36 153.36 39.11 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 158.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -144.16 122.86 12.57 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.409 1.883 . . . . 0.0 107.098 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.9 m -127.59 125.18 39.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 172.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -91.49 158.41 16.49 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.653 1.981 . . . . 0.0 106.928 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -105.22 130.93 53.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -144.6 141.23 29.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.133 2.173 . . . . 0.0 107.152 166.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -175.54 147.92 0.88 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.601 2.36 . . . . 0.0 105.791 163.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -66.54 105.2 1.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -91.22 115.62 28.17 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 166.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 p -129.37 115.39 17.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.23 -170.25 2.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 164.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 m -80.44 -57.4 3.61 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 170.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.3 m -63.65 -66.96 0.47 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.345 0.658 . . . . 0.0 110.655 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.97 19.21 0.03 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 119.505 -1.331 . . . . 0.0 115.435 -157.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -90.47 91.5 8.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.105 1.953 . . . . 0.0 107.796 169.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -96.19 158.07 15.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.045 1.338 . . . . 0.0 108.068 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -84.02 124.33 30.96 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.298 -0.876 . . . . 0.0 110.335 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -132.51 168.71 17.73 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.024 0.529 . . . . 0.0 109.776 166.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 m120 49.79 172.14 0.01 OUTLIER 'General case' 0 C--O 1.239 0.532 0 C-N-CA 128.49 2.716 . . . . 0.0 111.75 -155.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -123.5 147.58 47.08 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 120.968 -1.083 . . . . 0.0 110.284 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -76.11 128.37 34.84 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -109.81 117.83 34.88 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.7 89.41 0.29 Allowed Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -161.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.2 pp -109.47 141.55 24.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.762 0.791 . . . . 0.0 110.455 -166.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -111.38 148.45 33.01 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 170.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.95 159.02 43.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.359 0.6 . . . . 0.0 109.55 163.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.13 164.99 10.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.045 1.307 . . . . 0.0 110.626 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.88 144.47 53.51 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.962 2.442 . . . . 0.0 111.553 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.03 122.59 33.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 160.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -79.44 126.99 31.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 167.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -69.78 128.77 37.56 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.7 tt -76.42 -178.85 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.709 0.766 . . . . 0.0 109.954 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -60.9 -0.04 0.26 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.279 2.232 . . . . 0.0 115.963 -170.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -136.21 -87.52 0.33 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 120.2 1.364 . . . . 0.0 110.056 168.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.78 70.21 0.63 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.091 1.314 . . . . 0.0 109.958 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.16 -169.04 3.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.477 1.911 . . . . 0.0 107.296 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 t -122.43 170.16 10.25 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.903 1.681 . . . . 0.0 110.496 -162.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.83 167.99 25.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 121.528 -0.733 . . . . 0.0 111.696 -176.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -104.27 123.98 48.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.903 2.081 . . . . 0.0 109.134 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.17 73.62 0.02 OUTLIER Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.71 171.89 13.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 117.863 0.831 . . . . 0.0 109.66 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.14 130.42 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.37 148.16 18.92 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 170.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.9 132.3 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 165.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.76 152.89 18.72 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 162.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.58 165.2 29.35 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.597 0.759 . . . . 0.0 109.094 163.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.26 -167.95 43.93 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 113.634 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? 51.7 70.35 0.56 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.837 1.303 . . . . 0.0 108.01 -163.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.53 78.56 1.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -131.77 145.68 51.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 163.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.7 m -107.78 137.82 45.11 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 163.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.12 -4.13 52.84 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 124.201 1.0 . . . . 0.0 111.347 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -115.84 -87.22 0.6 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -151.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -63.08 158.62 53.71 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.578 1.951 . . . . 0.0 110.821 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.85 1.37 1.12 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.708 3.605 . . . . 0.0 115.964 -175.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.1 m -66.97 -9.76 42.09 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 120.872 -1.143 . . . . 0.0 111.697 159.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -53.25 -16.59 1.33 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -160.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -90.24 76.39 6.83 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 157.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -63.98 -56.22 16.73 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.75 -55.11 0.54 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.081 2.552 . . . . 0.0 113.267 172.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.5 t -72.7 149.53 43.72 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.899 0.88 . . . . 0.0 108.996 169.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.2 m -120.2 161.78 20.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.687 1.195 . . . . 0.0 108.213 166.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.29 176.69 9.54 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.971 1.308 . . . . 0.0 108.999 159.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -115.9 166.91 11.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 150.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.17 122.39 1.45 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -73.91 152.32 40.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.635 1.174 . . . . 0.0 109.754 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.5 t -134.44 143.65 47.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.891 0.876 . . . . 0.0 110.293 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -80.48 99.48 8.04 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.82 125.51 7.11 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -175.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.65 145.29 32.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.085 1.754 . . . . 0.0 107.439 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.32 148.63 8.58 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.521 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -139.43 142.63 37.43 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.555 2.342 . . . . 0.0 107.878 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -105.69 160.92 14.84 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.222 1.809 . . . . 0.0 109.82 169.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -91.65 171.69 8.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -57.1 111.43 3.36 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.491 1.116 . . . . 0.0 108.472 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -85.17 162.95 11.47 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.422 2.081 . . . . 0.0 111.971 -168.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 68.3 mtm -154.28 171.47 19.19 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 128.804 2.842 . . . . 0.0 108.649 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -44.12 -55.19 4.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 131.396 3.878 . . . . 0.0 109.77 -164.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . 0.3 0.2 OUTLIER -132.28 37.53 3.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.198 0.523 . . . . 0.0 110.224 171.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.46 110.22 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.81 157.53 40.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 161.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.7 132.25 40.41 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 102.752 -3.055 . . . . 0.0 102.752 176.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -140.32 128.97 22.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.54 1.064 . . . . 0.0 109.824 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -136.41 145.99 45.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.376 1.07 . . . . 0.0 108.135 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.75 166.74 25.0 Favored 'General case' 0 C--O 1.239 0.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.127 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -142.66 118.39 10.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 169.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.87 108.43 9.4 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -99.5 132.97 44.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.5 p -129.85 159.41 36.65 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.591 1.157 . . . . 0.0 109.951 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 47.8 mtt-85 -122.2 98.0 5.73 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.485 0.659 . . . . 0.0 109.466 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 10.9 mm -82.41 81.12 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.384 1.073 . . . . 0.0 108.165 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 64.14 -55.87 0.24 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.692 2.797 . . . . 0.0 114.08 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.3 t -149.85 -0.94 0.44 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.587 1.555 . . . . 0.0 110.546 169.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.18 135.66 24.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.9 137.17 32.57 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.0 t -139.33 108.0 3.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.039 1.336 . . . . 0.0 108.674 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.08 151.76 35.58 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 167.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 t -140.38 153.31 46.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 146.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -137.86 110.79 7.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 172.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.9 pp -81.72 154.57 4.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.0 166.41 22.47 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 163.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -176.57 167.46 38.96 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.5 m -144.35 148.7 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 173.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -163.16 -145.72 4.46 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.409 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . 8.1 m-85 -136.23 158.73 43.72 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.901 2.081 . . . . 0.0 108.395 -163.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.68 112.1 5.81 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.713 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 124.576 1.151 . . . . 0.0 108.367 178.362 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 t -151.05 158.14 43.71 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.384 1.074 . . . . 0.0 108.601 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.05 114.93 17.71 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 124.045 1.879 . . . . 0.0 109.038 168.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m -89.06 103.54 16.15 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -92.31 100.13 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 p -126.26 160.95 28.9 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.51 0.671 . . . . 0.0 111.15 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.95 178.41 48.16 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.51 -151.57 23.31 Favored Glycine 0 C--O 1.24 0.529 0 CA-C-N 118.741 1.27 . . . . 0.0 111.698 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.86 157.83 20.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.959 0.903 . . . . 0.0 109.151 -177.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.08 154.33 47.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.096 1.359 . . . . 0.0 108.355 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HG3' ' HA ' ' A' ' 20' ' ' LYS . 5.1 mp0 -124.98 104.19 8.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 167.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.2 t -84.87 115.02 22.53 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 159.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.83 155.11 49.56 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.576 1.15 . . . . 0.0 108.482 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -143.12 163.93 31.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 110.058 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 60.17 9.51 1.91 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.924 1.689 . . . . 0.0 114.023 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.72 94.72 0.35 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.417 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 3.7 pm0 -45.38 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.29 2.236 . . . . 0.0 111.588 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -148.82 -2.44 0.47 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -118.48 113.01 20.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 122.884 1.326 . . . . 0.0 114.316 -162.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.424 ' HA ' ' HG3' ' A' ' 11' ' ' GLN . 45.5 mtpt -66.68 96.12 0.38 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 161.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.5 mtt -133.14 103.95 6.26 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 167.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.46 -170.95 23.73 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 128.335 2.874 . . . . 0.0 106.545 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.15 -84.25 0.05 OUTLIER Glycine 0 C--N 1.328 0.108 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 -169.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.82 174.17 10.78 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.348 1.459 . . . . 0.0 108.17 163.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -138.59 152.32 48.05 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.824 1.249 . . . . 0.0 107.746 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.68 131.06 19.72 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.664 1.986 . . . . 0.0 106.035 166.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -122.54 133.8 54.56 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -156.45 108.62 2.53 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -171.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -142.04 163.06 33.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.973 0.892 . . . . 0.0 111.127 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -99.66 157.47 16.45 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.164 1.385 . . . . 0.0 108.369 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.24 147.95 50.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -172.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -75.89 166.34 23.65 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.617 1.567 . . . . 0.0 111.67 -159.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -112.66 40.95 2.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.551 1.167 . . . . 0.0 108.565 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -167.59 -75.42 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.32 162.42 66.5 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.016 0.926 . . . . 0.0 109.601 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.91 62.6 8.48 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.669 2.913 . . . . 0.0 108.99 165.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.8 tp -112.01 123.79 51.0 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.182 1.393 . . . . 0.0 107.539 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.39 176.88 16.26 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 56.2 t -126.03 155.88 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 tt -132.94 121.03 43.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.35 108.85 2.08 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 m -80.49 142.11 34.54 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.163 0.982 . . . . 0.0 109.19 161.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -143.29 125.76 15.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 167.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.6 t -118.17 150.92 38.59 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.995 0.816 . . . . 0.0 109.5 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -142.99 123.72 14.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.0 p -114.17 121.56 44.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.59 29.41 0.93 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.899 0.772 . . . . 0.0 110.275 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -103.85 147.1 27.7 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.701 2.001 . . . . 0.0 108.528 177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 m -122.6 154.95 37.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.811 1.645 . . . . 0.0 108.19 168.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.333 0 CA-C-N 118.14 0.427 . . . . 0.0 110.618 -171.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 122.479 1.133 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -51.94 93.11 0.01 OUTLIER 'General case' 0 C--O 1.237 0.433 0 C-N-CA 128.221 2.609 . . . . 0.0 113.655 -167.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.02 168.35 16.02 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.522 -0.736 . . . . 0.0 109.632 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t30 61.58 176.9 0.12 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.774 1.23 . . . . 0.0 110.591 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -129.23 154.31 46.92 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 166.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.36 159.12 24.45 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -141.16 135.35 30.74 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.11 116.65 0.86 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -167.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.28 110.1 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.3 m -128.34 144.04 51.08 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.757 1.623 . . . . 0.0 107.848 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.96 167.61 24.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.285 1.034 . . . . 0.0 110.754 -172.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.42 174.0 34.57 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 128.137 2.78 . . . . 0.0 110.795 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 20.3 Cg_endo -85.75 -179.75 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.961 3.774 . . . . 0.0 110.8 171.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.97 135.1 35.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.856 1.662 . . . . 0.0 107.367 164.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -150.14 154.87 38.78 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.065 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -87.97 148.45 24.55 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.061 1.3 . . . . 0.0 111.145 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.406 HD12 ' H ' ' A' ' 73' ' ' ILE . 4.2 mp -69.91 -57.02 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -132.43 -75.9 0.5 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -165.55 74.98 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -130.89 -60.28 0.97 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.318 1.447 . . . . 0.0 109.175 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.84 164.6 32.34 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.653 1.181 . . . . 0.0 109.304 -174.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 p -125.44 109.46 12.75 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.054 1.341 . . . . 0.0 107.637 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.26 151.7 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -150.11 165.73 31.92 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.117 0.872 . . . . 0.0 110.86 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.37 139.18 21.44 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.58 152.21 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.43 1.115 . . . . 0.0 109.149 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.66 150.81 15.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.885 0.874 . . . . 0.0 109.193 -167.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.52 -165.7 27.31 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 123.306 0.479 . . . . 0.0 112.614 -168.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.53 150.33 18.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.73 1.212 . . . . 0.0 107.747 171.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.57 130.85 7.63 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.835 1.683 . . . . 0.0 109.159 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -127.57 117.51 22.18 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.246 1.418 . . . . 0.0 110.022 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.57 142.61 11.42 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 170.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.078 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -174.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.7 t . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -159.71 174.79 14.01 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 165.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -124.02 159.8 29.05 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.906 1.683 . . . . 0.0 107.737 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.11 137.49 9.41 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -75.78 102.21 5.37 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -67.39 135.03 52.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -148.12 171.47 15.83 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 121.929 -0.482 . . . . 0.0 110.047 168.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.18 -149.63 20.89 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.09 148.16 48.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.335 1.054 . . . . 0.0 109.602 174.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.23 124.11 7.68 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.03 139.42 49.88 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -170.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -138.48 129.9 27.48 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -92.83 171.59 8.88 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.149 0.5 . . . . 0.0 110.112 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -66.2 117.0 38.9 Favored Pre-proline 0 C--O 1.241 0.608 0 C-N-CA 123.95 0.9 . . . . 0.0 108.579 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.97 176.54 9.34 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.234 2.623 . . . . 0.0 112.0 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.14 -176.38 4.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.458 2.303 . . . . 0.0 107.49 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -91.14 -7.95 50.07 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.008 2.123 . . . . 0.0 110.121 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.72 12.18 0.25 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.99 1.716 . . . . 0.0 110.511 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.4 t -136.91 137.84 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.03 -1.669 . . . . 0.0 108.844 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -136.18 155.21 50.48 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -139.29 115.07 10.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.84 141.69 48.58 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 126.425 1.89 . . . . 0.0 106.646 -172.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -135.2 142.69 46.1 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 p -127.16 149.2 50.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 158.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.15 119.64 14.91 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 169.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -127.72 138.18 52.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -129.83 139.39 51.23 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.5 m -130.72 159.98 35.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.806 2.043 . . . . 0.0 107.186 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -132.33 145.62 51.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.19 95.95 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 75.27 -74.88 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.742 2.417 . . . . 0.0 111.512 165.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.7 m -148.75 27.05 0.9 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.432 1.493 . . . . 0.0 109.646 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.75 120.53 61.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 166.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.38 152.58 34.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.67 137.43 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 164.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.22 140.96 14.41 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 168.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.1 m -140.67 120.34 13.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 -105.03 153.16 21.83 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 166.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.7 mt -136.68 131.56 47.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.97 129.86 35.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -113.37 96.54 0.81 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.8 t -116.54 152.09 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 157.28 -143.01 9.1 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 106.429 -2.668 . . . . 0.0 106.429 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -121.76 176.87 5.51 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.604 1.962 . . . . 0.0 110.068 -166.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 129.95 13.44 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.283 171.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.5 p90 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 124.469 1.108 . . . . 0.0 108.37 175.231 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -92.4 151.09 20.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -143.46 107.09 4.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 162.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 t -138.83 150.91 46.56 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.089 0.947 . . . . 0.0 108.894 167.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.53 137.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 111.521 -2.581 . . . . 0.0 106.468 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.7 m -152.78 144.01 23.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.79 -178.55 44.75 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.74 -172.37 25.03 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.99 158.37 17.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.12 170.03 9.55 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.798 0.332 . . . . 0.0 110.722 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -140.99 113.04 7.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 156.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.5 t -84.75 151.3 24.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.062 0.934 . . . . 0.0 108.967 164.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -136.76 170.82 15.45 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.776 2.43 . . . . 0.0 107.863 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.19 159.5 42.1 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 161.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -75.63 64.77 1.73 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.707 1.203 . . . . 0.0 109.536 174.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 160.01 -37.95 0.46 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 126.855 2.169 . . . . 0.0 110.686 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -129.72 96.51 4.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.074 0.937 . . . . 0.0 109.758 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.5 mtt -78.3 58.15 2.04 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.637 0.732 . . . . 0.0 109.338 166.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.99 93.86 1.8 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 164.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.518 ' HD3' ' H ' ' A' ' 20' ' ' LYS . 0.5 OUTLIER -58.74 106.12 0.37 Allowed 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 81.9 mtp -136.06 109.69 8.03 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -169.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.07 -178.5 37.65 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.19 -128.67 0.96 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 104.86 -3.296 . . . . 0.0 104.86 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.89 150.25 37.36 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -122.04 162.77 20.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.62 1.968 . . . . 0.0 107.529 173.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -147.6 167.84 23.52 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -138.11 159.99 40.56 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.245 1.018 . . . . 0.0 108.894 170.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -136.19 141.57 44.04 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.517 2.327 . . . . 0.0 106.377 164.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.71 160.33 23.55 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 160.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -131.96 156.45 46.16 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.394 1.478 . . . . 0.0 107.328 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -98.25 140.16 32.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.667 0.746 . . . . 0.0 109.258 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.05 156.96 23.17 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 127.008 2.123 . . . . 0.0 107.19 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -133.26 71.66 1.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.96 -37.97 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.823 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -162.41 153.95 15.36 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 124.36 1.064 . . . . 0.0 109.207 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.56 88.42 1.42 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.376 2.717 . . . . 0.0 109.21 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 37' ' ' LEU . 17.9 tp -143.74 156.94 44.68 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 128.314 2.645 . . . . 0.0 105.791 172.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.89 175.89 21.55 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 91.1 t -124.61 157.21 32.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 118.189 0.994 . . . . 0.0 111.198 -168.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.75 141.53 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 126.779 2.032 . . . . 0.0 106.86 161.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.81 108.95 0.39 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 p -124.87 154.22 41.38 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.276 1.03 . . . . 0.0 110.613 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -131.66 122.45 25.98 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -170.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.8 p -95.47 146.8 24.15 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -171.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.98 154.95 50.92 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.623 1.169 . . . . 0.0 109.411 -178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.1 m -132.43 130.51 40.67 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.863 1.211 . . . . 0.0 112.564 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -110.95 -14.18 13.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.639 1.176 . . . . 0.0 112.856 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -66.42 145.73 55.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.813 0.845 . . . . 0.0 110.585 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 p -74.92 144.36 43.32 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.922 0.783 . . . . 0.0 109.405 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 . . . . . 0 N--CA 1.444 -0.755 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 158.693 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.49 -60.19 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.922 0.889 . . . . 0.0 110.216 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -102.46 133.07 48.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 122.0 -0.437 . . . . 0.0 110.543 -159.109 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -146.46 19.25 1.35 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -166.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -110.21 128.15 55.34 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 120.986 1.721 . . . . 0.0 107.855 -158.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -152.5 119.98 5.99 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.02 116.86 29.13 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.06 131.53 10.82 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 158.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.3 mt -119.68 109.54 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 167.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 8.9 t -120.01 147.59 44.61 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.554 2.342 . . . . 0.0 108.166 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.28 172.76 15.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.492 1.517 . . . . 0.0 109.188 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.44 175.59 43.92 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 161.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -74.33 175.75 10.57 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.471 2.114 . . . . 0.0 110.235 160.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.39 109.21 8.08 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.619 1.967 . . . . 0.0 108.085 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.37 130.25 35.25 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -111.38 118.45 35.87 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 170.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.06 -65.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -167.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -135.72 -79.31 0.42 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 161.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -158.69 80.52 0.8 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.049 1.295 . . . . 0.0 110.996 167.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -129.55 -40.51 1.41 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.28 1.432 . . . . 0.0 109.783 164.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.37 174.0 13.86 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.472 1.109 . . . . 0.0 109.733 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 t -148.87 105.26 3.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.11 156.5 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.795 0.838 . . . . 0.0 110.794 -172.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -151.18 173.34 14.52 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.024 1.329 . . . . 0.0 111.624 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.71 114.93 4.94 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.969 1.747 . . . . 0.0 108.759 170.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -110.36 161.08 9.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.224 1.409 . . . . 0.0 110.917 -164.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 66' ' ' THR . 0.5 OUTLIER -140.39 165.36 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 C-N-CA 124.249 1.02 . . . . 0.0 110.578 -169.259 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.11 -164.71 30.23 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 p -148.55 137.88 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 169.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.97 108.92 2.24 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 127.575 2.512 . . . . 0.0 109.623 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.58 140.29 31.42 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.417 1.087 . . . . 0.0 108.594 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.3 160.36 27.84 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 118.446 0.566 . . . . 0.0 112.424 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 C--O 1.236 0.362 0 C-N-CA 127.146 2.178 . . . . 0.0 106.502 173.273 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -129.14 129.01 44.61 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -92.65 160.03 15.19 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 166.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.98 131.47 5.12 Favored Glycine 0 C--N 1.33 0.248 0 N-CA-C 107.959 -2.057 . . . . 0.0 107.959 170.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.49 126.38 30.9 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 m -92.58 131.25 37.85 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -146.22 133.02 20.03 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.05 -172.09 34.67 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.153 1.359 . . . . 0.0 111.144 -160.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.31 158.29 44.74 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.864 0.866 . . . . 0.0 110.555 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -134.21 104.75 0.53 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.074 1.321 . . . . 0.0 111.345 -168.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.4 148.3 37.9 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.62 1.568 . . . . 0.0 107.243 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.38 159.4 34.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.436 1.095 . . . . 0.0 108.816 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -133.91 159.19 41.44 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 126.461 1.904 . . . . 0.0 107.023 -171.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -56.38 114.75 8.31 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 123.779 0.832 . . . . 0.0 110.351 -158.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.43 171.61 11.0 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.281 3.321 . . . . 0.0 113.514 -168.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.9 mtm -145.85 177.68 8.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.175 2.19 . . . . 0.0 108.916 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -93.01 18.22 9.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.556 1.942 . . . . 0.0 112.995 -166.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.408 ' H ' ' H ' ' A' ' 121' ' ' VAL . 10.1 p-10 -174.68 -7.92 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.035 2.134 . . . . 0.0 111.643 -168.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.408 ' H ' ' H ' ' A' ' 120' ' ' ASN . 4.9 t -143.41 140.9 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 128.646 2.778 . . . . 0.0 103.551 -170.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.62 159.62 42.17 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -137.63 117.15 12.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.73 150.7 40.57 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 168.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -140.93 123.45 15.97 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.1 m -122.49 136.16 54.82 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -126.23 122.23 34.98 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.412 1.885 . . . . 0.0 106.98 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.83 157.05 42.6 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.662 1.185 . . . . 0.0 110.212 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -132.26 152.97 51.1 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.287 1.035 . . . . 0.0 108.479 172.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.3 t -141.17 160.51 39.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 127.402 2.281 . . . . 0.0 107.349 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -128.87 107.09 9.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.6 pt -137.04 151.78 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.809 1.244 . . . . 0.0 108.152 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.45 18.89 6.0 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.784 1.634 . . . . 0.0 112.292 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.9 m 53.48 34.54 18.53 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.887 1.221 . . . . 0.0 112.03 -164.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.39 149.31 23.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 122.019 0.914 . . . . 0.0 108.842 161.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.8 140.13 53.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 168.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -136.26 98.64 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.32 151.34 32.86 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -141.65 154.2 45.21 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 146.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -139.21 155.23 47.95 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 168.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.4 pt -121.3 140.24 45.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -173.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.04 135.07 33.58 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -113.44 121.77 5.59 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 106.509 -2.636 . . . . 0.0 106.509 170.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.81 148.16 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 129.387 3.075 . . . . 0.0 103.988 169.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.72 -125.46 1.37 Allowed Glycine 0 C--O 1.227 -0.322 0 CA-C-O 118.014 -1.437 . . . . 0.0 109.904 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.84 143.04 22.44 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 127.287 2.235 . . . . 0.0 106.625 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -136.68 96.29 3.3 Favored 'General case' 0 CA--C 1.518 -0.279 0 O-C-N 120.863 -1.148 . . . . 0.0 108.298 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 115.13 -2.367 . . . . 0.0 112.379 159.757 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.9 m -137.29 152.93 50.31 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 171.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -142.07 133.89 27.14 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 122.311 1.053 . . . . 0.0 108.66 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -152.44 145.46 24.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.69 132.09 64.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.8 p -137.82 130.41 29.62 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.75 159.13 23.13 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.84 -152.39 19.28 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 107.346 -2.302 . . . . 0.0 107.346 -164.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -99.85 153.27 19.28 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.357 0.579 . . . . 0.0 110.353 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.93 142.01 50.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 170.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.9 149.58 50.31 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.795 1.238 . . . . 0.0 108.514 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.7 m -137.27 121.53 18.05 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.396 1.079 . . . . 0.0 109.802 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -103.61 162.16 13.29 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.58 146.02 51.42 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 118.295 0.498 . . . . 0.0 110.854 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 61.6 -60.09 0.1 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 130.253 3.421 . . . . 0.0 112.018 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.83 -66.16 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 105.892 -2.883 . . . . 0.0 105.892 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.86 96.81 4.75 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.027 1.331 . . . . 0.0 109.231 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.5 ttt -152.91 -69.02 0.15 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.299 0.639 . . . . 0.0 109.553 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.83 146.6 19.34 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.971 0.908 . . . . 0.0 110.243 -172.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -120.33 154.54 34.88 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 124.99 1.316 . . . . 0.0 108.912 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.4 ptp -131.24 159.17 38.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.09 175.45 23.19 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.696 1.141 . . . . 0.0 111.064 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.8 -177.32 47.55 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 118.064 0.932 . . . . 0.0 111.29 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -99.83 147.87 25.04 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -137.91 150.73 47.33 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.921 1.688 . . . . 0.0 109.673 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mt -139.22 161.68 36.84 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 128.039 2.536 . . . . 0.0 108.619 171.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.49 176.43 12.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.27 1.828 . . . . 0.0 107.954 157.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -144.86 114.61 7.28 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 120.877 -1.139 . . . . 0.0 108.478 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 109.15 20.78 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -99.86 158.86 15.5 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.792 1.637 . . . . 0.0 109.224 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -115.2 152.31 32.87 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -121.28 166.76 13.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.021 1.329 . . . . 0.0 110.42 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -125.4 56.72 1.35 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.79 1.236 . . . . 0.0 108.071 -163.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.21 -47.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.181 1.392 . . . . 0.0 109.092 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.5 m -134.96 152.02 76.54 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.907 1.683 . . . . 0.0 107.899 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.84 13.2 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.939 3.759 . . . . 0.0 114.929 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 tp -87.24 118.91 26.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.157 1.783 . . . . 0.0 110.222 -165.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.22 177.27 49.0 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.1 t -133.87 145.27 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.172 1.389 . . . . 0.0 109.293 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 mp -139.68 131.91 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.469 1.908 . . . . 0.0 107.13 168.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.17 148.93 18.75 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 142.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 p -125.0 154.34 41.4 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.326 1.051 . . . . 0.0 110.515 165.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -112.77 148.97 33.67 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.318 1.047 . . . . 0.0 108.746 169.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 m -93.93 146.61 23.79 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.68 0.792 . . . . 0.0 109.218 165.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.424 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 48.5 m-85 -117.62 153.74 32.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.563 1.545 . . . . 0.0 108.593 166.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.85 143.21 34.31 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.008 0.822 . . . . 0.0 111.293 168.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.78 -11.49 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.012 2.525 . . . . 0.0 112.076 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.82 147.06 30.61 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.074 -1.641 . . . . 0.0 110.39 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.2 p -111.14 155.88 22.21 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.417 1.487 . . . . 0.0 109.132 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 162.804 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 C--O 1.239 0.546 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.2 128.63 36.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.14 -0.975 . . . . 0.0 108.666 171.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -144.63 172.65 12.69 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 84.92 -177.69 0.03 OUTLIER 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.843 2.057 . . . . 0.0 109.018 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.83 169.84 14.08 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.657 1.583 . . . . 0.0 107.919 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.424 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 25.2 p90 -73.73 139.22 45.14 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 159.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -140.39 117.54 11.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 157.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.52 121.69 1.05 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.46 150.46 34.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.1 p -140.48 157.36 45.63 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.23 140.53 21.36 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.041 0.837 . . . . 0.0 111.158 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.523 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -176.02 160.19 28.05 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 156.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.19 -179.81 5.8 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.14 1.893 . . . . 0.0 111.668 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.56 146.02 41.26 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.208 1.403 . . . . 0.0 108.251 164.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -128.85 130.03 46.36 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -67.18 111.93 4.2 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.838 1.655 . . . . 0.0 109.301 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 tt -73.75 171.38 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.026 0.441 . . . . 0.0 109.875 -176.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -88.73 37.48 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.102 1.761 . . . . 0.0 110.091 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -149.51 -119.98 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.591 1.957 . . . . 0.0 105.73 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -128.67 66.25 1.41 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.506 1.922 . . . . 0.0 109.441 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.1 176.02 13.04 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.657 -1.277 . . . . 0.0 110.766 168.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 m -137.94 112.95 9.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 164.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.71 147.21 23.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -150.4 164.88 34.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 119.665 1.12 . . . . 0.0 110.564 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.69 129.99 9.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.523 HG12 ' HA3' ' A' ' 68' ' ' GLY . 32.6 m -126.92 -176.52 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 124.374 1.07 . . . . 0.0 111.166 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.86 165.56 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.677 1.991 . . . . 0.0 107.874 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.88 -172.26 31.14 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 162.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.51 138.97 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.47 139.13 10.72 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -132.66 116.98 17.31 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.583 1.953 . . . . 0.0 106.935 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.14 125.9 0.79 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? . . . . . 0 C--O 1.238 0.488 0 CA-C-N 118.06 0.93 . . . . 0.0 109.523 165.705 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 C--O 1.237 0.441 0 CA-C-O 121.319 0.58 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -144.22 164.83 29.6 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 127.214 2.205 . . . . 0.0 108.33 172.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -68.54 123.61 21.32 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -104.88 123.15 7.55 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 170.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -81.2 151.29 28.26 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.5 p -146.11 151.64 38.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -141.73 167.72 21.46 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.729 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 166.81 -172.7 42.04 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.8 149.55 31.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.628 0.714 . . . . 0.0 110.548 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.21 122.23 6.64 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 170.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -115.69 139.9 49.7 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -121.14 159.38 25.93 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.693 0.759 . . . . 0.0 109.886 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.5 170.54 8.0 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.825 1.65 . . . . 0.0 106.623 158.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -60.43 110.71 3.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.138 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.55 120.67 7.91 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.44 2.093 . . . . 0.0 108.805 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -177.06 164.7 2.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.932 1.242 . . . . 0.0 108.878 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 103.89 27.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.898 2.479 . . . . 0.0 109.051 154.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.2 m120 64.94 15.91 10.22 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.689 1.595 . . . . 0.0 110.961 -169.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.73 171.33 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.7 159.65 39.03 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.375 1.87 . . . . 0.0 105.956 163.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 123' ' ' LEU . 2.2 mm? -125.22 114.95 19.64 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 161.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -136.17 133.96 37.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 174.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -139.73 142.81 36.81 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 -172.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.8 m -146.53 165.26 29.99 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.592 -0.693 . . . . 0.0 111.318 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -140.0 129.26 23.88 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.727 2.411 . . . . 0.0 105.332 -171.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -137.81 108.2 6.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -99.22 111.61 23.95 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.1 m -76.82 150.88 36.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.452 0.701 . . . . 0.0 110.56 171.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.7 ptt85 -140.72 96.54 3.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.763 1.625 . . . . 0.0 106.91 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.2 mt -100.79 81.37 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 -175.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 56.75 -64.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 129.728 3.211 . . . . 0.0 113.575 -171.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 p -145.8 26.76 1.23 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.685 1.994 . . . . 0.0 110.107 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.8 t -123.27 103.4 12.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -82.3 131.99 35.23 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.7 101.18 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.73 115.43 4.34 Favored Glycine 0 C--O 1.242 0.604 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -174.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 57.4 m -107.85 142.29 38.14 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -141.72 141.3 33.27 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.0 pt -135.95 151.3 29.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.49 148.92 47.4 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.706 1.203 . . . . 0.0 108.57 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.36 94.53 0.2 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 124.924 1.249 . . . . 0.0 110.415 -169.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.25 171.87 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.552 1.941 . . . . 0.0 107.586 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.99 -116.12 0.7 Allowed Glycine 0 C--O 1.221 -0.666 0 O-C-N 119.913 -1.742 . . . . 0.0 108.87 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -163.81 163.42 23.9 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.958 1.879 . . . . 0.0 110.079 171.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -90.07 147.47 23.62 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.868 161.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 115.432 -2.223 . . . . 0.0 107.489 174.735 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.8 m -139.47 149.66 44.26 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m -106.73 107.09 17.93 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.435 1.494 . . . . 0.0 107.841 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.1 m -131.12 127.13 37.46 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.38 133.1 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 127.011 2.124 . . . . 0.0 105.915 -163.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.9 t -157.15 146.6 20.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.96 164.08 37.58 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.859 -1.697 . . . . 0.0 108.859 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.55 -154.72 23.54 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.77 159.33 41.67 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 109.142 -160.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.34 168.92 11.87 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.337 1.065 . . . . 0.0 113.767 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -125.0 117.49 24.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.407 1.483 . . . . 0.0 107.205 155.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.6 t -84.0 145.63 28.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 160.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -138.63 158.13 44.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.194 1.798 . . . . 0.0 107.944 -165.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.77 158.19 43.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 120.979 1.718 . . . . 0.0 111.31 159.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -78.76 56.76 1.94 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.685 0.755 . . . . 0.0 110.921 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.98 -39.13 0.2 Allowed Glycine 0 CA--C 1.519 0.282 0 O-C-N 120.06 -1.65 . . . . 0.0 110.434 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.55 96.36 2.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.681 0.753 . . . . 0.0 109.414 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.1 mtm -74.9 64.5 1.3 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.834 2.454 . . . . 0.0 108.195 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -66.33 102.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -64.17 98.04 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.881 1.272 . . . . 0.0 108.539 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 52.0 mtp -133.98 129.7 36.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.49 -145.47 4.13 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 170.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.04 -127.23 1.48 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 119.691 1.745 . . . . 0.0 110.668 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -132.58 121.17 22.83 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.983 1.313 . . . . 0.0 108.953 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -96.15 160.96 14.17 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.426 1.49 . . . . 0.0 110.107 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.95 139.86 29.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 162.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.33 149.81 49.82 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 118.775 0.716 . . . . 0.0 109.875 165.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -149.45 110.08 4.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.58 119.64 33.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.99 157.12 16.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -130.09 153.19 48.73 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.837 0.855 . . . . 0.0 109.481 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.43 172.24 9.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.704 0.801 . . . . 0.0 110.538 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -101.99 -26.31 13.45 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.752 -1.218 . . . . 0.0 109.719 161.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.65 -25.29 53.61 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.3 m -152.17 157.23 34.07 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.739 1.215 . . . . 0.0 109.508 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.42 21.4 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.354 3.369 . . . . 0.0 113.515 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.6 tp -91.45 136.53 33.05 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.153 -0.967 . . . . 0.0 109.248 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.12 -168.61 12.48 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.816 1.198 . . . . 0.0 111.299 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.95 148.14 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.437 1.095 . . . . 0.0 110.657 -172.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.3 mm -119.3 119.76 61.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 127.077 2.151 . . . . 0.0 107.936 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.04 119.9 1.05 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 106.759 -2.536 . . . . 0.0 106.759 164.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.82 149.75 42.89 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.421 1.888 . . . . 0.0 106.584 175.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -144.13 128.41 17.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.9 m -126.51 132.07 51.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 168.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -91.44 150.17 21.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.4 p -98.1 138.34 35.55 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.01 163.95 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.176 1.39 . . . . 0.0 109.65 163.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 113.79 4.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -170.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 m -115.73 103.75 10.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.382 1.087 . . . . 0.0 110.502 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HA ' ' H ' ' A' ' 58' ' ' ASN . 24.5 ptt-85 . . . . . 0 N--CA 1.444 -0.77 0 C-N-CA 129.344 3.057 . . . . 0.0 108.89 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 . . . . . 0 C--O 1.236 0.349 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.404 ' H ' ' HA ' ' A' ' 50' ' ' ARG . 11.0 t-20 -81.2 92.11 6.26 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -160.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -155.77 116.35 3.79 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.071 0.948 . . . . 0.0 108.961 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -149.66 -160.88 1.23 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 160.043 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.475 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 10.2 pt20 -126.86 128.8 47.08 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 164.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -97.31 114.04 25.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.67 117.84 29.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.88 96.68 0.96 Allowed Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.0 141.31 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 t -133.65 157.39 45.88 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 171.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.28 138.98 20.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.588 -0.695 . . . . 0.0 111.411 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.86 166.15 32.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.753 1.644 . . . . 0.0 109.314 160.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.438 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 66.7 Cg_endo -73.88 -177.96 3.5 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.734 2.289 . . . . 0.0 112.538 171.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.55 128.77 44.92 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.708 2.003 . . . . 0.0 108.032 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.1 130.29 28.84 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 ttp-105 -80.4 89.93 5.6 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.8 pp -93.29 1.57 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.244 1.018 . . . . 0.0 112.054 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -128.49 -178.28 4.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.941 1.696 . . . . 0.0 107.244 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -52.0 -67.53 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.72 2.008 . . . . 0.0 109.255 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.42 42.83 2.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.965 2.106 . . . . 0.0 110.559 -169.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.31 151.71 33.35 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.68 141.53 49.6 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.384 1.074 . . . . 0.0 109.422 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.48 154.82 6.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.234 1.413 . . . . 0.0 107.391 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.438 ' CE2' ' HD2' ' A' ' 69' ' ' PRO . 36.0 t80 -149.81 150.68 32.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.166 1.386 . . . . 0.0 107.857 169.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.26 109.84 3.35 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.2 m -103.76 161.8 4.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.967 0.907 . . . . 0.0 109.876 -167.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 t -109.08 131.07 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -116.34 159.88 13.68 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.53 150.84 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 170.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.97 158.3 21.4 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.946 1.736 . . . . 0.0 109.774 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -140.91 127.7 20.4 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.26 -171.66 16.64 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.0 pttt . . . . . 0 N--CA 1.483 1.181 0 C-N-CA 127.709 2.403 . . . . 0.0 112.919 160.973 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -94.91 151.76 18.93 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 164.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -95.1 110.6 22.52 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.155 1.382 . . . . 0.0 107.819 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.13 98.44 0.56 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.22 133.78 42.7 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.391 1.096 . . . . 0.0 108.296 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 p -133.06 173.62 11.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.351 1.072 . . . . 0.0 111.659 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -161.78 163.69 29.34 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.254 1.822 . . . . 0.0 106.353 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 177.18 -162.28 30.31 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -140.88 130.55 24.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 167.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.6 142.19 15.97 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 172.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.35 140.52 51.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.39 1.876 . . . . 0.0 108.539 -168.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.68 159.82 35.26 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.816 1.246 . . . . 0.0 110.769 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -91.87 171.09 9.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 168.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -56.92 154.21 19.88 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.793 168.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.98 109.91 0.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.254 0 N-CA-C 107.647 -1.713 . . . . 0.0 107.647 162.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.1 mmt -81.08 -174.97 5.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.974 2.11 . . . . 0.0 107.095 153.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -117.69 -4.24 11.21 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.359 -1.463 . . . . 0.0 110.736 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -137.45 0.14 2.25 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 124.561 1.144 . . . . 0.0 111.316 166.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.77 147.08 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 120.363 -1.461 . . . . 0.0 107.69 -162.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -143.62 153.06 42.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.456 1.903 . . . . 0.0 106.846 167.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.479 HD13 HG12 ' A' ' 144' ' ' VAL . 2.3 mm? -133.78 130.46 38.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 172.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -146.59 129.79 16.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 119.211 0.914 . . . . 0.0 109.176 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -149.65 151.9 34.5 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.512 0.596 . . . . 0.0 110.479 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.9 t -145.48 166.61 25.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.564 0.746 . . . . 0.0 110.338 173.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -143.57 106.13 4.45 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.595 1.958 . . . . 0.0 106.178 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -131.38 114.72 15.31 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -99.3 107.84 20.22 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -169.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.0 t -81.73 157.55 24.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.771 0.829 . . . . 0.0 108.833 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -130.0 129.07 43.26 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.0 mm -118.19 91.4 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -166.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.39 -82.71 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 126.156 1.782 . . . . 0.0 108.585 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.74 23.96 3.11 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.395 1.078 . . . . 0.0 112.551 171.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.94 148.79 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 119.413 1.006 . . . . 0.0 108.574 171.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.08 129.27 39.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.605 1.562 . . . . 0.0 107.652 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 79.6 t -136.82 92.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.866 1.666 . . . . 0.0 109.531 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.4 152.49 41.28 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.524 -0.735 . . . . 0.0 111.557 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.85 143.92 49.85 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 155.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -130.8 119.74 22.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.7 133.02 70.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.95 138.39 26.83 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -153.1 167.86 31.82 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 124.286 0.946 . . . . 0.0 110.926 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.479 HG12 HD13 ' A' ' 123' ' ' LEU . 17.4 m -140.3 168.33 17.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.084 1.353 . . . . 0.0 107.841 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -166.76 -103.85 0.17 Allowed Glycine 0 C--N 1.334 0.438 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.632 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -164.11 176.47 9.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.206 1.802 . . . . 0.0 109.511 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.11 145.05 35.26 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 168.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.0 p90 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 117.869 -1.062 . . . . 0.0 109.651 -179.233 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.477 0.18 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -141.7 141.31 33.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 121.414 -0.804 . . . . 0.0 108.987 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.07 107.01 11.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -95.75 139.74 31.55 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.48 HG13 ' H ' ' A' ' 146' ' ' TYR . 2.4 p -142.78 128.94 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.897 1.679 . . . . 0.0 107.524 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.6 p -138.51 163.56 31.68 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.453 0.569 . . . . 0.0 110.653 168.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.77 155.52 26.79 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.47 -165.43 37.95 Favored Glycine 0 C--O 1.236 0.272 0 O-C-N 121.793 -0.828 . . . . 0.0 112.75 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.74 157.58 16.39 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.246 1.018 . . . . 0.0 110.087 -169.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.79 162.89 34.05 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.921 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -143.73 154.34 43.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.331 1.053 . . . . 0.0 108.222 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 t -115.12 151.13 34.88 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 162.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.33 170.75 12.15 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.272 2.229 . . . . 0.0 105.296 160.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.91 164.49 28.19 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.5 -0.75 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -74.04 85.35 1.8 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 159.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.83 90.41 0.45 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.48 94.74 0.29 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 122.302 1.048 . . . . 0.0 109.74 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -151.21 -58.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.208 1.803 . . . . 0.0 108.03 170.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -63.69 103.92 0.61 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.168 1.387 . . . . 0.0 109.266 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -129.81 75.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 161.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -81.47 161.32 23.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.739 1.616 . . . . 0.0 109.282 164.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.93 179.88 40.93 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 108.209 -1.957 . . . . 0.0 108.209 171.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.74 -163.63 30.26 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 118.285 1.043 . . . . 0.0 111.858 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -99.62 153.97 18.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.24 1.416 . . . . 0.0 108.747 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -137.93 153.26 49.51 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.873 1.669 . . . . 0.0 107.648 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.6 mt -133.41 148.29 51.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 162.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -125.92 127.22 45.65 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 164.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -155.64 108.43 2.69 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -169.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -141.18 165.93 26.18 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.845 1.258 . . . . 0.0 108.707 -171.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -111.35 157.2 20.48 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -107.71 149.57 27.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 168.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.54 151.27 41.89 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 170.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.54 2.85 55.67 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.342 -0.849 . . . . 0.0 110.886 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -141.44 -70.32 0.36 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.47 1.508 . . . . 0.0 109.277 -153.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.1 t -72.67 122.83 88.58 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 167.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.47 68.28 6.94 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.629 2.22 . . . . 0.0 111.229 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 tp -142.35 121.61 13.06 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.932 1.293 . . . . 0.0 109.234 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -103.84 178.48 24.9 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -127.74 157.41 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.3 mm -124.94 151.62 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.93 1.692 . . . . 0.0 107.399 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.94 108.68 0.37 Allowed Glycine 0 C--N 1.336 0.563 0 O-C-N 120.136 -1.603 . . . . 0.0 111.372 159.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -67.46 151.65 47.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 166.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -136.51 103.04 5.12 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -92.99 150.84 20.27 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -172.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.2 157.76 40.92 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.413 1.085 . . . . 0.0 109.757 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 m -99.81 130.47 46.01 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 160.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -135.63 -56.59 0.79 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.544 1.938 . . . . 0.0 106.619 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.68 113.73 5.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.325 1.45 . . . . 0.0 107.508 174.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -101.6 155.59 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.059 2.143 . . . . 0.0 109.435 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.515 ' H ' ' HB2' ' A' ' 58' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 164.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.235 0.336 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.515 ' HB2' ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -124.77 98.92 5.92 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 170.467 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -115.12 147.65 39.97 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 72.86 -177.84 0.19 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.59 2.356 . . . . 0.0 110.838 -168.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -124.99 163.74 21.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.078 1.751 . . . . 0.0 108.403 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.69 142.35 29.1 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -130.41 118.52 21.32 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.57 166.26 19.43 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 122.43 1.017 . . . . 0.0 112.235 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.7 142.83 42.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 167.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.9 m -139.79 130.95 26.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.88 164.55 31.61 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.617 0.767 . . . . 0.0 110.09 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.14 162.53 10.76 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 126.667 2.08 . . . . 0.0 107.993 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.05 156.62 38.44 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.576 1.517 . . . . 0.0 111.745 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.59 104.06 16.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 157.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -103.14 117.55 34.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -66.94 146.95 53.85 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.82 0.448 . . . . 0.0 110.469 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 pt -141.99 164.05 18.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.8 0.81 . . . . 0.0 111.168 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 t30 65.49 -74.87 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 130.448 3.499 . . . . 0.0 113.072 164.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -132.02 -56.48 0.98 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 117.074 -1.441 . . . . 0.0 109.372 165.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -151.67 27.02 0.65 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.117 1.767 . . . . 0.0 111.037 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.65 172.2 8.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.365 1.466 . . . . 0.0 110.263 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -127.83 168.98 14.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.724 1.609 . . . . 0.0 110.773 -173.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.31 162.1 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.67 1.188 . . . . 0.0 110.77 -172.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -104.65 124.72 49.84 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 127.731 2.412 . . . . 0.0 108.564 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.69 42.76 0.08 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.7 m -104.95 164.34 3.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.74 140.04 28.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -161.32 172.81 37.63 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-O 121.612 0.562 . . . . 0.0 112.789 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.69 149.09 16.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.63 145.15 18.56 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 166.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -135.04 152.15 51.44 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.635 1.574 . . . . 0.0 108.316 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.97 -156.43 12.83 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt . . . . . 0 C--O 1.235 0.336 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.789 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.236 0.371 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -85.69 138.72 31.93 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.061 0.944 . . . . 0.0 109.212 -173.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.97 126.7 49.16 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.054 1.341 . . . . 0.0 107.903 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.66 83.41 0.28 Allowed Glycine 0 CA--C 1.522 0.483 0 CA-C-N 119.078 0.853 . . . . 0.0 111.624 -173.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -74.35 141.16 45.19 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.76 1.224 . . . . 0.0 109.364 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.66 -150.31 0.15 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.984 0.811 . . . . 0.0 110.622 154.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -128.18 162.49 26.83 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.321 1.848 . . . . 0.0 110.001 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.71 -176.2 15.12 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.755 0.693 . . . . 0.0 112.461 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.22 174.22 6.64 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.944 1.698 . . . . 0.0 111.232 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -157.86 84.37 0.13 Allowed Glycine 0 C--N 1.342 0.865 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.643 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.13 139.61 49.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.178 0.989 . . . . 0.0 108.746 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -137.43 159.37 42.12 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.091 1.356 . . . . 0.0 107.674 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -92.85 170.71 9.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 119.619 1.1 . . . . 0.0 108.38 171.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -61.27 104.49 0.47 Allowed Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.439 1.096 . . . . 0.0 110.524 -170.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.15 106.64 2.31 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.642 2.228 . . . . 0.0 109.908 -166.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.7 ptm -164.68 169.77 16.47 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.406 0.548 . . . . 0.0 110.774 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 63.69 35.65 11.29 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.601 1.16 . . . . 0.0 108.67 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 60.01 14.11 4.16 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.864 1.266 . . . . 0.0 113.318 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.26 110.43 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 123.734 1.73 . . . . 0.0 109.309 171.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -113.9 110.25 19.79 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.229 2.612 . . . . 0.0 106.395 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.37 131.66 34.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.78 148.76 42.68 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.727 0.694 . . . . 0.0 110.594 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -143.35 150.7 39.52 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.99 1.316 . . . . 0.0 108.51 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 p -144.08 152.99 41.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.657 0.741 . . . . 0.0 111.367 152.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -108.18 125.09 51.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.144 2.177 . . . . 0.0 105.733 168.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -136.61 145.24 44.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.238 1.815 . . . . 0.0 107.873 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -127.29 161.67 28.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.729 0.775 . . . . 0.0 110.993 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 p -141.22 159.89 41.26 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.831 2.052 . . . . 0.0 108.084 170.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -128.79 114.93 17.18 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 87.2 mt -105.9 98.03 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.18 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 129.179 2.992 . . . . 0.0 109.893 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.5 p -137.78 20.76 2.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.471 1.108 . . . . 0.0 111.245 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.82 115.71 50.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 167.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.29 130.46 40.84 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 168.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.4 t -135.49 112.35 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -172.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.25 144.92 16.94 Favored Glycine 0 C--O 1.238 0.357 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -169.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.3 p -138.0 148.85 45.57 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.436 0.695 . . . . 0.0 110.218 -164.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -121.18 150.27 41.55 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 166.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.45 131.45 65.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.83 131.79 20.3 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.666 0.786 . . . . 0.0 109.045 -171.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -161.97 173.52 38.32 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 114.599 0.6 . . . . 0.0 114.599 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.0 178.06 2.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.951 2.1 . . . . 0.0 108.78 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 167.67 -165.15 38.49 Favored Glycine 0 C--O 1.217 -0.952 0 O-C-N 120.545 -1.347 . . . . 0.0 110.367 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.48 ' H ' HG13 ' A' ' 5' ' ' VAL . 51.4 m-85 -104.92 175.45 5.49 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -166.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.87 130.32 19.98 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 120.813 -1.18 . . . . 0.0 108.13 170.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.191 1.396 . . . . 0.0 107.848 -179.112 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.6 p -132.79 157.17 45.64 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 149.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.85 106.71 4.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.133 0.973 . . . . 0.0 108.822 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -134.35 125.55 27.83 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.985 -1.072 . . . . 0.0 109.095 -168.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.38 112.85 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.468 1.107 . . . . 0.0 108.663 -168.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.5 p -149.15 123.58 9.67 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.927 0.891 . . . . 0.0 109.14 -166.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.34 158.53 27.71 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.794 1.187 . . . . 0.0 111.463 176.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.25 -139.35 5.09 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -167.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -150.33 154.93 38.69 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 117.668 0.734 . . . . 0.0 110.97 -166.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.93 160.19 39.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.461 1.105 . . . . 0.0 111.03 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -132.73 114.12 13.77 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -84.96 144.35 28.38 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.866 0.866 . . . . 0.0 109.004 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -138.39 119.31 14.29 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.34 1.856 . . . . 0.0 109.357 -173.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.03 166.45 19.76 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.499 1.12 . . . . 0.0 110.765 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -39.27 -20.33 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.275 2.63 . . . . 0.0 115.948 169.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.26 -108.7 0.56 Allowed Glycine 0 C--N 1.338 0.659 0 CA-C-N 120.192 1.36 . . . . 0.0 110.584 167.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -141.14 101.81 4.11 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.719 1.26 . . . . 0.0 109.311 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 58.2 mtp -130.32 -75.09 0.54 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.17 99.28 3.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -78.61 132.06 36.96 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB2' HG23 ' A' ' 46' ' ' THR . 3.9 ptp -133.99 149.16 51.2 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.07 177.46 47.69 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.73 -162.41 28.19 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -171.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.06 110.16 22.46 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -170.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -95.69 150.81 19.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.049 -1.464 . . . . 0.0 107.049 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.33 145.03 20.12 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -170.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -132.87 150.11 52.19 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.68 139.62 50.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 170.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -129.53 109.0 10.67 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -115.9 132.5 56.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.59 153.12 45.96 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.777 1.631 . . . . 0.0 107.532 172.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -141.64 155.57 45.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -69.46 -19.97 63.76 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.538 -0.726 . . . . 0.0 110.146 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -21.05 65.98 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 125.548 1.539 . . . . 0.0 112.83 173.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -152.12 90.16 3.85 Favored Pre-proline 0 C--O 1.238 0.448 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.61 64.73 4.73 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.226 2.618 . . . . 0.0 112.012 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.86 125.58 10.4 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 167.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.05 174.19 54.59 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 118.555 0.616 . . . . 0.0 111.859 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.0 t -132.39 148.37 31.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.938 1.695 . . . . 0.0 107.659 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.33 120.74 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 126.592 1.957 . . . . 0.0 106.231 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.78 127.59 4.13 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 168.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 t -125.98 154.9 42.23 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.618 1.167 . . . . 0.0 110.729 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -112.68 140.3 47.56 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.905 0.882 . . . . 0.0 109.01 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.7 m -118.3 116.04 25.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.038 1.335 . . . . 0.0 107.973 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -112.9 149.68 32.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.232 1.413 . . . . 0.0 109.353 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 21' ' ' MET . 7.2 m -123.95 122.43 37.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -136.73 88.93 2.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -174.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -150.7 134.58 16.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.402 1.081 . . . . 0.0 109.288 -161.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.8 p -131.24 122.56 26.72 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.654 1.182 . . . . 0.0 112.155 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 . . . . . 0 C--O 1.224 -0.251 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 162.251 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -81.24 66.53 6.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.391 0.615 . . . . 0.0 109.401 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -134.49 115.72 14.27 Favored 'General case' 0 CA--C 1.523 -0.06 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -158.93 161.78 36.79 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.692 1.997 . . . . 0.0 106.514 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -112.7 128.16 56.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 168.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -107.96 138.32 44.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 170.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -141.39 163.89 31.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.21 169.97 34.35 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.68 143.96 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 t -141.19 127.84 20.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.84 139.1 48.74 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.428 0.558 . . . . 0.0 110.978 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -172.97 167.16 39.92 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 163.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.22 177.79 8.16 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.589 2.193 . . . . 0.0 110.163 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.18 107.31 6.04 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.839 1.256 . . . . 0.0 107.63 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.19 148.66 22.21 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -91.34 142.76 27.35 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 122.074 -0.391 . . . . 0.0 110.308 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.3 mt -83.51 -102.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -129.76 12.04 5.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.487 1.515 . . . . 0.0 109.919 172.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -157.75 -178.41 7.3 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.851 -1.156 . . . . 0.0 112.865 -158.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -69.82 16.56 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.534 2.334 . . . . 0.0 114.292 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.97 141.0 48.7 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.6 1.16 . . . . 0.0 108.537 167.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 p -146.66 120.17 9.09 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.1 149.97 23.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -150.32 171.96 16.14 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.05 0.94 . . . . 0.0 108.922 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.28 150.16 38.33 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 164.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.72 165.49 28.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.284 1.034 . . . . 0.0 108.954 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.62 131.33 73.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.12 156.68 21.34 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.55 150.09 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.51 154.4 20.37 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -132.53 140.24 48.23 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.612 1.965 . . . . 0.0 108.434 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.39 171.67 32.12 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -174.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.397 0 C-N-CA 127.286 2.234 . . . . 0.0 107.657 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.466 0.333 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -149.59 151.66 34.17 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.55 0.691 . . . . 0.0 110.722 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -105.18 125.4 50.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 129.082 2.953 . . . . 0.0 106.991 -165.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.21 105.64 3.31 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.99 139.19 42.76 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.8 m -133.82 177.16 7.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.178 0.991 . . . . 0.0 109.401 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -168.12 167.8 12.18 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.937 2.095 . . . . 0.0 107.464 159.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.73 -166.33 35.19 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.08 158.49 44.28 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.77 1.228 . . . . 0.0 108.681 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.3 113.63 3.32 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.85 140.57 49.75 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.516 1.158 . . . . 0.0 109.35 -166.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -117.42 134.78 54.45 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.553 0.741 . . . . 0.0 109.957 -171.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.45 171.07 9.14 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -57.08 118.17 22.41 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.936 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.82 170.09 15.85 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.022 2.481 . . . . 0.0 112.612 170.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 46.3 mtt -152.98 162.95 40.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 130.03 3.332 . . . . 0.0 106.684 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.55 -4.84 1.5 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 129.178 2.991 . . . . 0.0 114.413 -171.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -145.21 8.89 1.23 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.087 0.955 . . . . 0.0 111.51 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.24 139.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 120.221 1.373 . . . . 0.0 108.842 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.9 154.1 38.97 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 119.907 -1.746 . . . . 0.0 107.566 161.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 132.88 46.13 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -140.98 130.69 24.17 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -129.31 151.25 50.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.48 1.112 . . . . 0.0 108.409 -173.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.96 162.42 37.85 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.636 0.732 . . . . 0.0 109.722 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -130.93 136.64 48.76 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -136.72 132.46 34.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 103.944 -2.614 . . . . 0.0 103.944 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -99.41 154.61 18.08 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 170.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 72.2 m -135.42 149.04 49.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -137.8 118.82 14.36 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 61.3 mt -123.38 105.5 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.68 50.89 17.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.076 1.35 . . . . 0.0 113.28 169.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.7 10.13 3.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.207 1.403 . . . . 0.0 111.518 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.63 119.5 43.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 166.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -71.67 133.14 45.46 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.9 t -133.25 157.06 42.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.25 152.19 23.11 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -140.26 153.9 46.66 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 167.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -136.35 118.74 15.73 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.7 mt -99.75 136.13 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.004 1.722 . . . . 0.0 107.35 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.32 139.62 35.47 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.32 163.05 36.61 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.9 m -139.08 173.54 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.001 1.32 . . . . 0.0 109.426 -172.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 180.0 -99.6 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-O 118.337 -1.257 . . . . 0.0 109.989 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -152.51 173.85 14.64 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.308 1.443 . . . . 0.0 110.513 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.2 tpt85 -133.3 150.97 51.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 162.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.6 p90 . . . . . 0 C--O 1.254 1.301 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 165.113 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.687 0.279 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.95 146.66 26.41 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 174.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -93.07 145.9 24.05 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.725 0.774 . . . . 0.0 109.113 165.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.1 m -153.72 125.71 7.84 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 119.565 -1.959 . . . . 0.0 110.041 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.71 127.61 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.688 0.795 . . . . 0.0 110.958 -170.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 p -139.18 119.99 14.3 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.402 1.081 . . . . 0.0 109.293 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.31 164.13 31.83 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.022 1.296 . . . . 0.0 110.49 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.17 -117.39 0.62 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -168.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -149.68 158.92 44.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.857 0.863 . . . . 0.0 109.735 -169.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.22 152.97 34.67 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.949 1.3 . . . . 0.0 107.802 168.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -142.37 154.37 44.58 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.291 0.636 . . . . 0.0 109.602 162.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 p -139.4 147.06 40.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 128.186 2.594 . . . . 0.0 107.46 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -126.82 113.37 16.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.595 0.712 . . . . 0.0 110.561 -155.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.62 106.14 1.39 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.337 1.055 . . . . 0.0 112.906 -156.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 64.44 8.46 4.3 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.922 1.689 . . . . 0.0 113.391 162.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.18 -101.32 0.23 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 104.178 -3.569 . . . . 0.0 104.178 -169.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -141.08 130.69 24.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 160.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.8 ttp -157.75 -34.91 0.07 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.383 0.427 . . . . 0.0 110.481 155.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -129.17 152.8 48.36 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 126.414 1.886 . . . . 0.0 106.424 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -123.51 80.93 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 171.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -67.61 129.4 39.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.89 176.04 29.6 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.79 -156.36 12.63 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 -171.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -98.55 156.16 16.93 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.391 1.096 . . . . 0.0 109.476 -169.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.77 144.43 41.6 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 124.278 1.031 . . . . 0.0 109.223 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -161.54 126.57 3.52 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -121.96 151.74 40.43 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 109.492 170.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -120.87 139.71 52.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -133.92 157.68 45.4 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 122.888 0.475 . . . . 0.0 110.064 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.71 157.67 38.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 173.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -108.89 125.1 51.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 154.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.76 173.04 3.75 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -117.06 37.68 3.76 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 169.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -148.72 -78.98 0.14 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 m -65.12 143.39 98.84 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.75 29.48 0.38 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.825 3.684 . . . . 0.0 110.972 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 tp -117.34 155.86 28.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.362 1.865 . . . . 0.0 108.791 -168.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.78 -172.99 13.83 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 168.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.1 t -139.56 142.33 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.91 152.91 38.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 163.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.0 136.08 4.2 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 105.021 -3.232 . . . . 0.0 105.021 165.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 t -124.56 142.89 51.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 117.922 0.861 . . . . 0.0 108.874 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -92.35 140.11 29.93 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.282 0.633 . . . . 0.0 110.211 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.89 130.02 37.74 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 167.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -116.84 156.43 27.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 156.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.7 m -138.3 122.2 17.74 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.68 42.26 2.18 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.528 1.931 . . . . 0.0 108.951 -164.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.525 ' H ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -65.3 138.54 58.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.003 1.321 . . . . 0.0 107.92 -175.017 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.5 p -130.39 155.06 47.03 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.196 0.522 . . . . 0.0 111.871 -169.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 C-N-CA 124.861 1.264 . . . . 0.0 111.887 -175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.1 t80 . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -56.29 140.19 45.74 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -116.65 168.48 10.15 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.573 0.701 . . . . 0.0 110.936 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 45.0 -165.44 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 130.081 3.352 . . . . 0.0 113.526 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -135.53 149.11 49.37 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.715 1.206 . . . . 0.0 108.759 -169.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -103.84 140.01 38.25 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 169.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -140.46 118.13 11.64 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.87 139.34 15.05 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.35 117.08 38.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.8 p -105.02 159.4 15.85 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.263 1.025 . . . . 0.0 109.629 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.18 144.02 28.64 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.027 -1.046 . . . . 0.0 109.703 164.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.76 121.07 1.36 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.66 127.64 21.22 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 N-CA-C 106.471 -2.165 . . . . 0.0 106.471 157.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.58 103.65 16.22 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.25 155.01 20.26 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 164.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -106.1 150.78 25.47 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.696 1.598 . . . . 0.0 106.801 161.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.1 mm -77.92 -104.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -129.54 7.29 5.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.986 1.267 . . . . 0.0 112.207 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -136.52 10.19 3.18 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.688 2.395 . . . . 0.0 111.894 -155.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 66.8 m95 51.03 70.58 0.51 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.507 1.523 . . . . 0.0 110.013 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.07 -169.03 1.89 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.435 1.894 . . . . 0.0 109.162 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 t -126.57 169.7 12.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.131 2.172 . . . . 0.0 106.365 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 tp -134.16 157.78 41.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.705 1.602 . . . . 0.0 108.494 -171.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -103.0 176.08 5.26 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 128.064 2.546 . . . . 0.0 109.097 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.16 53.23 2.87 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.71 160.66 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 m -95.45 154.43 3.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 121.561 -0.712 . . . . 0.0 109.676 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.67 134.63 4.82 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.89 129.17 68.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -118.71 115.09 3.0 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -168.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -121.15 123.71 42.96 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.064 0.932 . . . . 0.0 110.294 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.5 161.65 8.79 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.1 tttt . . . . . 0 C--O 1.233 0.211 0 C-N-CA 126.275 1.83 . . . . 0.0 106.899 -170.378 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.2 135.24 38.96 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -145.87 157.1 43.92 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.647 1.979 . . . . 0.0 108.016 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.32 160.56 33.2 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.371 0.986 . . . . 0.0 110.642 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -138.33 151.95 48.02 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 128.632 2.773 . . . . 0.0 109.111 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 m -170.31 -146.83 0.05 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.949 2.499 . . . . 0.0 108.748 159.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -136.94 177.51 7.8 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.942 1.697 . . . . 0.0 109.376 -171.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.38 177.19 37.79 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 121.285 -0.885 . . . . 0.0 113.657 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.63 161.89 14.17 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.008 0.923 . . . . 0.0 111.341 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.33 84.81 0.15 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.03 159.93 20.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.828 0.851 . . . . 0.0 109.767 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.04 154.97 43.07 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.067 1.347 . . . . 0.0 108.424 170.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -92.54 170.07 10.03 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -56.05 130.82 74.03 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.84 127.17 18.05 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -87.64 -175.19 5.1 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 152.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -109.97 -25.6 10.18 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 126.932 2.093 . . . . 0.0 108.458 -173.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.97 5.56 10.4 Favored 'General case' 0 C--O 1.225 -0.188 0 O-C-N 121.067 -1.021 . . . . 0.0 109.357 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.1 t -137.45 144.54 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.51 153.26 51.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.156 1.382 . . . . 0.0 108.56 164.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.468 HD13 HG12 ' A' ' 144' ' ' VAL . 2.4 mm? -143.98 115.86 8.29 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.908 1.683 . . . . 0.0 108.696 -174.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.32 148.04 44.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.951 2.1 . . . . 0.0 109.405 173.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -137.32 122.99 19.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.84 1.256 . . . . 0.0 109.123 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 t -139.54 151.77 46.37 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.516 1.126 . . . . 0.0 108.219 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -149.81 145.17 26.45 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -137.8 165.22 26.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.971 1.709 . . . . 0.0 108.772 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -119.9 159.55 24.44 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.216 -1.553 . . . . 0.0 110.633 169.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 t -140.43 159.82 41.36 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 170.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -141.11 97.85 3.26 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.69 83.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 54.62 48.97 19.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.263 1.025 . . . . 0.0 111.73 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 m 62.4 5.14 1.49 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.534 1.534 . . . . 0.0 114.876 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.7 t -82.2 148.74 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 121.169 1.804 . . . . 0.0 107.232 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 t70 78.02 -59.27 0.44 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.56 2.744 . . . . 0.0 113.032 171.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.4 t 68.82 -72.83 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 127.868 2.467 . . . . 0.0 113.089 165.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.15 116.18 1.09 Allowed Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.2 t -106.11 150.71 25.54 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.954 0.883 . . . . 0.0 109.466 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -134.9 133.28 39.46 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.5 pt -130.41 159.57 42.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.98 150.01 50.58 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.526 1.53 . . . . 0.0 109.27 -171.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -153.85 106.62 0.3 Allowed Glycine 0 C--O 1.22 -0.775 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 123' ' ' LEU . 34.3 m -128.85 167.13 24.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 118.848 1.324 . . . . 0.0 109.213 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.59 -122.29 1.06 Allowed Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -163.14 177.21 9.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.445 1.898 . . . . 0.0 109.556 -167.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -121.54 163.12 19.38 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.211 -0.931 . . . . 0.0 111.239 171.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . 0.258 0.0 OUTLIER . . . . . 0 C--O 1.251 1.173 0 CA-C-O 116.521 -1.704 . . . . 0.0 107.475 160.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 115.829 -2.034 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -139.14 152.04 47.12 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 123.335 2.788 . . . . 0.0 109.928 -163.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m -143.53 160.04 41.35 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 161.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -142.93 105.11 4.42 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 119.689 -1.882 . . . . 0.0 107.939 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 m -92.69 138.2 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.524 1.529 . . . . 0.0 107.273 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 m -148.92 143.72 26.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 168.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.47 164.19 32.41 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.44 -111.9 0.47 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -173.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -124.87 158.38 33.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.373 1.087 . . . . 0.0 111.018 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.51 133.26 34.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 128.517 2.727 . . . . 0.0 104.03 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -140.0 131.89 27.65 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 164.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -85.27 151.2 24.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 161.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 18' ' ' MET . 0.8 OUTLIER -138.74 169.96 16.86 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.121 1.368 . . . . 0.0 107.693 160.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.92 40.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.345 1.43 . . . . 0.0 109.603 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -70.75 97.62 1.4 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.038 0.923 . . . . 0.0 110.821 -168.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.48 -26.06 3.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 127.592 2.52 . . . . 0.0 109.419 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -146.79 96.07 2.69 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.481 1.512 . . . . 0.0 107.059 -170.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.449 ' HA ' ' HB2' ' A' ' 13' ' ' ASP . 2.5 mpt? -76.82 61.01 1.83 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.307 1.043 . . . . 0.0 109.187 172.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -70.74 99.11 1.64 Allowed 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 124.995 1.318 . . . . 0.0 107.538 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -70.47 108.51 4.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -136.75 130.95 32.75 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.26 -173.5 44.53 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -161.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.88 -94.24 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -149.64 137.95 20.63 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -101.19 148.84 24.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.673 1.589 . . . . 0.0 109.487 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.86 136.65 27.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.733 1.213 . . . . 0.0 107.881 163.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.07 150.81 50.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.44 1.096 . . . . 0.0 108.274 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -135.88 122.28 20.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -107.69 128.55 54.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -99.06 147.95 24.53 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 167.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -111.54 114.51 27.64 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 156.46 37.11 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.09 -20.54 17.93 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.276 1.031 . . . . 0.0 110.345 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.12 -8.16 59.71 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -170.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.37 163.28 18.61 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.99 -7.92 19.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.082 1.855 . . . . 0.0 112.775 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 tp -81.45 139.53 35.16 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.883 1.219 . . . . 0.0 109.655 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.32 -169.57 13.09 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.881 1.229 . . . . 0.0 110.445 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.47 150.29 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.807 0.843 . . . . 0.0 109.437 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.6 tp -135.8 141.77 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.24 145.53 11.08 Favored Glycine 0 C--O 1.239 0.408 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.6 m -112.08 141.14 46.12 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -170.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -111.95 115.3 28.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.4 m -91.47 150.89 21.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -140.47 142.31 35.35 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 160.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.2 m -143.06 133.59 24.96 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.957 0.903 . . . . 0.0 109.57 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -130.27 171.15 13.22 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 149.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -157.66 146.37 19.43 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 p -79.06 107.07 11.55 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 157.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 167.172 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.71 111.99 24.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -165.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -113.68 130.4 56.42 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -171.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -160.17 165.95 30.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.577 1.551 . . . . 0.0 110.045 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.14 140.79 49.08 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 162.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -107.95 123.34 48.49 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -126.08 135.74 52.09 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 163.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.92 95.05 0.32 Allowed Glycine 0 C--N 1.331 0.278 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -174.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.6 mt -77.45 108.99 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 p -131.35 128.21 39.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.593 1.957 . . . . 0.0 106.637 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.62 174.03 13.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.737 0.415 . . . . 0.0 111.396 -172.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.87 176.57 48.09 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 123.34 0.495 . . . . 0.0 113.072 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.73 129.73 10.17 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.89 3.06 . . . . 0.0 109.421 168.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.74 149.09 22.17 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.629 0.772 . . . . 0.0 110.044 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -141.29 127.43 19.6 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.071 0.948 . . . . 0.0 108.683 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.6 120.32 16.05 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 125.164 1.385 . . . . 0.0 109.625 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mp -67.67 165.99 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.744 1.618 . . . . 0.0 107.161 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -79.03 14.64 1.34 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.524 -1.36 . . . . 0.0 112.313 -174.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -139.13 60.87 1.58 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.471 1.508 . . . . 0.0 108.485 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 57.2 m95 58.35 -16.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 129.079 2.951 . . . . 0.0 117.716 170.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.52 161.12 29.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.492 1.117 . . . . 0.0 108.758 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.2 p -142.93 115.98 8.87 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 117.657 -1.163 . . . . 0.0 108.478 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.785 HG12 HD13 ' A' ' 113' ' ' LEU . 1.9 mp -142.1 151.26 18.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.09 1.356 . . . . 0.0 108.297 -174.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -150.29 173.95 13.4 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.84 1.256 . . . . 0.0 109.1 160.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.21 140.46 27.51 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.34 143.8 37.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.196 0.998 . . . . 0.0 108.731 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.95 165.41 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.062 0.945 . . . . 0.0 109.819 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 177.25 -162.62 30.79 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.884 -166.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.69 139.89 19.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.579 0.751 . . . . 0.0 109.287 173.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.51 146.41 16.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 125.403 1.478 . . . . 0.0 109.466 168.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 3.7 p90 -149.37 166.96 27.47 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 122.095 -0.65 . . . . 0.0 111.926 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.64 -93.96 0.1 OUTLIER Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 149.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.19 0 C-N-CA 128.557 2.743 . . . . 0.0 108.813 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.8 m . . . . . 0 CA--C 1.533 0.317 0 CA-C-O 121.526 0.679 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 45.5 p30 -161.69 176.02 11.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.404 3.082 . . . . 0.0 109.586 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 54.83 17.27 1.71 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.904 2.081 . . . . 0.0 114.959 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.97 104.33 1.31 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.21 148.52 45.48 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.5 p -136.79 161.19 36.66 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.621 0.725 . . . . 0.0 111.518 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.57 157.23 37.96 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.497 1.519 . . . . 0.0 108.957 174.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.02 -168.3 37.91 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.881 1.705 . . . . 0.0 108.987 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.68 152.1 51.8 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.1 116.85 4.08 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.785 HD13 HG12 ' A' ' 79' ' ' ILE . 1.8 mm? -115.64 139.71 49.86 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -166.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.66 145.55 38.59 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 120.916 -1.115 . . . . 0.0 109.4 -172.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -93.15 164.4 13.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -56.86 103.92 0.39 Allowed Pre-proline 0 CA--C 1.528 0.125 0 C-N-CA 125.062 1.345 . . . . 0.0 110.579 -166.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.14 120.26 5.64 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.37 1.38 . . . . 0.0 109.058 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.7 mtm 166.9 153.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 129.917 3.287 . . . . 0.0 105.682 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 113.96 28.2 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 129.767 3.227 . . . . 0.0 107.494 160.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.9 t30 44.08 26.69 0.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.372 1.469 . . . . 0.0 113.727 -153.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.64 169.3 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 108.477 160.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.89 135.89 5.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.016 2.926 . . . . 0.0 103.155 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.46 HD22 HG12 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -122.22 146.87 46.85 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -172.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -141.16 152.94 45.09 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.243 1.017 . . . . 0.0 109.196 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -150.34 114.76 5.18 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.38 2.272 . . . . 0.0 105.603 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.1 m -118.3 154.23 32.66 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 168.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.49 120.85 11.62 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -136.61 136.11 38.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.234 1.413 . . . . 0.0 108.792 -168.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -100.05 150.68 22.21 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.799 0.84 . . . . 0.0 109.31 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.3 m -133.87 160.05 38.82 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.824 1.65 . . . . 0.0 108.039 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.52 97.79 4.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.907 1.283 . . . . 0.0 111.208 -166.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.4 mt -134.31 89.03 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.093 0.957 . . . . 0.0 108.888 -166.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.22 -161.31 0.18 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.5 m -77.34 58.55 1.68 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.543 1.065 . . . . 0.0 109.438 168.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.65 149.42 33.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 170.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -122.2 80.46 1.72 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.842 0.746 . . . . 0.0 110.766 -174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.9 t -78.99 96.55 2.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.931 1.693 . . . . 0.0 108.887 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.66 144.65 23.27 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 164.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.12 152.83 45.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 172.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -140.87 147.65 39.26 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 164.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.02 150.47 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.64 166.11 26.12 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.681 0.792 . . . . 0.0 108.9 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.18 178.77 47.14 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.642 -0.789 . . . . 0.0 114.107 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.46 HG12 HD22 ' A' ' 123' ' ' LEU . 11.6 m -129.5 163.33 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 127.783 2.433 . . . . 0.0 107.042 167.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -166.56 -119.25 0.47 Allowed Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -163.17 164.39 25.23 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.579 1.19 . . . . 0.0 110.711 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -91.36 125.93 36.28 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 116.865 -1.54 . . . . 0.0 107.613 164.615 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 t -150.42 142.08 23.62 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 120.728 -1.232 . . . . 0.0 108.937 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -140.71 106.86 5.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.801 0.81 . . . . 0.0 109.419 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.1 p -104.84 129.01 53.24 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 p -91.7 145.28 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 165.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 t -158.14 161.07 37.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.89 173.72 27.66 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.07 -162.06 34.84 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -171.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -91.6 144.5 25.47 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -172.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB3' ' H ' ' A' ' 23' ' ' GLY . . . -95.57 134.92 37.89 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.5 104.14 5.26 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 127.394 2.278 . . . . 0.0 106.552 -175.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 t -84.66 140.64 31.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.286 1.434 . . . . 0.0 107.393 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -138.78 126.89 22.6 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.059 1.744 . . . . 0.0 106.798 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.85 147.45 43.93 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.778 1.626 . . . . 0.0 107.613 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -63.24 92.58 0.06 Allowed 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 124.052 0.845 . . . . 0.0 108.722 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.84 41.72 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-O 117.434 -1.759 . . . . 0.0 111.922 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -150.76 94.91 2.14 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 157.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.6 mtt -76.73 57.26 1.25 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.882 2.873 . . . . 0.0 109.441 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -71.41 101.57 2.44 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -63.13 102.4 0.37 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.64 159.61 41.3 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.166 1.787 . . . . 0.0 106.983 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.11 -176.37 17.8 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -171.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 10' ' ' ALA . . . -163.69 -137.4 2.18 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 -164.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.76 157.69 25.1 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.211 1.506 . . . . 0.0 109.469 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -134.57 148.59 50.5 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.894 1.678 . . . . 0.0 107.995 -173.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.95 124.95 19.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -120.55 132.56 55.22 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -155.61 106.52 2.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -166.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 164.91 28.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.999 0.428 . . . . 0.0 110.88 -173.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -125.4 157.74 36.06 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.061 2.144 . . . . 0.0 106.59 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -128.79 159.94 34.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 168.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -136.12 125.84 25.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -67.41 1.46 2.24 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.933 1.293 . . . . 0.0 113.203 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -55.73 -27.07 48.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.723 0.809 . . . . 0.0 111.376 159.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.7 m -147.44 107.04 3.82 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 169.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.99 78.01 2.26 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.487 2.791 . . . . 0.0 109.713 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.41 126.31 10.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 128.83 2.852 . . . . 0.0 105.433 173.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.39 176.87 48.58 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.484 ' O ' HD13 ' A' ' 40' ' ' ILE . 48.6 t -122.23 146.78 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 170.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.69 HD11 ' HB2' ' A' ' 70' ' ' ALA . 17.1 mm -138.44 116.27 12.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -170.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.09 124.05 1.75 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 107.009 -2.436 . . . . 0.0 107.009 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 p -122.71 153.92 38.79 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.129 1.771 . . . . 0.0 107.557 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -129.49 120.21 25.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -160.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.9 p -119.69 115.15 23.34 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.906 0.776 . . . . 0.0 110.07 -152.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.93 153.85 32.9 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.307 -0.871 . . . . 0.0 110.954 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.5 t -131.58 122.34 25.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.913 0.885 . . . . 0.0 109.035 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -131.59 74.81 1.61 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.04 1.736 . . . . 0.0 106.926 174.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -153.76 146.45 24.24 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.5 t -131.06 155.78 46.32 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.911 2.084 . . . . 0.0 107.925 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 172.116 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.249 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -66.65 112.36 4.13 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.15 0.886 . . . . 0.0 111.931 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -89.31 171.04 10.05 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.893 -1.129 . . . . 0.0 108.093 161.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 66.35 175.67 0.23 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.563 2.345 . . . . 0.0 112.46 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -139.02 155.88 47.63 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.855 1.662 . . . . 0.0 107.321 -167.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -77.57 157.68 30.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -140.97 117.33 10.74 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 154.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.91 106.05 2.32 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 106.882 -2.487 . . . . 0.0 106.882 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.21 108.95 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.3 p -128.96 159.16 36.76 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -137.45 163.5 30.94 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.3 156.32 27.28 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 157.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.02 178.86 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.281 2.654 . . . . 0.0 112.083 145.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.69 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -126.35 144.49 50.8 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.698 1.599 . . . . 0.0 108.191 154.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -133.35 155.87 48.66 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.065 1.346 . . . . 0.0 109.323 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.94 94.99 5.37 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 170.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 33.8 mt -28.09 -70.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 129.832 3.253 . . . . 0.0 110.324 -170.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.411 ' H ' ' H ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -170.12 5.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.67 1.588 . . . . 0.0 110.368 177.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.411 ' H ' ' H ' ' A' ' 74' ' ' ASN . 2.0 t70 -150.08 -177.1 5.73 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.6 1.16 . . . . 0.0 108.714 -175.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -73.98 63.22 0.92 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.84 2.456 . . . . 0.0 112.936 -166.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.64 175.86 10.06 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.792 1.637 . . . . 0.0 108.648 166.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -143.21 112.28 6.63 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 155.66 18.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.689 0.796 . . . . 0.0 109.71 -173.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.55 162.77 39.51 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 155.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.7 131.77 10.62 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 163.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.33 144.59 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 118.712 1.256 . . . . 0.0 108.446 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 m -145.97 165.13 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.301 0.64 . . . . 0.0 111.423 -174.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.41 -143.62 9.54 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 p -133.38 146.33 32.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -170.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.42 113.4 1.51 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 125.087 1.327 . . . . 0.0 109.831 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -95.57 117.12 29.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.476 1.91 . . . . 0.0 107.202 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.98 77.86 0.38 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.1 tttt . . . . . 0 C--O 1.235 0.315 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.456 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.08 177.12 9.0 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.981 0.913 . . . . 0.0 111.616 -159.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -72.59 123.87 24.1 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.624 0.77 . . . . 0.0 110.079 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.76 165.43 17.7 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 159.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -90.3 135.16 33.85 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.1 m -104.98 131.84 51.99 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -143.05 134.69 26.49 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.83 -162.86 14.29 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 124.55 1.071 . . . . 0.0 110.868 -161.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.54 174.44 11.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.922 1.289 . . . . 0.0 109.503 171.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.01 142.34 13.76 Favored Glycine 0 C--N 1.33 0.249 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 168.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.31 140.23 52.34 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -131.86 149.52 52.43 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -109.62 171.38 7.48 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 126.416 1.886 . . . . 0.0 108.726 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -56.49 111.38 3.19 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.639 1.176 . . . . 0.0 110.834 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.64 114.23 3.98 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.932 3.088 . . . . 0.0 110.795 -169.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 49.1 mtt -80.13 158.07 26.46 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.791 1.281 . . . . 0.0 109.738 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -81.12 90.68 6.05 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 134.59 -20.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 132.414 4.285 . . . . 0.0 112.235 170.178 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.13 119.06 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 120.17 1.35 . . . . 0.0 108.898 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.26 155.37 34.42 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 120.201 -1.562 . . . . 0.0 107.729 155.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -125.58 114.58 18.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 161.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -155.5 151.67 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -147.84 151.81 36.58 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.47 1.508 . . . . 0.0 108.68 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.4 t -125.18 141.97 51.78 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 161.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -115.5 124.94 52.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -132.43 119.24 20.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.251 1.02 . . . . 0.0 108.734 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -109.57 107.32 17.36 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 170.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 t -85.21 160.37 19.9 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 163.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -136.65 151.71 49.61 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 155.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.89 111.42 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.9 ttt-85 52.86 46.14 27.35 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.309 1.044 . . . . 0.0 111.893 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.1 m 56.1 39.43 30.39 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.272 1.029 . . . . 0.0 113.134 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.59 140.95 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 153.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -101.3 122.07 43.02 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 126.428 1.891 . . . . 0.0 108.376 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.5 t -128.85 93.45 2.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -166.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.74 139.26 17.0 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -141.34 119.48 12.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -123.79 113.74 18.96 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.6 pp -108.29 147.5 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.649 1.113 . . . . 0.0 109.477 -172.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.58 163.45 15.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -147.81 102.83 0.25 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 107.669 -2.172 . . . . 0.0 107.669 -172.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.08 153.3 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.59 -141.93 7.55 Favored Glycine 0 C--O 1.218 -0.87 0 CA-C-O 117.532 -1.705 . . . . 0.0 109.203 -159.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -163.41 167.09 22.1 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 121.609 2.705 . . . . 0.0 111.003 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -89.35 144.92 25.71 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 159.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.781 154.829 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -150.66 164.72 35.42 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -143.48 159.72 41.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.3 1.84 . . . . 0.0 108.173 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -131.5 146.08 52.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.85 98.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.9 t -148.38 119.81 7.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -159.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.65 171.17 40.03 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.34 -123.08 1.12 Allowed Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 -163.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -146.6 158.3 43.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -159.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.02 156.69 31.62 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.094 0.958 . . . . 0.0 109.725 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -125.47 111.9 15.62 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 167.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.8 m -85.48 140.9 30.31 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 160.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -138.79 172.02 13.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.12 2.568 . . . . 0.0 107.062 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.91 164.49 33.57 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.875 1.216 . . . . 0.0 110.794 162.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.81 86.19 5.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.092 0.949 . . . . 0.0 109.201 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.3 -32.02 1.53 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.576 1.56 . . . . 0.0 109.892 172.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -137.6 99.29 3.9 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.6 mtt -69.3 71.38 0.28 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 160.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -71.98 91.97 1.25 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 166.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -68.12 120.36 14.2 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.0 mtp -137.28 134.4 36.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.46 -179.76 24.66 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 162.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.59 -105.37 0.28 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 104.428 -3.469 . . . . 0.0 104.428 170.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -127.97 153.98 46.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.144 1.378 . . . . 0.0 108.723 167.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -138.81 129.58 26.33 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.123 2.169 . . . . 0.0 109.651 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 tp -135.56 143.17 45.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.937 1.244 . . . . 0.0 109.896 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -127.05 166.27 17.91 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.356 1.863 . . . . 0.0 109.07 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.5 141.24 18.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.899 1.68 . . . . 0.0 106.971 -166.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -116.74 147.62 41.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.089 0.859 . . . . 0.0 109.395 165.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.14 120.0 21.7 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.654 1.582 . . . . 0.0 107.574 166.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -101.59 112.49 25.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.5 101.02 12.8 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.475 1.91 . . . . 0.0 107.896 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 38.04 64.05 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.683 1.993 . . . . 0.0 111.981 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 62.35 40.15 11.51 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.775 2.03 . . . . 0.0 112.394 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.8 p -63.82 122.96 79.98 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.57 -37.39 12.81 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.211 1.941 . . . . 0.0 112.08 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.06 155.3 32.59 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 164.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.59 -167.35 12.18 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 172.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.41 146.17 34.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.23 137.08 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 167.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.28 108.55 0.36 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 165.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 p -125.52 137.59 53.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.444 0.622 . . . . 0.0 110.925 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.65 153.62 20.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.5 m -120.3 132.7 55.42 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 161.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -120.36 153.33 36.64 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.806 2.042 . . . . 0.0 106.109 167.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.9 p -133.19 145.38 50.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.103 0.865 . . . . 0.0 111.741 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -129.77 115.95 18.04 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 163.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -162.66 147.28 11.87 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 m -65.22 155.05 36.32 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 157.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 t80 . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -160.3 172.85 16.61 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.684 0.794 . . . . 0.0 109.705 -167.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -60.33 130.47 46.78 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -154.01 148.86 26.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.695 0.798 . . . . 0.0 108.977 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -152.74 146.42 25.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 164.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -97.95 122.72 41.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 157.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.9 125.55 45.9 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.04 135.49 12.89 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.7 mm -141.89 135.92 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 127.667 2.387 . . . . 0.0 105.603 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 t -140.28 153.61 46.55 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.201 1.4 . . . . 0.0 108.168 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.65 152.97 44.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.871 1.268 . . . . 0.0 108.308 170.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.55 141.43 3.16 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 168.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.88 169.69 18.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 121.71 1.607 . . . . 0.0 110.163 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.86 157.86 16.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.465 1.906 . . . . 0.0 107.34 168.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -145.58 116.55 7.8 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -84.22 134.38 34.55 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.0 mp -77.37 -79.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -171.61 1.94 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.245 0.929 . . . . 0.0 113.374 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -135.15 66.81 1.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -162.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 93.3 m95 53.47 -38.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 131.013 3.725 . . . . 0.0 117.569 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.21 162.9 28.47 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.182 1.793 . . . . 0.0 110.603 -170.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 t -148.45 110.08 4.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.87 145.76 34.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -151.07 164.91 35.35 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.91 0.884 . . . . 0.0 109.333 166.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.62 130.45 20.54 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 170.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 m -119.57 172.17 6.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.298 1.039 . . . . 0.0 108.666 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.1 158.55 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 C-N-CA 125.682 1.593 . . . . 0.0 108.783 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.0 162.64 25.03 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 170.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.2 p -134.54 136.33 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.44 110.92 1.76 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 107.191 -2.363 . . . . 0.0 107.191 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -129.11 156.62 43.58 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.89 174.04 39.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 C--O 1.239 0.52 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 167.476 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.41 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -161.58 176.05 11.44 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.729 0.812 . . . . 0.0 109.223 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -139.62 165.19 27.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.346 1.458 . . . . 0.0 109.032 170.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.29 167.55 38.91 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 165.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -102.85 152.39 21.33 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.323 1.849 . . . . 0.0 110.363 -173.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 p -137.41 168.33 19.86 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.416 1.487 . . . . 0.0 110.101 165.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -146.3 153.12 40.19 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.704 0.802 . . . . 0.0 108.901 168.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.24 -153.94 9.36 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.75 160.28 41.96 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.514 1.125 . . . . 0.0 108.955 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -99.06 121.82 7.35 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 171.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.7 138.94 50.61 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -141.83 155.71 45.56 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.071 -1.018 . . . . 0.0 109.548 -161.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -93.14 163.63 13.56 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -57.02 134.86 80.29 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.336 -0.84 . . . . 0.0 108.759 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.45 104.28 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.444 2.096 . . . . 0.0 110.42 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttt -75.34 -175.02 2.59 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.803 1.241 . . . . 0.0 107.676 167.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -106.08 -13.81 15.34 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.624 1.57 . . . . 0.0 110.438 -159.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.41 25.5 0.35 Allowed 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 125.267 1.427 . . . . 0.0 108.967 166.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.68 137.35 27.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.72 145.2 30.77 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.89 135.68 51.28 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -131.03 145.22 51.96 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.24 1.416 . . . . 0.0 110.362 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -147.5 144.79 28.81 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.487 1.915 . . . . 0.0 108.225 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.2 p -145.82 163.62 34.47 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 151.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -137.27 137.46 39.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -138.21 165.16 27.38 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.021 0.929 . . . . 0.0 109.175 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -127.07 118.24 24.02 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 165.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.6 m -83.24 154.5 24.16 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.833 0.853 . . . . 0.0 109.684 167.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -116.78 102.96 9.85 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.18 93.95 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.631 0.651 . . . . 0.0 110.996 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 88.57 39.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.79 2.836 . . . . 0.0 109.995 164.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m 52.85 43.77 31.13 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.208 1.403 . . . . 0.0 111.564 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.47 130.28 53.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 127.994 2.517 . . . . 0.0 105.075 165.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.75 104.96 15.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.368 0.667 . . . . 0.0 109.724 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.87 92.07 2.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.92 1.288 . . . . 0.0 107.866 -169.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.57 151.81 43.67 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.0 t -138.33 153.49 48.99 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.492 1.117 . . . . 0.0 108.405 165.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -139.36 157.22 46.26 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 152.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.6 pt -120.61 149.03 23.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 168.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.2 123.52 12.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 166.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.02 154.13 25.39 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.84 -179.55 3.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 125.795 1.638 . . . . 0.0 107.963 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 174.78 -96.09 0.11 Allowed Glycine 0 C--O 1.228 -0.281 0 O-C-N 120.29 -1.506 . . . . 0.0 111.58 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -146.63 176.02 10.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.992 1.317 . . . . 0.0 110.522 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -141.31 139.39 33.61 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 10.8 p90 . . . . . 0 C--O 1.252 1.217 0 CA-C-N 119.371 0.987 . . . . 0.0 109.28 176.689 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.3 m -146.36 166.65 25.69 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.688 1.595 . . . . 0.0 106.751 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -122.95 140.61 52.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.102 0.961 . . . . 0.0 109.967 -173.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 t -151.42 173.2 14.83 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.58 120.76 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -139.89 122.25 16.03 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -161.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.38 -159.89 33.14 Favored Glycine 0 C--N 1.332 0.331 0 O-C-N 119.931 -1.731 . . . . 0.0 113.635 -157.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 114.44 -99.83 0.97 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 106.984 -2.447 . . . . 0.0 106.984 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -139.74 157.68 45.34 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.029 1.414 . . . . 0.0 108.753 -163.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.14 132.24 41.41 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.053 1.741 . . . . 0.0 107.703 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -100.04 113.17 25.58 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -85.01 137.72 32.9 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 157.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -138.14 170.65 15.67 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.449 1.1 . . . . 0.0 108.397 171.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -114.23 165.48 12.63 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.264 1.026 . . . . 0.0 111.866 -165.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -46.2 -20.39 0.1 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.28 2.632 . . . . 0.0 113.693 172.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.15 94.71 0.15 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 168.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -42.48 102.94 0.03 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 129.772 3.229 . . . . 0.0 112.408 -173.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.3 ttm -145.83 -36.17 0.28 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.003 1.721 . . . . 0.0 111.056 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.89 103.25 7.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.86 1.264 . . . . 0.0 111.658 173.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 157.34 18.0 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.742 172.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.9 mtm -130.21 159.7 36.07 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.198 0.999 . . . . 0.0 109.785 172.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.26 176.03 38.94 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.026 1.774 . . . . 0.0 110.164 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.91 -84.58 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.53 156.72 41.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 172.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -137.41 150.22 47.49 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 164.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.8 tp -150.73 131.77 14.33 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 168.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -131.02 161.28 32.32 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.896 2.078 . . . . 0.0 110.143 -176.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -145.46 142.33 29.16 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.761 1.624 . . . . 0.0 108.356 -172.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.438 HH12 ' CB ' ' A' ' 78' ' ' SER . 4.9 tmm_? -131.63 115.27 15.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.475 0.71 . . . . 0.0 109.298 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -98.94 156.57 16.83 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.733 0.697 . . . . 0.0 110.01 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -139.91 113.19 8.35 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.943 1.697 . . . . 0.0 108.939 -165.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -64.35 169.06 4.98 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.414 1.486 . . . . 0.0 110.828 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.2 -30.72 12.84 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.749 0.82 . . . . 0.0 109.37 167.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.83 -82.59 0.06 Allowed 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.56 0.744 . . . . 0.0 109.45 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.5 p -89.07 173.45 6.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.772 0.829 . . . . 0.0 110.943 -171.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.46 -3.86 14.51 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.628 2.219 . . . . 0.0 112.44 165.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.5 tp -70.67 155.94 40.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.32 0.964 . . . . 0.0 110.13 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.17 -166.77 28.76 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 t -132.87 151.08 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 118.163 0.981 . . . . 0.0 109.822 -166.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.448 HD12 ' CE2' ' A' ' 80' ' ' TYR . 46.3 mm -119.88 143.99 29.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 125.74 1.616 . . . . 0.0 107.867 169.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.06 144.37 15.93 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 148.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.0 m -123.51 153.54 40.42 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 127.021 2.128 . . . . 0.0 106.568 168.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -121.15 122.29 39.69 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 m -93.54 116.4 28.92 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -166.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -139.22 125.2 19.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.688 0.395 . . . . 0.0 110.781 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -133.23 130.97 39.75 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -72.25 -177.45 2.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.962 167.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.13 118.87 4.94 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 119.807 -1.808 . . . . 0.0 109.648 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 m -123.48 128.94 50.51 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.835 1.254 . . . . 0.0 108.229 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 164.096 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.405 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.49 116.98 17.68 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -149.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -143.54 170.8 15.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 118.469 0.577 . . . . 0.0 110.758 -169.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 t30 53.53 -177.23 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.859 1.264 . . . . 0.0 109.026 -150.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -113.53 169.34 9.04 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.914 1.286 . . . . 0.0 108.217 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -97.06 103.43 15.36 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -98.12 147.55 24.45 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.17 170.42 36.24 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.82 138.11 46.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.9 m -134.39 127.07 30.87 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.16 149.02 26.62 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.869 0.468 . . . . 0.0 109.775 -172.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.54 -178.28 31.41 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.611 0.624 . . . . 0.0 111.746 176.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -81.29 -177.28 3.57 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.906 3.738 . . . . 0.0 112.141 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.74 146.23 45.56 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.159 -0.963 . . . . 0.0 109.448 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -88.99 101.09 13.74 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -71.83 146.25 48.1 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 162.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.8 mm -97.92 -105.34 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 167.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -155.26 -57.15 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.85 170.57 3.33 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.26 2.224 . . . . 0.0 108.864 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.82 59.47 1.23 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.859 1.264 . . . . 0.0 112.956 -173.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.05 162.9 34.31 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.743 1.617 . . . . 0.0 108.78 158.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.438 ' CB ' HH12 ' A' ' 29' ' ' ARG . 74.4 m -150.05 167.29 27.18 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.755 -1.216 . . . . 0.0 110.342 166.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.54 146.85 24.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' HD12 ' A' ' 40' ' ' ILE . 2.9 m-85 -107.16 148.19 29.16 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 171.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.84 83.19 0.16 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -131.13 167.67 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.513 1.125 . . . . 0.0 110.451 -175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.48 131.22 60.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -175.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.68 122.5 3.24 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.74 146.2 28.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.119 0.968 . . . . 0.0 108.834 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.62 145.27 16.29 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 124.04 0.829 . . . . 0.0 111.984 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -126.86 117.7 23.13 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.1 1.36 . . . . 0.0 107.492 165.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.57 133.78 9.06 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 106.003 -2.839 . . . . 0.0 106.003 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm . . . . . 0 C--N 1.331 -0.228 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 168.719 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.235 0.324 0 N-CA-C 111.101 0.037 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -137.7 128.49 27.04 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 109.912 -165.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -90.65 159.51 16.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 163.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.33 136.54 8.67 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 105.775 -2.93 . . . . 0.0 105.775 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -130.39 130.3 44.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -171.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.82 -175.19 3.88 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.072 1.349 . . . . 0.0 109.65 -167.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -135.23 148.71 49.69 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 165.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.46 64.24 1.11 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 125.436 1.493 . . . . 0.0 109.81 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -95.81 64.29 2.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.755 0.822 . . . . 0.0 109.672 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -96.19 165.72 24.13 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.808 1.67 . . . . 0.0 112.645 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -138.03 140.6 40.18 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.369 1.868 . . . . 0.0 108.857 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -113.45 141.01 47.62 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.041 1.337 . . . . 0.0 109.393 -167.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -119.05 171.83 7.99 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.376 1.071 . . . . 0.0 109.171 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -56.15 110.26 2.2 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.96 1.304 . . . . 0.0 110.15 -173.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 125.98 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.389 2.726 . . . . 0.0 111.013 -169.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.4 ttp -90.63 155.6 18.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 122.919 1.342 . . . . 0.0 110.111 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -80.55 30.1 0.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 128.942 2.897 . . . . 0.0 110.025 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.81 -14.3 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.219 1.808 . . . . 0.0 112.021 171.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.9 m -152.16 121.81 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 126.327 1.851 . . . . 0.0 108.058 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.75 165.59 17.02 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 119.996 -1.69 . . . . 0.0 109.64 160.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -139.13 114.58 9.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 165.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -156.83 155.58 31.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -137.84 114.62 10.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.616 1.566 . . . . 0.0 107.248 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 m -113.91 135.24 54.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 165.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -136.84 113.07 9.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 -169.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -121.29 143.47 49.15 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.143 0.977 . . . . 0.0 108.783 -173.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -133.46 125.0 28.06 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.271 1.428 . . . . 0.0 109.461 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 p -139.1 160.34 40.03 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 120.007 1.276 . . . . 0.0 111.516 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -113.73 117.22 30.9 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 44.7 mt -120.75 109.72 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.66 41.23 28.68 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.478 1.111 . . . . 0.0 110.903 172.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 56.6 m 58.66 16.5 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.81 128.89 39.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 160.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.12 131.1 41.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 169.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.3 t -132.7 133.23 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.2 153.42 17.62 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.3 t -132.69 129.91 39.39 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 159.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -102.04 110.07 21.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 169.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.6 mt -93.86 118.38 39.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.63 145.13 24.85 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -124.37 82.75 0.35 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.99 179.59 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 168.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.9 -120.53 1.23 Allowed Glycine 0 N--CA 1.465 0.618 0 CA-C-O 117.477 -1.735 . . . . 0.0 111.287 -169.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -164.23 164.39 22.53 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.578 1.951 . . . . 0.0 109.701 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.77 132.03 36.26 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.133 -1.604 . . . . 0.0 109.252 175.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.852 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.4 p -141.98 165.96 26.02 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 165.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.47 107.69 4.76 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.971 1.308 . . . . 0.0 110.047 -167.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -61.95 142.09 57.64 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 159.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 146' ' ' TYR . 0.9 OUTLIER -131.84 100.23 4.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 171.553 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -150.67 146.11 26.27 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.086 -1.634 . . . . 0.0 109.231 -165.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.38 170.81 38.91 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 121.452 0.473 . . . . 0.0 112.125 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.81 -127.32 1.4 Allowed Glycine 0 C--O 1.227 -0.309 0 O-C-N 121.164 -1.198 . . . . 0.0 111.748 -170.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -139.7 158.7 43.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.174 0.989 . . . . 0.0 109.982 -166.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.72 125.76 47.34 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.957 1.303 . . . . 0.0 107.738 169.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -101.94 104.48 15.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 163.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.0 m -89.14 141.94 28.07 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 159.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -138.23 165.03 27.71 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.682 1.993 . . . . 0.0 108.399 170.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.76 164.97 21.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 111.35 -170.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -62.07 5.97 0.09 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.24 102.63 0.23 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 104.521 -3.432 . . . . 0.0 104.521 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -65.09 95.92 0.19 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.894 1.278 . . . . 0.0 109.626 -164.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.2 mtt -153.8 10.7 0.41 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.082 2.553 . . . . 0.0 110.596 -176.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -131.78 143.66 50.38 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 120.707 -1.246 . . . . 0.0 109.0 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -137.63 76.99 1.61 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.461 1.904 . . . . 0.0 106.649 164.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.9 mtm -83.45 154.74 23.78 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.78 170.08 12.71 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.294 1.902 . . . . 0.0 111.447 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.37 -141.39 3.22 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -170.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -99.26 123.6 43.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.131 0.966 . . . . 0.0 109.649 -171.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -94.98 151.06 19.5 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.642 1.177 . . . . 0.0 107.846 -172.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.677 HD13 ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -144.56 148.99 35.08 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.292 1.437 . . . . 0.0 107.923 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.677 ' H ' HD13 ' A' ' 26' ' ' LEU . 40.2 mmtt -137.63 130.73 30.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.867 1.667 . . . . 0.0 107.63 -167.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.45 138.62 29.42 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -170.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 163.24 33.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.292 1.037 . . . . 0.0 108.608 167.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -120.4 157.87 28.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 161.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -101.94 112.29 24.86 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.09 178.81 6.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.401 1.08 . . . . 0.0 110.315 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -135.37 13.81 3.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.687 1.595 . . . . 0.0 111.504 -156.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -137.44 -28.35 0.92 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.085 0.954 . . . . 0.0 111.503 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 p -120.74 114.71 32.52 Favored Pre-proline 0 CA--C 1.535 0.382 0 O-C-N 120.919 -1.113 . . . . 0.0 111.07 -169.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.75 80.19 2.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.334 2.022 . . . . 0.0 109.227 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.34 156.29 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.111 2.164 . . . . 0.0 106.659 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -93.75 167.69 28.52 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.6 -1.111 . . . . 0.0 111.56 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.47 139.01 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 119.313 1.556 . . . . 0.0 107.929 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' A' ' 70' ' ' ALA . 4.9 mp -132.5 110.46 16.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.65 123.39 5.22 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 107.244 -2.343 . . . . 0.0 107.244 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 m -122.55 154.36 38.01 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.509 1.523 . . . . 0.0 109.605 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -121.12 132.71 55.02 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.407 0.683 . . . . 0.0 110.586 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -127.64 150.53 49.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.271 1.428 . . . . 0.0 108.185 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -138.62 157.11 46.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.222 3.009 . . . . 0.0 106.493 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 t -99.65 132.81 44.75 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -143.74 40.95 1.42 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.982 0.913 . . . . 0.0 109.888 -166.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -148.35 138.21 22.35 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 120.937 -1.102 . . . . 0.0 110.852 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -90.3 144.58 25.7 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.0 mtp85 . . . . . 0 CA--C 1.521 -0.169 0 CA-C-O 117.167 -1.397 . . . . 0.0 108.084 157.831 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 . . . . . 0 N--CA 1.463 0.177 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -39.09 103.9 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.172 2.189 . . . . 0.0 110.906 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -120.87 122.94 41.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.833 1.197 . . . . 0.0 109.579 -166.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 66.28 -166.26 0.22 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.206 1.802 . . . . 0.0 107.67 -165.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -113.79 151.92 31.35 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.051 1.296 . . . . 0.0 110.166 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -75.17 136.65 41.04 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 155.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -122.11 117.59 26.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 174.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.22 124.48 4.54 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.77 157.08 38.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 171.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.8 t -140.61 158.63 43.7 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.14 145.36 24.66 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.024 0.93 . . . . 0.0 108.616 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.65 161.13 33.98 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 151.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.94 154.62 33.66 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.834 1.689 . . . . 0.0 109.398 165.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.546 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -90.15 167.08 13.0 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 161.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -140.69 154.89 46.55 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.772 -0.58 . . . . 0.0 109.933 165.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -111.27 148.56 32.63 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.458 1.103 . . . . 0.0 108.866 -175.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.3 mp -114.74 -58.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.874 1.27 . . . . 0.0 108.343 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 172.37 -41.14 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.877 2.471 . . . . 0.0 107.957 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.33 165.63 3.48 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.435 2.294 . . . . 0.0 110.406 -177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -82.44 46.93 1.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.279 163.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.94 151.59 36.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.516 2.326 . . . . 0.0 106.69 170.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.04 168.45 23.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 163.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.54 148.58 24.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 174.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -150.67 124.33 9.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.353 0.661 . . . . 0.0 110.211 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.27 142.21 47.03 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 163.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.53 176.08 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.042 0.937 . . . . 0.0 108.877 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -127.57 155.2 38.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.64 163.67 26.83 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.82 131.95 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 171.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.44 109.32 0.95 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 107.17 -2.372 . . . . 0.0 107.17 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -128.84 146.3 50.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.41 -175.59 33.28 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 118.225 -1.941 . . . . 0.0 112.56 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.2 mttt . . . . . 0 C--N 1.324 -0.529 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -162.368 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.23 143.5 40.17 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.255 1.822 . . . . 0.0 107.103 -166.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.91 88.08 2.47 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.224 1.009 . . . . 0.0 108.336 -156.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.15 39.71 1.87 Allowed Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.322 1.439 . . . . 0.0 111.804 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -73.99 121.23 20.71 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 t -157.29 -161.83 1.12 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -129.58 174.16 9.93 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 126.719 2.008 . . . . 0.0 108.848 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.11 -173.8 31.23 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.72 105.37 8.93 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.706 1.602 . . . . 0.0 108.244 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.26 141.93 15.89 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -138.15 161.44 36.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.657 1.983 . . . . 0.0 108.2 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -139.46 159.72 41.5 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.116 0.967 . . . . 0.0 108.419 167.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.409 ' CD2' HD12 ' A' ' 123' ' ' LEU . 4.0 m-30 -92.98 171.54 8.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.444 1.498 . . . . 0.0 108.52 165.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -56.48 119.95 32.41 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.411 1.484 . . . . 0.0 109.117 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.12 148.84 70.14 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.166 1.911 . . . . 0.0 110.5 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 95.2 mtp -116.25 -176.52 2.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.322 1.449 . . . . 0.0 108.804 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.88 -15.88 59.56 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.04 1.336 . . . . 0.0 110.139 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -164.59 14.37 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.836 2.455 . . . . 0.0 111.805 -168.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.94 148.16 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.53 ' C ' HD23 ' A' ' 123' ' ' LEU . . . -156.94 154.05 29.09 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 164.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -133.32 115.78 15.33 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.03 109.51 16.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.509 1.523 . . . . 0.0 107.432 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -115.34 143.66 44.94 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.296 1.038 . . . . 0.0 109.251 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 p -145.92 162.58 37.46 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.379 1.072 . . . . 0.0 110.656 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -151.12 105.48 3.23 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.372 1.069 . . . . 0.0 109.219 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -123.28 163.58 20.43 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.609 1.564 . . . . 0.0 109.956 -170.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -118.52 158.19 25.86 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.762 0.825 . . . . 0.0 111.577 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 t -140.93 105.96 4.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.267 1.827 . . . . 0.0 109.246 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -78.6 97.93 5.97 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 120.851 -1.155 . . . . 0.0 110.109 169.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.5 81.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.96 -70.87 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 128.522 2.729 . . . . 0.0 112.831 -171.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.83 3.82 2.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.298 2.639 . . . . 0.0 110.902 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.72 129.53 46.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -83.27 109.02 16.89 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.2 t -118.72 152.97 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.705 1.202 . . . . 0.0 108.368 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -140.2 152.74 22.99 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 128.123 2.773 . . . . 0.0 107.874 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -135.49 136.08 40.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.414 1.107 . . . . 0.0 109.644 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -112.45 110.67 21.01 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.1 mt -113.65 129.5 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.31 162.1 35.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.33 1.062 . . . . 0.0 109.679 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -158.07 164.37 33.26 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 167.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 m -137.65 166.36 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 166.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -174.82 -107.19 0.2 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 106.982 -2.447 . . . . 0.0 106.982 167.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.419 ' HB2' HG23 ' A' ' 5' ' ' VAL . 5.3 m-85 -141.76 176.6 8.79 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.827 2.051 . . . . 0.0 109.335 -170.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.31 151.76 35.94 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.715 -0.616 . . . . 0.0 110.078 171.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 C--O 1.248 1.014 0 C-N-CA 126.303 1.841 . . . . 0.0 107.97 168.922 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.5 p -96.65 138.2 34.58 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.661 -0.649 . . . . 0.0 109.507 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -89.97 159.18 17.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.947 1.299 . . . . 0.0 108.627 162.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -159.92 144.9 15.08 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 167.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.31 100.14 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.572 0.749 . . . . 0.0 109.143 -171.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 m -132.44 141.35 48.8 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 119.977 -1.702 . . . . 0.0 109.022 -170.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.0 -164.9 26.49 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -166.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.07 -114.05 0.86 Allowed Glycine 0 C--O 1.233 0.094 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.82 158.07 45.11 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.363 1.865 . . . . 0.0 109.223 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.44 136.92 51.35 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 160.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -120.07 122.48 41.18 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -131.66 151.05 51.92 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.34 170.69 15.57 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.754 1.622 . . . . 0.0 109.195 -173.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.67 164.89 27.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.391 1.076 . . . . 0.0 111.493 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -58.93 74.82 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.268 2.627 . . . . 0.0 110.27 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.71 82.86 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 107.835 -2.106 . . . . 0.0 107.835 -171.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -46.02 96.02 0.01 OUTLIER 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.923 2.489 . . . . 0.0 110.094 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.18 -12.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.993 2.117 . . . . 0.0 111.09 -176.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -105.25 123.69 48.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.347 1.459 . . . . 0.0 107.283 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -133.56 95.83 3.57 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.33 159.29 34.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.065 0.936 . . . . 0.0 108.736 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.56 156.09 16.8 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.38 -88.7 0.09 OUTLIER Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -165.42 164.62 19.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.221 1.008 . . . . 0.0 109.251 173.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -130.9 142.17 50.35 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.481 2.312 . . . . 0.0 107.068 166.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -150.44 140.13 21.69 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.791 1.236 . . . . 0.0 108.192 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -151.53 168.16 25.79 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.048 0.939 . . . . 0.0 110.945 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -141.31 114.51 8.67 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.778 0.831 . . . . 0.0 109.127 -167.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -93.73 108.32 20.09 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -103.55 118.26 36.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -140.55 143.3 35.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 7.9 tp10 -143.33 147.46 34.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -175.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.89 2.41 20.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.557 1.143 . . . . 0.0 112.184 -175.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.483 ' H ' ' HG3' ' A' ' 32' ' ' GLU . 4.0 m120 -73.93 -39.07 64.06 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.116 1.366 . . . . 0.0 110.335 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 t -153.37 110.58 2.61 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.4 68.23 5.25 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.992 3.128 . . . . 0.0 110.025 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.1 tp -139.05 105.3 5.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.8 -177.53 47.31 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 123.677 0.656 . . . . 0.0 111.669 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.1 t -134.61 139.72 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.8 pt -129.43 109.73 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 163.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.28 146.55 18.48 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 154.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.39 155.47 40.3 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 128.404 2.682 . . . . 0.0 106.348 160.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -115.78 131.1 57.04 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 167.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 m -92.73 147.45 22.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 156.65 45.23 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.104 1.762 . . . . 0.0 107.106 172.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -143.11 162.43 35.56 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.647 -0.658 . . . . 0.0 109.56 157.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.82 134.21 51.74 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.452 1.901 . . . . 0.0 107.898 166.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.62 147.8 1.1 Allowed 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.513 1.525 . . . . 0.0 107.577 -175.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -130.22 119.01 22.24 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 . . . . . 0 CA--C 1.521 -0.149 0 C-N-CA 125.522 1.529 . . . . 0.0 109.388 175.168 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.4 t80 . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 175.79 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 128.286 2.634 . . . . 0.0 105.423 152.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -150.98 157.02 42.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 128.205 2.602 . . . . 0.0 105.913 168.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -133.48 80.33 1.87 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -165.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -113.25 150.17 32.79 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -169.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -141.74 159.34 42.43 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 168.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -128.37 173.26 10.34 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.05 140.9 9.77 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -123.31 107.53 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 170.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -138.11 142.28 40.19 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 128.067 2.547 . . . . 0.0 104.868 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.26 40.06 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 118.562 0.619 . . . . 0.0 110.693 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.7 170.04 30.53 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.959 1.742 . . . . 0.0 109.103 161.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.9 179.79 5.36 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.405 2.07 . . . . 0.0 109.006 164.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.66 144.16 48.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 153.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -141.24 125.91 17.92 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -83.51 93.56 7.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.069 0.849 . . . . 0.0 109.973 -165.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.1 pp -142.52 -168.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.597 1.559 . . . . 0.0 110.354 -174.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 64.38 -95.51 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 128.744 2.818 . . . . 0.0 107.494 -170.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -147.76 115.44 6.37 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 120.55 1.523 . . . . 0.0 108.443 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 12.8 m0 59.81 8.13 1.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.027 2.531 . . . . 0.0 115.27 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.9 179.83 4.24 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.397 0.999 . . . . 0.0 109.218 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -144.99 105.32 4.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.87 152.45 35.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.99 167.2 27.4 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.649 0.38 . . . . 0.0 109.99 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.89 150.44 50.47 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 163.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -131.36 143.78 39.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.2 153.41 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 123.297 0.639 . . . . 0.0 110.643 -177.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.96 -170.81 39.15 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 123.624 0.577 . . . . 0.0 113.118 -169.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.09 141.26 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.048 1.339 . . . . 0.0 107.946 172.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.86 143.69 16.04 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 125.658 1.599 . . . . 0.0 109.519 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.9 130.47 35.96 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.208 1.803 . . . . 0.0 107.305 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.86 -145.39 13.09 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.186 1.85 . . . . 0.0 110.091 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.367 0 C-N-CA 127.484 2.313 . . . . 0.0 110.459 -170.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.237 0.421 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.89 162.02 21.7 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 168.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -146.88 144.57 29.37 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -125.81 107.16 0.93 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 124.594 1.092 . . . . 0.0 111.018 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.68 118.3 15.43 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.8 m -98.05 132.82 43.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -144.91 61.43 1.31 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.3 1.04 . . . . 0.0 110.916 -171.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.63 -164.35 40.23 Favored Glycine 0 CA--C 1.52 0.393 0 O-C-N 121.097 -1.002 . . . . 0.0 113.254 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.94 159.18 40.71 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 151.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -122.46 116.25 2.97 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 107.851 -2.099 . . . . 0.0 107.851 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -117.85 155.72 29.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.104 2.561 . . . . 0.0 106.622 -166.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.28 149.45 33.87 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.935 -1.103 . . . . 0.0 112.152 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.11 172.16 8.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.244 1.818 . . . . 0.0 109.817 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -59.15 130.67 87.0 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 119.12 -0.467 . . . . 0.0 110.796 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.3 118.32 5.29 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.682 2.255 . . . . 0.0 110.361 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 ttt -78.18 -176.03 4.42 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 150.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -86.68 -28.34 23.21 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 123.856 0.862 . . . . 0.0 109.827 172.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.68 3.59 4.54 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 110.755 -162.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.5 t -150.54 112.25 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 127.82 2.448 . . . . 0.0 105.69 -170.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.92 134.0 51.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.67 132.76 46.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -172.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -141.27 155.67 45.97 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.385 1.474 . . . . 0.0 109.182 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -138.1 123.09 19.02 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 124.525 1.13 . . . . 0.0 108.92 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.2 m -122.42 144.76 48.84 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 164.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -149.79 114.85 5.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.86 137.39 38.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.777 1.231 . . . . 0.0 108.339 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -99.76 161.64 13.49 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 169.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p -140.14 108.08 5.71 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.407 1.083 . . . . 0.0 109.351 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.8 ttm105 -62.28 123.79 19.16 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 168.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.7 mt -123.43 104.78 14.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.63 50.93 12.61 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.864 1.265 . . . . 0.0 111.713 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 61.4 m 48.87 29.66 2.39 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -174.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.57 138.58 19.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 156.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -86.21 121.0 28.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.98 134.16 31.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.34 146.63 17.78 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.7 p -124.16 136.38 54.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -131.63 157.74 42.89 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 163.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.3 mt -127.03 128.25 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -167.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.06 126.91 35.64 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.36 101.99 0.57 Allowed Glycine 0 C--O 1.224 -0.529 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 -170.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 t -138.41 139.17 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 127.291 2.236 . . . . 0.0 106.306 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -179.27 -129.61 1.34 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -146.83 177.1 9.37 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.77 2.028 . . . . 0.0 110.046 -158.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.23 166.28 24.14 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 166.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 12.6 p90 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.486 -1.721 . . . . 0.0 108.278 174.85 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.912 -0.033 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.3 p -140.52 160.35 40.2 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.423 0.689 . . . . 0.0 109.782 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.6 106.64 10.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.632 0.73 . . . . 0.0 110.291 -173.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.78 159.57 29.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 161.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.03 101.18 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 166.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 t -122.06 143.99 49.18 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.4 160.93 25.95 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.783 1.658 . . . . 0.0 109.043 -175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.75 -172.21 45.25 Favored Glycine 0 CA--C 1.51 -0.277 0 O-C-N 119.406 -2.232 . . . . 0.0 110.732 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -90.78 139.82 30.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.121 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.73 154.8 17.03 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.115 1.366 . . . . 0.0 109.123 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -152.54 118.8 5.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.62 151.12 24.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -138.42 159.94 40.79 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 150.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.63 160.45 37.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.619 0.645 . . . . 0.0 110.948 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.41 77.27 3.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.255 0.55 . . . . 0.0 111.176 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.69 -2.8 7.53 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.253 1.406 . . . . 0.0 112.377 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -150.99 96.39 2.32 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.075 1.437 . . . . 0.0 107.994 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.9 mtt -75.99 65.13 1.99 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.863 2.465 . . . . 0.0 110.344 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -78.89 95.94 5.55 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 108.766 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -76.35 77.9 3.1 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.563 0.697 . . . . 0.0 109.556 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.3 mmm -114.25 159.42 20.17 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.904 1.282 . . . . 0.0 108.273 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.54 163.89 12.73 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -168.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.53 -120.95 1.07 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 104.356 -3.498 . . . . 0.0 104.356 -172.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.33 170.32 8.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.335 1.068 . . . . 0.0 109.948 -171.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -137.22 163.14 31.61 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 128.029 2.532 . . . . 0.0 106.387 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.69 158.77 43.82 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 164.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -139.48 156.59 46.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.53 130.85 33.08 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -105.63 115.07 29.62 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -98.21 118.67 35.37 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 103.625 -2.731 . . . . 0.0 103.625 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -87.78 128.34 35.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -109.15 178.44 4.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.52 16.42 8.21 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.293 1.437 . . . . 0.0 109.922 -167.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.38 -63.58 0.98 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.191 1.396 . . . . 0.0 110.351 172.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.0 m -75.19 133.29 75.26 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 117.921 0.328 . . . . 0.0 110.768 -172.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.42 -9.22 18.76 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.521 2.814 . . . . 0.0 112.995 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -88.92 155.57 19.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.166 0.986 . . . . 0.0 109.811 173.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.72 -172.94 17.16 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 166.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -130.52 143.92 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 pt -140.27 142.01 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.85 1.26 . . . . 0.0 109.165 165.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.28 108.08 0.34 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.568 1.08 . . . . 0.0 110.435 166.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.85 153.87 42.36 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.354 1.062 . . . . 0.0 110.374 173.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -120.62 148.38 43.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 153.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 t -127.38 150.93 49.39 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.452 1.901 . . . . 0.0 105.928 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -142.72 156.97 45.09 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.309 0.504 . . . . 0.0 110.214 171.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.3 t -100.06 143.98 29.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.729 0.812 . . . . 0.0 110.291 -176.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -151.05 29.27 0.66 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.927 2.091 . . . . 0.0 110.572 -172.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -133.68 148.4 51.48 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 118.985 -2.322 . . . . 0.0 111.545 -175.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.2 m -113.17 121.74 45.42 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.939 1.296 . . . . 0.0 107.629 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.5 t80 . . . . . 0 C--O 1.237 0.408 0 CA-C-O 119.368 -0.348 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -114.03 143.4 44.81 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 171.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -149.7 120.61 7.65 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 156.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.457 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 41.7 t30 -157.83 -158.41 0.73 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 155.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.457 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 10.8 mp0 -111.36 165.09 12.25 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 165.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.67 116.17 13.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 174.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -97.04 133.86 41.16 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -173.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.09 104.8 0.35 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.6 tt -126.46 114.37 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.443 1.097 . . . . 0.0 108.762 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 t -122.57 151.84 41.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.75 158.41 39.49 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.067 0.947 . . . . 0.0 109.127 168.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.22 -178.56 42.34 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 168.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.52 142.43 44.57 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.015 1.81 . . . . 0.0 110.377 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.31 103.15 15.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 153.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.7 144.97 33.22 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 167.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -74.06 127.38 32.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mm -50.27 -60.86 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.19 0.996 . . . . 0.0 108.848 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -156.89 -43.53 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 167.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.3 -89.51 0.05 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.034 1.333 . . . . 0.0 107.577 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.34 7.11 0.2 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -166.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.84 167.99 20.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.346 1.43 . . . . 0.0 111.161 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 p -74.0 168.76 18.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.983 0.913 . . . . 0.0 110.166 164.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -129.74 164.57 32.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.108 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.53 ' H ' HD13 ' A' ' 79' ' ' ILE . 43.6 p90 -105.08 171.0 7.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.826 2.051 . . . . 0.0 110.971 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.57 70.76 1.16 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.74 168.72 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 117.95 0.875 . . . . 0.0 110.405 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.49 154.12 3.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.76 171.51 36.15 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 118.434 0.561 . . . . 0.0 111.999 163.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.33 126.42 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 170.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.99 104.97 2.02 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 166.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -112.95 135.75 53.38 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.564 1.146 . . . . 0.0 107.974 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.25 -166.54 39.35 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.158 0 C-N-CA 125.924 1.69 . . . . 0.0 110.056 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -151.18 157.95 43.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 167.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -70.89 157.45 38.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 117.894 -1.522 . . . . 0.0 108.729 163.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.3 122.55 6.33 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 105.568 -3.013 . . . . 0.0 105.568 159.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -78.63 117.18 19.55 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 78.7 p -103.02 158.33 16.37 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.306 1.051 . . . . 0.0 112.077 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -105.11 112.84 26.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.13 143.03 16.31 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 118.558 0.617 . . . . 0.0 111.783 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -140.18 160.64 39.5 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.689 1.196 . . . . 0.0 109.504 172.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.59 122.12 0.87 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.08 140.52 51.9 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.109 1.364 . . . . 0.0 107.482 173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -120.22 149.76 41.76 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.189 0.995 . . . . 0.0 108.85 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -92.66 172.27 8.46 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.947 1.299 . . . . 0.0 109.62 -174.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -57.18 154.71 19.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.552 -0.717 . . . . 0.0 110.702 169.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.46 143.47 52.4 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.77 2.314 . . . . 0.0 111.538 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.7 mmt -108.44 -176.73 3.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -92.84 -30.33 15.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 109.404 -170.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -142.34 9.72 1.86 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.248 1.419 . . . . 0.0 110.693 -171.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.261 0.2 OUTLIER -141.31 140.43 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 119.582 1.083 . . . . 0.0 108.551 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.4 153.32 18.66 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -133.39 116.16 15.72 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 162.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -141.09 137.71 33.03 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.864 1.666 . . . . 0.0 107.425 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -133.63 121.81 22.57 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.325 0.966 . . . . 0.0 109.178 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.5 m -127.62 149.94 49.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 140' ' ' TRP . 1.5 t80 -145.01 137.25 25.93 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -127.58 153.87 45.87 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.377 1.071 . . . . 0.0 108.774 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -131.52 154.82 48.39 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 168.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.4 m -136.66 156.77 48.09 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.914 2.086 . . . . 0.0 108.534 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -134.1 97.17 3.79 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.3 90.97 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 60.79 -93.11 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 126.656 1.982 . . . . 0.0 110.573 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.17 1.76 20.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.349 0.977 . . . . 0.0 112.633 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.37 112.81 41.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-N 119.847 1.203 . . . . 0.0 108.599 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.43 136.47 57.92 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 162.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.9 t -125.86 116.85 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 169.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.48 149.84 20.04 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 170.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 87.6 m -141.12 120.42 13.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 164.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.448 ' HB3' ' CE2' ' A' ' 127' ' ' TYR . 5.6 p-90 -90.88 141.89 28.34 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 170.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.96 134.88 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.69 164.39 14.73 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 172.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -146.63 104.09 0.29 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.47 -179.83 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.372 1.869 . . . . 0.0 105.989 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 146.15 -115.12 0.78 Allowed Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 106.883 -2.487 . . . . 0.0 106.883 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -147.75 175.8 10.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.01 1.324 . . . . 0.0 110.679 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -140.28 165.81 26.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 164.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 C--O 1.25 1.101 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 170.203 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 p -140.48 141.38 35.41 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 168.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -122.93 158.78 29.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 m -145.78 154.82 42.45 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 166.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.1 98.96 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.1 p -117.47 135.15 54.12 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.928 1.291 . . . . 0.0 107.917 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.12 168.42 38.56 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.44 -169.15 42.1 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.483 -173.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -92.04 157.86 16.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.722 1.209 . . . . 0.0 109.026 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.02 172.91 8.17 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.157 0.983 . . . . 0.0 111.307 -174.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -148.24 104.56 3.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 155.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t -84.39 134.02 34.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 157.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -103.28 171.38 7.4 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.37 158.25 44.02 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 161.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.16 97.45 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 162.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.16 -29.81 2.68 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.778 1.18 . . . . 0.0 110.664 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -151.1 93.88 1.98 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -88.34 69.52 9.06 Favored 'General case' 0 C--N 1.335 -0.065 0 CA-C-O 123.954 1.835 . . . . 0.0 107.005 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.49 -177.77 4.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 128.168 2.587 . . . . 0.0 108.476 -168.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -90.79 96.78 10.81 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 164.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 62.2 mtm -70.57 159.23 34.73 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 138.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.77 -161.91 17.96 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.46 -140.48 5.04 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -160.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.99 154.45 20.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.864 1.266 . . . . 0.0 109.703 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -137.66 153.89 49.78 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.452 2.701 . . . . 0.0 107.634 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -150.25 141.41 23.1 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.787 1.635 . . . . 0.0 107.768 168.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -116.43 146.42 42.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.693 1.997 . . . . 0.0 107.363 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.66 110.91 10.19 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -93.23 157.7 16.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -143.63 158.25 43.81 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.823 0.283 . . . . 0.0 110.553 165.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -125.02 112.55 16.69 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.564 0.697 . . . . 0.0 109.147 169.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.0 164.09 21.69 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.81 8.44 41.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.777 1.631 . . . . 0.0 112.912 -169.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -1.27 22.55 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -172.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.06 139.82 8.36 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 126.555 1.942 . . . . 0.0 107.306 166.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.79 81.06 2.45 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.516 2.144 . . . . 0.0 108.301 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 tp -150.65 156.65 41.77 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.202 1.801 . . . . 0.0 107.94 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.18 -177.9 15.26 Favored Glycine 0 C--O 1.226 -0.346 0 O-C-N 121.571 -0.706 . . . . 0.0 111.539 172.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.2 t -143.5 137.37 25.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.367 1.467 . . . . 0.0 108.25 -165.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.6 mm -139.9 141.39 34.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.977 1.311 . . . . 0.0 109.91 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.64 167.89 20.64 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 107.729 -2.149 . . . . 0.0 107.729 144.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.8 t -127.45 155.27 43.95 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.208 -1.76 . . . . 0.0 106.877 143.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -98.48 143.82 28.49 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 165.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -127.7 134.18 49.57 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.858 1.263 . . . . 0.0 108.389 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -141.96 123.87 15.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.593 1.157 . . . . 0.0 108.395 -172.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -99.21 126.85 45.1 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -163.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -139.14 0.48 1.93 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.308 0.575 . . . . 0.0 112.254 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.19 123.49 26.97 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.001 -1.687 . . . . 0.0 109.1 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.9 p -67.06 152.25 46.12 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.396 0.998 . . . . 0.0 110.633 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 157.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.8 t80 . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -62.74 109.2 1.35 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.244 0.929 . . . . 0.0 109.908 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -121.25 170.93 9.11 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.259 1.424 . . . . 0.0 110.968 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 58.22 -159.0 0.28 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.71 1.604 . . . . 0.0 111.112 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 158.64 38.09 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 120.507 -1.371 . . . . 0.0 108.616 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -115.73 158.95 22.06 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -127.91 157.14 41.33 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.312 1.845 . . . . 0.0 107.77 -173.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.32 88.82 0.14 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.73 113.47 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.9 m -131.16 128.0 39.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.59 149.28 25.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.373 1.069 . . . . 0.0 108.969 -174.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.13 175.87 31.58 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 166.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.66 175.4 11.15 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.451 2.768 . . . . 0.0 113.036 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.51 138.58 52.34 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.283 1.833 . . . . 0.0 110.712 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -121.02 128.42 52.66 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.08 1.352 . . . . 0.0 108.93 -168.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.53 149.45 24.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.71 0.804 . . . . 0.0 110.223 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -78.88 179.06 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 163.575 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -61.32 -52.65 63.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.617 -1.302 . . . . 0.0 110.718 -176.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -159.98 148.52 17.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 149.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 11.6 m0 145.1 -49.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 130.746 3.618 . . . . 0.0 108.87 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' H ' HG22 ' A' ' 73' ' ' ILE . . . -148.71 168.69 22.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.758 0.823 . . . . 0.0 109.516 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 m -133.48 156.99 46.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 163.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.521 HG22 HD23 ' A' ' 113' ' ' LEU . 16.3 pt -127.47 167.68 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.84 2.056 . . . . 0.0 108.575 -176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.15 123.96 26.61 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.268 -0.895 . . . . 0.0 108.885 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.43 86.58 0.4 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 106.908 -2.477 . . . . 0.0 106.908 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.6 HG22 ' HB2' ' A' ' 111' ' ' ALA . 2.3 m -113.66 -176.62 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.336 0.655 . . . . 0.0 109.867 -175.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.4 m -116.33 151.01 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 166.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.77 158.4 20.05 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 167.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.8 p -145.86 121.62 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.05 106.35 3.22 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -108.59 117.4 34.07 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.43 174.1 19.41 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm . . . . . 0 CA--C 1.516 -0.355 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 170.523 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -141.11 159.26 42.58 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 165.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -85.68 165.83 16.65 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.494 -0.754 . . . . 0.0 110.267 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.51 142.31 14.27 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 163.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -118.11 93.2 4.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.572 1.186 . . . . 0.0 109.034 -160.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.7 t -87.21 147.51 25.55 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.976 0.893 . . . . 0.0 110.198 -173.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.12 144.24 51.25 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 128.398 2.679 . . . . 0.0 106.479 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.69 -170.13 14.56 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 -165.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.6 ' HB2' HG22 ' A' ' 82' ' ' VAL . . . -166.97 -65.53 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.413 1.107 . . . . 0.0 109.203 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 155.11 174.35 24.91 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -167.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.521 HD23 HG22 ' A' ' 79' ' ' ILE . 4.2 mp -145.17 143.84 30.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -104.24 149.51 25.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -173.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.8 171.17 8.82 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -58.75 142.16 84.21 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-O 119.165 -0.445 . . . . 0.0 109.865 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.43 152.55 78.62 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 120.931 1.087 . . . . 0.0 111.007 172.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -109.09 -174.19 2.45 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 130.955 3.702 . . . . 0.0 105.503 162.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -110.93 -11.8 14.3 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.309 1.844 . . . . 0.0 109.294 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -142.01 17.22 2.11 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.176 1.39 . . . . 0.0 111.6 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.82 156.04 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 172.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.41 156.71 42.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.777 0.717 . . . . 0.0 109.166 157.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -136.89 122.36 19.54 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.991 2.117 . . . . 0.0 108.403 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -124.61 160.52 28.28 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.773 2.429 . . . . 0.0 107.64 163.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -140.87 116.69 10.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.23 144.16 51.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.418 0.554 . . . . 0.0 109.939 -168.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -137.29 156.62 48.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -129.79 147.61 51.59 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 155.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -132.84 112.2 11.72 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.8 t -139.56 160.3 40.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.624 1.57 . . . . 0.0 108.228 -157.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.65 145.83 37.11 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.45 110.35 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 171.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 50.17 40.91 23.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.302 1.041 . . . . 0.0 111.97 -173.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 m 47.76 36.84 6.19 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.6 t -81.48 112.79 19.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 143.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.16 137.2 58.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.5 t -139.26 97.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.88 152.4 34.98 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 164.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.8 m -141.0 130.88 24.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 120.775 -1.427 . . . . 0.0 108.047 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -121.23 143.19 49.28 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.8 mt -144.75 132.31 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.805 1.242 . . . . 0.0 107.873 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.61 165.88 14.51 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -154.26 87.36 0.13 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.66 162.61 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 152.81 -119.37 0.95 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -150.59 176.38 11.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.119 1.368 . . . . 0.0 109.564 -158.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 137.9 23.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.039 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 12.0 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-N 119.34 0.973 . . . . 0.0 108.655 167.288 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 p -141.08 136.95 32.49 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 t -127.9 106.81 9.36 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -117.24 118.8 33.3 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.281 5.9 p -110.56 119.41 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 122.006 0.908 . . . . 0.0 111.093 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.32 137.77 23.36 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.728 1.211 . . . . 0.0 108.943 -167.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.5 170.07 40.08 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.59 -152.01 10.02 Favored Glycine 0 C--N 1.319 -0.375 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -172.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -91.87 157.7 16.71 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.47 113.29 11.68 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 169.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.32 148.04 29.52 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.8 t -138.88 115.57 10.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.982 2.113 . . . . 0.0 107.206 -171.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.38 160.69 34.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.068 0.947 . . . . 0.0 109.163 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.72 148.47 52.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.727 0.811 . . . . 0.0 110.986 -167.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 54.65 -70.15 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 128.323 2.649 . . . . 0.0 112.067 -175.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.75 -42.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.7 0 CA-C-N 119.975 1.261 . . . . 0.0 111.04 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -145.21 119.49 9.55 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.438 1.095 . . . . 0.0 108.461 164.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.2 ttm -157.18 -51.75 0.07 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.212 1.005 . . . . 0.0 109.324 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -142.19 158.22 43.98 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.232 1.813 . . . . 0.0 107.733 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -135.76 77.33 1.66 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 170.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.06 138.62 49.06 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 166.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.84 157.22 27.34 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.61 -166.68 38.17 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -170.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -99.89 154.74 18.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.326 0.563 . . . . 0.0 110.402 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -102.43 144.06 31.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.939 1.296 . . . . 0.0 108.271 161.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.0 mt -127.13 150.86 49.3 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 149.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.45 161.09 41.77 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 165.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -144.16 140.41 29.35 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -120.08 114.48 22.05 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.246 0.93 . . . . 0.0 109.357 169.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -99.32 151.92 20.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 163.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -134.69 130.57 36.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -172.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -76.71 163.11 27.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.352 1.072 . . . . 0.0 112.11 -161.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -86.71 27.47 0.98 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.616 1.566 . . . . 0.0 110.885 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -143.1 -65.05 0.39 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.156 1.782 . . . . 0.0 108.983 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.5 p -92.96 127.8 46.03 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.872 1.669 . . . . 0.0 108.921 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -76.92 54.81 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 124.088 3.192 . . . . 0.0 110.252 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.27 106.65 5.81 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.631 2.373 . . . . 0.0 106.73 -159.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.18 178.72 22.07 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.984 1.278 . . . . 0.0 111.082 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.85 144.68 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 124.266 1.026 . . . . 0.0 109.555 -156.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.7 mt -126.54 109.8 21.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.94 1.296 . . . . 0.0 108.083 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.01 148.04 18.35 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 105.862 -2.895 . . . . 0.0 105.862 151.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 p -108.89 144.17 37.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.255 1.027 . . . . 0.0 109.196 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -91.9 145.79 24.27 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 162.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 t -128.91 152.44 48.55 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.061 1.744 . . . . 0.0 108.084 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -136.98 156.65 48.17 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 175.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.4 m -98.35 121.96 40.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 165.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.56 53.45 1.05 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.474 2.31 . . . . 0.0 107.108 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -158.93 146.63 17.75 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 128.524 2.729 . . . . 0.0 108.464 169.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 p -127.7 156.66 42.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.929 2.491 . . . . 0.0 107.599 163.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.862 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -66.06 107.08 1.78 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.396 -171.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -135.8 146.25 47.37 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 118.739 0.699 . . . . 0.0 110.213 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 51.2 -161.69 0.08 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.352 1.861 . . . . 0.0 110.745 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.67 176.13 7.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.154 1.381 . . . . 0.0 111.527 -171.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -89.3 130.87 35.62 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 160.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.63 120.04 41.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 165.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.31 88.67 0.19 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.47 141.07 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 p -126.36 155.79 41.52 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.737 1.615 . . . . 0.0 107.782 171.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.62 150.58 45.14 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.74 0.7 . . . . 0.0 110.284 170.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 173.53 137.35 2.39 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 174.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.22 164.83 34.4 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 CA-C-N 120.405 2.102 . . . . 0.0 110.706 167.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.14 103.98 13.07 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.236 1.414 . . . . 0.0 107.879 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.71 112.24 21.47 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.336 0.516 . . . . 0.0 109.713 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -67.96 136.67 54.3 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 168.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 77' ' ' ALA . 1.9 pp -144.84 178.67 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 126.91 2.084 . . . . 0.0 105.88 172.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.8 t30 38.39 -121.37 0.26 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.435 1.494 . . . . 0.0 109.077 -162.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -110.19 104.14 12.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.202 1.801 . . . . 0.0 108.631 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 65.8 m95 60.84 19.46 9.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.381 2.272 . . . . 0.0 114.73 167.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' HB3' HD12 ' A' ' 73' ' ' ILE . . . -74.57 -169.85 0.92 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.293 0.951 . . . . 0.0 110.468 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.1 m -140.95 169.16 18.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.148 1.379 . . . . 0.0 107.726 167.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.8 mm -133.83 158.61 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 122.804 1.288 . . . . 0.0 109.235 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -105.43 175.48 5.48 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 130.048 3.339 . . . . 0.0 109.627 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 54.05 0.88 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.58 173.22 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.35 160.41 10.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 O-C-N 120.525 -1.359 . . . . 0.0 108.26 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -156.42 165.45 32.91 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-O 122.182 0.879 . . . . 0.0 112.936 162.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -115.26 150.51 17.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 127.055 2.142 . . . . 0.0 106.065 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.89 149.78 18.41 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 165.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -150.77 145.47 25.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.042 1.337 . . . . 0.0 108.944 172.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.62 -133.87 12.07 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.3 tttp . . . . . 0 N--CA 1.474 0.77 0 C-N-CA 128.586 2.754 . . . . 0.0 114.709 178.431 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.64 128.74 36.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -171.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -114.68 142.83 45.96 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -102.35 168.5 18.79 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -138.43 151.72 47.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 164.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -169.4 -164.47 0.45 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.775 0.83 . . . . 0.0 110.56 166.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -134.5 160.3 38.44 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.51 1.924 . . . . 0.0 108.446 -176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -153.25 -158.19 8.43 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.771 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -139.83 168.76 19.06 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -167.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.24 86.42 0.1 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mt -130.15 149.85 51.67 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.6 1.16 . . . . 0.0 107.939 -173.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -135.25 158.88 43.24 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.199 0.454 . . . . 0.0 111.602 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -101.01 171.14 7.82 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.711 1.204 . . . . 0.0 107.77 166.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -56.77 107.01 0.76 Allowed Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.619 0.768 . . . . 0.0 110.653 -170.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.89 158.06 34.81 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.963 2.442 . . . . 0.0 109.59 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 49.4 ttm -135.95 159.82 40.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.127 1.371 . . . . 0.0 109.189 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -69.88 25.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 130.873 3.669 . . . . 0.0 110.75 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.14 -32.16 0.1 Allowed 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.885 -1.135 . . . . 0.0 113.015 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.5 m -145.78 135.77 18.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -174.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.19 155.32 18.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.098 0.863 . . . . 0.0 109.427 168.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -130.44 114.08 15.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 155.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.01 148.99 45.68 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.415 2.286 . . . . 0.0 105.607 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -149.83 138.98 21.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 120.644 -1.285 . . . . 0.0 109.471 -162.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.7 m -134.45 166.37 23.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 166.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -145.98 137.89 25.14 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -134.4 163.6 29.3 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -122.02 169.81 10.46 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 127.018 2.127 . . . . 0.0 106.48 170.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.7 t -131.82 159.9 37.19 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 163.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -123.82 97.08 5.2 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.3 mt -86.88 81.95 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 65.94 -78.92 0.03 OUTLIER 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.248 2.219 . . . . 0.0 111.11 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -146.15 61.06 1.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.167 1.787 . . . . 0.0 107.102 166.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.9 t -125.08 145.61 32.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 162.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.25 137.17 39.95 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.864 1.666 . . . . 0.0 107.423 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.4 t -138.45 151.52 24.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 126.649 1.98 . . . . 0.0 106.937 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -137.05 143.86 15.27 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -140.48 135.99 32.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -123.83 131.18 53.54 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.5 115.93 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.499 . . . . 0.0 107.504 -166.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.85 152.3 21.34 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.143 0.577 . . . . 0.0 110.055 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.26 82.56 0.29 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.818 1.675 . . . . 0.0 109.719 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.8 t -104.19 158.41 5.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 126.516 1.926 . . . . 0.0 106.704 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.33 -107.25 0.28 Allowed Glycine 0 C--O 1.221 -0.677 0 C-N-CA 118.657 -1.735 . . . . 0.0 112.799 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.5 165.85 23.27 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.046 1.738 . . . . 0.0 106.858 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -148.99 136.24 20.09 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 119.835 -1.79 . . . . 0.0 111.555 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 128.805 2.842 . . . . 0.0 111.252 168.952 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.6 m -141.2 125.01 16.98 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -98.86 132.63 44.06 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.496 1.119 . . . . 0.0 109.159 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -143.58 118.78 10.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.453 HG23 ' H ' ' A' ' 146' ' ' TYR . 2.4 m -92.38 143.82 10.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.4 m -158.35 139.57 13.29 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.971 1.708 . . . . 0.0 107.989 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.48 172.59 31.15 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.81 -160.68 29.0 Favored Glycine 0 N--CA 1.462 0.384 0 CA-C-N 120.33 2.065 . . . . 0.0 110.903 -172.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -91.71 157.34 16.99 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.405 1.102 . . . . 0.0 109.845 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.704 ' HB2' HD21 ' A' ' 25' ' ' ASN . . . -119.93 155.07 33.48 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.517 1.527 . . . . 0.0 110.035 -175.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -148.09 118.35 7.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 162.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -83.79 139.63 32.57 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 167.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -116.68 153.86 31.59 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 157.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.1 106.57 3.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.547 1.939 . . . . 0.0 108.524 -171.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 71.38 -54.1 0.67 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.762 2.025 . . . . 0.0 112.63 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.81 -81.38 0.05 OUTLIER Glycine 0 C--N 1.337 0.638 0 CA-C-N 119.469 1.031 . . . . 0.0 114.257 -172.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -152.57 95.87 2.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.279 1.539 . . . . 0.0 108.913 166.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.8 mtt -144.71 -48.87 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.654 0.782 . . . . 0.0 110.314 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -128.37 109.73 11.7 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -169.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -131.41 77.84 1.8 Allowed 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.717 1.207 . . . . 0.0 107.89 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.81 145.23 47.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 169.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . -159.36 -179.93 34.52 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 128.678 3.037 . . . . 0.0 106.747 167.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.81 -90.95 0.08 OUTLIER Glycine 0 CA--C 1.523 0.545 0 CA-C-N 118.998 1.399 . . . . 0.0 110.646 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -164.71 143.09 6.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 168.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.704 HD21 ' HB2' ' A' ' 10' ' ' ALA . 38.9 m-80 -125.32 163.26 22.93 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.133 0.973 . . . . 0.0 110.233 -166.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 mt -142.79 163.1 33.72 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.148 0.979 . . . . 0.0 110.516 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -140.03 161.06 38.51 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.477 2.311 . . . . 0.0 106.538 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -147.81 112.19 5.26 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -105.3 159.42 15.9 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.163 -0.96 . . . . 0.0 108.945 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -142.77 155.84 44.89 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.942 0.897 . . . . 0.0 108.86 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.41 113.06 19.78 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.335 0.654 . . . . 0.0 109.781 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.85 159.2 26.54 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.304 0.574 . . . . 0.0 109.674 167.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -128.83 39.54 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -156.66 -16.32 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.995 1.318 . . . . 0.0 112.15 -173.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.6 t -155.07 133.48 7.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.854 1.662 . . . . 0.0 108.193 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.84 -5.0 16.39 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.312 3.342 . . . . 0.0 113.867 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -77.5 123.97 27.29 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.105 -0.997 . . . . 0.0 109.025 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.36 -167.39 36.91 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.7 t -127.08 147.78 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.344 1.458 . . . . 0.0 108.675 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 mm -122.48 127.85 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 166.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.17 108.71 0.39 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 107.226 -2.35 . . . . 0.0 107.226 163.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.6 t -88.23 150.72 23.12 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.849 1.66 . . . . 0.0 108.293 167.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -127.72 131.13 49.75 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.394 1.878 . . . . 0.0 107.976 172.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -127.32 117.0 21.39 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.978 1.711 . . . . 0.0 109.073 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -113.52 133.91 54.97 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.284 1.434 . . . . 0.0 107.827 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 p -126.6 130.06 49.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.318 0.58 . . . . 0.0 110.878 -168.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -140.17 93.21 2.61 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.363 1.465 . . . . 0.0 108.155 -170.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -162.75 147.46 11.81 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.879 0.872 . . . . 0.0 109.11 -174.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.1 p -121.63 153.93 37.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.51 -0.564 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 119.646 -0.216 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.21 122.34 6.72 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.758 -0.589 . . . . 0.0 109.843 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -115.26 171.64 7.57 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.892 1.677 . . . . 0.0 108.516 170.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.89 -176.01 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.379 1.072 . . . . 0.0 110.202 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 pm0 -137.1 162.15 34.16 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 160.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -83.87 143.09 30.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.61 117.71 21.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.844 2.057 . . . . 0.0 106.455 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.87 92.98 1.05 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.3 mm -79.71 146.43 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 p -133.66 155.42 49.74 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.02 139.21 21.22 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.22 175.33 34.96 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.176 0.417 . . . . 0.0 112.249 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -79.02 176.04 10.26 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.886 2.391 . . . . 0.0 110.351 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.01 150.48 38.54 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.631 1.173 . . . . 0.0 108.841 162.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.2 124.2 41.93 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.099 0.96 . . . . 0.0 108.571 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -71.8 133.27 45.42 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.012 0.369 . . . . 0.0 110.049 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.8 mt -77.95 -76.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 165.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -83.09 -76.07 0.29 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 170.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -148.09 -62.01 0.26 Allowed 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -104.48 105.95 16.27 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.279 1.037 . . . . 0.0 109.56 172.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.42 -169.02 3.24 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.389 1.876 . . . . 0.0 108.754 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.97 169.67 17.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 157.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mm -143.06 147.3 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.628 ' HA ' ' HB3' ' A' ' 111' ' ' ALA . 21.9 p90 -105.4 141.59 36.65 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.425 2.29 . . . . 0.0 107.972 177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.82 50.42 0.21 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -161.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.526 HG22 ' HB2' ' A' ' 111' ' ' ALA . 3.6 m -123.04 176.4 4.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 163.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.55 130.22 54.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.55 158.41 15.13 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.01 118.36 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 170.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.63 122.69 7.62 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 107.372 -2.291 . . . . 0.0 107.372 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -132.63 116.93 17.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -169.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.23 101.55 0.22 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt . . . . . 0 C--O 1.234 0.249 0 CA-C-N 117.666 0.733 . . . . 0.0 109.654 165.608 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.67 165.13 35.11 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.997 -1.065 . . . . 0.0 110.894 170.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.17 109.48 18.92 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 166.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.86 93.42 1.89 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -74.52 111.65 9.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.64 1.176 . . . . 0.0 109.704 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 p -105.79 151.06 24.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.33 1.052 . . . . 0.0 111.211 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -136.85 80.84 1.84 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.468 1.907 . . . . 0.0 107.972 -170.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.08 -161.48 11.0 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 126.512 2.005 . . . . 0.0 108.144 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 80' ' ' TYR . . . -164.28 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 153.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.449 ' C ' HD22 ' A' ' 113' ' ' LEU . . . 164.71 170.83 30.19 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -171.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 112' ' ' GLY . 3.7 mm? -133.29 150.83 51.88 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.58 1.952 . . . . 0.0 106.836 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -132.64 154.2 50.33 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.139 0.971 . . . . 0.0 110.023 -171.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -104.64 174.44 5.88 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 128.044 2.537 . . . . 0.0 109.107 173.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -55.62 114.09 6.75 Favored Pre-proline 0 C--O 1.234 0.269 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.28 103.56 1.7 Allowed 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.044 -1.56 . . . . 0.0 108.044 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.1 ttt -74.64 155.55 37.67 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -54.64 -33.25 60.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 126.787 2.035 . . . . 0.0 110.991 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -104.45 -25.95 12.6 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 117.271 -1.347 . . . . 0.0 113.602 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.93 109.47 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.308 0.958 . . . . 0.0 108.885 -174.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.97 154.17 42.04 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 162.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -132.26 116.35 16.81 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 168.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.84 146.58 37.74 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.913 2.085 . . . . 0.0 107.301 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -129.68 135.61 48.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.3 m -124.23 148.24 47.47 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 171.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -149.86 132.92 16.24 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -136.63 145.22 44.61 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.62 1.568 . . . . 0.0 107.693 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -116.75 129.07 55.89 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 171.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 t -111.11 159.57 17.7 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.188 0.995 . . . . 0.0 108.934 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -136.45 97.4 3.56 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -172.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.57 94.34 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 167.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.3 ttm-85 63.93 58.53 1.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.618 1.167 . . . . 0.0 111.741 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m 53.72 27.89 7.47 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.342 1.057 . . . . 0.0 113.073 171.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.45 149.0 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.392 1.477 . . . . 0.0 108.094 172.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.72 102.4 13.6 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 169.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.3 t -131.85 103.68 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.87 133.17 7.49 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.4 t -125.48 139.89 53.24 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.479 1.512 . . . . 0.0 107.457 -175.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -129.7 151.18 50.57 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 171.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.8 pt -136.23 145.16 31.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.13 158.04 18.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.25 101.95 0.36 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 106.664 -2.574 . . . . 0.0 106.664 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.87 160.44 20.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.06 -149.84 9.45 Favored Glycine 0 C--O 1.221 -0.718 0 C-N-CA 118.688 -1.72 . . . . 0.0 109.799 -172.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.453 ' H ' HG23 ' A' ' 5' ' ' VAL . 42.4 p90 -162.66 175.32 11.49 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.937 1.695 . . . . 0.0 106.988 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -102.98 147.67 26.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 C--O 1.249 1.064 0 C-N-CA 126.174 1.789 . . . . 0.0 108.049 170.79 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 p -131.82 137.58 48.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -132.21 106.89 8.23 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.8 t -135.96 127.21 28.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.496 HG11 ' CD1' ' A' ' 146' ' ' TYR 0.259 9.7 p -101.93 153.4 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.735 0.779 . . . . 0.0 109.512 -173.418 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.9 124.08 4.24 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 174.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.39 -172.7 45.67 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 118.594 0.634 . . . . 0.0 113.235 -166.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.31 -116.44 1.54 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.602 1.572 . . . . 0.0 110.818 169.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.35 146.26 45.47 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.617 1.209 . . . . 0.0 108.307 -163.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.39 120.84 24.88 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -169.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -99.65 148.15 24.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 168.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -130.93 131.34 44.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 165.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -119.25 111.17 17.87 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.4 143.04 27.03 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.324 1.049 . . . . 0.0 108.286 -170.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 60.89 -75.48 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.243 1.817 . . . . 0.0 109.537 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.46 -73.35 0.02 OUTLIER Glycine 0 CA--C 1.52 0.405 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -126.12 105.91 9.2 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ttt -148.21 -54.63 0.2 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.206 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -144.62 133.05 21.94 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -167.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -121.15 77.82 1.35 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -170.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -58.08 157.73 7.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.294 1.437 . . . . 0.0 110.31 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.69 155.16 26.25 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.07 -175.4 39.4 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 118.386 1.093 . . . . 0.0 111.688 -173.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.11 146.43 43.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.771 0.785 . . . . 0.0 111.604 -164.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.62 HD21 ' HA ' ' A' ' 44' ' ' THR . 1.0 OUTLIER -139.36 152.52 47.22 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.536 1.935 . . . . 0.0 109.531 176.454 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.441 HD21 ' CG2' ' A' ' 5' ' ' VAL . 1.3 tm? -156.28 116.11 3.59 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.667 0.787 . . . . 0.0 108.883 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 128.6 38.82 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.513 1.125 . . . . 0.0 109.58 175.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -95.74 141.5 29.14 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.778 2.431 . . . . 0.0 108.095 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 69.7 mtm-85 -128.37 162.85 26.13 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.958 1.254 . . . . 0.0 109.74 166.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.21 138.52 31.53 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -88.09 135.16 33.55 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 171.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -136.48 162.22 33.69 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.768 0.827 . . . . 0.0 110.639 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.68 47.09 2.18 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.247 1.419 . . . . 0.0 108.411 -166.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.51 -48.18 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.708 1.203 . . . . 0.0 109.455 171.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.97 115.07 45.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.602 1.161 . . . . 0.0 108.375 175.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.99 -43.81 6.1 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.809 1.673 . . . . 0.0 109.901 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.481 HD12 ' CB ' ' A' ' 69' ' ' PRO . 1.9 pt? -73.09 148.33 44.11 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.125 2.17 . . . . 0.0 110.597 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.72 -178.21 36.61 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.677 1.132 . . . . 0.0 110.613 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.5 t -117.95 139.57 44.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.353 1.861 . . . . 0.0 108.519 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 mm -134.04 127.36 51.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 124.502 1.121 . . . . 0.0 108.301 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.02 108.86 0.37 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 172.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 t -126.71 155.01 43.36 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.704 -0.88 . . . . 0.0 108.666 161.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -114.91 147.78 39.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.62 ' HA ' HD21 ' A' ' 25' ' ' ASN . 1.2 p -116.24 115.22 25.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -169.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -142.8 123.76 14.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.3 p -140.83 124.7 17.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -165.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -137.09 90.58 2.54 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -125.79 120.96 31.96 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 p -65.55 155.82 34.54 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.706 2.002 . . . . 0.0 110.457 -170.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 . . . . . 0 N--CA 1.448 -0.54 0 CA-C-O 122.242 1.02 . . . . 0.0 108.694 166.365 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -70.89 62.49 0.28 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.566 1.947 . . . . 0.0 111.551 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -86.28 167.43 14.83 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.643 1.577 . . . . 0.0 110.589 -171.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 m120 50.41 -163.1 0.05 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.076 1.35 . . . . 0.0 110.032 -165.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -147.15 169.02 20.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.69 1.196 . . . . 0.0 109.599 -164.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -78.42 158.58 28.67 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.224 1.01 . . . . 0.0 108.686 159.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -135.87 117.74 15.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 161.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.49 154.1 16.63 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 170.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 tt -142.16 112.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.1 p -128.58 126.85 41.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.38 155.67 43.3 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.12 165.45 38.77 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 171.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CB ' HD12 ' A' ' 37' ' ' LEU . 3.6 Cg_endo -66.98 168.58 16.88 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 CA-C-N 119.622 1.711 . . . . 0.0 109.572 156.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.01 154.9 19.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 159.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -93.02 154.81 17.91 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 152.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -140.42 96.71 3.08 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.89 -55.5 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 118.039 0.381 . . . . 0.0 110.294 -170.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -79.17 178.53 7.99 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.983 1.313 . . . . 0.0 108.67 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.91 47.48 1.26 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.29 1.036 . . . . 0.0 110.333 172.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 22.2 p-90 -156.16 -57.93 0.09 Allowed 'General case' 0 CA--C 1.529 0.152 0 O-C-N 120.975 -1.078 . . . . 0.0 110.15 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.43 154.02 44.23 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.999 0.92 . . . . 0.0 108.674 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -147.67 168.35 22.27 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.911 0.884 . . . . 0.0 110.609 -176.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -128.15 146.33 33.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -175.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -150.44 158.96 44.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.367 0.667 . . . . 0.0 109.773 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.3 129.87 7.32 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.45 151.89 6.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.17 159.79 13.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 123.843 0.857 . . . . 0.0 109.396 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 157.52 -136.39 4.84 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.55 151.06 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -166.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.89 158.38 22.25 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 161.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -149.45 160.34 43.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.122 1.769 . . . . 0.0 107.777 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.58 172.91 33.55 Favored Glycine 0 C--N 1.331 0.282 0 O-C-N 120.861 -1.149 . . . . 0.0 111.562 175.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? . . . . . 0 CA--C 1.52 -0.173 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 171.48 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.55 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -151.52 171.64 17.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.77 0.714 . . . . 0.0 110.918 166.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -102.94 94.87 5.79 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -83.89 130.95 10.06 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -74.13 150.58 40.4 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.084 0.942 . . . . 0.0 109.162 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.0 m -131.35 135.98 47.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -155.42 95.72 1.72 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -172.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.01 169.57 13.59 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 125.06 1.314 . . . . 0.0 111.293 -169.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.02 156.76 32.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.817 1.247 . . . . 0.0 108.747 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.487 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -159.4 150.34 20.71 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 173.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.487 HD22 ' C ' ' A' ' 112' ' ' GLY . 3.8 mm? -138.26 139.75 39.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 -169.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -136.66 139.55 42.1 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.954 0.797 . . . . 0.0 110.199 -169.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -118.94 171.19 8.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.334 1.454 . . . . 0.0 108.208 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -59.89 114.6 10.1 Favored Pre-proline 0 N--CA 1.456 -0.152 0 C-N-CA 125.546 1.539 . . . . 0.0 107.912 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -81.48 122.81 4.15 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.468 1.446 . . . . 0.0 109.323 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.1 ttm -170.53 149.68 3.3 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.143 2.177 . . . . 0.0 107.051 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 117.3 12.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 131.23 3.812 . . . . 0.0 109.409 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 62.03 28.81 17.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.098 1.759 . . . . 0.0 111.196 -160.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.09 145.99 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.696 1.198 . . . . 0.0 108.4 156.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.38 163.13 23.06 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 120.183 -1.573 . . . . 0.0 109.927 149.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -118.99 113.56 21.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 158.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -148.36 149.54 31.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -129.45 151.71 49.78 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.31 0.959 . . . . 0.0 109.997 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.9 m -136.31 145.92 46.03 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.903 0.881 . . . . 0.0 110.729 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -138.76 148.38 43.8 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.671 1.988 . . . . 0.0 107.473 162.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -137.25 147.94 46.09 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 165.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -132.0 129.15 39.75 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 169.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.6 m -140.36 154.34 46.71 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.536 1.134 . . . . 0.0 108.098 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -121.6 98.13 5.82 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 121.449 -0.782 . . . . 0.0 109.388 -171.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.1 mm -66.0 91.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 67.27 -79.67 0.04 OUTLIER 'General case' 0 C--O 1.232 0.146 0 C-N-CA 127.924 2.49 . . . . 0.0 109.144 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.2 p -134.4 -2.16 2.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.12 1.368 . . . . 0.0 111.92 -170.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.17 149.31 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.366 1.066 . . . . 0.0 108.222 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.62 156.52 25.09 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.6 t -142.61 143.45 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 163.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -140.86 128.18 3.67 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -126.08 142.72 51.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -169.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -134.26 119.18 18.41 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 -165.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.1 mp -128.67 136.64 59.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.18 157.95 18.08 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -127.37 65.27 0.57 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.7 m -124.76 -176.35 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.519 1.527 . . . . 0.0 110.652 -164.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.27 -84.14 0.17 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 117.001 1.56 . . . . 0.0 117.001 174.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.496 ' CD1' HG11 ' A' ' 5' ' ' VAL . 19.6 p90 -163.32 177.41 8.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.699 2.799 . . . . 0.0 107.976 177.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -132.61 140.53 48.27 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 119.33 -2.106 . . . . 0.0 110.092 161.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 128.509 2.723 . . . . 0.0 113.367 169.05 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 t -142.1 165.75 26.59 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 121.32 -0.863 . . . . 0.0 108.816 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 m -134.06 140.86 46.93 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.3 t -157.75 161.1 38.46 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 120.424 -1.422 . . . . 0.0 107.545 -171.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.75 119.77 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -160.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 p -135.49 155.36 50.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.469 1.128 . . . . 0.0 110.456 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.14 -159.2 30.9 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -164.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.03 -127.06 7.48 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -164.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -134.72 149.15 50.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.682 0.793 . . . . 0.0 109.061 -171.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.28 113.83 21.46 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 105.474 -2.046 . . . . 0.0 105.474 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -124.96 123.52 40.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -162.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.3 t -139.29 140.5 37.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.936 1.295 . . . . 0.0 107.75 -163.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -138.96 157.94 45.11 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.378 1.071 . . . . 0.0 110.746 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' A' ' 137' ' ' VAL . . . -94.17 165.05 12.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.406 1.082 . . . . 0.0 111.73 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -73.59 61.08 0.7 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.463 1.105 . . . . 0.0 110.318 168.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.65 104.02 0.28 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -53.74 96.32 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.326 2.251 . . . . 0.0 111.357 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 96.7 mtp -149.35 -56.4 0.19 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.906 2.082 . . . . 0.0 107.834 173.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.15 111.94 19.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.148 1.379 . . . . 0.0 109.231 -170.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.57 150.33 41.04 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 45.6 mtt -115.42 143.41 45.34 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.096 1.759 . . . . 0.0 107.01 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.26 168.05 40.62 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 126.601 2.048 . . . . 0.0 108.055 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.83 -85.03 0.1 OUTLIER Glycine 0 C--O 1.225 -0.41 0 N-CA-C 107.916 -2.073 . . . . 0.0 107.916 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.46 ' H ' ' HB3' ' A' ' 45' ' ' TYR . 7.0 m-85 -146.36 172.07 14.05 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.635 1.974 . . . . 0.0 108.633 173.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -125.35 152.76 44.32 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 160.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 tp -145.74 140.26 27.07 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.675 0.671 . . . . 0.0 109.358 161.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -138.98 163.21 32.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.167 1.387 . . . . 0.0 107.523 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -143.39 140.24 30.37 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -132.78 144.04 49.98 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -117.27 147.16 42.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 161.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.87 136.69 32.58 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 156.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -86.73 179.13 6.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.28 2.232 . . . . 0.0 111.232 -166.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.81 -22.67 14.32 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.442 -0.786 . . . . 0.0 112.071 165.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -104.62 5.25 33.54 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.106 1.362 . . . . 0.0 113.209 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -153.44 104.02 2.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.94 1.696 . . . . 0.0 106.81 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.05 78.29 3.22 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.993 2.462 . . . . 0.0 109.463 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 tp -149.78 131.71 15.2 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.084 0.954 . . . . 0.0 109.748 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.16 176.75 18.74 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 168.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 m -137.11 160.48 36.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 125.938 1.695 . . . . 0.0 108.988 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mm -140.17 109.74 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.387 1.475 . . . . 0.0 107.729 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.69 167.06 33.27 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 153.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p -125.5 151.54 46.16 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 118.685 1.242 . . . . 0.0 108.804 146.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.61 148.89 27.77 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.905 1.23 . . . . 0.0 109.206 156.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -94.11 148.97 21.66 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 162.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.46 ' HB3' ' H ' ' A' ' 24' ' ' PHE . 3.8 t80 -143.08 110.08 5.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.289 1.404 . . . . 0.0 108.161 176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.8 p -101.97 120.57 40.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 121.191 1.814 . . . . 0.0 111.224 -166.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -162.61 76.75 0.45 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.057 1.343 . . . . 0.0 108.289 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -162.42 114.15 1.61 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 164.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 155.57 39.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.845 1.202 . . . . 0.0 110.225 174.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 123.235 1.493 . . . . 0.0 107.961 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -67.26 105.11 1.64 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.645 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -143.85 114.67 7.73 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.598 1.09 . . . . 0.0 108.669 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 151.56 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.024 2.93 . . . . 0.0 106.482 -164.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.8 170.46 8.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.704 1.602 . . . . 0.0 107.69 -162.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -76.81 143.05 40.04 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.9 -1.125 . . . . 0.0 109.719 166.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -141.63 118.35 11.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.735 1.614 . . . . 0.0 107.018 161.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.89 158.09 28.8 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.454 -1.859 . . . . 0.0 108.454 162.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.39 143.77 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 169.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 84' ' ' GLY . 89.5 m -139.67 148.05 41.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 161.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.96 150.03 28.82 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.386 0.674 . . . . 0.0 110.897 -164.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.02 163.52 12.85 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.94 1.733 . . . . 0.0 110.861 166.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.68 172.46 15.73 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.736 2.291 . . . . 0.0 110.526 168.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.62 153.89 47.44 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.484 1.114 . . . . 0.0 109.81 163.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -151.17 151.54 32.06 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -164.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -82.07 149.91 27.8 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.127 0.571 . . . . 0.0 109.634 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 73' ' ' ILE . 3.2 mp -78.55 -103.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 162.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.02 0.73 1.4 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.218 1.372 . . . . 0.0 112.881 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -113.77 -118.99 0.31 Allowed 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -129.87 -9.31 4.43 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -165.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.53 159.7 30.12 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 121.606 2.003 . . . . 0.0 109.578 164.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.6 m -135.86 125.06 24.56 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -136.84 147.09 27.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.49 174.74 12.17 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.385 1.474 . . . . 0.0 109.413 171.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.16 138.8 14.12 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 168.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.9 m -131.4 159.42 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.214 1.007 . . . . 0.0 110.222 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.28 135.42 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 C-N-CA 125.136 1.374 . . . . 0.0 109.495 -168.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 66' ' ' THR . . . -128.3 168.05 20.31 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 123.922 0.763 . . . . 0.0 113.137 -169.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.88 150.79 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 127.386 2.274 . . . . 0.0 106.894 170.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.49 158.69 22.23 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 161.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.4 116.86 21.12 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.612 0.765 . . . . 0.0 109.978 173.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.06 112.52 3.6 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 167.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt . . . . . 0 N--CA 1.47 0.532 0 CA-C-N 118.749 1.275 . . . . 0.0 112.093 175.678 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.83 0.824 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -155.83 166.67 32.79 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.489 1.116 . . . . 0.0 108.885 -171.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -78.87 131.35 36.41 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.546 0.738 . . . . 0.0 110.152 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.05 82.52 0.4 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -73.14 151.17 41.67 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 118.585 1.192 . . . . 0.0 108.323 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.9 p -146.44 162.64 37.83 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.962 0.905 . . . . 0.0 110.827 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -141.27 155.11 46.03 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.68 -146.84 7.05 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.47 158.93 43.32 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.853 0.861 . . . . 0.0 110.317 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -136.35 133.68 6.72 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.64 143.47 14.63 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.992 0.396 . . . . 0.0 110.019 -170.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -142.91 145.15 32.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.944 0.878 . . . . 0.0 111.572 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -139.73 111.63 7.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 166.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 117.3 61.2 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.64 -33.78 2.19 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.336 1.358 . . . . 0.0 110.868 172.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.5 mtt -157.89 159.27 36.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.975 0.91 . . . . 0.0 111.124 -165.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -91.65 42.61 1.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 126.09 1.756 . . . . 0.0 109.658 -174.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.538 ' HA ' ' CD2' ' A' ' 146' ' ' TYR . 23.3 p30 -160.7 -14.21 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.623 1.969 . . . . 0.0 111.269 -174.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.93 117.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 165.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.81 163.85 18.52 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 160.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.6 114.74 10.85 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 161.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.35 149.66 47.91 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 127.887 2.475 . . . . 0.0 107.06 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -129.66 151.44 50.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.2 m -145.52 166.32 26.04 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 145.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -143.41 145.75 32.89 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 160.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -138.13 159.86 40.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 119.734 1.152 . . . . 0.0 110.056 160.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -122.83 114.9 21.13 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.758 1.223 . . . . 0.0 109.596 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.5 p -100.88 130.57 46.91 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.779 2.032 . . . . 0.0 112.538 -171.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.81 111.89 24.31 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.44 81.55 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 171.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 53.8 -102.32 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.956 1.702 . . . . 0.0 108.508 -164.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m -105.29 3.52 30.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.27 1.028 . . . . 0.0 112.221 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.2 t -82.66 110.96 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 173.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -92.89 126.85 38.17 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 14' ' ' ALA . 4.5 t -133.78 146.75 31.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 171.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.69 150.53 18.7 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 169.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -122.87 146.5 47.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -135.84 123.67 22.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 167.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.8 pt -116.93 139.79 42.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -168.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.22 134.94 33.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -120.27 74.55 0.32 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.43 168.03 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.708 1.203 . . . . 0.0 108.747 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.56 -105.07 0.25 Allowed Glycine 0 C--O 1.227 -0.344 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.538 ' CD2' ' HA ' ' A' ' 120' ' ' ASN . 0.3 OUTLIER -161.39 167.62 25.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.063 2.545 . . . . 0.0 107.624 -170.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -138.78 158.29 44.49 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.362 -1.461 . . . . 0.0 108.853 166.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 126.408 1.883 . . . . 0.0 109.766 -175.337 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.431 HG23 HH21 ' A' ' 147' ' ' ARG . 52.6 m -145.89 157.8 43.89 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 168.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 m -127.16 140.13 52.47 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 167.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 m -148.22 129.72 14.89 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 120.244 -1.535 . . . . 0.0 107.35 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.583 HG23 ' H ' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -108.93 138.41 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.165 1.386 . . . . 0.0 108.505 173.764 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 p -157.2 117.72 3.55 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.8 2.04 . . . . 0.0 105.581 -169.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -173.18 165.64 37.88 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.39 -127.14 1.39 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -147.7 158.39 43.99 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.335 1.068 . . . . 0.0 110.698 -169.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.15 154.66 48.12 Favored 'General case' 0 C--N 1.335 -0.051 0 C-N-CA 125.129 1.372 . . . . 0.0 110.133 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -113.0 104.84 12.8 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 162.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -85.05 124.54 31.86 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 166.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.97 163.72 12.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.533 1.533 . . . . 0.0 107.412 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.57 161.96 37.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -55.6 81.37 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.911 1.684 . . . . 0.0 113.089 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.67 -15.23 5.21 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.593 1.568 . . . . 0.0 112.458 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -132.95 93.66 3.23 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.68 1.229 . . . . 0.0 108.48 172.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -90.27 60.02 4.6 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 129.437 3.095 . . . . 0.0 109.585 173.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -137.03 -178.47 5.21 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.887 1.275 . . . . 0.0 110.662 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -89.22 84.32 6.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.526 1.93 . . . . 0.0 107.116 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.5 ttm -92.52 147.83 22.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 153.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.9 -160.83 30.31 Favored Glycine 0 C--O 1.228 -0.252 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.21 -155.44 7.57 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 105.646 -2.982 . . . . 0.0 105.646 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.73 145.28 25.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.442 ' ND2' HD13 ' A' ' 141' ' ' ILE . 1.2 t30 -95.01 135.87 36.02 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 103.671 -2.714 . . . . 0.0 103.671 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.2 tp -145.97 116.71 7.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.16 140.96 48.76 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -137.56 121.41 17.6 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.96 143.08 45.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -118.53 158.14 25.95 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.462 1.905 . . . . 0.0 108.263 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -125.56 143.04 51.19 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.531 -1.356 . . . . 0.0 107.787 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -114.65 159.3 20.65 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.051 0.94 . . . . 0.0 108.78 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -95.19 15.26 19.63 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.123 -0.986 . . . . 0.0 111.701 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.41 0.73 2.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.698 1.199 . . . . 0.0 113.865 -172.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.4 125.3 3.02 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.124 168.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -72.46 79.91 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.547 3.498 . . . . 0.0 109.027 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.1 tp -150.42 155.81 40.27 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.589 1.556 . . . . 0.0 107.39 -160.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.24 -175.84 14.03 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 161.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.15 162.41 39.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 127.749 2.42 . . . . 0.0 106.218 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.8 mm -114.82 120.29 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.33 108.8 1.05 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 105.308 -3.117 . . . . 0.0 105.308 155.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -122.36 153.36 39.11 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 158.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -144.16 122.86 12.57 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.409 1.883 . . . . 0.0 107.098 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.9 m -127.59 125.18 39.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 172.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -91.49 158.41 16.49 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.653 1.981 . . . . 0.0 106.928 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -105.22 130.93 53.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -144.6 141.23 29.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.133 2.173 . . . . 0.0 107.152 166.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -175.54 147.92 0.88 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.601 2.36 . . . . 0.0 105.791 163.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -66.54 105.2 1.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 166.21 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -84.02 124.33 30.96 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.298 -0.876 . . . . 0.0 110.335 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -132.51 168.71 17.73 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.024 0.529 . . . . 0.0 109.776 166.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 m120 49.79 172.14 0.01 OUTLIER 'General case' 0 C--O 1.239 0.532 0 C-N-CA 128.49 2.716 . . . . 0.0 111.75 -155.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -123.5 147.58 47.08 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 120.968 -1.083 . . . . 0.0 110.284 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -76.11 128.37 34.84 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -109.81 117.83 34.88 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.7 89.41 0.29 Allowed Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -161.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.2 pp -109.47 141.55 24.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.762 0.791 . . . . 0.0 110.455 -166.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -111.38 148.45 33.01 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 170.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.95 159.02 43.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.359 0.6 . . . . 0.0 109.55 163.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.13 164.99 10.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.045 1.307 . . . . 0.0 110.626 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.88 144.47 53.51 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.962 2.442 . . . . 0.0 111.553 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.03 122.59 33.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 160.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -79.44 126.99 31.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 167.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -69.78 128.77 37.56 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 74' ' ' ASN . 6.7 tt -76.42 -178.85 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.709 0.766 . . . . 0.0 109.954 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.417 ' H ' HG12 ' A' ' 73' ' ' ILE . 7.9 t30 -60.9 -0.04 0.26 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.279 2.232 . . . . 0.0 115.963 -170.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -136.21 -87.52 0.33 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 120.2 1.364 . . . . 0.0 110.056 168.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.78 70.21 0.63 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.091 1.314 . . . . 0.0 109.958 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.16 -169.04 3.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.477 1.911 . . . . 0.0 107.296 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 t -122.43 170.16 10.25 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.903 1.681 . . . . 0.0 110.496 -162.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.83 167.99 25.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 121.528 -0.733 . . . . 0.0 111.696 -176.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -104.27 123.98 48.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.903 2.081 . . . . 0.0 109.134 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.17 73.62 0.02 OUTLIER Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.71 171.89 13.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 117.863 0.831 . . . . 0.0 109.66 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.14 130.42 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.37 148.16 18.92 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 170.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.9 132.3 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 165.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.76 152.89 18.72 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 162.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.58 165.2 29.35 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.597 0.759 . . . . 0.0 109.094 163.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.26 -167.95 43.93 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 113.634 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 122.837 1.303 . . . . 0.0 108.01 -163.405 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.29 176.69 9.54 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.971 1.308 . . . . 0.0 108.999 159.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -115.9 166.91 11.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 150.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.17 122.39 1.45 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -73.91 152.32 40.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.635 1.174 . . . . 0.0 109.754 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.5 t -134.44 143.65 47.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.891 0.876 . . . . 0.0 110.293 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -80.48 99.48 8.04 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.82 125.51 7.11 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.65 145.29 32.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.085 1.754 . . . . 0.0 107.439 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.32 148.63 8.58 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.521 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -139.43 142.63 37.43 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.555 2.342 . . . . 0.0 107.878 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -105.69 160.92 14.84 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.222 1.809 . . . . 0.0 109.82 169.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -91.65 171.69 8.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -57.1 111.43 3.36 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.491 1.116 . . . . 0.0 108.472 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -85.17 162.95 11.47 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.422 2.081 . . . . 0.0 111.971 -168.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 68.3 mtm -154.28 171.47 19.19 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 128.804 2.842 . . . . 0.0 108.649 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -44.12 -55.19 4.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 131.396 3.878 . . . . 0.0 109.77 -164.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.414 ' HB2' ' CD1' ' A' ' 146' ' ' TYR 0.3 0.2 OUTLIER -132.28 37.53 3.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.198 0.523 . . . . 0.0 110.224 171.739 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.46 110.22 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.81 157.53 40.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 161.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.674 HD13 HG12 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -133.7 132.25 40.41 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 102.752 -3.055 . . . . 0.0 102.752 176.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -140.32 128.97 22.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.54 1.064 . . . . 0.0 109.824 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -136.41 145.99 45.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.376 1.07 . . . . 0.0 108.135 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.75 166.74 25.0 Favored 'General case' 0 C--O 1.239 0.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.127 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.42 ' HB3' ' CE3' ' A' ' 140' ' ' TRP . 42.5 p90 -142.66 118.39 10.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 169.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.87 108.43 9.4 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -99.5 132.97 44.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.5 p -129.85 159.41 36.65 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.591 1.157 . . . . 0.0 109.951 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 47.8 mtt-85 -122.2 98.0 5.73 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.485 0.659 . . . . 0.0 109.466 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 10.9 mm -82.41 81.12 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.384 1.073 . . . . 0.0 108.165 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 64.14 -55.87 0.24 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.692 2.797 . . . . 0.0 114.08 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.3 t -149.85 -0.94 0.44 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.587 1.555 . . . . 0.0 110.546 169.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.18 135.66 24.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.9 137.17 32.57 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.0 t -139.33 108.0 3.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.039 1.336 . . . . 0.0 108.674 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.08 151.76 35.58 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 167.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 t -140.38 153.31 46.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 146.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.42 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 7.4 m95 -137.86 110.79 7.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 172.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.442 HD13 ' ND2' ' A' ' 25' ' ' ASN . 1.9 pp -81.72 154.57 4.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.0 166.41 22.47 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 163.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -176.57 167.46 38.96 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.674 HG12 HD13 ' A' ' 123' ' ' LEU . 1.5 m -144.35 148.7 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -163.16 -145.72 4.46 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.583 ' H ' HG23 ' A' ' 5' ' ' VAL . 8.1 m-85 -136.23 158.73 43.72 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.901 2.081 . . . . 0.0 108.395 -163.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.431 HH21 HG23 ' A' ' 2' ' ' THR . 0.8 OUTLIER -145.68 112.1 5.81 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.713 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 124.576 1.151 . . . . 0.0 108.367 178.362 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 t -151.05 158.14 43.71 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.384 1.074 . . . . 0.0 108.601 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.05 114.93 17.71 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 124.045 1.879 . . . . 0.0 109.038 168.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m -89.06 103.54 16.15 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -92.31 100.13 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 p -126.26 160.95 28.9 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.51 0.671 . . . . 0.0 111.15 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.95 178.41 48.16 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.51 -151.57 23.31 Favored Glycine 0 C--O 1.24 0.529 0 CA-C-N 118.741 1.27 . . . . 0.0 111.698 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.86 157.83 20.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.959 0.903 . . . . 0.0 109.151 -177.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.08 154.33 47.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.096 1.359 . . . . 0.0 108.355 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HG3' ' HA ' ' A' ' 20' ' ' LYS . 5.1 mp0 -124.98 104.19 8.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 167.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.2 t -84.87 115.02 22.53 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 159.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.83 155.11 49.56 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.576 1.15 . . . . 0.0 108.482 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -143.12 163.93 31.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 110.058 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 60.17 9.51 1.91 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.924 1.689 . . . . 0.0 114.023 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.72 94.72 0.35 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.417 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 3.7 pm0 -45.38 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.29 2.236 . . . . 0.0 111.588 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -148.82 -2.44 0.47 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -118.48 113.01 20.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 122.884 1.326 . . . . 0.0 114.316 -162.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.424 ' HA ' ' HG3' ' A' ' 11' ' ' GLN . 45.5 mtpt -66.68 96.12 0.38 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 161.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.5 mtt -133.14 103.95 6.26 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 167.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.46 -170.95 23.73 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 128.335 2.874 . . . . 0.0 106.545 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.15 -84.25 0.05 OUTLIER Glycine 0 C--N 1.328 0.108 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 -169.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.82 174.17 10.78 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.348 1.459 . . . . 0.0 108.17 163.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -138.59 152.32 48.05 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.824 1.249 . . . . 0.0 107.746 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.68 131.06 19.72 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.664 1.986 . . . . 0.0 106.035 166.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -122.54 133.8 54.56 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -156.45 108.62 2.53 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -171.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -142.04 163.06 33.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.973 0.892 . . . . 0.0 111.127 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -99.66 157.47 16.45 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.164 1.385 . . . . 0.0 108.369 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.24 147.95 50.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -172.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -75.89 166.34 23.65 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.617 1.567 . . . . 0.0 111.67 -159.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -112.66 40.95 2.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.551 1.167 . . . . 0.0 108.565 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -167.59 -75.42 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.32 162.42 66.5 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.016 0.926 . . . . 0.0 109.601 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.91 62.6 8.48 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.669 2.913 . . . . 0.0 108.99 165.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.8 tp -112.01 123.79 51.0 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.182 1.393 . . . . 0.0 107.539 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.39 176.88 16.26 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 56.2 t -126.03 155.88 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 tt -132.94 121.03 43.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.35 108.85 2.08 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 m -80.49 142.11 34.54 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.163 0.982 . . . . 0.0 109.19 161.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -143.29 125.76 15.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 167.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.6 t -118.17 150.92 38.59 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.995 0.816 . . . . 0.0 109.5 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -142.99 123.72 14.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.0 p -114.17 121.56 44.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.59 29.41 0.93 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.899 0.772 . . . . 0.0 110.275 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -103.85 147.1 27.7 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.701 2.001 . . . . 0.0 108.528 177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 m -122.6 154.95 37.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.811 1.645 . . . . 0.0 108.19 168.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HB3' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -130.46 96.96 4.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.14 0.427 . . . . 0.0 110.618 -171.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -84.1 174.24 10.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 165.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.44 -86.37 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 128.937 2.895 . . . . 0.0 103.981 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -170.14 78.85 0.09 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 129.013 2.925 . . . . 0.0 104.192 167.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.6 m -162.99 -43.24 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.119 1.768 . . . . 0.0 109.913 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.46 38.06 1.52 Allowed Glycine 0 CA--C 1.535 1.294 0 N-CA-C 114.488 0.555 . . . . 0.0 114.488 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.6 91.73 3.43 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 120.948 -1.325 . . . . 0.0 107.551 171.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -110.89 76.38 0.97 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.479 1.133 . . . . 0.0 110.459 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -51.94 93.11 0.01 OUTLIER 'General case' 0 C--O 1.237 0.433 0 C-N-CA 128.221 2.609 . . . . 0.0 113.655 -167.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.02 168.35 16.02 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.522 -0.736 . . . . 0.0 109.632 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t30 61.58 176.9 0.12 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.774 1.23 . . . . 0.0 110.591 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -129.23 154.31 46.92 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 166.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.36 159.12 24.45 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -141.16 135.35 30.74 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.11 116.65 0.86 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -167.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.28 110.1 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.3 m -128.34 144.04 51.08 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.757 1.623 . . . . 0.0 107.848 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.96 167.61 24.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.285 1.034 . . . . 0.0 110.754 -172.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.42 174.0 34.57 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 128.137 2.78 . . . . 0.0 110.795 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 20.3 Cg_endo -85.75 -179.75 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.961 3.774 . . . . 0.0 110.8 171.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.97 135.1 35.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.856 1.662 . . . . 0.0 107.367 164.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -150.14 154.87 38.78 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.065 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -87.97 148.45 24.55 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.061 1.3 . . . . 0.0 111.145 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.406 HD12 ' H ' ' A' ' 73' ' ' ILE . 4.2 mp -69.91 -57.02 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -132.43 -75.9 0.5 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -165.55 74.98 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -130.89 -60.28 0.97 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.318 1.447 . . . . 0.0 109.175 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.84 164.6 32.34 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.653 1.181 . . . . 0.0 109.304 -174.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 p -125.44 109.46 12.75 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.054 1.341 . . . . 0.0 107.637 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.26 151.7 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -150.11 165.73 31.92 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.117 0.872 . . . . 0.0 110.86 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.37 139.18 21.44 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.58 152.21 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.43 1.115 . . . . 0.0 109.149 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.66 150.81 15.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.885 0.874 . . . . 0.0 109.193 -167.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.52 -165.7 27.31 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 123.306 0.479 . . . . 0.0 112.614 -168.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.53 150.33 18.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.73 1.212 . . . . 0.0 107.747 171.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.57 130.85 7.63 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.835 1.683 . . . . 0.0 109.159 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -127.57 117.51 22.18 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.246 1.418 . . . . 0.0 110.022 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.57 142.61 11.42 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 170.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.47 68.95 1.48 Allowed 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -70.16 -179.71 2.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.071 1.348 . . . . 0.0 111.011 -172.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -163.27 143.39 8.92 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.644 1.178 . . . . 0.0 109.15 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p -69.49 117.15 10.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.981 1.712 . . . . 0.0 106.701 171.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 20.9 m -118.13 49.7 1.23 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.424 1.09 . . . . 0.0 109.623 -168.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -148.59 -70.16 0.21 Allowed 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.907 1.683 . . . . 0.0 107.969 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -61.76 150.12 83.02 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 124.046 0.938 . . . . 0.0 110.305 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.99 77.84 1.88 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.898 3.065 . . . . 0.0 110.197 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.3 m -156.24 -28.27 0.1 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.932 2.093 . . . . 0.0 109.075 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 50.57 -150.77 0.23 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.647 1.579 . . . . 0.0 110.528 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -54.72 120.91 7.44 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 120.929 -1.107 . . . . 0.0 108.543 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -80.18 -91.8 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -141.73 24.06 2.06 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.09 1.756 . . . . 0.0 110.843 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 p -70.09 155.3 40.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.055 0.942 . . . . 0.0 112.134 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.7 t 132.67 104.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 1 C-N-CA 131.997 4.119 . . . . 0.0 107.192 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -159.71 174.79 14.01 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 165.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -124.02 159.8 29.05 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.906 1.683 . . . . 0.0 107.737 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.11 137.49 9.41 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -75.78 102.21 5.37 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -67.39 135.03 52.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -148.12 171.47 15.83 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 121.929 -0.482 . . . . 0.0 110.047 168.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.18 -149.63 20.89 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.09 148.16 48.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.335 1.054 . . . . 0.0 109.602 174.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.23 124.11 7.68 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.03 139.42 49.88 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -170.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -138.48 129.9 27.48 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -92.83 171.59 8.88 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.149 0.5 . . . . 0.0 110.112 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -66.2 117.0 38.9 Favored Pre-proline 0 C--O 1.241 0.608 0 C-N-CA 123.95 0.9 . . . . 0.0 108.579 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.97 176.54 9.34 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.234 2.623 . . . . 0.0 112.0 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.14 -176.38 4.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.458 2.303 . . . . 0.0 107.49 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -91.14 -7.95 50.07 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.008 2.123 . . . . 0.0 110.121 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.72 12.18 0.25 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.99 1.716 . . . . 0.0 110.511 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.4 t -136.91 137.84 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.03 -1.669 . . . . 0.0 108.844 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -136.18 155.21 50.48 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -139.29 115.07 10.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.84 141.69 48.58 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 126.425 1.89 . . . . 0.0 106.646 -172.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -135.2 142.69 46.1 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 p -127.16 149.2 50.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 158.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.15 119.64 14.91 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 169.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -127.72 138.18 52.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -129.83 139.39 51.23 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.5 m -130.72 159.98 35.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.806 2.043 . . . . 0.0 107.186 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -132.33 145.62 51.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.19 95.95 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 75.27 -74.88 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.742 2.417 . . . . 0.0 111.512 165.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.7 m -148.75 27.05 0.9 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.432 1.493 . . . . 0.0 109.646 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.75 120.53 61.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 166.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.38 152.58 34.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.67 137.43 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 164.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.22 140.96 14.41 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 168.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.1 m -140.67 120.34 13.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 -105.03 153.16 21.83 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 166.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.7 mt -136.68 131.56 47.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.97 129.86 35.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -113.37 96.54 0.81 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.8 t -116.54 152.09 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 157.28 -143.01 9.1 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 106.429 -2.668 . . . . 0.0 106.429 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -121.76 176.87 5.51 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.604 1.962 . . . . 0.0 110.068 -166.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 129.95 13.44 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.283 171.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.5 p90 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 124.469 1.108 . . . . 0.0 108.37 175.231 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -92.4 151.09 20.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -143.46 107.09 4.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 162.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 t -138.83 150.91 46.56 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.089 0.947 . . . . 0.0 108.894 167.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.53 137.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 111.521 -2.581 . . . . 0.0 106.468 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.7 m -152.78 144.01 23.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.79 -178.55 44.75 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.74 -172.37 25.03 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.99 158.37 17.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.12 170.03 9.55 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.798 0.332 . . . . 0.0 110.722 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -140.99 113.04 7.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 156.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.5 t -84.75 151.3 24.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.062 0.934 . . . . 0.0 108.967 164.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -136.76 170.82 15.45 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.776 2.43 . . . . 0.0 107.863 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.19 159.5 42.1 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 161.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -75.63 64.77 1.73 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.707 1.203 . . . . 0.0 109.536 174.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 160.01 -37.95 0.46 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 126.855 2.169 . . . . 0.0 110.686 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -129.72 96.51 4.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.074 0.937 . . . . 0.0 109.758 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.5 mtt -78.3 58.15 2.04 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.637 0.732 . . . . 0.0 109.338 166.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -72.99 93.86 1.8 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 164.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.518 ' HD3' ' H ' ' A' ' 20' ' ' LYS . 0.5 OUTLIER -58.74 106.12 0.37 Allowed 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 81.9 mtp -136.06 109.69 8.03 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -169.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.07 -178.5 37.65 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.19 -128.67 0.96 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 104.86 -3.296 . . . . 0.0 104.86 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.89 150.25 37.36 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -122.04 162.77 20.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.62 1.968 . . . . 0.0 107.529 173.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -147.6 167.84 23.52 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -138.11 159.99 40.56 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.245 1.018 . . . . 0.0 108.894 170.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -136.19 141.57 44.04 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.517 2.327 . . . . 0.0 106.377 164.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.71 160.33 23.55 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 160.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -131.96 156.45 46.16 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.394 1.478 . . . . 0.0 107.328 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -98.25 140.16 32.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.667 0.746 . . . . 0.0 109.258 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.05 156.96 23.17 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 127.008 2.123 . . . . 0.0 107.19 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -133.26 71.66 1.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.96 -37.97 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.823 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -162.41 153.95 15.36 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 124.36 1.064 . . . . 0.0 109.207 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.56 88.42 1.42 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.376 2.717 . . . . 0.0 109.21 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 37' ' ' LEU . 17.9 tp -143.74 156.94 44.68 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 128.314 2.645 . . . . 0.0 105.791 172.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.89 175.89 21.55 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 91.1 t -124.61 157.21 32.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 118.189 0.994 . . . . 0.0 111.198 -168.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.75 141.53 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 126.779 2.032 . . . . 0.0 106.86 161.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.81 108.95 0.39 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 p -124.87 154.22 41.38 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.276 1.03 . . . . 0.0 110.613 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -131.66 122.45 25.98 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -170.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.8 p -95.47 146.8 24.15 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -171.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.98 154.95 50.92 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.623 1.169 . . . . 0.0 109.411 -178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.1 m -132.43 130.51 40.67 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.863 1.211 . . . . 0.0 112.564 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -110.95 -14.18 13.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.639 1.176 . . . . 0.0 112.856 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -66.42 145.73 55.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.813 0.845 . . . . 0.0 110.585 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 p -74.92 144.36 43.32 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.922 0.783 . . . . 0.0 109.405 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -80.24 141.38 35.63 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 158.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -148.32 118.15 7.12 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 161.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.26 -87.31 0.19 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 t -160.55 79.46 0.65 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 171.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m 57.41 84.85 0.09 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.643 1.177 . . . . 0.0 110.538 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.05 -40.32 0.05 OUTLIER Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.602 159.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -120.13 96.01 4.98 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.603 1.561 . . . . 0.0 107.5 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -131.58 81.1 1.96 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.441 -0.787 . . . . 0.0 109.513 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.49 -60.19 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.922 0.889 . . . . 0.0 110.216 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -102.46 133.07 48.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 122.0 -0.437 . . . . 0.0 110.543 -159.109 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -146.46 19.25 1.35 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -166.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -110.21 128.15 55.34 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 120.986 1.721 . . . . 0.0 107.855 -158.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -152.5 119.98 5.99 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.02 116.86 29.13 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.06 131.53 10.82 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 158.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.3 mt -119.68 109.54 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 167.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 8.9 t -120.01 147.59 44.61 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.554 2.342 . . . . 0.0 108.166 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.28 172.76 15.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.492 1.517 . . . . 0.0 109.188 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.44 175.59 43.92 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 161.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -74.33 175.75 10.57 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.471 2.114 . . . . 0.0 110.235 160.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.39 109.21 8.08 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.619 1.967 . . . . 0.0 108.085 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.37 130.25 35.25 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -111.38 118.45 35.87 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 170.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.06 -65.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -167.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -135.72 -79.31 0.42 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 161.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -158.69 80.52 0.8 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.049 1.295 . . . . 0.0 110.996 167.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -129.55 -40.51 1.41 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.28 1.432 . . . . 0.0 109.783 164.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.37 174.0 13.86 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.472 1.109 . . . . 0.0 109.733 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 t -148.87 105.26 3.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.11 156.5 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.795 0.838 . . . . 0.0 110.794 -172.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -151.18 173.34 14.52 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.024 1.329 . . . . 0.0 111.624 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.71 114.93 4.94 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.969 1.747 . . . . 0.0 108.759 170.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -110.36 161.08 9.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.224 1.409 . . . . 0.0 110.917 -164.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 66' ' ' THR . 0.5 OUTLIER -140.39 165.36 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 C-N-CA 124.249 1.02 . . . . 0.0 110.578 -169.259 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.11 -164.71 30.23 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 p -148.55 137.88 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 169.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.97 108.92 2.24 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 127.575 2.512 . . . . 0.0 109.623 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.58 140.29 31.42 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.417 1.087 . . . . 0.0 108.594 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.3 160.36 27.84 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 118.446 0.566 . . . . 0.0 112.424 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -131.3 160.25 35.5 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.146 2.178 . . . . 0.0 106.502 173.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -127.94 170.01 13.32 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 159.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -148.52 144.45 27.33 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 173.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.4 m -120.28 132.57 55.38 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -164.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -132.56 32.33 3.9 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 125.39 1.476 . . . . 0.0 109.438 -161.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -150.6 -47.52 0.12 Allowed 'General case' 0 N--CA 1.462 0.165 0 O-C-N 120.939 -1.101 . . . . 0.0 110.111 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -68.38 153.2 95.95 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 121.898 -0.501 . . . . 0.0 110.501 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.09 -7.26 19.34 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.338 2.692 . . . . 0.0 113.129 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -67.53 5.48 0.79 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.985 1.714 . . . . 0.0 113.084 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -24.59 -39.31 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 130.568 3.547 . . . . 0.0 116.755 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.96 65.54 9.28 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.793 -1.192 . . . . 0.0 108.528 169.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -116.02 109.11 17.08 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -114.84 142.76 46.13 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.596 -0.69 . . . . 0.0 110.705 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 81.4 p -138.42 158.08 44.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.769 1.628 . . . . 0.0 107.116 172.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.9 m -145.56 106.18 4.1 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -129.14 129.01 44.61 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -92.65 160.03 15.19 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 166.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.98 131.47 5.12 Favored Glycine 0 C--N 1.33 0.248 0 N-CA-C 107.959 -2.057 . . . . 0.0 107.959 170.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.49 126.38 30.9 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 m -92.58 131.25 37.85 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -146.22 133.02 20.03 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.05 -172.09 34.67 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.153 1.359 . . . . 0.0 111.144 -160.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.31 158.29 44.74 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.864 0.866 . . . . 0.0 110.555 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -134.21 104.75 0.53 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.074 1.321 . . . . 0.0 111.345 -168.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.4 148.3 37.9 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.62 1.568 . . . . 0.0 107.243 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.38 159.4 34.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.436 1.095 . . . . 0.0 108.816 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -133.91 159.19 41.44 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 126.461 1.904 . . . . 0.0 107.023 -171.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -56.38 114.75 8.31 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 123.779 0.832 . . . . 0.0 110.351 -158.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.43 171.61 11.0 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.281 3.321 . . . . 0.0 113.514 -168.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.9 mtm -145.85 177.68 8.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.175 2.19 . . . . 0.0 108.916 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -93.01 18.22 9.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.556 1.942 . . . . 0.0 112.995 -166.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.408 ' H ' ' H ' ' A' ' 121' ' ' VAL . 10.1 p-10 -174.68 -7.92 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.035 2.134 . . . . 0.0 111.643 -168.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.408 ' H ' ' H ' ' A' ' 120' ' ' ASN . 4.9 t -143.41 140.9 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 128.646 2.778 . . . . 0.0 103.551 -170.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.62 159.62 42.17 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -137.63 117.15 12.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.73 150.7 40.57 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 168.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -140.93 123.45 15.97 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.1 m -122.49 136.16 54.82 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -126.23 122.23 34.98 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.412 1.885 . . . . 0.0 106.98 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.83 157.05 42.6 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.662 1.185 . . . . 0.0 110.212 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -132.26 152.97 51.1 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.287 1.035 . . . . 0.0 108.479 172.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.3 t -141.17 160.51 39.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 127.402 2.281 . . . . 0.0 107.349 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -128.87 107.09 9.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.6 pt -137.04 151.78 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.809 1.244 . . . . 0.0 108.152 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.45 18.89 6.0 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.784 1.634 . . . . 0.0 112.292 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.9 m 53.48 34.54 18.53 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.887 1.221 . . . . 0.0 112.03 -164.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.39 149.31 23.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 122.019 0.914 . . . . 0.0 108.842 161.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.8 140.13 53.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 168.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -136.26 98.64 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.32 151.34 32.86 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -141.65 154.2 45.21 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 146.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -139.21 155.23 47.95 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 168.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.4 pt -121.3 140.24 45.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -173.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.04 135.07 33.58 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -113.44 121.77 5.59 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 106.509 -2.636 . . . . 0.0 106.509 170.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.81 148.16 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 129.387 3.075 . . . . 0.0 103.988 169.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.72 -125.46 1.37 Allowed Glycine 0 C--O 1.227 -0.322 0 CA-C-O 118.014 -1.437 . . . . 0.0 109.904 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.84 143.04 22.44 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 127.287 2.235 . . . . 0.0 106.625 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -136.68 96.29 3.3 Favored 'General case' 0 CA--C 1.518 -0.279 0 O-C-N 120.863 -1.148 . . . . 0.0 108.298 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 115.13 -2.367 . . . . 0.0 112.379 159.757 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.9 m -137.29 152.93 50.31 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 171.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -142.07 133.89 27.14 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 122.311 1.053 . . . . 0.0 108.66 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -152.44 145.46 24.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.69 132.09 64.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.8 p -137.82 130.41 29.62 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.75 159.13 23.13 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.84 -152.39 19.28 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 107.346 -2.302 . . . . 0.0 107.346 -164.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -99.85 153.27 19.28 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.357 0.579 . . . . 0.0 110.353 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.93 142.01 50.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 170.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.9 149.58 50.31 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.795 1.238 . . . . 0.0 108.514 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.7 m -137.27 121.53 18.05 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.396 1.079 . . . . 0.0 109.802 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -103.61 162.16 13.29 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.58 146.02 51.42 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 118.295 0.498 . . . . 0.0 110.854 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 61.6 -60.09 0.1 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 130.253 3.421 . . . . 0.0 112.018 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.83 -66.16 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 105.892 -2.883 . . . . 0.0 105.892 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.86 96.81 4.75 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.027 1.331 . . . . 0.0 109.231 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.5 ttt -152.91 -69.02 0.15 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.299 0.639 . . . . 0.0 109.553 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.83 146.6 19.34 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.971 0.908 . . . . 0.0 110.243 -172.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -120.33 154.54 34.88 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 124.99 1.316 . . . . 0.0 108.912 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.4 ptp -131.24 159.17 38.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.09 175.45 23.19 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.696 1.141 . . . . 0.0 111.064 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.8 -177.32 47.55 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 118.064 0.932 . . . . 0.0 111.29 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -99.83 147.87 25.04 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -137.91 150.73 47.33 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.921 1.688 . . . . 0.0 109.673 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mt -139.22 161.68 36.84 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 128.039 2.536 . . . . 0.0 108.619 171.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.49 176.43 12.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.27 1.828 . . . . 0.0 107.954 157.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -144.86 114.61 7.28 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 120.877 -1.139 . . . . 0.0 108.478 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 109.15 20.78 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -99.86 158.86 15.5 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.792 1.637 . . . . 0.0 109.224 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -115.2 152.31 32.87 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -121.28 166.76 13.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.021 1.329 . . . . 0.0 110.42 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -125.4 56.72 1.35 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.79 1.236 . . . . 0.0 108.071 -163.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.21 -47.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.181 1.392 . . . . 0.0 109.092 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.5 m -134.96 152.02 76.54 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.907 1.683 . . . . 0.0 107.899 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.84 13.2 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.939 3.759 . . . . 0.0 114.929 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 tp -87.24 118.91 26.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.157 1.783 . . . . 0.0 110.222 -165.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.22 177.27 49.0 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.1 t -133.87 145.27 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.172 1.389 . . . . 0.0 109.293 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 mp -139.68 131.91 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.469 1.908 . . . . 0.0 107.13 168.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.17 148.93 18.75 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 142.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 p -125.0 154.34 41.4 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.326 1.051 . . . . 0.0 110.515 165.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -112.77 148.97 33.67 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.318 1.047 . . . . 0.0 108.746 169.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 m -93.93 146.61 23.79 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.68 0.792 . . . . 0.0 109.218 165.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.424 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 48.5 m-85 -117.62 153.74 32.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.563 1.545 . . . . 0.0 108.593 166.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.85 143.21 34.31 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.008 0.822 . . . . 0.0 111.293 168.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.78 -11.49 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.012 2.525 . . . . 0.0 112.076 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.82 147.06 30.61 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.074 -1.641 . . . . 0.0 110.39 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.2 p -111.14 155.88 22.21 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.417 1.487 . . . . 0.0 109.132 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -129.96 130.71 45.4 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 162.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t 177.09 89.4 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -168.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.17 -59.64 3.07 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.278 -0.889 . . . . 0.0 109.403 171.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.9 m -148.27 -56.5 0.22 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 125.725 1.61 . . . . 0.0 107.431 169.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -161.99 102.14 1.13 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 102.704 -3.073 . . . . 0.0 102.704 173.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.05 -56.68 0.03 OUTLIER Glycine 0 CA--C 1.51 -0.267 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -119.75 115.31 23.64 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 162.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -94.37 152.73 18.41 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.343 1.457 . . . . 0.0 107.937 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.2 128.63 36.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.14 -0.975 . . . . 0.0 108.666 171.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -144.63 172.65 12.69 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 84.92 -177.69 0.03 OUTLIER 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.843 2.057 . . . . 0.0 109.018 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.83 169.84 14.08 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.657 1.583 . . . . 0.0 107.919 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.424 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 25.2 p90 -73.73 139.22 45.14 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 159.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -140.39 117.54 11.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 157.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.52 121.69 1.05 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.46 150.46 34.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.1 p -140.48 157.36 45.63 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.23 140.53 21.36 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.041 0.837 . . . . 0.0 111.158 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.523 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -176.02 160.19 28.05 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 156.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.19 -179.81 5.8 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.14 1.893 . . . . 0.0 111.668 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.56 146.02 41.26 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.208 1.403 . . . . 0.0 108.251 164.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -128.85 130.03 46.36 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -67.18 111.93 4.2 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.838 1.655 . . . . 0.0 109.301 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 tt -73.75 171.38 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.026 0.441 . . . . 0.0 109.875 -176.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -88.73 37.48 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.102 1.761 . . . . 0.0 110.091 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -149.51 -119.98 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.591 1.957 . . . . 0.0 105.73 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -128.67 66.25 1.41 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.506 1.922 . . . . 0.0 109.441 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.1 176.02 13.04 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.657 -1.277 . . . . 0.0 110.766 168.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 m -137.94 112.95 9.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 164.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.71 147.21 23.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -150.4 164.88 34.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 119.665 1.12 . . . . 0.0 110.564 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.69 129.99 9.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.523 HG12 ' HA3' ' A' ' 68' ' ' GLY . 32.6 m -126.92 -176.52 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 124.374 1.07 . . . . 0.0 111.166 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.86 165.56 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.677 1.991 . . . . 0.0 107.874 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.88 -172.26 31.14 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 162.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.51 138.97 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.47 139.13 10.72 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -132.66 116.98 17.31 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.583 1.953 . . . . 0.0 106.935 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.14 125.9 0.79 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -162.53 165.05 26.57 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 118.06 0.93 . . . . 0.0 109.523 165.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -60.63 161.42 7.77 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.369 1.467 . . . . 0.0 111.612 -175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -98.43 169.22 9.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 164.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.6 115.07 23.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.839 1.656 . . . . 0.0 106.722 172.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -146.79 64.18 1.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 123.03 1.395 . . . . 0.0 108.954 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.69 -32.28 72.82 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 120.818 -1.176 . . . . 0.0 111.377 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.26 155.54 79.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 126.039 1.735 . . . . 0.0 106.447 174.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.45 -13.75 41.4 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.413 2.075 . . . . 0.0 114.149 -170.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 p -76.13 -37.67 57.73 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.856 1.663 . . . . 0.0 111.764 172.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -72.56 114.59 10.85 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -163.03 117.27 1.67 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 171.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -160.66 127.39 4.17 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 155.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.71 125.57 28.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.926 0.89 . . . . 0.0 108.665 165.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.1 m -140.51 111.24 6.89 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.436 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.8 m -144.82 175.71 9.99 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.348 1.459 . . . . 0.0 109.618 161.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -144.22 164.83 29.6 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 127.214 2.205 . . . . 0.0 108.33 172.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -68.54 123.61 21.32 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -104.88 123.15 7.55 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 170.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -81.2 151.29 28.26 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.5 p -146.11 151.64 38.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -141.73 167.72 21.46 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.729 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 166.81 -172.7 42.04 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.8 149.55 31.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.628 0.714 . . . . 0.0 110.548 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.21 122.23 6.64 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 170.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -115.69 139.9 49.7 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -121.14 159.38 25.93 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.693 0.759 . . . . 0.0 109.886 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.5 170.54 8.0 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.825 1.65 . . . . 0.0 106.623 158.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -60.43 110.71 3.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.138 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.55 120.67 7.91 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.44 2.093 . . . . 0.0 108.805 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -177.06 164.7 2.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.932 1.242 . . . . 0.0 108.878 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 103.89 27.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.898 2.479 . . . . 0.0 109.051 154.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.2 m120 64.94 15.91 10.22 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.689 1.595 . . . . 0.0 110.961 -169.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.73 171.33 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.7 159.65 39.03 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.375 1.87 . . . . 0.0 105.956 163.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 123' ' ' LEU . 2.2 mm? -125.22 114.95 19.64 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 161.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -136.17 133.96 37.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 174.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -139.73 142.81 36.81 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 -172.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.8 m -146.53 165.26 29.99 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.592 -0.693 . . . . 0.0 111.318 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -140.0 129.26 23.88 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.727 2.411 . . . . 0.0 105.332 -171.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -137.81 108.2 6.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -99.22 111.61 23.95 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.1 m -76.82 150.88 36.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.452 0.701 . . . . 0.0 110.56 171.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.7 ptt85 -140.72 96.54 3.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.763 1.625 . . . . 0.0 106.91 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.2 mt -100.79 81.37 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 -175.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 56.75 -64.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 129.728 3.211 . . . . 0.0 113.575 -171.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 p -145.8 26.76 1.23 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.685 1.994 . . . . 0.0 110.107 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.8 t -123.27 103.4 12.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -82.3 131.99 35.23 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.7 101.18 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.73 115.43 4.34 Favored Glycine 0 C--O 1.242 0.604 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -174.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 57.4 m -107.85 142.29 38.14 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -141.72 141.3 33.27 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.0 pt -135.95 151.3 29.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.49 148.92 47.4 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.706 1.203 . . . . 0.0 108.57 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.36 94.53 0.2 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 124.924 1.249 . . . . 0.0 110.415 -169.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.25 171.87 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.552 1.941 . . . . 0.0 107.586 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.99 -116.12 0.7 Allowed Glycine 0 C--O 1.221 -0.666 0 O-C-N 119.913 -1.742 . . . . 0.0 108.87 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -163.81 163.42 23.9 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.958 1.879 . . . . 0.0 110.079 171.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -90.07 147.47 23.62 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.868 161.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 115.432 -2.223 . . . . 0.0 107.489 174.735 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.8 m -139.47 149.66 44.26 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m -106.73 107.09 17.93 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.435 1.494 . . . . 0.0 107.841 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.1 m -131.12 127.13 37.46 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.38 133.1 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 127.011 2.124 . . . . 0.0 105.915 -163.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.9 t -157.15 146.6 20.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.96 164.08 37.58 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.859 -1.697 . . . . 0.0 108.859 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.55 -154.72 23.54 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.77 159.33 41.67 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 109.142 -160.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.34 168.92 11.87 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.337 1.065 . . . . 0.0 113.767 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -125.0 117.49 24.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.407 1.483 . . . . 0.0 107.205 155.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.6 t -84.0 145.63 28.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 160.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -138.63 158.13 44.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.194 1.798 . . . . 0.0 107.944 -165.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.77 158.19 43.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 120.979 1.718 . . . . 0.0 111.31 159.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -78.76 56.76 1.94 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.685 0.755 . . . . 0.0 110.921 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.98 -39.13 0.2 Allowed Glycine 0 CA--C 1.519 0.282 0 O-C-N 120.06 -1.65 . . . . 0.0 110.434 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.55 96.36 2.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.681 0.753 . . . . 0.0 109.414 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.1 mtm -74.9 64.5 1.3 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.834 2.454 . . . . 0.0 108.195 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -66.33 102.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -64.17 98.04 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.881 1.272 . . . . 0.0 108.539 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 52.0 mtp -133.98 129.7 36.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.49 -145.47 4.13 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 170.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.04 -127.23 1.48 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 119.691 1.745 . . . . 0.0 110.668 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -132.58 121.17 22.83 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.983 1.313 . . . . 0.0 108.953 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -96.15 160.96 14.17 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.426 1.49 . . . . 0.0 110.107 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.95 139.86 29.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 162.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.33 149.81 49.82 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 118.775 0.716 . . . . 0.0 109.875 165.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -149.45 110.08 4.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.58 119.64 33.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.99 157.12 16.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -130.09 153.19 48.73 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.837 0.855 . . . . 0.0 109.481 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.43 172.24 9.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.704 0.801 . . . . 0.0 110.538 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -101.99 -26.31 13.45 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.752 -1.218 . . . . 0.0 109.719 161.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.65 -25.29 53.61 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.3 m -152.17 157.23 34.07 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.739 1.215 . . . . 0.0 109.508 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.42 21.4 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.354 3.369 . . . . 0.0 113.515 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.6 tp -91.45 136.53 33.05 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.153 -0.967 . . . . 0.0 109.248 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.12 -168.61 12.48 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.816 1.198 . . . . 0.0 111.299 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.95 148.14 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.437 1.095 . . . . 0.0 110.657 -172.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.3 mm -119.3 119.76 61.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 127.077 2.151 . . . . 0.0 107.936 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.04 119.9 1.05 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 106.759 -2.536 . . . . 0.0 106.759 164.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.82 149.75 42.89 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.421 1.888 . . . . 0.0 106.584 175.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -144.13 128.41 17.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.9 m -126.51 132.07 51.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 168.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -91.44 150.17 21.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.4 p -98.1 138.34 35.55 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.01 163.95 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.176 1.39 . . . . 0.0 109.65 163.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 113.79 4.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -170.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 m -115.73 103.75 10.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.382 1.087 . . . . 0.0 110.502 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HA ' ' H ' ' A' ' 58' ' ' ASN . 24.5 ptt-85 -71.51 111.31 6.71 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 129.344 3.057 . . . . 0.0 108.89 177.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -53.14 -37.45 61.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.679 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 49.85 60.88 3.49 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 125.539 1.536 . . . . 0.0 110.087 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 t -164.36 -88.92 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -59.68 -56.28 23.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.801 -0.619 . . . . 0.0 110.755 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.84 4.8 0.1 OUTLIER Glycine 0 C--N 1.343 0.93 0 CA-C-O 118.259 -1.3 . . . . 0.0 115.814 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -71.03 90.95 0.86 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.122 1.961 . . . . 0.0 108.015 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -82.89 78.56 9.46 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.404 ' H ' ' HA ' ' A' ' 50' ' ' ARG . 11.0 t-20 -81.2 92.11 6.26 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -160.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -155.77 116.35 3.79 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.071 0.948 . . . . 0.0 108.961 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -149.66 -160.88 1.23 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 160.043 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.475 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 10.2 pt20 -126.86 128.8 47.08 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 164.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -97.31 114.04 25.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.67 117.84 29.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.88 96.68 0.96 Allowed Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.0 141.31 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 t -133.65 157.39 45.88 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 171.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.28 138.98 20.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.588 -0.695 . . . . 0.0 111.411 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.86 166.15 32.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.753 1.644 . . . . 0.0 109.314 160.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.438 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 66.7 Cg_endo -73.88 -177.96 3.5 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.734 2.289 . . . . 0.0 112.538 171.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.55 128.77 44.92 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.708 2.003 . . . . 0.0 108.032 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.1 130.29 28.84 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 ttp-105 -80.4 89.93 5.6 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.8 pp -93.29 1.57 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.244 1.018 . . . . 0.0 112.054 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -128.49 -178.28 4.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.941 1.696 . . . . 0.0 107.244 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -52.0 -67.53 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.72 2.008 . . . . 0.0 109.255 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.42 42.83 2.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.965 2.106 . . . . 0.0 110.559 -169.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.31 151.71 33.35 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.68 141.53 49.6 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.384 1.074 . . . . 0.0 109.422 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.48 154.82 6.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.234 1.413 . . . . 0.0 107.391 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.438 ' CE2' ' HD2' ' A' ' 69' ' ' PRO . 36.0 t80 -149.81 150.68 32.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.166 1.386 . . . . 0.0 107.857 169.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.26 109.84 3.35 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.2 m -103.76 161.8 4.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.967 0.907 . . . . 0.0 109.876 -167.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 t -109.08 131.07 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -116.34 159.88 13.68 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.53 150.84 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 170.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.97 158.3 21.4 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.946 1.736 . . . . 0.0 109.774 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -140.91 127.7 20.4 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.26 -171.66 16.64 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.0 pttt 175.28 -2.48 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.709 2.403 . . . . 0.0 112.919 160.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.56 -153.66 0.52 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 80.17 -71.37 0.08 Allowed 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 126.645 1.978 . . . . 0.0 109.897 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 p -74.3 99.88 3.59 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.255 12.1 t -81.76 61.62 5.21 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 175.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.391 12.3 pt-20 59.04 -18.06 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 130.824 3.649 . . . . 0.0 118.078 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -39.95 -72.84 0.1 Allowed Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.608 1.563 . . . . 0.0 114.553 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.3 -54.33 0.86 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 CA-C-N 122.182 1.815 . . . . 0.0 113.669 -173.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.6 m -154.49 65.67 0.69 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.509 1.049 . . . . 0.0 111.761 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 64.86 169.66 0.19 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.53 1.132 . . . . 0.0 110.245 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -62.41 150.01 40.94 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 119.69 -1.881 . . . . 0.0 109.374 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -47.21 -57.85 4.71 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 125.147 1.529 . . . . 0.0 112.777 -170.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -167.01 -174.32 2.64 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.679 1.992 . . . . 0.0 106.448 160.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 p -111.43 92.77 4.17 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.972 -1.08 . . . . 0.0 108.764 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 m 49.5 66.89 0.99 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.106 1.362 . . . . 0.0 112.182 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -94.91 151.76 18.93 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 164.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -95.1 110.6 22.52 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.155 1.382 . . . . 0.0 107.819 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.13 98.44 0.56 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.22 133.78 42.7 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.391 1.096 . . . . 0.0 108.296 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 p -133.06 173.62 11.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.351 1.072 . . . . 0.0 111.659 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -161.78 163.69 29.34 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.254 1.822 . . . . 0.0 106.353 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 177.18 -162.28 30.31 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -140.88 130.55 24.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 167.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.6 142.19 15.97 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 172.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.35 140.52 51.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.39 1.876 . . . . 0.0 108.539 -168.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.68 159.82 35.26 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.816 1.246 . . . . 0.0 110.769 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -91.87 171.09 9.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 168.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -56.92 154.21 19.88 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.793 168.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.98 109.91 0.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.254 0 N-CA-C 107.647 -1.713 . . . . 0.0 107.647 162.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.1 mmt -81.08 -174.97 5.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.974 2.11 . . . . 0.0 107.095 153.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -117.69 -4.24 11.21 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.359 -1.463 . . . . 0.0 110.736 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -137.45 0.14 2.25 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 124.561 1.144 . . . . 0.0 111.316 166.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.77 147.08 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 120.363 -1.461 . . . . 0.0 107.69 -162.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -143.62 153.06 42.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.456 1.903 . . . . 0.0 106.846 167.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.479 HD13 HG12 ' A' ' 144' ' ' VAL . 2.3 mm? -133.78 130.46 38.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 172.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -146.59 129.79 16.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 119.211 0.914 . . . . 0.0 109.176 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -149.65 151.9 34.5 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.512 0.596 . . . . 0.0 110.479 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.9 t -145.48 166.61 25.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.564 0.746 . . . . 0.0 110.338 173.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -143.57 106.13 4.45 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.595 1.958 . . . . 0.0 106.178 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -131.38 114.72 15.31 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -99.3 107.84 20.22 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -169.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.0 t -81.73 157.55 24.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.771 0.829 . . . . 0.0 108.833 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -130.0 129.07 43.26 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.0 mm -118.19 91.4 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -166.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.39 -82.71 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 126.156 1.782 . . . . 0.0 108.585 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.74 23.96 3.11 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.395 1.078 . . . . 0.0 112.551 171.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.94 148.79 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 119.413 1.006 . . . . 0.0 108.574 171.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.08 129.27 39.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.605 1.562 . . . . 0.0 107.652 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 79.6 t -136.82 92.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.866 1.666 . . . . 0.0 109.531 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.4 152.49 41.28 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.524 -0.735 . . . . 0.0 111.557 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.85 143.92 49.85 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 155.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -130.8 119.74 22.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.7 133.02 70.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.95 138.39 26.83 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -153.1 167.86 31.82 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 124.286 0.946 . . . . 0.0 110.926 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.479 HG12 HD13 ' A' ' 123' ' ' LEU . 17.4 m -140.3 168.33 17.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.084 1.353 . . . . 0.0 107.841 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -166.76 -103.85 0.17 Allowed Glycine 0 C--N 1.334 0.438 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.632 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -164.11 176.47 9.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.206 1.802 . . . . 0.0 109.511 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.11 145.05 35.26 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 168.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.0 p90 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 117.869 -1.062 . . . . 0.0 109.651 -179.233 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.477 0.18 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -141.7 141.31 33.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 121.414 -0.804 . . . . 0.0 108.987 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.07 107.01 11.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -95.75 139.74 31.55 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.48 HG13 ' H ' ' A' ' 146' ' ' TYR . 2.4 p -142.78 128.94 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.897 1.679 . . . . 0.0 107.524 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.6 p -138.51 163.56 31.68 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.453 0.569 . . . . 0.0 110.653 168.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.77 155.52 26.79 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.47 -165.43 37.95 Favored Glycine 0 C--O 1.236 0.272 0 O-C-N 121.793 -0.828 . . . . 0.0 112.75 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.74 157.58 16.39 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.246 1.018 . . . . 0.0 110.087 -169.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.79 162.89 34.05 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.921 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -143.73 154.34 43.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.331 1.053 . . . . 0.0 108.222 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 t -115.12 151.13 34.88 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 162.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.33 170.75 12.15 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.272 2.229 . . . . 0.0 105.296 160.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.91 164.49 28.19 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.5 -0.75 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -74.04 85.35 1.8 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 159.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.83 90.41 0.45 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.48 94.74 0.29 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 122.302 1.048 . . . . 0.0 109.74 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -151.21 -58.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.208 1.803 . . . . 0.0 108.03 170.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -63.69 103.92 0.61 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.168 1.387 . . . . 0.0 109.266 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -129.81 75.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 161.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -81.47 161.32 23.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.739 1.616 . . . . 0.0 109.282 164.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.93 179.88 40.93 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 108.209 -1.957 . . . . 0.0 108.209 171.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.74 -163.63 30.26 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 118.285 1.043 . . . . 0.0 111.858 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -99.62 153.97 18.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.24 1.416 . . . . 0.0 108.747 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -137.93 153.26 49.51 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.873 1.669 . . . . 0.0 107.648 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.6 mt -133.41 148.29 51.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 162.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -125.92 127.22 45.65 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 164.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -155.64 108.43 2.69 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -169.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -141.18 165.93 26.18 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.845 1.258 . . . . 0.0 108.707 -171.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -111.35 157.2 20.48 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -107.71 149.57 27.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 168.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.54 151.27 41.89 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 170.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.54 2.85 55.67 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.342 -0.849 . . . . 0.0 110.886 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -141.44 -70.32 0.36 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.47 1.508 . . . . 0.0 109.277 -153.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.1 t -72.67 122.83 88.58 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 167.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.47 68.28 6.94 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.629 2.22 . . . . 0.0 111.229 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 tp -142.35 121.61 13.06 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.932 1.293 . . . . 0.0 109.234 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -103.84 178.48 24.9 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -127.74 157.41 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.3 mm -124.94 151.62 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.93 1.692 . . . . 0.0 107.399 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.94 108.68 0.37 Allowed Glycine 0 C--N 1.336 0.563 0 O-C-N 120.136 -1.603 . . . . 0.0 111.372 159.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -67.46 151.65 47.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 166.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -136.51 103.04 5.12 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -92.99 150.84 20.27 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -172.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.2 157.76 40.92 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.413 1.085 . . . . 0.0 109.757 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 m -99.81 130.47 46.01 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 160.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -135.63 -56.59 0.79 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.544 1.938 . . . . 0.0 106.619 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.68 113.73 5.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.325 1.45 . . . . 0.0 107.508 174.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -101.6 155.59 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.059 2.143 . . . . 0.0 109.435 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.515 ' H ' ' HB2' ' A' ' 58' ' ' ASN . 0.3 OUTLIER -109.28 145.86 35.23 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 164.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t 178.63 149.24 0.22 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 130.353 3.461 . . . . 0.0 104.691 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 46.36 66.69 0.9 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.773 2.029 . . . . 0.0 110.596 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.3 t -162.63 -43.04 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.823 -0.608 . . . . 0.0 111.58 -172.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.72 3.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.859 0.863 . . . . 0.0 112.769 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.4 -0.66 53.97 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 121.192 1.814 . . . . 0.0 111.761 -171.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -71.1 91.28 0.9 Allowed 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.878 2.071 . . . . 0.0 106.408 165.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -72.5 144.45 48.01 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.515 ' HB2' ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -124.77 98.92 5.92 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 170.467 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -115.12 147.65 39.97 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 72.86 -177.84 0.19 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.59 2.356 . . . . 0.0 110.838 -168.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -124.99 163.74 21.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.078 1.751 . . . . 0.0 108.403 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.69 142.35 29.1 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -130.41 118.52 21.32 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.57 166.26 19.43 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 122.43 1.017 . . . . 0.0 112.235 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.7 142.83 42.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 167.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.9 m -139.79 130.95 26.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.88 164.55 31.61 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.617 0.767 . . . . 0.0 110.09 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.14 162.53 10.76 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 126.667 2.08 . . . . 0.0 107.993 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.05 156.62 38.44 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.576 1.517 . . . . 0.0 111.745 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.59 104.06 16.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 157.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -103.14 117.55 34.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -66.94 146.95 53.85 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.82 0.448 . . . . 0.0 110.469 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 pt -141.99 164.05 18.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.8 0.81 . . . . 0.0 111.168 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 t30 65.49 -74.87 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 130.448 3.499 . . . . 0.0 113.072 164.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -132.02 -56.48 0.98 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 117.074 -1.441 . . . . 0.0 109.372 165.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -151.67 27.02 0.65 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.117 1.767 . . . . 0.0 111.037 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.65 172.2 8.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.365 1.466 . . . . 0.0 110.263 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -127.83 168.98 14.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.724 1.609 . . . . 0.0 110.773 -173.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.31 162.1 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.67 1.188 . . . . 0.0 110.77 -172.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -104.65 124.72 49.84 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 127.731 2.412 . . . . 0.0 108.564 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.69 42.76 0.08 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.7 m -104.95 164.34 3.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.74 140.04 28.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -161.32 172.81 37.63 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-O 121.612 0.562 . . . . 0.0 112.789 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.69 149.09 16.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.63 145.15 18.56 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 166.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -135.04 152.15 51.44 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.635 1.574 . . . . 0.0 108.316 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.97 -156.43 12.83 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -154.4 88.44 1.22 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -65.37 151.55 46.0 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -133.78 151.01 51.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.761 155.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.2 t -137.75 117.6 13.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 163.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.0 p -101.19 -124.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -167.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 75.38 -53.67 0.65 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.544 2.338 . . . . 0.0 113.277 162.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.86 150.59 82.17 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 167.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.03 6.64 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.346 2.698 . . . . 0.0 113.38 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.7 t -142.48 53.39 1.42 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.183 1.393 . . . . 0.0 108.642 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.4 p90 47.88 -124.54 1.7 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.183 1.393 . . . . 0.0 109.625 171.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -161.69 -61.99 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 148.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -161.96 150.0 14.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -150.06 105.46 3.38 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.684 1.193 . . . . 0.0 107.804 -170.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.19 164.4 30.16 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.328 -0.858 . . . . 0.0 110.611 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 p -82.04 115.14 21.05 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 165.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -85.69 138.72 31.93 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.061 0.944 . . . . 0.0 109.212 -173.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.97 126.7 49.16 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.054 1.341 . . . . 0.0 107.903 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.66 83.41 0.28 Allowed Glycine 0 CA--C 1.522 0.483 0 CA-C-N 119.078 0.853 . . . . 0.0 111.624 -173.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -74.35 141.16 45.19 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.76 1.224 . . . . 0.0 109.364 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.66 -150.31 0.15 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.984 0.811 . . . . 0.0 110.622 154.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -128.18 162.49 26.83 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.321 1.848 . . . . 0.0 110.001 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.71 -176.2 15.12 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.755 0.693 . . . . 0.0 112.461 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.22 174.22 6.64 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.944 1.698 . . . . 0.0 111.232 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -157.86 84.37 0.13 Allowed Glycine 0 C--N 1.342 0.865 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.643 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.13 139.61 49.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.178 0.989 . . . . 0.0 108.746 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -137.43 159.37 42.12 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.091 1.356 . . . . 0.0 107.674 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -92.85 170.71 9.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 119.619 1.1 . . . . 0.0 108.38 171.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -61.27 104.49 0.47 Allowed Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.439 1.096 . . . . 0.0 110.524 -170.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.15 106.64 2.31 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.642 2.228 . . . . 0.0 109.908 -166.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.7 ptm -164.68 169.77 16.47 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.406 0.548 . . . . 0.0 110.774 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 63.69 35.65 11.29 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.601 1.16 . . . . 0.0 108.67 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 60.01 14.11 4.16 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.864 1.266 . . . . 0.0 113.318 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.26 110.43 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 123.734 1.73 . . . . 0.0 109.309 171.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -113.9 110.25 19.79 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.229 2.612 . . . . 0.0 106.395 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.37 131.66 34.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.78 148.76 42.68 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.727 0.694 . . . . 0.0 110.594 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -143.35 150.7 39.52 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.99 1.316 . . . . 0.0 108.51 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 p -144.08 152.99 41.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.657 0.741 . . . . 0.0 111.367 152.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -108.18 125.09 51.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.144 2.177 . . . . 0.0 105.733 168.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -136.61 145.24 44.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.238 1.815 . . . . 0.0 107.873 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -127.29 161.67 28.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.729 0.775 . . . . 0.0 110.993 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 p -141.22 159.89 41.26 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.831 2.052 . . . . 0.0 108.084 170.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -128.79 114.93 17.18 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 87.2 mt -105.9 98.03 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.18 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 129.179 2.992 . . . . 0.0 109.893 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.5 p -137.78 20.76 2.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.471 1.108 . . . . 0.0 111.245 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.82 115.71 50.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 167.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.29 130.46 40.84 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 168.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.4 t -135.49 112.35 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -172.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.25 144.92 16.94 Favored Glycine 0 C--O 1.238 0.357 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -169.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.3 p -138.0 148.85 45.57 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.436 0.695 . . . . 0.0 110.218 -164.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -121.18 150.27 41.55 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 166.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.45 131.45 65.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.83 131.79 20.3 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.666 0.786 . . . . 0.0 109.045 -171.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -161.97 173.52 38.32 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 114.599 0.6 . . . . 0.0 114.599 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.0 178.06 2.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.951 2.1 . . . . 0.0 108.78 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 167.67 -165.15 38.49 Favored Glycine 0 C--O 1.217 -0.952 0 O-C-N 120.545 -1.347 . . . . 0.0 110.367 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.48 ' H ' HG13 ' A' ' 5' ' ' VAL . 51.4 m-85 -104.92 175.45 5.49 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -166.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.87 130.32 19.98 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 120.813 -1.18 . . . . 0.0 108.13 170.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.191 1.396 . . . . 0.0 107.848 -179.112 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.6 p -132.79 157.17 45.64 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 149.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.85 106.71 4.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.133 0.973 . . . . 0.0 108.822 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -134.35 125.55 27.83 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.985 -1.072 . . . . 0.0 109.095 -168.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.38 112.85 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.468 1.107 . . . . 0.0 108.663 -168.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.5 p -149.15 123.58 9.67 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.927 0.891 . . . . 0.0 109.14 -166.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.34 158.53 27.71 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.794 1.187 . . . . 0.0 111.463 176.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.25 -139.35 5.09 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -167.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -150.33 154.93 38.69 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 117.668 0.734 . . . . 0.0 110.97 -166.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.93 160.19 39.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.461 1.105 . . . . 0.0 111.03 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -132.73 114.12 13.77 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -84.96 144.35 28.38 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.866 0.866 . . . . 0.0 109.004 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -138.39 119.31 14.29 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.34 1.856 . . . . 0.0 109.357 -173.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.03 166.45 19.76 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.499 1.12 . . . . 0.0 110.765 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -39.27 -20.33 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.275 2.63 . . . . 0.0 115.948 169.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.26 -108.7 0.56 Allowed Glycine 0 C--N 1.338 0.659 0 CA-C-N 120.192 1.36 . . . . 0.0 110.584 167.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -141.14 101.81 4.11 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.719 1.26 . . . . 0.0 109.311 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 58.2 mtp -130.32 -75.09 0.54 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.17 99.28 3.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -78.61 132.06 36.96 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB2' HG23 ' A' ' 46' ' ' THR . 3.9 ptp -133.99 149.16 51.2 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.07 177.46 47.69 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.73 -162.41 28.19 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -171.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.06 110.16 22.46 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -170.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -95.69 150.81 19.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.049 -1.464 . . . . 0.0 107.049 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.33 145.03 20.12 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -170.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -132.87 150.11 52.19 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.68 139.62 50.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 170.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -129.53 109.0 10.67 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -115.9 132.5 56.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.59 153.12 45.96 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.777 1.631 . . . . 0.0 107.532 172.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -141.64 155.57 45.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -69.46 -19.97 63.76 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.538 -0.726 . . . . 0.0 110.146 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -21.05 65.98 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 125.548 1.539 . . . . 0.0 112.83 173.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -152.12 90.16 3.85 Favored Pre-proline 0 C--O 1.238 0.448 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.61 64.73 4.73 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.226 2.618 . . . . 0.0 112.012 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.86 125.58 10.4 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 167.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.05 174.19 54.59 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 118.555 0.616 . . . . 0.0 111.859 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.0 t -132.39 148.37 31.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.938 1.695 . . . . 0.0 107.659 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.33 120.74 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 126.592 1.957 . . . . 0.0 106.231 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.78 127.59 4.13 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 168.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 t -125.98 154.9 42.23 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.618 1.167 . . . . 0.0 110.729 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -112.68 140.3 47.56 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.905 0.882 . . . . 0.0 109.01 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.7 m -118.3 116.04 25.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.038 1.335 . . . . 0.0 107.973 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -112.9 149.68 32.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.232 1.413 . . . . 0.0 109.353 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 21' ' ' MET . 7.2 m -123.95 122.43 37.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -136.73 88.93 2.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -174.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -150.7 134.58 16.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.402 1.081 . . . . 0.0 109.288 -161.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.8 p -131.24 122.56 26.72 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.654 1.182 . . . . 0.0 112.155 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -134.66 113.71 11.99 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 162.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.6 t -141.59 136.72 31.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 156.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.33 -102.65 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.3 m -138.83 97.09 3.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.2 m 61.28 51.38 4.3 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.986 161.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.4 -35.02 0.03 OUTLIER Glycine 0 CA--C 1.532 1.14 0 N-CA-C 114.066 0.386 . . . . 0.0 114.066 172.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -119.21 111.67 18.52 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.83 80.59 1.66 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 172.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -81.24 66.53 6.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.391 0.615 . . . . 0.0 109.401 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -134.49 115.72 14.27 Favored 'General case' 0 CA--C 1.523 -0.06 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -158.93 161.78 36.79 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.692 1.997 . . . . 0.0 106.514 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -112.7 128.16 56.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 168.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -107.96 138.32 44.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 170.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -141.39 163.89 31.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.21 169.97 34.35 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.68 143.96 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 t -141.19 127.84 20.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.84 139.1 48.74 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.428 0.558 . . . . 0.0 110.978 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -172.97 167.16 39.92 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 163.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.22 177.79 8.16 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.589 2.193 . . . . 0.0 110.163 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.18 107.31 6.04 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.839 1.256 . . . . 0.0 107.63 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.19 148.66 22.21 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -91.34 142.76 27.35 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 122.074 -0.391 . . . . 0.0 110.308 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.3 mt -83.51 -102.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -129.76 12.04 5.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.487 1.515 . . . . 0.0 109.919 172.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -157.75 -178.41 7.3 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.851 -1.156 . . . . 0.0 112.865 -158.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -69.82 16.56 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.534 2.334 . . . . 0.0 114.292 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.97 141.0 48.7 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.6 1.16 . . . . 0.0 108.537 167.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 p -146.66 120.17 9.09 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.1 149.97 23.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -150.32 171.96 16.14 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.05 0.94 . . . . 0.0 108.922 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.28 150.16 38.33 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 164.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.72 165.49 28.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.284 1.034 . . . . 0.0 108.954 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.62 131.33 73.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.12 156.68 21.34 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.55 150.09 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.51 154.4 20.37 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -132.53 140.24 48.23 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.612 1.965 . . . . 0.0 108.434 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.39 171.67 32.12 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -174.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.21 156.56 0.77 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.286 2.234 . . . . 0.0 107.657 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -49.04 149.47 1.91 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.715 1.206 . . . . 0.0 111.396 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.93 158.58 21.8 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -170.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -136.97 122.17 19.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.789 1.636 . . . . 0.0 108.194 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.7 m -137.85 95.57 3.07 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -76.45 76.65 3.18 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.908 2.483 . . . . 0.0 108.037 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.419 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 41.7 m-85 59.42 -179.82 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 127.35 2.26 . . . . 0.0 112.233 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 95' ' ' TYR . 37.2 Cg_endo -65.19 15.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 121.899 1.733 . . . . 0.0 115.091 170.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 t -114.34 -24.2 9.01 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.063 1.302 . . . . 0.0 112.84 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -149.44 175.51 11.41 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 120.682 1.583 . . . . 0.0 110.054 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -164.81 165.74 20.34 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.772 1.629 . . . . 0.0 108.084 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -146.82 111.52 5.28 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -148.85 150.96 33.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 119.01 0.823 . . . . 0.0 108.848 171.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.4 m -140.71 117.7 11.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.065 1.346 . . . . 0.0 108.801 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.5 p -70.02 108.63 4.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.405 1.457 . . . . 0.0 107.532 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -149.59 151.66 34.17 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.55 0.691 . . . . 0.0 110.722 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -105.18 125.4 50.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 129.082 2.953 . . . . 0.0 106.991 -165.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.21 105.64 3.31 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.99 139.19 42.76 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.8 m -133.82 177.16 7.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.178 0.991 . . . . 0.0 109.401 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -168.12 167.8 12.18 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.937 2.095 . . . . 0.0 107.464 159.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.73 -166.33 35.19 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.08 158.49 44.28 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.77 1.228 . . . . 0.0 108.681 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.3 113.63 3.32 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.85 140.57 49.75 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.516 1.158 . . . . 0.0 109.35 -166.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -117.42 134.78 54.45 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.553 0.741 . . . . 0.0 109.957 -171.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.45 171.07 9.14 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -57.08 118.17 22.41 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.936 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.82 170.09 15.85 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.022 2.481 . . . . 0.0 112.612 170.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 46.3 mtt -152.98 162.95 40.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 130.03 3.332 . . . . 0.0 106.684 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.55 -4.84 1.5 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 129.178 2.991 . . . . 0.0 114.413 -171.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -145.21 8.89 1.23 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.087 0.955 . . . . 0.0 111.51 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.24 139.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 120.221 1.373 . . . . 0.0 108.842 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.9 154.1 38.97 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 119.907 -1.746 . . . . 0.0 107.566 161.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 132.88 46.13 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -140.98 130.69 24.17 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -129.31 151.25 50.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.48 1.112 . . . . 0.0 108.409 -173.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.96 162.42 37.85 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.636 0.732 . . . . 0.0 109.722 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -130.93 136.64 48.76 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -136.72 132.46 34.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 103.944 -2.614 . . . . 0.0 103.944 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -99.41 154.61 18.08 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 170.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 72.2 m -135.42 149.04 49.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -137.8 118.82 14.36 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 61.3 mt -123.38 105.5 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.68 50.89 17.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.076 1.35 . . . . 0.0 113.28 169.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.7 10.13 3.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.207 1.403 . . . . 0.0 111.518 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.63 119.5 43.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 166.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -71.67 133.14 45.46 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.9 t -133.25 157.06 42.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.25 152.19 23.11 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -140.26 153.9 46.66 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 167.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -136.35 118.74 15.73 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.7 mt -99.75 136.13 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.004 1.722 . . . . 0.0 107.35 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.32 139.62 35.47 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.32 163.05 36.61 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.9 m -139.08 173.54 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.001 1.32 . . . . 0.0 109.426 -172.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 180.0 -99.6 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-O 118.337 -1.257 . . . . 0.0 109.989 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -152.51 173.85 14.64 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.308 1.443 . . . . 0.0 110.513 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.2 tpt85 -133.3 150.97 51.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 162.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.6 p90 . . . . . 0 C--O 1.254 1.301 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 165.113 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.687 0.279 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.95 146.66 26.41 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 174.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -93.07 145.9 24.05 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.725 0.774 . . . . 0.0 109.113 165.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.1 m -153.72 125.71 7.84 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 119.565 -1.959 . . . . 0.0 110.041 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.71 127.61 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.688 0.795 . . . . 0.0 110.958 -170.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 p -139.18 119.99 14.3 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.402 1.081 . . . . 0.0 109.293 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.31 164.13 31.83 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.022 1.296 . . . . 0.0 110.49 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.17 -117.39 0.62 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -168.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -149.68 158.92 44.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.857 0.863 . . . . 0.0 109.735 -169.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.22 152.97 34.67 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.949 1.3 . . . . 0.0 107.802 168.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -142.37 154.37 44.58 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.291 0.636 . . . . 0.0 109.602 162.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 p -139.4 147.06 40.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 128.186 2.594 . . . . 0.0 107.46 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -126.82 113.37 16.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.595 0.712 . . . . 0.0 110.561 -155.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.62 106.14 1.39 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.337 1.055 . . . . 0.0 112.906 -156.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 64.44 8.46 4.3 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.922 1.689 . . . . 0.0 113.391 162.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.18 -101.32 0.23 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 104.178 -3.569 . . . . 0.0 104.178 -169.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -141.08 130.69 24.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 160.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.8 ttp -157.75 -34.91 0.07 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.383 0.427 . . . . 0.0 110.481 155.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -129.17 152.8 48.36 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 126.414 1.886 . . . . 0.0 106.424 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -123.51 80.93 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 171.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -67.61 129.4 39.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.89 176.04 29.6 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.79 -156.36 12.63 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 -171.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -98.55 156.16 16.93 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.391 1.096 . . . . 0.0 109.476 -169.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.77 144.43 41.6 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 124.278 1.031 . . . . 0.0 109.223 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -161.54 126.57 3.52 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -121.96 151.74 40.43 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 109.492 170.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -120.87 139.71 52.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -133.92 157.68 45.4 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 122.888 0.475 . . . . 0.0 110.064 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.71 157.67 38.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 173.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -108.89 125.1 51.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 154.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.76 173.04 3.75 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -117.06 37.68 3.76 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 169.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -148.72 -78.98 0.14 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 m -65.12 143.39 98.84 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.75 29.48 0.38 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.825 3.684 . . . . 0.0 110.972 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 tp -117.34 155.86 28.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.362 1.865 . . . . 0.0 108.791 -168.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.78 -172.99 13.83 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 168.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.1 t -139.56 142.33 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.91 152.91 38.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 163.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.0 136.08 4.2 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 105.021 -3.232 . . . . 0.0 105.021 165.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 t -124.56 142.89 51.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 117.922 0.861 . . . . 0.0 108.874 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -92.35 140.11 29.93 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.282 0.633 . . . . 0.0 110.211 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.89 130.02 37.74 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 167.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -116.84 156.43 27.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 156.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.7 m -138.3 122.2 17.74 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.68 42.26 2.18 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.528 1.931 . . . . 0.0 108.951 -164.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.525 ' H ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -65.3 138.54 58.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.003 1.321 . . . . 0.0 107.92 -175.017 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.5 p -130.39 155.06 47.03 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.196 0.522 . . . . 0.0 111.871 -169.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.6 99.87 12.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.861 1.264 . . . . 0.0 111.887 -175.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 t -158.4 16.16 0.21 Allowed 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.459 -0.775 . . . . 0.0 112.911 171.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.18 15.26 1.03 Allowed 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.347 -0.846 . . . . 0.0 112.18 -154.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.34 -116.61 0.17 Allowed 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 -173.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.6 m -126.09 13.02 7.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.039 1.336 . . . . 0.0 111.468 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.84 22.84 8.14 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 118.987 0.812 . . . . 0.0 113.838 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.434 ' HA ' ' HG3' ' A' ' 94' ' ' GLU . 5.7 t70 -70.68 104.19 2.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 168.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -58.44 106.29 0.37 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.435 -1.711 . . . . 0.0 108.176 162.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -56.29 140.19 45.74 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -116.65 168.48 10.15 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.573 0.701 . . . . 0.0 110.936 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 45.0 -165.44 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 130.081 3.352 . . . . 0.0 113.526 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -135.53 149.11 49.37 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.715 1.206 . . . . 0.0 108.759 -169.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -103.84 140.01 38.25 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 169.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -140.46 118.13 11.64 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.87 139.34 15.05 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.35 117.08 38.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.8 p -105.02 159.4 15.85 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.263 1.025 . . . . 0.0 109.629 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.18 144.02 28.64 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.027 -1.046 . . . . 0.0 109.703 164.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.76 121.07 1.36 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.66 127.64 21.22 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 N-CA-C 106.471 -2.165 . . . . 0.0 106.471 157.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.58 103.65 16.22 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.25 155.01 20.26 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 164.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -106.1 150.78 25.47 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.696 1.598 . . . . 0.0 106.801 161.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.1 mm -77.92 -104.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -129.54 7.29 5.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.986 1.267 . . . . 0.0 112.207 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -136.52 10.19 3.18 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.688 2.395 . . . . 0.0 111.894 -155.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 66.8 m95 51.03 70.58 0.51 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.507 1.523 . . . . 0.0 110.013 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.07 -169.03 1.89 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.435 1.894 . . . . 0.0 109.162 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 t -126.57 169.7 12.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.131 2.172 . . . . 0.0 106.365 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 tp -134.16 157.78 41.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.705 1.602 . . . . 0.0 108.494 -171.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -103.0 176.08 5.26 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 128.064 2.546 . . . . 0.0 109.097 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.16 53.23 2.87 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.71 160.66 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 m -95.45 154.43 3.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 121.561 -0.712 . . . . 0.0 109.676 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.67 134.63 4.82 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.89 129.17 68.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -118.71 115.09 3.0 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -168.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -121.15 123.71 42.96 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.064 0.932 . . . . 0.0 110.294 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.5 161.65 8.79 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -165.58 128.77 2.17 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.275 1.83 . . . . 0.0 106.899 -170.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -67.29 165.66 15.86 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.694 0.679 . . . . 0.0 111.17 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -122.38 179.9 4.41 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.256 1.422 . . . . 0.0 109.234 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.8 p -136.43 145.27 45.06 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.565 1.075 . . . . 0.0 110.375 158.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.4 m -131.6 25.04 4.75 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.8 0.84 . . . . 0.0 110.747 -155.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -145.44 -53.09 0.27 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.323 -1.485 . . . . 0.0 112.219 178.048 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -59.99 139.12 90.87 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-O 118.215 -0.898 . . . . 0.0 108.643 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.12 84.13 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.959 3.106 . . . . 0.0 110.382 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 m -154.68 -45.44 0.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.973 1.309 . . . . 0.0 108.067 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 37.25 63.43 0.72 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.106 1.762 . . . . 0.0 112.452 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -51.87 -48.66 63.94 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.8 t30 40.17 64.74 0.85 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.441 1.496 . . . . 0.0 110.755 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.78 129.32 9.17 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 127.723 2.409 . . . . 0.0 105.706 -173.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.7 p -132.46 104.69 6.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 123.987 0.804 . . . . 0.0 108.968 168.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -140.59 72.76 1.4 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 160.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.2 135.24 38.96 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -145.87 157.1 43.92 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.647 1.979 . . . . 0.0 108.016 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.32 160.56 33.2 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.371 0.986 . . . . 0.0 110.642 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -138.33 151.95 48.02 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 128.632 2.773 . . . . 0.0 109.111 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 m -170.31 -146.83 0.05 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.949 2.499 . . . . 0.0 108.748 159.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -136.94 177.51 7.8 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.942 1.697 . . . . 0.0 109.376 -171.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.38 177.19 37.79 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 121.285 -0.885 . . . . 0.0 113.657 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.63 161.89 14.17 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.008 0.923 . . . . 0.0 111.341 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.33 84.81 0.15 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.03 159.93 20.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.828 0.851 . . . . 0.0 109.767 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.04 154.97 43.07 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.067 1.347 . . . . 0.0 108.424 170.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -92.54 170.07 10.03 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -56.05 130.82 74.03 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.84 127.17 18.05 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -87.64 -175.19 5.1 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 152.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -109.97 -25.6 10.18 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 126.932 2.093 . . . . 0.0 108.458 -173.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.97 5.56 10.4 Favored 'General case' 0 C--O 1.225 -0.188 0 O-C-N 121.067 -1.021 . . . . 0.0 109.357 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.1 t -137.45 144.54 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.51 153.26 51.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.156 1.382 . . . . 0.0 108.56 164.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.468 HD13 HG12 ' A' ' 144' ' ' VAL . 2.4 mm? -143.98 115.86 8.29 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.908 1.683 . . . . 0.0 108.696 -174.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.32 148.04 44.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.951 2.1 . . . . 0.0 109.405 173.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -137.32 122.99 19.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.84 1.256 . . . . 0.0 109.123 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 t -139.54 151.77 46.37 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.516 1.126 . . . . 0.0 108.219 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -149.81 145.17 26.45 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -137.8 165.22 26.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.971 1.709 . . . . 0.0 108.772 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -119.9 159.55 24.44 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.216 -1.553 . . . . 0.0 110.633 169.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 t -140.43 159.82 41.36 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 170.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -141.11 97.85 3.26 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.69 83.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 54.62 48.97 19.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.263 1.025 . . . . 0.0 111.73 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 m 62.4 5.14 1.49 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.534 1.534 . . . . 0.0 114.876 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.7 t -82.2 148.74 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 121.169 1.804 . . . . 0.0 107.232 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 t70 78.02 -59.27 0.44 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.56 2.744 . . . . 0.0 113.032 171.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.4 t 68.82 -72.83 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 127.868 2.467 . . . . 0.0 113.089 165.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.15 116.18 1.09 Allowed Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.2 t -106.11 150.71 25.54 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.954 0.883 . . . . 0.0 109.466 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -134.9 133.28 39.46 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.5 pt -130.41 159.57 42.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.98 150.01 50.58 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.526 1.53 . . . . 0.0 109.27 -171.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -153.85 106.62 0.3 Allowed Glycine 0 C--O 1.22 -0.775 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 123' ' ' LEU . 34.3 m -128.85 167.13 24.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 118.848 1.324 . . . . 0.0 109.213 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.59 -122.29 1.06 Allowed Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -163.14 177.21 9.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.445 1.898 . . . . 0.0 109.556 -167.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -121.54 163.12 19.38 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.211 -0.931 . . . . 0.0 111.239 171.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . 0.258 0.0 OUTLIER . . . . . 0 C--O 1.251 1.173 0 CA-C-O 116.521 -1.704 . . . . 0.0 107.475 160.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 115.829 -2.034 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -139.14 152.04 47.12 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 123.335 2.788 . . . . 0.0 109.928 -163.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m -143.53 160.04 41.35 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 161.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -142.93 105.11 4.42 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 119.689 -1.882 . . . . 0.0 107.939 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 m -92.69 138.2 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.524 1.529 . . . . 0.0 107.273 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 m -148.92 143.72 26.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 168.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.47 164.19 32.41 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.44 -111.9 0.47 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -173.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -124.87 158.38 33.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.373 1.087 . . . . 0.0 111.018 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.51 133.26 34.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 128.517 2.727 . . . . 0.0 104.03 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -140.0 131.89 27.65 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 164.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -85.27 151.2 24.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 161.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 18' ' ' MET . 0.8 OUTLIER -138.74 169.96 16.86 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.121 1.368 . . . . 0.0 107.693 160.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.92 40.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.345 1.43 . . . . 0.0 109.603 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -70.75 97.62 1.4 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.038 0.923 . . . . 0.0 110.821 -168.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.48 -26.06 3.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 127.592 2.52 . . . . 0.0 109.419 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -146.79 96.07 2.69 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.481 1.512 . . . . 0.0 107.059 -170.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.449 ' HA ' ' HB2' ' A' ' 13' ' ' ASP . 2.5 mpt? -76.82 61.01 1.83 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.307 1.043 . . . . 0.0 109.187 172.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -70.74 99.11 1.64 Allowed 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 124.995 1.318 . . . . 0.0 107.538 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -70.47 108.51 4.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -136.75 130.95 32.75 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.26 -173.5 44.53 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -161.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.88 -94.24 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -149.64 137.95 20.63 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -101.19 148.84 24.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.673 1.589 . . . . 0.0 109.487 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.86 136.65 27.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.733 1.213 . . . . 0.0 107.881 163.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.07 150.81 50.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.44 1.096 . . . . 0.0 108.274 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -135.88 122.28 20.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -107.69 128.55 54.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -99.06 147.95 24.53 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 167.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -111.54 114.51 27.64 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 156.46 37.11 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.09 -20.54 17.93 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.276 1.031 . . . . 0.0 110.345 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.12 -8.16 59.71 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -170.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.37 163.28 18.61 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.99 -7.92 19.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.082 1.855 . . . . 0.0 112.775 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 tp -81.45 139.53 35.16 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.883 1.219 . . . . 0.0 109.655 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.32 -169.57 13.09 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.881 1.229 . . . . 0.0 110.445 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.47 150.29 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.807 0.843 . . . . 0.0 109.437 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.6 tp -135.8 141.77 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.24 145.53 11.08 Favored Glycine 0 C--O 1.239 0.408 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.6 m -112.08 141.14 46.12 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -170.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -111.95 115.3 28.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.4 m -91.47 150.89 21.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -140.47 142.31 35.35 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 160.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.2 m -143.06 133.59 24.96 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.957 0.903 . . . . 0.0 109.57 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -130.27 171.15 13.22 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 149.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -157.66 146.37 19.43 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 p -79.06 107.07 11.55 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 157.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -105.55 105.0 14.83 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 167.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -163.41 179.62 7.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.563 1.145 . . . . 0.0 109.542 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.45 -86.31 0.16 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.856 2.063 . . . . 0.0 105.64 166.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -124.01 -7.77 7.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.164 1.386 . . . . 0.0 114.218 -173.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 m 129.93 70.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 131.682 3.993 . . . . 0.0 109.745 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -134.26 -82.11 0.17 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 169.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -73.35 103.11 3.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.518 2.327 . . . . 0.0 107.651 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -117.77 88.61 2.95 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.71 111.99 24.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -165.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -113.68 130.4 56.42 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -171.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -160.17 165.95 30.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.577 1.551 . . . . 0.0 110.045 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.14 140.79 49.08 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 162.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -107.95 123.34 48.49 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -126.08 135.74 52.09 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 163.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.92 95.05 0.32 Allowed Glycine 0 C--N 1.331 0.278 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -174.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.6 mt -77.45 108.99 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 p -131.35 128.21 39.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.593 1.957 . . . . 0.0 106.637 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.62 174.03 13.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.737 0.415 . . . . 0.0 111.396 -172.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.87 176.57 48.09 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 123.34 0.495 . . . . 0.0 113.072 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.73 129.73 10.17 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.89 3.06 . . . . 0.0 109.421 168.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.74 149.09 22.17 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.629 0.772 . . . . 0.0 110.044 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -141.29 127.43 19.6 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.071 0.948 . . . . 0.0 108.683 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.6 120.32 16.05 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 125.164 1.385 . . . . 0.0 109.625 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mp -67.67 165.99 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.744 1.618 . . . . 0.0 107.161 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -79.03 14.64 1.34 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.524 -1.36 . . . . 0.0 112.313 -174.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -139.13 60.87 1.58 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.471 1.508 . . . . 0.0 108.485 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 57.2 m95 58.35 -16.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 129.079 2.951 . . . . 0.0 117.716 170.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.52 161.12 29.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.492 1.117 . . . . 0.0 108.758 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.2 p -142.93 115.98 8.87 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 117.657 -1.163 . . . . 0.0 108.478 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.785 HG12 HD13 ' A' ' 113' ' ' LEU . 1.9 mp -142.1 151.26 18.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.09 1.356 . . . . 0.0 108.297 -174.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -150.29 173.95 13.4 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.84 1.256 . . . . 0.0 109.1 160.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.21 140.46 27.51 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.34 143.8 37.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.196 0.998 . . . . 0.0 108.731 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.95 165.41 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.062 0.945 . . . . 0.0 109.819 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 177.25 -162.62 30.79 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.884 -166.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.69 139.89 19.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.579 0.751 . . . . 0.0 109.287 173.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.51 146.41 16.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 125.403 1.478 . . . . 0.0 109.466 168.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 3.7 p90 -149.37 166.96 27.47 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 122.095 -0.65 . . . . 0.0 111.926 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.64 -93.96 0.1 OUTLIER Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 149.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.89 105.67 0.07 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 128.557 2.743 . . . . 0.0 108.813 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -131.2 -75.83 0.52 Allowed 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.242 0.617 . . . . 0.0 110.659 -167.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -156.64 137.32 13.26 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.0 m -137.3 137.71 39.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 166.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.8 t -133.93 54.9 1.92 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -162.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -79.92 60.71 3.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.4 1.08 . . . . 0.0 111.764 -159.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -39.55 -53.65 4.22 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -166.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.98 9.8 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.915 3.076 . . . . 0.0 114.864 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 m -137.29 -65.9 0.52 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.846 2.058 . . . . 0.0 109.849 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -169.29 -167.41 0.71 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.717 1.207 . . . . 0.0 110.511 -170.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.5 109.6 6.45 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 173.89 155.15 0.12 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 127.097 2.159 . . . . 0.0 105.267 -167.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.92 122.3 14.95 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.071 1.749 . . . . 0.0 109.347 -174.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.0 t -140.59 94.11 2.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.014 0.926 . . . . 0.0 110.202 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.8 m -157.12 88.55 1.03 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.845 -1.159 . . . . 0.0 109.925 164.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 45.5 p30 -161.69 176.02 11.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.404 3.082 . . . . 0.0 109.586 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 54.83 17.27 1.71 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.904 2.081 . . . . 0.0 114.959 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.97 104.33 1.31 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.21 148.52 45.48 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.5 p -136.79 161.19 36.66 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.621 0.725 . . . . 0.0 111.518 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.57 157.23 37.96 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.497 1.519 . . . . 0.0 108.957 174.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.02 -168.3 37.91 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.881 1.705 . . . . 0.0 108.987 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.68 152.1 51.8 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.1 116.85 4.08 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.785 HD13 HG12 ' A' ' 79' ' ' ILE . 1.8 mm? -115.64 139.71 49.86 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -166.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.66 145.55 38.59 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 120.916 -1.115 . . . . 0.0 109.4 -172.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -93.15 164.4 13.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -56.86 103.92 0.39 Allowed Pre-proline 0 CA--C 1.528 0.125 0 C-N-CA 125.062 1.345 . . . . 0.0 110.579 -166.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.14 120.26 5.64 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.37 1.38 . . . . 0.0 109.058 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.7 mtm 166.9 153.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 129.917 3.287 . . . . 0.0 105.682 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 113.96 28.2 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 129.767 3.227 . . . . 0.0 107.494 160.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.9 t30 44.08 26.69 0.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.372 1.469 . . . . 0.0 113.727 -153.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.64 169.3 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 108.477 160.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.89 135.89 5.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.016 2.926 . . . . 0.0 103.155 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.46 HD22 HG12 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -122.22 146.87 46.85 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -172.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -141.16 152.94 45.09 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.243 1.017 . . . . 0.0 109.196 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -150.34 114.76 5.18 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.38 2.272 . . . . 0.0 105.603 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.1 m -118.3 154.23 32.66 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 168.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.49 120.85 11.62 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -136.61 136.11 38.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.234 1.413 . . . . 0.0 108.792 -168.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -100.05 150.68 22.21 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.799 0.84 . . . . 0.0 109.31 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.3 m -133.87 160.05 38.82 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.824 1.65 . . . . 0.0 108.039 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.52 97.79 4.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.907 1.283 . . . . 0.0 111.208 -166.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.4 mt -134.31 89.03 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.093 0.957 . . . . 0.0 108.888 -166.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.22 -161.31 0.18 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.5 m -77.34 58.55 1.68 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.543 1.065 . . . . 0.0 109.438 168.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.65 149.42 33.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 170.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -122.2 80.46 1.72 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.842 0.746 . . . . 0.0 110.766 -174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.9 t -78.99 96.55 2.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.931 1.693 . . . . 0.0 108.887 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.66 144.65 23.27 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 164.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.12 152.83 45.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 172.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -140.87 147.65 39.26 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 164.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.02 150.47 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.64 166.11 26.12 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.681 0.792 . . . . 0.0 108.9 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.18 178.77 47.14 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.642 -0.789 . . . . 0.0 114.107 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.46 HG12 HD22 ' A' ' 123' ' ' LEU . 11.6 m -129.5 163.33 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 127.783 2.433 . . . . 0.0 107.042 167.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -166.56 -119.25 0.47 Allowed Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -163.17 164.39 25.23 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.579 1.19 . . . . 0.0 110.711 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -91.36 125.93 36.28 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 116.865 -1.54 . . . . 0.0 107.613 164.615 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 t -150.42 142.08 23.62 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 120.728 -1.232 . . . . 0.0 108.937 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -140.71 106.86 5.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.801 0.81 . . . . 0.0 109.419 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.1 p -104.84 129.01 53.24 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 p -91.7 145.28 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 165.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 t -158.14 161.07 37.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.89 173.72 27.66 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.07 -162.06 34.84 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -171.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -91.6 144.5 25.47 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -172.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB3' ' H ' ' A' ' 23' ' ' GLY . . . -95.57 134.92 37.89 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.5 104.14 5.26 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 127.394 2.278 . . . . 0.0 106.552 -175.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 t -84.66 140.64 31.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.286 1.434 . . . . 0.0 107.393 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -138.78 126.89 22.6 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.059 1.744 . . . . 0.0 106.798 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.85 147.45 43.93 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.778 1.626 . . . . 0.0 107.613 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -63.24 92.58 0.06 Allowed 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 124.052 0.845 . . . . 0.0 108.722 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.84 41.72 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-O 117.434 -1.759 . . . . 0.0 111.922 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -150.76 94.91 2.14 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 157.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.6 mtt -76.73 57.26 1.25 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.882 2.873 . . . . 0.0 109.441 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -71.41 101.57 2.44 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -63.13 102.4 0.37 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.64 159.61 41.3 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.166 1.787 . . . . 0.0 106.983 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.11 -176.37 17.8 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -171.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 10' ' ' ALA . . . -163.69 -137.4 2.18 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 -164.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.76 157.69 25.1 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.211 1.506 . . . . 0.0 109.469 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -134.57 148.59 50.5 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.894 1.678 . . . . 0.0 107.995 -173.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.95 124.95 19.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -120.55 132.56 55.22 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -155.61 106.52 2.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -166.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 164.91 28.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.999 0.428 . . . . 0.0 110.88 -173.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -125.4 157.74 36.06 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.061 2.144 . . . . 0.0 106.59 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -128.79 159.94 34.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 168.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -136.12 125.84 25.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -67.41 1.46 2.24 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.933 1.293 . . . . 0.0 113.203 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -55.73 -27.07 48.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.723 0.809 . . . . 0.0 111.376 159.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.7 m -147.44 107.04 3.82 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 169.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.99 78.01 2.26 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.487 2.791 . . . . 0.0 109.713 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.41 126.31 10.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 128.83 2.852 . . . . 0.0 105.433 173.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.39 176.87 48.58 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' O ' HD13 ' A' ' 40' ' ' ILE . 48.6 t -122.23 146.78 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 170.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.69 HD11 ' HB2' ' A' ' 70' ' ' ALA . 17.1 mm -138.44 116.27 12.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -170.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.09 124.05 1.75 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 107.009 -2.436 . . . . 0.0 107.009 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 p -122.71 153.92 38.79 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.129 1.771 . . . . 0.0 107.557 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -129.49 120.21 25.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -160.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.9 p -119.69 115.15 23.34 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.906 0.776 . . . . 0.0 110.07 -152.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.93 153.85 32.9 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.307 -0.871 . . . . 0.0 110.954 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.5 t -131.58 122.34 25.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.913 0.885 . . . . 0.0 109.035 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -131.59 74.81 1.61 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.04 1.736 . . . . 0.0 106.926 174.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -153.76 146.45 24.24 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.5 t -131.06 155.78 46.32 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.911 2.084 . . . . 0.0 107.925 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -126.96 101.25 6.49 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 172.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 p -142.04 93.47 2.55 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.96 36.79 2.15 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.971 1.309 . . . . 0.0 111.073 -173.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 m 105.46 44.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 1 C-N-CA 131.878 4.071 . . . . 0.0 111.409 175.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.3 m -126.04 -59.0 1.35 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.098 0.959 . . . . 0.0 108.633 166.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.63 74.91 1.29 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 105.763 -2.935 . . . . 0.0 105.763 -162.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -120.09 91.69 3.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.54 91.94 7.82 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -66.65 112.36 4.13 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.15 0.886 . . . . 0.0 111.931 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -89.31 171.04 10.05 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.893 -1.129 . . . . 0.0 108.093 161.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 66.35 175.67 0.23 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.563 2.345 . . . . 0.0 112.46 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -139.02 155.88 47.63 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.855 1.662 . . . . 0.0 107.321 -167.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -77.57 157.68 30.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -140.97 117.33 10.74 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 154.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.91 106.05 2.32 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 106.882 -2.487 . . . . 0.0 106.882 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.21 108.95 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.3 p -128.96 159.16 36.76 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -137.45 163.5 30.94 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.3 156.32 27.28 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 157.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.02 178.86 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.281 2.654 . . . . 0.0 112.083 145.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.69 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -126.35 144.49 50.8 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.698 1.599 . . . . 0.0 108.191 154.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -133.35 155.87 48.66 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.065 1.346 . . . . 0.0 109.323 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.94 94.99 5.37 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 170.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 33.8 mt -28.09 -70.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 129.832 3.253 . . . . 0.0 110.324 -170.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.411 ' H ' ' H ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -170.12 5.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.67 1.588 . . . . 0.0 110.368 177.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.411 ' H ' ' H ' ' A' ' 74' ' ' ASN . 2.0 t70 -150.08 -177.1 5.73 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.6 1.16 . . . . 0.0 108.714 -175.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -73.98 63.22 0.92 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.84 2.456 . . . . 0.0 112.936 -166.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.64 175.86 10.06 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.792 1.637 . . . . 0.0 108.648 166.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -143.21 112.28 6.63 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 155.66 18.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.689 0.796 . . . . 0.0 109.71 -173.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.55 162.77 39.51 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 155.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.7 131.77 10.62 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 163.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.33 144.59 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 118.712 1.256 . . . . 0.0 108.446 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 m -145.97 165.13 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.301 0.64 . . . . 0.0 111.423 -174.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.41 -143.62 9.54 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 p -133.38 146.33 32.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -170.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.42 113.4 1.51 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 125.087 1.327 . . . . 0.0 109.831 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -95.57 117.12 29.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.476 1.91 . . . . 0.0 107.202 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.98 77.86 0.38 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -84.59 77.28 10.07 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -67.62 83.01 0.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.573 1.149 . . . . 0.0 110.757 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -63.72 116.7 5.97 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 165.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.3 t -129.46 165.74 21.0 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 157.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.24 -11.25 0.42 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 116.938 -1.506 . . . . 0.0 114.266 -175.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -82.15 -94.14 0.05 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.298 1.408 . . . . 0.0 108.957 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -49.24 94.91 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -162.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.1 -2.89 12.75 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 CA-C-N 122.192 1.819 . . . . 0.0 113.319 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.7 m 57.85 88.28 0.06 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.703 1.201 . . . . 0.0 111.294 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 70.06 -148.35 0.1 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.841 1.656 . . . . 0.0 110.516 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -55.63 113.07 1.31 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.234 1.014 . . . . 0.0 110.539 -171.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -45.35 -45.85 12.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.212 1.405 . . . . 0.0 113.985 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 144.51 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.236 1 C-N-CA 132.276 4.23 . . . . 0.0 111.797 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 t -135.03 110.58 9.16 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.591 -1.318 . . . . 0.0 108.222 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.7 m -156.5 67.55 0.57 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.601 1.56 . . . . 0.0 107.577 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.08 177.12 9.0 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.981 0.913 . . . . 0.0 111.616 -159.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -72.59 123.87 24.1 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.624 0.77 . . . . 0.0 110.079 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.76 165.43 17.7 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 159.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -90.3 135.16 33.85 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.1 m -104.98 131.84 51.99 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -143.05 134.69 26.49 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.83 -162.86 14.29 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 124.55 1.071 . . . . 0.0 110.868 -161.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.54 174.44 11.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.922 1.289 . . . . 0.0 109.503 171.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.01 142.34 13.76 Favored Glycine 0 C--N 1.33 0.249 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 168.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.31 140.23 52.34 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -131.86 149.52 52.43 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -109.62 171.38 7.48 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 126.416 1.886 . . . . 0.0 108.726 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -56.49 111.38 3.19 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.639 1.176 . . . . 0.0 110.834 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.64 114.23 3.98 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.932 3.088 . . . . 0.0 110.795 -169.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 49.1 mtt -80.13 158.07 26.46 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.791 1.281 . . . . 0.0 109.738 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -81.12 90.68 6.05 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 134.59 -20.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 132.414 4.285 . . . . 0.0 112.235 170.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.13 119.06 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 120.17 1.35 . . . . 0.0 108.898 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.26 155.37 34.42 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 120.201 -1.562 . . . . 0.0 107.729 155.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -125.58 114.58 18.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 161.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -155.5 151.67 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -147.84 151.81 36.58 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.47 1.508 . . . . 0.0 108.68 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.4 t -125.18 141.97 51.78 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 161.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -115.5 124.94 52.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -132.43 119.24 20.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.251 1.02 . . . . 0.0 108.734 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -109.57 107.32 17.36 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 170.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 t -85.21 160.37 19.9 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 163.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -136.65 151.71 49.61 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 155.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.89 111.42 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.9 ttt-85 52.86 46.14 27.35 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.309 1.044 . . . . 0.0 111.893 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.1 m 56.1 39.43 30.39 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.272 1.029 . . . . 0.0 113.134 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.59 140.95 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 153.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -101.3 122.07 43.02 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 126.428 1.891 . . . . 0.0 108.376 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.5 t -128.85 93.45 2.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -166.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.74 139.26 17.0 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -141.34 119.48 12.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -123.79 113.74 18.96 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.6 pp -108.29 147.5 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.649 1.113 . . . . 0.0 109.477 -172.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.58 163.45 15.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -147.81 102.83 0.25 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 107.669 -2.172 . . . . 0.0 107.669 -172.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.08 153.3 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.59 -141.93 7.55 Favored Glycine 0 C--O 1.218 -0.87 0 CA-C-O 117.532 -1.705 . . . . 0.0 109.203 -159.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -163.41 167.09 22.1 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 121.609 2.705 . . . . 0.0 111.003 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -89.35 144.92 25.71 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 159.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.781 154.829 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -150.66 164.72 35.42 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -143.48 159.72 41.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.3 1.84 . . . . 0.0 108.173 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -131.5 146.08 52.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.85 98.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.9 t -148.38 119.81 7.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -159.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.65 171.17 40.03 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.34 -123.08 1.12 Allowed Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 -163.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -146.6 158.3 43.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -159.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.02 156.69 31.62 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.094 0.958 . . . . 0.0 109.725 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -125.47 111.9 15.62 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 167.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.8 m -85.48 140.9 30.31 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 160.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -138.79 172.02 13.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.12 2.568 . . . . 0.0 107.062 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.91 164.49 33.57 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.875 1.216 . . . . 0.0 110.794 162.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.81 86.19 5.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.092 0.949 . . . . 0.0 109.201 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.3 -32.02 1.53 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.576 1.56 . . . . 0.0 109.892 172.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -137.6 99.29 3.9 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.6 mtt -69.3 71.38 0.28 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 160.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -71.98 91.97 1.25 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 166.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -68.12 120.36 14.2 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.0 mtp -137.28 134.4 36.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.46 -179.76 24.66 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 162.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.59 -105.37 0.28 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 104.428 -3.469 . . . . 0.0 104.428 170.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -127.97 153.98 46.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.144 1.378 . . . . 0.0 108.723 167.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -138.81 129.58 26.33 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.123 2.169 . . . . 0.0 109.651 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 tp -135.56 143.17 45.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.937 1.244 . . . . 0.0 109.896 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -127.05 166.27 17.91 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.356 1.863 . . . . 0.0 109.07 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.5 141.24 18.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.899 1.68 . . . . 0.0 106.971 -166.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -116.74 147.62 41.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.089 0.859 . . . . 0.0 109.395 165.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.14 120.0 21.7 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.654 1.582 . . . . 0.0 107.574 166.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -101.59 112.49 25.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.5 101.02 12.8 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.475 1.91 . . . . 0.0 107.896 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 38.04 64.05 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.683 1.993 . . . . 0.0 111.981 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 62.35 40.15 11.51 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.775 2.03 . . . . 0.0 112.394 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.8 p -63.82 122.96 79.98 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.57 -37.39 12.81 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.211 1.941 . . . . 0.0 112.08 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.06 155.3 32.59 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 164.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.59 -167.35 12.18 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 172.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.41 146.17 34.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.23 137.08 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 167.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.28 108.55 0.36 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 165.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 p -125.52 137.59 53.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.444 0.622 . . . . 0.0 110.925 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.65 153.62 20.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.5 m -120.3 132.7 55.42 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 161.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -120.36 153.33 36.64 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.806 2.042 . . . . 0.0 106.109 167.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.9 p -133.19 145.38 50.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.103 0.865 . . . . 0.0 111.741 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -129.77 115.95 18.04 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 163.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -162.66 147.28 11.87 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 m -65.22 155.05 36.32 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.07 137.46 51.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 157.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 t -171.91 110.08 0.27 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.528 1.531 . . . . 0.0 107.342 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.69 1.02 0.13 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 119.915 -1.741 . . . . 0.0 114.51 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.3 t -143.3 87.17 1.94 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 127.229 2.212 . . . . 0.0 106.07 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 m 57.77 38.88 27.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.358 1.063 . . . . 0.0 111.273 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.82 33.08 66.32 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.425 -0.653 . . . . 0.0 113.331 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -70.88 91.35 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.174 2.19 . . . . 0.0 109.371 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -116.13 128.02 55.31 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.456 2.303 . . . . 0.0 106.745 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -160.3 172.85 16.61 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.684 0.794 . . . . 0.0 109.705 -167.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -60.33 130.47 46.78 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -154.01 148.86 26.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.695 0.798 . . . . 0.0 108.977 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -152.74 146.42 25.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 164.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -97.95 122.72 41.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 157.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.9 125.55 45.9 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.04 135.49 12.89 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.7 mm -141.89 135.92 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 127.667 2.387 . . . . 0.0 105.603 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 t -140.28 153.61 46.55 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.201 1.4 . . . . 0.0 108.168 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.65 152.97 44.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.871 1.268 . . . . 0.0 108.308 170.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.55 141.43 3.16 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 168.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.88 169.69 18.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 121.71 1.607 . . . . 0.0 110.163 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.86 157.86 16.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.465 1.906 . . . . 0.0 107.34 168.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -145.58 116.55 7.8 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -84.22 134.38 34.55 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.0 mp -77.37 -79.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -171.61 1.94 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.245 0.929 . . . . 0.0 113.374 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -135.15 66.81 1.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -162.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 93.3 m95 53.47 -38.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 131.013 3.725 . . . . 0.0 117.569 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.21 162.9 28.47 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.182 1.793 . . . . 0.0 110.603 -170.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 t -148.45 110.08 4.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.87 145.76 34.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -151.07 164.91 35.35 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.91 0.884 . . . . 0.0 109.333 166.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.62 130.45 20.54 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 170.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 m -119.57 172.17 6.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.298 1.039 . . . . 0.0 108.666 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.1 158.55 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 C-N-CA 125.682 1.593 . . . . 0.0 108.783 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.0 162.64 25.03 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 170.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.2 p -134.54 136.33 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.44 110.92 1.76 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 107.191 -2.363 . . . . 0.0 107.191 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -129.11 156.62 43.58 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.89 174.04 39.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -127.27 145.61 50.72 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 167.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -162.35 152.04 16.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.746 0.703 . . . . 0.0 110.438 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -111.17 165.29 12.03 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.0 m -136.29 111.62 9.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.332 1.453 . . . . 0.0 107.468 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.301 2.9 m 69.74 -60.61 0.47 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.648 1.979 . . . . 0.0 109.445 -175.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.07 -23.0 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 129.32 3.048 . . . . 0.0 114.299 -171.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -57.36 152.79 30.54 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 164.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.94 -9.92 20.91 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.849 2.366 . . . . 0.0 113.818 -172.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -21.97 60.34 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.877 1.671 . . . . 0.0 112.734 174.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -157.24 -38.52 0.07 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.716 1.144 . . . . 0.0 113.432 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 53.6 tttm 35.43 65.18 0.41 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.211 2.204 . . . . 0.0 114.998 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -110.39 102.65 11.26 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.949 0.899 . . . . 0.0 109.729 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.21 143.16 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.63 0.772 . . . . 0.0 109.223 164.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.5 m -140.01 144.74 37.1 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.397 -0.815 . . . . 0.0 110.49 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.97 153.4 48.42 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 154.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -161.58 176.05 11.44 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.729 0.812 . . . . 0.0 109.223 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -139.62 165.19 27.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.346 1.458 . . . . 0.0 109.032 170.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.29 167.55 38.91 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 165.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -102.85 152.39 21.33 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.323 1.849 . . . . 0.0 110.363 -173.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 p -137.41 168.33 19.86 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.416 1.487 . . . . 0.0 110.101 165.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -146.3 153.12 40.19 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.704 0.802 . . . . 0.0 108.901 168.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.24 -153.94 9.36 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.75 160.28 41.96 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.514 1.125 . . . . 0.0 108.955 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -99.06 121.82 7.35 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 171.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.7 138.94 50.61 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -141.83 155.71 45.56 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.071 -1.018 . . . . 0.0 109.548 -161.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -93.14 163.63 13.56 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -57.02 134.86 80.29 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.336 -0.84 . . . . 0.0 108.759 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.45 104.28 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.444 2.096 . . . . 0.0 110.42 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttt -75.34 -175.02 2.59 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.803 1.241 . . . . 0.0 107.676 167.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -106.08 -13.81 15.34 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.624 1.57 . . . . 0.0 110.438 -159.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.41 25.5 0.35 Allowed 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 125.267 1.427 . . . . 0.0 108.967 166.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.68 137.35 27.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.72 145.2 30.77 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.89 135.68 51.28 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -131.03 145.22 51.96 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.24 1.416 . . . . 0.0 110.362 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -147.5 144.79 28.81 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.487 1.915 . . . . 0.0 108.225 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.2 p -145.82 163.62 34.47 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 151.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -137.27 137.46 39.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -138.21 165.16 27.38 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.021 0.929 . . . . 0.0 109.175 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -127.07 118.24 24.02 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 165.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.6 m -83.24 154.5 24.16 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.833 0.853 . . . . 0.0 109.684 167.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -116.78 102.96 9.85 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.18 93.95 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.631 0.651 . . . . 0.0 110.996 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 88.57 39.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.79 2.836 . . . . 0.0 109.995 164.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m 52.85 43.77 31.13 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.208 1.403 . . . . 0.0 111.564 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.47 130.28 53.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 127.994 2.517 . . . . 0.0 105.075 165.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.75 104.96 15.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.368 0.667 . . . . 0.0 109.724 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.87 92.07 2.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.92 1.288 . . . . 0.0 107.866 -169.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.57 151.81 43.67 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.0 t -138.33 153.49 48.99 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.492 1.117 . . . . 0.0 108.405 165.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -139.36 157.22 46.26 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 152.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.6 pt -120.61 149.03 23.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 168.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.2 123.52 12.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 166.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.02 154.13 25.39 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.84 -179.55 3.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 125.795 1.638 . . . . 0.0 107.963 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 174.78 -96.09 0.11 Allowed Glycine 0 C--O 1.228 -0.281 0 O-C-N 120.29 -1.506 . . . . 0.0 111.58 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -146.63 176.02 10.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.992 1.317 . . . . 0.0 110.522 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -141.31 139.39 33.61 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 10.8 p90 . . . . . 0 C--O 1.252 1.217 0 CA-C-N 119.371 0.987 . . . . 0.0 109.28 176.689 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.3 m -146.36 166.65 25.69 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.688 1.595 . . . . 0.0 106.751 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -122.95 140.61 52.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.102 0.961 . . . . 0.0 109.967 -173.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 t -151.42 173.2 14.83 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.58 120.76 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -139.89 122.25 16.03 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -161.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.38 -159.89 33.14 Favored Glycine 0 C--N 1.332 0.331 0 O-C-N 119.931 -1.731 . . . . 0.0 113.635 -157.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 114.44 -99.83 0.97 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 106.984 -2.447 . . . . 0.0 106.984 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -139.74 157.68 45.34 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.029 1.414 . . . . 0.0 108.753 -163.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.14 132.24 41.41 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.053 1.741 . . . . 0.0 107.703 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -100.04 113.17 25.58 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -85.01 137.72 32.9 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 157.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -138.14 170.65 15.67 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.449 1.1 . . . . 0.0 108.397 171.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -114.23 165.48 12.63 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.264 1.026 . . . . 0.0 111.866 -165.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -46.2 -20.39 0.1 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.28 2.632 . . . . 0.0 113.693 172.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.15 94.71 0.15 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 168.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -42.48 102.94 0.03 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 129.772 3.229 . . . . 0.0 112.408 -173.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.3 ttm -145.83 -36.17 0.28 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.003 1.721 . . . . 0.0 111.056 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.89 103.25 7.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.86 1.264 . . . . 0.0 111.658 173.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 157.34 18.0 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.742 172.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.9 mtm -130.21 159.7 36.07 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.198 0.999 . . . . 0.0 109.785 172.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.26 176.03 38.94 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.026 1.774 . . . . 0.0 110.164 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.91 -84.58 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.53 156.72 41.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 172.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -137.41 150.22 47.49 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 164.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.8 tp -150.73 131.77 14.33 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 168.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -131.02 161.28 32.32 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.896 2.078 . . . . 0.0 110.143 -176.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -145.46 142.33 29.16 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.761 1.624 . . . . 0.0 108.356 -172.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.438 HH12 ' CB ' ' A' ' 78' ' ' SER . 4.9 tmm_? -131.63 115.27 15.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.475 0.71 . . . . 0.0 109.298 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -98.94 156.57 16.83 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.733 0.697 . . . . 0.0 110.01 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -139.91 113.19 8.35 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.943 1.697 . . . . 0.0 108.939 -165.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -64.35 169.06 4.98 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.414 1.486 . . . . 0.0 110.828 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.2 -30.72 12.84 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.749 0.82 . . . . 0.0 109.37 167.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.83 -82.59 0.06 Allowed 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.56 0.744 . . . . 0.0 109.45 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.5 p -89.07 173.45 6.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.772 0.829 . . . . 0.0 110.943 -171.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.46 -3.86 14.51 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.628 2.219 . . . . 0.0 112.44 165.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.5 tp -70.67 155.94 40.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.32 0.964 . . . . 0.0 110.13 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.17 -166.77 28.76 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 t -132.87 151.08 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 118.163 0.981 . . . . 0.0 109.822 -166.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.448 HD12 ' CE2' ' A' ' 80' ' ' TYR . 46.3 mm -119.88 143.99 29.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 125.74 1.616 . . . . 0.0 107.867 169.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.06 144.37 15.93 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 148.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.0 m -123.51 153.54 40.42 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 127.021 2.128 . . . . 0.0 106.568 168.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -121.15 122.29 39.69 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 m -93.54 116.4 28.92 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -166.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -139.22 125.2 19.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.688 0.395 . . . . 0.0 110.781 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -133.23 130.97 39.75 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -72.25 -177.45 2.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.962 167.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.13 118.87 4.94 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 119.807 -1.808 . . . . 0.0 109.648 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 m -123.48 128.94 50.51 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.835 1.254 . . . . 0.0 108.229 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -70.0 99.81 1.5 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 164.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t 179.85 95.28 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.537 2.335 . . . . 0.0 105.864 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.48 5.59 7.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.216 2.206 . . . . 0.0 111.214 170.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 88.65 -37.11 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 128.376 2.67 . . . . 0.0 109.624 177.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 p -82.6 -66.15 0.92 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 152.67 82.28 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 107.066 -2.414 . . . . 0.0 107.066 -155.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -119.42 99.22 6.55 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 163.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.93 77.32 3.5 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -167.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.49 116.98 17.68 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -149.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -143.54 170.8 15.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 118.469 0.577 . . . . 0.0 110.758 -169.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 t30 53.53 -177.23 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.859 1.264 . . . . 0.0 109.026 -150.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -113.53 169.34 9.04 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.914 1.286 . . . . 0.0 108.217 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -97.06 103.43 15.36 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -98.12 147.55 24.45 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.17 170.42 36.24 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.82 138.11 46.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.9 m -134.39 127.07 30.87 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.16 149.02 26.62 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.869 0.468 . . . . 0.0 109.775 -172.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.54 -178.28 31.41 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.611 0.624 . . . . 0.0 111.746 176.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -81.29 -177.28 3.57 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.906 3.738 . . . . 0.0 112.141 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.74 146.23 45.56 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.159 -0.963 . . . . 0.0 109.448 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -88.99 101.09 13.74 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -71.83 146.25 48.1 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 162.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.8 mm -97.92 -105.34 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 167.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -155.26 -57.15 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.85 170.57 3.33 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.26 2.224 . . . . 0.0 108.864 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.82 59.47 1.23 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.859 1.264 . . . . 0.0 112.956 -173.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.05 162.9 34.31 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.743 1.617 . . . . 0.0 108.78 158.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.438 ' CB ' HH12 ' A' ' 29' ' ' ARG . 74.4 m -150.05 167.29 27.18 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.755 -1.216 . . . . 0.0 110.342 166.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.54 146.85 24.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' HD12 ' A' ' 40' ' ' ILE . 2.9 m-85 -107.16 148.19 29.16 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 171.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.84 83.19 0.16 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -131.13 167.67 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.513 1.125 . . . . 0.0 110.451 -175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.48 131.22 60.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -175.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.68 122.5 3.24 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.74 146.2 28.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.119 0.968 . . . . 0.0 108.834 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.62 145.27 16.29 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 124.04 0.829 . . . . 0.0 111.984 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -126.86 117.7 23.13 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.1 1.36 . . . . 0.0 107.492 165.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.57 133.78 9.06 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 106.003 -2.839 . . . . 0.0 106.003 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -76.36 96.91 4.1 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 168.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -70.04 111.68 5.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -64.84 151.88 44.34 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 167.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.3 141.81 51.59 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 44.1 m -67.51 -6.51 20.09 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.409 1.484 . . . . 0.0 112.706 -171.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 87.12 -28.72 0.06 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.549 2.34 . . . . 0.0 111.709 157.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -37.55 -58.31 1.3 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 128.309 2.644 . . . . 0.0 114.493 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.6 15.12 1.1 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.384 2.056 . . . . 0.0 113.399 -173.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . 0.305 0.6 OUTLIER 65.81 81.34 0.21 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 123.229 1.49 . . . . 0.0 107.922 -169.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.18 -54.25 1.19 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.937 1.295 . . . . 0.0 110.364 -177.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? 41.81 67.26 0.59 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.46 1.904 . . . . 0.0 114.255 171.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.5 t30 42.55 65.55 0.9 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.877 2.471 . . . . 0.0 113.682 167.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.32 -58.32 2.99 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 126.39 1.876 . . . . 0.0 112.517 -165.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.42 157.83 44.93 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.273 -0.892 . . . . 0.0 109.09 164.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -103.2 176.71 5.06 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.71 1.204 . . . . 0.0 111.101 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -137.7 128.49 27.04 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 109.912 -165.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -90.65 159.51 16.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 163.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.33 136.54 8.67 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 105.775 -2.93 . . . . 0.0 105.775 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -130.39 130.3 44.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -171.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.82 -175.19 3.88 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.072 1.349 . . . . 0.0 109.65 -167.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -135.23 148.71 49.69 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 165.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.46 64.24 1.11 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 125.436 1.493 . . . . 0.0 109.81 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -95.81 64.29 2.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.755 0.822 . . . . 0.0 109.672 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -96.19 165.72 24.13 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.808 1.67 . . . . 0.0 112.645 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -138.03 140.6 40.18 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.369 1.868 . . . . 0.0 108.857 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -113.45 141.01 47.62 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.041 1.337 . . . . 0.0 109.393 -167.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -119.05 171.83 7.99 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.376 1.071 . . . . 0.0 109.171 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -56.15 110.26 2.2 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.96 1.304 . . . . 0.0 110.15 -173.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 125.98 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.389 2.726 . . . . 0.0 111.013 -169.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.4 ttp -90.63 155.6 18.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 122.919 1.342 . . . . 0.0 110.111 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -80.55 30.1 0.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 128.942 2.897 . . . . 0.0 110.025 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.81 -14.3 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.219 1.808 . . . . 0.0 112.021 171.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.9 m -152.16 121.81 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 126.327 1.851 . . . . 0.0 108.058 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.75 165.59 17.02 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 119.996 -1.69 . . . . 0.0 109.64 160.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -139.13 114.58 9.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 165.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -156.83 155.58 31.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -137.84 114.62 10.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.616 1.566 . . . . 0.0 107.248 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 m -113.91 135.24 54.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 165.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -136.84 113.07 9.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 -169.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -121.29 143.47 49.15 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.143 0.977 . . . . 0.0 108.783 -173.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -133.46 125.0 28.06 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.271 1.428 . . . . 0.0 109.461 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 p -139.1 160.34 40.03 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 120.007 1.276 . . . . 0.0 111.516 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -113.73 117.22 30.9 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 44.7 mt -120.75 109.72 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.66 41.23 28.68 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.478 1.111 . . . . 0.0 110.903 172.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 56.6 m 58.66 16.5 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.81 128.89 39.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 160.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.12 131.1 41.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 169.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.3 t -132.7 133.23 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.2 153.42 17.62 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.3 t -132.69 129.91 39.39 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 159.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -102.04 110.07 21.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 169.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.6 mt -93.86 118.38 39.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.63 145.13 24.85 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -124.37 82.75 0.35 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.99 179.59 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 168.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.9 -120.53 1.23 Allowed Glycine 0 N--CA 1.465 0.618 0 CA-C-O 117.477 -1.735 . . . . 0.0 111.287 -169.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -164.23 164.39 22.53 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.578 1.951 . . . . 0.0 109.701 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.77 132.03 36.26 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.133 -1.604 . . . . 0.0 109.252 175.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.852 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.4 p -141.98 165.96 26.02 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 165.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.47 107.69 4.76 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.971 1.308 . . . . 0.0 110.047 -167.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -61.95 142.09 57.64 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 159.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 146' ' ' TYR . 0.9 OUTLIER -131.84 100.23 4.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 171.553 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -150.67 146.11 26.27 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.086 -1.634 . . . . 0.0 109.231 -165.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.38 170.81 38.91 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 121.452 0.473 . . . . 0.0 112.125 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.81 -127.32 1.4 Allowed Glycine 0 C--O 1.227 -0.309 0 O-C-N 121.164 -1.198 . . . . 0.0 111.748 -170.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -139.7 158.7 43.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.174 0.989 . . . . 0.0 109.982 -166.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.72 125.76 47.34 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.957 1.303 . . . . 0.0 107.738 169.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -101.94 104.48 15.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 163.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.0 m -89.14 141.94 28.07 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 159.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -138.23 165.03 27.71 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.682 1.993 . . . . 0.0 108.399 170.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.76 164.97 21.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 111.35 -170.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -62.07 5.97 0.09 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.24 102.63 0.23 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 104.521 -3.432 . . . . 0.0 104.521 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -65.09 95.92 0.19 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.894 1.278 . . . . 0.0 109.626 -164.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.2 mtt -153.8 10.7 0.41 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.082 2.553 . . . . 0.0 110.596 -176.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -131.78 143.66 50.38 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 120.707 -1.246 . . . . 0.0 109.0 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -137.63 76.99 1.61 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.461 1.904 . . . . 0.0 106.649 164.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.9 mtm -83.45 154.74 23.78 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.78 170.08 12.71 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.294 1.902 . . . . 0.0 111.447 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.37 -141.39 3.22 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -170.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -99.26 123.6 43.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.131 0.966 . . . . 0.0 109.649 -171.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -94.98 151.06 19.5 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.642 1.177 . . . . 0.0 107.846 -172.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.677 HD13 ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -144.56 148.99 35.08 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.292 1.437 . . . . 0.0 107.923 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.677 ' H ' HD13 ' A' ' 26' ' ' LEU . 40.2 mmtt -137.63 130.73 30.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.867 1.667 . . . . 0.0 107.63 -167.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.45 138.62 29.42 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -170.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 163.24 33.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.292 1.037 . . . . 0.0 108.608 167.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -120.4 157.87 28.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 161.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -101.94 112.29 24.86 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.09 178.81 6.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.401 1.08 . . . . 0.0 110.315 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -135.37 13.81 3.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.687 1.595 . . . . 0.0 111.504 -156.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -137.44 -28.35 0.92 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.085 0.954 . . . . 0.0 111.503 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 p -120.74 114.71 32.52 Favored Pre-proline 0 CA--C 1.535 0.382 0 O-C-N 120.919 -1.113 . . . . 0.0 111.07 -169.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.75 80.19 2.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.334 2.022 . . . . 0.0 109.227 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.34 156.29 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.111 2.164 . . . . 0.0 106.659 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -93.75 167.69 28.52 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.6 -1.111 . . . . 0.0 111.56 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.47 139.01 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 119.313 1.556 . . . . 0.0 107.929 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' A' ' 70' ' ' ALA . 4.9 mp -132.5 110.46 16.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.65 123.39 5.22 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 107.244 -2.343 . . . . 0.0 107.244 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 m -122.55 154.36 38.01 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.509 1.523 . . . . 0.0 109.605 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -121.12 132.71 55.02 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.407 0.683 . . . . 0.0 110.586 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -127.64 150.53 49.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.271 1.428 . . . . 0.0 108.185 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -138.62 157.11 46.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.222 3.009 . . . . 0.0 106.493 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 t -99.65 132.81 44.75 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -143.74 40.95 1.42 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.982 0.913 . . . . 0.0 109.888 -166.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -148.35 138.21 22.35 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 120.937 -1.102 . . . . 0.0 110.852 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -90.3 144.58 25.7 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.0 mtp85 -134.91 118.1 16.56 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 117.167 -1.397 . . . . 0.0 108.084 157.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.5 m -128.67 123.12 32.37 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 120.238 1.381 . . . . 0.0 108.464 172.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.74 89.02 1.87 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.263 0.625 . . . . 0.0 110.705 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m 60.08 16.97 6.35 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.491 1.117 . . . . 0.0 113.097 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 m -135.68 4.83 3.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.929 1.292 . . . . 0.0 111.123 -169.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.89 23.56 63.66 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.078 0.847 . . . . 0.0 113.543 173.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.5 101.8 6.63 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 128.759 2.824 . . . . 0.0 105.819 177.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -121.61 115.98 23.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.113 165.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -39.09 103.9 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.172 2.189 . . . . 0.0 110.906 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -120.87 122.94 41.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.833 1.197 . . . . 0.0 109.579 -166.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 66.28 -166.26 0.22 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.206 1.802 . . . . 0.0 107.67 -165.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -113.79 151.92 31.35 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.051 1.296 . . . . 0.0 110.166 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -75.17 136.65 41.04 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 155.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -122.11 117.59 26.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 174.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.22 124.48 4.54 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.77 157.08 38.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 171.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.8 t -140.61 158.63 43.7 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.14 145.36 24.66 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.024 0.93 . . . . 0.0 108.616 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.65 161.13 33.98 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 151.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.94 154.62 33.66 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.834 1.689 . . . . 0.0 109.398 165.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.546 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -90.15 167.08 13.0 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 161.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -140.69 154.89 46.55 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.772 -0.58 . . . . 0.0 109.933 165.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -111.27 148.56 32.63 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.458 1.103 . . . . 0.0 108.866 -175.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.3 mp -114.74 -58.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.874 1.27 . . . . 0.0 108.343 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 172.37 -41.14 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.877 2.471 . . . . 0.0 107.957 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.33 165.63 3.48 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.435 2.294 . . . . 0.0 110.406 -177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -82.44 46.93 1.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.279 163.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.94 151.59 36.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.516 2.326 . . . . 0.0 106.69 170.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.04 168.45 23.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 163.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.54 148.58 24.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 174.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -150.67 124.33 9.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.353 0.661 . . . . 0.0 110.211 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.27 142.21 47.03 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 163.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.53 176.08 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.042 0.937 . . . . 0.0 108.877 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -127.57 155.2 38.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.64 163.67 26.83 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.82 131.95 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 171.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.44 109.32 0.95 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 107.17 -2.372 . . . . 0.0 107.17 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -128.84 146.3 50.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.41 -175.59 33.28 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 118.225 -1.941 . . . . 0.0 112.56 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -118.16 120.87 39.03 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -162.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -73.53 0.16 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.781 0.832 . . . . 0.0 112.7 -168.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -175.9 44.97 0.01 OUTLIER 'General case' 0 C--O 1.235 0.304 0 C-N-CA 127.716 2.406 . . . . 0.0 111.84 -165.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.2 95.52 1.28 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.254 1.026 . . . . 0.0 109.485 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 p -145.03 28.26 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.277 1.431 . . . . 0.0 108.985 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.48 -56.87 7.83 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.742 0.817 . . . . 0.0 110.504 -170.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 171.28 -62.93 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 128.243 2.617 . . . . 0.0 108.087 -174.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.54 169.66 10.9 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.702 1.601 . . . . 0.0 110.764 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.5 p -71.05 15.0 0.12 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.885 1.674 . . . . 0.0 112.896 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.16 -171.9 3.98 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.361 1.864 . . . . 0.0 107.796 -164.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 133.19 -66.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 131.529 3.932 . . . . 0.0 108.656 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -87.95 -71.78 0.56 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 121.129 1.786 . . . . 0.0 109.423 171.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.2 t0 56.68 -160.36 0.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.496 1.118 . . . . 0.0 110.568 -158.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.9 t -125.38 117.8 24.51 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 126.759 2.024 . . . . 0.0 106.245 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -158.85 38.27 0.22 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.624 1.17 . . . . 0.0 108.132 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.23 143.5 40.17 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.255 1.822 . . . . 0.0 107.103 -166.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.91 88.08 2.47 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.224 1.009 . . . . 0.0 108.336 -156.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.15 39.71 1.87 Allowed Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.322 1.439 . . . . 0.0 111.804 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -73.99 121.23 20.71 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 t -157.29 -161.83 1.12 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -129.58 174.16 9.93 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 126.719 2.008 . . . . 0.0 108.848 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.11 -173.8 31.23 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.72 105.37 8.93 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.706 1.602 . . . . 0.0 108.244 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.26 141.93 15.89 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -138.15 161.44 36.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.657 1.983 . . . . 0.0 108.2 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -139.46 159.72 41.5 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.116 0.967 . . . . 0.0 108.419 167.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.409 ' CD2' HD12 ' A' ' 123' ' ' LEU . 4.0 m-30 -92.98 171.54 8.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.444 1.498 . . . . 0.0 108.52 165.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -56.48 119.95 32.41 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.411 1.484 . . . . 0.0 109.117 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.12 148.84 70.14 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.166 1.911 . . . . 0.0 110.5 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 95.2 mtp -116.25 -176.52 2.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.322 1.449 . . . . 0.0 108.804 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.88 -15.88 59.56 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.04 1.336 . . . . 0.0 110.139 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -164.59 14.37 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.836 2.455 . . . . 0.0 111.805 -168.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.94 148.16 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.53 ' C ' HD23 ' A' ' 123' ' ' LEU . . . -156.94 154.05 29.09 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 164.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -133.32 115.78 15.33 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.03 109.51 16.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.509 1.523 . . . . 0.0 107.432 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -115.34 143.66 44.94 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.296 1.038 . . . . 0.0 109.251 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 p -145.92 162.58 37.46 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.379 1.072 . . . . 0.0 110.656 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -151.12 105.48 3.23 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.372 1.069 . . . . 0.0 109.219 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -123.28 163.58 20.43 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.609 1.564 . . . . 0.0 109.956 -170.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -118.52 158.19 25.86 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.762 0.825 . . . . 0.0 111.577 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 t -140.93 105.96 4.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.267 1.827 . . . . 0.0 109.246 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -78.6 97.93 5.97 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 120.851 -1.155 . . . . 0.0 110.109 169.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.5 81.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.96 -70.87 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 128.522 2.729 . . . . 0.0 112.831 -171.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.83 3.82 2.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.298 2.639 . . . . 0.0 110.902 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.72 129.53 46.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -83.27 109.02 16.89 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.2 t -118.72 152.97 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.705 1.202 . . . . 0.0 108.368 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -140.2 152.74 22.99 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 128.123 2.773 . . . . 0.0 107.874 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -135.49 136.08 40.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.414 1.107 . . . . 0.0 109.644 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -112.45 110.67 21.01 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.1 mt -113.65 129.5 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.31 162.1 35.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.33 1.062 . . . . 0.0 109.679 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -158.07 164.37 33.26 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 167.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 m -137.65 166.36 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 166.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -174.82 -107.19 0.2 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 106.982 -2.447 . . . . 0.0 106.982 167.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.419 ' HB2' HG23 ' A' ' 5' ' ' VAL . 5.3 m-85 -141.76 176.6 8.79 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.827 2.051 . . . . 0.0 109.335 -170.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.31 151.76 35.94 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.715 -0.616 . . . . 0.0 110.078 171.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 C--O 1.248 1.014 0 C-N-CA 126.303 1.841 . . . . 0.0 107.97 168.922 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.5 p -96.65 138.2 34.58 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.661 -0.649 . . . . 0.0 109.507 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -89.97 159.18 17.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.947 1.299 . . . . 0.0 108.627 162.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -159.92 144.9 15.08 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 167.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.31 100.14 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.572 0.749 . . . . 0.0 109.143 -171.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 m -132.44 141.35 48.8 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 119.977 -1.702 . . . . 0.0 109.022 -170.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.0 -164.9 26.49 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -166.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.07 -114.05 0.86 Allowed Glycine 0 C--O 1.233 0.094 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.82 158.07 45.11 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.363 1.865 . . . . 0.0 109.223 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.44 136.92 51.35 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 160.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -120.07 122.48 41.18 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -131.66 151.05 51.92 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.34 170.69 15.57 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.754 1.622 . . . . 0.0 109.195 -173.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.67 164.89 27.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.391 1.076 . . . . 0.0 111.493 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -58.93 74.82 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.268 2.627 . . . . 0.0 110.27 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.71 82.86 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 107.835 -2.106 . . . . 0.0 107.835 -171.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -46.02 96.02 0.01 OUTLIER 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.923 2.489 . . . . 0.0 110.094 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.18 -12.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.993 2.117 . . . . 0.0 111.09 -176.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -105.25 123.69 48.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.347 1.459 . . . . 0.0 107.283 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -133.56 95.83 3.57 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.33 159.29 34.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.065 0.936 . . . . 0.0 108.736 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.56 156.09 16.8 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.38 -88.7 0.09 OUTLIER Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -165.42 164.62 19.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.221 1.008 . . . . 0.0 109.251 173.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -130.9 142.17 50.35 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.481 2.312 . . . . 0.0 107.068 166.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -150.44 140.13 21.69 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.791 1.236 . . . . 0.0 108.192 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -151.53 168.16 25.79 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.048 0.939 . . . . 0.0 110.945 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -141.31 114.51 8.67 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.778 0.831 . . . . 0.0 109.127 -167.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -93.73 108.32 20.09 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -103.55 118.26 36.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -140.55 143.3 35.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 7.9 tp10 -143.33 147.46 34.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -175.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.89 2.41 20.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.557 1.143 . . . . 0.0 112.184 -175.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.483 ' H ' ' HG3' ' A' ' 32' ' ' GLU . 4.0 m120 -73.93 -39.07 64.06 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.116 1.366 . . . . 0.0 110.335 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 t -153.37 110.58 2.61 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.4 68.23 5.25 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.992 3.128 . . . . 0.0 110.025 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.1 tp -139.05 105.3 5.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.8 -177.53 47.31 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 123.677 0.656 . . . . 0.0 111.669 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.1 t -134.61 139.72 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.8 pt -129.43 109.73 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 163.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.28 146.55 18.48 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 154.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.39 155.47 40.3 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 128.404 2.682 . . . . 0.0 106.348 160.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -115.78 131.1 57.04 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 167.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 m -92.73 147.45 22.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 156.65 45.23 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.104 1.762 . . . . 0.0 107.106 172.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -143.11 162.43 35.56 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.647 -0.658 . . . . 0.0 109.56 157.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.82 134.21 51.74 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.452 1.901 . . . . 0.0 107.898 166.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.62 147.8 1.1 Allowed 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.513 1.525 . . . . 0.0 107.577 -175.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -130.22 119.01 22.24 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -134.16 178.31 7.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.522 1.529 . . . . 0.0 109.388 175.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.5 t -154.64 38.07 0.42 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.061 1.745 . . . . 0.0 110.325 -173.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.85 107.44 0.45 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.706 0.802 . . . . 0.0 109.306 -172.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.1 m 149.73 -81.74 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 1 C-N-CA 132.643 4.377 . . . . 0.0 108.408 170.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.7 m -119.3 19.42 12.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.328 1.051 . . . . 0.0 112.312 -171.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.61 -2.2 88.01 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 118.447 -1.196 . . . . 0.0 114.486 160.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -72.37 106.12 4.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 163.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -121.78 108.88 14.01 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 126.055 1.742 . . . . 0.0 108.195 159.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 175.79 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 128.286 2.634 . . . . 0.0 105.423 152.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -150.98 157.02 42.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 128.205 2.602 . . . . 0.0 105.913 168.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -133.48 80.33 1.87 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -165.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -113.25 150.17 32.79 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -169.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -141.74 159.34 42.43 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 168.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -128.37 173.26 10.34 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.05 140.9 9.77 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -123.31 107.53 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 170.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -138.11 142.28 40.19 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 128.067 2.547 . . . . 0.0 104.868 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.26 40.06 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 118.562 0.619 . . . . 0.0 110.693 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.7 170.04 30.53 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.959 1.742 . . . . 0.0 109.103 161.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.9 179.79 5.36 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.405 2.07 . . . . 0.0 109.006 164.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.66 144.16 48.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 153.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -141.24 125.91 17.92 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -83.51 93.56 7.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.069 0.849 . . . . 0.0 109.973 -165.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.1 pp -142.52 -168.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.597 1.559 . . . . 0.0 110.354 -174.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 64.38 -95.51 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 128.744 2.818 . . . . 0.0 107.494 -170.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -147.76 115.44 6.37 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 120.55 1.523 . . . . 0.0 108.443 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 12.8 m0 59.81 8.13 1.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.027 2.531 . . . . 0.0 115.27 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.9 179.83 4.24 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.397 0.999 . . . . 0.0 109.218 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -144.99 105.32 4.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.87 152.45 35.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.99 167.2 27.4 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.649 0.38 . . . . 0.0 109.99 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.89 150.44 50.47 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 163.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -131.36 143.78 39.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.2 153.41 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 123.297 0.639 . . . . 0.0 110.643 -177.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.96 -170.81 39.15 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 123.624 0.577 . . . . 0.0 113.118 -169.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.09 141.26 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.048 1.339 . . . . 0.0 107.946 172.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.86 143.69 16.04 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 125.658 1.599 . . . . 0.0 109.519 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.9 130.47 35.96 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.208 1.803 . . . . 0.0 107.305 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.86 -145.39 13.09 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.186 1.85 . . . . 0.0 110.091 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.31 133.62 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.484 2.313 . . . . 0.0 110.459 -170.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -135.32 -66.38 0.58 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 117.665 -1.16 . . . . 0.0 112.086 165.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.79 115.73 14.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 120.108 1.322 . . . . 0.0 108.4 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.58 115.48 16.15 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -166.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 p -138.5 -48.69 0.53 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.399 1.454 . . . . 0.0 111.636 -167.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 49.71 -68.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 131.2 3.8 . . . . 0.0 112.743 -163.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.514 ' H ' ' HD2' ' A' ' 96' ' ' PRO . 36.4 m-85 -162.14 -54.37 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 129.073 2.949 . . . . 0.0 109.795 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 95' ' ' TYR . 79.3 Cg_endo -68.58 -2.16 8.77 Favored 'Trans proline' 0 C--N 1.354 0.864 0 CA-C-N 121.892 1.711 . . . . 0.0 113.099 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.9 m 68.87 75.82 0.25 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.784 2.034 . . . . 0.0 108.286 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -59.16 -45.48 90.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.397 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.5 pttp 35.07 49.27 0.41 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.382 2.273 . . . . 0.0 112.358 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -163.97 -80.57 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 118.289 -0.863 . . . . 0.0 109.761 -169.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.8 t0 76.36 154.49 0.15 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 130.075 3.35 . . . . 0.0 112.034 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.7 p -63.38 113.3 3.16 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 162.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.9 p -61.89 103.72 0.38 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.89 162.02 21.7 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 168.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -146.88 144.57 29.37 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -125.81 107.16 0.93 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 124.594 1.092 . . . . 0.0 111.018 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.68 118.3 15.43 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.8 m -98.05 132.82 43.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -144.91 61.43 1.31 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.3 1.04 . . . . 0.0 110.916 -171.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.63 -164.35 40.23 Favored Glycine 0 CA--C 1.52 0.393 0 O-C-N 121.097 -1.002 . . . . 0.0 113.254 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.94 159.18 40.71 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 151.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -122.46 116.25 2.97 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 107.851 -2.099 . . . . 0.0 107.851 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -117.85 155.72 29.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.104 2.561 . . . . 0.0 106.622 -166.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.28 149.45 33.87 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.935 -1.103 . . . . 0.0 112.152 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.11 172.16 8.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.244 1.818 . . . . 0.0 109.817 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -59.15 130.67 87.0 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 119.12 -0.467 . . . . 0.0 110.796 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.3 118.32 5.29 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.682 2.255 . . . . 0.0 110.361 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 ttt -78.18 -176.03 4.42 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 150.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -86.68 -28.34 23.21 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 123.856 0.862 . . . . 0.0 109.827 172.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.68 3.59 4.54 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 110.755 -162.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.5 t -150.54 112.25 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 127.82 2.448 . . . . 0.0 105.69 -170.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.92 134.0 51.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.67 132.76 46.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -172.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -141.27 155.67 45.97 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.385 1.474 . . . . 0.0 109.182 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -138.1 123.09 19.02 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 124.525 1.13 . . . . 0.0 108.92 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.2 m -122.42 144.76 48.84 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 164.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -149.79 114.85 5.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.86 137.39 38.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.777 1.231 . . . . 0.0 108.339 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -99.76 161.64 13.49 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 169.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p -140.14 108.08 5.71 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.407 1.083 . . . . 0.0 109.351 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.8 ttm105 -62.28 123.79 19.16 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 168.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.7 mt -123.43 104.78 14.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.63 50.93 12.61 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.864 1.265 . . . . 0.0 111.713 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 61.4 m 48.87 29.66 2.39 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -174.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.57 138.58 19.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 156.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -86.21 121.0 28.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.98 134.16 31.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.34 146.63 17.78 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.7 p -124.16 136.38 54.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -131.63 157.74 42.89 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 163.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.3 mt -127.03 128.25 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -167.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.06 126.91 35.64 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.36 101.99 0.57 Allowed Glycine 0 C--O 1.224 -0.529 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 -170.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 t -138.41 139.17 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 127.291 2.236 . . . . 0.0 106.306 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -179.27 -129.61 1.34 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -146.83 177.1 9.37 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.77 2.028 . . . . 0.0 110.046 -158.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.23 166.28 24.14 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 166.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 12.6 p90 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.486 -1.721 . . . . 0.0 108.278 174.85 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.912 -0.033 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.3 p -140.52 160.35 40.2 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.423 0.689 . . . . 0.0 109.782 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.6 106.64 10.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.632 0.73 . . . . 0.0 110.291 -173.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.78 159.57 29.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 161.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.03 101.18 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 166.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 t -122.06 143.99 49.18 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.4 160.93 25.95 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.783 1.658 . . . . 0.0 109.043 -175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.75 -172.21 45.25 Favored Glycine 0 CA--C 1.51 -0.277 0 O-C-N 119.406 -2.232 . . . . 0.0 110.732 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -90.78 139.82 30.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.121 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.73 154.8 17.03 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.115 1.366 . . . . 0.0 109.123 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -152.54 118.8 5.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.62 151.12 24.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -138.42 159.94 40.79 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 150.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.63 160.45 37.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.619 0.645 . . . . 0.0 110.948 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.41 77.27 3.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.255 0.55 . . . . 0.0 111.176 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.69 -2.8 7.53 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.253 1.406 . . . . 0.0 112.377 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -150.99 96.39 2.32 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.075 1.437 . . . . 0.0 107.994 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.9 mtt -75.99 65.13 1.99 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.863 2.465 . . . . 0.0 110.344 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -78.89 95.94 5.55 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 108.766 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -76.35 77.9 3.1 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.563 0.697 . . . . 0.0 109.556 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.3 mmm -114.25 159.42 20.17 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.904 1.282 . . . . 0.0 108.273 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.54 163.89 12.73 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -168.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.53 -120.95 1.07 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 104.356 -3.498 . . . . 0.0 104.356 -172.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.33 170.32 8.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.335 1.068 . . . . 0.0 109.948 -171.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -137.22 163.14 31.61 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 128.029 2.532 . . . . 0.0 106.387 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.69 158.77 43.82 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 164.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -139.48 156.59 46.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.53 130.85 33.08 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -105.63 115.07 29.62 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -98.21 118.67 35.37 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 103.625 -2.731 . . . . 0.0 103.625 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -87.78 128.34 35.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -109.15 178.44 4.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.52 16.42 8.21 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.293 1.437 . . . . 0.0 109.922 -167.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.38 -63.58 0.98 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.191 1.396 . . . . 0.0 110.351 172.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.0 m -75.19 133.29 75.26 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 117.921 0.328 . . . . 0.0 110.768 -172.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.42 -9.22 18.76 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.521 2.814 . . . . 0.0 112.995 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -88.92 155.57 19.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.166 0.986 . . . . 0.0 109.811 173.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.72 -172.94 17.16 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 166.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -130.52 143.92 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 pt -140.27 142.01 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.85 1.26 . . . . 0.0 109.165 165.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.28 108.08 0.34 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.568 1.08 . . . . 0.0 110.435 166.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.85 153.87 42.36 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.354 1.062 . . . . 0.0 110.374 173.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -120.62 148.38 43.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 153.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 t -127.38 150.93 49.39 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.452 1.901 . . . . 0.0 105.928 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -142.72 156.97 45.09 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.309 0.504 . . . . 0.0 110.214 171.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.3 t -100.06 143.98 29.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.729 0.812 . . . . 0.0 110.291 -176.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -151.05 29.27 0.66 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.927 2.091 . . . . 0.0 110.572 -172.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -133.68 148.4 51.48 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 118.985 -2.322 . . . . 0.0 111.545 -175.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.2 m -113.17 121.74 45.42 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.939 1.296 . . . . 0.0 107.629 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.11 103.5 13.3 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -137.45 166.09 24.68 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 164.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.95 -89.02 0.35 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 166.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.1 m -151.38 62.39 0.89 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.399 -0.813 . . . . 0.0 109.145 172.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 m 64.3 79.2 0.26 Allowed 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.477 1.511 . . . . 0.0 111.349 -177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.4 -74.19 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 103.627 -3.789 . . . . 0.0 103.627 156.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -86.11 115.8 23.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 174.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -130.89 117.86 19.89 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 123.42 0.688 . . . . 0.0 110.139 161.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -114.03 143.4 44.81 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 171.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -149.7 120.61 7.65 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 156.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.457 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 41.7 t30 -157.83 -158.41 0.73 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 155.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.457 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 10.8 mp0 -111.36 165.09 12.25 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 165.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.67 116.17 13.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 174.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -97.04 133.86 41.16 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -173.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.09 104.8 0.35 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.6 tt -126.46 114.37 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.443 1.097 . . . . 0.0 108.762 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 t -122.57 151.84 41.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.75 158.41 39.49 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.067 0.947 . . . . 0.0 109.127 168.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.22 -178.56 42.34 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 168.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.52 142.43 44.57 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.015 1.81 . . . . 0.0 110.377 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.31 103.15 15.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 153.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.7 144.97 33.22 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 167.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -74.06 127.38 32.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mm -50.27 -60.86 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.19 0.996 . . . . 0.0 108.848 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -156.89 -43.53 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 167.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.3 -89.51 0.05 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.034 1.333 . . . . 0.0 107.577 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.34 7.11 0.2 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -166.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.84 167.99 20.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.346 1.43 . . . . 0.0 111.161 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 p -74.0 168.76 18.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.983 0.913 . . . . 0.0 110.166 164.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -129.74 164.57 32.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.108 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.53 ' H ' HD13 ' A' ' 79' ' ' ILE . 43.6 p90 -105.08 171.0 7.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.826 2.051 . . . . 0.0 110.971 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.57 70.76 1.16 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.74 168.72 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 117.95 0.875 . . . . 0.0 110.405 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.49 154.12 3.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.76 171.51 36.15 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 118.434 0.561 . . . . 0.0 111.999 163.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.33 126.42 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 170.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.99 104.97 2.02 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 166.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -112.95 135.75 53.38 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.564 1.146 . . . . 0.0 107.974 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.25 -166.54 39.35 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.79 102.6 0.05 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.924 1.69 . . . . 0.0 110.056 -176.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -124.09 -78.49 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 175.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -69.87 142.4 53.03 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.42 -0.8 . . . . 0.0 110.835 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.456 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 1.1 m -136.01 137.06 40.82 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.029 2.132 . . . . 0.0 105.712 174.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 29.0 m -169.41 101.86 0.34 Allowed 'General case' 0 N--CA 1.444 -0.773 1 N-CA-C 99.653 -4.202 . . . . 0.0 99.653 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -111.01 -36.32 5.68 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.966 1.306 . . . . 0.0 108.038 174.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -160.96 -70.37 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.21 1.404 . . . . 0.0 109.292 160.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.7 -2.03 4.79 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.351 2.701 . . . . 0.0 115.702 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.6 m 66.43 15.21 10.03 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 120.34 1.427 . . . . 0.0 112.728 162.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -56.42 -37.67 70.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.386 1.075 . . . . 0.0 111.649 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.456 ' HG3' ' H ' ' A' ' 92' ' ' THR . 6.2 ttpt 69.2 158.46 0.16 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.676 2.791 . . . . 0.0 112.139 176.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.64 -56.57 1.95 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -171.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 55.13 15.12 1.14 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.062 1.745 . . . . 0.0 112.649 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.9 p -67.37 95.2 0.43 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.773 2.029 . . . . 0.0 111.132 -173.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 p -76.48 125.37 29.1 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -151.18 157.95 43.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 167.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -70.89 157.45 38.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 117.894 -1.522 . . . . 0.0 108.729 163.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.3 122.55 6.33 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 105.568 -3.013 . . . . 0.0 105.568 159.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -78.63 117.18 19.55 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 78.7 p -103.02 158.33 16.37 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.306 1.051 . . . . 0.0 112.077 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -105.11 112.84 26.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.13 143.03 16.31 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 118.558 0.617 . . . . 0.0 111.783 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -140.18 160.64 39.5 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.689 1.196 . . . . 0.0 109.504 172.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.59 122.12 0.87 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.08 140.52 51.9 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.109 1.364 . . . . 0.0 107.482 173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -120.22 149.76 41.76 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.189 0.995 . . . . 0.0 108.85 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -92.66 172.27 8.46 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.947 1.299 . . . . 0.0 109.62 -174.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -57.18 154.71 19.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.552 -0.717 . . . . 0.0 110.702 169.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.46 143.47 52.4 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.77 2.314 . . . . 0.0 111.538 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.7 mmt -108.44 -176.73 3.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -92.84 -30.33 15.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 109.404 -170.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -142.34 9.72 1.86 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.248 1.419 . . . . 0.0 110.693 -171.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.261 0.2 OUTLIER -141.31 140.43 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 119.582 1.083 . . . . 0.0 108.551 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.4 153.32 18.66 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -133.39 116.16 15.72 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 162.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -141.09 137.71 33.03 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.864 1.666 . . . . 0.0 107.425 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -133.63 121.81 22.57 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.325 0.966 . . . . 0.0 109.178 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.5 m -127.62 149.94 49.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 140' ' ' TRP . 1.5 t80 -145.01 137.25 25.93 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -127.58 153.87 45.87 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.377 1.071 . . . . 0.0 108.774 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -131.52 154.82 48.39 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 168.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.4 m -136.66 156.77 48.09 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.914 2.086 . . . . 0.0 108.534 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -134.1 97.17 3.79 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.3 90.97 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 60.79 -93.11 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 126.656 1.982 . . . . 0.0 110.573 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.17 1.76 20.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.349 0.977 . . . . 0.0 112.633 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.37 112.81 41.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-N 119.847 1.203 . . . . 0.0 108.599 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.43 136.47 57.92 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 162.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.9 t -125.86 116.85 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 169.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.48 149.84 20.04 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 170.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 87.6 m -141.12 120.42 13.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 164.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.448 ' HB3' ' CE2' ' A' ' 127' ' ' TYR . 5.6 p-90 -90.88 141.89 28.34 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 170.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.96 134.88 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.69 164.39 14.73 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 172.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -146.63 104.09 0.29 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.47 -179.83 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.372 1.869 . . . . 0.0 105.989 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 146.15 -115.12 0.78 Allowed Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 106.883 -2.487 . . . . 0.0 106.883 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -147.75 175.8 10.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.01 1.324 . . . . 0.0 110.679 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -140.28 165.81 26.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 164.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 C--O 1.25 1.101 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 170.203 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 p -140.48 141.38 35.41 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 168.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -122.93 158.78 29.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 m -145.78 154.82 42.45 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 166.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.1 98.96 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.1 p -117.47 135.15 54.12 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.928 1.291 . . . . 0.0 107.917 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.12 168.42 38.56 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.44 -169.15 42.1 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.483 -173.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -92.04 157.86 16.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.722 1.209 . . . . 0.0 109.026 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.02 172.91 8.17 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.157 0.983 . . . . 0.0 111.307 -174.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -148.24 104.56 3.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 155.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t -84.39 134.02 34.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 157.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -103.28 171.38 7.4 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.37 158.25 44.02 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 161.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.16 97.45 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 162.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.16 -29.81 2.68 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.778 1.18 . . . . 0.0 110.664 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -151.1 93.88 1.98 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -88.34 69.52 9.06 Favored 'General case' 0 C--N 1.335 -0.065 0 CA-C-O 123.954 1.835 . . . . 0.0 107.005 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.49 -177.77 4.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 128.168 2.587 . . . . 0.0 108.476 -168.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -90.79 96.78 10.81 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 164.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 62.2 mtm -70.57 159.23 34.73 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 138.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.77 -161.91 17.96 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.46 -140.48 5.04 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -160.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.99 154.45 20.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.864 1.266 . . . . 0.0 109.703 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -137.66 153.89 49.78 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.452 2.701 . . . . 0.0 107.634 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -150.25 141.41 23.1 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.787 1.635 . . . . 0.0 107.768 168.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -116.43 146.42 42.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.693 1.997 . . . . 0.0 107.363 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.66 110.91 10.19 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -93.23 157.7 16.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -143.63 158.25 43.81 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.823 0.283 . . . . 0.0 110.553 165.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -125.02 112.55 16.69 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.564 0.697 . . . . 0.0 109.147 169.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.0 164.09 21.69 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.81 8.44 41.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.777 1.631 . . . . 0.0 112.912 -169.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -1.27 22.55 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -172.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.06 139.82 8.36 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 126.555 1.942 . . . . 0.0 107.306 166.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.79 81.06 2.45 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.516 2.144 . . . . 0.0 108.301 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 tp -150.65 156.65 41.77 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.202 1.801 . . . . 0.0 107.94 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.18 -177.9 15.26 Favored Glycine 0 C--O 1.226 -0.346 0 O-C-N 121.571 -0.706 . . . . 0.0 111.539 172.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.2 t -143.5 137.37 25.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.367 1.467 . . . . 0.0 108.25 -165.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.6 mm -139.9 141.39 34.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.977 1.311 . . . . 0.0 109.91 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.64 167.89 20.64 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 107.729 -2.149 . . . . 0.0 107.729 144.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.8 t -127.45 155.27 43.95 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.208 -1.76 . . . . 0.0 106.877 143.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -98.48 143.82 28.49 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 165.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -127.7 134.18 49.57 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.858 1.263 . . . . 0.0 108.389 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -141.96 123.87 15.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.593 1.157 . . . . 0.0 108.395 -172.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -99.21 126.85 45.1 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -163.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -139.14 0.48 1.93 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.308 0.575 . . . . 0.0 112.254 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.19 123.49 26.97 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.001 -1.687 . . . . 0.0 109.1 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.9 p -67.06 152.25 46.12 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.396 0.998 . . . . 0.0 110.633 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.93 123.22 25.54 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 157.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -157.92 -176.33 5.86 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 161.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.77 -54.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.331 1.452 . . . . 0.0 108.878 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 m -147.93 -43.12 0.16 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.917 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 p 173.18 84.04 0.0 OUTLIER 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.401 1.881 . . . . 0.0 106.027 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.66 -74.89 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 O-C-N 121.849 -0.532 . . . . 0.0 113.261 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -119.28 91.17 3.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.989 0.895 . . . . 0.0 109.806 -166.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -88.74 126.21 35.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.894 0.878 . . . . 0.0 110.284 -162.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -62.74 109.2 1.35 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.244 0.929 . . . . 0.0 109.908 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -121.25 170.93 9.11 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.259 1.424 . . . . 0.0 110.968 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 58.22 -159.0 0.28 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.71 1.604 . . . . 0.0 111.112 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 158.64 38.09 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 120.507 -1.371 . . . . 0.0 108.616 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -115.73 158.95 22.06 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -127.91 157.14 41.33 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.312 1.845 . . . . 0.0 107.77 -173.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.32 88.82 0.14 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.73 113.47 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.9 m -131.16 128.0 39.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.59 149.28 25.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.373 1.069 . . . . 0.0 108.969 -174.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.13 175.87 31.58 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 166.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.66 175.4 11.15 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.451 2.768 . . . . 0.0 113.036 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.51 138.58 52.34 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.283 1.833 . . . . 0.0 110.712 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -121.02 128.42 52.66 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.08 1.352 . . . . 0.0 108.93 -168.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.53 149.45 24.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.71 0.804 . . . . 0.0 110.223 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -78.88 179.06 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 163.575 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -61.32 -52.65 63.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.617 -1.302 . . . . 0.0 110.718 -176.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -159.98 148.52 17.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 149.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 11.6 m0 145.1 -49.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 130.746 3.618 . . . . 0.0 108.87 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' H ' HG22 ' A' ' 73' ' ' ILE . . . -148.71 168.69 22.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.758 0.823 . . . . 0.0 109.516 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 m -133.48 156.99 46.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 163.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.521 HG22 HD23 ' A' ' 113' ' ' LEU . 16.3 pt -127.47 167.68 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.84 2.056 . . . . 0.0 108.575 -176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.15 123.96 26.61 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.268 -0.895 . . . . 0.0 108.885 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.43 86.58 0.4 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 106.908 -2.477 . . . . 0.0 106.908 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.6 HG22 ' HB2' ' A' ' 111' ' ' ALA . 2.3 m -113.66 -176.62 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.336 0.655 . . . . 0.0 109.867 -175.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.4 m -116.33 151.01 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 166.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.77 158.4 20.05 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 167.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.8 p -145.86 121.62 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.05 106.35 3.22 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -108.59 117.4 34.07 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.43 174.1 19.41 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -154.46 98.92 2.15 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 170.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -70.64 152.63 43.68 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 157.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -148.76 104.64 3.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.536 0.684 . . . . 0.0 109.694 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -66.55 123.32 19.72 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 127.23 2.212 . . . . 0.0 106.977 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -126.27 4.5 7.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.46 -163.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -126.5 -61.2 1.21 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.682 1.193 . . . . 0.0 109.054 -164.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -60.02 153.53 55.13 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 167.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.79 81.83 1.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.693 2.929 . . . . 0.0 109.354 171.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.7 m -138.5 -46.75 0.5 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.484 1.514 . . . . 0.0 109.384 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 68.6 -68.04 0.19 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.026 2.13 . . . . 0.0 112.851 169.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.47 93.8 4.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -70.2 -47.61 60.72 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -176.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.88 176.53 10.07 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.789 1.236 . . . . 0.0 107.786 166.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.4 m -85.17 156.7 20.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 166.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 p -69.68 155.57 40.31 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 175.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -141.11 159.26 42.58 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 165.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -85.68 165.83 16.65 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.494 -0.754 . . . . 0.0 110.267 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.51 142.31 14.27 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 163.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -118.11 93.2 4.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.572 1.186 . . . . 0.0 109.034 -160.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.7 t -87.21 147.51 25.55 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.976 0.893 . . . . 0.0 110.198 -173.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.12 144.24 51.25 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 128.398 2.679 . . . . 0.0 106.479 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.69 -170.13 14.56 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 -165.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.6 ' HB2' HG22 ' A' ' 82' ' ' VAL . . . -166.97 -65.53 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.413 1.107 . . . . 0.0 109.203 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 155.11 174.35 24.91 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -167.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.521 HD23 HG22 ' A' ' 79' ' ' ILE . 4.2 mp -145.17 143.84 30.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -104.24 149.51 25.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -173.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.8 171.17 8.82 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -58.75 142.16 84.21 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-O 119.165 -0.445 . . . . 0.0 109.865 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.43 152.55 78.62 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 120.931 1.087 . . . . 0.0 111.007 172.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -109.09 -174.19 2.45 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 130.955 3.702 . . . . 0.0 105.503 162.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -110.93 -11.8 14.3 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.309 1.844 . . . . 0.0 109.294 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -142.01 17.22 2.11 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.176 1.39 . . . . 0.0 111.6 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.82 156.04 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 172.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.41 156.71 42.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.777 0.717 . . . . 0.0 109.166 157.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -136.89 122.36 19.54 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.991 2.117 . . . . 0.0 108.403 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -124.61 160.52 28.28 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.773 2.429 . . . . 0.0 107.64 163.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -140.87 116.69 10.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.23 144.16 51.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.418 0.554 . . . . 0.0 109.939 -168.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -137.29 156.62 48.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -129.79 147.61 51.59 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 155.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -132.84 112.2 11.72 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.8 t -139.56 160.3 40.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.624 1.57 . . . . 0.0 108.228 -157.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.65 145.83 37.11 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.45 110.35 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 171.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 50.17 40.91 23.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.302 1.041 . . . . 0.0 111.97 -173.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 m 47.76 36.84 6.19 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.6 t -81.48 112.79 19.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 143.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.16 137.2 58.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.5 t -139.26 97.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.88 152.4 34.98 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 164.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.8 m -141.0 130.88 24.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 120.775 -1.427 . . . . 0.0 108.047 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -121.23 143.19 49.28 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.8 mt -144.75 132.31 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.805 1.242 . . . . 0.0 107.873 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.61 165.88 14.51 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -154.26 87.36 0.13 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.66 162.61 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 152.81 -119.37 0.95 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -150.59 176.38 11.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.119 1.368 . . . . 0.0 109.564 -158.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 137.9 23.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.039 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 12.0 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-N 119.34 0.973 . . . . 0.0 108.655 167.288 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 p -141.08 136.95 32.49 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 t -127.9 106.81 9.36 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -117.24 118.8 33.3 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.281 5.9 p -110.56 119.41 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 122.006 0.908 . . . . 0.0 111.093 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.32 137.77 23.36 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.728 1.211 . . . . 0.0 108.943 -167.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.5 170.07 40.08 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.59 -152.01 10.02 Favored Glycine 0 C--N 1.319 -0.375 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -172.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -91.87 157.7 16.71 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.47 113.29 11.68 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 169.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.32 148.04 29.52 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.8 t -138.88 115.57 10.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.982 2.113 . . . . 0.0 107.206 -171.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.38 160.69 34.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.068 0.947 . . . . 0.0 109.163 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.72 148.47 52.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.727 0.811 . . . . 0.0 110.986 -167.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 54.65 -70.15 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 128.323 2.649 . . . . 0.0 112.067 -175.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.75 -42.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.7 0 CA-C-N 119.975 1.261 . . . . 0.0 111.04 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -145.21 119.49 9.55 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.438 1.095 . . . . 0.0 108.461 164.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.2 ttm -157.18 -51.75 0.07 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.212 1.005 . . . . 0.0 109.324 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -142.19 158.22 43.98 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.232 1.813 . . . . 0.0 107.733 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -135.76 77.33 1.66 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 170.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.06 138.62 49.06 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 166.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.84 157.22 27.34 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.61 -166.68 38.17 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -170.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -99.89 154.74 18.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.326 0.563 . . . . 0.0 110.402 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -102.43 144.06 31.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.939 1.296 . . . . 0.0 108.271 161.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.0 mt -127.13 150.86 49.3 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 149.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.45 161.09 41.77 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 165.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -144.16 140.41 29.35 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -120.08 114.48 22.05 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.246 0.93 . . . . 0.0 109.357 169.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -99.32 151.92 20.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 163.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -134.69 130.57 36.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -172.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -76.71 163.11 27.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.352 1.072 . . . . 0.0 112.11 -161.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -86.71 27.47 0.98 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.616 1.566 . . . . 0.0 110.885 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -143.1 -65.05 0.39 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.156 1.782 . . . . 0.0 108.983 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.5 p -92.96 127.8 46.03 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.872 1.669 . . . . 0.0 108.921 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -76.92 54.81 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 124.088 3.192 . . . . 0.0 110.252 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.27 106.65 5.81 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.631 2.373 . . . . 0.0 106.73 -159.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.18 178.72 22.07 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.984 1.278 . . . . 0.0 111.082 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.85 144.68 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 124.266 1.026 . . . . 0.0 109.555 -156.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.7 mt -126.54 109.8 21.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.94 1.296 . . . . 0.0 108.083 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.01 148.04 18.35 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 105.862 -2.895 . . . . 0.0 105.862 151.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 p -108.89 144.17 37.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.255 1.027 . . . . 0.0 109.196 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -91.9 145.79 24.27 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 162.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 t -128.91 152.44 48.55 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.061 1.744 . . . . 0.0 108.084 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -136.98 156.65 48.17 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 175.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.4 m -98.35 121.96 40.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 165.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.56 53.45 1.05 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.474 2.31 . . . . 0.0 107.108 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -158.93 146.63 17.75 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 128.524 2.729 . . . . 0.0 108.464 169.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 p -127.7 156.66 42.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.929 2.491 . . . . 0.0 107.599 163.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 -133.74 146.19 50.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -145.75 147.73 32.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 54.81 52.8 11.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.555 1.542 . . . . 0.0 111.935 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t -142.34 -49.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.213 1.405 . . . . 0.0 107.879 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.1 m -136.68 -43.4 0.6 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.649 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.02 8.15 15.78 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 118.977 0.808 . . . . 0.0 112.684 -170.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -72.02 91.01 1.2 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.833 1.653 . . . . 0.0 106.963 170.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -71.75 96.62 1.64 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.847 2.059 . . . . 0.0 107.861 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -66.06 107.08 1.78 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.396 -171.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' HZ2' HG21 ' A' ' 93' ' ' THR . 86.4 mttt -135.8 146.25 47.37 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 118.739 0.699 . . . . 0.0 110.213 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 51.2 -161.69 0.08 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.352 1.861 . . . . 0.0 110.745 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.67 176.13 7.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.154 1.381 . . . . 0.0 111.527 -171.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -89.3 130.87 35.62 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 160.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.63 120.04 41.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 165.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.31 88.67 0.19 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.47 141.07 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 p -126.36 155.79 41.52 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.737 1.615 . . . . 0.0 107.782 171.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.62 150.58 45.14 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.74 0.7 . . . . 0.0 110.284 170.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 173.53 137.35 2.39 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 174.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.22 164.83 34.4 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 CA-C-N 120.405 2.102 . . . . 0.0 110.706 167.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.14 103.98 13.07 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.236 1.414 . . . . 0.0 107.879 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.71 112.24 21.47 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.336 0.516 . . . . 0.0 109.713 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -67.96 136.67 54.3 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 168.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 77' ' ' ALA . 1.9 pp -144.84 178.67 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 126.91 2.084 . . . . 0.0 105.88 172.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.8 t30 38.39 -121.37 0.26 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.435 1.494 . . . . 0.0 109.077 -162.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -110.19 104.14 12.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.202 1.801 . . . . 0.0 108.631 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 65.8 m95 60.84 19.46 9.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.381 2.272 . . . . 0.0 114.73 167.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' HB3' HD12 ' A' ' 73' ' ' ILE . . . -74.57 -169.85 0.92 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.293 0.951 . . . . 0.0 110.468 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.1 m -140.95 169.16 18.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.148 1.379 . . . . 0.0 107.726 167.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.8 mm -133.83 158.61 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 122.804 1.288 . . . . 0.0 109.235 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -105.43 175.48 5.48 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 130.048 3.339 . . . . 0.0 109.627 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 54.05 0.88 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.58 173.22 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.35 160.41 10.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 O-C-N 120.525 -1.359 . . . . 0.0 108.26 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -156.42 165.45 32.91 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-O 122.182 0.879 . . . . 0.0 112.936 162.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -115.26 150.51 17.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 127.055 2.142 . . . . 0.0 106.065 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.89 149.78 18.41 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 165.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -150.77 145.47 25.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.042 1.337 . . . . 0.0 108.944 172.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.62 -133.87 12.07 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.3 tttp 32.6 82.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.586 2.754 . . . . 0.0 114.709 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.52 -45.71 0.82 Allowed 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.594 -0.691 . . . . 0.0 112.603 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 56.84 27.51 13.04 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 p -94.39 97.49 10.23 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.09 1.356 . . . . 0.0 109.201 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.406 HG21 ' HZ2' ' A' ' 59' ' ' LYS . 52.1 m -138.61 -65.38 0.5 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 171.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.294 7.7 tt0 26.32 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.933 2.493 . . . . 0.0 111.666 -150.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -138.51 -69.06 0.02 OUTLIER Pre-proline 0 C--O 1.235 0.294 0 CA-C-O 117.342 -1.313 . . . . 0.0 111.369 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.26 -34.12 36.93 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.198 1.464 . . . . 0.0 112.837 -170.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.7 m -65.79 -55.09 19.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.299 0.954 . . . . 0.0 109.588 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.5 t80 43.92 34.76 0.97 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.774 1.63 . . . . 0.0 113.176 -174.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -64.36 -45.16 88.96 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.612 -1.305 . . . . 0.0 108.692 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 72.07 -74.17 0.09 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 127.315 2.246 . . . . 0.0 108.876 167.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -133.82 146.38 50.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.394 1.877 . . . . 0.0 108.853 170.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 t -139.09 148.21 43.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.69 1.596 . . . . 0.0 106.94 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 t -79.34 24.67 0.34 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.747 1.619 . . . . 0.0 111.353 -175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.64 128.74 36.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -171.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -114.68 142.83 45.96 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -102.35 168.5 18.79 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -138.43 151.72 47.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 164.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -169.4 -164.47 0.45 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.775 0.83 . . . . 0.0 110.56 166.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -134.5 160.3 38.44 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.51 1.924 . . . . 0.0 108.446 -176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -153.25 -158.19 8.43 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.771 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -139.83 168.76 19.06 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -167.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.24 86.42 0.1 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mt -130.15 149.85 51.67 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.6 1.16 . . . . 0.0 107.939 -173.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -135.25 158.88 43.24 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.199 0.454 . . . . 0.0 111.602 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -101.01 171.14 7.82 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.711 1.204 . . . . 0.0 107.77 166.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -56.77 107.01 0.76 Allowed Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.619 0.768 . . . . 0.0 110.653 -170.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.89 158.06 34.81 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.963 2.442 . . . . 0.0 109.59 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 49.4 ttm -135.95 159.82 40.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.127 1.371 . . . . 0.0 109.189 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -69.88 25.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 130.873 3.669 . . . . 0.0 110.75 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.14 -32.16 0.1 Allowed 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.885 -1.135 . . . . 0.0 113.015 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.5 m -145.78 135.77 18.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -174.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.19 155.32 18.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.098 0.863 . . . . 0.0 109.427 168.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -130.44 114.08 15.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 155.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.01 148.99 45.68 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.415 2.286 . . . . 0.0 105.607 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -149.83 138.98 21.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 120.644 -1.285 . . . . 0.0 109.471 -162.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.7 m -134.45 166.37 23.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 166.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -145.98 137.89 25.14 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -134.4 163.6 29.3 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -122.02 169.81 10.46 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 127.018 2.127 . . . . 0.0 106.48 170.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.7 t -131.82 159.9 37.19 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 163.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -123.82 97.08 5.2 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.3 mt -86.88 81.95 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 65.94 -78.92 0.03 OUTLIER 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.248 2.219 . . . . 0.0 111.11 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -146.15 61.06 1.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.167 1.787 . . . . 0.0 107.102 166.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.9 t -125.08 145.61 32.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 162.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.25 137.17 39.95 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.864 1.666 . . . . 0.0 107.423 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.4 t -138.45 151.52 24.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 126.649 1.98 . . . . 0.0 106.937 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -137.05 143.86 15.27 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -140.48 135.99 32.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -123.83 131.18 53.54 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.5 115.93 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.499 . . . . 0.0 107.504 -166.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.85 152.3 21.34 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.143 0.577 . . . . 0.0 110.055 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.26 82.56 0.29 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.818 1.675 . . . . 0.0 109.719 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.8 t -104.19 158.41 5.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 126.516 1.926 . . . . 0.0 106.704 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.33 -107.25 0.28 Allowed Glycine 0 C--O 1.221 -0.677 0 C-N-CA 118.657 -1.735 . . . . 0.0 112.799 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.5 165.85 23.27 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.046 1.738 . . . . 0.0 106.858 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -148.99 136.24 20.09 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 119.835 -1.79 . . . . 0.0 111.555 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 128.805 2.842 . . . . 0.0 111.252 168.952 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.6 m -141.2 125.01 16.98 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -98.86 132.63 44.06 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.496 1.119 . . . . 0.0 109.159 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -143.58 118.78 10.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.453 HG23 ' H ' ' A' ' 146' ' ' TYR . 2.4 m -92.38 143.82 10.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.4 m -158.35 139.57 13.29 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.971 1.708 . . . . 0.0 107.989 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.48 172.59 31.15 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.81 -160.68 29.0 Favored Glycine 0 N--CA 1.462 0.384 0 CA-C-N 120.33 2.065 . . . . 0.0 110.903 -172.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -91.71 157.34 16.99 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.405 1.102 . . . . 0.0 109.845 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.704 ' HB2' HD21 ' A' ' 25' ' ' ASN . . . -119.93 155.07 33.48 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.517 1.527 . . . . 0.0 110.035 -175.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -148.09 118.35 7.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 162.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -83.79 139.63 32.57 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 167.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -116.68 153.86 31.59 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 157.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.1 106.57 3.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.547 1.939 . . . . 0.0 108.524 -171.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 71.38 -54.1 0.67 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.762 2.025 . . . . 0.0 112.63 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.81 -81.38 0.05 OUTLIER Glycine 0 C--N 1.337 0.638 0 CA-C-N 119.469 1.031 . . . . 0.0 114.257 -172.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -152.57 95.87 2.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.279 1.539 . . . . 0.0 108.913 166.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.8 mtt -144.71 -48.87 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.654 0.782 . . . . 0.0 110.314 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -128.37 109.73 11.7 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -169.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -131.41 77.84 1.8 Allowed 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.717 1.207 . . . . 0.0 107.89 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.81 145.23 47.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 169.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . -159.36 -179.93 34.52 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 128.678 3.037 . . . . 0.0 106.747 167.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.81 -90.95 0.08 OUTLIER Glycine 0 CA--C 1.523 0.545 0 CA-C-N 118.998 1.399 . . . . 0.0 110.646 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -164.71 143.09 6.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 168.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.704 HD21 ' HB2' ' A' ' 10' ' ' ALA . 38.9 m-80 -125.32 163.26 22.93 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.133 0.973 . . . . 0.0 110.233 -166.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 mt -142.79 163.1 33.72 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.148 0.979 . . . . 0.0 110.516 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -140.03 161.06 38.51 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.477 2.311 . . . . 0.0 106.538 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -147.81 112.19 5.26 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -105.3 159.42 15.9 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.163 -0.96 . . . . 0.0 108.945 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -142.77 155.84 44.89 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.942 0.897 . . . . 0.0 108.86 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.41 113.06 19.78 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.335 0.654 . . . . 0.0 109.781 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.85 159.2 26.54 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.304 0.574 . . . . 0.0 109.674 167.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -128.83 39.54 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -156.66 -16.32 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.995 1.318 . . . . 0.0 112.15 -173.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.6 t -155.07 133.48 7.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.854 1.662 . . . . 0.0 108.193 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.84 -5.0 16.39 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.312 3.342 . . . . 0.0 113.867 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -77.5 123.97 27.29 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.105 -0.997 . . . . 0.0 109.025 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.36 -167.39 36.91 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.7 t -127.08 147.78 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.344 1.458 . . . . 0.0 108.675 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 mm -122.48 127.85 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 166.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.17 108.71 0.39 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 107.226 -2.35 . . . . 0.0 107.226 163.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.6 t -88.23 150.72 23.12 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.849 1.66 . . . . 0.0 108.293 167.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -127.72 131.13 49.75 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.394 1.878 . . . . 0.0 107.976 172.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -127.32 117.0 21.39 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.978 1.711 . . . . 0.0 109.073 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -113.52 133.91 54.97 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.284 1.434 . . . . 0.0 107.827 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 p -126.6 130.06 49.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.318 0.58 . . . . 0.0 110.878 -168.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -140.17 93.21 2.61 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.363 1.465 . . . . 0.0 108.155 -170.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -162.75 147.46 11.81 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.879 0.872 . . . . 0.0 109.11 -174.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.1 p -121.63 153.93 37.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.07 100.4 6.95 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 t -159.21 99.88 1.51 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -166.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.98 81.45 1.27 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.2 t 58.2 67.53 0.94 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 122.702 1.239 . . . . 0.0 107.697 -174.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.38 -32.01 0.39 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.533 173.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.96 47.02 68.0 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.36 104.62 10.18 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.959 2.103 . . . . 0.0 105.73 -175.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -90.8 98.27 11.68 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.475 -1.39 . . . . 0.0 110.446 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.21 122.34 6.72 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.758 -0.589 . . . . 0.0 109.843 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -115.26 171.64 7.57 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.892 1.677 . . . . 0.0 108.516 170.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.89 -176.01 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.379 1.072 . . . . 0.0 110.202 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 pm0 -137.1 162.15 34.16 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 160.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -83.87 143.09 30.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.61 117.71 21.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.844 2.057 . . . . 0.0 106.455 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.87 92.98 1.05 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.3 mm -79.71 146.43 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 p -133.66 155.42 49.74 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.02 139.21 21.22 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.22 175.33 34.96 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.176 0.417 . . . . 0.0 112.249 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -79.02 176.04 10.26 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.886 2.391 . . . . 0.0 110.351 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.01 150.48 38.54 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.631 1.173 . . . . 0.0 108.841 162.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.2 124.2 41.93 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.099 0.96 . . . . 0.0 108.571 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -71.8 133.27 45.42 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.012 0.369 . . . . 0.0 110.049 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.8 mt -77.95 -76.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 165.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -83.09 -76.07 0.29 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 170.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -148.09 -62.01 0.26 Allowed 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -104.48 105.95 16.27 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.279 1.037 . . . . 0.0 109.56 172.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.42 -169.02 3.24 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.389 1.876 . . . . 0.0 108.754 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.97 169.67 17.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 157.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mm -143.06 147.3 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.628 ' HA ' ' HB3' ' A' ' 111' ' ' ALA . 21.9 p90 -105.4 141.59 36.65 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.425 2.29 . . . . 0.0 107.972 177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.82 50.42 0.21 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -161.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.526 HG22 ' HB2' ' A' ' 111' ' ' ALA . 3.6 m -123.04 176.4 4.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 163.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.55 130.22 54.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.55 158.41 15.13 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.01 118.36 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 170.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.63 122.69 7.62 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 107.372 -2.291 . . . . 0.0 107.372 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -132.63 116.93 17.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -169.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.23 101.55 0.22 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -56.67 161.5 2.74 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.666 0.733 . . . . 0.0 109.654 165.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -129.78 171.44 12.68 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 126.182 1.793 . . . . 0.0 106.493 167.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -143.52 135.32 26.5 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 120.92 -1.113 . . . . 0.0 108.592 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.3 p -105.84 108.11 19.46 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -170.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.4 m 50.64 -87.01 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.888 1.675 . . . . 0.0 109.62 -158.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -158.41 11.21 0.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.233 1.013 . . . . 0.0 110.831 -176.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -140.69 155.79 69.28 Favored Pre-proline 0 C--O 1.236 0.358 0 O-C-N 120.415 -1.428 . . . . 0.0 110.795 -173.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.9 -34.71 47.55 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.51 1.473 . . . . 0.0 109.85 170.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.4 m -52.38 -37.31 56.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 128.447 2.699 . . . . 0.0 112.953 -173.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -62.48 -53.54 53.25 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.618 0.644 . . . . 0.0 111.742 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.48 -60.45 0.11 Allowed 'General case' 0 C--O 1.226 -0.174 0 CA-C-O 117.158 -1.401 . . . . 0.0 109.078 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 32.97 89.57 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.644 2.378 . . . . 0.0 110.979 -165.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -66.21 164.07 16.5 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.992 -1.068 . . . . 0.0 109.489 160.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.7 p -67.76 150.26 48.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.53 -0.731 . . . . 0.0 110.11 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 p -71.75 177.48 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 161.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.67 165.13 35.11 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.997 -1.065 . . . . 0.0 110.894 170.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.17 109.48 18.92 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 166.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.86 93.42 1.89 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -74.52 111.65 9.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.64 1.176 . . . . 0.0 109.704 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 p -105.79 151.06 24.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.33 1.052 . . . . 0.0 111.211 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -136.85 80.84 1.84 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.468 1.907 . . . . 0.0 107.972 -170.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.08 -161.48 11.0 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 126.512 2.005 . . . . 0.0 108.144 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 80' ' ' TYR . . . -164.28 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 153.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.449 ' C ' HD22 ' A' ' 113' ' ' LEU . . . 164.71 170.83 30.19 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -171.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 112' ' ' GLY . 3.7 mm? -133.29 150.83 51.88 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.58 1.952 . . . . 0.0 106.836 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -132.64 154.2 50.33 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.139 0.971 . . . . 0.0 110.023 -171.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -104.64 174.44 5.88 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 128.044 2.537 . . . . 0.0 109.107 173.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -55.62 114.09 6.75 Favored Pre-proline 0 C--O 1.234 0.269 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.28 103.56 1.7 Allowed 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.044 -1.56 . . . . 0.0 108.044 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.1 ttt -74.64 155.55 37.67 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -54.64 -33.25 60.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 126.787 2.035 . . . . 0.0 110.991 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -104.45 -25.95 12.6 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 117.271 -1.347 . . . . 0.0 113.602 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.93 109.47 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.308 0.958 . . . . 0.0 108.885 -174.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.97 154.17 42.04 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 162.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -132.26 116.35 16.81 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 168.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.84 146.58 37.74 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.913 2.085 . . . . 0.0 107.301 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -129.68 135.61 48.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.3 m -124.23 148.24 47.47 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 171.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -149.86 132.92 16.24 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -136.63 145.22 44.61 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.62 1.568 . . . . 0.0 107.693 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -116.75 129.07 55.89 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 171.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 t -111.11 159.57 17.7 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.188 0.995 . . . . 0.0 108.934 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -136.45 97.4 3.56 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -172.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.57 94.34 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 167.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.3 ttm-85 63.93 58.53 1.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.618 1.167 . . . . 0.0 111.741 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m 53.72 27.89 7.47 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.342 1.057 . . . . 0.0 113.073 171.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.45 149.0 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.392 1.477 . . . . 0.0 108.094 172.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.72 102.4 13.6 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 169.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.3 t -131.85 103.68 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.87 133.17 7.49 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.4 t -125.48 139.89 53.24 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.479 1.512 . . . . 0.0 107.457 -175.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -129.7 151.18 50.57 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 171.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.8 pt -136.23 145.16 31.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.13 158.04 18.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.25 101.95 0.36 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 106.664 -2.574 . . . . 0.0 106.664 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.87 160.44 20.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.06 -149.84 9.45 Favored Glycine 0 C--O 1.221 -0.718 0 C-N-CA 118.688 -1.72 . . . . 0.0 109.799 -172.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.453 ' H ' HG23 ' A' ' 5' ' ' VAL . 42.4 p90 -162.66 175.32 11.49 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.937 1.695 . . . . 0.0 106.988 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -102.98 147.67 26.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 C--O 1.249 1.064 0 C-N-CA 126.174 1.789 . . . . 0.0 108.049 170.79 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 p -131.82 137.58 48.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -132.21 106.89 8.23 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.8 t -135.96 127.21 28.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.496 HG11 ' CD1' ' A' ' 146' ' ' TYR 0.259 9.7 p -101.93 153.4 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.735 0.779 . . . . 0.0 109.512 -173.418 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.9 124.08 4.24 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 174.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.39 -172.7 45.67 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 118.594 0.634 . . . . 0.0 113.235 -166.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.31 -116.44 1.54 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.602 1.572 . . . . 0.0 110.818 169.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.35 146.26 45.47 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.617 1.209 . . . . 0.0 108.307 -163.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.39 120.84 24.88 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -169.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -99.65 148.15 24.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 168.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -130.93 131.34 44.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 165.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -119.25 111.17 17.87 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.4 143.04 27.03 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.324 1.049 . . . . 0.0 108.286 -170.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 60.89 -75.48 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.243 1.817 . . . . 0.0 109.537 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.46 -73.35 0.02 OUTLIER Glycine 0 CA--C 1.52 0.405 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -126.12 105.91 9.2 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ttt -148.21 -54.63 0.2 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.206 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -144.62 133.05 21.94 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -167.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -121.15 77.82 1.35 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -170.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -58.08 157.73 7.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.294 1.437 . . . . 0.0 110.31 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.69 155.16 26.25 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.07 -175.4 39.4 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 118.386 1.093 . . . . 0.0 111.688 -173.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.11 146.43 43.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.771 0.785 . . . . 0.0 111.604 -164.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.62 HD21 ' HA ' ' A' ' 44' ' ' THR . 1.0 OUTLIER -139.36 152.52 47.22 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.536 1.935 . . . . 0.0 109.531 176.454 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.441 HD21 ' CG2' ' A' ' 5' ' ' VAL . 1.3 tm? -156.28 116.11 3.59 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.667 0.787 . . . . 0.0 108.883 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 128.6 38.82 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.513 1.125 . . . . 0.0 109.58 175.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -95.74 141.5 29.14 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.778 2.431 . . . . 0.0 108.095 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 69.7 mtm-85 -128.37 162.85 26.13 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.958 1.254 . . . . 0.0 109.74 166.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.21 138.52 31.53 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -88.09 135.16 33.55 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 171.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -136.48 162.22 33.69 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.768 0.827 . . . . 0.0 110.639 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.68 47.09 2.18 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.247 1.419 . . . . 0.0 108.411 -166.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.51 -48.18 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.708 1.203 . . . . 0.0 109.455 171.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.97 115.07 45.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.602 1.161 . . . . 0.0 108.375 175.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.99 -43.81 6.1 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.809 1.673 . . . . 0.0 109.901 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.481 HD12 ' CB ' ' A' ' 69' ' ' PRO . 1.9 pt? -73.09 148.33 44.11 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.125 2.17 . . . . 0.0 110.597 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.72 -178.21 36.61 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.677 1.132 . . . . 0.0 110.613 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.5 t -117.95 139.57 44.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.353 1.861 . . . . 0.0 108.519 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 mm -134.04 127.36 51.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 124.502 1.121 . . . . 0.0 108.301 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.02 108.86 0.37 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 172.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 t -126.71 155.01 43.36 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.704 -0.88 . . . . 0.0 108.666 161.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -114.91 147.78 39.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.62 ' HA ' HD21 ' A' ' 25' ' ' ASN . 1.2 p -116.24 115.22 25.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -169.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -142.8 123.76 14.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.3 p -140.83 124.7 17.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -165.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -137.09 90.58 2.54 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -125.79 120.96 31.96 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 p -65.55 155.82 34.54 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.706 2.002 . . . . 0.0 110.457 -170.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -128.22 154.12 46.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 122.242 1.02 . . . . 0.0 108.694 166.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -162.71 103.51 1.04 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 101.35 -3.574 . . . . 0.0 101.35 163.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.0 -98.37 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 166.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -153.74 73.95 0.97 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 172.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.0 t -166.7 -62.34 0.03 OUTLIER 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.01 2.124 . . . . 0.0 105.898 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.96 60.31 0.34 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -85.4 91.38 8.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -75.81 88.88 2.85 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.122 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -70.89 62.49 0.28 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.566 1.947 . . . . 0.0 111.551 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -86.28 167.43 14.83 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.643 1.577 . . . . 0.0 110.589 -171.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 m120 50.41 -163.1 0.05 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.076 1.35 . . . . 0.0 110.032 -165.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -147.15 169.02 20.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.69 1.196 . . . . 0.0 109.599 -164.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -78.42 158.58 28.67 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.224 1.01 . . . . 0.0 108.686 159.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -135.87 117.74 15.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 161.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.49 154.1 16.63 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 170.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 tt -142.16 112.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.1 p -128.58 126.85 41.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.38 155.67 43.3 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.12 165.45 38.77 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 171.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CB ' HD12 ' A' ' 37' ' ' LEU . 3.6 Cg_endo -66.98 168.58 16.88 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 CA-C-N 119.622 1.711 . . . . 0.0 109.572 156.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.01 154.9 19.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 159.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -93.02 154.81 17.91 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 152.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -140.42 96.71 3.08 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.89 -55.5 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 118.039 0.381 . . . . 0.0 110.294 -170.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -79.17 178.53 7.99 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.983 1.313 . . . . 0.0 108.67 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.91 47.48 1.26 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.29 1.036 . . . . 0.0 110.333 172.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 22.2 p-90 -156.16 -57.93 0.09 Allowed 'General case' 0 CA--C 1.529 0.152 0 O-C-N 120.975 -1.078 . . . . 0.0 110.15 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.43 154.02 44.23 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.999 0.92 . . . . 0.0 108.674 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -147.67 168.35 22.27 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.911 0.884 . . . . 0.0 110.609 -176.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -128.15 146.33 33.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -175.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -150.44 158.96 44.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.367 0.667 . . . . 0.0 109.773 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.3 129.87 7.32 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.45 151.89 6.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.17 159.79 13.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 123.843 0.857 . . . . 0.0 109.396 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 157.52 -136.39 4.84 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.55 151.06 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -166.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.89 158.38 22.25 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 161.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -149.45 160.34 43.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.122 1.769 . . . . 0.0 107.777 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.58 172.91 33.55 Favored Glycine 0 C--N 1.331 0.282 0 O-C-N 120.861 -1.149 . . . . 0.0 111.562 175.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -148.33 98.37 2.9 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 171.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -142.6 100.71 3.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -161.98 -78.93 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -132.04 128.97 39.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.8 m -154.6 84.1 1.11 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -151.44 -70.93 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.1 -67.19 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 116.671 -1.633 . . . . 0.0 109.885 169.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -62.34 149.41 90.85 Favored 'Trans proline' 0 C--N 1.352 0.726 0 CA-C-N 121.877 1.706 . . . . 0.0 111.082 -173.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m 66.86 -14.28 0.17 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.777 2.031 . . . . 0.0 113.303 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 46.98 -143.76 0.33 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.428 1.891 . . . . 0.0 111.551 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -69.83 98.4 1.23 Allowed 'General case' 0 C--O 1.234 0.249 0 O-C-N 119.877 -1.764 . . . . 0.0 106.657 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -69.79 -73.35 0.16 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.863 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.21 124.28 20.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.678 1.191 . . . . 0.0 109.932 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.0 m -82.89 160.22 22.18 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.32 1.448 . . . . 0.0 110.335 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.32 117.05 9.61 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.964 1.706 . . . . 0.0 108.946 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -151.52 171.64 17.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.77 0.714 . . . . 0.0 110.918 166.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -102.94 94.87 5.79 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -83.89 130.95 10.06 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -74.13 150.58 40.4 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.084 0.942 . . . . 0.0 109.162 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.0 m -131.35 135.98 47.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -155.42 95.72 1.72 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -172.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.01 169.57 13.59 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 125.06 1.314 . . . . 0.0 111.293 -169.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.02 156.76 32.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.817 1.247 . . . . 0.0 108.747 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.487 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -159.4 150.34 20.71 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 173.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.487 HD22 ' C ' ' A' ' 112' ' ' GLY . 3.8 mm? -138.26 139.75 39.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 -169.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -136.66 139.55 42.1 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.954 0.797 . . . . 0.0 110.199 -169.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -118.94 171.19 8.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.334 1.454 . . . . 0.0 108.208 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -59.89 114.6 10.1 Favored Pre-proline 0 N--CA 1.456 -0.152 0 C-N-CA 125.546 1.539 . . . . 0.0 107.912 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -81.48 122.81 4.15 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.468 1.446 . . . . 0.0 109.323 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.1 ttm -170.53 149.68 3.3 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.143 2.177 . . . . 0.0 107.051 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 117.3 12.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 131.23 3.812 . . . . 0.0 109.409 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 62.03 28.81 17.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.098 1.759 . . . . 0.0 111.196 -160.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.09 145.99 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.696 1.198 . . . . 0.0 108.4 156.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.38 163.13 23.06 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 120.183 -1.573 . . . . 0.0 109.927 149.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -118.99 113.56 21.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 158.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -148.36 149.54 31.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -129.45 151.71 49.78 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.31 0.959 . . . . 0.0 109.997 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.9 m -136.31 145.92 46.03 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.903 0.881 . . . . 0.0 110.729 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -138.76 148.38 43.8 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.671 1.988 . . . . 0.0 107.473 162.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -137.25 147.94 46.09 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 165.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -132.0 129.15 39.75 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 169.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.6 m -140.36 154.34 46.71 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.536 1.134 . . . . 0.0 108.098 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -121.6 98.13 5.82 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 121.449 -0.782 . . . . 0.0 109.388 -171.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.1 mm -66.0 91.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 67.27 -79.67 0.04 OUTLIER 'General case' 0 C--O 1.232 0.146 0 C-N-CA 127.924 2.49 . . . . 0.0 109.144 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.2 p -134.4 -2.16 2.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.12 1.368 . . . . 0.0 111.92 -170.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.17 149.31 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.366 1.066 . . . . 0.0 108.222 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.62 156.52 25.09 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.6 t -142.61 143.45 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 163.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -140.86 128.18 3.67 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -126.08 142.72 51.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -169.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -134.26 119.18 18.41 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 -165.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.1 mp -128.67 136.64 59.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.18 157.95 18.08 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -127.37 65.27 0.57 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.7 m -124.76 -176.35 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.519 1.527 . . . . 0.0 110.652 -164.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.27 -84.14 0.17 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 117.001 1.56 . . . . 0.0 117.001 174.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.496 ' CD1' HG11 ' A' ' 5' ' ' VAL . 19.6 p90 -163.32 177.41 8.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.699 2.799 . . . . 0.0 107.976 177.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -132.61 140.53 48.27 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 119.33 -2.106 . . . . 0.0 110.092 161.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 128.509 2.723 . . . . 0.0 113.367 169.05 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 t -142.1 165.75 26.59 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 121.32 -0.863 . . . . 0.0 108.816 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 m -134.06 140.86 46.93 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.3 t -157.75 161.1 38.46 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 120.424 -1.422 . . . . 0.0 107.545 -171.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.75 119.77 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -160.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 p -135.49 155.36 50.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.469 1.128 . . . . 0.0 110.456 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.14 -159.2 30.9 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -164.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.03 -127.06 7.48 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -164.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -134.72 149.15 50.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.682 0.793 . . . . 0.0 109.061 -171.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.28 113.83 21.46 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 105.474 -2.046 . . . . 0.0 105.474 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -124.96 123.52 40.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -162.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.3 t -139.29 140.5 37.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.936 1.295 . . . . 0.0 107.75 -163.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -138.96 157.94 45.11 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.378 1.071 . . . . 0.0 110.746 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' A' ' 137' ' ' VAL . . . -94.17 165.05 12.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.406 1.082 . . . . 0.0 111.73 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -73.59 61.08 0.7 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.463 1.105 . . . . 0.0 110.318 168.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.65 104.02 0.28 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -53.74 96.32 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.326 2.251 . . . . 0.0 111.357 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 96.7 mtp -149.35 -56.4 0.19 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.906 2.082 . . . . 0.0 107.834 173.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.15 111.94 19.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.148 1.379 . . . . 0.0 109.231 -170.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.57 150.33 41.04 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 45.6 mtt -115.42 143.41 45.34 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.096 1.759 . . . . 0.0 107.01 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.26 168.05 40.62 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 126.601 2.048 . . . . 0.0 108.055 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.83 -85.03 0.1 OUTLIER Glycine 0 C--O 1.225 -0.41 0 N-CA-C 107.916 -2.073 . . . . 0.0 107.916 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.46 ' H ' ' HB3' ' A' ' 45' ' ' TYR . 7.0 m-85 -146.36 172.07 14.05 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.635 1.974 . . . . 0.0 108.633 173.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -125.35 152.76 44.32 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 160.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 tp -145.74 140.26 27.07 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.675 0.671 . . . . 0.0 109.358 161.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -138.98 163.21 32.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.167 1.387 . . . . 0.0 107.523 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -143.39 140.24 30.37 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -132.78 144.04 49.98 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -117.27 147.16 42.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 161.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.87 136.69 32.58 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 156.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -86.73 179.13 6.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.28 2.232 . . . . 0.0 111.232 -166.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.81 -22.67 14.32 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.442 -0.786 . . . . 0.0 112.071 165.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -104.62 5.25 33.54 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.106 1.362 . . . . 0.0 113.209 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -153.44 104.02 2.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.94 1.696 . . . . 0.0 106.81 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.05 78.29 3.22 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.993 2.462 . . . . 0.0 109.463 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 tp -149.78 131.71 15.2 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.084 0.954 . . . . 0.0 109.748 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.16 176.75 18.74 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 168.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 m -137.11 160.48 36.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 125.938 1.695 . . . . 0.0 108.988 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mm -140.17 109.74 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.387 1.475 . . . . 0.0 107.729 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.69 167.06 33.27 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 153.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p -125.5 151.54 46.16 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 118.685 1.242 . . . . 0.0 108.804 146.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.61 148.89 27.77 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.905 1.23 . . . . 0.0 109.206 156.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -94.11 148.97 21.66 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 162.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.46 ' HB3' ' H ' ' A' ' 24' ' ' PHE . 3.8 t80 -143.08 110.08 5.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.289 1.404 . . . . 0.0 108.161 176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.8 p -101.97 120.57 40.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 121.191 1.814 . . . . 0.0 111.224 -166.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -162.61 76.75 0.45 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.057 1.343 . . . . 0.0 108.289 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -162.42 114.15 1.61 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 164.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 155.57 39.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.845 1.202 . . . . 0.0 110.225 174.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.35 102.45 5.55 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 175.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.9 m -148.17 76.24 1.36 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -169.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.15 19.36 1.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.893 1.677 . . . . 0.0 110.763 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -145.58 -105.98 0.1 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -46.51 59.52 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 121.144 1.793 . . . . 0.0 110.169 167.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.89 74.28 0.27 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.66 90.42 1.81 Allowed 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.0 77.88 10.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 123.235 1.493 . . . . 0.0 107.961 -176.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -67.26 105.11 1.64 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.645 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -143.85 114.67 7.73 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.598 1.09 . . . . 0.0 108.669 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 151.56 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.024 2.93 . . . . 0.0 106.482 -164.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.8 170.46 8.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.704 1.602 . . . . 0.0 107.69 -162.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -76.81 143.05 40.04 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.9 -1.125 . . . . 0.0 109.719 166.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -141.63 118.35 11.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.735 1.614 . . . . 0.0 107.018 161.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.89 158.09 28.8 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.454 -1.859 . . . . 0.0 108.454 162.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.39 143.77 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 169.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 84' ' ' GLY . 89.5 m -139.67 148.05 41.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 161.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.96 150.03 28.82 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.386 0.674 . . . . 0.0 110.897 -164.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.02 163.52 12.85 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.94 1.733 . . . . 0.0 110.861 166.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.68 172.46 15.73 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.736 2.291 . . . . 0.0 110.526 168.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.62 153.89 47.44 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.484 1.114 . . . . 0.0 109.81 163.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -151.17 151.54 32.06 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -164.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -82.07 149.91 27.8 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.127 0.571 . . . . 0.0 109.634 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 73' ' ' ILE . 3.2 mp -78.55 -103.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 162.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.02 0.73 1.4 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.218 1.372 . . . . 0.0 112.881 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -113.77 -118.99 0.31 Allowed 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -129.87 -9.31 4.43 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -165.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.53 159.7 30.12 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 121.606 2.003 . . . . 0.0 109.578 164.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.6 m -135.86 125.06 24.56 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -136.84 147.09 27.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.49 174.74 12.17 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.385 1.474 . . . . 0.0 109.413 171.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.16 138.8 14.12 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 168.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.9 m -131.4 159.42 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.214 1.007 . . . . 0.0 110.222 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.28 135.42 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 C-N-CA 125.136 1.374 . . . . 0.0 109.495 -168.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 66' ' ' THR . . . -128.3 168.05 20.31 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 123.922 0.763 . . . . 0.0 113.137 -169.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.88 150.79 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 127.386 2.274 . . . . 0.0 106.894 170.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.49 158.69 22.23 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 161.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.4 116.86 21.12 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.612 0.765 . . . . 0.0 109.978 173.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.06 112.52 3.6 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 167.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -54.12 -59.15 5.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.749 1.275 . . . . 0.0 112.093 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -147.32 -63.55 0.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.503 1.521 . . . . 0.0 107.053 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 73.13 -56.2 0.66 Allowed 'General case' 0 C--N 1.346 0.449 0 C-N-CA 124.706 1.202 . . . . 0.0 109.29 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.483 HG21 ' H ' ' A' ' 100' ' ' ASN . 8.8 t -67.08 113.54 5.13 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 165.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.3 p -119.8 74.44 1.02 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 167.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 55.1 19.2 2.68 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.373 1.869 . . . . 0.0 114.592 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.427 ' H ' ' HD2' ' A' ' 96' ' ' PRO . 9.7 m-85 -120.93 -56.68 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.791 2.036 . . . . 0.0 111.399 177.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.427 ' HD2' ' H ' ' A' ' 95' ' ' TYR . 42.0 Cg_endo -82.64 52.76 4.18 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 CA-C-N 121.962 1.737 . . . . 0.0 112.744 -172.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p 47.14 69.55 0.49 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.101 2.16 . . . . 0.0 112.108 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 30.52 61.8 0.2 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.903 2.481 . . . . 0.0 113.045 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -77.55 -47.15 20.19 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.761 -159.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.483 ' H ' HG21 ' A' ' 92' ' ' THR . 11.0 t-20 -152.25 65.8 0.83 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.94 0.896 . . . . 0.0 110.731 -171.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -68.23 -59.99 2.8 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.049 1.34 . . . . 0.0 109.804 -171.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -68.12 97.03 0.67 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.345 1.858 . . . . 0.0 108.889 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.4 p -66.39 155.98 35.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.83 0.824 . . . . 0.0 111.165 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -155.83 166.67 32.79 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.489 1.116 . . . . 0.0 108.885 -171.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -78.87 131.35 36.41 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.546 0.738 . . . . 0.0 110.152 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.05 82.52 0.4 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -73.14 151.17 41.67 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 118.585 1.192 . . . . 0.0 108.323 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.9 p -146.44 162.64 37.83 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.962 0.905 . . . . 0.0 110.827 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -141.27 155.11 46.03 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.68 -146.84 7.05 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.47 158.93 43.32 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.853 0.861 . . . . 0.0 110.317 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -136.35 133.68 6.72 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.64 143.47 14.63 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.992 0.396 . . . . 0.0 110.019 -170.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -142.91 145.15 32.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.944 0.878 . . . . 0.0 111.572 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -139.73 111.63 7.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 166.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 117.3 61.2 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.64 -33.78 2.19 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.336 1.358 . . . . 0.0 110.868 172.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.5 mtt -157.89 159.27 36.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.975 0.91 . . . . 0.0 111.124 -165.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -91.65 42.61 1.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 126.09 1.756 . . . . 0.0 109.658 -174.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.538 ' HA ' ' CD2' ' A' ' 146' ' ' TYR . 23.3 p30 -160.7 -14.21 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.623 1.969 . . . . 0.0 111.269 -174.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.93 117.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 165.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.81 163.85 18.52 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 160.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.6 114.74 10.85 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 161.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.35 149.66 47.91 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 127.887 2.475 . . . . 0.0 107.06 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -129.66 151.44 50.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.2 m -145.52 166.32 26.04 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 145.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -143.41 145.75 32.89 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 160.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -138.13 159.86 40.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 119.734 1.152 . . . . 0.0 110.056 160.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -122.83 114.9 21.13 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.758 1.223 . . . . 0.0 109.596 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.5 p -100.88 130.57 46.91 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.779 2.032 . . . . 0.0 112.538 -171.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.81 111.89 24.31 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.44 81.55 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 171.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 53.8 -102.32 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.956 1.702 . . . . 0.0 108.508 -164.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m -105.29 3.52 30.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.27 1.028 . . . . 0.0 112.221 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.2 t -82.66 110.96 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 173.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -92.89 126.85 38.17 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 14' ' ' ALA . 4.5 t -133.78 146.75 31.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 171.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.69 150.53 18.7 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 169.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -122.87 146.5 47.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -135.84 123.67 22.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 167.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.8 pt -116.93 139.79 42.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -168.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.22 134.94 33.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -120.27 74.55 0.32 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.43 168.03 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.708 1.203 . . . . 0.0 108.747 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.56 -105.07 0.25 Allowed Glycine 0 C--O 1.227 -0.344 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.538 ' CD2' ' HA ' ' A' ' 120' ' ' ASN . 0.3 OUTLIER -161.39 167.62 25.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.063 2.545 . . . . 0.0 107.624 -170.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -138.78 158.29 44.49 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.362 -1.461 . . . . 0.0 108.853 166.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 126.408 1.883 . . . . 0.0 109.766 -175.337 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.431 HG23 HH21 ' A' ' 147' ' ' ARG . 52.6 m -145.89 157.8 43.89 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 168.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 m -127.16 140.13 52.47 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 167.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 m -148.22 129.72 14.89 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 120.244 -1.535 . . . . 0.0 107.35 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.583 HG23 ' H ' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -108.93 138.41 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.165 1.386 . . . . 0.0 108.505 173.764 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 p -157.2 117.72 3.55 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.8 2.04 . . . . 0.0 105.581 -169.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -173.18 165.64 37.88 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.39 -127.14 1.39 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -147.7 158.39 43.99 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.335 1.068 . . . . 0.0 110.698 -169.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.15 154.66 48.12 Favored 'General case' 0 C--N 1.335 -0.051 0 C-N-CA 125.129 1.372 . . . . 0.0 110.133 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -113.0 104.84 12.8 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 162.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -85.05 124.54 31.86 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 166.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.97 163.72 12.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.533 1.533 . . . . 0.0 107.412 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.57 161.96 37.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -55.6 81.37 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.911 1.684 . . . . 0.0 113.089 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.67 -15.23 5.21 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.593 1.568 . . . . 0.0 112.458 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -132.95 93.66 3.23 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.68 1.229 . . . . 0.0 108.48 172.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -90.27 60.02 4.6 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 129.437 3.095 . . . . 0.0 109.585 173.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -137.03 -178.47 5.21 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.887 1.275 . . . . 0.0 110.662 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -89.22 84.32 6.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.526 1.93 . . . . 0.0 107.116 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.5 ttm -92.52 147.83 22.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 153.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.9 -160.83 30.31 Favored Glycine 0 C--O 1.228 -0.252 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.21 -155.44 7.57 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 105.646 -2.982 . . . . 0.0 105.646 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.73 145.28 25.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.442 ' ND2' HD13 ' A' ' 141' ' ' ILE . 1.2 t30 -95.01 135.87 36.02 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 103.671 -2.714 . . . . 0.0 103.671 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.2 tp -145.97 116.71 7.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.16 140.96 48.76 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -137.56 121.41 17.6 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.96 143.08 45.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -118.53 158.14 25.95 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.462 1.905 . . . . 0.0 108.263 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -125.56 143.04 51.19 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.531 -1.356 . . . . 0.0 107.787 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -114.65 159.3 20.65 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.051 0.94 . . . . 0.0 108.78 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -95.19 15.26 19.63 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.123 -0.986 . . . . 0.0 111.701 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.41 0.73 2.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.698 1.199 . . . . 0.0 113.865 -172.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.4 125.3 3.02 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.124 168.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -72.46 79.91 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.547 3.498 . . . . 0.0 109.027 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.1 tp -150.42 155.81 40.27 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.589 1.556 . . . . 0.0 107.39 -160.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.24 -175.84 14.03 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 161.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.15 162.41 39.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 127.749 2.42 . . . . 0.0 106.218 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.8 mm -114.82 120.29 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.33 108.8 1.05 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 105.308 -3.117 . . . . 0.0 105.308 155.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -122.36 153.36 39.11 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 158.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -144.16 122.86 12.57 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.409 1.883 . . . . 0.0 107.098 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.9 m -127.59 125.18 39.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 172.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -91.49 158.41 16.49 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.653 1.981 . . . . 0.0 106.928 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -105.22 130.93 53.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -144.6 141.23 29.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.133 2.173 . . . . 0.0 107.152 166.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -175.54 147.92 0.88 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.601 2.36 . . . . 0.0 105.791 163.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -66.54 105.2 1.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -91.22 115.62 28.17 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 166.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 p -129.37 115.39 17.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.23 -170.25 2.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 164.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 m -80.44 -57.4 3.61 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 170.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.3 m -63.65 -66.96 0.47 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.345 0.658 . . . . 0.0 110.655 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.97 19.21 0.03 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 119.505 -1.331 . . . . 0.0 115.435 -157.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -90.47 91.5 8.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.105 1.953 . . . . 0.0 107.796 169.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -96.19 158.07 15.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.045 1.338 . . . . 0.0 108.068 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -84.02 124.33 30.96 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.298 -0.876 . . . . 0.0 110.335 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -132.51 168.71 17.73 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.024 0.529 . . . . 0.0 109.776 166.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 m120 49.79 172.14 0.01 OUTLIER 'General case' 0 C--O 1.239 0.532 0 C-N-CA 128.49 2.716 . . . . 0.0 111.75 -155.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -123.5 147.58 47.08 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 120.968 -1.083 . . . . 0.0 110.284 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -76.11 128.37 34.84 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -109.81 117.83 34.88 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.7 89.41 0.29 Allowed Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -161.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.2 pp -109.47 141.55 24.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.762 0.791 . . . . 0.0 110.455 -166.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -111.38 148.45 33.01 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 170.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.95 159.02 43.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.359 0.6 . . . . 0.0 109.55 163.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.13 164.99 10.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.045 1.307 . . . . 0.0 110.626 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.88 144.47 53.51 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.962 2.442 . . . . 0.0 111.553 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.03 122.59 33.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 160.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -79.44 126.99 31.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 167.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -69.78 128.77 37.56 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 74' ' ' ASN . 6.7 tt -76.42 -178.85 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.709 0.766 . . . . 0.0 109.954 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.417 ' H ' HG12 ' A' ' 73' ' ' ILE . 7.9 t30 -60.9 -0.04 0.26 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.279 2.232 . . . . 0.0 115.963 -170.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -136.21 -87.52 0.33 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 120.2 1.364 . . . . 0.0 110.056 168.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.78 70.21 0.63 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.091 1.314 . . . . 0.0 109.958 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.16 -169.04 3.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.477 1.911 . . . . 0.0 107.296 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 t -122.43 170.16 10.25 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.903 1.681 . . . . 0.0 110.496 -162.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.83 167.99 25.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 121.528 -0.733 . . . . 0.0 111.696 -176.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -104.27 123.98 48.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.903 2.081 . . . . 0.0 109.134 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.17 73.62 0.02 OUTLIER Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.71 171.89 13.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 117.863 0.831 . . . . 0.0 109.66 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.14 130.42 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.37 148.16 18.92 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 170.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.9 132.3 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 165.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.76 152.89 18.72 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 162.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.58 165.2 29.35 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.597 0.759 . . . . 0.0 109.094 163.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.26 -167.95 43.93 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 113.634 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? 51.7 70.35 0.56 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.837 1.303 . . . . 0.0 108.01 -163.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.53 78.56 1.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -131.77 145.68 51.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 163.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 94' ' ' GLU . 20.7 m -107.78 137.82 45.11 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 163.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.12 -4.13 52.84 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 124.201 1.0 . . . . 0.0 111.347 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.611 ' H ' HG22 ' A' ' 92' ' ' THR . 1.2 tp10 -115.84 -87.22 0.6 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -151.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -63.08 158.62 53.71 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.578 1.951 . . . . 0.0 110.821 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.85 1.37 1.12 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.708 3.605 . . . . 0.0 115.964 -175.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.1 m -66.97 -9.76 42.09 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 120.872 -1.143 . . . . 0.0 111.697 159.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -53.25 -16.59 1.33 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -160.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -90.24 76.39 6.83 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 157.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -63.98 -56.22 16.73 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.75 -55.11 0.54 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.081 2.552 . . . . 0.0 113.267 172.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.5 t -72.7 149.53 43.72 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.899 0.88 . . . . 0.0 108.996 169.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.2 m -120.2 161.78 20.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.687 1.195 . . . . 0.0 108.213 166.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.29 176.69 9.54 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.971 1.308 . . . . 0.0 108.999 159.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -115.9 166.91 11.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 150.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.17 122.39 1.45 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -73.91 152.32 40.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.635 1.174 . . . . 0.0 109.754 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.5 t -134.44 143.65 47.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.891 0.876 . . . . 0.0 110.293 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -80.48 99.48 8.04 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.82 125.51 7.11 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.65 145.29 32.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.085 1.754 . . . . 0.0 107.439 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.32 148.63 8.58 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.521 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -139.43 142.63 37.43 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.555 2.342 . . . . 0.0 107.878 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -105.69 160.92 14.84 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.222 1.809 . . . . 0.0 109.82 169.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -91.65 171.69 8.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -57.1 111.43 3.36 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.491 1.116 . . . . 0.0 108.472 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -85.17 162.95 11.47 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.422 2.081 . . . . 0.0 111.971 -168.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 68.3 mtm -154.28 171.47 19.19 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 128.804 2.842 . . . . 0.0 108.649 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -44.12 -55.19 4.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 131.396 3.878 . . . . 0.0 109.77 -164.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.414 ' HB2' ' CD1' ' A' ' 146' ' ' TYR 0.3 0.2 OUTLIER -132.28 37.53 3.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.198 0.523 . . . . 0.0 110.224 171.739 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.46 110.22 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.81 157.53 40.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 161.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.674 HD13 HG12 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -133.7 132.25 40.41 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 102.752 -3.055 . . . . 0.0 102.752 176.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -140.32 128.97 22.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.54 1.064 . . . . 0.0 109.824 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -136.41 145.99 45.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.376 1.07 . . . . 0.0 108.135 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.75 166.74 25.0 Favored 'General case' 0 C--O 1.239 0.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.127 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.42 ' HB3' ' CE3' ' A' ' 140' ' ' TRP . 42.5 p90 -142.66 118.39 10.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 169.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.87 108.43 9.4 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -99.5 132.97 44.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.5 p -129.85 159.41 36.65 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.591 1.157 . . . . 0.0 109.951 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 47.8 mtt-85 -122.2 98.0 5.73 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.485 0.659 . . . . 0.0 109.466 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 10.9 mm -82.41 81.12 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.384 1.073 . . . . 0.0 108.165 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 64.14 -55.87 0.24 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.692 2.797 . . . . 0.0 114.08 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.3 t -149.85 -0.94 0.44 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.587 1.555 . . . . 0.0 110.546 169.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.18 135.66 24.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.9 137.17 32.57 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.0 t -139.33 108.0 3.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.039 1.336 . . . . 0.0 108.674 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.08 151.76 35.58 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 167.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 t -140.38 153.31 46.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 146.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.42 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 7.4 m95 -137.86 110.79 7.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 172.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.442 HD13 ' ND2' ' A' ' 25' ' ' ASN . 1.9 pp -81.72 154.57 4.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.0 166.41 22.47 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 163.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -176.57 167.46 38.96 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.674 HG12 HD13 ' A' ' 123' ' ' LEU . 1.5 m -144.35 148.7 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -163.16 -145.72 4.46 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.583 ' H ' HG23 ' A' ' 5' ' ' VAL . 8.1 m-85 -136.23 158.73 43.72 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.901 2.081 . . . . 0.0 108.395 -163.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.431 HH21 HG23 ' A' ' 2' ' ' THR . 0.8 OUTLIER -145.68 112.1 5.81 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.713 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 124.576 1.151 . . . . 0.0 108.367 178.362 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 t -151.05 158.14 43.71 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.384 1.074 . . . . 0.0 108.601 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.05 114.93 17.71 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 124.045 1.879 . . . . 0.0 109.038 168.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m -89.06 103.54 16.15 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -92.31 100.13 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 p -126.26 160.95 28.9 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.51 0.671 . . . . 0.0 111.15 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.95 178.41 48.16 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.51 -151.57 23.31 Favored Glycine 0 C--O 1.24 0.529 0 CA-C-N 118.741 1.27 . . . . 0.0 111.698 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.86 157.83 20.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.959 0.903 . . . . 0.0 109.151 -177.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.08 154.33 47.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.096 1.359 . . . . 0.0 108.355 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.497 ' NE2' ' HE1' ' A' ' 140' ' ' TRP . 2.3 mp0 -124.98 104.19 8.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 167.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.2 t -84.87 115.02 22.53 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 159.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.83 155.11 49.56 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.576 1.15 . . . . 0.0 108.482 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -143.12 163.93 31.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 110.058 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 60.17 9.51 1.91 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.924 1.689 . . . . 0.0 114.023 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.72 94.72 0.35 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.417 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 3.7 pm0 -45.38 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.29 2.236 . . . . 0.0 111.588 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -148.82 -2.44 0.47 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -118.48 113.01 20.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 122.884 1.326 . . . . 0.0 114.316 -162.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.424 ' HA ' ' HG3' ' A' ' 11' ' ' GLN . 45.5 mtpt -66.68 96.12 0.38 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 161.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.5 mtt -133.14 103.95 6.26 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 167.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.46 -170.95 23.73 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 128.335 2.874 . . . . 0.0 106.545 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.15 -84.25 0.05 OUTLIER Glycine 0 C--N 1.328 0.108 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 -169.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.82 174.17 10.78 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.348 1.459 . . . . 0.0 108.17 163.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -138.59 152.32 48.05 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.824 1.249 . . . . 0.0 107.746 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.68 131.06 19.72 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.664 1.986 . . . . 0.0 106.035 166.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -122.54 133.8 54.56 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -156.45 108.62 2.53 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -171.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -142.04 163.06 33.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.973 0.892 . . . . 0.0 111.127 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -99.66 157.47 16.45 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.164 1.385 . . . . 0.0 108.369 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.24 147.95 50.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -172.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -75.89 166.34 23.65 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.617 1.567 . . . . 0.0 111.67 -159.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -112.66 40.95 2.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.551 1.167 . . . . 0.0 108.565 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -167.59 -75.42 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.32 162.42 66.5 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.016 0.926 . . . . 0.0 109.601 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.91 62.6 8.48 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.669 2.913 . . . . 0.0 108.99 165.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.8 tp -112.01 123.79 51.0 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.182 1.393 . . . . 0.0 107.539 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.39 176.88 16.26 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 56.2 t -126.03 155.88 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 tt -132.94 121.03 43.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.35 108.85 2.08 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 m -80.49 142.11 34.54 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.163 0.982 . . . . 0.0 109.19 161.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -143.29 125.76 15.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 167.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.6 t -118.17 150.92 38.59 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.995 0.816 . . . . 0.0 109.5 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -142.99 123.72 14.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.0 p -114.17 121.56 44.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.59 29.41 0.93 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.899 0.772 . . . . 0.0 110.275 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -103.85 147.1 27.7 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.701 2.001 . . . . 0.0 108.528 177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 m -122.6 154.95 37.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.811 1.645 . . . . 0.0 108.19 168.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.567 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.333 0 CA-C-N 118.14 0.427 . . . . 0.0 110.618 -171.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 122.479 1.133 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -51.94 93.11 0.01 OUTLIER 'General case' 0 C--O 1.237 0.433 0 C-N-CA 128.221 2.609 . . . . 0.0 113.655 -167.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.02 168.35 16.02 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.522 -0.736 . . . . 0.0 109.632 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t30 61.58 176.9 0.12 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.774 1.23 . . . . 0.0 110.591 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -129.23 154.31 46.92 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 166.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.36 159.12 24.45 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -141.16 135.35 30.74 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.11 116.65 0.86 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -167.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.28 110.1 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.3 m -128.34 144.04 51.08 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.757 1.623 . . . . 0.0 107.848 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.96 167.61 24.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.285 1.034 . . . . 0.0 110.754 -172.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.42 174.0 34.57 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 128.137 2.78 . . . . 0.0 110.795 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 20.3 Cg_endo -85.75 -179.75 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.961 3.774 . . . . 0.0 110.8 171.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.97 135.1 35.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.856 1.662 . . . . 0.0 107.367 164.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -150.14 154.87 38.78 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.065 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -87.97 148.45 24.55 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.061 1.3 . . . . 0.0 111.145 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 73' ' ' ILE . 4.2 mp -69.91 -57.02 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -132.43 -75.9 0.5 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -165.55 74.98 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -130.89 -60.28 0.97 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.318 1.447 . . . . 0.0 109.175 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.84 164.6 32.34 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.653 1.181 . . . . 0.0 109.304 -174.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 p -125.44 109.46 12.75 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.054 1.341 . . . . 0.0 107.637 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.26 151.7 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -150.11 165.73 31.92 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.117 0.872 . . . . 0.0 110.86 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.37 139.18 21.44 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.58 152.21 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.43 1.115 . . . . 0.0 109.149 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.66 150.81 15.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.885 0.874 . . . . 0.0 109.193 -167.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.52 -165.7 27.31 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 123.306 0.479 . . . . 0.0 112.614 -168.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.53 150.33 18.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.73 1.212 . . . . 0.0 107.747 171.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.57 130.85 7.63 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.835 1.683 . . . . 0.0 109.159 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -127.57 117.51 22.18 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.246 1.418 . . . . 0.0 110.022 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.57 142.61 11.42 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 170.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.078 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -174.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.7 t . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -159.71 174.79 14.01 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 165.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -124.02 159.8 29.05 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.906 1.683 . . . . 0.0 107.737 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.11 137.49 9.41 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -75.78 102.21 5.37 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -67.39 135.03 52.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -148.12 171.47 15.83 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 121.929 -0.482 . . . . 0.0 110.047 168.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.18 -149.63 20.89 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.09 148.16 48.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.335 1.054 . . . . 0.0 109.602 174.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.23 124.11 7.68 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.03 139.42 49.88 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -170.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -138.48 129.9 27.48 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -92.83 171.59 8.88 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.149 0.5 . . . . 0.0 110.112 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -66.2 117.0 38.9 Favored Pre-proline 0 C--O 1.241 0.608 0 C-N-CA 123.95 0.9 . . . . 0.0 108.579 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.97 176.54 9.34 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.234 2.623 . . . . 0.0 112.0 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.14 -176.38 4.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.458 2.303 . . . . 0.0 107.49 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -91.14 -7.95 50.07 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.008 2.123 . . . . 0.0 110.121 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.72 12.18 0.25 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.99 1.716 . . . . 0.0 110.511 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.4 t -136.91 137.84 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.03 -1.669 . . . . 0.0 108.844 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -136.18 155.21 50.48 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -139.29 115.07 10.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.84 141.69 48.58 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 126.425 1.89 . . . . 0.0 106.646 -172.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -135.2 142.69 46.1 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 p -127.16 149.2 50.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 158.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.15 119.64 14.91 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 169.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -127.72 138.18 52.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -129.83 139.39 51.23 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.5 m -130.72 159.98 35.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.806 2.043 . . . . 0.0 107.186 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -132.33 145.62 51.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.19 95.95 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 75.27 -74.88 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.742 2.417 . . . . 0.0 111.512 165.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.7 m -148.75 27.05 0.9 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.432 1.493 . . . . 0.0 109.646 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.75 120.53 61.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 166.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.38 152.58 34.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.67 137.43 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 164.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.22 140.96 14.41 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 168.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.1 m -140.67 120.34 13.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.497 ' HE1' ' NE2' ' A' ' 11' ' ' GLN . 3.2 p-90 -105.03 153.16 21.83 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 166.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.7 mt -136.68 131.56 47.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.97 129.86 35.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -113.37 96.54 0.81 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.8 t -116.54 152.09 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 157.28 -143.01 9.1 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 106.429 -2.668 . . . . 0.0 106.429 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -121.76 176.87 5.51 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.604 1.962 . . . . 0.0 110.068 -166.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 129.95 13.44 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.283 171.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.5 p90 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 124.469 1.108 . . . . 0.0 108.37 175.231 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -92.4 151.09 20.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -143.46 107.09 4.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 162.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 t -138.83 150.91 46.56 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.089 0.947 . . . . 0.0 108.894 167.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.53 137.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 111.521 -2.581 . . . . 0.0 106.468 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.7 m -152.78 144.01 23.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.79 -178.55 44.75 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.74 -172.37 25.03 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.99 158.37 17.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.12 170.03 9.55 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.798 0.332 . . . . 0.0 110.722 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -140.99 113.04 7.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 156.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.5 t -84.75 151.3 24.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.062 0.934 . . . . 0.0 108.967 164.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -136.76 170.82 15.45 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.776 2.43 . . . . 0.0 107.863 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.19 159.5 42.1 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 161.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -75.63 64.77 1.73 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.707 1.203 . . . . 0.0 109.536 174.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 160.01 -37.95 0.46 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 126.855 2.169 . . . . 0.0 110.686 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -129.72 96.51 4.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.074 0.937 . . . . 0.0 109.758 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.5 mtt -78.3 58.15 2.04 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.637 0.732 . . . . 0.0 109.338 166.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.99 93.86 1.8 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 164.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 20' ' ' LYS . 0.5 OUTLIER -58.74 106.12 0.37 Allowed 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 81.9 mtp -136.06 109.69 8.03 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -169.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.07 -178.5 37.65 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.19 -128.67 0.96 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 104.86 -3.296 . . . . 0.0 104.86 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.89 150.25 37.36 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -122.04 162.77 20.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.62 1.968 . . . . 0.0 107.529 173.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -147.6 167.84 23.52 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -138.11 159.99 40.56 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.245 1.018 . . . . 0.0 108.894 170.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -136.19 141.57 44.04 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.517 2.327 . . . . 0.0 106.377 164.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.71 160.33 23.55 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 160.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -131.96 156.45 46.16 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.394 1.478 . . . . 0.0 107.328 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -98.25 140.16 32.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.667 0.746 . . . . 0.0 109.258 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.05 156.96 23.17 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 127.008 2.123 . . . . 0.0 107.19 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -133.26 71.66 1.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.96 -37.97 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.823 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -162.41 153.95 15.36 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 124.36 1.064 . . . . 0.0 109.207 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.56 88.42 1.42 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.376 2.717 . . . . 0.0 109.21 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 37' ' ' LEU . 17.9 tp -143.74 156.94 44.68 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 128.314 2.645 . . . . 0.0 105.791 172.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.89 175.89 21.55 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 91.1 t -124.61 157.21 32.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 118.189 0.994 . . . . 0.0 111.198 -168.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.75 141.53 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 126.779 2.032 . . . . 0.0 106.86 161.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.81 108.95 0.39 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 p -124.87 154.22 41.38 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.276 1.03 . . . . 0.0 110.613 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -131.66 122.45 25.98 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -170.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.8 p -95.47 146.8 24.15 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -171.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.98 154.95 50.92 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.623 1.169 . . . . 0.0 109.411 -178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.1 m -132.43 130.51 40.67 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.863 1.211 . . . . 0.0 112.564 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -110.95 -14.18 13.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.639 1.176 . . . . 0.0 112.856 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -66.42 145.73 55.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.813 0.845 . . . . 0.0 110.585 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 p -74.92 144.36 43.32 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.922 0.783 . . . . 0.0 109.405 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 . . . . . 0 N--CA 1.444 -0.755 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 158.693 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.49 -60.19 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.922 0.889 . . . . 0.0 110.216 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -102.46 133.07 48.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 122.0 -0.437 . . . . 0.0 110.543 -159.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -146.46 19.25 1.35 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -166.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -110.21 128.15 55.34 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 120.986 1.721 . . . . 0.0 107.855 -158.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -152.5 119.98 5.99 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.02 116.86 29.13 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.06 131.53 10.82 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 158.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.3 mt -119.68 109.54 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 167.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 8.9 t -120.01 147.59 44.61 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.554 2.342 . . . . 0.0 108.166 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.28 172.76 15.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.492 1.517 . . . . 0.0 109.188 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.44 175.59 43.92 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 161.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -74.33 175.75 10.57 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.471 2.114 . . . . 0.0 110.235 160.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.39 109.21 8.08 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.619 1.967 . . . . 0.0 108.085 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.37 130.25 35.25 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -111.38 118.45 35.87 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 170.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.06 -65.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -167.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -135.72 -79.31 0.42 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 161.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -158.69 80.52 0.8 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.049 1.295 . . . . 0.0 110.996 167.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -129.55 -40.51 1.41 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.28 1.432 . . . . 0.0 109.783 164.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.37 174.0 13.86 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.472 1.109 . . . . 0.0 109.733 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 t -148.87 105.26 3.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.11 156.5 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.795 0.838 . . . . 0.0 110.794 -172.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -151.18 173.34 14.52 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.024 1.329 . . . . 0.0 111.624 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.71 114.93 4.94 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.969 1.747 . . . . 0.0 108.759 170.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -110.36 161.08 9.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.224 1.409 . . . . 0.0 110.917 -164.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 66' ' ' THR . 0.5 OUTLIER -140.39 165.36 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 C-N-CA 124.249 1.02 . . . . 0.0 110.578 -169.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.11 -164.71 30.23 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 p -148.55 137.88 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 169.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.97 108.92 2.24 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 127.575 2.512 . . . . 0.0 109.623 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.58 140.29 31.42 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.417 1.087 . . . . 0.0 108.594 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.3 160.36 27.84 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 118.446 0.566 . . . . 0.0 112.424 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 tttp . . . . . 0 C--O 1.236 0.362 0 C-N-CA 127.146 2.178 . . . . 0.0 106.502 173.273 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -129.14 129.01 44.61 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -92.65 160.03 15.19 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 166.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.98 131.47 5.12 Favored Glycine 0 C--N 1.33 0.248 0 N-CA-C 107.959 -2.057 . . . . 0.0 107.959 170.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.49 126.38 30.9 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 m -92.58 131.25 37.85 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -146.22 133.02 20.03 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.05 -172.09 34.67 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.153 1.359 . . . . 0.0 111.144 -160.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.31 158.29 44.74 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.864 0.866 . . . . 0.0 110.555 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -134.21 104.75 0.53 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.074 1.321 . . . . 0.0 111.345 -168.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.4 148.3 37.9 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.62 1.568 . . . . 0.0 107.243 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.38 159.4 34.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.436 1.095 . . . . 0.0 108.816 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -133.91 159.19 41.44 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 126.461 1.904 . . . . 0.0 107.023 -171.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -56.38 114.75 8.31 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 123.779 0.832 . . . . 0.0 110.351 -158.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.43 171.61 11.0 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.281 3.321 . . . . 0.0 113.514 -168.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.9 mtm -145.85 177.68 8.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.175 2.19 . . . . 0.0 108.916 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -93.01 18.22 9.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.556 1.942 . . . . 0.0 112.995 -166.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.414 HD22 ' N ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -174.68 -7.92 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.035 2.134 . . . . 0.0 111.643 -168.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.408 ' H ' ' H ' ' A' ' 120' ' ' ASN . 4.9 t -143.41 140.9 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 128.646 2.778 . . . . 0.0 103.551 -170.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.62 159.62 42.17 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -137.63 117.15 12.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.73 150.7 40.57 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 168.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -140.93 123.45 15.97 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.1 m -122.49 136.16 54.82 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -126.23 122.23 34.98 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.412 1.885 . . . . 0.0 106.98 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.83 157.05 42.6 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.662 1.185 . . . . 0.0 110.212 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -132.26 152.97 51.1 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.287 1.035 . . . . 0.0 108.479 172.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.3 t -141.17 160.51 39.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 127.402 2.281 . . . . 0.0 107.349 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -128.87 107.09 9.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.6 pt -137.04 151.78 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.809 1.244 . . . . 0.0 108.152 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.45 18.89 6.0 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.784 1.634 . . . . 0.0 112.292 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.9 m 53.48 34.54 18.53 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.887 1.221 . . . . 0.0 112.03 -164.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.39 149.31 23.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 122.019 0.914 . . . . 0.0 108.842 161.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.8 140.13 53.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 168.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -136.26 98.64 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.32 151.34 32.86 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -141.65 154.2 45.21 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 146.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -139.21 155.23 47.95 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 168.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.4 pt -121.3 140.24 45.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -173.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.04 135.07 33.58 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -113.44 121.77 5.59 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 106.509 -2.636 . . . . 0.0 106.509 170.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.81 148.16 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 129.387 3.075 . . . . 0.0 103.988 169.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.72 -125.46 1.37 Allowed Glycine 0 C--O 1.227 -0.322 0 CA-C-O 118.014 -1.437 . . . . 0.0 109.904 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.84 143.04 22.44 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 127.287 2.235 . . . . 0.0 106.625 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -136.68 96.29 3.3 Favored 'General case' 0 CA--C 1.518 -0.279 0 O-C-N 120.863 -1.148 . . . . 0.0 108.298 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 115.13 -2.367 . . . . 0.0 112.379 159.757 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.9 m -137.29 152.93 50.31 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 171.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -142.07 133.89 27.14 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 122.311 1.053 . . . . 0.0 108.66 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -152.44 145.46 24.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.69 132.09 64.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.8 p -137.82 130.41 29.62 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.75 159.13 23.13 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.84 -152.39 19.28 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 107.346 -2.302 . . . . 0.0 107.346 -164.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -99.85 153.27 19.28 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.357 0.579 . . . . 0.0 110.353 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.93 142.01 50.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 170.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.9 149.58 50.31 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.795 1.238 . . . . 0.0 108.514 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.7 m -137.27 121.53 18.05 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.396 1.079 . . . . 0.0 109.802 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -103.61 162.16 13.29 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.58 146.02 51.42 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 118.295 0.498 . . . . 0.0 110.854 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 61.6 -60.09 0.1 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 130.253 3.421 . . . . 0.0 112.018 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.83 -66.16 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 105.892 -2.883 . . . . 0.0 105.892 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.86 96.81 4.75 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.027 1.331 . . . . 0.0 109.231 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.5 ttt -152.91 -69.02 0.15 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.299 0.639 . . . . 0.0 109.553 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.83 146.6 19.34 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.971 0.908 . . . . 0.0 110.243 -172.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -120.33 154.54 34.88 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 124.99 1.316 . . . . 0.0 108.912 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.4 ptp -131.24 159.17 38.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.09 175.45 23.19 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.696 1.141 . . . . 0.0 111.064 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.8 -177.32 47.55 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 118.064 0.932 . . . . 0.0 111.29 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -99.83 147.87 25.04 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.434 HD21 ' HB2' ' A' ' 42' ' ' SER . 24.5 t-20 -137.91 150.73 47.33 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.921 1.688 . . . . 0.0 109.673 -176.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mt -139.22 161.68 36.84 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 128.039 2.536 . . . . 0.0 108.619 171.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.49 176.43 12.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.27 1.828 . . . . 0.0 107.954 157.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -144.86 114.61 7.28 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 120.877 -1.139 . . . . 0.0 108.478 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 109.15 20.78 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -99.86 158.86 15.5 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.792 1.637 . . . . 0.0 109.224 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -115.2 152.31 32.87 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -121.28 166.76 13.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.021 1.329 . . . . 0.0 110.42 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -125.4 56.72 1.35 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.79 1.236 . . . . 0.0 108.071 -163.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.21 -47.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.181 1.392 . . . . 0.0 109.092 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.5 m -134.96 152.02 76.54 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.907 1.683 . . . . 0.0 107.899 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.84 13.2 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.939 3.759 . . . . 0.0 114.929 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 tp -87.24 118.91 26.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.157 1.783 . . . . 0.0 110.222 -165.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.22 177.27 49.0 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.1 t -133.87 145.27 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.172 1.389 . . . . 0.0 109.293 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 mp -139.68 131.91 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.469 1.908 . . . . 0.0 107.13 168.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.17 148.93 18.75 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 142.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.434 ' HB2' HD21 ' A' ' 25' ' ' ASN . 4.9 p -125.0 154.34 41.4 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.326 1.051 . . . . 0.0 110.515 165.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -112.77 148.97 33.67 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.318 1.047 . . . . 0.0 108.746 169.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 m -93.93 146.61 23.79 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.68 0.792 . . . . 0.0 109.218 165.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.424 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 48.5 m-85 -117.62 153.74 32.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.563 1.545 . . . . 0.0 108.593 166.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.85 143.21 34.31 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.008 0.822 . . . . 0.0 111.293 168.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.78 -11.49 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.012 2.525 . . . . 0.0 112.076 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.82 147.06 30.61 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.074 -1.641 . . . . 0.0 110.39 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.2 p -111.14 155.88 22.21 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.417 1.487 . . . . 0.0 109.132 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 162.804 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 C--O 1.239 0.546 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.2 128.63 36.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.14 -0.975 . . . . 0.0 108.666 171.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -144.63 172.65 12.69 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 84.92 -177.69 0.03 OUTLIER 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.843 2.057 . . . . 0.0 109.018 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.83 169.84 14.08 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.657 1.583 . . . . 0.0 107.919 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.424 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 25.2 p90 -73.73 139.22 45.14 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 159.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -140.39 117.54 11.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 157.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.52 121.69 1.05 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.46 150.46 34.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.1 p -140.48 157.36 45.63 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.23 140.53 21.36 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.041 0.837 . . . . 0.0 111.158 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.523 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -176.02 160.19 28.05 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 156.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.19 -179.81 5.8 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.14 1.893 . . . . 0.0 111.668 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.56 146.02 41.26 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.208 1.403 . . . . 0.0 108.251 164.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -128.85 130.03 46.36 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -67.18 111.93 4.2 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.838 1.655 . . . . 0.0 109.301 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 tt -73.75 171.38 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.026 0.441 . . . . 0.0 109.875 -176.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -88.73 37.48 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.102 1.761 . . . . 0.0 110.091 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -149.51 -119.98 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.591 1.957 . . . . 0.0 105.73 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -128.67 66.25 1.41 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.506 1.922 . . . . 0.0 109.441 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.1 176.02 13.04 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.657 -1.277 . . . . 0.0 110.766 168.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 m -137.94 112.95 9.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 164.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.71 147.21 23.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -150.4 164.88 34.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 119.665 1.12 . . . . 0.0 110.564 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.69 129.99 9.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.523 HG12 ' HA3' ' A' ' 68' ' ' GLY . 32.6 m -126.92 -176.52 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 124.374 1.07 . . . . 0.0 111.166 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.86 165.56 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.677 1.991 . . . . 0.0 107.874 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.88 -172.26 31.14 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 162.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.51 138.97 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.47 139.13 10.72 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -132.66 116.98 17.31 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.583 1.953 . . . . 0.0 106.935 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.14 125.9 0.79 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? . . . . . 0 C--O 1.238 0.488 0 CA-C-N 118.06 0.93 . . . . 0.0 109.523 165.705 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 C--O 1.237 0.441 0 CA-C-O 121.319 0.58 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -144.22 164.83 29.6 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 127.214 2.205 . . . . 0.0 108.33 172.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -68.54 123.61 21.32 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -104.88 123.15 7.55 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 170.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -81.2 151.29 28.26 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.5 p -146.11 151.64 38.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -141.73 167.72 21.46 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.729 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 166.81 -172.7 42.04 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.8 149.55 31.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.628 0.714 . . . . 0.0 110.548 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.21 122.23 6.64 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 170.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -115.69 139.9 49.7 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -121.14 159.38 25.93 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.693 0.759 . . . . 0.0 109.886 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.5 170.54 8.0 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.825 1.65 . . . . 0.0 106.623 158.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -60.43 110.71 3.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.138 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.55 120.67 7.91 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.44 2.093 . . . . 0.0 108.805 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -177.06 164.7 2.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.932 1.242 . . . . 0.0 108.878 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 103.89 27.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.898 2.479 . . . . 0.0 109.051 154.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.94 15.91 10.22 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.689 1.595 . . . . 0.0 110.961 -169.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.73 171.33 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.7 159.65 39.03 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.375 1.87 . . . . 0.0 105.956 163.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 123' ' ' LEU . 2.2 mm? -125.22 114.95 19.64 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 161.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -136.17 133.96 37.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 174.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -139.73 142.81 36.81 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 -172.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.8 m -146.53 165.26 29.99 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.592 -0.693 . . . . 0.0 111.318 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -140.0 129.26 23.88 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.727 2.411 . . . . 0.0 105.332 -171.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -137.81 108.2 6.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -99.22 111.61 23.95 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.1 m -76.82 150.88 36.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.452 0.701 . . . . 0.0 110.56 171.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.7 ptt85 -140.72 96.54 3.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.763 1.625 . . . . 0.0 106.91 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.2 mt -100.79 81.37 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 -175.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 56.75 -64.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 129.728 3.211 . . . . 0.0 113.575 -171.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 p -145.8 26.76 1.23 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.685 1.994 . . . . 0.0 110.107 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.8 t -123.27 103.4 12.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -82.3 131.99 35.23 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.7 101.18 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.73 115.43 4.34 Favored Glycine 0 C--O 1.242 0.604 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -174.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 57.4 m -107.85 142.29 38.14 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -141.72 141.3 33.27 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.0 pt -135.95 151.3 29.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.49 148.92 47.4 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.706 1.203 . . . . 0.0 108.57 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.36 94.53 0.2 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 124.924 1.249 . . . . 0.0 110.415 -169.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.25 171.87 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.552 1.941 . . . . 0.0 107.586 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.99 -116.12 0.7 Allowed Glycine 0 C--O 1.221 -0.666 0 O-C-N 119.913 -1.742 . . . . 0.0 108.87 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -163.81 163.42 23.9 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.958 1.879 . . . . 0.0 110.079 171.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -90.07 147.47 23.62 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.868 161.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 115.432 -2.223 . . . . 0.0 107.489 174.735 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.8 m -139.47 149.66 44.26 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m -106.73 107.09 17.93 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.435 1.494 . . . . 0.0 107.841 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.1 m -131.12 127.13 37.46 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.38 133.1 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 127.011 2.124 . . . . 0.0 105.915 -163.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.9 t -157.15 146.6 20.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.96 164.08 37.58 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.859 -1.697 . . . . 0.0 108.859 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.55 -154.72 23.54 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.77 159.33 41.67 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 109.142 -160.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.34 168.92 11.87 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.337 1.065 . . . . 0.0 113.767 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -125.0 117.49 24.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.407 1.483 . . . . 0.0 107.205 155.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.6 t -84.0 145.63 28.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 160.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -138.63 158.13 44.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.194 1.798 . . . . 0.0 107.944 -165.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.77 158.19 43.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 120.979 1.718 . . . . 0.0 111.31 159.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -78.76 56.76 1.94 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.685 0.755 . . . . 0.0 110.921 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.98 -39.13 0.2 Allowed Glycine 0 CA--C 1.519 0.282 0 O-C-N 120.06 -1.65 . . . . 0.0 110.434 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.55 96.36 2.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.681 0.753 . . . . 0.0 109.414 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.1 mtm -74.9 64.5 1.3 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.834 2.454 . . . . 0.0 108.195 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -66.33 102.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -64.17 98.04 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.881 1.272 . . . . 0.0 108.539 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 52.0 mtp -133.98 129.7 36.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.49 -145.47 4.13 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 170.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.04 -127.23 1.48 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 119.691 1.745 . . . . 0.0 110.668 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -132.58 121.17 22.83 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.983 1.313 . . . . 0.0 108.953 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -96.15 160.96 14.17 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.426 1.49 . . . . 0.0 110.107 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.95 139.86 29.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 162.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.33 149.81 49.82 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 118.775 0.716 . . . . 0.0 109.875 165.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -149.45 110.08 4.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.58 119.64 33.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.99 157.12 16.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -130.09 153.19 48.73 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.837 0.855 . . . . 0.0 109.481 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.43 172.24 9.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.704 0.801 . . . . 0.0 110.538 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -101.99 -26.31 13.45 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.752 -1.218 . . . . 0.0 109.719 161.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.65 -25.29 53.61 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.3 m -152.17 157.23 34.07 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.739 1.215 . . . . 0.0 109.508 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.42 21.4 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.354 3.369 . . . . 0.0 113.515 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.6 tp -91.45 136.53 33.05 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.153 -0.967 . . . . 0.0 109.248 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.12 -168.61 12.48 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.816 1.198 . . . . 0.0 111.299 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.95 148.14 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.437 1.095 . . . . 0.0 110.657 -172.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.3 mm -119.3 119.76 61.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 127.077 2.151 . . . . 0.0 107.936 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.04 119.9 1.05 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 106.759 -2.536 . . . . 0.0 106.759 164.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.82 149.75 42.89 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.421 1.888 . . . . 0.0 106.584 175.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -144.13 128.41 17.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.9 m -126.51 132.07 51.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 168.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -91.44 150.17 21.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.4 p -98.1 138.34 35.55 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.01 163.95 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.176 1.39 . . . . 0.0 109.65 163.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HB2' HD22 ' A' ' 58' ' ' ASN . 0.0 OUTLIER -152.27 113.79 4.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -170.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 m -115.73 103.75 10.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.382 1.087 . . . . 0.0 110.502 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HA ' ' H ' ' A' ' 58' ' ' ASN . 24.5 ptt-85 . . . . . 0 N--CA 1.444 -0.77 0 C-N-CA 129.344 3.057 . . . . 0.0 108.89 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 . . . . . 0 C--O 1.236 0.349 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.443 HD22 ' HB2' ' A' ' 48' ' ' LYS . 2.3 t30 -81.2 92.11 6.26 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -160.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -155.77 116.35 3.79 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.071 0.948 . . . . 0.0 108.961 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -149.66 -160.88 1.23 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 160.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.475 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 10.2 pt20 -126.86 128.8 47.08 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 164.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -97.31 114.04 25.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.67 117.84 29.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.88 96.68 0.96 Allowed Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.0 141.31 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 t -133.65 157.39 45.88 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 171.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.28 138.98 20.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.588 -0.695 . . . . 0.0 111.411 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.86 166.15 32.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.753 1.644 . . . . 0.0 109.314 160.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.438 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 66.7 Cg_endo -73.88 -177.96 3.5 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.734 2.289 . . . . 0.0 112.538 171.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.55 128.77 44.92 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.708 2.003 . . . . 0.0 108.032 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.1 130.29 28.84 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 ttp-105 -80.4 89.93 5.6 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.8 pp -93.29 1.57 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.244 1.018 . . . . 0.0 112.054 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -128.49 -178.28 4.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.941 1.696 . . . . 0.0 107.244 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -52.0 -67.53 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.72 2.008 . . . . 0.0 109.255 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.42 42.83 2.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.965 2.106 . . . . 0.0 110.559 -169.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.31 151.71 33.35 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.68 141.53 49.6 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.384 1.074 . . . . 0.0 109.422 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.48 154.82 6.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.234 1.413 . . . . 0.0 107.391 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.438 ' CE2' ' HD2' ' A' ' 69' ' ' PRO . 36.0 t80 -149.81 150.68 32.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.166 1.386 . . . . 0.0 107.857 169.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.26 109.84 3.35 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.2 m -103.76 161.8 4.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.967 0.907 . . . . 0.0 109.876 -167.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 t -109.08 131.07 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -116.34 159.88 13.68 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.53 150.84 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 170.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.97 158.3 21.4 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.946 1.736 . . . . 0.0 109.774 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -140.91 127.7 20.4 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.26 -171.66 16.64 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.0 pttt . . . . . 0 N--CA 1.483 1.181 0 C-N-CA 127.709 2.403 . . . . 0.0 112.919 160.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -94.91 151.76 18.93 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 164.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -95.1 110.6 22.52 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.155 1.382 . . . . 0.0 107.819 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.13 98.44 0.56 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.22 133.78 42.7 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.391 1.096 . . . . 0.0 108.296 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 p -133.06 173.62 11.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.351 1.072 . . . . 0.0 111.659 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -161.78 163.69 29.34 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.254 1.822 . . . . 0.0 106.353 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 177.18 -162.28 30.31 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -140.88 130.55 24.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 167.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.6 142.19 15.97 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 172.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.35 140.52 51.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.39 1.876 . . . . 0.0 108.539 -168.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.68 159.82 35.26 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.816 1.246 . . . . 0.0 110.769 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -91.87 171.09 9.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 168.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -56.92 154.21 19.88 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.793 168.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.98 109.91 0.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.254 0 N-CA-C 107.647 -1.713 . . . . 0.0 107.647 162.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.1 mmt -81.08 -174.97 5.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.974 2.11 . . . . 0.0 107.095 153.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -117.69 -4.24 11.21 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.359 -1.463 . . . . 0.0 110.736 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -137.45 0.14 2.25 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 124.561 1.144 . . . . 0.0 111.316 166.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.77 147.08 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 120.363 -1.461 . . . . 0.0 107.69 -162.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -143.62 153.06 42.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.456 1.903 . . . . 0.0 106.846 167.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.479 HD13 HG12 ' A' ' 144' ' ' VAL . 2.3 mm? -133.78 130.46 38.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 172.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -146.59 129.79 16.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 119.211 0.914 . . . . 0.0 109.176 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -149.65 151.9 34.5 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.512 0.596 . . . . 0.0 110.479 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.9 t -145.48 166.61 25.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.564 0.746 . . . . 0.0 110.338 173.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -143.57 106.13 4.45 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.595 1.958 . . . . 0.0 106.178 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -131.38 114.72 15.31 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -99.3 107.84 20.22 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -169.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.0 t -81.73 157.55 24.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.771 0.829 . . . . 0.0 108.833 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -130.0 129.07 43.26 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.0 mm -118.19 91.4 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -166.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.39 -82.71 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 126.156 1.782 . . . . 0.0 108.585 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.74 23.96 3.11 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.395 1.078 . . . . 0.0 112.551 171.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.94 148.79 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 119.413 1.006 . . . . 0.0 108.574 171.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.08 129.27 39.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.605 1.562 . . . . 0.0 107.652 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 79.6 t -136.82 92.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.866 1.666 . . . . 0.0 109.531 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.4 152.49 41.28 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.524 -0.735 . . . . 0.0 111.557 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.85 143.92 49.85 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 155.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -130.8 119.74 22.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.7 133.02 70.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.95 138.39 26.83 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -153.1 167.86 31.82 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 124.286 0.946 . . . . 0.0 110.926 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.479 HG12 HD13 ' A' ' 123' ' ' LEU . 17.4 m -140.3 168.33 17.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.084 1.353 . . . . 0.0 107.841 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -166.76 -103.85 0.17 Allowed Glycine 0 C--N 1.334 0.438 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.632 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -164.11 176.47 9.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.206 1.802 . . . . 0.0 109.511 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.11 145.05 35.26 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 168.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.0 p90 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 117.869 -1.062 . . . . 0.0 109.651 -179.233 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.477 0.18 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -141.7 141.31 33.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 121.414 -0.804 . . . . 0.0 108.987 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.07 107.01 11.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -95.75 139.74 31.55 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.48 HG13 ' H ' ' A' ' 146' ' ' TYR . 2.4 p -142.78 128.94 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.897 1.679 . . . . 0.0 107.524 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.6 p -138.51 163.56 31.68 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.453 0.569 . . . . 0.0 110.653 168.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.77 155.52 26.79 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.47 -165.43 37.95 Favored Glycine 0 C--O 1.236 0.272 0 O-C-N 121.793 -0.828 . . . . 0.0 112.75 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.74 157.58 16.39 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.246 1.018 . . . . 0.0 110.087 -169.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.79 162.89 34.05 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.921 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -143.73 154.34 43.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.331 1.053 . . . . 0.0 108.222 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 t -115.12 151.13 34.88 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 162.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.33 170.75 12.15 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.272 2.229 . . . . 0.0 105.296 160.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.91 164.49 28.19 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.5 -0.75 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -74.04 85.35 1.8 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 159.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.83 90.41 0.45 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.48 94.74 0.29 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 122.302 1.048 . . . . 0.0 109.74 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -151.21 -58.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.208 1.803 . . . . 0.0 108.03 170.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -63.69 103.92 0.61 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.168 1.387 . . . . 0.0 109.266 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -129.81 75.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 161.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -81.47 161.32 23.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.739 1.616 . . . . 0.0 109.282 164.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.93 179.88 40.93 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 108.209 -1.957 . . . . 0.0 108.209 171.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.74 -163.63 30.26 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 118.285 1.043 . . . . 0.0 111.858 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -99.62 153.97 18.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.24 1.416 . . . . 0.0 108.747 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -137.93 153.26 49.51 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.873 1.669 . . . . 0.0 107.648 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.6 mt -133.41 148.29 51.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 162.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -125.92 127.22 45.65 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 164.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -155.64 108.43 2.69 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -169.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -141.18 165.93 26.18 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.845 1.258 . . . . 0.0 108.707 -171.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -111.35 157.2 20.48 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -107.71 149.57 27.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 168.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.54 151.27 41.89 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 170.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.54 2.85 55.67 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.342 -0.849 . . . . 0.0 110.886 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -141.44 -70.32 0.36 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.47 1.508 . . . . 0.0 109.277 -153.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.1 t -72.67 122.83 88.58 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 167.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.47 68.28 6.94 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.629 2.22 . . . . 0.0 111.229 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 tp -142.35 121.61 13.06 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.932 1.293 . . . . 0.0 109.234 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -103.84 178.48 24.9 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -127.74 157.41 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.3 mm -124.94 151.62 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.93 1.692 . . . . 0.0 107.399 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.94 108.68 0.37 Allowed Glycine 0 C--N 1.336 0.563 0 O-C-N 120.136 -1.603 . . . . 0.0 111.372 159.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -67.46 151.65 47.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 166.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -136.51 103.04 5.12 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -92.99 150.84 20.27 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -172.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.2 157.76 40.92 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.413 1.085 . . . . 0.0 109.757 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 m -99.81 130.47 46.01 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 160.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -135.63 -56.59 0.79 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.544 1.938 . . . . 0.0 106.619 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.68 113.73 5.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.325 1.45 . . . . 0.0 107.508 174.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -101.6 155.59 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.059 2.143 . . . . 0.0 109.435 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.515 ' H ' ' HB2' ' A' ' 58' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 164.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.235 0.336 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.515 ' HB2' ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -124.77 98.92 5.92 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 170.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -115.12 147.65 39.97 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 72.86 -177.84 0.19 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.59 2.356 . . . . 0.0 110.838 -168.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -124.99 163.74 21.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.078 1.751 . . . . 0.0 108.403 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.69 142.35 29.1 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -130.41 118.52 21.32 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.57 166.26 19.43 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 122.43 1.017 . . . . 0.0 112.235 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.7 142.83 42.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 167.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.9 m -139.79 130.95 26.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.88 164.55 31.61 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.617 0.767 . . . . 0.0 110.09 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.14 162.53 10.76 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 126.667 2.08 . . . . 0.0 107.993 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.05 156.62 38.44 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.576 1.517 . . . . 0.0 111.745 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.59 104.06 16.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 157.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -103.14 117.55 34.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -66.94 146.95 53.85 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.82 0.448 . . . . 0.0 110.469 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 pt -141.99 164.05 18.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.8 0.81 . . . . 0.0 111.168 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 t30 65.49 -74.87 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 130.448 3.499 . . . . 0.0 113.072 164.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -132.02 -56.48 0.98 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 117.074 -1.441 . . . . 0.0 109.372 165.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -151.67 27.02 0.65 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.117 1.767 . . . . 0.0 111.037 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.65 172.2 8.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.365 1.466 . . . . 0.0 110.263 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -127.83 168.98 14.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.724 1.609 . . . . 0.0 110.773 -173.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.31 162.1 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.67 1.188 . . . . 0.0 110.77 -172.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -104.65 124.72 49.84 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 127.731 2.412 . . . . 0.0 108.564 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.69 42.76 0.08 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.7 m -104.95 164.34 3.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.74 140.04 28.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -161.32 172.81 37.63 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-O 121.612 0.562 . . . . 0.0 112.789 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.69 149.09 16.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.63 145.15 18.56 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 166.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -135.04 152.15 51.44 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.635 1.574 . . . . 0.0 108.316 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.97 -156.43 12.83 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt . . . . . 0 C--O 1.235 0.336 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.789 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.236 0.371 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -85.69 138.72 31.93 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.061 0.944 . . . . 0.0 109.212 -173.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.97 126.7 49.16 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.054 1.341 . . . . 0.0 107.903 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.66 83.41 0.28 Allowed Glycine 0 CA--C 1.522 0.483 0 CA-C-N 119.078 0.853 . . . . 0.0 111.624 -173.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -74.35 141.16 45.19 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.76 1.224 . . . . 0.0 109.364 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.66 -150.31 0.15 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.984 0.811 . . . . 0.0 110.622 154.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -128.18 162.49 26.83 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.321 1.848 . . . . 0.0 110.001 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.71 -176.2 15.12 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.755 0.693 . . . . 0.0 112.461 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.22 174.22 6.64 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.944 1.698 . . . . 0.0 111.232 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -157.86 84.37 0.13 Allowed Glycine 0 C--N 1.342 0.865 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.643 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.13 139.61 49.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.178 0.989 . . . . 0.0 108.746 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -137.43 159.37 42.12 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.091 1.356 . . . . 0.0 107.674 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -92.85 170.71 9.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 119.619 1.1 . . . . 0.0 108.38 171.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -61.27 104.49 0.47 Allowed Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.439 1.096 . . . . 0.0 110.524 -170.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.15 106.64 2.31 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.642 2.228 . . . . 0.0 109.908 -166.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.7 ptm -164.68 169.77 16.47 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.406 0.548 . . . . 0.0 110.774 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 63.69 35.65 11.29 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.601 1.16 . . . . 0.0 108.67 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 60.01 14.11 4.16 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.864 1.266 . . . . 0.0 113.318 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.26 110.43 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 123.734 1.73 . . . . 0.0 109.309 171.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -113.9 110.25 19.79 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.229 2.612 . . . . 0.0 106.395 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.37 131.66 34.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.78 148.76 42.68 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.727 0.694 . . . . 0.0 110.594 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -143.35 150.7 39.52 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.99 1.316 . . . . 0.0 108.51 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 p -144.08 152.99 41.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.657 0.741 . . . . 0.0 111.367 152.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -108.18 125.09 51.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.144 2.177 . . . . 0.0 105.733 168.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -136.61 145.24 44.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.238 1.815 . . . . 0.0 107.873 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -127.29 161.67 28.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.729 0.775 . . . . 0.0 110.993 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 p -141.22 159.89 41.26 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.831 2.052 . . . . 0.0 108.084 170.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -128.79 114.93 17.18 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 87.2 mt -105.9 98.03 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.18 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 129.179 2.992 . . . . 0.0 109.893 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.5 p -137.78 20.76 2.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.471 1.108 . . . . 0.0 111.245 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.82 115.71 50.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 167.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.29 130.46 40.84 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 168.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.4 t -135.49 112.35 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -172.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.25 144.92 16.94 Favored Glycine 0 C--O 1.238 0.357 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -169.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.3 p -138.0 148.85 45.57 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.436 0.695 . . . . 0.0 110.218 -164.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -121.18 150.27 41.55 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 166.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.45 131.45 65.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.83 131.79 20.3 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.666 0.786 . . . . 0.0 109.045 -171.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -161.97 173.52 38.32 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 114.599 0.6 . . . . 0.0 114.599 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.0 178.06 2.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.951 2.1 . . . . 0.0 108.78 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 167.67 -165.15 38.49 Favored Glycine 0 C--O 1.217 -0.952 0 O-C-N 120.545 -1.347 . . . . 0.0 110.367 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.48 ' H ' HG13 ' A' ' 5' ' ' VAL . 51.4 m-85 -104.92 175.45 5.49 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -166.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.87 130.32 19.98 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 120.813 -1.18 . . . . 0.0 108.13 170.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.191 1.396 . . . . 0.0 107.848 -179.112 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.6 p -132.79 157.17 45.64 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 149.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.85 106.71 4.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.133 0.973 . . . . 0.0 108.822 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -134.35 125.55 27.83 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.985 -1.072 . . . . 0.0 109.095 -168.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.38 112.85 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.468 1.107 . . . . 0.0 108.663 -168.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.5 p -149.15 123.58 9.67 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.927 0.891 . . . . 0.0 109.14 -166.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.34 158.53 27.71 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.794 1.187 . . . . 0.0 111.463 176.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.25 -139.35 5.09 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -167.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -150.33 154.93 38.69 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 117.668 0.734 . . . . 0.0 110.97 -166.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.93 160.19 39.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.461 1.105 . . . . 0.0 111.03 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -132.73 114.12 13.77 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -84.96 144.35 28.38 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.866 0.866 . . . . 0.0 109.004 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -138.39 119.31 14.29 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.34 1.856 . . . . 0.0 109.357 -173.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.03 166.45 19.76 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.499 1.12 . . . . 0.0 110.765 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -39.27 -20.33 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.275 2.63 . . . . 0.0 115.948 169.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.26 -108.7 0.56 Allowed Glycine 0 C--N 1.338 0.659 0 CA-C-N 120.192 1.36 . . . . 0.0 110.584 167.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -141.14 101.81 4.11 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.719 1.26 . . . . 0.0 109.311 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 58.2 mtp -130.32 -75.09 0.54 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.17 99.28 3.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -78.61 132.06 36.96 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB2' HG23 ' A' ' 46' ' ' THR . 3.9 ptp -133.99 149.16 51.2 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.07 177.46 47.69 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.73 -162.41 28.19 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -171.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.06 110.16 22.46 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -170.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -95.69 150.81 19.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.049 -1.464 . . . . 0.0 107.049 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.33 145.03 20.12 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -170.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -132.87 150.11 52.19 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.68 139.62 50.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 170.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -129.53 109.0 10.67 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -115.9 132.5 56.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.59 153.12 45.96 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.777 1.631 . . . . 0.0 107.532 172.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -141.64 155.57 45.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -69.46 -19.97 63.76 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.538 -0.726 . . . . 0.0 110.146 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -21.05 65.98 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 125.548 1.539 . . . . 0.0 112.83 173.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -152.12 90.16 3.85 Favored Pre-proline 0 C--O 1.238 0.448 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.61 64.73 4.73 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.226 2.618 . . . . 0.0 112.012 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.86 125.58 10.4 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 167.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.05 174.19 54.59 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 118.555 0.616 . . . . 0.0 111.859 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.0 t -132.39 148.37 31.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.938 1.695 . . . . 0.0 107.659 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.33 120.74 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 126.592 1.957 . . . . 0.0 106.231 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.78 127.59 4.13 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 168.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 t -125.98 154.9 42.23 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.618 1.167 . . . . 0.0 110.729 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -112.68 140.3 47.56 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.905 0.882 . . . . 0.0 109.01 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.7 m -118.3 116.04 25.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.038 1.335 . . . . 0.0 107.973 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -112.9 149.68 32.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.232 1.413 . . . . 0.0 109.353 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 21' ' ' MET . 7.2 m -123.95 122.43 37.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -136.73 88.93 2.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -174.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -150.7 134.58 16.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.402 1.081 . . . . 0.0 109.288 -161.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.8 p -131.24 122.56 26.72 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.654 1.182 . . . . 0.0 112.155 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 . . . . . 0 C--O 1.224 -0.251 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 162.251 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -81.24 66.53 6.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.391 0.615 . . . . 0.0 109.401 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -134.49 115.72 14.27 Favored 'General case' 0 CA--C 1.523 -0.06 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -158.93 161.78 36.79 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.692 1.997 . . . . 0.0 106.514 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -112.7 128.16 56.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 168.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -107.96 138.32 44.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 170.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -141.39 163.89 31.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.21 169.97 34.35 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.68 143.96 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 t -141.19 127.84 20.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.84 139.1 48.74 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.428 0.558 . . . . 0.0 110.978 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -172.97 167.16 39.92 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 163.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.22 177.79 8.16 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.589 2.193 . . . . 0.0 110.163 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.18 107.31 6.04 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.839 1.256 . . . . 0.0 107.63 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.19 148.66 22.21 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -91.34 142.76 27.35 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 122.074 -0.391 . . . . 0.0 110.308 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.3 mt -83.51 -102.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -129.76 12.04 5.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.487 1.515 . . . . 0.0 109.919 172.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -157.75 -178.41 7.3 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.851 -1.156 . . . . 0.0 112.865 -158.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -69.82 16.56 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.534 2.334 . . . . 0.0 114.292 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.97 141.0 48.7 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.6 1.16 . . . . 0.0 108.537 167.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 p -146.66 120.17 9.09 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.1 149.97 23.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -150.32 171.96 16.14 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.05 0.94 . . . . 0.0 108.922 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.28 150.16 38.33 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 164.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.72 165.49 28.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.284 1.034 . . . . 0.0 108.954 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.62 131.33 73.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.12 156.68 21.34 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.55 150.09 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.51 154.4 20.37 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -132.53 140.24 48.23 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.612 1.965 . . . . 0.0 108.434 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.39 171.67 32.12 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -174.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.397 0 C-N-CA 127.286 2.234 . . . . 0.0 107.657 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.466 0.333 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -149.59 151.66 34.17 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.55 0.691 . . . . 0.0 110.722 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -105.18 125.4 50.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 129.082 2.953 . . . . 0.0 106.991 -165.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.21 105.64 3.31 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.99 139.19 42.76 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.8 m -133.82 177.16 7.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.178 0.991 . . . . 0.0 109.401 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -168.12 167.8 12.18 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.937 2.095 . . . . 0.0 107.464 159.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.73 -166.33 35.19 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.08 158.49 44.28 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.77 1.228 . . . . 0.0 108.681 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.3 113.63 3.32 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.85 140.57 49.75 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.516 1.158 . . . . 0.0 109.35 -166.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -117.42 134.78 54.45 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.553 0.741 . . . . 0.0 109.957 -171.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.45 171.07 9.14 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -57.08 118.17 22.41 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.936 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.82 170.09 15.85 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.022 2.481 . . . . 0.0 112.612 170.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 46.3 mtt -152.98 162.95 40.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 130.03 3.332 . . . . 0.0 106.684 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.55 -4.84 1.5 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 129.178 2.991 . . . . 0.0 114.413 -171.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -145.21 8.89 1.23 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.087 0.955 . . . . 0.0 111.51 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.24 139.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 120.221 1.373 . . . . 0.0 108.842 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.9 154.1 38.97 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 119.907 -1.746 . . . . 0.0 107.566 161.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 132.88 46.13 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -140.98 130.69 24.17 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -129.31 151.25 50.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.48 1.112 . . . . 0.0 108.409 -173.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.96 162.42 37.85 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.636 0.732 . . . . 0.0 109.722 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -130.93 136.64 48.76 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -136.72 132.46 34.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 103.944 -2.614 . . . . 0.0 103.944 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -99.41 154.61 18.08 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 170.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 72.2 m -135.42 149.04 49.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -137.8 118.82 14.36 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 61.3 mt -123.38 105.5 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.68 50.89 17.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.076 1.35 . . . . 0.0 113.28 169.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.7 10.13 3.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.207 1.403 . . . . 0.0 111.518 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.63 119.5 43.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 166.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -71.67 133.14 45.46 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.9 t -133.25 157.06 42.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.25 152.19 23.11 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -140.26 153.9 46.66 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 167.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -136.35 118.74 15.73 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.7 mt -99.75 136.13 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.004 1.722 . . . . 0.0 107.35 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.32 139.62 35.47 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.32 163.05 36.61 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.9 m -139.08 173.54 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.001 1.32 . . . . 0.0 109.426 -172.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 180.0 -99.6 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-O 118.337 -1.257 . . . . 0.0 109.989 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -152.51 173.85 14.64 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.308 1.443 . . . . 0.0 110.513 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.2 tpt85 -133.3 150.97 51.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 162.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.6 p90 . . . . . 0 C--O 1.254 1.301 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 165.113 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.687 0.279 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.95 146.66 26.41 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 174.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -93.07 145.9 24.05 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.725 0.774 . . . . 0.0 109.113 165.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.1 m -153.72 125.71 7.84 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 119.565 -1.959 . . . . 0.0 110.041 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.71 127.61 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.688 0.795 . . . . 0.0 110.958 -170.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 p -139.18 119.99 14.3 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.402 1.081 . . . . 0.0 109.293 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.31 164.13 31.83 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.022 1.296 . . . . 0.0 110.49 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.17 -117.39 0.62 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -168.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -149.68 158.92 44.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.857 0.863 . . . . 0.0 109.735 -169.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.22 152.97 34.67 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.949 1.3 . . . . 0.0 107.802 168.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -142.37 154.37 44.58 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.291 0.636 . . . . 0.0 109.602 162.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 p -139.4 147.06 40.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 128.186 2.594 . . . . 0.0 107.46 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -126.82 113.37 16.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.595 0.712 . . . . 0.0 110.561 -155.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.62 106.14 1.39 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.337 1.055 . . . . 0.0 112.906 -156.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 64.44 8.46 4.3 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.922 1.689 . . . . 0.0 113.391 162.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.18 -101.32 0.23 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 104.178 -3.569 . . . . 0.0 104.178 -169.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -141.08 130.69 24.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 160.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.8 ttp -157.75 -34.91 0.07 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.383 0.427 . . . . 0.0 110.481 155.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -129.17 152.8 48.36 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 126.414 1.886 . . . . 0.0 106.424 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -123.51 80.93 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 171.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -67.61 129.4 39.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.89 176.04 29.6 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.79 -156.36 12.63 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 -171.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -98.55 156.16 16.93 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.391 1.096 . . . . 0.0 109.476 -169.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.77 144.43 41.6 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 124.278 1.031 . . . . 0.0 109.223 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -161.54 126.57 3.52 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -121.96 151.74 40.43 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 109.492 170.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -120.87 139.71 52.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -133.92 157.68 45.4 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 122.888 0.475 . . . . 0.0 110.064 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.71 157.67 38.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 173.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -108.89 125.1 51.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 154.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.76 173.04 3.75 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -117.06 37.68 3.76 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 169.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -148.72 -78.98 0.14 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 m -65.12 143.39 98.84 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.75 29.48 0.38 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.825 3.684 . . . . 0.0 110.972 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 tp -117.34 155.86 28.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.362 1.865 . . . . 0.0 108.791 -168.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.78 -172.99 13.83 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 168.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.1 t -139.56 142.33 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.91 152.91 38.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 163.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.0 136.08 4.2 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 105.021 -3.232 . . . . 0.0 105.021 165.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 t -124.56 142.89 51.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 117.922 0.861 . . . . 0.0 108.874 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -92.35 140.11 29.93 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.282 0.633 . . . . 0.0 110.211 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.89 130.02 37.74 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 167.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -116.84 156.43 27.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 156.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.7 m -138.3 122.2 17.74 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.68 42.26 2.18 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.528 1.931 . . . . 0.0 108.951 -164.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.525 ' H ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -65.3 138.54 58.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.003 1.321 . . . . 0.0 107.92 -175.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.5 p -130.39 155.06 47.03 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.196 0.522 . . . . 0.0 111.871 -169.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 C-N-CA 124.861 1.264 . . . . 0.0 111.887 -175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.1 t80 . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -56.29 140.19 45.74 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -116.65 168.48 10.15 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.573 0.701 . . . . 0.0 110.936 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 8.2 t30 45.0 -165.44 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 130.081 3.352 . . . . 0.0 113.526 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.477 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 12.3 pt20 -135.53 149.11 49.37 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.715 1.206 . . . . 0.0 108.759 -169.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -103.84 140.01 38.25 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 169.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -140.46 118.13 11.64 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.87 139.34 15.05 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.35 117.08 38.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.8 p -105.02 159.4 15.85 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.263 1.025 . . . . 0.0 109.629 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.18 144.02 28.64 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.027 -1.046 . . . . 0.0 109.703 164.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.76 121.07 1.36 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.66 127.64 21.22 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 N-CA-C 106.471 -2.165 . . . . 0.0 106.471 157.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.58 103.65 16.22 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.25 155.01 20.26 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 164.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -106.1 150.78 25.47 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.696 1.598 . . . . 0.0 106.801 161.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.1 mm -77.92 -104.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -129.54 7.29 5.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.986 1.267 . . . . 0.0 112.207 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -136.52 10.19 3.18 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.688 2.395 . . . . 0.0 111.894 -155.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 66.8 m95 51.03 70.58 0.51 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.507 1.523 . . . . 0.0 110.013 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.07 -169.03 1.89 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.435 1.894 . . . . 0.0 109.162 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 t -126.57 169.7 12.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.131 2.172 . . . . 0.0 106.365 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 tp -134.16 157.78 41.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.705 1.602 . . . . 0.0 108.494 -171.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -103.0 176.08 5.26 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 128.064 2.546 . . . . 0.0 109.097 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.16 53.23 2.87 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.71 160.66 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 m -95.45 154.43 3.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 121.561 -0.712 . . . . 0.0 109.676 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.67 134.63 4.82 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.89 129.17 68.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -118.71 115.09 3.0 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -168.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -121.15 123.71 42.96 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.064 0.932 . . . . 0.0 110.294 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.5 161.65 8.79 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.1 tttt . . . . . 0 C--O 1.233 0.211 0 C-N-CA 126.275 1.83 . . . . 0.0 106.899 -170.378 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.2 135.24 38.96 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -145.87 157.1 43.92 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.647 1.979 . . . . 0.0 108.016 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.32 160.56 33.2 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.371 0.986 . . . . 0.0 110.642 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -138.33 151.95 48.02 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 128.632 2.773 . . . . 0.0 109.111 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 m -170.31 -146.83 0.05 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.949 2.499 . . . . 0.0 108.748 159.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -136.94 177.51 7.8 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.942 1.697 . . . . 0.0 109.376 -171.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.38 177.19 37.79 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 121.285 -0.885 . . . . 0.0 113.657 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.63 161.89 14.17 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.008 0.923 . . . . 0.0 111.341 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.33 84.81 0.15 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.03 159.93 20.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.828 0.851 . . . . 0.0 109.767 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.04 154.97 43.07 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.067 1.347 . . . . 0.0 108.424 170.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -92.54 170.07 10.03 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -56.05 130.82 74.03 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.84 127.17 18.05 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -87.64 -175.19 5.1 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 152.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -109.97 -25.6 10.18 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 126.932 2.093 . . . . 0.0 108.458 -173.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.97 5.56 10.4 Favored 'General case' 0 C--O 1.225 -0.188 0 O-C-N 121.067 -1.021 . . . . 0.0 109.357 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.1 t -137.45 144.54 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.51 153.26 51.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.156 1.382 . . . . 0.0 108.56 164.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.468 HD13 HG12 ' A' ' 144' ' ' VAL . 2.4 mm? -143.98 115.86 8.29 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.908 1.683 . . . . 0.0 108.696 -174.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.32 148.04 44.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.951 2.1 . . . . 0.0 109.405 173.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -137.32 122.99 19.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.84 1.256 . . . . 0.0 109.123 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 t -139.54 151.77 46.37 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.516 1.126 . . . . 0.0 108.219 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -149.81 145.17 26.45 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -137.8 165.22 26.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.971 1.709 . . . . 0.0 108.772 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -119.9 159.55 24.44 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.216 -1.553 . . . . 0.0 110.633 169.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 t -140.43 159.82 41.36 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 170.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -141.11 97.85 3.26 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.69 83.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 54.62 48.97 19.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.263 1.025 . . . . 0.0 111.73 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 m 62.4 5.14 1.49 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.534 1.534 . . . . 0.0 114.876 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.7 t -82.2 148.74 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 121.169 1.804 . . . . 0.0 107.232 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 t70 78.02 -59.27 0.44 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.56 2.744 . . . . 0.0 113.032 171.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.4 t 68.82 -72.83 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 127.868 2.467 . . . . 0.0 113.089 165.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.15 116.18 1.09 Allowed Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.2 t -106.11 150.71 25.54 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.954 0.883 . . . . 0.0 109.466 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -134.9 133.28 39.46 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.5 pt -130.41 159.57 42.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.98 150.01 50.58 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.526 1.53 . . . . 0.0 109.27 -171.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -153.85 106.62 0.3 Allowed Glycine 0 C--O 1.22 -0.775 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 123' ' ' LEU . 34.3 m -128.85 167.13 24.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 118.848 1.324 . . . . 0.0 109.213 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.59 -122.29 1.06 Allowed Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -163.14 177.21 9.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.445 1.898 . . . . 0.0 109.556 -167.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -121.54 163.12 19.38 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.211 -0.931 . . . . 0.0 111.239 171.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . 0.258 0.0 OUTLIER . . . . . 0 C--O 1.251 1.173 0 CA-C-O 116.521 -1.704 . . . . 0.0 107.475 160.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 115.829 -2.034 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -139.14 152.04 47.12 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 123.335 2.788 . . . . 0.0 109.928 -163.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m -143.53 160.04 41.35 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 161.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -142.93 105.11 4.42 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 119.689 -1.882 . . . . 0.0 107.939 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 m -92.69 138.2 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.524 1.529 . . . . 0.0 107.273 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 m -148.92 143.72 26.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 168.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.47 164.19 32.41 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.44 -111.9 0.47 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -173.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -124.87 158.38 33.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.373 1.087 . . . . 0.0 111.018 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.51 133.26 34.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 128.517 2.727 . . . . 0.0 104.03 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -140.0 131.89 27.65 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 164.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -85.27 151.2 24.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 161.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 18' ' ' MET . 0.8 OUTLIER -138.74 169.96 16.86 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.121 1.368 . . . . 0.0 107.693 160.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.92 40.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.345 1.43 . . . . 0.0 109.603 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -70.75 97.62 1.4 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.038 0.923 . . . . 0.0 110.821 -168.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.48 -26.06 3.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 127.592 2.52 . . . . 0.0 109.419 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -146.79 96.07 2.69 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.481 1.512 . . . . 0.0 107.059 -170.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.449 ' HA ' ' HB2' ' A' ' 13' ' ' ASP . 2.5 mpt? -76.82 61.01 1.83 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.307 1.043 . . . . 0.0 109.187 172.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -70.74 99.11 1.64 Allowed 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 124.995 1.318 . . . . 0.0 107.538 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -70.47 108.51 4.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -136.75 130.95 32.75 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.26 -173.5 44.53 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -161.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.88 -94.24 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -149.64 137.95 20.63 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -101.19 148.84 24.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.673 1.589 . . . . 0.0 109.487 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.86 136.65 27.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.733 1.213 . . . . 0.0 107.881 163.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.07 150.81 50.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.44 1.096 . . . . 0.0 108.274 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -135.88 122.28 20.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -107.69 128.55 54.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -99.06 147.95 24.53 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 167.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -111.54 114.51 27.64 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 156.46 37.11 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.09 -20.54 17.93 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.276 1.031 . . . . 0.0 110.345 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.12 -8.16 59.71 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -170.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.37 163.28 18.61 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.99 -7.92 19.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.082 1.855 . . . . 0.0 112.775 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 tp -81.45 139.53 35.16 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.883 1.219 . . . . 0.0 109.655 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.32 -169.57 13.09 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.881 1.229 . . . . 0.0 110.445 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.47 150.29 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.807 0.843 . . . . 0.0 109.437 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.6 tp -135.8 141.77 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.24 145.53 11.08 Favored Glycine 0 C--O 1.239 0.408 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.6 m -112.08 141.14 46.12 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -170.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -111.95 115.3 28.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.4 m -91.47 150.89 21.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -140.47 142.31 35.35 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 160.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.2 m -143.06 133.59 24.96 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.957 0.903 . . . . 0.0 109.57 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -130.27 171.15 13.22 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 149.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -157.66 146.37 19.43 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 p -79.06 107.07 11.55 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 157.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 167.172 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.71 111.99 24.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -165.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -113.68 130.4 56.42 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -171.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -160.17 165.95 30.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.577 1.551 . . . . 0.0 110.045 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.14 140.79 49.08 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 162.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -107.95 123.34 48.49 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -126.08 135.74 52.09 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 163.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.92 95.05 0.32 Allowed Glycine 0 C--N 1.331 0.278 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -174.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.6 mt -77.45 108.99 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 p -131.35 128.21 39.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.593 1.957 . . . . 0.0 106.637 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.62 174.03 13.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.737 0.415 . . . . 0.0 111.396 -172.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.87 176.57 48.09 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 123.34 0.495 . . . . 0.0 113.072 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.73 129.73 10.17 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.89 3.06 . . . . 0.0 109.421 168.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.74 149.09 22.17 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.629 0.772 . . . . 0.0 110.044 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -141.29 127.43 19.6 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.071 0.948 . . . . 0.0 108.683 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.6 120.32 16.05 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 125.164 1.385 . . . . 0.0 109.625 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mp -67.67 165.99 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.744 1.618 . . . . 0.0 107.161 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -79.03 14.64 1.34 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.524 -1.36 . . . . 0.0 112.313 -174.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -139.13 60.87 1.58 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.471 1.508 . . . . 0.0 108.485 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 57.2 m95 58.35 -16.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 129.079 2.951 . . . . 0.0 117.716 170.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.52 161.12 29.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.492 1.117 . . . . 0.0 108.758 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.2 p -142.93 115.98 8.87 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 117.657 -1.163 . . . . 0.0 108.478 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.785 HG12 HD13 ' A' ' 113' ' ' LEU . 1.9 mp -142.1 151.26 18.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.09 1.356 . . . . 0.0 108.297 -174.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -150.29 173.95 13.4 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.84 1.256 . . . . 0.0 109.1 160.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.21 140.46 27.51 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.34 143.8 37.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.196 0.998 . . . . 0.0 108.731 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.95 165.41 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.062 0.945 . . . . 0.0 109.819 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 177.25 -162.62 30.79 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.884 -166.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.69 139.89 19.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.579 0.751 . . . . 0.0 109.287 173.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.51 146.41 16.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 125.403 1.478 . . . . 0.0 109.466 168.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 3.7 p90 -149.37 166.96 27.47 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 122.095 -0.65 . . . . 0.0 111.926 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.64 -93.96 0.1 OUTLIER Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 149.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.19 0 C-N-CA 128.557 2.743 . . . . 0.0 108.813 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.8 m . . . . . 0 CA--C 1.533 0.317 0 CA-C-O 121.526 0.679 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 45.5 p30 -161.69 176.02 11.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.404 3.082 . . . . 0.0 109.586 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 54.83 17.27 1.71 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.904 2.081 . . . . 0.0 114.959 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.97 104.33 1.31 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.21 148.52 45.48 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.5 p -136.79 161.19 36.66 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.621 0.725 . . . . 0.0 111.518 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.57 157.23 37.96 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.497 1.519 . . . . 0.0 108.957 174.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.02 -168.3 37.91 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.881 1.705 . . . . 0.0 108.987 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.68 152.1 51.8 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.1 116.85 4.08 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.785 HD13 HG12 ' A' ' 79' ' ' ILE . 1.8 mm? -115.64 139.71 49.86 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -166.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.66 145.55 38.59 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 120.916 -1.115 . . . . 0.0 109.4 -172.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -93.15 164.4 13.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -56.86 103.92 0.39 Allowed Pre-proline 0 CA--C 1.528 0.125 0 C-N-CA 125.062 1.345 . . . . 0.0 110.579 -166.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.14 120.26 5.64 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.37 1.38 . . . . 0.0 109.058 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.7 mtm 166.9 153.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 129.917 3.287 . . . . 0.0 105.682 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 113.96 28.2 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 129.767 3.227 . . . . 0.0 107.494 160.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.9 t30 44.08 26.69 0.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.372 1.469 . . . . 0.0 113.727 -153.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.64 169.3 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 108.477 160.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.89 135.89 5.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.016 2.926 . . . . 0.0 103.155 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.46 HD22 HG12 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -122.22 146.87 46.85 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -172.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -141.16 152.94 45.09 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.243 1.017 . . . . 0.0 109.196 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -150.34 114.76 5.18 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.38 2.272 . . . . 0.0 105.603 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.1 m -118.3 154.23 32.66 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 168.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.49 120.85 11.62 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -136.61 136.11 38.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.234 1.413 . . . . 0.0 108.792 -168.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -100.05 150.68 22.21 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.799 0.84 . . . . 0.0 109.31 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.3 m -133.87 160.05 38.82 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.824 1.65 . . . . 0.0 108.039 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.52 97.79 4.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.907 1.283 . . . . 0.0 111.208 -166.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.4 mt -134.31 89.03 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.093 0.957 . . . . 0.0 108.888 -166.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.22 -161.31 0.18 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.5 m -77.34 58.55 1.68 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.543 1.065 . . . . 0.0 109.438 168.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.65 149.42 33.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 170.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -122.2 80.46 1.72 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.842 0.746 . . . . 0.0 110.766 -174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.9 t -78.99 96.55 2.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.931 1.693 . . . . 0.0 108.887 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.66 144.65 23.27 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 164.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.12 152.83 45.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 172.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -140.87 147.65 39.26 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 164.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.02 150.47 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.64 166.11 26.12 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.681 0.792 . . . . 0.0 108.9 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.18 178.77 47.14 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.642 -0.789 . . . . 0.0 114.107 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.46 HG12 HD22 ' A' ' 123' ' ' LEU . 11.6 m -129.5 163.33 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 127.783 2.433 . . . . 0.0 107.042 167.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -166.56 -119.25 0.47 Allowed Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -163.17 164.39 25.23 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.579 1.19 . . . . 0.0 110.711 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -91.36 125.93 36.28 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 116.865 -1.54 . . . . 0.0 107.613 164.615 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 t -150.42 142.08 23.62 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 120.728 -1.232 . . . . 0.0 108.937 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -140.71 106.86 5.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.801 0.81 . . . . 0.0 109.419 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.1 p -104.84 129.01 53.24 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 p -91.7 145.28 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 165.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 t -158.14 161.07 37.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.89 173.72 27.66 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.07 -162.06 34.84 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -171.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -91.6 144.5 25.47 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -172.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB3' ' H ' ' A' ' 23' ' ' GLY . . . -95.57 134.92 37.89 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.5 104.14 5.26 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 127.394 2.278 . . . . 0.0 106.552 -175.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 t -84.66 140.64 31.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.286 1.434 . . . . 0.0 107.393 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -138.78 126.89 22.6 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.059 1.744 . . . . 0.0 106.798 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.85 147.45 43.93 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.778 1.626 . . . . 0.0 107.613 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -63.24 92.58 0.06 Allowed 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 124.052 0.845 . . . . 0.0 108.722 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.84 41.72 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-O 117.434 -1.759 . . . . 0.0 111.922 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -150.76 94.91 2.14 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 157.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.6 mtt -76.73 57.26 1.25 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.882 2.873 . . . . 0.0 109.441 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -71.41 101.57 2.44 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -63.13 102.4 0.37 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.64 159.61 41.3 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.166 1.787 . . . . 0.0 106.983 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.11 -176.37 17.8 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -171.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 10' ' ' ALA . . . -163.69 -137.4 2.18 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 -164.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.76 157.69 25.1 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.211 1.506 . . . . 0.0 109.469 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -134.57 148.59 50.5 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.894 1.678 . . . . 0.0 107.995 -173.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.95 124.95 19.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -120.55 132.56 55.22 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -155.61 106.52 2.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -166.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 164.91 28.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.999 0.428 . . . . 0.0 110.88 -173.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -125.4 157.74 36.06 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.061 2.144 . . . . 0.0 106.59 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -128.79 159.94 34.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 168.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -136.12 125.84 25.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -67.41 1.46 2.24 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.933 1.293 . . . . 0.0 113.203 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -55.73 -27.07 48.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.723 0.809 . . . . 0.0 111.376 159.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.7 m -147.44 107.04 3.82 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 169.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.99 78.01 2.26 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.487 2.791 . . . . 0.0 109.713 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.41 126.31 10.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 128.83 2.852 . . . . 0.0 105.433 173.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.39 176.87 48.58 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.484 ' O ' HD13 ' A' ' 40' ' ' ILE . 48.6 t -122.23 146.78 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 170.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.69 HD11 ' HB2' ' A' ' 70' ' ' ALA . 17.1 mm -138.44 116.27 12.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -170.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.09 124.05 1.75 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 107.009 -2.436 . . . . 0.0 107.009 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 p -122.71 153.92 38.79 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.129 1.771 . . . . 0.0 107.557 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -129.49 120.21 25.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -160.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.9 p -119.69 115.15 23.34 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.906 0.776 . . . . 0.0 110.07 -152.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.93 153.85 32.9 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.307 -0.871 . . . . 0.0 110.954 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.5 t -131.58 122.34 25.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.913 0.885 . . . . 0.0 109.035 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -131.59 74.81 1.61 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.04 1.736 . . . . 0.0 106.926 174.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -153.76 146.45 24.24 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.5 t -131.06 155.78 46.32 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.911 2.084 . . . . 0.0 107.925 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 172.116 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.249 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -66.65 112.36 4.13 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.15 0.886 . . . . 0.0 111.931 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -89.31 171.04 10.05 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.893 -1.129 . . . . 0.0 108.093 161.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 66.35 175.67 0.23 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.563 2.345 . . . . 0.0 112.46 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -139.02 155.88 47.63 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.855 1.662 . . . . 0.0 107.321 -167.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -77.57 157.68 30.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -140.97 117.33 10.74 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 154.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.91 106.05 2.32 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 106.882 -2.487 . . . . 0.0 106.882 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.21 108.95 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.3 p -128.96 159.16 36.76 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -137.45 163.5 30.94 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.3 156.32 27.28 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 157.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.02 178.86 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.281 2.654 . . . . 0.0 112.083 145.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.69 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -126.35 144.49 50.8 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.698 1.599 . . . . 0.0 108.191 154.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -133.35 155.87 48.66 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.065 1.346 . . . . 0.0 109.323 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.94 94.99 5.37 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 170.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 33.8 mt -28.09 -70.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 129.832 3.253 . . . . 0.0 110.324 -170.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.411 ' H ' ' H ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -170.12 5.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.67 1.588 . . . . 0.0 110.368 177.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.411 ' H ' ' H ' ' A' ' 74' ' ' ASN . 2.0 t70 -150.08 -177.1 5.73 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.6 1.16 . . . . 0.0 108.714 -175.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -73.98 63.22 0.92 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.84 2.456 . . . . 0.0 112.936 -166.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.64 175.86 10.06 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.792 1.637 . . . . 0.0 108.648 166.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -143.21 112.28 6.63 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 155.66 18.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.689 0.796 . . . . 0.0 109.71 -173.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.55 162.77 39.51 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 155.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.7 131.77 10.62 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 163.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.33 144.59 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 118.712 1.256 . . . . 0.0 108.446 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 m -145.97 165.13 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.301 0.64 . . . . 0.0 111.423 -174.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.41 -143.62 9.54 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 p -133.38 146.33 32.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -170.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.42 113.4 1.51 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 125.087 1.327 . . . . 0.0 109.831 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -95.57 117.12 29.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.476 1.91 . . . . 0.0 107.202 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.98 77.86 0.38 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.1 tttt . . . . . 0 C--O 1.235 0.315 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.456 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.08 177.12 9.0 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.981 0.913 . . . . 0.0 111.616 -159.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -72.59 123.87 24.1 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.624 0.77 . . . . 0.0 110.079 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.76 165.43 17.7 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 159.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -90.3 135.16 33.85 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.1 m -104.98 131.84 51.99 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -143.05 134.69 26.49 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.83 -162.86 14.29 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 124.55 1.071 . . . . 0.0 110.868 -161.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.54 174.44 11.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.922 1.289 . . . . 0.0 109.503 171.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.01 142.34 13.76 Favored Glycine 0 C--N 1.33 0.249 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 168.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.31 140.23 52.34 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -131.86 149.52 52.43 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -109.62 171.38 7.48 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 126.416 1.886 . . . . 0.0 108.726 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -56.49 111.38 3.19 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.639 1.176 . . . . 0.0 110.834 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.64 114.23 3.98 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.932 3.088 . . . . 0.0 110.795 -169.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 49.1 mtt -80.13 158.07 26.46 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.791 1.281 . . . . 0.0 109.738 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -81.12 90.68 6.05 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 134.59 -20.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 132.414 4.285 . . . . 0.0 112.235 170.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.13 119.06 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 120.17 1.35 . . . . 0.0 108.898 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.26 155.37 34.42 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 120.201 -1.562 . . . . 0.0 107.729 155.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -125.58 114.58 18.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 161.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -155.5 151.67 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -147.84 151.81 36.58 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.47 1.508 . . . . 0.0 108.68 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.4 t -125.18 141.97 51.78 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 161.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -115.5 124.94 52.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -132.43 119.24 20.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.251 1.02 . . . . 0.0 108.734 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -109.57 107.32 17.36 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 170.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 t -85.21 160.37 19.9 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 163.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -136.65 151.71 49.61 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 155.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.89 111.42 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.9 ttt-85 52.86 46.14 27.35 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.309 1.044 . . . . 0.0 111.893 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.1 m 56.1 39.43 30.39 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.272 1.029 . . . . 0.0 113.134 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.59 140.95 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 153.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -101.3 122.07 43.02 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 126.428 1.891 . . . . 0.0 108.376 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.5 t -128.85 93.45 2.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -166.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.74 139.26 17.0 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -141.34 119.48 12.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -123.79 113.74 18.96 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.6 pp -108.29 147.5 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.649 1.113 . . . . 0.0 109.477 -172.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.58 163.45 15.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -147.81 102.83 0.25 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 107.669 -2.172 . . . . 0.0 107.669 -172.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.08 153.3 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.59 -141.93 7.55 Favored Glycine 0 C--O 1.218 -0.87 0 CA-C-O 117.532 -1.705 . . . . 0.0 109.203 -159.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -163.41 167.09 22.1 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 121.609 2.705 . . . . 0.0 111.003 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -89.35 144.92 25.71 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 159.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.781 154.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -150.66 164.72 35.42 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -143.48 159.72 41.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.3 1.84 . . . . 0.0 108.173 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -131.5 146.08 52.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.85 98.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.9 t -148.38 119.81 7.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -159.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.65 171.17 40.03 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.34 -123.08 1.12 Allowed Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 -163.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -146.6 158.3 43.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -159.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.02 156.69 31.62 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.094 0.958 . . . . 0.0 109.725 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -125.47 111.9 15.62 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 167.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.8 m -85.48 140.9 30.31 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 160.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -138.79 172.02 13.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.12 2.568 . . . . 0.0 107.062 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.91 164.49 33.57 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.875 1.216 . . . . 0.0 110.794 162.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.81 86.19 5.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.092 0.949 . . . . 0.0 109.201 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.3 -32.02 1.53 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.576 1.56 . . . . 0.0 109.892 172.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -137.6 99.29 3.9 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.6 mtt -69.3 71.38 0.28 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 160.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -71.98 91.97 1.25 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 166.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -68.12 120.36 14.2 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.0 mtp -137.28 134.4 36.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.46 -179.76 24.66 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 162.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.59 -105.37 0.28 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 104.428 -3.469 . . . . 0.0 104.428 170.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -127.97 153.98 46.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.144 1.378 . . . . 0.0 108.723 167.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -138.81 129.58 26.33 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.123 2.169 . . . . 0.0 109.651 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 tp -135.56 143.17 45.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.937 1.244 . . . . 0.0 109.896 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -127.05 166.27 17.91 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.356 1.863 . . . . 0.0 109.07 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.5 141.24 18.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.899 1.68 . . . . 0.0 106.971 -166.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -116.74 147.62 41.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.089 0.859 . . . . 0.0 109.395 165.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.14 120.0 21.7 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.654 1.582 . . . . 0.0 107.574 166.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -101.59 112.49 25.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.5 101.02 12.8 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.475 1.91 . . . . 0.0 107.896 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 38.04 64.05 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.683 1.993 . . . . 0.0 111.981 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 62.35 40.15 11.51 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.775 2.03 . . . . 0.0 112.394 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.8 p -63.82 122.96 79.98 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.57 -37.39 12.81 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.211 1.941 . . . . 0.0 112.08 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.06 155.3 32.59 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 164.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.59 -167.35 12.18 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 172.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.41 146.17 34.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.23 137.08 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 167.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.28 108.55 0.36 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 165.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 p -125.52 137.59 53.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.444 0.622 . . . . 0.0 110.925 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.65 153.62 20.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.5 m -120.3 132.7 55.42 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 161.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -120.36 153.33 36.64 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.806 2.042 . . . . 0.0 106.109 167.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.9 p -133.19 145.38 50.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.103 0.865 . . . . 0.0 111.741 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -129.77 115.95 18.04 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 163.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -162.66 147.28 11.87 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 m -65.22 155.05 36.32 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 157.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 t80 . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -160.3 172.85 16.61 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.684 0.794 . . . . 0.0 109.705 -167.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -60.33 130.47 46.78 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -154.01 148.86 26.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.695 0.798 . . . . 0.0 108.977 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -152.74 146.42 25.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 164.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -97.95 122.72 41.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 157.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.9 125.55 45.9 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.04 135.49 12.89 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.7 mm -141.89 135.92 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 127.667 2.387 . . . . 0.0 105.603 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 t -140.28 153.61 46.55 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.201 1.4 . . . . 0.0 108.168 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.65 152.97 44.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.871 1.268 . . . . 0.0 108.308 170.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.55 141.43 3.16 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 168.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.88 169.69 18.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 121.71 1.607 . . . . 0.0 110.163 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.86 157.86 16.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.465 1.906 . . . . 0.0 107.34 168.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -145.58 116.55 7.8 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -84.22 134.38 34.55 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.0 mp -77.37 -79.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -171.61 1.94 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.245 0.929 . . . . 0.0 113.374 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -135.15 66.81 1.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -162.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 93.3 m95 53.47 -38.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 131.013 3.725 . . . . 0.0 117.569 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.21 162.9 28.47 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.182 1.793 . . . . 0.0 110.603 -170.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 t -148.45 110.08 4.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.87 145.76 34.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -151.07 164.91 35.35 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.91 0.884 . . . . 0.0 109.333 166.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.62 130.45 20.54 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 170.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 m -119.57 172.17 6.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.298 1.039 . . . . 0.0 108.666 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.1 158.55 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 C-N-CA 125.682 1.593 . . . . 0.0 108.783 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.0 162.64 25.03 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 170.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.2 p -134.54 136.33 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.44 110.92 1.76 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 107.191 -2.363 . . . . 0.0 107.191 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -129.11 156.62 43.58 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.89 174.04 39.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 C--O 1.239 0.52 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 167.476 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.41 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -161.58 176.05 11.44 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.729 0.812 . . . . 0.0 109.223 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -139.62 165.19 27.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.346 1.458 . . . . 0.0 109.032 170.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.29 167.55 38.91 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 165.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -102.85 152.39 21.33 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.323 1.849 . . . . 0.0 110.363 -173.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 p -137.41 168.33 19.86 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.416 1.487 . . . . 0.0 110.101 165.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -146.3 153.12 40.19 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.704 0.802 . . . . 0.0 108.901 168.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.24 -153.94 9.36 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.75 160.28 41.96 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.514 1.125 . . . . 0.0 108.955 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -99.06 121.82 7.35 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 171.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.7 138.94 50.61 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -141.83 155.71 45.56 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.071 -1.018 . . . . 0.0 109.548 -161.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -93.14 163.63 13.56 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -57.02 134.86 80.29 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.336 -0.84 . . . . 0.0 108.759 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.45 104.28 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.444 2.096 . . . . 0.0 110.42 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttt -75.34 -175.02 2.59 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.803 1.241 . . . . 0.0 107.676 167.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -106.08 -13.81 15.34 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.624 1.57 . . . . 0.0 110.438 -159.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.41 25.5 0.35 Allowed 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 125.267 1.427 . . . . 0.0 108.967 166.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.68 137.35 27.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.72 145.2 30.77 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.89 135.68 51.28 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -131.03 145.22 51.96 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.24 1.416 . . . . 0.0 110.362 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -147.5 144.79 28.81 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.487 1.915 . . . . 0.0 108.225 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.2 p -145.82 163.62 34.47 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 151.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -137.27 137.46 39.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -138.21 165.16 27.38 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.021 0.929 . . . . 0.0 109.175 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -127.07 118.24 24.02 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 165.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.6 m -83.24 154.5 24.16 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.833 0.853 . . . . 0.0 109.684 167.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -116.78 102.96 9.85 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.18 93.95 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.631 0.651 . . . . 0.0 110.996 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 88.57 39.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.79 2.836 . . . . 0.0 109.995 164.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m 52.85 43.77 31.13 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.208 1.403 . . . . 0.0 111.564 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.47 130.28 53.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 127.994 2.517 . . . . 0.0 105.075 165.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.75 104.96 15.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.368 0.667 . . . . 0.0 109.724 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.87 92.07 2.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.92 1.288 . . . . 0.0 107.866 -169.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.57 151.81 43.67 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.0 t -138.33 153.49 48.99 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.492 1.117 . . . . 0.0 108.405 165.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -139.36 157.22 46.26 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 152.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.6 pt -120.61 149.03 23.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 168.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.2 123.52 12.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 166.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.02 154.13 25.39 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.84 -179.55 3.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 125.795 1.638 . . . . 0.0 107.963 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 174.78 -96.09 0.11 Allowed Glycine 0 C--O 1.228 -0.281 0 O-C-N 120.29 -1.506 . . . . 0.0 111.58 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -146.63 176.02 10.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.992 1.317 . . . . 0.0 110.522 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -141.31 139.39 33.61 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 10.8 p90 . . . . . 0 C--O 1.252 1.217 0 CA-C-N 119.371 0.987 . . . . 0.0 109.28 176.689 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.3 m -146.36 166.65 25.69 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.688 1.595 . . . . 0.0 106.751 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -122.95 140.61 52.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.102 0.961 . . . . 0.0 109.967 -173.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 t -151.42 173.2 14.83 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.58 120.76 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -139.89 122.25 16.03 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -161.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.38 -159.89 33.14 Favored Glycine 0 C--N 1.332 0.331 0 O-C-N 119.931 -1.731 . . . . 0.0 113.635 -157.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 114.44 -99.83 0.97 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 106.984 -2.447 . . . . 0.0 106.984 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -139.74 157.68 45.34 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.029 1.414 . . . . 0.0 108.753 -163.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.14 132.24 41.41 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.053 1.741 . . . . 0.0 107.703 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -100.04 113.17 25.58 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -85.01 137.72 32.9 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 157.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -138.14 170.65 15.67 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.449 1.1 . . . . 0.0 108.397 171.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -114.23 165.48 12.63 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.264 1.026 . . . . 0.0 111.866 -165.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -46.2 -20.39 0.1 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.28 2.632 . . . . 0.0 113.693 172.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.15 94.71 0.15 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 168.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -42.48 102.94 0.03 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 129.772 3.229 . . . . 0.0 112.408 -173.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.3 ttm -145.83 -36.17 0.28 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.003 1.721 . . . . 0.0 111.056 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.89 103.25 7.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.86 1.264 . . . . 0.0 111.658 173.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 157.34 18.0 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.742 172.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.9 mtm -130.21 159.7 36.07 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.198 0.999 . . . . 0.0 109.785 172.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.26 176.03 38.94 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.026 1.774 . . . . 0.0 110.164 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.91 -84.58 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.53 156.72 41.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 172.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -137.41 150.22 47.49 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 164.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.8 tp -150.73 131.77 14.33 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 168.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -131.02 161.28 32.32 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.896 2.078 . . . . 0.0 110.143 -176.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -145.46 142.33 29.16 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.761 1.624 . . . . 0.0 108.356 -172.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.438 HH12 ' CB ' ' A' ' 78' ' ' SER . 4.9 tmm_? -131.63 115.27 15.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.475 0.71 . . . . 0.0 109.298 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -98.94 156.57 16.83 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.733 0.697 . . . . 0.0 110.01 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -139.91 113.19 8.35 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.943 1.697 . . . . 0.0 108.939 -165.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -64.35 169.06 4.98 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.414 1.486 . . . . 0.0 110.828 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.2 -30.72 12.84 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.749 0.82 . . . . 0.0 109.37 167.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.83 -82.59 0.06 Allowed 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.56 0.744 . . . . 0.0 109.45 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.5 p -89.07 173.45 6.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.772 0.829 . . . . 0.0 110.943 -171.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.46 -3.86 14.51 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.628 2.219 . . . . 0.0 112.44 165.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.5 tp -70.67 155.94 40.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.32 0.964 . . . . 0.0 110.13 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.17 -166.77 28.76 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 t -132.87 151.08 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 118.163 0.981 . . . . 0.0 109.822 -166.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.448 HD12 ' CE2' ' A' ' 80' ' ' TYR . 46.3 mm -119.88 143.99 29.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 125.74 1.616 . . . . 0.0 107.867 169.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.06 144.37 15.93 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 148.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.0 m -123.51 153.54 40.42 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 127.021 2.128 . . . . 0.0 106.568 168.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -121.15 122.29 39.69 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 m -93.54 116.4 28.92 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -166.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -139.22 125.2 19.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.688 0.395 . . . . 0.0 110.781 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -133.23 130.97 39.75 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -72.25 -177.45 2.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.962 167.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.13 118.87 4.94 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 119.807 -1.808 . . . . 0.0 109.648 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 m -123.48 128.94 50.51 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.835 1.254 . . . . 0.0 108.229 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 164.096 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.405 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.49 116.98 17.68 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -149.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -143.54 170.8 15.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 118.469 0.577 . . . . 0.0 110.758 -169.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 t30 53.53 -177.23 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.859 1.264 . . . . 0.0 109.026 -150.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -113.53 169.34 9.04 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.914 1.286 . . . . 0.0 108.217 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -97.06 103.43 15.36 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -98.12 147.55 24.45 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.17 170.42 36.24 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.82 138.11 46.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.9 m -134.39 127.07 30.87 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.16 149.02 26.62 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.869 0.468 . . . . 0.0 109.775 -172.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.54 -178.28 31.41 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.611 0.624 . . . . 0.0 111.746 176.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -81.29 -177.28 3.57 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.906 3.738 . . . . 0.0 112.141 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.74 146.23 45.56 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.159 -0.963 . . . . 0.0 109.448 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -88.99 101.09 13.74 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -71.83 146.25 48.1 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 162.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.8 mm -97.92 -105.34 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 167.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -155.26 -57.15 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.85 170.57 3.33 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.26 2.224 . . . . 0.0 108.864 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.82 59.47 1.23 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.859 1.264 . . . . 0.0 112.956 -173.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.05 162.9 34.31 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.743 1.617 . . . . 0.0 108.78 158.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.438 ' CB ' HH12 ' A' ' 29' ' ' ARG . 74.4 m -150.05 167.29 27.18 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.755 -1.216 . . . . 0.0 110.342 166.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.54 146.85 24.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' HD12 ' A' ' 40' ' ' ILE . 2.9 m-85 -107.16 148.19 29.16 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 171.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.84 83.19 0.16 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -131.13 167.67 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.513 1.125 . . . . 0.0 110.451 -175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.48 131.22 60.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -175.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.68 122.5 3.24 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.74 146.2 28.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.119 0.968 . . . . 0.0 108.834 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.62 145.27 16.29 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 124.04 0.829 . . . . 0.0 111.984 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -126.86 117.7 23.13 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.1 1.36 . . . . 0.0 107.492 165.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.57 133.78 9.06 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 106.003 -2.839 . . . . 0.0 106.003 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm . . . . . 0 C--N 1.331 -0.228 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 168.719 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.235 0.324 0 N-CA-C 111.101 0.037 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -137.7 128.49 27.04 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 109.912 -165.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -90.65 159.51 16.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 163.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.33 136.54 8.67 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 105.775 -2.93 . . . . 0.0 105.775 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -130.39 130.3 44.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -171.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.82 -175.19 3.88 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.072 1.349 . . . . 0.0 109.65 -167.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -135.23 148.71 49.69 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 165.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.46 64.24 1.11 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 125.436 1.493 . . . . 0.0 109.81 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -95.81 64.29 2.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.755 0.822 . . . . 0.0 109.672 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -96.19 165.72 24.13 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.808 1.67 . . . . 0.0 112.645 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -138.03 140.6 40.18 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.369 1.868 . . . . 0.0 108.857 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -113.45 141.01 47.62 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.041 1.337 . . . . 0.0 109.393 -167.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -119.05 171.83 7.99 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.376 1.071 . . . . 0.0 109.171 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -56.15 110.26 2.2 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.96 1.304 . . . . 0.0 110.15 -173.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 125.98 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.389 2.726 . . . . 0.0 111.013 -169.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.4 ttp -90.63 155.6 18.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 122.919 1.342 . . . . 0.0 110.111 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -80.55 30.1 0.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 128.942 2.897 . . . . 0.0 110.025 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.81 -14.3 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.219 1.808 . . . . 0.0 112.021 171.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.9 m -152.16 121.81 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 126.327 1.851 . . . . 0.0 108.058 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.75 165.59 17.02 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 119.996 -1.69 . . . . 0.0 109.64 160.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -139.13 114.58 9.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 165.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -156.83 155.58 31.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -137.84 114.62 10.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.616 1.566 . . . . 0.0 107.248 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 m -113.91 135.24 54.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 165.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -136.84 113.07 9.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 -169.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -121.29 143.47 49.15 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.143 0.977 . . . . 0.0 108.783 -173.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -133.46 125.0 28.06 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.271 1.428 . . . . 0.0 109.461 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 p -139.1 160.34 40.03 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 120.007 1.276 . . . . 0.0 111.516 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -113.73 117.22 30.9 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 44.7 mt -120.75 109.72 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.66 41.23 28.68 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.478 1.111 . . . . 0.0 110.903 172.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 56.6 m 58.66 16.5 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.81 128.89 39.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 160.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.12 131.1 41.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 169.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.3 t -132.7 133.23 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.2 153.42 17.62 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.3 t -132.69 129.91 39.39 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 159.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -102.04 110.07 21.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 169.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.6 mt -93.86 118.38 39.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.63 145.13 24.85 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -124.37 82.75 0.35 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.99 179.59 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 168.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.9 -120.53 1.23 Allowed Glycine 0 N--CA 1.465 0.618 0 CA-C-O 117.477 -1.735 . . . . 0.0 111.287 -169.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -164.23 164.39 22.53 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.578 1.951 . . . . 0.0 109.701 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.77 132.03 36.26 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.133 -1.604 . . . . 0.0 109.252 175.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.852 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.4 p -141.98 165.96 26.02 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 165.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.47 107.69 4.76 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.971 1.308 . . . . 0.0 110.047 -167.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -61.95 142.09 57.64 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 159.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 146' ' ' TYR . 0.9 OUTLIER -131.84 100.23 4.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 171.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -150.67 146.11 26.27 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.086 -1.634 . . . . 0.0 109.231 -165.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.38 170.81 38.91 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 121.452 0.473 . . . . 0.0 112.125 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.81 -127.32 1.4 Allowed Glycine 0 C--O 1.227 -0.309 0 O-C-N 121.164 -1.198 . . . . 0.0 111.748 -170.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -139.7 158.7 43.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.174 0.989 . . . . 0.0 109.982 -166.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.72 125.76 47.34 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.957 1.303 . . . . 0.0 107.738 169.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -101.94 104.48 15.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 163.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.0 m -89.14 141.94 28.07 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 159.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -138.23 165.03 27.71 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.682 1.993 . . . . 0.0 108.399 170.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.76 164.97 21.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 111.35 -170.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -62.07 5.97 0.09 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.24 102.63 0.23 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 104.521 -3.432 . . . . 0.0 104.521 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -65.09 95.92 0.19 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.894 1.278 . . . . 0.0 109.626 -164.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.2 mtt -153.8 10.7 0.41 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.082 2.553 . . . . 0.0 110.596 -176.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -131.78 143.66 50.38 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 120.707 -1.246 . . . . 0.0 109.0 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -137.63 76.99 1.61 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.461 1.904 . . . . 0.0 106.649 164.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.9 mtm -83.45 154.74 23.78 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.78 170.08 12.71 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.294 1.902 . . . . 0.0 111.447 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.37 -141.39 3.22 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -170.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -99.26 123.6 43.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.131 0.966 . . . . 0.0 109.649 -171.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -94.98 151.06 19.5 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.642 1.177 . . . . 0.0 107.846 -172.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.677 HD13 ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -144.56 148.99 35.08 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.292 1.437 . . . . 0.0 107.923 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.677 ' H ' HD13 ' A' ' 26' ' ' LEU . 40.2 mmtt -137.63 130.73 30.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.867 1.667 . . . . 0.0 107.63 -167.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.45 138.62 29.42 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -170.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 163.24 33.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.292 1.037 . . . . 0.0 108.608 167.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -120.4 157.87 28.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 161.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -101.94 112.29 24.86 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.09 178.81 6.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.401 1.08 . . . . 0.0 110.315 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -135.37 13.81 3.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.687 1.595 . . . . 0.0 111.504 -156.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -137.44 -28.35 0.92 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.085 0.954 . . . . 0.0 111.503 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 p -120.74 114.71 32.52 Favored Pre-proline 0 CA--C 1.535 0.382 0 O-C-N 120.919 -1.113 . . . . 0.0 111.07 -169.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.75 80.19 2.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.334 2.022 . . . . 0.0 109.227 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.34 156.29 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.111 2.164 . . . . 0.0 106.659 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -93.75 167.69 28.52 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.6 -1.111 . . . . 0.0 111.56 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.47 139.01 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 119.313 1.556 . . . . 0.0 107.929 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' A' ' 70' ' ' ALA . 4.9 mp -132.5 110.46 16.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.65 123.39 5.22 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 107.244 -2.343 . . . . 0.0 107.244 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 m -122.55 154.36 38.01 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.509 1.523 . . . . 0.0 109.605 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -121.12 132.71 55.02 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.407 0.683 . . . . 0.0 110.586 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -127.64 150.53 49.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.271 1.428 . . . . 0.0 108.185 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -138.62 157.11 46.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.222 3.009 . . . . 0.0 106.493 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 t -99.65 132.81 44.75 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -143.74 40.95 1.42 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.982 0.913 . . . . 0.0 109.888 -166.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -148.35 138.21 22.35 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 120.937 -1.102 . . . . 0.0 110.852 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -90.3 144.58 25.7 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.0 mtp85 . . . . . 0 CA--C 1.521 -0.169 0 CA-C-O 117.167 -1.397 . . . . 0.0 108.084 157.831 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 . . . . . 0 N--CA 1.463 0.177 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -39.09 103.9 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.172 2.189 . . . . 0.0 110.906 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -120.87 122.94 41.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.833 1.197 . . . . 0.0 109.579 -166.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 66.28 -166.26 0.22 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.206 1.802 . . . . 0.0 107.67 -165.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -113.79 151.92 31.35 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.051 1.296 . . . . 0.0 110.166 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -75.17 136.65 41.04 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 155.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -122.11 117.59 26.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 174.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.22 124.48 4.54 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.77 157.08 38.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 171.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.8 t -140.61 158.63 43.7 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.14 145.36 24.66 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.024 0.93 . . . . 0.0 108.616 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.65 161.13 33.98 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 151.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.94 154.62 33.66 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.834 1.689 . . . . 0.0 109.398 165.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.546 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -90.15 167.08 13.0 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 161.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -140.69 154.89 46.55 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.772 -0.58 . . . . 0.0 109.933 165.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -111.27 148.56 32.63 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.458 1.103 . . . . 0.0 108.866 -175.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.3 mp -114.74 -58.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.874 1.27 . . . . 0.0 108.343 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 172.37 -41.14 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.877 2.471 . . . . 0.0 107.957 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.33 165.63 3.48 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.435 2.294 . . . . 0.0 110.406 -177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -82.44 46.93 1.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.279 163.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.94 151.59 36.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.516 2.326 . . . . 0.0 106.69 170.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.04 168.45 23.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 163.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.54 148.58 24.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 174.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -150.67 124.33 9.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.353 0.661 . . . . 0.0 110.211 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.27 142.21 47.03 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 163.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.53 176.08 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.042 0.937 . . . . 0.0 108.877 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -127.57 155.2 38.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.64 163.67 26.83 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.82 131.95 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 171.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.44 109.32 0.95 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 107.17 -2.372 . . . . 0.0 107.17 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -128.84 146.3 50.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.41 -175.59 33.28 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 118.225 -1.941 . . . . 0.0 112.56 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.2 mttt . . . . . 0 C--N 1.324 -0.529 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -162.368 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.23 143.5 40.17 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.255 1.822 . . . . 0.0 107.103 -166.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.91 88.08 2.47 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.224 1.009 . . . . 0.0 108.336 -156.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.15 39.71 1.87 Allowed Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.322 1.439 . . . . 0.0 111.804 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -73.99 121.23 20.71 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 t -157.29 -161.83 1.12 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -129.58 174.16 9.93 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 126.719 2.008 . . . . 0.0 108.848 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.11 -173.8 31.23 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.72 105.37 8.93 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.706 1.602 . . . . 0.0 108.244 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.26 141.93 15.89 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -138.15 161.44 36.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.657 1.983 . . . . 0.0 108.2 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -139.46 159.72 41.5 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.116 0.967 . . . . 0.0 108.419 167.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.409 ' CD2' HD12 ' A' ' 123' ' ' LEU . 4.0 m-30 -92.98 171.54 8.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.444 1.498 . . . . 0.0 108.52 165.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -56.48 119.95 32.41 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.411 1.484 . . . . 0.0 109.117 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.12 148.84 70.14 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.166 1.911 . . . . 0.0 110.5 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 95.2 mtp -116.25 -176.52 2.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.322 1.449 . . . . 0.0 108.804 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.88 -15.88 59.56 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.04 1.336 . . . . 0.0 110.139 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -164.59 14.37 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.836 2.455 . . . . 0.0 111.805 -168.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.94 148.16 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.53 ' C ' HD23 ' A' ' 123' ' ' LEU . . . -156.94 154.05 29.09 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 164.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -133.32 115.78 15.33 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.03 109.51 16.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.509 1.523 . . . . 0.0 107.432 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -115.34 143.66 44.94 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.296 1.038 . . . . 0.0 109.251 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 p -145.92 162.58 37.46 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.379 1.072 . . . . 0.0 110.656 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -151.12 105.48 3.23 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.372 1.069 . . . . 0.0 109.219 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -123.28 163.58 20.43 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.609 1.564 . . . . 0.0 109.956 -170.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -118.52 158.19 25.86 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.762 0.825 . . . . 0.0 111.577 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 t -140.93 105.96 4.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.267 1.827 . . . . 0.0 109.246 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -78.6 97.93 5.97 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 120.851 -1.155 . . . . 0.0 110.109 169.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.5 81.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.96 -70.87 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 128.522 2.729 . . . . 0.0 112.831 -171.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.83 3.82 2.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.298 2.639 . . . . 0.0 110.902 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.72 129.53 46.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -83.27 109.02 16.89 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.2 t -118.72 152.97 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.705 1.202 . . . . 0.0 108.368 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -140.2 152.74 22.99 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 128.123 2.773 . . . . 0.0 107.874 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -135.49 136.08 40.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.414 1.107 . . . . 0.0 109.644 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -112.45 110.67 21.01 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.1 mt -113.65 129.5 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.31 162.1 35.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.33 1.062 . . . . 0.0 109.679 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -158.07 164.37 33.26 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 167.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 m -137.65 166.36 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 166.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -174.82 -107.19 0.2 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 106.982 -2.447 . . . . 0.0 106.982 167.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.419 ' HB2' HG23 ' A' ' 5' ' ' VAL . 5.3 m-85 -141.76 176.6 8.79 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.827 2.051 . . . . 0.0 109.335 -170.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.31 151.76 35.94 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.715 -0.616 . . . . 0.0 110.078 171.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 C--O 1.248 1.014 0 C-N-CA 126.303 1.841 . . . . 0.0 107.97 168.922 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.5 p -96.65 138.2 34.58 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.661 -0.649 . . . . 0.0 109.507 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -89.97 159.18 17.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.947 1.299 . . . . 0.0 108.627 162.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -159.92 144.9 15.08 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 167.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.31 100.14 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.572 0.749 . . . . 0.0 109.143 -171.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 m -132.44 141.35 48.8 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 119.977 -1.702 . . . . 0.0 109.022 -170.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.0 -164.9 26.49 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -166.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.07 -114.05 0.86 Allowed Glycine 0 C--O 1.233 0.094 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.82 158.07 45.11 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.363 1.865 . . . . 0.0 109.223 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.44 136.92 51.35 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 160.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -120.07 122.48 41.18 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -131.66 151.05 51.92 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.34 170.69 15.57 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.754 1.622 . . . . 0.0 109.195 -173.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.67 164.89 27.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.391 1.076 . . . . 0.0 111.493 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -58.93 74.82 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.268 2.627 . . . . 0.0 110.27 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.71 82.86 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 107.835 -2.106 . . . . 0.0 107.835 -171.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -46.02 96.02 0.01 OUTLIER 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.923 2.489 . . . . 0.0 110.094 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.18 -12.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.993 2.117 . . . . 0.0 111.09 -176.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -105.25 123.69 48.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.347 1.459 . . . . 0.0 107.283 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -133.56 95.83 3.57 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.33 159.29 34.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.065 0.936 . . . . 0.0 108.736 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.56 156.09 16.8 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.38 -88.7 0.09 OUTLIER Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -165.42 164.62 19.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.221 1.008 . . . . 0.0 109.251 173.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -130.9 142.17 50.35 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.481 2.312 . . . . 0.0 107.068 166.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -150.44 140.13 21.69 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.791 1.236 . . . . 0.0 108.192 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -151.53 168.16 25.79 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.048 0.939 . . . . 0.0 110.945 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -141.31 114.51 8.67 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.778 0.831 . . . . 0.0 109.127 -167.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -93.73 108.32 20.09 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -103.55 118.26 36.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -140.55 143.3 35.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 7.9 tp10 -143.33 147.46 34.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -175.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.89 2.41 20.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.557 1.143 . . . . 0.0 112.184 -175.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.483 ' H ' ' HG3' ' A' ' 32' ' ' GLU . 4.0 m120 -73.93 -39.07 64.06 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.116 1.366 . . . . 0.0 110.335 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 t -153.37 110.58 2.61 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.4 68.23 5.25 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.992 3.128 . . . . 0.0 110.025 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.1 tp -139.05 105.3 5.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.8 -177.53 47.31 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 123.677 0.656 . . . . 0.0 111.669 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.1 t -134.61 139.72 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.8 pt -129.43 109.73 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 163.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.28 146.55 18.48 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 154.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.39 155.47 40.3 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 128.404 2.682 . . . . 0.0 106.348 160.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -115.78 131.1 57.04 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 167.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 m -92.73 147.45 22.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 156.65 45.23 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.104 1.762 . . . . 0.0 107.106 172.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -143.11 162.43 35.56 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.647 -0.658 . . . . 0.0 109.56 157.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.82 134.21 51.74 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.452 1.901 . . . . 0.0 107.898 166.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.62 147.8 1.1 Allowed 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.513 1.525 . . . . 0.0 107.577 -175.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -130.22 119.01 22.24 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 . . . . . 0 CA--C 1.521 -0.149 0 C-N-CA 125.522 1.529 . . . . 0.0 109.388 175.168 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.4 t80 . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 175.79 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 128.286 2.634 . . . . 0.0 105.423 152.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -150.98 157.02 42.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 128.205 2.602 . . . . 0.0 105.913 168.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -133.48 80.33 1.87 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -165.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -113.25 150.17 32.79 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -169.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -141.74 159.34 42.43 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 168.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -128.37 173.26 10.34 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.05 140.9 9.77 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -123.31 107.53 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 170.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -138.11 142.28 40.19 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 128.067 2.547 . . . . 0.0 104.868 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.26 40.06 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 118.562 0.619 . . . . 0.0 110.693 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.7 170.04 30.53 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.959 1.742 . . . . 0.0 109.103 161.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.9 179.79 5.36 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.405 2.07 . . . . 0.0 109.006 164.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.66 144.16 48.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 153.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -141.24 125.91 17.92 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -83.51 93.56 7.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.069 0.849 . . . . 0.0 109.973 -165.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.1 pp -142.52 -168.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.597 1.559 . . . . 0.0 110.354 -174.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 64.38 -95.51 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 128.744 2.818 . . . . 0.0 107.494 -170.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -147.76 115.44 6.37 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 120.55 1.523 . . . . 0.0 108.443 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 12.8 m0 59.81 8.13 1.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.027 2.531 . . . . 0.0 115.27 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.9 179.83 4.24 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.397 0.999 . . . . 0.0 109.218 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -144.99 105.32 4.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.87 152.45 35.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.99 167.2 27.4 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.649 0.38 . . . . 0.0 109.99 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.89 150.44 50.47 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 163.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -131.36 143.78 39.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.2 153.41 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 123.297 0.639 . . . . 0.0 110.643 -177.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.96 -170.81 39.15 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 123.624 0.577 . . . . 0.0 113.118 -169.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.09 141.26 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.048 1.339 . . . . 0.0 107.946 172.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.86 143.69 16.04 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 125.658 1.599 . . . . 0.0 109.519 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.9 130.47 35.96 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.208 1.803 . . . . 0.0 107.305 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.86 -145.39 13.09 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.186 1.85 . . . . 0.0 110.091 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.367 0 C-N-CA 127.484 2.313 . . . . 0.0 110.459 -170.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.237 0.421 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.89 162.02 21.7 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 168.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -146.88 144.57 29.37 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -125.81 107.16 0.93 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 124.594 1.092 . . . . 0.0 111.018 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.68 118.3 15.43 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.8 m -98.05 132.82 43.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -144.91 61.43 1.31 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.3 1.04 . . . . 0.0 110.916 -171.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.63 -164.35 40.23 Favored Glycine 0 CA--C 1.52 0.393 0 O-C-N 121.097 -1.002 . . . . 0.0 113.254 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.94 159.18 40.71 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 151.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -122.46 116.25 2.97 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 107.851 -2.099 . . . . 0.0 107.851 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -117.85 155.72 29.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.104 2.561 . . . . 0.0 106.622 -166.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.28 149.45 33.87 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.935 -1.103 . . . . 0.0 112.152 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.11 172.16 8.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.244 1.818 . . . . 0.0 109.817 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -59.15 130.67 87.0 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 119.12 -0.467 . . . . 0.0 110.796 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.3 118.32 5.29 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.682 2.255 . . . . 0.0 110.361 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 ttt -78.18 -176.03 4.42 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 150.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -86.68 -28.34 23.21 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 123.856 0.862 . . . . 0.0 109.827 172.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.68 3.59 4.54 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 110.755 -162.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.5 t -150.54 112.25 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 127.82 2.448 . . . . 0.0 105.69 -170.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.92 134.0 51.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.67 132.76 46.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -172.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -141.27 155.67 45.97 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.385 1.474 . . . . 0.0 109.182 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -138.1 123.09 19.02 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 124.525 1.13 . . . . 0.0 108.92 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.2 m -122.42 144.76 48.84 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 164.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -149.79 114.85 5.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.86 137.39 38.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.777 1.231 . . . . 0.0 108.339 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -99.76 161.64 13.49 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 169.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p -140.14 108.08 5.71 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.407 1.083 . . . . 0.0 109.351 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.8 ttm105 -62.28 123.79 19.16 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 168.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.7 mt -123.43 104.78 14.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.63 50.93 12.61 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.864 1.265 . . . . 0.0 111.713 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 61.4 m 48.87 29.66 2.39 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -174.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.57 138.58 19.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 156.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -86.21 121.0 28.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.98 134.16 31.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.34 146.63 17.78 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.7 p -124.16 136.38 54.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -131.63 157.74 42.89 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 163.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.3 mt -127.03 128.25 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -167.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.06 126.91 35.64 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.36 101.99 0.57 Allowed Glycine 0 C--O 1.224 -0.529 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 -170.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 t -138.41 139.17 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 127.291 2.236 . . . . 0.0 106.306 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -179.27 -129.61 1.34 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -146.83 177.1 9.37 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.77 2.028 . . . . 0.0 110.046 -158.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.23 166.28 24.14 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 166.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 12.6 p90 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.486 -1.721 . . . . 0.0 108.278 174.85 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.912 -0.033 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.3 p -140.52 160.35 40.2 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.423 0.689 . . . . 0.0 109.782 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.6 106.64 10.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.632 0.73 . . . . 0.0 110.291 -173.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.78 159.57 29.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 161.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.03 101.18 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 166.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 t -122.06 143.99 49.18 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.4 160.93 25.95 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.783 1.658 . . . . 0.0 109.043 -175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.75 -172.21 45.25 Favored Glycine 0 CA--C 1.51 -0.277 0 O-C-N 119.406 -2.232 . . . . 0.0 110.732 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -90.78 139.82 30.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.121 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.73 154.8 17.03 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.115 1.366 . . . . 0.0 109.123 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -152.54 118.8 5.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.62 151.12 24.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -138.42 159.94 40.79 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 150.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.63 160.45 37.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.619 0.645 . . . . 0.0 110.948 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.41 77.27 3.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.255 0.55 . . . . 0.0 111.176 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.69 -2.8 7.53 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.253 1.406 . . . . 0.0 112.377 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -150.99 96.39 2.32 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.075 1.437 . . . . 0.0 107.994 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.9 mtt -75.99 65.13 1.99 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.863 2.465 . . . . 0.0 110.344 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -78.89 95.94 5.55 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 108.766 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -76.35 77.9 3.1 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.563 0.697 . . . . 0.0 109.556 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.3 mmm -114.25 159.42 20.17 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.904 1.282 . . . . 0.0 108.273 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.54 163.89 12.73 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -168.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.53 -120.95 1.07 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 104.356 -3.498 . . . . 0.0 104.356 -172.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.33 170.32 8.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.335 1.068 . . . . 0.0 109.948 -171.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -137.22 163.14 31.61 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 128.029 2.532 . . . . 0.0 106.387 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.69 158.77 43.82 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 164.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -139.48 156.59 46.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.53 130.85 33.08 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -105.63 115.07 29.62 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -98.21 118.67 35.37 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 103.625 -2.731 . . . . 0.0 103.625 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -87.78 128.34 35.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -109.15 178.44 4.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.52 16.42 8.21 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.293 1.437 . . . . 0.0 109.922 -167.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.38 -63.58 0.98 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.191 1.396 . . . . 0.0 110.351 172.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.0 m -75.19 133.29 75.26 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 117.921 0.328 . . . . 0.0 110.768 -172.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.42 -9.22 18.76 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.521 2.814 . . . . 0.0 112.995 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -88.92 155.57 19.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.166 0.986 . . . . 0.0 109.811 173.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.72 -172.94 17.16 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 166.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -130.52 143.92 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 pt -140.27 142.01 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.85 1.26 . . . . 0.0 109.165 165.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.28 108.08 0.34 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.568 1.08 . . . . 0.0 110.435 166.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.85 153.87 42.36 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.354 1.062 . . . . 0.0 110.374 173.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -120.62 148.38 43.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 153.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 t -127.38 150.93 49.39 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.452 1.901 . . . . 0.0 105.928 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -142.72 156.97 45.09 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.309 0.504 . . . . 0.0 110.214 171.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.3 t -100.06 143.98 29.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.729 0.812 . . . . 0.0 110.291 -176.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -151.05 29.27 0.66 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.927 2.091 . . . . 0.0 110.572 -172.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -133.68 148.4 51.48 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 118.985 -2.322 . . . . 0.0 111.545 -175.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.2 m -113.17 121.74 45.42 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.939 1.296 . . . . 0.0 107.629 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.5 t80 . . . . . 0 C--O 1.237 0.408 0 CA-C-O 119.368 -0.348 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -114.03 143.4 44.81 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 171.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -149.7 120.61 7.65 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 156.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.457 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 41.7 t30 -157.83 -158.41 0.73 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 155.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.457 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 10.8 mp0 -111.36 165.09 12.25 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 165.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.67 116.17 13.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 174.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -97.04 133.86 41.16 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -173.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.09 104.8 0.35 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.6 tt -126.46 114.37 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.443 1.097 . . . . 0.0 108.762 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 t -122.57 151.84 41.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.75 158.41 39.49 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.067 0.947 . . . . 0.0 109.127 168.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.22 -178.56 42.34 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 168.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.52 142.43 44.57 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.015 1.81 . . . . 0.0 110.377 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.31 103.15 15.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 153.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.7 144.97 33.22 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 167.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -74.06 127.38 32.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mm -50.27 -60.86 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.19 0.996 . . . . 0.0 108.848 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -156.89 -43.53 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 167.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.3 -89.51 0.05 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.034 1.333 . . . . 0.0 107.577 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.34 7.11 0.2 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -166.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.84 167.99 20.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.346 1.43 . . . . 0.0 111.161 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 p -74.0 168.76 18.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.983 0.913 . . . . 0.0 110.166 164.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -129.74 164.57 32.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.53 ' H ' HD13 ' A' ' 79' ' ' ILE . 43.6 p90 -105.08 171.0 7.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.826 2.051 . . . . 0.0 110.971 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.57 70.76 1.16 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.74 168.72 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 117.95 0.875 . . . . 0.0 110.405 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.49 154.12 3.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.76 171.51 36.15 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 118.434 0.561 . . . . 0.0 111.999 163.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.33 126.42 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 170.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.99 104.97 2.02 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 166.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -112.95 135.75 53.38 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.564 1.146 . . . . 0.0 107.974 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.25 -166.54 39.35 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.158 0 C-N-CA 125.924 1.69 . . . . 0.0 110.056 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -151.18 157.95 43.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 167.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -70.89 157.45 38.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 117.894 -1.522 . . . . 0.0 108.729 163.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.3 122.55 6.33 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 105.568 -3.013 . . . . 0.0 105.568 159.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -78.63 117.18 19.55 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 78.7 p -103.02 158.33 16.37 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.306 1.051 . . . . 0.0 112.077 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -105.11 112.84 26.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.13 143.03 16.31 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 118.558 0.617 . . . . 0.0 111.783 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -140.18 160.64 39.5 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.689 1.196 . . . . 0.0 109.504 172.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.59 122.12 0.87 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.08 140.52 51.9 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.109 1.364 . . . . 0.0 107.482 173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -120.22 149.76 41.76 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.189 0.995 . . . . 0.0 108.85 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -92.66 172.27 8.46 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.947 1.299 . . . . 0.0 109.62 -174.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -57.18 154.71 19.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.552 -0.717 . . . . 0.0 110.702 169.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.46 143.47 52.4 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.77 2.314 . . . . 0.0 111.538 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.7 mmt -108.44 -176.73 3.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -92.84 -30.33 15.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 109.404 -170.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -142.34 9.72 1.86 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.248 1.419 . . . . 0.0 110.693 -171.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.261 0.2 OUTLIER -141.31 140.43 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 119.582 1.083 . . . . 0.0 108.551 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.4 153.32 18.66 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -133.39 116.16 15.72 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 162.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -141.09 137.71 33.03 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.864 1.666 . . . . 0.0 107.425 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -133.63 121.81 22.57 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.325 0.966 . . . . 0.0 109.178 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.5 m -127.62 149.94 49.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 140' ' ' TRP . 1.5 t80 -145.01 137.25 25.93 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -127.58 153.87 45.87 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.377 1.071 . . . . 0.0 108.774 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -131.52 154.82 48.39 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 168.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.4 m -136.66 156.77 48.09 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.914 2.086 . . . . 0.0 108.534 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -134.1 97.17 3.79 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.3 90.97 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 60.79 -93.11 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 126.656 1.982 . . . . 0.0 110.573 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.17 1.76 20.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.349 0.977 . . . . 0.0 112.633 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.37 112.81 41.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-N 119.847 1.203 . . . . 0.0 108.599 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.43 136.47 57.92 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 162.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.9 t -125.86 116.85 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 169.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.48 149.84 20.04 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 170.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 87.6 m -141.12 120.42 13.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 164.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.448 ' HB3' ' CE2' ' A' ' 127' ' ' TYR . 5.6 p-90 -90.88 141.89 28.34 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 170.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.96 134.88 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.69 164.39 14.73 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 172.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -146.63 104.09 0.29 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.47 -179.83 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.372 1.869 . . . . 0.0 105.989 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 146.15 -115.12 0.78 Allowed Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 106.883 -2.487 . . . . 0.0 106.883 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -147.75 175.8 10.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.01 1.324 . . . . 0.0 110.679 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -140.28 165.81 26.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 164.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 C--O 1.25 1.101 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 170.203 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 p -140.48 141.38 35.41 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 168.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -122.93 158.78 29.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 m -145.78 154.82 42.45 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 166.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.1 98.96 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.1 p -117.47 135.15 54.12 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.928 1.291 . . . . 0.0 107.917 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.12 168.42 38.56 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.44 -169.15 42.1 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.483 -173.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -92.04 157.86 16.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.722 1.209 . . . . 0.0 109.026 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.02 172.91 8.17 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.157 0.983 . . . . 0.0 111.307 -174.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -148.24 104.56 3.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 155.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t -84.39 134.02 34.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 157.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -103.28 171.38 7.4 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.37 158.25 44.02 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 161.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.16 97.45 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 162.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.16 -29.81 2.68 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.778 1.18 . . . . 0.0 110.664 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -151.1 93.88 1.98 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -88.34 69.52 9.06 Favored 'General case' 0 C--N 1.335 -0.065 0 CA-C-O 123.954 1.835 . . . . 0.0 107.005 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.49 -177.77 4.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 128.168 2.587 . . . . 0.0 108.476 -168.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -90.79 96.78 10.81 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 164.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 62.2 mtm -70.57 159.23 34.73 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 138.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.77 -161.91 17.96 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.46 -140.48 5.04 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -160.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.99 154.45 20.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.864 1.266 . . . . 0.0 109.703 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -137.66 153.89 49.78 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.452 2.701 . . . . 0.0 107.634 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -150.25 141.41 23.1 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.787 1.635 . . . . 0.0 107.768 168.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -116.43 146.42 42.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.693 1.997 . . . . 0.0 107.363 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.66 110.91 10.19 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -93.23 157.7 16.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -143.63 158.25 43.81 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.823 0.283 . . . . 0.0 110.553 165.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -125.02 112.55 16.69 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.564 0.697 . . . . 0.0 109.147 169.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.0 164.09 21.69 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.81 8.44 41.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.777 1.631 . . . . 0.0 112.912 -169.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -1.27 22.55 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -172.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.06 139.82 8.36 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 126.555 1.942 . . . . 0.0 107.306 166.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.79 81.06 2.45 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.516 2.144 . . . . 0.0 108.301 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 tp -150.65 156.65 41.77 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.202 1.801 . . . . 0.0 107.94 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.18 -177.9 15.26 Favored Glycine 0 C--O 1.226 -0.346 0 O-C-N 121.571 -0.706 . . . . 0.0 111.539 172.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.2 t -143.5 137.37 25.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.367 1.467 . . . . 0.0 108.25 -165.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.6 mm -139.9 141.39 34.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.977 1.311 . . . . 0.0 109.91 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.64 167.89 20.64 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 107.729 -2.149 . . . . 0.0 107.729 144.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.8 t -127.45 155.27 43.95 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.208 -1.76 . . . . 0.0 106.877 143.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -98.48 143.82 28.49 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 165.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -127.7 134.18 49.57 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.858 1.263 . . . . 0.0 108.389 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -141.96 123.87 15.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.593 1.157 . . . . 0.0 108.395 -172.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -99.21 126.85 45.1 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -163.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -139.14 0.48 1.93 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.308 0.575 . . . . 0.0 112.254 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.19 123.49 26.97 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.001 -1.687 . . . . 0.0 109.1 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.9 p -67.06 152.25 46.12 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.396 0.998 . . . . 0.0 110.633 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 157.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.8 t80 . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -62.74 109.2 1.35 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.244 0.929 . . . . 0.0 109.908 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -121.25 170.93 9.11 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.259 1.424 . . . . 0.0 110.968 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 8.0 t30 58.22 -159.0 0.28 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.71 1.604 . . . . 0.0 111.112 175.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.417 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -128.77 158.64 38.09 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 120.507 -1.371 . . . . 0.0 108.616 174.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -115.73 158.95 22.06 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -127.91 157.14 41.33 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.312 1.845 . . . . 0.0 107.77 -173.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.32 88.82 0.14 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.73 113.47 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.9 m -131.16 128.0 39.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.59 149.28 25.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.373 1.069 . . . . 0.0 108.969 -174.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.13 175.87 31.58 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 166.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.66 175.4 11.15 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.451 2.768 . . . . 0.0 113.036 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.51 138.58 52.34 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.283 1.833 . . . . 0.0 110.712 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -121.02 128.42 52.66 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.08 1.352 . . . . 0.0 108.93 -168.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.53 149.45 24.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.71 0.804 . . . . 0.0 110.223 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -78.88 179.06 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 163.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -61.32 -52.65 63.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.617 -1.302 . . . . 0.0 110.718 -176.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -159.98 148.52 17.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 149.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 11.6 m0 145.1 -49.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 130.746 3.618 . . . . 0.0 108.87 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' H ' HG22 ' A' ' 73' ' ' ILE . . . -148.71 168.69 22.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.758 0.823 . . . . 0.0 109.516 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 m -133.48 156.99 46.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 163.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.521 HG22 HD23 ' A' ' 113' ' ' LEU . 16.3 pt -127.47 167.68 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.84 2.056 . . . . 0.0 108.575 -176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.15 123.96 26.61 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.268 -0.895 . . . . 0.0 108.885 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.43 86.58 0.4 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 106.908 -2.477 . . . . 0.0 106.908 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.6 HG22 ' HB2' ' A' ' 111' ' ' ALA . 2.3 m -113.66 -176.62 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.336 0.655 . . . . 0.0 109.867 -175.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.4 m -116.33 151.01 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 166.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.77 158.4 20.05 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 167.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.8 p -145.86 121.62 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.05 106.35 3.22 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -108.59 117.4 34.07 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.43 174.1 19.41 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm . . . . . 0 CA--C 1.516 -0.355 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 170.523 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -141.11 159.26 42.58 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 165.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -85.68 165.83 16.65 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.494 -0.754 . . . . 0.0 110.267 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.51 142.31 14.27 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 163.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -118.11 93.2 4.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.572 1.186 . . . . 0.0 109.034 -160.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.7 t -87.21 147.51 25.55 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.976 0.893 . . . . 0.0 110.198 -173.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.12 144.24 51.25 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 128.398 2.679 . . . . 0.0 106.479 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.69 -170.13 14.56 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 -165.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.6 ' HB2' HG22 ' A' ' 82' ' ' VAL . . . -166.97 -65.53 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.413 1.107 . . . . 0.0 109.203 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 155.11 174.35 24.91 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -167.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.521 HD23 HG22 ' A' ' 79' ' ' ILE . 4.2 mp -145.17 143.84 30.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -104.24 149.51 25.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -173.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.8 171.17 8.82 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -58.75 142.16 84.21 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-O 119.165 -0.445 . . . . 0.0 109.865 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.43 152.55 78.62 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 120.931 1.087 . . . . 0.0 111.007 172.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -109.09 -174.19 2.45 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 130.955 3.702 . . . . 0.0 105.503 162.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -110.93 -11.8 14.3 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.309 1.844 . . . . 0.0 109.294 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -142.01 17.22 2.11 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.176 1.39 . . . . 0.0 111.6 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.82 156.04 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 172.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.41 156.71 42.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.777 0.717 . . . . 0.0 109.166 157.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -136.89 122.36 19.54 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.991 2.117 . . . . 0.0 108.403 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -124.61 160.52 28.28 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.773 2.429 . . . . 0.0 107.64 163.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -140.87 116.69 10.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.23 144.16 51.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.418 0.554 . . . . 0.0 109.939 -168.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -137.29 156.62 48.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -129.79 147.61 51.59 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 155.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -132.84 112.2 11.72 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.8 t -139.56 160.3 40.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.624 1.57 . . . . 0.0 108.228 -157.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.65 145.83 37.11 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.45 110.35 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 171.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 50.17 40.91 23.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.302 1.041 . . . . 0.0 111.97 -173.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 m 47.76 36.84 6.19 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.6 t -81.48 112.79 19.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 143.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.16 137.2 58.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.5 t -139.26 97.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.88 152.4 34.98 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 164.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.8 m -141.0 130.88 24.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 120.775 -1.427 . . . . 0.0 108.047 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -121.23 143.19 49.28 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.8 mt -144.75 132.31 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.805 1.242 . . . . 0.0 107.873 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.61 165.88 14.51 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -154.26 87.36 0.13 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.66 162.61 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 152.81 -119.37 0.95 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -150.59 176.38 11.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.119 1.368 . . . . 0.0 109.564 -158.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 137.9 23.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.039 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 12.0 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-N 119.34 0.973 . . . . 0.0 108.655 167.288 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 p -141.08 136.95 32.49 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 t -127.9 106.81 9.36 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -117.24 118.8 33.3 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.281 5.9 p -110.56 119.41 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 122.006 0.908 . . . . 0.0 111.093 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.32 137.77 23.36 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.728 1.211 . . . . 0.0 108.943 -167.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.5 170.07 40.08 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.59 -152.01 10.02 Favored Glycine 0 C--N 1.319 -0.375 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -172.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -91.87 157.7 16.71 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.47 113.29 11.68 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 169.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.32 148.04 29.52 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.8 t -138.88 115.57 10.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.982 2.113 . . . . 0.0 107.206 -171.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.38 160.69 34.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.068 0.947 . . . . 0.0 109.163 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.72 148.47 52.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.727 0.811 . . . . 0.0 110.986 -167.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 54.65 -70.15 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 128.323 2.649 . . . . 0.0 112.067 -175.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.75 -42.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.7 0 CA-C-N 119.975 1.261 . . . . 0.0 111.04 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -145.21 119.49 9.55 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.438 1.095 . . . . 0.0 108.461 164.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.2 ttm -157.18 -51.75 0.07 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.212 1.005 . . . . 0.0 109.324 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -142.19 158.22 43.98 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.232 1.813 . . . . 0.0 107.733 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -135.76 77.33 1.66 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 170.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.06 138.62 49.06 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 166.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.84 157.22 27.34 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.61 -166.68 38.17 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -170.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -99.89 154.74 18.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.326 0.563 . . . . 0.0 110.402 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -102.43 144.06 31.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.939 1.296 . . . . 0.0 108.271 161.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.0 mt -127.13 150.86 49.3 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 149.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.45 161.09 41.77 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 165.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -144.16 140.41 29.35 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -120.08 114.48 22.05 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.246 0.93 . . . . 0.0 109.357 169.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -99.32 151.92 20.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 163.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -134.69 130.57 36.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -172.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -76.71 163.11 27.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.352 1.072 . . . . 0.0 112.11 -161.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -86.71 27.47 0.98 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.616 1.566 . . . . 0.0 110.885 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -143.1 -65.05 0.39 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.156 1.782 . . . . 0.0 108.983 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.5 p -92.96 127.8 46.03 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.872 1.669 . . . . 0.0 108.921 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -76.92 54.81 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 124.088 3.192 . . . . 0.0 110.252 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.27 106.65 5.81 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.631 2.373 . . . . 0.0 106.73 -159.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.18 178.72 22.07 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.984 1.278 . . . . 0.0 111.082 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.85 144.68 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 124.266 1.026 . . . . 0.0 109.555 -156.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.7 mt -126.54 109.8 21.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.94 1.296 . . . . 0.0 108.083 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.01 148.04 18.35 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 105.862 -2.895 . . . . 0.0 105.862 151.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 p -108.89 144.17 37.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.255 1.027 . . . . 0.0 109.196 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -91.9 145.79 24.27 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 162.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 t -128.91 152.44 48.55 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.061 1.744 . . . . 0.0 108.084 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -136.98 156.65 48.17 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 175.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.4 m -98.35 121.96 40.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 165.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.56 53.45 1.05 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.474 2.31 . . . . 0.0 107.108 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -158.93 146.63 17.75 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 128.524 2.729 . . . . 0.0 108.464 169.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 p -127.7 156.66 42.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.929 2.491 . . . . 0.0 107.599 163.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.862 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -66.06 107.08 1.78 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.396 -171.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -135.8 146.25 47.37 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 118.739 0.699 . . . . 0.0 110.213 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 51.2 -161.69 0.08 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.352 1.861 . . . . 0.0 110.745 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.67 176.13 7.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.154 1.381 . . . . 0.0 111.527 -171.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -89.3 130.87 35.62 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 160.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.63 120.04 41.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 165.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.31 88.67 0.19 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.47 141.07 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 p -126.36 155.79 41.52 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.737 1.615 . . . . 0.0 107.782 171.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.62 150.58 45.14 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.74 0.7 . . . . 0.0 110.284 170.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 173.53 137.35 2.39 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 174.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.22 164.83 34.4 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 CA-C-N 120.405 2.102 . . . . 0.0 110.706 167.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.14 103.98 13.07 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.236 1.414 . . . . 0.0 107.879 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.71 112.24 21.47 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.336 0.516 . . . . 0.0 109.713 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -67.96 136.67 54.3 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 168.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 77' ' ' ALA . 1.9 pp -144.84 178.67 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 126.91 2.084 . . . . 0.0 105.88 172.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.8 t30 38.39 -121.37 0.26 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.435 1.494 . . . . 0.0 109.077 -162.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -110.19 104.14 12.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.202 1.801 . . . . 0.0 108.631 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 65.8 m95 60.84 19.46 9.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.381 2.272 . . . . 0.0 114.73 167.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' HB3' HD12 ' A' ' 73' ' ' ILE . . . -74.57 -169.85 0.92 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.293 0.951 . . . . 0.0 110.468 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.1 m -140.95 169.16 18.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.148 1.379 . . . . 0.0 107.726 167.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.8 mm -133.83 158.61 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 122.804 1.288 . . . . 0.0 109.235 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -105.43 175.48 5.48 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 130.048 3.339 . . . . 0.0 109.627 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 54.05 0.88 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.58 173.22 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.35 160.41 10.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 O-C-N 120.525 -1.359 . . . . 0.0 108.26 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -156.42 165.45 32.91 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-O 122.182 0.879 . . . . 0.0 112.936 162.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -115.26 150.51 17.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 127.055 2.142 . . . . 0.0 106.065 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.89 149.78 18.41 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 165.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -150.77 145.47 25.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.042 1.337 . . . . 0.0 108.944 172.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.62 -133.87 12.07 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.3 tttp . . . . . 0 N--CA 1.474 0.77 0 C-N-CA 128.586 2.754 . . . . 0.0 114.709 178.431 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.64 128.74 36.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -171.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -114.68 142.83 45.96 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -102.35 168.5 18.79 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -138.43 151.72 47.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 164.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -169.4 -164.47 0.45 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.775 0.83 . . . . 0.0 110.56 166.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -134.5 160.3 38.44 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.51 1.924 . . . . 0.0 108.446 -176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -153.25 -158.19 8.43 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.771 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -139.83 168.76 19.06 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -167.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.24 86.42 0.1 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mt -130.15 149.85 51.67 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.6 1.16 . . . . 0.0 107.939 -173.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -135.25 158.88 43.24 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.199 0.454 . . . . 0.0 111.602 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -101.01 171.14 7.82 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.711 1.204 . . . . 0.0 107.77 166.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -56.77 107.01 0.76 Allowed Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.619 0.768 . . . . 0.0 110.653 -170.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.89 158.06 34.81 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.963 2.442 . . . . 0.0 109.59 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 49.4 ttm -135.95 159.82 40.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.127 1.371 . . . . 0.0 109.189 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -69.88 25.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 130.873 3.669 . . . . 0.0 110.75 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.14 -32.16 0.1 Allowed 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.885 -1.135 . . . . 0.0 113.015 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.5 m -145.78 135.77 18.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -174.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.19 155.32 18.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.098 0.863 . . . . 0.0 109.427 168.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -130.44 114.08 15.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 155.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.01 148.99 45.68 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.415 2.286 . . . . 0.0 105.607 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -149.83 138.98 21.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 120.644 -1.285 . . . . 0.0 109.471 -162.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.7 m -134.45 166.37 23.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 166.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -145.98 137.89 25.14 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -134.4 163.6 29.3 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -122.02 169.81 10.46 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 127.018 2.127 . . . . 0.0 106.48 170.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.7 t -131.82 159.9 37.19 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 163.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -123.82 97.08 5.2 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.3 mt -86.88 81.95 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 65.94 -78.92 0.03 OUTLIER 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.248 2.219 . . . . 0.0 111.11 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -146.15 61.06 1.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.167 1.787 . . . . 0.0 107.102 166.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.9 t -125.08 145.61 32.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 162.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.25 137.17 39.95 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.864 1.666 . . . . 0.0 107.423 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.4 t -138.45 151.52 24.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 126.649 1.98 . . . . 0.0 106.937 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -137.05 143.86 15.27 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -140.48 135.99 32.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -123.83 131.18 53.54 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.5 115.93 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.499 . . . . 0.0 107.504 -166.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.85 152.3 21.34 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.143 0.577 . . . . 0.0 110.055 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.26 82.56 0.29 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.818 1.675 . . . . 0.0 109.719 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.8 t -104.19 158.41 5.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 126.516 1.926 . . . . 0.0 106.704 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.33 -107.25 0.28 Allowed Glycine 0 C--O 1.221 -0.677 0 C-N-CA 118.657 -1.735 . . . . 0.0 112.799 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.5 165.85 23.27 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.046 1.738 . . . . 0.0 106.858 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -148.99 136.24 20.09 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 119.835 -1.79 . . . . 0.0 111.555 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 128.805 2.842 . . . . 0.0 111.252 168.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.6 m -141.2 125.01 16.98 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -98.86 132.63 44.06 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.496 1.119 . . . . 0.0 109.159 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -143.58 118.78 10.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.453 HG23 ' H ' ' A' ' 146' ' ' TYR . 2.4 m -92.38 143.82 10.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.4 m -158.35 139.57 13.29 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.971 1.708 . . . . 0.0 107.989 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.48 172.59 31.15 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.81 -160.68 29.0 Favored Glycine 0 N--CA 1.462 0.384 0 CA-C-N 120.33 2.065 . . . . 0.0 110.903 -172.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -91.71 157.34 16.99 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.405 1.102 . . . . 0.0 109.845 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.704 ' HB2' HD21 ' A' ' 25' ' ' ASN . . . -119.93 155.07 33.48 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.517 1.527 . . . . 0.0 110.035 -175.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -148.09 118.35 7.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 162.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -83.79 139.63 32.57 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 167.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -116.68 153.86 31.59 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 157.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.1 106.57 3.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.547 1.939 . . . . 0.0 108.524 -171.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 71.38 -54.1 0.67 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.762 2.025 . . . . 0.0 112.63 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.81 -81.38 0.05 OUTLIER Glycine 0 C--N 1.337 0.638 0 CA-C-N 119.469 1.031 . . . . 0.0 114.257 -172.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -152.57 95.87 2.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.279 1.539 . . . . 0.0 108.913 166.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.8 mtt -144.71 -48.87 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.654 0.782 . . . . 0.0 110.314 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -128.37 109.73 11.7 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -169.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -131.41 77.84 1.8 Allowed 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.717 1.207 . . . . 0.0 107.89 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.81 145.23 47.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 169.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . -159.36 -179.93 34.52 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 128.678 3.037 . . . . 0.0 106.747 167.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.81 -90.95 0.08 OUTLIER Glycine 0 CA--C 1.523 0.545 0 CA-C-N 118.998 1.399 . . . . 0.0 110.646 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -164.71 143.09 6.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 168.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.704 HD21 ' HB2' ' A' ' 10' ' ' ALA . 38.9 m-80 -125.32 163.26 22.93 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.133 0.973 . . . . 0.0 110.233 -166.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 mt -142.79 163.1 33.72 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.148 0.979 . . . . 0.0 110.516 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -140.03 161.06 38.51 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.477 2.311 . . . . 0.0 106.538 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -147.81 112.19 5.26 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -105.3 159.42 15.9 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.163 -0.96 . . . . 0.0 108.945 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -142.77 155.84 44.89 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.942 0.897 . . . . 0.0 108.86 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.41 113.06 19.78 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.335 0.654 . . . . 0.0 109.781 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.85 159.2 26.54 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.304 0.574 . . . . 0.0 109.674 167.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -128.83 39.54 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.66 -16.32 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.995 1.318 . . . . 0.0 112.15 -173.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.6 t -155.07 133.48 7.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.854 1.662 . . . . 0.0 108.193 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.84 -5.0 16.39 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.312 3.342 . . . . 0.0 113.867 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -77.5 123.97 27.29 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.105 -0.997 . . . . 0.0 109.025 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.36 -167.39 36.91 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.7 t -127.08 147.78 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.344 1.458 . . . . 0.0 108.675 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 mm -122.48 127.85 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 166.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.17 108.71 0.39 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 107.226 -2.35 . . . . 0.0 107.226 163.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.6 t -88.23 150.72 23.12 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.849 1.66 . . . . 0.0 108.293 167.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -127.72 131.13 49.75 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.394 1.878 . . . . 0.0 107.976 172.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -127.32 117.0 21.39 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.978 1.711 . . . . 0.0 109.073 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -113.52 133.91 54.97 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.284 1.434 . . . . 0.0 107.827 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 p -126.6 130.06 49.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.318 0.58 . . . . 0.0 110.878 -168.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -140.17 93.21 2.61 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.363 1.465 . . . . 0.0 108.155 -170.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -162.75 147.46 11.81 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.879 0.872 . . . . 0.0 109.11 -174.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.1 p -121.63 153.93 37.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.51 -0.564 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 119.646 -0.216 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.21 122.34 6.72 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.758 -0.589 . . . . 0.0 109.843 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -115.26 171.64 7.57 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.892 1.677 . . . . 0.0 108.516 170.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.89 -176.01 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.379 1.072 . . . . 0.0 110.202 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 pm0 -137.1 162.15 34.16 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 160.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -83.87 143.09 30.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.61 117.71 21.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.844 2.057 . . . . 0.0 106.455 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.87 92.98 1.05 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.3 mm -79.71 146.43 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 p -133.66 155.42 49.74 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.02 139.21 21.22 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.22 175.33 34.96 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.176 0.417 . . . . 0.0 112.249 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -79.02 176.04 10.26 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.886 2.391 . . . . 0.0 110.351 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.01 150.48 38.54 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.631 1.173 . . . . 0.0 108.841 162.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.2 124.2 41.93 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.099 0.96 . . . . 0.0 108.571 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -71.8 133.27 45.42 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.012 0.369 . . . . 0.0 110.049 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.8 mt -77.95 -76.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 165.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -83.09 -76.07 0.29 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 170.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -148.09 -62.01 0.26 Allowed 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -104.48 105.95 16.27 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.279 1.037 . . . . 0.0 109.56 172.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.42 -169.02 3.24 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.389 1.876 . . . . 0.0 108.754 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.97 169.67 17.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 157.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mm -143.06 147.3 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.628 ' HA ' ' HB3' ' A' ' 111' ' ' ALA . 21.9 p90 -105.4 141.59 36.65 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.425 2.29 . . . . 0.0 107.972 177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.82 50.42 0.21 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -161.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.526 HG22 ' HB2' ' A' ' 111' ' ' ALA . 3.6 m -123.04 176.4 4.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 163.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.55 130.22 54.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.55 158.41 15.13 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.01 118.36 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 170.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.63 122.69 7.62 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 107.372 -2.291 . . . . 0.0 107.372 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -132.63 116.93 17.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -169.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.23 101.55 0.22 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt . . . . . 0 C--O 1.234 0.249 0 CA-C-N 117.666 0.733 . . . . 0.0 109.654 165.608 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.67 165.13 35.11 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.997 -1.065 . . . . 0.0 110.894 170.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.17 109.48 18.92 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 166.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.86 93.42 1.89 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -74.52 111.65 9.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.64 1.176 . . . . 0.0 109.704 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 p -105.79 151.06 24.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.33 1.052 . . . . 0.0 111.211 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -136.85 80.84 1.84 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.468 1.907 . . . . 0.0 107.972 -170.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.08 -161.48 11.0 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 126.512 2.005 . . . . 0.0 108.144 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 80' ' ' TYR . . . -164.28 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 153.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.449 ' C ' HD22 ' A' ' 113' ' ' LEU . . . 164.71 170.83 30.19 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -171.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 112' ' ' GLY . 3.7 mm? -133.29 150.83 51.88 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.58 1.952 . . . . 0.0 106.836 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -132.64 154.2 50.33 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.139 0.971 . . . . 0.0 110.023 -171.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -104.64 174.44 5.88 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 128.044 2.537 . . . . 0.0 109.107 173.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -55.62 114.09 6.75 Favored Pre-proline 0 C--O 1.234 0.269 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.28 103.56 1.7 Allowed 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.044 -1.56 . . . . 0.0 108.044 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.1 ttt -74.64 155.55 37.67 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -54.64 -33.25 60.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 126.787 2.035 . . . . 0.0 110.991 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -104.45 -25.95 12.6 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 117.271 -1.347 . . . . 0.0 113.602 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.93 109.47 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.308 0.958 . . . . 0.0 108.885 -174.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.97 154.17 42.04 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 162.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -132.26 116.35 16.81 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 168.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.84 146.58 37.74 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.913 2.085 . . . . 0.0 107.301 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -129.68 135.61 48.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.3 m -124.23 148.24 47.47 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 171.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -149.86 132.92 16.24 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -136.63 145.22 44.61 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.62 1.568 . . . . 0.0 107.693 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -116.75 129.07 55.89 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 171.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 t -111.11 159.57 17.7 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.188 0.995 . . . . 0.0 108.934 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -136.45 97.4 3.56 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -172.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.57 94.34 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 167.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.3 ttm-85 63.93 58.53 1.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.618 1.167 . . . . 0.0 111.741 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m 53.72 27.89 7.47 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.342 1.057 . . . . 0.0 113.073 171.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.45 149.0 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.392 1.477 . . . . 0.0 108.094 172.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.72 102.4 13.6 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 169.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.3 t -131.85 103.68 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.87 133.17 7.49 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.4 t -125.48 139.89 53.24 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.479 1.512 . . . . 0.0 107.457 -175.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -129.7 151.18 50.57 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 171.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.8 pt -136.23 145.16 31.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.13 158.04 18.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.25 101.95 0.36 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 106.664 -2.574 . . . . 0.0 106.664 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.87 160.44 20.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.06 -149.84 9.45 Favored Glycine 0 C--O 1.221 -0.718 0 C-N-CA 118.688 -1.72 . . . . 0.0 109.799 -172.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.453 ' H ' HG23 ' A' ' 5' ' ' VAL . 42.4 p90 -162.66 175.32 11.49 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.937 1.695 . . . . 0.0 106.988 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -102.98 147.67 26.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 C--O 1.249 1.064 0 C-N-CA 126.174 1.789 . . . . 0.0 108.049 170.79 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 p -131.82 137.58 48.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -132.21 106.89 8.23 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.8 t -135.96 127.21 28.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.496 HG11 ' CD1' ' A' ' 146' ' ' TYR 0.259 9.7 p -101.93 153.4 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.735 0.779 . . . . 0.0 109.512 -173.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.9 124.08 4.24 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 174.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.39 -172.7 45.67 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 118.594 0.634 . . . . 0.0 113.235 -166.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.31 -116.44 1.54 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.602 1.572 . . . . 0.0 110.818 169.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.35 146.26 45.47 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.617 1.209 . . . . 0.0 108.307 -163.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.39 120.84 24.88 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -169.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -99.65 148.15 24.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 168.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -130.93 131.34 44.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 165.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -119.25 111.17 17.87 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.4 143.04 27.03 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.324 1.049 . . . . 0.0 108.286 -170.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 60.89 -75.48 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.243 1.817 . . . . 0.0 109.537 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.46 -73.35 0.02 OUTLIER Glycine 0 CA--C 1.52 0.405 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -126.12 105.91 9.2 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ttt -148.21 -54.63 0.2 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.206 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -144.62 133.05 21.94 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -167.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -121.15 77.82 1.35 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -170.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -58.08 157.73 7.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.294 1.437 . . . . 0.0 110.31 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.69 155.16 26.25 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.07 -175.4 39.4 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 118.386 1.093 . . . . 0.0 111.688 -173.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.11 146.43 43.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.771 0.785 . . . . 0.0 111.604 -164.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.62 HD21 ' HA ' ' A' ' 44' ' ' THR . 1.0 OUTLIER -139.36 152.52 47.22 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.536 1.935 . . . . 0.0 109.531 176.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.441 HD21 ' CG2' ' A' ' 5' ' ' VAL . 1.3 tm? -156.28 116.11 3.59 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.667 0.787 . . . . 0.0 108.883 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 128.6 38.82 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.513 1.125 . . . . 0.0 109.58 175.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -95.74 141.5 29.14 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.778 2.431 . . . . 0.0 108.095 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 69.7 mtm-85 -128.37 162.85 26.13 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.958 1.254 . . . . 0.0 109.74 166.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.21 138.52 31.53 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -88.09 135.16 33.55 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 171.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -136.48 162.22 33.69 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.768 0.827 . . . . 0.0 110.639 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.68 47.09 2.18 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.247 1.419 . . . . 0.0 108.411 -166.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.51 -48.18 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.708 1.203 . . . . 0.0 109.455 171.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.97 115.07 45.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.602 1.161 . . . . 0.0 108.375 175.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.99 -43.81 6.1 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.809 1.673 . . . . 0.0 109.901 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.481 HD12 ' CB ' ' A' ' 69' ' ' PRO . 1.9 pt? -73.09 148.33 44.11 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.125 2.17 . . . . 0.0 110.597 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.72 -178.21 36.61 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.677 1.132 . . . . 0.0 110.613 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.5 t -117.95 139.57 44.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.353 1.861 . . . . 0.0 108.519 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 mm -134.04 127.36 51.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 124.502 1.121 . . . . 0.0 108.301 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.02 108.86 0.37 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 172.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 t -126.71 155.01 43.36 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.704 -0.88 . . . . 0.0 108.666 161.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -114.91 147.78 39.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.62 ' HA ' HD21 ' A' ' 25' ' ' ASN . 1.2 p -116.24 115.22 25.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -169.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -142.8 123.76 14.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.3 p -140.83 124.7 17.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -165.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -137.09 90.58 2.54 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -125.79 120.96 31.96 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 p -65.55 155.82 34.54 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.706 2.002 . . . . 0.0 110.457 -170.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 . . . . . 0 N--CA 1.448 -0.54 0 CA-C-O 122.242 1.02 . . . . 0.0 108.694 166.365 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -70.89 62.49 0.28 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.566 1.947 . . . . 0.0 111.551 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -86.28 167.43 14.83 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.643 1.577 . . . . 0.0 110.589 -171.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 m120 50.41 -163.1 0.05 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.076 1.35 . . . . 0.0 110.032 -165.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -147.15 169.02 20.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.69 1.196 . . . . 0.0 109.599 -164.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -78.42 158.58 28.67 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.224 1.01 . . . . 0.0 108.686 159.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -135.87 117.74 15.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 161.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.49 154.1 16.63 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 170.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 tt -142.16 112.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.1 p -128.58 126.85 41.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.38 155.67 43.3 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.12 165.45 38.77 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 171.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CB ' HD12 ' A' ' 37' ' ' LEU . 3.6 Cg_endo -66.98 168.58 16.88 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 CA-C-N 119.622 1.711 . . . . 0.0 109.572 156.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.01 154.9 19.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 159.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -93.02 154.81 17.91 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 152.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -140.42 96.71 3.08 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.89 -55.5 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 118.039 0.381 . . . . 0.0 110.294 -170.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -79.17 178.53 7.99 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.983 1.313 . . . . 0.0 108.67 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.91 47.48 1.26 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.29 1.036 . . . . 0.0 110.333 172.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 22.2 p-90 -156.16 -57.93 0.09 Allowed 'General case' 0 CA--C 1.529 0.152 0 O-C-N 120.975 -1.078 . . . . 0.0 110.15 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.43 154.02 44.23 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.999 0.92 . . . . 0.0 108.674 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -147.67 168.35 22.27 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.911 0.884 . . . . 0.0 110.609 -176.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -128.15 146.33 33.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -175.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -150.44 158.96 44.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.367 0.667 . . . . 0.0 109.773 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.3 129.87 7.32 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.45 151.89 6.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.17 159.79 13.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 123.843 0.857 . . . . 0.0 109.396 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 157.52 -136.39 4.84 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.55 151.06 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -166.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.89 158.38 22.25 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 161.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -149.45 160.34 43.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.122 1.769 . . . . 0.0 107.777 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.58 172.91 33.55 Favored Glycine 0 C--N 1.331 0.282 0 O-C-N 120.861 -1.149 . . . . 0.0 111.562 175.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? . . . . . 0 CA--C 1.52 -0.173 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 171.48 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.55 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -151.52 171.64 17.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.77 0.714 . . . . 0.0 110.918 166.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -102.94 94.87 5.79 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -83.89 130.95 10.06 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -74.13 150.58 40.4 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.084 0.942 . . . . 0.0 109.162 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.0 m -131.35 135.98 47.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -155.42 95.72 1.72 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -172.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.01 169.57 13.59 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 125.06 1.314 . . . . 0.0 111.293 -169.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.02 156.76 32.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.817 1.247 . . . . 0.0 108.747 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.487 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -159.4 150.34 20.71 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 173.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.487 HD22 ' C ' ' A' ' 112' ' ' GLY . 3.8 mm? -138.26 139.75 39.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 -169.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -136.66 139.55 42.1 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.954 0.797 . . . . 0.0 110.199 -169.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -118.94 171.19 8.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.334 1.454 . . . . 0.0 108.208 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -59.89 114.6 10.1 Favored Pre-proline 0 N--CA 1.456 -0.152 0 C-N-CA 125.546 1.539 . . . . 0.0 107.912 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -81.48 122.81 4.15 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.468 1.446 . . . . 0.0 109.323 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.1 ttm -170.53 149.68 3.3 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.143 2.177 . . . . 0.0 107.051 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 117.3 12.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 131.23 3.812 . . . . 0.0 109.409 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 62.03 28.81 17.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.098 1.759 . . . . 0.0 111.196 -160.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.09 145.99 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.696 1.198 . . . . 0.0 108.4 156.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.38 163.13 23.06 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 120.183 -1.573 . . . . 0.0 109.927 149.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -118.99 113.56 21.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 158.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -148.36 149.54 31.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -129.45 151.71 49.78 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.31 0.959 . . . . 0.0 109.997 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.9 m -136.31 145.92 46.03 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.903 0.881 . . . . 0.0 110.729 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -138.76 148.38 43.8 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.671 1.988 . . . . 0.0 107.473 162.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -137.25 147.94 46.09 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 165.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -132.0 129.15 39.75 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 169.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.6 m -140.36 154.34 46.71 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.536 1.134 . . . . 0.0 108.098 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -121.6 98.13 5.82 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 121.449 -0.782 . . . . 0.0 109.388 -171.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.1 mm -66.0 91.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 67.27 -79.67 0.04 OUTLIER 'General case' 0 C--O 1.232 0.146 0 C-N-CA 127.924 2.49 . . . . 0.0 109.144 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.2 p -134.4 -2.16 2.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.12 1.368 . . . . 0.0 111.92 -170.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.17 149.31 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.366 1.066 . . . . 0.0 108.222 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.62 156.52 25.09 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.6 t -142.61 143.45 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 163.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -140.86 128.18 3.67 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -126.08 142.72 51.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -169.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -134.26 119.18 18.41 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 -165.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.1 mp -128.67 136.64 59.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.18 157.95 18.08 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -127.37 65.27 0.57 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.7 m -124.76 -176.35 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.519 1.527 . . . . 0.0 110.652 -164.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.27 -84.14 0.17 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 117.001 1.56 . . . . 0.0 117.001 174.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.496 ' CD1' HG11 ' A' ' 5' ' ' VAL . 19.6 p90 -163.32 177.41 8.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.699 2.799 . . . . 0.0 107.976 177.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -132.61 140.53 48.27 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 119.33 -2.106 . . . . 0.0 110.092 161.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 128.509 2.723 . . . . 0.0 113.367 169.05 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 t -142.1 165.75 26.59 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 121.32 -0.863 . . . . 0.0 108.816 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 m -134.06 140.86 46.93 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.3 t -157.75 161.1 38.46 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 120.424 -1.422 . . . . 0.0 107.545 -171.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.75 119.77 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -160.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 p -135.49 155.36 50.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.469 1.128 . . . . 0.0 110.456 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.14 -159.2 30.9 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -164.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.03 -127.06 7.48 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -164.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -134.72 149.15 50.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.682 0.793 . . . . 0.0 109.061 -171.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.28 113.83 21.46 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 105.474 -2.046 . . . . 0.0 105.474 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -124.96 123.52 40.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -162.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.3 t -139.29 140.5 37.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.936 1.295 . . . . 0.0 107.75 -163.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -138.96 157.94 45.11 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.378 1.071 . . . . 0.0 110.746 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' A' ' 137' ' ' VAL . . . -94.17 165.05 12.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.406 1.082 . . . . 0.0 111.73 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -73.59 61.08 0.7 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.463 1.105 . . . . 0.0 110.318 168.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.65 104.02 0.28 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -53.74 96.32 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.326 2.251 . . . . 0.0 111.357 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 96.7 mtp -149.35 -56.4 0.19 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.906 2.082 . . . . 0.0 107.834 173.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.15 111.94 19.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.148 1.379 . . . . 0.0 109.231 -170.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.57 150.33 41.04 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 45.6 mtt -115.42 143.41 45.34 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.096 1.759 . . . . 0.0 107.01 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.26 168.05 40.62 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 126.601 2.048 . . . . 0.0 108.055 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.83 -85.03 0.1 OUTLIER Glycine 0 C--O 1.225 -0.41 0 N-CA-C 107.916 -2.073 . . . . 0.0 107.916 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.46 ' H ' ' HB3' ' A' ' 45' ' ' TYR . 7.0 m-85 -146.36 172.07 14.05 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.635 1.974 . . . . 0.0 108.633 173.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -125.35 152.76 44.32 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 160.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 tp -145.74 140.26 27.07 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.675 0.671 . . . . 0.0 109.358 161.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -138.98 163.21 32.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.167 1.387 . . . . 0.0 107.523 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -143.39 140.24 30.37 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -132.78 144.04 49.98 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -117.27 147.16 42.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 161.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.87 136.69 32.58 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 156.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -86.73 179.13 6.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.28 2.232 . . . . 0.0 111.232 -166.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.81 -22.67 14.32 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.442 -0.786 . . . . 0.0 112.071 165.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.62 5.25 33.54 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.106 1.362 . . . . 0.0 113.209 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -153.44 104.02 2.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.94 1.696 . . . . 0.0 106.81 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.05 78.29 3.22 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.993 2.462 . . . . 0.0 109.463 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 tp -149.78 131.71 15.2 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.084 0.954 . . . . 0.0 109.748 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.16 176.75 18.74 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 168.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 m -137.11 160.48 36.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 125.938 1.695 . . . . 0.0 108.988 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mm -140.17 109.74 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.387 1.475 . . . . 0.0 107.729 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.69 167.06 33.27 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 153.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p -125.5 151.54 46.16 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 118.685 1.242 . . . . 0.0 108.804 146.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.61 148.89 27.77 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.905 1.23 . . . . 0.0 109.206 156.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -94.11 148.97 21.66 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 162.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.46 ' HB3' ' H ' ' A' ' 24' ' ' PHE . 3.8 t80 -143.08 110.08 5.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.289 1.404 . . . . 0.0 108.161 176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.8 p -101.97 120.57 40.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 121.191 1.814 . . . . 0.0 111.224 -166.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -162.61 76.75 0.45 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.057 1.343 . . . . 0.0 108.289 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -162.42 114.15 1.61 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 164.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 155.57 39.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.845 1.202 . . . . 0.0 110.225 174.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 123.235 1.493 . . . . 0.0 107.961 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -67.26 105.11 1.64 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.645 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -143.85 114.67 7.73 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.598 1.09 . . . . 0.0 108.669 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 151.56 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.024 2.93 . . . . 0.0 106.482 -164.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.8 170.46 8.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.704 1.602 . . . . 0.0 107.69 -162.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -76.81 143.05 40.04 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.9 -1.125 . . . . 0.0 109.719 166.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -141.63 118.35 11.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.735 1.614 . . . . 0.0 107.018 161.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.89 158.09 28.8 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.454 -1.859 . . . . 0.0 108.454 162.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.39 143.77 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 169.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 84' ' ' GLY . 89.5 m -139.67 148.05 41.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 161.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.96 150.03 28.82 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.386 0.674 . . . . 0.0 110.897 -164.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.02 163.52 12.85 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.94 1.733 . . . . 0.0 110.861 166.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.68 172.46 15.73 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.736 2.291 . . . . 0.0 110.526 168.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.62 153.89 47.44 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.484 1.114 . . . . 0.0 109.81 163.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -151.17 151.54 32.06 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -164.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -82.07 149.91 27.8 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.127 0.571 . . . . 0.0 109.634 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 73' ' ' ILE . 3.2 mp -78.55 -103.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 162.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.02 0.73 1.4 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.218 1.372 . . . . 0.0 112.881 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -113.77 -118.99 0.31 Allowed 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -129.87 -9.31 4.43 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -165.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.53 159.7 30.12 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 121.606 2.003 . . . . 0.0 109.578 164.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.6 m -135.86 125.06 24.56 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -136.84 147.09 27.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.49 174.74 12.17 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.385 1.474 . . . . 0.0 109.413 171.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.16 138.8 14.12 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 168.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.9 m -131.4 159.42 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.214 1.007 . . . . 0.0 110.222 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.28 135.42 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 C-N-CA 125.136 1.374 . . . . 0.0 109.495 -168.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 66' ' ' THR . . . -128.3 168.05 20.31 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 123.922 0.763 . . . . 0.0 113.137 -169.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.88 150.79 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 127.386 2.274 . . . . 0.0 106.894 170.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.49 158.69 22.23 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 161.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.4 116.86 21.12 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.612 0.765 . . . . 0.0 109.978 173.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.06 112.52 3.6 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 167.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt . . . . . 0 N--CA 1.47 0.532 0 CA-C-N 118.749 1.275 . . . . 0.0 112.093 175.678 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.4 p . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.83 0.824 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -155.83 166.67 32.79 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.489 1.116 . . . . 0.0 108.885 -171.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -78.87 131.35 36.41 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.546 0.738 . . . . 0.0 110.152 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.05 82.52 0.4 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -73.14 151.17 41.67 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 118.585 1.192 . . . . 0.0 108.323 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.9 p -146.44 162.64 37.83 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.962 0.905 . . . . 0.0 110.827 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -141.27 155.11 46.03 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.68 -146.84 7.05 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.47 158.93 43.32 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.853 0.861 . . . . 0.0 110.317 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -136.35 133.68 6.72 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.64 143.47 14.63 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.992 0.396 . . . . 0.0 110.019 -170.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -142.91 145.15 32.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.944 0.878 . . . . 0.0 111.572 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -139.73 111.63 7.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 166.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 117.3 61.2 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.64 -33.78 2.19 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.336 1.358 . . . . 0.0 110.868 172.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.5 mtt -157.89 159.27 36.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.975 0.91 . . . . 0.0 111.124 -165.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -91.65 42.61 1.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 126.09 1.756 . . . . 0.0 109.658 -174.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.538 ' HA ' ' CD2' ' A' ' 146' ' ' TYR . 0.7 OUTLIER -160.7 -14.21 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.623 1.969 . . . . 0.0 111.269 -174.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 120' ' ' ASN . 20.3 m -144.93 117.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 165.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.81 163.85 18.52 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 160.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.6 114.74 10.85 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 161.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.35 149.66 47.91 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 127.887 2.475 . . . . 0.0 107.06 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -129.66 151.44 50.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.2 m -145.52 166.32 26.04 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 145.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -143.41 145.75 32.89 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 160.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -138.13 159.86 40.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 119.734 1.152 . . . . 0.0 110.056 160.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -122.83 114.9 21.13 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.758 1.223 . . . . 0.0 109.596 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.5 p -100.88 130.57 46.91 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.779 2.032 . . . . 0.0 112.538 -171.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.81 111.89 24.31 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.44 81.55 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 171.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 53.8 -102.32 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.956 1.702 . . . . 0.0 108.508 -164.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m -105.29 3.52 30.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.27 1.028 . . . . 0.0 112.221 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.2 t -82.66 110.96 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 173.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -92.89 126.85 38.17 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 14' ' ' ALA . 4.5 t -133.78 146.75 31.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 171.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.69 150.53 18.7 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 169.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -122.87 146.5 47.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -135.84 123.67 22.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 167.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.8 pt -116.93 139.79 42.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -168.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.22 134.94 33.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -120.27 74.55 0.32 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.43 168.03 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.708 1.203 . . . . 0.0 108.747 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.56 -105.07 0.25 Allowed Glycine 0 C--O 1.227 -0.344 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.538 ' CD2' ' HA ' ' A' ' 120' ' ' ASN . 0.3 OUTLIER -161.39 167.62 25.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.063 2.545 . . . . 0.0 107.624 -170.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -138.78 158.29 44.49 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.362 -1.461 . . . . 0.0 108.853 166.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 126.408 1.883 . . . . 0.0 109.766 -175.337 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.431 HG23 HH21 ' A' ' 147' ' ' ARG . 52.6 m -145.89 157.8 43.89 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 168.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 m -127.16 140.13 52.47 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 167.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 m -148.22 129.72 14.89 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 120.244 -1.535 . . . . 0.0 107.35 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.583 HG23 ' H ' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -108.93 138.41 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.165 1.386 . . . . 0.0 108.505 173.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 p -157.2 117.72 3.55 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.8 2.04 . . . . 0.0 105.581 -169.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -173.18 165.64 37.88 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.39 -127.14 1.39 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -147.7 158.39 43.99 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.335 1.068 . . . . 0.0 110.698 -169.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.15 154.66 48.12 Favored 'General case' 0 C--N 1.335 -0.051 0 C-N-CA 125.129 1.372 . . . . 0.0 110.133 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -113.0 104.84 12.8 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 162.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -85.05 124.54 31.86 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 166.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.97 163.72 12.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.533 1.533 . . . . 0.0 107.412 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.57 161.96 37.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -55.6 81.37 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.911 1.684 . . . . 0.0 113.089 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.67 -15.23 5.21 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.593 1.568 . . . . 0.0 112.458 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -132.95 93.66 3.23 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.68 1.229 . . . . 0.0 108.48 172.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -90.27 60.02 4.6 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 129.437 3.095 . . . . 0.0 109.585 173.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -137.03 -178.47 5.21 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.887 1.275 . . . . 0.0 110.662 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -89.22 84.32 6.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.526 1.93 . . . . 0.0 107.116 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.5 ttm -92.52 147.83 22.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 153.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.9 -160.83 30.31 Favored Glycine 0 C--O 1.228 -0.252 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.21 -155.44 7.57 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 105.646 -2.982 . . . . 0.0 105.646 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.73 145.28 25.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.442 ' ND2' HD13 ' A' ' 141' ' ' ILE . 1.2 t30 -95.01 135.87 36.02 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 103.671 -2.714 . . . . 0.0 103.671 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.2 tp -145.97 116.71 7.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.16 140.96 48.76 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -137.56 121.41 17.6 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.96 143.08 45.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -118.53 158.14 25.95 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.462 1.905 . . . . 0.0 108.263 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -125.56 143.04 51.19 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.531 -1.356 . . . . 0.0 107.787 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -114.65 159.3 20.65 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.051 0.94 . . . . 0.0 108.78 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -95.19 15.26 19.63 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.123 -0.986 . . . . 0.0 111.701 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.41 0.73 2.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.698 1.199 . . . . 0.0 113.865 -172.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.4 125.3 3.02 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.124 168.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -72.46 79.91 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.547 3.498 . . . . 0.0 109.027 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.1 tp -150.42 155.81 40.27 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.589 1.556 . . . . 0.0 107.39 -160.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.24 -175.84 14.03 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 161.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.15 162.41 39.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 127.749 2.42 . . . . 0.0 106.218 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.8 mm -114.82 120.29 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.33 108.8 1.05 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 105.308 -3.117 . . . . 0.0 105.308 155.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -122.36 153.36 39.11 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 158.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -144.16 122.86 12.57 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.409 1.883 . . . . 0.0 107.098 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.9 m -127.59 125.18 39.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 172.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -91.49 158.41 16.49 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.653 1.981 . . . . 0.0 106.928 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -105.22 130.93 53.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -144.6 141.23 29.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.133 2.173 . . . . 0.0 107.152 166.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -175.54 147.92 0.88 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.601 2.36 . . . . 0.0 105.791 163.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -66.54 105.2 1.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 166.21 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -84.02 124.33 30.96 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.298 -0.876 . . . . 0.0 110.335 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -132.51 168.71 17.73 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.024 0.529 . . . . 0.0 109.776 166.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 m120 49.79 172.14 0.01 OUTLIER 'General case' 0 C--O 1.239 0.532 0 C-N-CA 128.49 2.716 . . . . 0.0 111.75 -155.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -123.5 147.58 47.08 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 120.968 -1.083 . . . . 0.0 110.284 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -76.11 128.37 34.84 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -109.81 117.83 34.88 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.7 89.41 0.29 Allowed Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -161.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.2 pp -109.47 141.55 24.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.762 0.791 . . . . 0.0 110.455 -166.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -111.38 148.45 33.01 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 170.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.95 159.02 43.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.359 0.6 . . . . 0.0 109.55 163.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.13 164.99 10.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.045 1.307 . . . . 0.0 110.626 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.88 144.47 53.51 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.962 2.442 . . . . 0.0 111.553 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.03 122.59 33.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 160.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -79.44 126.99 31.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 167.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -69.78 128.77 37.56 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 74' ' ' ASN . 6.7 tt -76.42 -178.85 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.709 0.766 . . . . 0.0 109.954 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.417 ' H ' HG12 ' A' ' 73' ' ' ILE . 7.9 t30 -60.9 -0.04 0.26 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.279 2.232 . . . . 0.0 115.963 -170.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -136.21 -87.52 0.33 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 120.2 1.364 . . . . 0.0 110.056 168.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.78 70.21 0.63 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.091 1.314 . . . . 0.0 109.958 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.16 -169.04 3.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.477 1.911 . . . . 0.0 107.296 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 t -122.43 170.16 10.25 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.903 1.681 . . . . 0.0 110.496 -162.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.83 167.99 25.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 121.528 -0.733 . . . . 0.0 111.696 -176.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -104.27 123.98 48.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.903 2.081 . . . . 0.0 109.134 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.17 73.62 0.02 OUTLIER Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.71 171.89 13.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 117.863 0.831 . . . . 0.0 109.66 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.14 130.42 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.37 148.16 18.92 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 170.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.9 132.3 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 165.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.76 152.89 18.72 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 162.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.58 165.2 29.35 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.597 0.759 . . . . 0.0 109.094 163.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.26 -167.95 43.93 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 113.634 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 122.837 1.303 . . . . 0.0 108.01 -163.405 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.29 176.69 9.54 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.971 1.308 . . . . 0.0 108.999 159.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -115.9 166.91 11.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 150.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.17 122.39 1.45 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -73.91 152.32 40.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.635 1.174 . . . . 0.0 109.754 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.5 t -134.44 143.65 47.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.891 0.876 . . . . 0.0 110.293 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -80.48 99.48 8.04 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.82 125.51 7.11 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.65 145.29 32.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.085 1.754 . . . . 0.0 107.439 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.32 148.63 8.58 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.521 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -139.43 142.63 37.43 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.555 2.342 . . . . 0.0 107.878 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -105.69 160.92 14.84 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.222 1.809 . . . . 0.0 109.82 169.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -91.65 171.69 8.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -57.1 111.43 3.36 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.491 1.116 . . . . 0.0 108.472 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -85.17 162.95 11.47 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.422 2.081 . . . . 0.0 111.971 -168.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 68.3 mtm -154.28 171.47 19.19 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 128.804 2.842 . . . . 0.0 108.649 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -44.12 -55.19 4.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 131.396 3.878 . . . . 0.0 109.77 -164.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.414 ' HB2' ' CD1' ' A' ' 146' ' ' TYR 0.3 0.2 OUTLIER -132.28 37.53 3.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.198 0.523 . . . . 0.0 110.224 171.739 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.46 110.22 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.81 157.53 40.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 161.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.674 HD13 HG12 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -133.7 132.25 40.41 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 102.752 -3.055 . . . . 0.0 102.752 176.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -140.32 128.97 22.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.54 1.064 . . . . 0.0 109.824 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -136.41 145.99 45.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.376 1.07 . . . . 0.0 108.135 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.75 166.74 25.0 Favored 'General case' 0 C--O 1.239 0.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.127 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.42 ' HB3' ' CE3' ' A' ' 140' ' ' TRP . 42.5 p90 -142.66 118.39 10.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 169.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.87 108.43 9.4 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -99.5 132.97 44.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.5 p -129.85 159.41 36.65 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.591 1.157 . . . . 0.0 109.951 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 47.8 mtt-85 -122.2 98.0 5.73 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.485 0.659 . . . . 0.0 109.466 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 10.9 mm -82.41 81.12 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.384 1.073 . . . . 0.0 108.165 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 64.14 -55.87 0.24 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.692 2.797 . . . . 0.0 114.08 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.3 t -149.85 -0.94 0.44 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.587 1.555 . . . . 0.0 110.546 169.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.18 135.66 24.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.9 137.17 32.57 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.0 t -139.33 108.0 3.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.039 1.336 . . . . 0.0 108.674 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.08 151.76 35.58 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 167.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 t -140.38 153.31 46.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 146.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.42 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 7.4 m95 -137.86 110.79 7.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 172.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.442 HD13 ' ND2' ' A' ' 25' ' ' ASN . 1.9 pp -81.72 154.57 4.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.0 166.41 22.47 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 163.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -176.57 167.46 38.96 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.674 HG12 HD13 ' A' ' 123' ' ' LEU . 1.5 m -144.35 148.7 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -163.16 -145.72 4.46 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.583 ' H ' HG23 ' A' ' 5' ' ' VAL . 8.1 m-85 -136.23 158.73 43.72 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.901 2.081 . . . . 0.0 108.395 -163.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.431 HH21 HG23 ' A' ' 2' ' ' THR . 0.8 OUTLIER -145.68 112.1 5.81 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.713 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 124.576 1.151 . . . . 0.0 108.367 178.362 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 t -151.05 158.14 43.71 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.384 1.074 . . . . 0.0 108.601 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.05 114.93 17.71 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 124.045 1.879 . . . . 0.0 109.038 168.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.9 m -89.06 103.54 16.15 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -92.31 100.13 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 p -126.26 160.95 28.9 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.51 0.671 . . . . 0.0 111.15 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.95 178.41 48.16 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.51 -151.57 23.31 Favored Glycine 0 C--O 1.24 0.529 0 CA-C-N 118.741 1.27 . . . . 0.0 111.698 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.86 157.83 20.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.959 0.903 . . . . 0.0 109.151 -177.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.08 154.33 47.02 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.096 1.359 . . . . 0.0 108.355 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.497 ' NE2' ' HE1' ' A' ' 140' ' ' TRP . 2.3 mp0 -124.98 104.19 8.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 167.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.2 t -84.87 115.02 22.53 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 159.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.83 155.11 49.56 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.576 1.15 . . . . 0.0 108.482 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -143.12 163.93 31.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.981 0.912 . . . . 0.0 110.058 -173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 60.17 9.51 1.91 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.924 1.689 . . . . 0.0 114.023 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.72 94.72 0.35 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 -174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.417 ' CD ' ' H ' ' A' ' 17' ' ' GLN . 3.7 pm0 -45.38 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.29 2.236 . . . . 0.0 111.588 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -148.82 -2.44 0.47 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -118.48 113.01 20.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 122.884 1.326 . . . . 0.0 114.316 -162.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.424 ' HA ' ' HG3' ' A' ' 11' ' ' GLN . 45.5 mtpt -66.68 96.12 0.38 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 161.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 59.5 mtt -133.14 103.95 6.26 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 167.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.46 -170.95 23.73 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 128.335 2.874 . . . . 0.0 106.545 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.15 -84.25 0.05 OUTLIER Glycine 0 C--N 1.328 0.108 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 -169.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.82 174.17 10.78 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.348 1.459 . . . . 0.0 108.17 163.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -138.59 152.32 48.05 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.824 1.249 . . . . 0.0 107.746 167.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.68 131.06 19.72 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.664 1.986 . . . . 0.0 106.035 166.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -122.54 133.8 54.56 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -156.45 108.62 2.53 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -171.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -142.04 163.06 33.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.973 0.892 . . . . 0.0 111.127 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -99.66 157.47 16.45 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.164 1.385 . . . . 0.0 108.369 -170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.24 147.95 50.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -172.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -75.89 166.34 23.65 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.617 1.567 . . . . 0.0 111.67 -159.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -112.66 40.95 2.14 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.551 1.167 . . . . 0.0 108.565 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -167.59 -75.42 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.32 162.42 66.5 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.016 0.926 . . . . 0.0 109.601 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -78.91 62.6 8.48 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.669 2.913 . . . . 0.0 108.99 165.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.8 tp -112.01 123.79 51.0 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.182 1.393 . . . . 0.0 107.539 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.39 176.88 16.26 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 56.2 t -126.03 155.88 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 tt -132.94 121.03 43.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.35 108.85 2.08 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 m -80.49 142.11 34.54 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.163 0.982 . . . . 0.0 109.19 161.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -143.29 125.76 15.76 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 167.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.6 t -118.17 150.92 38.59 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 118.995 0.816 . . . . 0.0 109.5 175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -142.99 123.72 14.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.0 p -114.17 121.56 44.13 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.59 29.41 0.93 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.899 0.772 . . . . 0.0 110.275 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -103.85 147.1 27.7 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.701 2.001 . . . . 0.0 108.528 177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.7 m -122.6 154.95 37.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.811 1.645 . . . . 0.0 108.19 168.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.567 HH11 ' HB3' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -130.46 96.96 4.26 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.14 0.427 . . . . 0.0 110.618 -171.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 t -84.1 174.24 10.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 165.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -171.44 -86.37 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 128.937 2.895 . . . . 0.0 103.981 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -170.14 78.85 0.09 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 129.013 2.925 . . . . 0.0 104.192 167.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.6 m -162.99 -43.24 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.119 1.768 . . . . 0.0 109.913 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.46 38.06 1.52 Allowed Glycine 0 CA--C 1.535 1.294 0 N-CA-C 114.488 0.555 . . . . 0.0 114.488 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.6 91.73 3.43 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 120.948 -1.325 . . . . 0.0 107.551 171.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -110.89 76.38 0.97 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 122.479 1.133 . . . . 0.0 110.459 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -51.94 93.11 0.01 OUTLIER 'General case' 0 C--O 1.237 0.433 0 C-N-CA 128.221 2.609 . . . . 0.0 113.655 -167.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.02 168.35 16.02 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.522 -0.736 . . . . 0.0 109.632 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t30 61.58 176.9 0.12 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.774 1.23 . . . . 0.0 110.591 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -129.23 154.31 46.92 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 166.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.36 159.12 24.45 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -141.16 135.35 30.74 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.11 116.65 0.86 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -167.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 pp -118.28 110.1 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.3 m -128.34 144.04 51.08 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.757 1.623 . . . . 0.0 107.848 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.96 167.61 24.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.285 1.034 . . . . 0.0 110.754 -172.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.42 174.0 34.57 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 128.137 2.78 . . . . 0.0 110.795 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 20.3 Cg_endo -85.75 -179.75 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.961 3.774 . . . . 0.0 110.8 171.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.97 135.1 35.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.856 1.662 . . . . 0.0 107.367 164.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -150.14 154.87 38.78 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.065 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -87.97 148.45 24.55 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.061 1.3 . . . . 0.0 111.145 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 73' ' ' ILE . 4.2 mp -69.91 -57.02 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -132.43 -75.9 0.5 Allowed 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -165.55 74.98 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -130.89 -60.28 0.97 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.318 1.447 . . . . 0.0 109.175 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.84 164.6 32.34 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.653 1.181 . . . . 0.0 109.304 -174.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 p -125.44 109.46 12.75 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.054 1.341 . . . . 0.0 107.637 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.26 151.7 28.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -150.11 165.73 31.92 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.117 0.872 . . . . 0.0 110.86 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.37 139.18 21.44 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.58 152.21 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.43 1.115 . . . . 0.0 109.149 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.66 150.81 15.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 123.885 0.874 . . . . 0.0 109.193 -167.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.52 -165.7 27.31 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 123.306 0.479 . . . . 0.0 112.614 -168.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.53 150.33 18.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.73 1.212 . . . . 0.0 107.747 171.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.57 130.85 7.63 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.835 1.683 . . . . 0.0 109.159 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -127.57 117.51 22.18 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.246 1.418 . . . . 0.0 110.022 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.57 142.61 11.42 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 170.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.47 68.95 1.48 Allowed 'General case' 0 C--O 1.23 0.078 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -70.16 -179.71 2.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.071 1.348 . . . . 0.0 111.011 -172.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -163.27 143.39 8.92 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.644 1.178 . . . . 0.0 109.15 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.5 p -69.49 117.15 10.74 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.981 1.712 . . . . 0.0 106.701 171.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 20.9 m -118.13 49.7 1.23 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.424 1.09 . . . . 0.0 109.623 -168.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -148.59 -70.16 0.21 Allowed 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.907 1.683 . . . . 0.0 107.969 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -61.76 150.12 83.02 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 124.046 0.938 . . . . 0.0 110.305 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.99 77.84 1.88 Allowed 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.898 3.065 . . . . 0.0 110.197 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.3 m -156.24 -28.27 0.1 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.932 2.093 . . . . 0.0 109.075 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 50.57 -150.77 0.23 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.647 1.579 . . . . 0.0 110.528 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -54.72 120.91 7.44 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 120.929 -1.107 . . . . 0.0 108.543 170.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -80.18 -91.8 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 39.8 p-10 -141.73 24.06 2.06 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.09 1.756 . . . . 0.0 110.843 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.6 p -70.09 155.3 40.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.055 0.942 . . . . 0.0 112.134 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.7 t 132.67 104.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 1 C-N-CA 131.997 4.119 . . . . 0.0 107.192 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -159.71 174.79 14.01 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 165.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -124.02 159.8 29.05 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.906 1.683 . . . . 0.0 107.737 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.11 137.49 9.41 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -75.78 102.21 5.37 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -67.39 135.03 52.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -148.12 171.47 15.83 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 121.929 -0.482 . . . . 0.0 110.047 168.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.18 -149.63 20.89 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.09 148.16 48.66 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.335 1.054 . . . . 0.0 109.602 174.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.23 124.11 7.68 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.03 139.42 49.88 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 -170.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -138.48 129.9 27.48 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -92.83 171.59 8.88 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.149 0.5 . . . . 0.0 110.112 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -66.2 117.0 38.9 Favored Pre-proline 0 C--O 1.241 0.608 0 C-N-CA 123.95 0.9 . . . . 0.0 108.579 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.97 176.54 9.34 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.234 2.623 . . . . 0.0 112.0 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.14 -176.38 4.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 127.458 2.303 . . . . 0.0 107.49 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -91.14 -7.95 50.07 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.008 2.123 . . . . 0.0 110.121 -174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.72 12.18 0.25 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.99 1.716 . . . . 0.0 110.511 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.4 t -136.91 137.84 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 120.03 -1.669 . . . . 0.0 108.844 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -136.18 155.21 50.48 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -139.29 115.07 10.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.84 141.69 48.58 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 126.425 1.89 . . . . 0.0 106.646 -172.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -135.2 142.69 46.1 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 p -127.16 149.2 50.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 158.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.15 119.64 14.91 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 169.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -127.72 138.18 52.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -129.83 139.39 51.23 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.5 m -130.72 159.98 35.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.806 2.043 . . . . 0.0 107.186 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -132.33 145.62 51.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 171.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.19 95.95 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 75.27 -74.88 0.08 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.742 2.417 . . . . 0.0 111.512 165.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.7 m -148.75 27.05 0.9 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.432 1.493 . . . . 0.0 109.646 174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.75 120.53 61.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 166.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.38 152.58 34.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.6 t -124.67 137.43 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 164.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.22 140.96 14.41 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 168.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.1 m -140.67 120.34 13.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.497 ' HE1' ' NE2' ' A' ' 11' ' ' GLN . 3.2 p-90 -105.03 153.16 21.83 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 166.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.7 mt -136.68 131.56 47.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.97 129.86 35.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -113.37 96.54 0.81 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.8 t -116.54 152.09 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 157.28 -143.01 9.1 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 106.429 -2.668 . . . . 0.0 106.429 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -121.76 176.87 5.51 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.604 1.962 . . . . 0.0 110.068 -166.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 129.95 13.44 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.283 171.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.5 p90 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 124.469 1.108 . . . . 0.0 108.37 175.231 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 m -92.4 151.09 20.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -143.46 107.09 4.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 162.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 t -138.83 150.91 46.56 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.089 0.947 . . . . 0.0 108.894 167.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.53 137.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 111.521 -2.581 . . . . 0.0 106.468 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.7 m -152.78 144.01 23.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.79 -178.55 44.75 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.74 -172.37 25.03 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -106.99 158.37 17.09 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.12 170.03 9.55 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.798 0.332 . . . . 0.0 110.722 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -140.99 113.04 7.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 156.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.5 t -84.75 151.3 24.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.062 0.934 . . . . 0.0 108.967 164.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -136.76 170.82 15.45 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.776 2.43 . . . . 0.0 107.863 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.19 159.5 42.1 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 161.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -75.63 64.77 1.73 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.707 1.203 . . . . 0.0 109.536 174.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 160.01 -37.95 0.46 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 126.855 2.169 . . . . 0.0 110.686 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -129.72 96.51 4.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.074 0.937 . . . . 0.0 109.758 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.5 mtt -78.3 58.15 2.04 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.637 0.732 . . . . 0.0 109.338 166.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.99 93.86 1.8 Allowed 'General case' 0 C--O 1.232 0.183 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 164.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 20' ' ' LYS . 0.5 OUTLIER -58.74 106.12 0.37 Allowed 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 81.9 mtp -136.06 109.69 8.03 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -169.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.07 -178.5 37.65 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.19 -128.67 0.96 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 104.86 -3.296 . . . . 0.0 104.86 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.89 150.25 37.36 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -122.04 162.77 20.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.62 1.968 . . . . 0.0 107.529 173.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -147.6 167.84 23.52 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -138.11 159.99 40.56 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.245 1.018 . . . . 0.0 108.894 170.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -136.19 141.57 44.04 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.517 2.327 . . . . 0.0 106.377 164.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -120.71 160.33 23.55 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 160.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -131.96 156.45 46.16 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.394 1.478 . . . . 0.0 107.328 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -98.25 140.16 32.96 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.667 0.746 . . . . 0.0 109.258 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.05 156.96 23.17 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 127.008 2.123 . . . . 0.0 107.19 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -133.26 71.66 1.47 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 -176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -164.96 -37.97 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.823 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -162.41 153.95 15.36 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 124.36 1.064 . . . . 0.0 109.207 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.56 88.42 1.42 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.376 2.717 . . . . 0.0 109.21 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 37' ' ' LEU . 17.9 tp -143.74 156.94 44.68 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 128.314 2.645 . . . . 0.0 105.791 172.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.89 175.89 21.55 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 91.1 t -124.61 157.21 32.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 118.189 0.994 . . . . 0.0 111.198 -168.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.75 141.53 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 126.779 2.032 . . . . 0.0 106.86 161.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.81 108.95 0.39 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.1 p -124.87 154.22 41.38 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.276 1.03 . . . . 0.0 110.613 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -131.66 122.45 25.98 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -170.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.8 p -95.47 146.8 24.15 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -171.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.98 154.95 50.92 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.623 1.169 . . . . 0.0 109.411 -178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.1 m -132.43 130.51 40.67 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.863 1.211 . . . . 0.0 112.564 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -110.95 -14.18 13.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.639 1.176 . . . . 0.0 112.856 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -66.42 145.73 55.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.813 0.845 . . . . 0.0 110.585 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 p -74.92 144.36 43.32 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.922 0.783 . . . . 0.0 109.405 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -80.24 141.38 35.63 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 105.402 -2.074 . . . . 0.0 105.402 158.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.5 t -148.32 118.15 7.12 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 161.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.26 -87.31 0.19 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.5 t -160.55 79.46 0.65 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 171.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m 57.41 84.85 0.09 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.643 1.177 . . . . 0.0 110.538 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.05 -40.32 0.05 OUTLIER Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.602 159.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -120.13 96.01 4.98 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.603 1.561 . . . . 0.0 107.5 -175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -131.58 81.1 1.96 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.441 -0.787 . . . . 0.0 109.513 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.49 -60.19 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.922 0.889 . . . . 0.0 110.216 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -102.46 133.07 48.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 122.0 -0.437 . . . . 0.0 110.543 -159.109 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -146.46 19.25 1.35 Allowed 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -166.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -110.21 128.15 55.34 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 120.986 1.721 . . . . 0.0 107.855 -158.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -152.5 119.98 5.99 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -169.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.02 116.86 29.13 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.06 131.53 10.82 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 158.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.3 mt -119.68 109.54 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 103.325 -2.843 . . . . 0.0 103.325 167.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 8.9 t -120.01 147.59 44.61 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.554 2.342 . . . . 0.0 108.166 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.28 172.76 15.36 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.492 1.517 . . . . 0.0 109.188 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.44 175.59 43.92 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 161.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -74.33 175.75 10.57 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.471 2.114 . . . . 0.0 110.235 160.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.39 109.21 8.08 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.619 1.967 . . . . 0.0 108.085 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.37 130.25 35.25 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -176.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -111.38 118.45 35.87 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 170.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.06 -65.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -167.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -135.72 -79.31 0.42 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 161.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -158.69 80.52 0.8 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.049 1.295 . . . . 0.0 110.996 167.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -129.55 -40.51 1.41 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.28 1.432 . . . . 0.0 109.783 164.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.37 174.0 13.86 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.472 1.109 . . . . 0.0 109.733 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 t -148.87 105.26 3.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.11 156.5 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.795 0.838 . . . . 0.0 110.794 -172.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -151.18 173.34 14.52 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.024 1.329 . . . . 0.0 111.624 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.71 114.93 4.94 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.969 1.747 . . . . 0.0 108.759 170.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -110.36 161.08 9.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.224 1.409 . . . . 0.0 110.917 -164.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 66' ' ' THR . 0.5 OUTLIER -140.39 165.36 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 C-N-CA 124.249 1.02 . . . . 0.0 110.578 -169.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.11 -164.71 30.23 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 p -148.55 137.88 15.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 169.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -112.97 108.92 2.24 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 127.575 2.512 . . . . 0.0 109.623 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.58 140.29 31.42 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.417 1.087 . . . . 0.0 108.594 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.3 160.36 27.84 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 118.446 0.566 . . . . 0.0 112.424 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -131.3 160.25 35.5 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.146 2.178 . . . . 0.0 106.502 173.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -127.94 170.01 13.32 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 159.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -148.52 144.45 27.33 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 173.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.4 m -120.28 132.57 55.38 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -164.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 t -132.56 32.33 3.9 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 125.39 1.476 . . . . 0.0 109.438 -161.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -150.6 -47.52 0.12 Allowed 'General case' 0 N--CA 1.462 0.165 0 O-C-N 120.939 -1.101 . . . . 0.0 110.111 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -68.38 153.2 95.95 Favored Pre-proline 0 CA--C 1.541 0.607 0 O-C-N 121.898 -0.501 . . . . 0.0 110.501 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.09 -7.26 19.34 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.338 2.692 . . . . 0.0 113.129 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -67.53 5.48 0.79 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.985 1.714 . . . . 0.0 113.084 172.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -24.59 -39.31 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 130.568 3.547 . . . . 0.0 116.755 -176.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.96 65.54 9.28 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.793 -1.192 . . . . 0.0 108.528 169.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -116.02 109.11 17.08 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -114.84 142.76 46.13 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.596 -0.69 . . . . 0.0 110.705 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 81.4 p -138.42 158.08 44.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.769 1.628 . . . . 0.0 107.116 172.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.9 m -145.56 106.18 4.1 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -129.14 129.01 44.61 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -92.65 160.03 15.19 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 166.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.98 131.47 5.12 Favored Glycine 0 C--N 1.33 0.248 0 N-CA-C 107.959 -2.057 . . . . 0.0 107.959 170.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.49 126.38 30.9 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.0 m -92.58 131.25 37.85 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -146.22 133.02 20.03 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 173.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.05 -172.09 34.67 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.153 1.359 . . . . 0.0 111.144 -160.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.31 158.29 44.74 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.864 0.866 . . . . 0.0 110.555 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -134.21 104.75 0.53 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.074 1.321 . . . . 0.0 111.345 -168.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.4 148.3 37.9 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.62 1.568 . . . . 0.0 107.243 -168.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.38 159.4 34.56 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.436 1.095 . . . . 0.0 108.816 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -133.91 159.19 41.44 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 126.461 1.904 . . . . 0.0 107.023 -171.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -56.38 114.75 8.31 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 123.779 0.832 . . . . 0.0 110.351 -158.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -83.43 171.61 11.0 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.281 3.321 . . . . 0.0 113.514 -168.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.9 mtm -145.85 177.68 8.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.175 2.19 . . . . 0.0 108.916 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -93.01 18.22 9.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.556 1.942 . . . . 0.0 112.995 -166.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.414 HD22 ' N ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -174.68 -7.92 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.035 2.134 . . . . 0.0 111.643 -168.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.408 ' H ' ' H ' ' A' ' 120' ' ' ASN . 4.9 t -143.41 140.9 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 128.646 2.778 . . . . 0.0 103.551 -170.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.62 159.62 42.17 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -137.63 117.15 12.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.73 150.7 40.57 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 168.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -140.93 123.45 15.97 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.1 m -122.49 136.16 54.82 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 170.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -126.23 122.23 34.98 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.412 1.885 . . . . 0.0 106.98 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -128.83 157.05 42.6 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.662 1.185 . . . . 0.0 110.212 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -132.26 152.97 51.1 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.287 1.035 . . . . 0.0 108.479 172.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.3 t -141.17 160.51 39.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 127.402 2.281 . . . . 0.0 107.349 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -128.87 107.09 9.36 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.6 pt -137.04 151.78 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.809 1.244 . . . . 0.0 108.152 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.45 18.89 6.0 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.784 1.634 . . . . 0.0 112.292 -175.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.9 m 53.48 34.54 18.53 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.887 1.221 . . . . 0.0 112.03 -164.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.9 m -120.39 149.31 23.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 122.019 0.914 . . . . 0.0 108.842 161.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.8 140.13 53.29 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 168.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -136.26 98.64 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.32 151.34 32.86 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -141.65 154.2 45.21 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 146.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -139.21 155.23 47.95 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 168.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.4 pt -121.3 140.24 45.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -173.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.04 135.07 33.58 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -113.44 121.77 5.59 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 106.509 -2.636 . . . . 0.0 106.509 170.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.81 148.16 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 129.387 3.075 . . . . 0.0 103.988 169.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 164.72 -125.46 1.37 Allowed Glycine 0 C--O 1.227 -0.322 0 CA-C-O 118.014 -1.437 . . . . 0.0 109.904 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.84 143.04 22.44 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 127.287 2.235 . . . . 0.0 106.625 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -136.68 96.29 3.3 Favored 'General case' 0 CA--C 1.518 -0.279 0 O-C-N 120.863 -1.148 . . . . 0.0 108.298 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 115.13 -2.367 . . . . 0.0 112.379 159.757 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.9 m -137.29 152.93 50.31 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 171.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -142.07 133.89 27.14 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 122.311 1.053 . . . . 0.0 108.66 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -152.44 145.46 24.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.69 132.09 64.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.8 p -137.82 130.41 29.62 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.75 159.13 23.13 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.84 -152.39 19.28 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 107.346 -2.302 . . . . 0.0 107.346 -164.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -99.85 153.27 19.28 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.357 0.579 . . . . 0.0 110.353 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.93 142.01 50.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 170.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.9 149.58 50.31 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.795 1.238 . . . . 0.0 108.514 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.7 m -137.27 121.53 18.05 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.396 1.079 . . . . 0.0 109.802 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -103.61 162.16 13.29 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 173.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.58 146.02 51.42 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 118.295 0.498 . . . . 0.0 110.854 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 61.6 -60.09 0.1 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 130.253 3.421 . . . . 0.0 112.018 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.83 -66.16 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 105.892 -2.883 . . . . 0.0 105.892 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.86 96.81 4.75 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.027 1.331 . . . . 0.0 109.231 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.5 ttt -152.91 -69.02 0.15 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.299 0.639 . . . . 0.0 109.553 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -157.83 146.6 19.34 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.971 0.908 . . . . 0.0 110.243 -172.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -120.33 154.54 34.88 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 124.99 1.316 . . . . 0.0 108.912 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.4 ptp -131.24 159.17 38.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.09 175.45 23.19 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.696 1.141 . . . . 0.0 111.064 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.8 -177.32 47.55 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 118.064 0.932 . . . . 0.0 111.29 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -99.83 147.87 25.04 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.434 HD21 ' HB2' ' A' ' 42' ' ' SER . 24.5 t-20 -137.91 150.73 47.33 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.921 1.688 . . . . 0.0 109.673 -176.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 mt -139.22 161.68 36.84 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 128.039 2.536 . . . . 0.0 108.619 171.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.49 176.43 12.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.27 1.828 . . . . 0.0 107.954 157.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -144.86 114.61 7.28 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 120.877 -1.139 . . . . 0.0 108.478 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 109.15 20.78 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -99.86 158.86 15.5 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.792 1.637 . . . . 0.0 109.224 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -115.2 152.31 32.87 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 172.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -121.28 166.76 13.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.021 1.329 . . . . 0.0 110.42 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -125.4 56.72 1.35 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.79 1.236 . . . . 0.0 108.071 -163.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.21 -47.37 0.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.181 1.392 . . . . 0.0 109.092 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.5 m -134.96 152.02 76.54 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.907 1.683 . . . . 0.0 107.899 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.84 13.2 0.38 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.939 3.759 . . . . 0.0 114.929 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 tp -87.24 118.91 26.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.157 1.783 . . . . 0.0 110.222 -165.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.22 177.27 49.0 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.1 t -133.87 145.27 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.172 1.389 . . . . 0.0 109.293 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 mp -139.68 131.91 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.469 1.908 . . . . 0.0 107.13 168.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.17 148.93 18.75 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 142.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.434 ' HB2' HD21 ' A' ' 25' ' ' ASN . 4.9 p -125.0 154.34 41.4 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.326 1.051 . . . . 0.0 110.515 165.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -112.77 148.97 33.67 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.318 1.047 . . . . 0.0 108.746 169.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 m -93.93 146.61 23.79 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.68 0.792 . . . . 0.0 109.218 165.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.424 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 48.5 m-85 -117.62 153.74 32.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.563 1.545 . . . . 0.0 108.593 166.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.85 143.21 34.31 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.008 0.822 . . . . 0.0 111.293 168.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.78 -11.49 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.012 2.525 . . . . 0.0 112.076 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.82 147.06 30.61 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.074 -1.641 . . . . 0.0 110.39 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.2 p -111.14 155.88 22.21 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.417 1.487 . . . . 0.0 109.132 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -129.96 130.71 45.4 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 162.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 t 177.09 89.4 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -168.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.17 -59.64 3.07 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.278 -0.889 . . . . 0.0 109.403 171.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.9 m -148.27 -56.5 0.22 Allowed 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 125.725 1.61 . . . . 0.0 107.431 169.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -161.99 102.14 1.13 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 102.704 -3.073 . . . . 0.0 102.704 173.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.05 -56.68 0.03 OUTLIER Glycine 0 CA--C 1.51 -0.267 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -119.75 115.31 23.64 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 162.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -94.37 152.73 18.41 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.343 1.457 . . . . 0.0 107.937 172.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.2 128.63 36.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.14 -0.975 . . . . 0.0 108.666 171.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -144.63 172.65 12.69 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 84.92 -177.69 0.03 OUTLIER 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.843 2.057 . . . . 0.0 109.018 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.83 169.84 14.08 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.657 1.583 . . . . 0.0 107.919 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.424 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 25.2 p90 -73.73 139.22 45.14 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 159.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -140.39 117.54 11.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 157.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.52 121.69 1.05 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -131.46 150.46 34.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.1 p -140.48 157.36 45.63 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.23 140.53 21.36 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.041 0.837 . . . . 0.0 111.158 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.523 ' HA3' HG12 ' A' ' 82' ' ' VAL . . . -176.02 160.19 28.05 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 156.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.19 -179.81 5.8 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.14 1.893 . . . . 0.0 111.668 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.56 146.02 41.26 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.208 1.403 . . . . 0.0 108.251 164.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -128.85 130.03 46.36 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -67.18 111.93 4.2 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.838 1.655 . . . . 0.0 109.301 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 tt -73.75 171.38 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.026 0.441 . . . . 0.0 109.875 -176.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -88.73 37.48 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.102 1.761 . . . . 0.0 110.091 -170.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -149.51 -119.98 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.591 1.957 . . . . 0.0 105.73 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -128.67 66.25 1.41 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.506 1.922 . . . . 0.0 109.441 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.1 176.02 13.04 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.657 -1.277 . . . . 0.0 110.766 168.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.8 m -137.94 112.95 9.12 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 104.053 -2.573 . . . . 0.0 104.053 164.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.71 147.21 23.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -150.4 164.88 34.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 119.665 1.12 . . . . 0.0 110.564 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.69 129.99 9.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.523 HG12 ' HA3' ' A' ' 68' ' ' GLY . 32.6 m -126.92 -176.52 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.527 0 C-N-CA 124.374 1.07 . . . . 0.0 111.166 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.86 165.56 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.677 1.991 . . . . 0.0 107.874 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.88 -172.26 31.14 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 162.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.51 138.97 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.47 139.13 10.72 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -132.66 116.98 17.31 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.583 1.953 . . . . 0.0 106.935 175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.14 125.9 0.79 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -162.53 165.05 26.57 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 118.06 0.93 . . . . 0.0 109.523 165.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -60.63 161.42 7.77 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.369 1.467 . . . . 0.0 111.612 -175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -98.43 169.22 9.7 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 164.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.6 115.07 23.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.839 1.656 . . . . 0.0 106.722 172.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -146.79 64.18 1.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 123.03 1.395 . . . . 0.0 108.954 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.69 -32.28 72.82 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 120.818 -1.176 . . . . 0.0 111.377 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.26 155.54 79.81 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 126.039 1.735 . . . . 0.0 106.447 174.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.45 -13.75 41.4 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.413 2.075 . . . . 0.0 114.149 -170.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 p -76.13 -37.67 57.73 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.856 1.663 . . . . 0.0 111.764 172.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -72.56 114.59 10.85 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -163.03 117.27 1.67 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 171.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -160.66 127.39 4.17 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 155.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.71 125.57 28.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.926 0.89 . . . . 0.0 108.665 165.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.1 m -140.51 111.24 6.89 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.436 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 74.8 m -144.82 175.71 9.99 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.348 1.459 . . . . 0.0 109.618 161.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -144.22 164.83 29.6 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 127.214 2.205 . . . . 0.0 108.33 172.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -68.54 123.61 21.32 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -104.88 123.15 7.55 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 170.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -81.2 151.29 28.26 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.5 p -146.11 151.64 38.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -141.73 167.72 21.46 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 121.38 -0.825 . . . . 0.0 109.729 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 166.81 -172.7 42.04 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -111.8 149.55 31.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 117.628 0.714 . . . . 0.0 110.548 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.21 122.23 6.64 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 170.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -115.69 139.9 49.7 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -121.14 159.38 25.93 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.693 0.759 . . . . 0.0 109.886 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.5 170.54 8.0 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.825 1.65 . . . . 0.0 106.623 158.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -60.43 110.71 3.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.138 178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -65.55 120.67 7.91 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.44 2.093 . . . . 0.0 108.805 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -177.06 164.7 2.28 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.932 1.242 . . . . 0.0 108.878 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 103.89 27.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 127.898 2.479 . . . . 0.0 109.051 154.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.94 15.91 10.22 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.689 1.595 . . . . 0.0 110.961 -169.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.73 171.33 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.7 159.65 39.03 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 126.375 1.87 . . . . 0.0 105.956 163.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 123' ' ' LEU . 2.2 mm? -125.22 114.95 19.64 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 161.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -136.17 133.96 37.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 174.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -139.73 142.81 36.81 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 -172.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.8 m -146.53 165.26 29.99 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.592 -0.693 . . . . 0.0 111.318 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -140.0 129.26 23.88 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.727 2.411 . . . . 0.0 105.332 -171.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -137.81 108.2 6.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -99.22 111.61 23.95 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.1 m -76.82 150.88 36.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.452 0.701 . . . . 0.0 110.56 171.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.7 ptt85 -140.72 96.54 3.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.763 1.625 . . . . 0.0 106.91 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.2 mt -100.79 81.37 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 -175.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 56.75 -64.84 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 129.728 3.211 . . . . 0.0 113.575 -171.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 p -145.8 26.76 1.23 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.685 1.994 . . . . 0.0 110.107 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.8 t -123.27 103.4 12.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -82.3 131.99 35.23 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.0 t -128.7 101.18 6.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.73 115.43 4.34 Favored Glycine 0 C--O 1.242 0.604 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -174.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 57.4 m -107.85 142.29 38.14 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -141.72 141.3 33.27 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.0 pt -135.95 151.3 29.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.49 148.92 47.4 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.706 1.203 . . . . 0.0 108.57 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.36 94.53 0.2 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 124.924 1.249 . . . . 0.0 110.415 -169.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.25 171.87 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 126.552 1.941 . . . . 0.0 107.586 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.99 -116.12 0.7 Allowed Glycine 0 C--O 1.221 -0.666 0 O-C-N 119.913 -1.742 . . . . 0.0 108.87 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -163.81 163.42 23.9 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 119.958 1.879 . . . . 0.0 110.079 171.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -90.07 147.47 23.62 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 118.047 -0.978 . . . . 0.0 108.868 161.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 115.432 -2.223 . . . . 0.0 107.489 174.735 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.8 m -139.47 149.66 44.26 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m -106.73 107.09 17.93 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.435 1.494 . . . . 0.0 107.841 172.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.1 m -131.12 127.13 37.46 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.38 133.1 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 127.011 2.124 . . . . 0.0 105.915 -163.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.9 t -157.15 146.6 20.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.96 164.08 37.58 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.859 -1.697 . . . . 0.0 108.859 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.55 -154.72 23.54 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 -168.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.77 159.33 41.67 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 109.142 -160.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.34 168.92 11.87 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 122.337 1.065 . . . . 0.0 113.767 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -125.0 117.49 24.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.407 1.483 . . . . 0.0 107.205 155.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.6 t -84.0 145.63 28.41 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 160.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -138.63 158.13 44.83 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.194 1.798 . . . . 0.0 107.944 -165.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.77 158.19 43.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 120.979 1.718 . . . . 0.0 111.31 159.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -78.76 56.76 1.94 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.685 0.755 . . . . 0.0 110.921 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.98 -39.13 0.2 Allowed Glycine 0 CA--C 1.519 0.282 0 O-C-N 120.06 -1.65 . . . . 0.0 110.434 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.55 96.36 2.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.681 0.753 . . . . 0.0 109.414 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.1 mtm -74.9 64.5 1.3 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.834 2.454 . . . . 0.0 108.195 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -66.33 102.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -64.17 98.04 0.21 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.881 1.272 . . . . 0.0 108.539 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 52.0 mtp -133.98 129.7 36.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -151.49 -145.47 4.13 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 170.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.04 -127.23 1.48 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 119.691 1.745 . . . . 0.0 110.668 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -132.58 121.17 22.83 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.983 1.313 . . . . 0.0 108.953 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -96.15 160.96 14.17 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.426 1.49 . . . . 0.0 110.107 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.95 139.86 29.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 162.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.33 149.81 49.82 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 118.775 0.716 . . . . 0.0 109.875 165.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -149.45 110.08 4.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -175.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.58 119.64 33.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.99 157.12 16.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 168.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -130.09 153.19 48.73 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.837 0.855 . . . . 0.0 109.481 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.43 172.24 9.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.704 0.801 . . . . 0.0 110.538 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -101.99 -26.31 13.45 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 120.752 -1.218 . . . . 0.0 109.719 161.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.65 -25.29 53.61 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.3 m -152.17 157.23 34.07 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.739 1.215 . . . . 0.0 109.508 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.42 21.4 0.55 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 124.354 3.369 . . . . 0.0 113.515 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.6 tp -91.45 136.53 33.05 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.153 -0.967 . . . . 0.0 109.248 -172.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.12 -168.61 12.48 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.816 1.198 . . . . 0.0 111.299 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.95 148.14 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.437 1.095 . . . . 0.0 110.657 -172.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.3 mm -119.3 119.76 61.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 127.077 2.151 . . . . 0.0 107.936 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.04 119.9 1.05 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 106.759 -2.536 . . . . 0.0 106.759 164.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.82 149.75 42.89 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.421 1.888 . . . . 0.0 106.584 175.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -144.13 128.41 17.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.9 m -126.51 132.07 51.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 168.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -91.44 150.17 21.37 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.4 p -98.1 138.34 35.55 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -61.01 163.95 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.176 1.39 . . . . 0.0 109.65 163.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HB2' HD22 ' A' ' 58' ' ' ASN . 0.0 OUTLIER -152.27 113.79 4.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -170.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.4 m -115.73 103.75 10.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.382 1.087 . . . . 0.0 110.502 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HA ' ' H ' ' A' ' 58' ' ' ASN . 24.5 ptt-85 -71.51 111.31 6.71 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 129.344 3.057 . . . . 0.0 108.89 177.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -53.14 -37.45 61.84 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.679 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 49.85 60.88 3.49 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 125.539 1.536 . . . . 0.0 110.087 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 t -164.36 -88.92 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -59.68 -56.28 23.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.801 -0.619 . . . . 0.0 110.755 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.84 4.8 0.1 OUTLIER Glycine 0 C--N 1.343 0.93 0 CA-C-O 118.259 -1.3 . . . . 0.0 115.814 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -71.03 90.95 0.86 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-N 120.122 1.961 . . . . 0.0 108.015 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -82.89 78.56 9.46 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.443 HD22 ' HB2' ' A' ' 48' ' ' LYS . 2.3 t30 -81.2 92.11 6.26 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -160.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -155.77 116.35 3.79 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.071 0.948 . . . . 0.0 108.961 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -149.66 -160.88 1.23 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 160.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.475 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 10.2 pt20 -126.86 128.8 47.08 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 164.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -97.31 114.04 25.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.67 117.84 29.34 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.88 96.68 0.96 Allowed Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.0 141.31 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 t -133.65 157.39 45.88 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 171.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.28 138.98 20.74 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.588 -0.695 . . . . 0.0 111.411 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.86 166.15 32.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.753 1.644 . . . . 0.0 109.314 160.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.438 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 66.7 Cg_endo -73.88 -177.96 3.5 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.734 2.289 . . . . 0.0 112.538 171.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.55 128.77 44.92 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.708 2.003 . . . . 0.0 108.032 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.1 130.29 28.84 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 ttp-105 -80.4 89.93 5.6 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.8 pp -93.29 1.57 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.244 1.018 . . . . 0.0 112.054 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -128.49 -178.28 4.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.941 1.696 . . . . 0.0 107.244 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -52.0 -67.53 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.72 2.008 . . . . 0.0 109.255 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.42 42.83 2.68 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.965 2.106 . . . . 0.0 110.559 -169.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.31 151.71 33.35 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.68 141.53 49.6 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.384 1.074 . . . . 0.0 109.422 175.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.48 154.82 6.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.234 1.413 . . . . 0.0 107.391 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.438 ' CE2' ' HD2' ' A' ' 69' ' ' PRO . 36.0 t80 -149.81 150.68 32.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.166 1.386 . . . . 0.0 107.857 169.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.26 109.84 3.35 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 174.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.2 m -103.76 161.8 4.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.967 0.907 . . . . 0.0 109.876 -167.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 t -109.08 131.07 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -116.34 159.88 13.68 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.53 150.84 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 170.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.97 158.3 21.4 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.946 1.736 . . . . 0.0 109.774 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -140.91 127.7 20.4 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.26 -171.66 16.64 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.0 pttt 175.28 -2.48 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.709 2.403 . . . . 0.0 112.919 160.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.56 -153.66 0.52 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 80.17 -71.37 0.08 Allowed 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 126.645 1.978 . . . . 0.0 109.897 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 p -74.3 99.88 3.59 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.255 12.1 t -81.76 61.62 5.21 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 175.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.391 12.3 pt-20 59.04 -18.06 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 130.824 3.649 . . . . 0.0 118.078 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -39.95 -72.84 0.1 Allowed Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 125.608 1.563 . . . . 0.0 114.553 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -64.3 -54.33 0.86 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 CA-C-N 122.182 1.815 . . . . 0.0 113.669 -173.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.6 m -154.49 65.67 0.69 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.509 1.049 . . . . 0.0 111.761 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 64.86 169.66 0.19 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.53 1.132 . . . . 0.0 110.245 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -62.41 150.01 40.94 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 119.69 -1.881 . . . . 0.0 109.374 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -47.21 -57.85 4.71 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 125.147 1.529 . . . . 0.0 112.777 -170.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -167.01 -174.32 2.64 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.679 1.992 . . . . 0.0 106.448 160.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.3 p -111.43 92.77 4.17 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 120.972 -1.08 . . . . 0.0 108.764 171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 m 49.5 66.89 0.99 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.106 1.362 . . . . 0.0 112.182 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -94.91 151.76 18.93 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 164.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -95.1 110.6 22.52 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.155 1.382 . . . . 0.0 107.819 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.13 98.44 0.56 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.22 133.78 42.7 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.391 1.096 . . . . 0.0 108.296 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 p -133.06 173.62 11.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 122.351 1.072 . . . . 0.0 111.659 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -161.78 163.69 29.34 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.254 1.822 . . . . 0.0 106.353 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 177.18 -162.28 30.31 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -140.88 130.55 24.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 167.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.6 142.19 15.97 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 172.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.35 140.52 51.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.39 1.876 . . . . 0.0 108.539 -168.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.68 159.82 35.26 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.816 1.246 . . . . 0.0 110.769 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -91.87 171.09 9.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 168.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -56.92 154.21 19.88 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.793 168.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.98 109.91 0.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.254 0 N-CA-C 107.647 -1.713 . . . . 0.0 107.647 162.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.1 mmt -81.08 -174.97 5.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.974 2.11 . . . . 0.0 107.095 153.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -117.69 -4.24 11.21 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.359 -1.463 . . . . 0.0 110.736 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -137.45 0.14 2.25 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 124.561 1.144 . . . . 0.0 111.316 166.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.77 147.08 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 120.363 -1.461 . . . . 0.0 107.69 -162.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -143.62 153.06 42.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.456 1.903 . . . . 0.0 106.846 167.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.479 HD13 HG12 ' A' ' 144' ' ' VAL . 2.3 mm? -133.78 130.46 38.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 172.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -146.59 129.79 16.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 119.211 0.914 . . . . 0.0 109.176 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -149.65 151.9 34.5 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.512 0.596 . . . . 0.0 110.479 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.9 t -145.48 166.61 25.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.564 0.746 . . . . 0.0 110.338 173.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -143.57 106.13 4.45 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.595 1.958 . . . . 0.0 106.178 -177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -131.38 114.72 15.31 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -99.3 107.84 20.22 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -169.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.0 t -81.73 157.55 24.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.771 0.829 . . . . 0.0 108.833 175.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -130.0 129.07 43.26 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.0 mm -118.19 91.4 1.8 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -166.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.39 -82.71 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 126.156 1.782 . . . . 0.0 108.585 -176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.74 23.96 3.11 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.395 1.078 . . . . 0.0 112.551 171.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.94 148.79 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 119.413 1.006 . . . . 0.0 108.574 171.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.08 129.27 39.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.605 1.562 . . . . 0.0 107.652 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 79.6 t -136.82 92.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.866 1.666 . . . . 0.0 109.531 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.4 152.49 41.28 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.524 -0.735 . . . . 0.0 111.557 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.85 143.92 49.85 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 155.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -130.8 119.74 22.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.7 133.02 70.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.95 138.39 26.83 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -153.1 167.86 31.82 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 124.286 0.946 . . . . 0.0 110.926 -177.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.479 HG12 HD13 ' A' ' 123' ' ' LEU . 17.4 m -140.3 168.33 17.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.084 1.353 . . . . 0.0 107.841 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -166.76 -103.85 0.17 Allowed Glycine 0 C--N 1.334 0.438 0 CA-C-O 117.902 -1.499 . . . . 0.0 113.632 173.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -164.11 176.47 9.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.206 1.802 . . . . 0.0 109.511 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.11 145.05 35.26 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 168.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.0 p90 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 117.869 -1.062 . . . . 0.0 109.651 -179.233 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.477 0.18 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -141.7 141.31 33.31 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 121.414 -0.804 . . . . 0.0 108.987 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.07 107.01 11.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -95.75 139.74 31.55 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.48 HG13 ' H ' ' A' ' 146' ' ' TYR . 2.4 p -142.78 128.94 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.897 1.679 . . . . 0.0 107.524 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.6 p -138.51 163.56 31.68 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.453 0.569 . . . . 0.0 110.653 168.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.77 155.52 26.79 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 171.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.47 -165.43 37.95 Favored Glycine 0 C--O 1.236 0.272 0 O-C-N 121.793 -0.828 . . . . 0.0 112.75 -172.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.74 157.58 16.39 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.246 1.018 . . . . 0.0 110.087 -169.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.79 162.89 34.05 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.921 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -143.73 154.34 43.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.331 1.053 . . . . 0.0 108.222 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 t -115.12 151.13 34.88 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 162.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.33 170.75 12.15 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 127.272 2.229 . . . . 0.0 105.296 160.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.91 164.49 28.19 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.5 -0.75 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -74.04 85.35 1.8 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 159.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.83 90.41 0.45 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -66.48 94.74 0.29 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 122.302 1.048 . . . . 0.0 109.74 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -151.21 -58.58 0.16 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.208 1.803 . . . . 0.0 108.03 170.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -63.69 103.92 0.61 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.168 1.387 . . . . 0.0 109.266 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -129.81 75.99 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 161.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -81.47 161.32 23.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.739 1.616 . . . . 0.0 109.282 164.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.93 179.88 40.93 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 108.209 -1.957 . . . . 0.0 108.209 171.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.74 -163.63 30.26 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 118.285 1.043 . . . . 0.0 111.858 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -99.62 153.97 18.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.24 1.416 . . . . 0.0 108.747 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -137.93 153.26 49.51 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.873 1.669 . . . . 0.0 107.648 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.6 mt -133.41 148.29 51.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 162.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -125.92 127.22 45.65 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 164.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -155.64 108.43 2.69 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -169.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -141.18 165.93 26.18 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.845 1.258 . . . . 0.0 108.707 -171.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -111.35 157.2 20.48 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -107.71 149.57 27.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 168.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.54 151.27 41.89 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 170.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.54 2.85 55.67 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.342 -0.849 . . . . 0.0 110.886 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -141.44 -70.32 0.36 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.47 1.508 . . . . 0.0 109.277 -153.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.1 t -72.67 122.83 88.58 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 167.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.47 68.28 6.94 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.629 2.22 . . . . 0.0 111.229 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 tp -142.35 121.61 13.06 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.932 1.293 . . . . 0.0 109.234 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -103.84 178.48 24.9 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.0 t -127.74 157.41 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.3 mm -124.94 151.62 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.93 1.692 . . . . 0.0 107.399 171.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.94 108.68 0.37 Allowed Glycine 0 C--N 1.336 0.563 0 O-C-N 120.136 -1.603 . . . . 0.0 111.372 159.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -67.46 151.65 47.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 166.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -136.51 103.04 5.12 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.6 m -92.99 150.84 20.27 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 -172.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.2 157.76 40.92 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 124.413 1.085 . . . . 0.0 109.757 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 m -99.81 130.47 46.01 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 160.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -135.63 -56.59 0.79 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.544 1.938 . . . . 0.0 106.619 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.68 113.73 5.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.325 1.45 . . . . 0.0 107.508 174.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -101.6 155.59 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 127.059 2.143 . . . . 0.0 109.435 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.515 ' H ' ' HB2' ' A' ' 58' ' ' ASN . 0.3 OUTLIER -109.28 145.86 35.23 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 164.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t 178.63 149.24 0.22 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 130.353 3.461 . . . . 0.0 104.691 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 46.36 66.69 0.9 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.773 2.029 . . . . 0.0 110.596 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.3 t -162.63 -43.04 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.823 -0.608 . . . . 0.0 111.58 -172.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.72 3.17 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.859 0.863 . . . . 0.0 112.769 -172.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.4 -0.66 53.97 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 121.192 1.814 . . . . 0.0 111.761 -171.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -71.1 91.28 0.9 Allowed 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.878 2.071 . . . . 0.0 106.408 165.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -72.5 144.45 48.01 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.515 ' HB2' ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -124.77 98.92 5.92 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 170.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -115.12 147.65 39.97 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 72.86 -177.84 0.19 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.59 2.356 . . . . 0.0 110.838 -168.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -124.99 163.74 21.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.078 1.751 . . . . 0.0 108.403 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.69 142.35 29.1 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -130.41 118.52 21.32 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.57 166.26 19.43 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 122.43 1.017 . . . . 0.0 112.235 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.7 142.83 42.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 167.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.9 m -139.79 130.95 26.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.88 164.55 31.61 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.617 0.767 . . . . 0.0 110.09 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.14 162.53 10.76 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 126.667 2.08 . . . . 0.0 107.993 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.05 156.62 38.44 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.576 1.517 . . . . 0.0 111.745 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.59 104.06 16.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 157.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -103.14 117.55 34.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -66.94 146.95 53.85 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.82 0.448 . . . . 0.0 110.469 -174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.6 pt -141.99 164.05 18.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.8 0.81 . . . . 0.0 111.168 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 t30 65.49 -74.87 0.05 Allowed 'General case' 0 C--O 1.233 0.191 0 C-N-CA 130.448 3.499 . . . . 0.0 113.072 164.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -132.02 -56.48 0.98 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 117.074 -1.441 . . . . 0.0 109.372 165.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -151.67 27.02 0.65 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.117 1.767 . . . . 0.0 111.037 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.65 172.2 8.65 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.365 1.466 . . . . 0.0 110.263 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m -127.83 168.98 14.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.724 1.609 . . . . 0.0 110.773 -173.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.31 162.1 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 124.67 1.188 . . . . 0.0 110.77 -172.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -104.65 124.72 49.84 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 127.731 2.412 . . . . 0.0 108.564 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.69 42.76 0.08 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.7 m -104.95 164.34 3.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.74 140.04 28.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -171.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -161.32 172.81 37.63 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-O 121.612 0.562 . . . . 0.0 112.789 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.69 149.09 16.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.63 145.15 18.56 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 166.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -135.04 152.15 51.44 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 125.635 1.574 . . . . 0.0 108.316 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -172.97 -156.43 12.83 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -154.4 88.44 1.22 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -65.37 151.55 46.0 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -133.78 151.01 51.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.761 155.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.2 t -137.75 117.6 13.24 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 163.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.0 p -101.19 -124.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -167.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 75.38 -53.67 0.65 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.544 2.338 . . . . 0.0 113.277 162.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.86 150.59 82.17 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 167.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.03 6.64 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.346 2.698 . . . . 0.0 113.38 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.7 t -142.48 53.39 1.42 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.183 1.393 . . . . 0.0 108.642 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.4 p90 47.88 -124.54 1.7 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.183 1.393 . . . . 0.0 109.625 171.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -161.69 -61.99 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 148.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -161.96 150.0 14.81 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -150.06 105.46 3.38 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.684 1.193 . . . . 0.0 107.804 -170.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.19 164.4 30.16 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.328 -0.858 . . . . 0.0 110.611 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 p -82.04 115.14 21.05 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 165.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -85.69 138.72 31.93 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.061 0.944 . . . . 0.0 109.212 -173.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.97 126.7 49.16 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.054 1.341 . . . . 0.0 107.903 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.66 83.41 0.28 Allowed Glycine 0 CA--C 1.522 0.483 0 CA-C-N 119.078 0.853 . . . . 0.0 111.624 -173.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -74.35 141.16 45.19 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.76 1.224 . . . . 0.0 109.364 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.66 -150.31 0.15 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.984 0.811 . . . . 0.0 110.622 154.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -128.18 162.49 26.83 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 126.321 1.848 . . . . 0.0 110.001 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.71 -176.2 15.12 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.755 0.693 . . . . 0.0 112.461 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -120.22 174.22 6.64 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.944 1.698 . . . . 0.0 111.232 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -157.86 84.37 0.13 Allowed Glycine 0 C--N 1.342 0.865 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.643 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.13 139.61 49.76 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.178 0.989 . . . . 0.0 108.746 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -137.43 159.37 42.12 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.091 1.356 . . . . 0.0 107.674 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -92.85 170.71 9.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 119.619 1.1 . . . . 0.0 108.38 171.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -61.27 104.49 0.47 Allowed Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.439 1.096 . . . . 0.0 110.524 -170.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.15 106.64 2.31 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.642 2.228 . . . . 0.0 109.908 -166.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.7 ptm -164.68 169.77 16.47 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.406 0.548 . . . . 0.0 110.774 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 63.69 35.65 11.29 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.601 1.16 . . . . 0.0 108.67 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 60.01 14.11 4.16 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.864 1.266 . . . . 0.0 113.318 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.26 110.43 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 123.734 1.73 . . . . 0.0 109.309 171.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -113.9 110.25 19.79 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.229 2.612 . . . . 0.0 106.395 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.37 131.66 34.22 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.78 148.76 42.68 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 118.727 0.694 . . . . 0.0 110.594 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -143.35 150.7 39.52 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.99 1.316 . . . . 0.0 108.51 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.4 p -144.08 152.99 41.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.657 0.741 . . . . 0.0 111.367 152.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -108.18 125.09 51.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.144 2.177 . . . . 0.0 105.733 168.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -136.61 145.24 44.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.238 1.815 . . . . 0.0 107.873 -174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -127.29 161.67 28.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.729 0.775 . . . . 0.0 110.993 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 p -141.22 159.89 41.26 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.831 2.052 . . . . 0.0 108.084 170.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -128.79 114.93 17.18 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 87.2 mt -105.9 98.03 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.18 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 129.179 2.992 . . . . 0.0 109.893 175.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.5 p -137.78 20.76 2.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.471 1.108 . . . . 0.0 111.245 174.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.8 m -111.82 115.71 50.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 167.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.29 130.46 40.84 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 168.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.4 t -135.49 112.35 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -172.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.25 144.92 16.94 Favored Glycine 0 C--O 1.238 0.357 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -169.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.3 p -138.0 148.85 45.57 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.436 0.695 . . . . 0.0 110.218 -164.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -121.18 150.27 41.55 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 166.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.45 131.45 65.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.83 131.79 20.3 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.666 0.786 . . . . 0.0 109.045 -171.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -161.97 173.52 38.32 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 114.599 0.6 . . . . 0.0 114.599 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.4 m -118.0 178.06 2.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.951 2.1 . . . . 0.0 108.78 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 167.67 -165.15 38.49 Favored Glycine 0 C--O 1.217 -0.952 0 O-C-N 120.545 -1.347 . . . . 0.0 110.367 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.48 ' H ' HG13 ' A' ' 5' ' ' VAL . 51.4 m-85 -104.92 175.45 5.49 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -166.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.87 130.32 19.98 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 120.813 -1.18 . . . . 0.0 108.13 170.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 125.191 1.396 . . . . 0.0 107.848 -179.112 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.6 p -132.79 157.17 45.64 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 149.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -143.85 106.71 4.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.133 0.973 . . . . 0.0 108.822 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -134.35 125.55 27.83 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 120.985 -1.072 . . . . 0.0 109.095 -168.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.38 112.85 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.468 1.107 . . . . 0.0 108.663 -168.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.5 p -149.15 123.58 9.67 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.927 0.891 . . . . 0.0 109.14 -166.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.34 158.53 27.71 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.794 1.187 . . . . 0.0 111.463 176.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 173.25 -139.35 5.09 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -167.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -150.33 154.93 38.69 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 117.668 0.734 . . . . 0.0 110.97 -166.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.93 160.19 39.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.461 1.105 . . . . 0.0 111.03 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -132.73 114.12 13.77 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -84.96 144.35 28.38 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.866 0.866 . . . . 0.0 109.004 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -138.39 119.31 14.29 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.34 1.856 . . . . 0.0 109.357 -173.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.03 166.45 19.76 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.499 1.12 . . . . 0.0 110.765 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -39.27 -20.33 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.275 2.63 . . . . 0.0 115.948 169.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.26 -108.7 0.56 Allowed Glycine 0 C--N 1.338 0.659 0 CA-C-N 120.192 1.36 . . . . 0.0 110.584 167.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -141.14 101.81 4.11 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.719 1.26 . . . . 0.0 109.311 -174.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 58.2 mtp -130.32 -75.09 0.54 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.17 99.28 3.14 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -78.61 132.06 36.96 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB2' HG23 ' A' ' 46' ' ' THR . 3.9 ptp -133.99 149.16 51.2 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.07 177.46 47.69 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.73 -162.41 28.19 Favored Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 -171.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.06 110.16 22.46 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -170.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -95.69 150.81 19.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.049 -1.464 . . . . 0.0 107.049 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.33 145.03 20.12 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -170.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -132.87 150.11 52.19 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.68 139.62 50.77 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 170.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -129.53 109.0 10.67 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -115.9 132.5 56.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.59 153.12 45.96 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.777 1.631 . . . . 0.0 107.532 172.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -141.64 155.57 45.7 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -69.46 -19.97 63.76 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.538 -0.726 . . . . 0.0 110.146 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -21.05 65.98 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 125.548 1.539 . . . . 0.0 112.83 173.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -152.12 90.16 3.85 Favored Pre-proline 0 C--O 1.238 0.448 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.61 64.73 4.73 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.226 2.618 . . . . 0.0 112.012 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.86 125.58 10.4 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 167.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.05 174.19 54.59 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 118.555 0.616 . . . . 0.0 111.859 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.0 t -132.39 148.37 31.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.938 1.695 . . . . 0.0 107.659 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.33 120.74 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 126.592 1.957 . . . . 0.0 106.231 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.78 127.59 4.13 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 168.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 t -125.98 154.9 42.23 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.618 1.167 . . . . 0.0 110.729 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -112.68 140.3 47.56 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.905 0.882 . . . . 0.0 109.01 174.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.7 m -118.3 116.04 25.95 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.038 1.335 . . . . 0.0 107.973 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -112.9 149.68 32.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.232 1.413 . . . . 0.0 109.353 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 21' ' ' MET . 7.2 m -123.95 122.43 37.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -136.73 88.93 2.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -174.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -150.7 134.58 16.69 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.402 1.081 . . . . 0.0 109.288 -161.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.8 p -131.24 122.56 26.72 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.654 1.182 . . . . 0.0 112.155 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -134.66 113.71 11.99 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 162.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.6 t -141.59 136.72 31.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 156.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.33 -102.65 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.3 m -138.83 97.09 3.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.2 m 61.28 51.38 4.3 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.986 161.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.4 -35.02 0.03 OUTLIER Glycine 0 CA--C 1.532 1.14 0 N-CA-C 114.066 0.386 . . . . 0.0 114.066 172.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -119.21 111.67 18.52 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.83 80.59 1.66 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 172.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -81.24 66.53 6.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.391 0.615 . . . . 0.0 109.401 -178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -134.49 115.72 14.27 Favored 'General case' 0 CA--C 1.523 -0.06 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -158.93 161.78 36.79 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.692 1.997 . . . . 0.0 106.514 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -112.7 128.16 56.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 168.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -107.96 138.32 44.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 170.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -141.39 163.89 31.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.21 169.97 34.35 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.68 143.96 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 t -141.19 127.84 20.23 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -131.84 139.1 48.74 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.428 0.558 . . . . 0.0 110.978 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -172.97 167.16 39.92 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 163.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.22 177.79 8.16 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.589 2.193 . . . . 0.0 110.163 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.18 107.31 6.04 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.839 1.256 . . . . 0.0 107.63 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.19 148.66 22.21 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -91.34 142.76 27.35 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 122.074 -0.391 . . . . 0.0 110.308 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.3 mt -83.51 -102.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -129.76 12.04 5.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.487 1.515 . . . . 0.0 109.919 172.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -157.75 -178.41 7.3 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.851 -1.156 . . . . 0.0 112.865 -158.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -69.82 16.56 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.534 2.334 . . . . 0.0 114.292 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.97 141.0 48.7 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.6 1.16 . . . . 0.0 108.537 167.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.0 p -146.66 120.17 9.09 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.1 149.97 23.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -150.32 171.96 16.14 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.05 0.94 . . . . 0.0 108.922 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.28 150.16 38.33 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 164.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.72 165.49 28.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.284 1.034 . . . . 0.0 108.954 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.62 131.33 73.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.12 156.68 21.34 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.55 150.09 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.51 154.4 20.37 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 170.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -132.53 140.24 48.23 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.612 1.965 . . . . 0.0 108.434 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.39 171.67 32.12 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -174.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.21 156.56 0.77 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.286 2.234 . . . . 0.0 107.657 176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -49.04 149.47 1.91 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.715 1.206 . . . . 0.0 111.396 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.93 158.58 21.8 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -170.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.2 p -136.97 122.17 19.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.789 1.636 . . . . 0.0 108.194 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.7 m -137.85 95.57 3.07 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -76.45 76.65 3.18 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.908 2.483 . . . . 0.0 108.037 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.419 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 41.7 m-85 59.42 -179.82 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 127.35 2.26 . . . . 0.0 112.233 -175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 95' ' ' TYR . 37.2 Cg_endo -65.19 15.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 121.899 1.733 . . . . 0.0 115.091 170.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.4 t -114.34 -24.2 9.01 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.063 1.302 . . . . 0.0 112.84 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -149.44 175.51 11.41 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 120.682 1.583 . . . . 0.0 110.054 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -164.81 165.74 20.34 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.772 1.629 . . . . 0.0 108.084 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -146.82 111.52 5.28 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -148.85 150.96 33.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 119.01 0.823 . . . . 0.0 108.848 171.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.4 m -140.71 117.7 11.16 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.065 1.346 . . . . 0.0 108.801 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.5 p -70.02 108.63 4.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.405 1.457 . . . . 0.0 107.532 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -149.59 151.66 34.17 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.55 0.691 . . . . 0.0 110.722 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -105.18 125.4 50.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 129.082 2.953 . . . . 0.0 106.991 -165.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.21 105.64 3.31 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.99 139.19 42.76 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.8 m -133.82 177.16 7.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.178 0.991 . . . . 0.0 109.401 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -168.12 167.8 12.18 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.937 2.095 . . . . 0.0 107.464 159.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.73 -166.33 35.19 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.08 158.49 44.28 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.77 1.228 . . . . 0.0 108.681 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.3 113.63 3.32 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.85 140.57 49.75 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.516 1.158 . . . . 0.0 109.35 -166.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -117.42 134.78 54.45 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.553 0.741 . . . . 0.0 109.957 -171.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.45 171.07 9.14 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -57.08 118.17 22.41 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.936 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.82 170.09 15.85 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.022 2.481 . . . . 0.0 112.612 170.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 46.3 mtt -152.98 162.95 40.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 130.03 3.332 . . . . 0.0 106.684 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.55 -4.84 1.5 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 129.178 2.991 . . . . 0.0 114.413 -171.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -145.21 8.89 1.23 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.087 0.955 . . . . 0.0 111.51 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.24 139.54 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 120.221 1.373 . . . . 0.0 108.842 -175.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.9 154.1 38.97 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 119.907 -1.746 . . . . 0.0 107.566 161.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 132.88 46.13 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -140.98 130.69 24.17 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -129.31 151.25 50.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.48 1.112 . . . . 0.0 108.409 -173.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.96 162.42 37.85 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.636 0.732 . . . . 0.0 109.722 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -130.93 136.64 48.76 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -136.72 132.46 34.89 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 103.944 -2.614 . . . . 0.0 103.944 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -99.41 154.61 18.08 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 170.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 72.2 m -135.42 149.04 49.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -137.8 118.82 14.36 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 61.3 mt -123.38 105.5 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.68 50.89 17.52 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.076 1.35 . . . . 0.0 113.28 169.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.7 10.13 3.41 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.207 1.403 . . . . 0.0 111.518 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.63 119.5 43.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 166.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -71.67 133.14 45.46 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.9 t -133.25 157.06 42.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.25 152.19 23.11 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -140.26 153.9 46.66 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 167.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -136.35 118.74 15.73 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.7 mt -99.75 136.13 32.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.004 1.722 . . . . 0.0 107.35 -174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.32 139.62 35.47 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -166.32 163.05 36.61 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.9 m -139.08 173.54 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 C-N-CA 125.001 1.32 . . . . 0.0 109.426 -172.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 180.0 -99.6 0.13 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-O 118.337 -1.257 . . . . 0.0 109.989 173.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -152.51 173.85 14.64 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.308 1.443 . . . . 0.0 110.513 -175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.2 tpt85 -133.3 150.97 51.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 162.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.6 p90 . . . . . 0 C--O 1.254 1.301 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 165.113 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.687 0.279 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.95 146.66 26.41 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 174.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -93.07 145.9 24.05 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.725 0.774 . . . . 0.0 109.113 165.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.1 m -153.72 125.71 7.84 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 119.565 -1.959 . . . . 0.0 110.041 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.71 127.61 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.688 0.795 . . . . 0.0 110.958 -170.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 p -139.18 119.99 14.3 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.402 1.081 . . . . 0.0 109.293 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.31 164.13 31.83 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.022 1.296 . . . . 0.0 110.49 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.17 -117.39 0.62 Allowed Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -168.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -149.68 158.92 44.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.857 0.863 . . . . 0.0 109.735 -169.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.22 152.97 34.67 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.949 1.3 . . . . 0.0 107.802 168.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -142.37 154.37 44.58 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.291 0.636 . . . . 0.0 109.602 162.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 p -139.4 147.06 40.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 128.186 2.594 . . . . 0.0 107.46 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -126.82 113.37 16.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.595 0.712 . . . . 0.0 110.561 -155.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.62 106.14 1.39 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.337 1.055 . . . . 0.0 112.906 -156.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 64.44 8.46 4.3 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.922 1.689 . . . . 0.0 113.391 162.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.18 -101.32 0.23 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 104.178 -3.569 . . . . 0.0 104.178 -169.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -141.08 130.69 24.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 160.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.8 ttp -157.75 -34.91 0.07 Allowed 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.383 0.427 . . . . 0.0 110.481 155.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -129.17 152.8 48.36 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 126.414 1.886 . . . . 0.0 106.424 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -123.51 80.93 1.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 171.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -67.61 129.4 39.79 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.89 176.04 29.6 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.79 -156.36 12.63 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 -171.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -98.55 156.16 16.93 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.391 1.096 . . . . 0.0 109.476 -169.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.77 144.43 41.6 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 124.278 1.031 . . . . 0.0 109.223 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -161.54 126.57 3.52 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -121.96 151.74 40.43 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.348 0.594 . . . . 0.0 109.492 170.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -120.87 139.71 52.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.0 ptt85 -133.92 157.68 45.4 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 122.888 0.475 . . . . 0.0 110.064 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.71 157.67 38.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 173.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -108.89 125.1 51.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 154.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.76 173.04 3.75 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -117.06 37.68 3.76 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 169.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -148.72 -78.98 0.14 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.2 m -65.12 143.39 98.84 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 168.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.75 29.48 0.38 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.825 3.684 . . . . 0.0 110.972 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.7 tp -117.34 155.86 28.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.362 1.865 . . . . 0.0 108.791 -168.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -123.78 -172.99 13.83 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 168.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.1 t -139.56 142.33 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.91 152.91 38.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 163.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.0 136.08 4.2 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 105.021 -3.232 . . . . 0.0 105.021 165.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 t -124.56 142.89 51.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 117.922 0.861 . . . . 0.0 108.874 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -92.35 140.11 29.93 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.282 0.633 . . . . 0.0 110.211 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.89 130.02 37.74 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 167.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -116.84 156.43 27.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 156.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.7 m -138.3 122.2 17.74 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.68 42.26 2.18 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.528 1.931 . . . . 0.0 108.951 -164.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.525 ' H ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -65.3 138.54 58.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.003 1.321 . . . . 0.0 107.92 -175.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.5 p -130.39 155.06 47.03 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.196 0.522 . . . . 0.0 111.871 -169.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.6 99.87 12.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.861 1.264 . . . . 0.0 111.887 -175.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 t -158.4 16.16 0.21 Allowed 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.459 -0.775 . . . . 0.0 112.911 171.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.18 15.26 1.03 Allowed 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.347 -0.846 . . . . 0.0 112.18 -154.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.34 -116.61 0.17 Allowed 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 -173.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.6 m -126.09 13.02 7.79 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.039 1.336 . . . . 0.0 111.468 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.84 22.84 8.14 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 118.987 0.812 . . . . 0.0 113.838 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.434 ' HA ' ' HG3' ' A' ' 94' ' ' GLU . 5.7 t70 -70.68 104.19 2.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 168.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -58.44 106.29 0.37 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.435 -1.711 . . . . 0.0 108.176 162.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -56.29 140.19 45.74 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -116.65 168.48 10.15 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.573 0.701 . . . . 0.0 110.936 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 8.2 t30 45.0 -165.44 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 130.081 3.352 . . . . 0.0 113.526 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.477 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 12.3 pt20 -135.53 149.11 49.37 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.715 1.206 . . . . 0.0 108.759 -169.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -103.84 140.01 38.25 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 169.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -140.46 118.13 11.64 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.87 139.34 15.05 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 174.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.35 117.08 38.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.8 p -105.02 159.4 15.85 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.263 1.025 . . . . 0.0 109.629 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.18 144.02 28.64 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.027 -1.046 . . . . 0.0 109.703 164.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.76 121.07 1.36 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 173.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.66 127.64 21.22 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 N-CA-C 106.471 -2.165 . . . . 0.0 106.471 157.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.58 103.65 16.22 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.25 155.01 20.26 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 164.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -106.1 150.78 25.47 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.696 1.598 . . . . 0.0 106.801 161.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.1 mm -77.92 -104.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -129.54 7.29 5.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.986 1.267 . . . . 0.0 112.207 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -136.52 10.19 3.18 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.688 2.395 . . . . 0.0 111.894 -155.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 66.8 m95 51.03 70.58 0.51 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.507 1.523 . . . . 0.0 110.013 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.07 -169.03 1.89 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.435 1.894 . . . . 0.0 109.162 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 t -126.57 169.7 12.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.131 2.172 . . . . 0.0 106.365 173.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 tp -134.16 157.78 41.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.705 1.602 . . . . 0.0 108.494 -171.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -103.0 176.08 5.26 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 128.064 2.546 . . . . 0.0 109.097 -171.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.16 53.23 2.87 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.71 160.66 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 m -95.45 154.43 3.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 121.561 -0.712 . . . . 0.0 109.676 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.67 134.63 4.82 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.89 129.17 68.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -118.71 115.09 3.0 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -168.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -121.15 123.71 42.96 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.064 0.932 . . . . 0.0 110.294 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.5 161.65 8.79 Favored Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -172.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -165.58 128.77 2.17 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.275 1.83 . . . . 0.0 106.899 -170.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -67.29 165.66 15.86 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.694 0.679 . . . . 0.0 111.17 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -122.38 179.9 4.41 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.256 1.422 . . . . 0.0 109.234 170.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.8 p -136.43 145.27 45.06 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.565 1.075 . . . . 0.0 110.375 158.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.4 m -131.6 25.04 4.75 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.8 0.84 . . . . 0.0 110.747 -155.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -145.44 -53.09 0.27 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.323 -1.485 . . . . 0.0 112.219 178.048 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -59.99 139.12 90.87 Favored Pre-proline 0 C--O 1.24 0.558 0 CA-C-O 118.215 -0.898 . . . . 0.0 108.643 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.12 84.13 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.959 3.106 . . . . 0.0 110.382 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 m -154.68 -45.44 0.09 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.973 1.309 . . . . 0.0 108.067 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 37.25 63.43 0.72 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.106 1.762 . . . . 0.0 112.452 174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -51.87 -48.66 63.94 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.8 t30 40.17 64.74 0.85 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.441 1.496 . . . . 0.0 110.755 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.78 129.32 9.17 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 127.723 2.409 . . . . 0.0 105.706 -173.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.7 p -132.46 104.69 6.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 123.987 0.804 . . . . 0.0 108.968 168.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.6 m -140.59 72.76 1.4 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 160.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.2 135.24 38.96 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -145.87 157.1 43.92 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.647 1.979 . . . . 0.0 108.016 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.32 160.56 33.2 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.371 0.986 . . . . 0.0 110.642 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -138.33 151.95 48.02 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 128.632 2.773 . . . . 0.0 109.111 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.7 m -170.31 -146.83 0.05 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.949 2.499 . . . . 0.0 108.748 159.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -136.94 177.51 7.8 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.942 1.697 . . . . 0.0 109.376 -171.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -161.38 177.19 37.79 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 121.285 -0.885 . . . . 0.0 113.657 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.63 161.89 14.17 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.008 0.923 . . . . 0.0 111.341 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.33 84.81 0.15 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.03 159.93 20.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.828 0.851 . . . . 0.0 109.767 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.04 154.97 43.07 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.067 1.347 . . . . 0.0 108.424 170.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -92.54 170.07 10.03 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -56.05 130.82 74.03 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.84 127.17 18.05 Favored 'Trans proline' 0 N--CA 1.442 -1.533 0 N-CA-C 107.589 -1.735 . . . . 0.0 107.589 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -87.64 -175.19 5.1 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 152.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -109.97 -25.6 10.18 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 126.932 2.093 . . . . 0.0 108.458 -173.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.97 5.56 10.4 Favored 'General case' 0 C--O 1.225 -0.188 0 O-C-N 121.067 -1.021 . . . . 0.0 109.357 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.1 t -137.45 144.54 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.51 153.26 51.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.156 1.382 . . . . 0.0 108.56 164.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.468 HD13 HG12 ' A' ' 144' ' ' VAL . 2.4 mm? -143.98 115.86 8.29 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.908 1.683 . . . . 0.0 108.696 -174.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.32 148.04 44.86 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.951 2.1 . . . . 0.0 109.405 173.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -137.32 122.99 19.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.84 1.256 . . . . 0.0 109.123 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 t -139.54 151.77 46.37 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.516 1.126 . . . . 0.0 108.219 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -149.81 145.17 26.45 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 170.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -137.8 165.22 26.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.971 1.709 . . . . 0.0 108.772 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -119.9 159.55 24.44 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.216 -1.553 . . . . 0.0 110.633 169.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 t -140.43 159.82 41.36 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 170.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -141.11 97.85 3.26 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.69 83.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 174.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.2 mtt-85 54.62 48.97 19.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.263 1.025 . . . . 0.0 111.73 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 m 62.4 5.14 1.49 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.534 1.534 . . . . 0.0 114.876 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.7 t -82.2 148.74 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 121.169 1.804 . . . . 0.0 107.232 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 t70 78.02 -59.27 0.44 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.56 2.744 . . . . 0.0 113.032 171.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.4 t 68.82 -72.83 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 127.868 2.467 . . . . 0.0 113.089 165.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.15 116.18 1.09 Allowed Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.2 t -106.11 150.71 25.54 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.954 0.883 . . . . 0.0 109.466 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -134.9 133.28 39.46 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.5 pt -130.41 159.57 42.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.98 150.01 50.58 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.526 1.53 . . . . 0.0 109.27 -171.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -153.85 106.62 0.3 Allowed Glycine 0 C--O 1.22 -0.775 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 123' ' ' LEU . 34.3 m -128.85 167.13 24.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 118.848 1.324 . . . . 0.0 109.213 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 165.59 -122.29 1.06 Allowed Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -163.14 177.21 9.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.445 1.898 . . . . 0.0 109.556 -167.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -121.54 163.12 19.38 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.211 -0.931 . . . . 0.0 111.239 171.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . 0.258 0.0 OUTLIER . . . . . 0 C--O 1.251 1.173 0 CA-C-O 116.521 -1.704 . . . . 0.0 107.475 160.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 115.829 -2.034 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -139.14 152.04 47.12 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 123.335 2.788 . . . . 0.0 109.928 -163.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m -143.53 160.04 41.35 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 161.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.8 m -142.93 105.11 4.42 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 119.689 -1.882 . . . . 0.0 107.939 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 m -92.69 138.2 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.524 1.529 . . . . 0.0 107.273 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.6 m -148.92 143.72 26.39 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 168.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.47 164.19 32.41 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.44 -111.9 0.47 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -173.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -124.87 158.38 33.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.373 1.087 . . . . 0.0 111.018 -168.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.51 133.26 34.37 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 128.517 2.727 . . . . 0.0 104.03 174.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -140.0 131.89 27.65 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 164.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -85.27 151.2 24.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 161.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 18' ' ' MET . 0.8 OUTLIER -138.74 169.96 16.86 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.121 1.368 . . . . 0.0 107.693 160.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.82 154.92 40.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.345 1.43 . . . . 0.0 109.603 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -70.75 97.62 1.4 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.038 0.923 . . . . 0.0 110.821 -168.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.48 -26.06 3.38 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 127.592 2.52 . . . . 0.0 109.419 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -146.79 96.07 2.69 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.481 1.512 . . . . 0.0 107.059 -170.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.449 ' HA ' ' HB2' ' A' ' 13' ' ' ASP . 2.5 mpt? -76.82 61.01 1.83 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.307 1.043 . . . . 0.0 109.187 172.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -70.74 99.11 1.64 Allowed 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 124.995 1.318 . . . . 0.0 107.538 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -70.47 108.51 4.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.9 ptt? -136.75 130.95 32.75 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.26 -173.5 44.53 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -161.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.88 -94.24 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -149.64 137.95 20.63 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -101.19 148.84 24.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.673 1.589 . . . . 0.0 109.487 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.86 136.65 27.27 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.733 1.213 . . . . 0.0 107.881 163.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.07 150.81 50.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.44 1.096 . . . . 0.0 108.274 166.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -135.88 122.28 20.61 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -107.69 128.55 54.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -99.06 147.95 24.53 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 167.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -111.54 114.51 27.64 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 156.46 37.11 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.09 -20.54 17.93 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.276 1.031 . . . . 0.0 110.345 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.12 -8.16 59.71 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -170.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.37 163.28 18.61 Favored Pre-proline 0 C--O 1.236 0.372 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.99 -7.92 19.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.082 1.855 . . . . 0.0 112.775 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 tp -81.45 139.53 35.16 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.883 1.219 . . . . 0.0 109.655 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.32 -169.57 13.09 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.881 1.229 . . . . 0.0 110.445 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -121.47 150.29 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.807 0.843 . . . . 0.0 109.437 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.6 tp -135.8 141.77 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.24 145.53 11.08 Favored Glycine 0 C--O 1.239 0.408 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.6 m -112.08 141.14 46.12 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -170.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -111.95 115.3 28.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 64.4 m -91.47 150.89 21.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -140.47 142.31 35.35 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 160.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.2 m -143.06 133.59 24.96 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.957 0.903 . . . . 0.0 109.57 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -130.27 171.15 13.22 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 149.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -157.66 146.37 19.43 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 p -79.06 107.07 11.55 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 157.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -105.55 105.0 14.83 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 167.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -163.41 179.62 7.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.563 1.145 . . . . 0.0 109.542 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.45 -86.31 0.16 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.856 2.063 . . . . 0.0 105.64 166.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -124.01 -7.77 7.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.164 1.386 . . . . 0.0 114.218 -173.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 m 129.93 70.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 131.682 3.993 . . . . 0.0 109.745 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -134.26 -82.11 0.17 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 169.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -73.35 103.11 3.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.518 2.327 . . . . 0.0 107.651 176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -117.77 88.61 2.95 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.71 111.99 24.91 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -165.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -113.68 130.4 56.42 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -171.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -160.17 165.95 30.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.577 1.551 . . . . 0.0 110.045 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -117.14 140.79 49.08 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 162.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -107.95 123.34 48.49 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -126.08 135.74 52.09 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 163.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.92 95.05 0.32 Allowed Glycine 0 C--N 1.331 0.278 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -174.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.6 mt -77.45 108.99 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 p -131.35 128.21 39.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.593 1.957 . . . . 0.0 106.637 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.62 174.03 13.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.737 0.415 . . . . 0.0 111.396 -172.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.87 176.57 48.09 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 123.34 0.495 . . . . 0.0 113.072 170.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.73 129.73 10.17 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.89 3.06 . . . . 0.0 109.421 168.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.74 149.09 22.17 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.629 0.772 . . . . 0.0 110.044 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -141.29 127.43 19.6 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.071 0.948 . . . . 0.0 108.683 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.6 120.32 16.05 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 125.164 1.385 . . . . 0.0 109.625 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mp -67.67 165.99 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.744 1.618 . . . . 0.0 107.161 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -79.03 14.64 1.34 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 120.524 -1.36 . . . . 0.0 112.313 -174.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -139.13 60.87 1.58 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.471 1.508 . . . . 0.0 108.485 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 57.2 m95 58.35 -16.68 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 129.079 2.951 . . . . 0.0 117.716 170.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.52 161.12 29.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.492 1.117 . . . . 0.0 108.758 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.2 p -142.93 115.98 8.87 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 117.657 -1.163 . . . . 0.0 108.478 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.785 HG12 HD13 ' A' ' 113' ' ' LEU . 1.9 mp -142.1 151.26 18.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.09 1.356 . . . . 0.0 108.297 -174.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -150.29 173.95 13.4 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.84 1.256 . . . . 0.0 109.1 160.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.21 140.46 27.51 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 168.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.2 m -125.34 143.8 37.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.196 0.998 . . . . 0.0 108.731 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.95 165.41 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.062 0.945 . . . . 0.0 109.819 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 177.25 -162.62 30.79 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.884 -166.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.69 139.89 19.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.579 0.751 . . . . 0.0 109.287 173.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.51 146.41 16.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 125.403 1.478 . . . . 0.0 109.466 168.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 3.7 p90 -149.37 166.96 27.47 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 122.095 -0.65 . . . . 0.0 111.926 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.64 -93.96 0.1 OUTLIER Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 149.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 72.89 105.67 0.07 Allowed 'General case' 0 C--O 1.233 0.19 0 C-N-CA 128.557 2.743 . . . . 0.0 108.813 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -131.2 -75.83 0.52 Allowed 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.242 0.617 . . . . 0.0 110.659 -167.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -156.64 137.32 13.26 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.0 m -137.3 137.71 39.25 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 166.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.8 t -133.93 54.9 1.92 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -162.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -79.92 60.71 3.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.4 1.08 . . . . 0.0 111.764 -159.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -39.55 -53.65 4.22 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -166.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.98 9.8 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.915 3.076 . . . . 0.0 114.864 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 m -137.29 -65.9 0.52 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.846 2.058 . . . . 0.0 109.849 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -169.29 -167.41 0.71 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.717 1.207 . . . . 0.0 110.511 -170.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.5 109.6 6.45 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 173.89 155.15 0.12 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 127.097 2.159 . . . . 0.0 105.267 -167.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.92 122.3 14.95 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.071 1.749 . . . . 0.0 109.347 -174.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.0 t -140.59 94.11 2.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.014 0.926 . . . . 0.0 110.202 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.8 m -157.12 88.55 1.03 Allowed 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.845 -1.159 . . . . 0.0 109.925 164.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 87' ' ' TYR . 45.5 p30 -161.69 176.02 11.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.404 3.082 . . . . 0.0 109.586 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 54.83 17.27 1.71 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.904 2.081 . . . . 0.0 114.959 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.97 104.33 1.31 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.21 148.52 45.48 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.5 p -136.79 161.19 36.66 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.621 0.725 . . . . 0.0 111.518 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.57 157.23 37.96 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.497 1.519 . . . . 0.0 108.957 174.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.02 -168.3 37.91 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.881 1.705 . . . . 0.0 108.987 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.68 152.1 51.8 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -113.1 116.85 4.08 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.785 HD13 HG12 ' A' ' 79' ' ' ILE . 1.8 mm? -115.64 139.71 49.86 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -166.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.66 145.55 38.59 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 120.916 -1.115 . . . . 0.0 109.4 -172.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -93.15 164.4 13.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 174.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -56.86 103.92 0.39 Allowed Pre-proline 0 CA--C 1.528 0.125 0 C-N-CA 125.062 1.345 . . . . 0.0 110.579 -166.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.14 120.26 5.64 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.37 1.38 . . . . 0.0 109.058 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.7 mtm 166.9 153.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 129.917 3.287 . . . . 0.0 105.682 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 113.96 28.2 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 129.767 3.227 . . . . 0.0 107.494 160.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.9 t30 44.08 26.69 0.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.372 1.469 . . . . 0.0 113.727 -153.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.64 169.3 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 108.477 160.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.89 135.89 5.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.016 2.926 . . . . 0.0 103.155 171.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.46 HD22 HG12 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -122.22 146.87 46.85 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -172.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -141.16 152.94 45.09 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.243 1.017 . . . . 0.0 109.196 -176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -150.34 114.76 5.18 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.38 2.272 . . . . 0.0 105.603 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.1 m -118.3 154.23 32.66 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 168.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.49 120.85 11.62 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -136.61 136.11 38.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.234 1.413 . . . . 0.0 108.792 -168.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -100.05 150.68 22.21 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.799 0.84 . . . . 0.0 109.31 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.3 m -133.87 160.05 38.82 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.824 1.65 . . . . 0.0 108.039 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.52 97.79 4.18 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.907 1.283 . . . . 0.0 111.208 -166.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.4 mt -134.31 89.03 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.093 0.957 . . . . 0.0 108.888 -166.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.22 -161.31 0.18 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -177.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.5 m -77.34 58.55 1.68 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.543 1.065 . . . . 0.0 109.438 168.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 25.2 t -129.65 149.42 33.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 170.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -122.2 80.46 1.72 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.842 0.746 . . . . 0.0 110.766 -174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.9 t -78.99 96.55 2.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.931 1.693 . . . . 0.0 108.887 -173.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -82.66 144.65 23.27 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 107.283 -2.327 . . . . 0.0 107.283 164.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.12 152.83 45.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 172.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -140.87 147.65 39.26 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 164.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.02 150.47 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.64 166.11 26.12 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.681 0.792 . . . . 0.0 108.9 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.18 178.77 47.14 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.642 -0.789 . . . . 0.0 114.107 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.46 HG12 HD22 ' A' ' 123' ' ' LEU . 11.6 m -129.5 163.33 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 127.783 2.433 . . . . 0.0 107.042 167.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -166.56 -119.25 0.47 Allowed Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -163.17 164.39 25.23 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.579 1.19 . . . . 0.0 110.711 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -91.36 125.93 36.28 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 166.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 116.865 -1.54 . . . . 0.0 107.613 164.615 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 t -150.42 142.08 23.62 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 120.728 -1.232 . . . . 0.0 108.937 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -140.71 106.86 5.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.801 0.81 . . . . 0.0 109.419 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.1 p -104.84 129.01 53.24 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 p -91.7 145.28 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 165.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.3 t -158.14 161.07 37.88 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.89 173.72 27.66 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.07 -162.06 34.84 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -171.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -91.6 144.5 25.47 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -172.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB3' ' H ' ' A' ' 23' ' ' GLY . . . -95.57 134.92 37.89 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 170.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.5 104.14 5.26 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 127.394 2.278 . . . . 0.0 106.552 -175.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 t -84.66 140.64 31.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.286 1.434 . . . . 0.0 107.393 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -138.78 126.89 22.6 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.059 1.744 . . . . 0.0 106.798 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -118.85 147.45 43.93 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 120.778 1.626 . . . . 0.0 107.613 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -63.24 92.58 0.06 Allowed 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 124.052 0.845 . . . . 0.0 108.722 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.65 15.84 41.72 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-O 117.434 -1.759 . . . . 0.0 111.922 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -150.76 94.91 2.14 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 157.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.6 mtt -76.73 57.26 1.25 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.882 2.873 . . . . 0.0 109.441 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -71.41 101.57 2.44 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -63.13 102.4 0.37 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.64 159.61 41.3 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.166 1.787 . . . . 0.0 106.983 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.11 -176.37 17.8 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -171.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 10' ' ' ALA . . . -163.69 -137.4 2.18 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 105.322 -3.111 . . . . 0.0 105.322 -164.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.76 157.69 25.1 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.211 1.506 . . . . 0.0 109.469 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -134.57 148.59 50.5 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.894 1.678 . . . . 0.0 107.995 -173.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.95 124.95 19.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.168 -1.789 . . . . 0.0 106.168 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -120.55 132.56 55.22 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -155.61 106.52 2.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -166.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.57 164.91 28.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.999 0.428 . . . . 0.0 110.88 -173.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -125.4 157.74 36.06 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.061 2.144 . . . . 0.0 106.59 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -128.79 159.94 34.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 168.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -136.12 125.84 25.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -67.41 1.46 2.24 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.933 1.293 . . . . 0.0 113.203 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -55.73 -27.07 48.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.723 0.809 . . . . 0.0 111.376 159.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.7 m -147.44 107.04 3.82 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 169.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.99 78.01 2.26 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.487 2.791 . . . . 0.0 109.713 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.41 126.31 10.44 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 128.83 2.852 . . . . 0.0 105.433 173.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.39 176.87 48.58 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' O ' HD13 ' A' ' 40' ' ' ILE . 48.6 t -122.23 146.78 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 170.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.69 HD11 ' HB2' ' A' ' 70' ' ' ALA . 17.1 mm -138.44 116.27 12.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -170.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.09 124.05 1.75 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 107.009 -2.436 . . . . 0.0 107.009 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.0 p -122.71 153.92 38.79 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.129 1.771 . . . . 0.0 107.557 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -129.49 120.21 25.03 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -160.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.9 p -119.69 115.15 23.34 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.906 0.776 . . . . 0.0 110.07 -152.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.93 153.85 32.9 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.307 -0.871 . . . . 0.0 110.954 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.5 t -131.58 122.34 25.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.913 0.885 . . . . 0.0 109.035 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.1 mp0 -131.59 74.81 1.61 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.04 1.736 . . . . 0.0 106.926 174.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -153.76 146.45 24.24 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.5 t -131.06 155.78 46.32 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.911 2.084 . . . . 0.0 107.925 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -126.96 101.25 6.49 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 172.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 p -142.04 93.47 2.55 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.96 36.79 2.15 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.971 1.309 . . . . 0.0 111.073 -173.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 m 105.46 44.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 1 C-N-CA 131.878 4.071 . . . . 0.0 111.409 175.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.3 m -126.04 -59.0 1.35 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.098 0.959 . . . . 0.0 108.633 166.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.63 74.91 1.29 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 105.763 -2.935 . . . . 0.0 105.763 -162.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -120.09 91.69 3.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.54 91.94 7.82 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -66.65 112.36 4.13 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.15 0.886 . . . . 0.0 111.931 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -89.31 171.04 10.05 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.893 -1.129 . . . . 0.0 108.093 161.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 66.35 175.67 0.23 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.563 2.345 . . . . 0.0 112.46 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -139.02 155.88 47.63 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.855 1.662 . . . . 0.0 107.321 -167.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -77.57 157.68 30.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -140.97 117.33 10.74 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 154.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.91 106.05 2.32 Favored Glycine 0 C--O 1.241 0.553 0 N-CA-C 106.882 -2.487 . . . . 0.0 106.882 170.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.6 tt -104.21 108.95 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.3 p -128.96 159.16 36.76 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -137.45 163.5 30.94 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.3 156.32 27.28 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 157.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.02 178.86 0.13 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.281 2.654 . . . . 0.0 112.083 145.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.69 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -126.35 144.49 50.8 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.698 1.599 . . . . 0.0 108.191 154.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -133.35 155.87 48.66 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.065 1.346 . . . . 0.0 109.323 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.94 94.99 5.37 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 170.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 33.8 mt -28.09 -70.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 129.832 3.253 . . . . 0.0 110.324 -170.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.411 ' H ' ' H ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -170.12 5.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.67 1.588 . . . . 0.0 110.368 177.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.411 ' H ' ' H ' ' A' ' 74' ' ' ASN . 2.0 t70 -150.08 -177.1 5.73 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.6 1.16 . . . . 0.0 108.714 -175.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -73.98 63.22 0.92 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.84 2.456 . . . . 0.0 112.936 -166.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.64 175.86 10.06 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.792 1.637 . . . . 0.0 108.648 166.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -143.21 112.28 6.63 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 155.66 18.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.689 0.796 . . . . 0.0 109.71 -173.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -149.55 162.77 39.51 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 155.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.7 131.77 10.62 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 163.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.33 144.59 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 118.712 1.256 . . . . 0.0 108.446 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 m -145.97 165.13 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 123.301 0.64 . . . . 0.0 111.423 -174.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.41 -143.62 9.54 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.9 p -133.38 146.33 32.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -170.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.42 113.4 1.51 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 125.087 1.327 . . . . 0.0 109.831 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -95.57 117.12 29.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.476 1.91 . . . . 0.0 107.202 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.98 77.86 0.38 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -84.59 77.28 10.07 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -67.62 83.01 0.18 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.573 1.149 . . . . 0.0 110.757 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -63.72 116.7 5.97 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 165.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.3 t -129.46 165.74 21.0 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 157.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.24 -11.25 0.42 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 116.938 -1.506 . . . . 0.0 114.266 -175.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -82.15 -94.14 0.05 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 120.298 1.408 . . . . 0.0 108.957 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.59 -49.24 94.91 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -162.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.1 -2.89 12.75 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 CA-C-N 122.192 1.819 . . . . 0.0 113.319 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.7 m 57.85 88.28 0.06 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.703 1.201 . . . . 0.0 111.294 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 70.06 -148.35 0.1 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.841 1.656 . . . . 0.0 110.516 -178.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -55.63 113.07 1.31 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.234 1.014 . . . . 0.0 110.539 -171.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -45.35 -45.85 12.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.212 1.405 . . . . 0.0 113.985 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 144.51 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.236 1 C-N-CA 132.276 4.23 . . . . 0.0 111.797 174.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.8 t -135.03 110.58 9.16 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 120.591 -1.318 . . . . 0.0 108.222 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.7 m -156.5 67.55 0.57 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.601 1.56 . . . . 0.0 107.577 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.08 177.12 9.0 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.981 0.913 . . . . 0.0 111.616 -159.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -72.59 123.87 24.1 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.624 0.77 . . . . 0.0 110.079 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.76 165.43 17.7 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 159.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -90.3 135.16 33.85 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.1 m -104.98 131.84 51.99 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -143.05 134.69 26.49 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.83 -162.86 14.29 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 124.55 1.071 . . . . 0.0 110.868 -161.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.54 174.44 11.73 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.922 1.289 . . . . 0.0 109.503 171.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -135.01 142.34 13.76 Favored Glycine 0 C--N 1.33 0.249 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 168.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.31 140.23 52.34 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -131.86 149.52 52.43 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -109.62 171.38 7.48 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 126.416 1.886 . . . . 0.0 108.726 174.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -56.49 111.38 3.19 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.639 1.176 . . . . 0.0 110.834 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.64 114.23 3.98 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.932 3.088 . . . . 0.0 110.795 -169.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 49.1 mtt -80.13 158.07 26.46 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.791 1.281 . . . . 0.0 109.738 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -81.12 90.68 6.05 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 168.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 134.59 -20.98 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.925 1 C-N-CA 132.414 4.285 . . . . 0.0 112.235 170.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.13 119.06 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 120.17 1.35 . . . . 0.0 108.898 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.26 155.37 34.42 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 120.201 -1.562 . . . . 0.0 107.729 155.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -125.58 114.58 18.92 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 161.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -155.5 151.67 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -147.84 151.81 36.58 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.47 1.508 . . . . 0.0 108.68 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.4 t -125.18 141.97 51.78 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 161.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -115.5 124.94 52.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -132.43 119.24 20.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.251 1.02 . . . . 0.0 108.734 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -109.57 107.32 17.36 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 170.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 34.2 t -85.21 160.37 19.9 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 163.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -136.65 151.71 49.61 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 155.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.89 111.42 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.9 ttt-85 52.86 46.14 27.35 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.309 1.044 . . . . 0.0 111.893 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.1 m 56.1 39.43 30.39 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.272 1.029 . . . . 0.0 113.134 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.59 140.95 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 153.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -101.3 122.07 43.02 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 126.428 1.891 . . . . 0.0 108.376 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.5 t -128.85 93.45 2.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -166.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.74 139.26 17.0 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 m -141.34 119.48 12.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -123.79 113.74 18.96 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.6 pp -108.29 147.5 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 119.649 1.113 . . . . 0.0 109.477 -172.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.58 163.45 15.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 173.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -147.81 102.83 0.25 Allowed Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 107.669 -2.172 . . . . 0.0 107.669 -172.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.08 153.3 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.59 -141.93 7.55 Favored Glycine 0 C--O 1.218 -0.87 0 CA-C-O 117.532 -1.705 . . . . 0.0 109.203 -159.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -163.41 167.09 22.1 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 121.609 2.705 . . . . 0.0 111.003 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -89.35 144.92 25.71 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 159.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.359 -0.829 . . . . 0.0 108.781 154.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -150.66 164.72 35.42 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 t -143.48 159.72 41.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.3 1.84 . . . . 0.0 108.173 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -131.5 146.08 52.06 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.85 98.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.9 t -148.38 119.81 7.91 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -159.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.65 171.17 40.03 Favored Glycine 0 CA--C 1.518 0.263 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.34 -123.08 1.12 Allowed Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 106.941 -2.463 . . . . 0.0 106.941 -163.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -146.6 158.3 43.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -159.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.02 156.69 31.62 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.094 0.958 . . . . 0.0 109.725 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -125.47 111.9 15.62 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 167.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.8 m -85.48 140.9 30.31 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 160.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -138.79 172.02 13.48 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.12 2.568 . . . . 0.0 107.062 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.91 164.49 33.57 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.875 1.216 . . . . 0.0 110.794 162.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.81 86.19 5.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 122.092 0.949 . . . . 0.0 109.201 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.3 -32.02 1.53 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.576 1.56 . . . . 0.0 109.892 172.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -137.6 99.29 3.9 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.6 mtt -69.3 71.38 0.28 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 160.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -71.98 91.97 1.25 Allowed 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 166.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -68.12 120.36 14.2 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.0 mtp -137.28 134.4 36.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.46 -179.76 24.66 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 107.509 -2.236 . . . . 0.0 107.509 162.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.59 -105.37 0.28 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 104.428 -3.469 . . . . 0.0 104.428 170.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -127.97 153.98 46.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.144 1.378 . . . . 0.0 108.723 167.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -138.81 129.58 26.33 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.123 2.169 . . . . 0.0 109.651 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 tp -135.56 143.17 45.54 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.937 1.244 . . . . 0.0 109.896 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -127.05 166.27 17.91 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.356 1.863 . . . . 0.0 109.07 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.5 141.24 18.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.899 1.68 . . . . 0.0 106.971 -166.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -116.74 147.62 41.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.089 0.859 . . . . 0.0 109.395 165.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.14 120.0 21.7 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.654 1.582 . . . . 0.0 107.574 166.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -101.59 112.49 25.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -86.5 101.02 12.8 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.475 1.91 . . . . 0.0 107.896 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 38.04 64.05 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.683 1.993 . . . . 0.0 111.981 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 62.35 40.15 11.51 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.775 2.03 . . . . 0.0 112.394 177.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.8 p -63.82 122.96 79.98 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.57 -37.39 12.81 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.211 1.941 . . . . 0.0 112.08 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.06 155.3 32.59 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 164.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.59 -167.35 12.18 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 172.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.41 146.17 34.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.23 137.08 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 104.087 -2.56 . . . . 0.0 104.087 167.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.28 108.55 0.36 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 165.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 p -125.52 137.59 53.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.444 0.622 . . . . 0.0 110.925 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.65 153.62 20.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.5 m -120.3 132.7 55.42 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 161.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -120.36 153.33 36.64 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 126.806 2.042 . . . . 0.0 106.109 167.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.9 p -133.19 145.38 50.55 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.103 0.865 . . . . 0.0 111.741 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -129.77 115.95 18.04 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 163.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -162.66 147.28 11.87 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.9 m -65.22 155.05 36.32 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.07 137.46 51.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 157.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 t -171.91 110.08 0.27 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.528 1.531 . . . . 0.0 107.342 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.69 1.02 0.13 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 119.915 -1.741 . . . . 0.0 114.51 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.3 t -143.3 87.17 1.94 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 127.229 2.212 . . . . 0.0 106.07 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 m 57.77 38.88 27.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.358 1.063 . . . . 0.0 111.273 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.82 33.08 66.32 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.425 -0.653 . . . . 0.0 113.331 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -70.88 91.35 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.174 2.19 . . . . 0.0 109.371 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -116.13 128.02 55.31 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.456 2.303 . . . . 0.0 106.745 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -160.3 172.85 16.61 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.684 0.794 . . . . 0.0 109.705 -167.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -60.33 130.47 46.78 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 170.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -154.01 148.86 26.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.695 0.798 . . . . 0.0 108.977 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -152.74 146.42 25.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 164.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -97.95 122.72 41.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 157.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.9 125.55 45.9 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.04 135.49 12.89 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 23.7 mm -141.89 135.92 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 127.667 2.387 . . . . 0.0 105.603 -176.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.6 t -140.28 153.61 46.55 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.201 1.4 . . . . 0.0 108.168 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.65 152.97 44.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.871 1.268 . . . . 0.0 108.308 170.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.55 141.43 3.16 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 168.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.88 169.69 18.47 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 121.71 1.607 . . . . 0.0 110.163 172.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -102.86 157.86 16.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.465 1.906 . . . . 0.0 107.34 168.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -145.58 116.55 7.8 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -84.22 134.38 34.55 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.0 mp -77.37 -79.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 173.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -171.61 1.94 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.245 0.929 . . . . 0.0 113.374 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -135.15 66.81 1.51 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -162.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 93.3 m95 53.47 -38.92 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 131.013 3.725 . . . . 0.0 117.569 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.21 162.9 28.47 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.182 1.793 . . . . 0.0 110.603 -170.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.2 t -148.45 110.08 4.47 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.87 145.76 34.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -151.07 164.91 35.35 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.91 0.884 . . . . 0.0 109.333 166.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.62 130.45 20.54 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 170.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.9 m -119.57 172.17 6.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 C-N-CA 124.298 1.039 . . . . 0.0 108.666 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.1 158.55 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.501 0 C-N-CA 125.682 1.593 . . . . 0.0 108.783 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.0 162.64 25.03 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 170.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.2 p -134.54 136.33 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.44 110.92 1.76 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 107.191 -2.363 . . . . 0.0 107.191 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -129.11 156.62 43.58 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.89 174.04 39.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -127.27 145.61 50.72 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 167.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -162.35 152.04 16.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.746 0.703 . . . . 0.0 110.438 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -111.17 165.29 12.03 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 173.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.0 m -136.29 111.62 9.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.332 1.453 . . . . 0.0 107.468 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.301 2.9 m 69.74 -60.61 0.47 Allowed 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.648 1.979 . . . . 0.0 109.445 -175.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.07 -23.0 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 129.32 3.048 . . . . 0.0 114.299 -171.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -57.36 152.79 30.54 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 164.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.94 -9.92 20.91 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.849 2.366 . . . . 0.0 113.818 -172.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -21.97 60.34 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.877 1.671 . . . . 0.0 112.734 174.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -157.24 -38.52 0.07 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.716 1.144 . . . . 0.0 113.432 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 53.6 tttm 35.43 65.18 0.41 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.211 2.204 . . . . 0.0 114.998 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -110.39 102.65 11.26 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.949 0.899 . . . . 0.0 109.729 175.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.21 143.16 31.57 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.63 0.772 . . . . 0.0 109.223 164.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.5 m -140.01 144.74 37.1 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.397 -0.815 . . . . 0.0 110.49 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.97 153.4 48.42 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 154.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -161.58 176.05 11.44 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.729 0.812 . . . . 0.0 109.223 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -139.62 165.19 27.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.346 1.458 . . . . 0.0 109.032 170.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.29 167.55 38.91 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 165.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -102.85 152.39 21.33 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.323 1.849 . . . . 0.0 110.363 -173.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 p -137.41 168.33 19.86 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.416 1.487 . . . . 0.0 110.101 165.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -146.3 153.12 40.19 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.704 0.802 . . . . 0.0 108.901 168.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.24 -153.94 9.36 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.75 160.28 41.96 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.514 1.125 . . . . 0.0 108.955 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -99.06 121.82 7.35 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 171.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.7 138.94 50.61 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -141.83 155.71 45.56 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.071 -1.018 . . . . 0.0 109.548 -161.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -93.14 163.63 13.56 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -57.02 134.86 80.29 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.336 -0.84 . . . . 0.0 108.759 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.45 104.28 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.444 2.096 . . . . 0.0 110.42 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttt -75.34 -175.02 2.59 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.803 1.241 . . . . 0.0 107.676 167.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -106.08 -13.81 15.34 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.624 1.57 . . . . 0.0 110.438 -159.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.41 25.5 0.35 Allowed 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 125.267 1.427 . . . . 0.0 108.967 166.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.68 137.35 27.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.72 145.2 30.77 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.89 135.68 51.28 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -131.03 145.22 51.96 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.24 1.416 . . . . 0.0 110.362 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -147.5 144.79 28.81 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.487 1.915 . . . . 0.0 108.225 -178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.2 p -145.82 163.62 34.47 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 151.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -137.27 137.46 39.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -138.21 165.16 27.38 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.021 0.929 . . . . 0.0 109.175 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -127.07 118.24 24.02 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 165.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 75.6 m -83.24 154.5 24.16 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.833 0.853 . . . . 0.0 109.684 167.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -116.78 102.96 9.85 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.18 93.95 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.631 0.651 . . . . 0.0 110.996 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 88.57 39.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.79 2.836 . . . . 0.0 109.995 164.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.4 m 52.85 43.77 31.13 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.208 1.403 . . . . 0.0 111.564 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.47 130.28 53.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 127.994 2.517 . . . . 0.0 105.075 165.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -85.75 104.96 15.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.368 0.667 . . . . 0.0 109.724 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.87 92.07 2.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.92 1.288 . . . . 0.0 107.866 -169.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.57 151.81 43.67 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.0 t -138.33 153.49 48.99 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.492 1.117 . . . . 0.0 108.405 165.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -139.36 157.22 46.26 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 152.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.6 pt -120.61 149.03 23.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 168.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.2 123.52 12.29 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 166.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -151.02 154.13 25.39 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.84 -179.55 3.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 125.795 1.638 . . . . 0.0 107.963 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 174.78 -96.09 0.11 Allowed Glycine 0 C--O 1.228 -0.281 0 O-C-N 120.29 -1.506 . . . . 0.0 111.58 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -146.63 176.02 10.15 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.992 1.317 . . . . 0.0 110.522 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -141.31 139.39 33.61 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 10.8 p90 . . . . . 0 C--O 1.252 1.217 0 CA-C-N 119.371 0.987 . . . . 0.0 109.28 176.689 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 110.712 -0.107 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.3 m -146.36 166.65 25.69 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.688 1.595 . . . . 0.0 106.751 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -122.95 140.61 52.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.102 0.961 . . . . 0.0 109.967 -173.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 t -151.42 173.2 14.83 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 m -140.58 120.76 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 m -139.89 122.25 16.03 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -161.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.38 -159.89 33.14 Favored Glycine 0 C--N 1.332 0.331 0 O-C-N 119.931 -1.731 . . . . 0.0 113.635 -157.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 114.44 -99.83 0.97 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 106.984 -2.447 . . . . 0.0 106.984 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -139.74 157.68 45.34 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 119.029 1.414 . . . . 0.0 108.753 -163.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -133.14 132.24 41.41 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.053 1.741 . . . . 0.0 107.703 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -100.04 113.17 25.58 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -85.01 137.72 32.9 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 157.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -138.14 170.65 15.67 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.449 1.1 . . . . 0.0 108.397 171.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -114.23 165.48 12.63 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.264 1.026 . . . . 0.0 111.866 -165.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -46.2 -20.39 0.1 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.28 2.632 . . . . 0.0 113.693 172.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.15 94.71 0.15 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 168.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -42.48 102.94 0.03 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 129.772 3.229 . . . . 0.0 112.408 -173.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 29.3 ttm -145.83 -36.17 0.28 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.003 1.721 . . . . 0.0 111.056 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.89 103.25 7.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.86 1.264 . . . . 0.0 111.658 173.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 157.34 18.0 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.742 172.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 58.9 mtm -130.21 159.7 36.07 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.198 0.999 . . . . 0.0 109.785 172.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.26 176.03 38.94 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 126.026 1.774 . . . . 0.0 110.164 175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.91 -84.58 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.53 156.72 41.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 172.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -137.41 150.22 47.49 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 164.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.8 tp -150.73 131.77 14.33 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 168.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -131.02 161.28 32.32 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.896 2.078 . . . . 0.0 110.143 -176.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -145.46 142.33 29.16 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.761 1.624 . . . . 0.0 108.356 -172.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.438 HH12 ' CB ' ' A' ' 78' ' ' SER . 4.9 tmm_? -131.63 115.27 15.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.475 0.71 . . . . 0.0 109.298 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -98.94 156.57 16.83 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.733 0.697 . . . . 0.0 110.01 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -139.91 113.19 8.35 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.943 1.697 . . . . 0.0 108.939 -165.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -64.35 169.06 4.98 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.414 1.486 . . . . 0.0 110.828 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.2 -30.72 12.84 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.749 0.82 . . . . 0.0 109.37 167.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.83 -82.59 0.06 Allowed 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.56 0.744 . . . . 0.0 109.45 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 84.5 p -89.07 173.45 6.05 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.772 0.829 . . . . 0.0 110.943 -171.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.46 -3.86 14.51 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.628 2.219 . . . . 0.0 112.44 165.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.5 tp -70.67 155.94 40.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.32 0.964 . . . . 0.0 110.13 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.17 -166.77 28.76 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.3 t -132.87 151.08 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 118.163 0.981 . . . . 0.0 109.822 -166.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.448 HD12 ' CE2' ' A' ' 80' ' ' TYR . 46.3 mm -119.88 143.99 29.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 125.74 1.616 . . . . 0.0 107.867 169.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.06 144.37 15.93 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 148.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.0 m -123.51 153.54 40.42 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 127.021 2.128 . . . . 0.0 106.568 168.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -121.15 122.29 39.69 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.5 m -93.54 116.4 28.92 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -166.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -139.22 125.2 19.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.688 0.395 . . . . 0.0 110.781 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 m -133.23 130.97 39.75 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -72.25 -177.45 2.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.962 167.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.13 118.87 4.94 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 119.807 -1.808 . . . . 0.0 109.648 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.3 m -123.48 128.94 50.51 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.835 1.254 . . . . 0.0 108.229 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -70.0 99.81 1.5 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 164.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t 179.85 95.28 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.537 2.335 . . . . 0.0 105.864 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.48 5.59 7.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.216 2.206 . . . . 0.0 111.214 170.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 88.65 -37.11 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 128.376 2.67 . . . . 0.0 109.624 177.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 p -82.6 -66.15 0.92 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 152.67 82.28 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 107.066 -2.414 . . . . 0.0 107.066 -155.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -119.42 99.22 6.55 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 163.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.93 77.32 3.5 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -167.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.49 116.98 17.68 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -149.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -143.54 170.8 15.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 118.469 0.577 . . . . 0.0 110.758 -169.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.4 t30 53.53 -177.23 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.859 1.264 . . . . 0.0 109.026 -150.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -113.53 169.34 9.04 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.914 1.286 . . . . 0.0 108.217 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -97.06 103.43 15.36 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 169.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -98.12 147.55 24.45 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -160.17 170.42 36.24 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.82 138.11 46.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.9 m -134.39 127.07 30.87 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.16 149.02 26.62 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.869 0.468 . . . . 0.0 109.775 -172.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 154.54 -178.28 31.41 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.611 0.624 . . . . 0.0 111.746 176.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -81.29 -177.28 3.57 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.906 3.738 . . . . 0.0 112.141 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.74 146.23 45.56 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.159 -0.963 . . . . 0.0 109.448 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -88.99 101.09 13.74 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.0 ttt-85 -71.83 146.25 48.1 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 162.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 21.8 mm -97.92 -105.34 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 167.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -155.26 -57.15 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 174.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.85 170.57 3.33 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.26 2.224 . . . . 0.0 108.864 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.82 59.47 1.23 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.859 1.264 . . . . 0.0 112.956 -173.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.05 162.9 34.31 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.743 1.617 . . . . 0.0 108.78 158.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.438 ' CB ' HH12 ' A' ' 29' ' ' ARG . 74.4 m -150.05 167.29 27.18 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.755 -1.216 . . . . 0.0 110.342 166.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.54 146.85 24.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' HD12 ' A' ' 40' ' ' ILE . 2.9 m-85 -107.16 148.19 29.16 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 171.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.84 83.19 0.16 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 105.591 -3.003 . . . . 0.0 105.591 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -131.13 167.67 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.513 1.125 . . . . 0.0 110.451 -175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.48 131.22 60.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -175.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -132.68 122.5 3.24 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.74 146.2 28.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.119 0.968 . . . . 0.0 108.834 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.62 145.27 16.29 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 124.04 0.829 . . . . 0.0 111.984 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -126.86 117.7 23.13 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.1 1.36 . . . . 0.0 107.492 165.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.57 133.78 9.06 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 106.003 -2.839 . . . . 0.0 106.003 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -76.36 96.91 4.1 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 168.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -70.04 111.68 5.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -64.84 151.88 44.34 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 167.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.3 141.81 51.59 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 44.1 m -67.51 -6.51 20.09 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.409 1.484 . . . . 0.0 112.706 -171.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 87.12 -28.72 0.06 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.549 2.34 . . . . 0.0 111.709 157.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -37.55 -58.31 1.3 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 128.309 2.644 . . . . 0.0 114.493 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -76.6 15.12 1.1 Allowed 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.384 2.056 . . . . 0.0 113.399 -173.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . 0.305 0.6 OUTLIER 65.81 81.34 0.21 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 123.229 1.49 . . . . 0.0 107.922 -169.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.18 -54.25 1.19 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.937 1.295 . . . . 0.0 110.364 -177.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? 41.81 67.26 0.59 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.46 1.904 . . . . 0.0 114.255 171.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.5 t30 42.55 65.55 0.9 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.877 2.471 . . . . 0.0 113.682 167.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -82.32 -58.32 2.99 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 126.39 1.876 . . . . 0.0 112.517 -165.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.42 157.83 44.93 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.273 -0.892 . . . . 0.0 109.09 164.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -103.2 176.71 5.06 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.71 1.204 . . . . 0.0 111.101 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -137.7 128.49 27.04 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.381 0.61 . . . . 0.0 109.912 -165.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -90.65 159.51 16.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 163.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.33 136.54 8.67 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 105.775 -2.93 . . . . 0.0 105.775 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -130.39 130.3 44.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -171.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.82 -175.19 3.88 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.072 1.349 . . . . 0.0 109.65 -167.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -135.23 148.71 49.69 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 165.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -96.46 64.24 1.11 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 125.436 1.493 . . . . 0.0 109.81 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -95.81 64.29 2.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.755 0.822 . . . . 0.0 109.672 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -96.19 165.72 24.13 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.808 1.67 . . . . 0.0 112.645 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -138.03 140.6 40.18 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.369 1.868 . . . . 0.0 108.857 -174.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -113.45 141.01 47.62 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.041 1.337 . . . . 0.0 109.393 -167.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -119.05 171.83 7.99 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.376 1.071 . . . . 0.0 109.171 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -56.15 110.26 2.2 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.96 1.304 . . . . 0.0 110.15 -173.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 125.98 5.27 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.389 2.726 . . . . 0.0 111.013 -169.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.4 ttp -90.63 155.6 18.73 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 122.919 1.342 . . . . 0.0 110.111 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -80.55 30.1 0.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 128.942 2.897 . . . . 0.0 110.025 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.81 -14.3 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 126.219 1.808 . . . . 0.0 112.021 171.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.9 m -152.16 121.81 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 126.327 1.851 . . . . 0.0 108.058 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.75 165.59 17.02 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 119.996 -1.69 . . . . 0.0 109.64 160.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -139.13 114.58 9.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.935 -2.987 . . . . 0.0 102.935 165.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -156.83 155.58 31.75 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -137.84 114.62 10.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.616 1.566 . . . . 0.0 107.248 -173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 m -113.91 135.24 54.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 165.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -136.84 113.07 9.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 -169.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -121.29 143.47 49.15 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.143 0.977 . . . . 0.0 108.783 -173.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -133.46 125.0 28.06 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.271 1.428 . . . . 0.0 109.461 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.5 p -139.1 160.34 40.03 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 120.007 1.276 . . . . 0.0 111.516 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -113.73 117.22 30.9 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 44.7 mt -120.75 109.72 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.66 41.23 28.68 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.478 1.111 . . . . 0.0 110.903 172.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 56.6 m 58.66 16.5 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.81 128.89 39.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 160.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.12 131.1 41.64 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 169.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.3 t -132.7 133.23 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.2 153.42 17.62 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 106.932 -2.467 . . . . 0.0 106.932 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.3 t -132.69 129.91 39.39 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 159.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -102.04 110.07 21.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 169.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.6 mt -93.86 118.38 39.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -91.63 145.13 24.85 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -124.37 82.75 0.35 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 m -104.99 179.59 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 168.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.9 -120.53 1.23 Allowed Glycine 0 N--CA 1.465 0.618 0 CA-C-O 117.477 -1.735 . . . . 0.0 111.287 -169.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -164.23 164.39 22.53 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.578 1.951 . . . . 0.0 109.701 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.77 132.03 36.26 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.133 -1.604 . . . . 0.0 109.252 175.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.852 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.4 p -141.98 165.96 26.02 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 165.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.47 107.69 4.76 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.971 1.308 . . . . 0.0 110.047 -167.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 m -61.95 142.09 57.64 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 159.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 146' ' ' TYR . 0.9 OUTLIER -131.84 100.23 4.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 171.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.8 m -150.67 146.11 26.27 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.086 -1.634 . . . . 0.0 109.231 -165.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.38 170.81 38.91 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 121.452 0.473 . . . . 0.0 112.125 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.81 -127.32 1.4 Allowed Glycine 0 C--O 1.227 -0.309 0 O-C-N 121.164 -1.198 . . . . 0.0 111.748 -170.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -139.7 158.7 43.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.174 0.989 . . . . 0.0 109.982 -166.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.72 125.76 47.34 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.957 1.303 . . . . 0.0 107.738 169.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -101.94 104.48 15.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 163.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.0 m -89.14 141.94 28.07 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 159.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -138.23 165.03 27.71 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.682 1.993 . . . . 0.0 108.399 170.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.76 164.97 21.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.852 1.261 . . . . 0.0 111.35 -170.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -62.07 5.97 0.09 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.24 102.63 0.23 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 104.521 -3.432 . . . . 0.0 104.521 173.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -65.09 95.92 0.19 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.894 1.278 . . . . 0.0 109.626 -164.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.2 mtt -153.8 10.7 0.41 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.082 2.553 . . . . 0.0 110.596 -176.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -131.78 143.66 50.38 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 120.707 -1.246 . . . . 0.0 109.0 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -137.63 76.99 1.61 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.461 1.904 . . . . 0.0 106.649 164.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 71.9 mtm -83.45 154.74 23.78 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.78 170.08 12.71 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.294 1.902 . . . . 0.0 111.447 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.37 -141.39 3.22 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 -170.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -99.26 123.6 43.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.131 0.966 . . . . 0.0 109.649 -171.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -94.98 151.06 19.5 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.642 1.177 . . . . 0.0 107.846 -172.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.677 HD13 ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -144.56 148.99 35.08 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.292 1.437 . . . . 0.0 107.923 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.677 ' H ' HD13 ' A' ' 26' ' ' LEU . 40.2 mmtt -137.63 130.73 30.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.867 1.667 . . . . 0.0 107.63 -167.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.45 138.62 29.42 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -170.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.21 163.24 33.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.292 1.037 . . . . 0.0 108.608 167.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -120.4 157.87 28.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 161.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -101.94 112.29 24.86 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.09 178.81 6.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.401 1.08 . . . . 0.0 110.315 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -135.37 13.81 3.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.687 1.595 . . . . 0.0 111.504 -156.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -137.44 -28.35 0.92 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.085 0.954 . . . . 0.0 111.503 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 p -120.74 114.71 32.52 Favored Pre-proline 0 CA--C 1.535 0.382 0 O-C-N 120.919 -1.113 . . . . 0.0 111.07 -169.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.75 80.19 2.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.334 2.022 . . . . 0.0 109.227 169.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.34 156.29 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.111 2.164 . . . . 0.0 106.659 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -93.75 167.69 28.52 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.6 -1.111 . . . . 0.0 111.56 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.8 t -124.47 139.01 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 119.313 1.556 . . . . 0.0 107.929 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' A' ' 70' ' ' ALA . 4.9 mp -132.5 110.46 16.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.65 123.39 5.22 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 107.244 -2.343 . . . . 0.0 107.244 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 m -122.55 154.36 38.01 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.509 1.523 . . . . 0.0 109.605 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -121.12 132.71 55.02 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.407 0.683 . . . . 0.0 110.586 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 t -127.64 150.53 49.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.271 1.428 . . . . 0.0 108.185 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -138.62 157.11 46.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.222 3.009 . . . . 0.0 106.493 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 t -99.65 132.81 44.75 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -143.74 40.95 1.42 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.982 0.913 . . . . 0.0 109.888 -166.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -148.35 138.21 22.35 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 120.937 -1.102 . . . . 0.0 110.852 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -90.3 144.58 25.7 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 53.0 mtp85 -134.91 118.1 16.56 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 117.167 -1.397 . . . . 0.0 108.084 157.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.5 m -128.67 123.12 32.37 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 120.238 1.381 . . . . 0.0 108.464 172.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.74 89.02 1.87 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.263 0.625 . . . . 0.0 110.705 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m 60.08 16.97 6.35 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.491 1.117 . . . . 0.0 113.097 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 m -135.68 4.83 3.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.929 1.292 . . . . 0.0 111.123 -169.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.89 23.56 63.66 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.078 0.847 . . . . 0.0 113.543 173.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.5 101.8 6.63 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 128.759 2.824 . . . . 0.0 105.819 177.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -121.61 115.98 23.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.113 165.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -39.09 103.9 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.172 2.189 . . . . 0.0 110.906 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -120.87 122.94 41.34 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.833 1.197 . . . . 0.0 109.579 -166.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 66.28 -166.26 0.22 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.206 1.802 . . . . 0.0 107.67 -165.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -113.79 151.92 31.35 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.051 1.296 . . . . 0.0 110.166 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -75.17 136.65 41.04 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 155.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -122.11 117.59 26.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 174.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.22 124.48 4.54 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 107.625 -2.19 . . . . 0.0 107.625 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.77 157.08 38.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 171.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.8 t -140.61 158.63 43.7 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.14 145.36 24.66 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.024 0.93 . . . . 0.0 108.616 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.65 161.13 33.98 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 151.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.94 154.62 33.66 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.834 1.689 . . . . 0.0 109.398 165.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.546 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -90.15 167.08 13.0 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 161.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -140.69 154.89 46.55 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.772 -0.58 . . . . 0.0 109.933 165.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -111.27 148.56 32.63 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.458 1.103 . . . . 0.0 108.866 -175.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.3 mp -114.74 -58.16 3.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.874 1.27 . . . . 0.0 108.343 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 172.37 -41.14 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.877 2.471 . . . . 0.0 107.957 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.33 165.63 3.48 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.435 2.294 . . . . 0.0 110.406 -177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -82.44 46.93 1.1 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.279 163.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.94 151.59 36.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.516 2.326 . . . . 0.0 106.69 170.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.04 168.45 23.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 163.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.54 148.58 24.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 174.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -150.67 124.33 9.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.353 0.661 . . . . 0.0 110.211 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -63.27 142.21 47.03 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 163.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.53 176.08 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.042 0.937 . . . . 0.0 108.877 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.2 t -127.57 155.2 38.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.64 163.67 26.83 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.82 131.95 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 171.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.44 109.32 0.95 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 107.17 -2.372 . . . . 0.0 107.17 -175.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -128.84 146.3 50.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.41 -175.59 33.28 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 118.225 -1.941 . . . . 0.0 112.56 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -118.16 120.87 39.03 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 -162.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.84 -73.53 0.16 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.781 0.832 . . . . 0.0 112.7 -168.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -175.9 44.97 0.01 OUTLIER 'General case' 0 C--O 1.235 0.304 0 C-N-CA 127.716 2.406 . . . . 0.0 111.84 -165.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.2 95.52 1.28 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.254 1.026 . . . . 0.0 109.485 177.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.4 p -145.03 28.26 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.277 1.431 . . . . 0.0 108.985 -178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.48 -56.87 7.83 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.742 0.817 . . . . 0.0 110.504 -170.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 171.28 -62.93 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 128.243 2.617 . . . . 0.0 108.087 -174.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.54 169.66 10.9 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.702 1.601 . . . . 0.0 110.764 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.5 p -71.05 15.0 0.12 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.885 1.674 . . . . 0.0 112.896 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -155.16 -171.9 3.98 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.361 1.864 . . . . 0.0 107.796 -164.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 133.19 -66.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 131.529 3.932 . . . . 0.0 108.656 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -87.95 -71.78 0.56 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 121.129 1.786 . . . . 0.0 109.423 171.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.2 t0 56.68 -160.36 0.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.496 1.118 . . . . 0.0 110.568 -158.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.9 t -125.38 117.8 24.51 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 126.759 2.024 . . . . 0.0 106.245 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -158.85 38.27 0.22 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.624 1.17 . . . . 0.0 108.132 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.23 143.5 40.17 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.255 1.822 . . . . 0.0 107.103 -166.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.91 88.08 2.47 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.224 1.009 . . . . 0.0 108.336 -156.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.15 39.71 1.87 Allowed Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.322 1.439 . . . . 0.0 111.804 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -73.99 121.23 20.71 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 t -157.29 -161.83 1.12 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -129.58 174.16 9.93 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 126.719 2.008 . . . . 0.0 108.848 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -162.11 -173.8 31.23 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -125.72 105.37 8.93 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.706 1.602 . . . . 0.0 108.244 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.26 141.93 15.89 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -138.15 161.44 36.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.657 1.983 . . . . 0.0 108.2 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -139.46 159.72 41.5 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.116 0.967 . . . . 0.0 108.419 167.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.409 ' CD2' HD12 ' A' ' 123' ' ' LEU . 4.0 m-30 -92.98 171.54 8.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.444 1.498 . . . . 0.0 108.52 165.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -56.48 119.95 32.41 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.411 1.484 . . . . 0.0 109.117 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.12 148.84 70.14 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.166 1.911 . . . . 0.0 110.5 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 95.2 mtp -116.25 -176.52 2.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.322 1.449 . . . . 0.0 108.804 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.88 -15.88 59.56 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.04 1.336 . . . . 0.0 110.139 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -164.59 14.37 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.836 2.455 . . . . 0.0 111.805 -168.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.94 148.16 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.53 ' C ' HD23 ' A' ' 123' ' ' LEU . . . -156.94 154.05 29.09 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 164.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -133.32 115.78 15.33 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.03 109.51 16.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.509 1.523 . . . . 0.0 107.432 -174.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -115.34 143.66 44.94 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.296 1.038 . . . . 0.0 109.251 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.7 p -145.92 162.58 37.46 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.379 1.072 . . . . 0.0 110.656 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -151.12 105.48 3.23 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.372 1.069 . . . . 0.0 109.219 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -123.28 163.58 20.43 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.609 1.564 . . . . 0.0 109.956 -170.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -118.52 158.19 25.86 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.762 0.825 . . . . 0.0 111.577 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 t -140.93 105.96 4.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.267 1.827 . . . . 0.0 109.246 -172.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -78.6 97.93 5.97 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 120.851 -1.155 . . . . 0.0 110.109 169.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.5 81.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.96 -70.87 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 128.522 2.729 . . . . 0.0 112.831 -171.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.83 3.82 2.06 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.298 2.639 . . . . 0.0 110.902 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.72 129.53 46.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -83.27 109.02 16.89 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.2 t -118.72 152.97 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.705 1.202 . . . . 0.0 108.368 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -140.2 152.74 22.99 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 128.123 2.773 . . . . 0.0 107.874 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -135.49 136.08 40.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 118.414 1.107 . . . . 0.0 109.644 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -112.45 110.67 21.01 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.1 mt -113.65 129.5 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.31 162.1 35.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.33 1.062 . . . . 0.0 109.679 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -158.07 164.37 33.26 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 167.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.4 m -137.65 166.36 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 166.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -174.82 -107.19 0.2 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 106.982 -2.447 . . . . 0.0 106.982 167.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.419 ' HB2' HG23 ' A' ' 5' ' ' VAL . 5.3 m-85 -141.76 176.6 8.79 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 126.827 2.051 . . . . 0.0 109.335 -170.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.31 151.76 35.94 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.715 -0.616 . . . . 0.0 110.078 171.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 . . . . . 0 C--O 1.248 1.014 0 C-N-CA 126.303 1.841 . . . . 0.0 107.97 168.922 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.5 p -96.65 138.2 34.58 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.661 -0.649 . . . . 0.0 109.507 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -89.97 159.18 17.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.947 1.299 . . . . 0.0 108.627 162.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.0 m -159.92 144.9 15.08 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 167.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 p -138.31 100.14 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.572 0.749 . . . . 0.0 109.143 -171.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 m -132.44 141.35 48.8 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 119.977 -1.702 . . . . 0.0 109.022 -170.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.0 -164.9 26.49 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -166.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.07 -114.05 0.86 Allowed Glycine 0 C--O 1.233 0.094 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.82 158.07 45.11 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 126.363 1.865 . . . . 0.0 109.223 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.44 136.92 51.35 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 160.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -120.07 122.48 41.18 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -131.66 151.05 51.92 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.34 170.69 15.57 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.754 1.622 . . . . 0.0 109.195 -173.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.67 164.89 27.72 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.391 1.076 . . . . 0.0 111.493 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -58.93 74.82 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.268 2.627 . . . . 0.0 110.27 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.71 82.86 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 107.835 -2.106 . . . . 0.0 107.835 -171.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -46.02 96.02 0.01 OUTLIER 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.923 2.489 . . . . 0.0 110.094 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.18 -12.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 126.993 2.117 . . . . 0.0 111.09 -176.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -105.25 123.69 48.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.347 1.459 . . . . 0.0 107.283 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -133.56 95.83 3.57 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.33 159.29 34.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.065 0.936 . . . . 0.0 108.736 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.56 156.09 16.8 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.38 -88.7 0.09 OUTLIER Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -165.42 164.62 19.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.221 1.008 . . . . 0.0 109.251 173.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -130.9 142.17 50.35 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.481 2.312 . . . . 0.0 107.068 166.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mt -150.44 140.13 21.69 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.791 1.236 . . . . 0.0 108.192 165.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -151.53 168.16 25.79 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.048 0.939 . . . . 0.0 110.945 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -141.31 114.51 8.67 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.778 0.831 . . . . 0.0 109.127 -167.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -93.73 108.32 20.09 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -103.55 118.26 36.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -140.55 143.3 35.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG3' ' H ' ' A' ' 34' ' ' ASN . 7.9 tp10 -143.33 147.46 34.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -175.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.89 2.41 20.2 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.557 1.143 . . . . 0.0 112.184 -175.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.483 ' H ' ' HG3' ' A' ' 32' ' ' GLU . 4.0 m120 -73.93 -39.07 64.06 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.116 1.366 . . . . 0.0 110.335 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 t -153.37 110.58 2.61 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.4 68.23 5.25 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.992 3.128 . . . . 0.0 110.025 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.1 tp -139.05 105.3 5.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 104.281 -2.488 . . . . 0.0 104.281 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.8 -177.53 47.31 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 123.677 0.656 . . . . 0.0 111.669 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.1 t -134.61 139.72 47.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 172.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.8 pt -129.43 109.73 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 163.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.28 146.55 18.48 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 154.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.39 155.47 40.3 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 128.404 2.682 . . . . 0.0 106.348 160.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -115.78 131.1 57.04 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 167.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.0 m -92.73 147.45 22.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 156.65 45.23 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.104 1.762 . . . . 0.0 107.106 172.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -143.11 162.43 35.56 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.647 -0.658 . . . . 0.0 109.56 157.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.82 134.21 51.74 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.452 1.901 . . . . 0.0 107.898 166.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.62 147.8 1.1 Allowed 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.513 1.525 . . . . 0.0 107.577 -175.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -130.22 119.01 22.24 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 173.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -134.16 178.31 7.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 125.522 1.529 . . . . 0.0 109.388 175.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.5 t -154.64 38.07 0.42 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.061 1.745 . . . . 0.0 110.325 -173.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.85 107.44 0.45 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.706 0.802 . . . . 0.0 109.306 -172.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.1 m 149.73 -81.74 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 1 C-N-CA 132.643 4.377 . . . . 0.0 108.408 170.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.7 m -119.3 19.42 12.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.328 1.051 . . . . 0.0 112.312 -171.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.61 -2.2 88.01 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-O 118.447 -1.196 . . . . 0.0 114.486 160.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -72.37 106.12 4.37 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 163.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -121.78 108.88 14.01 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 126.055 1.742 . . . . 0.0 108.195 159.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 175.79 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 128.286 2.634 . . . . 0.0 105.423 152.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -150.98 157.02 42.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 128.205 2.602 . . . . 0.0 105.913 168.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -133.48 80.33 1.87 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 -165.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -113.25 150.17 32.79 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -169.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -141.74 159.34 42.43 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 168.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -128.37 173.26 10.34 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.05 140.9 9.77 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -123.31 107.53 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 170.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -138.11 142.28 40.19 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 128.067 2.547 . . . . 0.0 104.868 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.26 40.06 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 118.562 0.619 . . . . 0.0 110.693 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.7 170.04 30.53 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.959 1.742 . . . . 0.0 109.103 161.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.9 179.79 5.36 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.405 2.07 . . . . 0.0 109.006 164.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.66 144.16 48.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 153.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -141.24 125.91 17.92 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttt-85 -83.51 93.56 7.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.069 0.849 . . . . 0.0 109.973 -165.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.1 pp -142.52 -168.79 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.597 1.559 . . . . 0.0 110.354 -174.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 64.38 -95.51 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 128.744 2.818 . . . . 0.0 107.494 -170.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -147.76 115.44 6.37 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 120.55 1.523 . . . . 0.0 108.443 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 12.8 m0 59.81 8.13 1.28 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.027 2.531 . . . . 0.0 115.27 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.9 179.83 4.24 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.397 0.999 . . . . 0.0 109.218 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -144.99 105.32 4.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.87 152.45 35.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -149.99 167.2 27.4 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.649 0.38 . . . . 0.0 109.99 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.89 150.44 50.47 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 163.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.1 m -131.36 143.78 39.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.2 153.41 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 C-N-CA 123.297 0.639 . . . . 0.0 110.643 -177.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.96 -170.81 39.15 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 123.624 0.577 . . . . 0.0 113.118 -169.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.09 141.26 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.048 1.339 . . . . 0.0 107.946 172.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.86 143.69 16.04 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 125.658 1.599 . . . . 0.0 109.519 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.9 130.47 35.96 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.208 1.803 . . . . 0.0 107.305 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -105.86 -145.39 13.09 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.186 1.85 . . . . 0.0 110.091 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.31 133.62 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.484 2.313 . . . . 0.0 110.459 -170.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -135.32 -66.38 0.58 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 117.665 -1.16 . . . . 0.0 112.086 165.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.79 115.73 14.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 120.108 1.322 . . . . 0.0 108.4 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.58 115.48 16.15 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -166.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 p -138.5 -48.69 0.53 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.399 1.454 . . . . 0.0 111.636 -167.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 49.71 -68.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 131.2 3.8 . . . . 0.0 112.743 -163.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.514 ' H ' ' HD2' ' A' ' 96' ' ' PRO . 36.4 m-85 -162.14 -54.37 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 129.073 2.949 . . . . 0.0 109.795 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 95' ' ' TYR . 79.3 Cg_endo -68.58 -2.16 8.77 Favored 'Trans proline' 0 C--N 1.354 0.864 0 CA-C-N 121.892 1.711 . . . . 0.0 113.099 -178.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.9 m 68.87 75.82 0.25 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.784 2.034 . . . . 0.0 108.286 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -59.16 -45.48 90.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.397 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.5 pttp 35.07 49.27 0.41 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.382 2.273 . . . . 0.0 112.358 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -163.97 -80.57 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 118.289 -0.863 . . . . 0.0 109.761 -169.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.8 t0 76.36 154.49 0.15 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 130.075 3.35 . . . . 0.0 112.034 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.7 p -63.38 113.3 3.16 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 162.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.9 p -61.89 103.72 0.38 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 169.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.89 162.02 21.7 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 168.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -146.88 144.57 29.37 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -125.81 107.16 0.93 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 124.594 1.092 . . . . 0.0 111.018 -172.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.68 118.3 15.43 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.8 m -98.05 132.82 43.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -144.91 61.43 1.31 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.3 1.04 . . . . 0.0 110.916 -171.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.63 -164.35 40.23 Favored Glycine 0 CA--C 1.52 0.393 0 O-C-N 121.097 -1.002 . . . . 0.0 113.254 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.94 159.18 40.71 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 151.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -122.46 116.25 2.97 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 107.851 -2.099 . . . . 0.0 107.851 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -117.85 155.72 29.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.104 2.561 . . . . 0.0 106.622 -166.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.28 149.45 33.87 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.935 -1.103 . . . . 0.0 112.152 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.11 172.16 8.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.244 1.818 . . . . 0.0 109.817 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -59.15 130.67 87.0 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 119.12 -0.467 . . . . 0.0 110.796 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.3 118.32 5.29 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.682 2.255 . . . . 0.0 110.361 170.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.1 ttt -78.18 -176.03 4.42 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 150.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -86.68 -28.34 23.21 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 123.856 0.862 . . . . 0.0 109.827 172.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.68 3.59 4.54 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 110.755 -162.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.5 t -150.54 112.25 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 127.82 2.448 . . . . 0.0 105.69 -170.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.92 134.0 51.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.67 132.76 46.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -172.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -141.27 155.67 45.97 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.385 1.474 . . . . 0.0 109.182 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -138.1 123.09 19.02 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 124.525 1.13 . . . . 0.0 108.92 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.2 m -122.42 144.76 48.84 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 164.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -149.79 114.85 5.4 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.86 137.39 38.06 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.777 1.231 . . . . 0.0 108.339 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -99.76 161.64 13.49 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 169.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p -140.14 108.08 5.71 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.407 1.083 . . . . 0.0 109.351 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.8 ttm105 -62.28 123.79 19.16 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 168.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 74.7 mt -123.43 104.78 14.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 46.63 50.93 12.61 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.864 1.265 . . . . 0.0 111.713 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 61.4 m 48.87 29.66 2.39 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -174.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.57 138.58 19.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 156.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -86.21 121.0 28.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 169.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.98 134.16 31.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.34 146.63 17.78 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.7 p -124.16 136.38 54.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -131.63 157.74 42.89 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 163.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.3 mt -127.03 128.25 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -167.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.06 126.91 35.64 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.36 101.99 0.57 Allowed Glycine 0 C--O 1.224 -0.529 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 -170.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 t -138.41 139.17 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 127.291 2.236 . . . . 0.0 106.306 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -179.27 -129.61 1.34 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -146.83 177.1 9.37 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.77 2.028 . . . . 0.0 110.046 -158.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.23 166.28 24.14 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 166.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 12.6 p90 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.486 -1.721 . . . . 0.0 108.278 174.85 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.912 -0.033 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.3 p -140.52 160.35 40.2 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.423 0.689 . . . . 0.0 109.782 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.6 106.64 10.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.632 0.73 . . . . 0.0 110.291 -173.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.78 159.57 29.22 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 161.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.03 101.18 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 166.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.6 t -122.06 143.99 49.18 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.4 160.93 25.95 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.783 1.658 . . . . 0.0 109.043 -175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.75 -172.21 45.25 Favored Glycine 0 CA--C 1.51 -0.277 0 O-C-N 119.406 -2.232 . . . . 0.0 110.732 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -90.78 139.82 30.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.121 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.73 154.8 17.03 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.115 1.366 . . . . 0.0 109.123 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -152.54 118.8 5.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.62 151.12 24.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -138.42 159.94 40.79 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 150.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.63 160.45 37.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.619 0.645 . . . . 0.0 110.948 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -77.41 77.27 3.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.255 0.55 . . . . 0.0 111.176 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.69 -2.8 7.53 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.253 1.406 . . . . 0.0 112.377 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -150.99 96.39 2.32 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.075 1.437 . . . . 0.0 107.994 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.9 mtt -75.99 65.13 1.99 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.863 2.465 . . . . 0.0 110.344 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -78.89 95.94 5.55 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 108.766 173.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -76.35 77.9 3.1 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.563 0.697 . . . . 0.0 109.556 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.3 mmm -114.25 159.42 20.17 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 124.904 1.282 . . . . 0.0 108.273 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.54 163.89 12.73 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -168.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -149.53 -120.95 1.07 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 104.356 -3.498 . . . . 0.0 104.356 -172.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.33 170.32 8.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.335 1.068 . . . . 0.0 109.948 -171.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -137.22 163.14 31.61 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 128.029 2.532 . . . . 0.0 106.387 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.69 158.77 43.82 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 164.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -139.48 156.59 46.84 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 168.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -136.53 130.85 33.08 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -105.63 115.07 29.62 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -98.21 118.67 35.37 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 103.625 -2.731 . . . . 0.0 103.625 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -87.78 128.34 35.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -109.15 178.44 4.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.52 16.42 8.21 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.293 1.437 . . . . 0.0 109.922 -167.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.38 -63.58 0.98 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.191 1.396 . . . . 0.0 110.351 172.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.0 m -75.19 133.29 75.26 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 117.921 0.328 . . . . 0.0 110.768 -172.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.42 -9.22 18.76 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.521 2.814 . . . . 0.0 112.995 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -88.92 155.57 19.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.166 0.986 . . . . 0.0 109.811 173.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -115.72 -172.94 17.16 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 166.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.1 t -130.52 143.92 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 8.9 pt -140.27 142.01 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.85 1.26 . . . . 0.0 109.165 165.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.28 108.08 0.34 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.568 1.08 . . . . 0.0 110.435 166.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.85 153.87 42.36 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.354 1.062 . . . . 0.0 110.374 173.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -120.62 148.38 43.97 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 153.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.2 t -127.38 150.93 49.39 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.452 1.901 . . . . 0.0 105.928 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -142.72 156.97 45.09 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.309 0.504 . . . . 0.0 110.214 171.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.3 t -100.06 143.98 29.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.729 0.812 . . . . 0.0 110.291 -176.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -151.05 29.27 0.66 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.927 2.091 . . . . 0.0 110.572 -172.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -133.68 148.4 51.48 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 118.985 -2.322 . . . . 0.0 111.545 -175.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.2 m -113.17 121.74 45.42 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.939 1.296 . . . . 0.0 107.629 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.11 103.5 13.3 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 171.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -137.45 166.09 24.68 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 164.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.95 -89.02 0.35 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 166.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.1 m -151.38 62.39 0.89 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.399 -0.813 . . . . 0.0 109.145 172.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 m 64.3 79.2 0.26 Allowed 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.477 1.511 . . . . 0.0 111.349 -177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.4 -74.19 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 103.627 -3.789 . . . . 0.0 103.627 156.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -86.11 115.8 23.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 174.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -130.89 117.86 19.89 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 123.42 0.688 . . . . 0.0 110.139 161.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -114.03 143.4 44.81 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 171.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -149.7 120.61 7.65 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 156.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.457 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 41.7 t30 -157.83 -158.41 0.73 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 155.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.457 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 10.8 mp0 -111.36 165.09 12.25 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 165.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.67 116.17 13.73 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 174.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -97.04 133.86 41.16 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -173.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.09 104.8 0.35 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 105.651 -2.98 . . . . 0.0 105.651 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.6 tt -126.46 114.37 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 124.443 1.097 . . . . 0.0 108.762 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 t -122.57 151.84 41.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.75 158.41 39.49 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.067 0.947 . . . . 0.0 109.127 168.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.22 -178.56 42.34 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 168.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.52 142.43 44.57 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.015 1.81 . . . . 0.0 110.377 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.31 103.15 15.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 153.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.7 144.97 33.22 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 167.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -74.06 127.38 32.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 mm -50.27 -60.86 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.19 0.996 . . . . 0.0 108.848 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -156.89 -43.53 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 167.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -79.3 -89.51 0.05 Allowed 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.034 1.333 . . . . 0.0 107.577 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.34 7.11 0.2 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -166.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.84 167.99 20.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.346 1.43 . . . . 0.0 111.161 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.6 p -74.0 168.76 18.86 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.983 0.913 . . . . 0.0 110.166 164.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 80' ' ' TYR . 0.3 OUTLIER -129.74 164.57 32.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.53 ' H ' HD13 ' A' ' 79' ' ' ILE . 43.6 p90 -105.08 171.0 7.55 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.826 2.051 . . . . 0.0 110.971 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.57 70.76 1.16 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.74 168.72 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 117.95 0.875 . . . . 0.0 110.405 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.49 154.12 3.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.76 171.51 36.15 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 118.434 0.561 . . . . 0.0 111.999 163.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.33 126.42 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 170.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.99 104.97 2.02 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 107.774 -2.13 . . . . 0.0 107.774 166.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -112.95 135.75 53.38 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.564 1.146 . . . . 0.0 107.974 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.25 -166.54 39.35 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.79 102.6 0.05 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.924 1.69 . . . . 0.0 110.056 -176.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -124.09 -78.49 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 175.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -69.87 142.4 53.03 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.42 -0.8 . . . . 0.0 110.835 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.456 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 1.1 m -136.01 137.06 40.82 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.029 2.132 . . . . 0.0 105.712 174.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 29.0 m -169.41 101.86 0.34 Allowed 'General case' 0 N--CA 1.444 -0.773 1 N-CA-C 99.653 -4.202 . . . . 0.0 99.653 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -111.01 -36.32 5.68 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.966 1.306 . . . . 0.0 108.038 174.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -160.96 -70.37 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.21 1.404 . . . . 0.0 109.292 160.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.7 -2.03 4.79 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.351 2.701 . . . . 0.0 115.702 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.6 m 66.43 15.21 10.03 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 120.34 1.427 . . . . 0.0 112.728 162.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -56.42 -37.67 70.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.386 1.075 . . . . 0.0 111.649 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.456 ' HG3' ' H ' ' A' ' 92' ' ' THR . 6.2 ttpt 69.2 158.46 0.16 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.676 2.791 . . . . 0.0 112.139 176.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.64 -56.57 1.95 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -171.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 55.13 15.12 1.14 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.062 1.745 . . . . 0.0 112.649 -176.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.9 p -67.37 95.2 0.43 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.773 2.029 . . . . 0.0 111.132 -173.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 p -76.48 125.37 29.1 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -151.18 157.95 43.32 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 167.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -70.89 157.45 38.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 117.894 -1.522 . . . . 0.0 108.729 163.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -110.3 122.55 6.33 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 105.568 -3.013 . . . . 0.0 105.568 159.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -78.63 117.18 19.55 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 78.7 p -103.02 158.33 16.37 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.306 1.051 . . . . 0.0 112.077 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -105.11 112.84 26.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.13 143.03 16.31 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 118.558 0.617 . . . . 0.0 111.783 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -140.18 160.64 39.5 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.689 1.196 . . . . 0.0 109.504 172.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.59 122.12 0.87 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -128.08 140.52 51.9 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.109 1.364 . . . . 0.0 107.482 173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -120.22 149.76 41.76 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.189 0.995 . . . . 0.0 108.85 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -92.66 172.27 8.46 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.947 1.299 . . . . 0.0 109.62 -174.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -57.18 154.71 19.82 Favored Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.552 -0.717 . . . . 0.0 110.702 169.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.46 143.47 52.4 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.77 2.314 . . . . 0.0 111.538 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.7 mmt -108.44 -176.73 3.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 161.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -92.84 -30.33 15.5 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 109.404 -170.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -142.34 9.72 1.86 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.248 1.419 . . . . 0.0 110.693 -171.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.261 0.2 OUTLIER -141.31 140.43 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 119.582 1.083 . . . . 0.0 108.551 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -98.4 153.32 18.66 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -133.39 116.16 15.72 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 162.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -141.09 137.71 33.03 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.864 1.666 . . . . 0.0 107.425 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -133.63 121.81 22.57 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.325 0.966 . . . . 0.0 109.178 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.5 m -127.62 149.94 49.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 140' ' ' TRP . 1.5 t80 -145.01 137.25 25.93 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -127.58 153.87 45.87 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.377 1.071 . . . . 0.0 108.774 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -131.52 154.82 48.39 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 168.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.4 m -136.66 156.77 48.09 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.914 2.086 . . . . 0.0 108.534 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -134.1 97.17 3.79 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -90.3 90.97 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 60.79 -93.11 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 126.656 1.982 . . . . 0.0 110.573 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.17 1.76 20.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.349 0.977 . . . . 0.0 112.633 177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -108.37 112.81 41.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-N 119.847 1.203 . . . . 0.0 108.599 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.43 136.47 57.92 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 162.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.9 t -125.86 116.85 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 169.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.48 149.84 20.04 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 170.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 87.6 m -141.12 120.42 13.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 164.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.448 ' HB3' ' CE2' ' A' ' 127' ' ' TYR . 5.6 p-90 -90.88 141.89 28.34 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 170.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 23.7 pt -131.96 134.88 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.69 164.39 14.73 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 172.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -146.63 104.09 0.29 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 107.541 -2.224 . . . . 0.0 107.541 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.6 t -134.47 -179.83 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.372 1.869 . . . . 0.0 105.989 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 146.15 -115.12 0.78 Allowed Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 106.883 -2.487 . . . . 0.0 106.883 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -147.75 175.8 10.62 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.01 1.324 . . . . 0.0 110.679 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -140.28 165.81 26.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 164.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 13.3 p90 . . . . . 0 C--O 1.25 1.101 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 170.203 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.5 p -140.48 141.38 35.41 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 168.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -122.93 158.78 29.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.1 m -145.78 154.82 42.45 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 166.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.1 98.96 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.1 p -117.47 135.15 54.12 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.928 1.291 . . . . 0.0 107.917 170.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.12 168.42 38.56 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 174.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.44 -169.15 42.1 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.483 -173.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -92.04 157.86 16.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.722 1.209 . . . . 0.0 109.026 -173.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.02 172.91 8.17 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.157 0.983 . . . . 0.0 111.307 -174.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -148.24 104.56 3.54 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 155.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t -84.39 134.02 34.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 157.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -103.28 171.38 7.4 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 167.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.37 158.25 44.02 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 161.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.16 97.45 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 162.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.16 -29.81 2.68 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.778 1.18 . . . . 0.0 110.664 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -151.1 93.88 1.98 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -88.34 69.52 9.06 Favored 'General case' 0 C--N 1.335 -0.065 0 CA-C-O 123.954 1.835 . . . . 0.0 107.005 174.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.49 -177.77 4.76 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 128.168 2.587 . . . . 0.0 108.476 -168.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -90.79 96.78 10.81 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 164.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 62.2 mtm -70.57 159.23 34.73 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 138.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.77 -161.91 17.96 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.46 -140.48 5.04 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -160.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.99 154.45 20.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.864 1.266 . . . . 0.0 109.703 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -137.66 153.89 49.78 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 128.452 2.701 . . . . 0.0 107.634 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mt -150.25 141.41 23.1 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.787 1.635 . . . . 0.0 107.768 168.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -116.43 146.42 42.54 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.693 1.997 . . . . 0.0 107.363 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.66 110.91 10.19 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -93.23 157.7 16.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -143.63 158.25 43.81 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.823 0.283 . . . . 0.0 110.553 165.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -125.02 112.55 16.69 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.564 0.697 . . . . 0.0 109.147 169.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.0 164.09 21.69 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 162.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.81 8.44 41.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.777 1.631 . . . . 0.0 112.912 -169.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -1.27 22.55 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -172.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.06 139.82 8.36 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 126.555 1.942 . . . . 0.0 107.306 166.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.79 81.06 2.45 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.516 2.144 . . . . 0.0 108.301 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 tp -150.65 156.65 41.77 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.202 1.801 . . . . 0.0 107.94 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.18 -177.9 15.26 Favored Glycine 0 C--O 1.226 -0.346 0 O-C-N 121.571 -0.706 . . . . 0.0 111.539 172.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.2 t -143.5 137.37 25.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.367 1.467 . . . . 0.0 108.25 -165.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.6 mm -139.9 141.39 34.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.977 1.311 . . . . 0.0 109.91 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.64 167.89 20.64 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 107.729 -2.149 . . . . 0.0 107.729 144.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.8 t -127.45 155.27 43.95 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.208 -1.76 . . . . 0.0 106.877 143.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -98.48 143.82 28.49 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 165.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -127.7 134.18 49.57 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.858 1.263 . . . . 0.0 108.389 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -141.96 123.87 15.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.593 1.157 . . . . 0.0 108.395 -172.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -99.21 126.85 45.1 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -163.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -139.14 0.48 1.93 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.308 0.575 . . . . 0.0 112.254 -174.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.19 123.49 26.97 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 120.001 -1.687 . . . . 0.0 109.1 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.9 p -67.06 152.25 46.12 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.396 0.998 . . . . 0.0 110.633 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.93 123.22 25.54 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 157.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -157.92 -176.33 5.86 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 161.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -137.77 -54.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.331 1.452 . . . . 0.0 108.878 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 m -147.93 -43.12 0.16 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.917 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 p 173.18 84.04 0.0 OUTLIER 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.401 1.881 . . . . 0.0 106.027 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.66 -74.89 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.799 0 O-C-N 121.849 -0.532 . . . . 0.0 113.261 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -119.28 91.17 3.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 117.989 0.895 . . . . 0.0 109.806 -166.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -88.74 126.21 35.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.894 0.878 . . . . 0.0 110.284 -162.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -62.74 109.2 1.35 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.244 0.929 . . . . 0.0 109.908 170.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -121.25 170.93 9.11 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.259 1.424 . . . . 0.0 110.968 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 61' ' ' GLN . 8.0 t30 58.22 -159.0 0.28 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.71 1.604 . . . . 0.0 111.112 175.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.417 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -128.77 158.64 38.09 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 120.507 -1.371 . . . . 0.0 108.616 174.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -115.73 158.95 22.06 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -127.91 157.14 41.33 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.312 1.845 . . . . 0.0 107.77 -173.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.32 88.82 0.14 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -83.73 113.47 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.9 m -131.16 128.0 39.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.59 149.28 25.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.373 1.069 . . . . 0.0 108.969 -174.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.13 175.87 31.58 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 112.718 -0.153 . . . . 0.0 112.718 166.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.66 175.4 11.15 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.451 2.768 . . . . 0.0 113.036 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.51 138.58 52.34 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.283 1.833 . . . . 0.0 110.712 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -121.02 128.42 52.66 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.08 1.352 . . . . 0.0 108.93 -168.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.53 149.45 24.39 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.71 0.804 . . . . 0.0 110.223 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -78.88 179.06 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 163.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -61.32 -52.65 63.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.617 -1.302 . . . . 0.0 110.718 -176.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -159.98 148.52 17.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 149.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 11.6 m0 145.1 -49.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 130.746 3.618 . . . . 0.0 108.87 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' H ' HG22 ' A' ' 73' ' ' ILE . . . -148.71 168.69 22.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.758 0.823 . . . . 0.0 109.516 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 m -133.48 156.99 46.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 163.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.521 HG22 HD23 ' A' ' 113' ' ' LEU . 16.3 pt -127.47 167.68 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.84 2.056 . . . . 0.0 108.575 -176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.15 123.96 26.61 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 121.268 -0.895 . . . . 0.0 108.885 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.43 86.58 0.4 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 106.908 -2.477 . . . . 0.0 106.908 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.6 HG22 ' HB2' ' A' ' 111' ' ' ALA . 2.3 m -113.66 -176.62 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.336 0.655 . . . . 0.0 109.867 -175.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.4 m -116.33 151.01 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 166.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.77 158.4 20.05 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 167.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.8 p -145.86 121.62 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.05 106.35 3.22 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.661 -1.775 . . . . 0.0 108.661 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -108.59 117.4 34.07 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.43 174.1 19.41 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -154.46 98.92 2.15 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 170.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -70.64 152.63 43.68 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 157.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -148.76 104.64 3.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.536 0.684 . . . . 0.0 109.694 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -66.55 123.32 19.72 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 127.23 2.212 . . . . 0.0 106.977 -178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -126.27 4.5 7.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.46 -163.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -126.5 -61.2 1.21 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.682 1.193 . . . . 0.0 109.054 -164.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -60.02 153.53 55.13 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 167.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -71.79 81.83 1.29 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.693 2.929 . . . . 0.0 109.354 171.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.7 m -138.5 -46.75 0.5 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.484 1.514 . . . . 0.0 109.384 -169.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 68.6 -68.04 0.19 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.026 2.13 . . . . 0.0 112.851 169.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.47 93.8 4.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -70.2 -47.61 60.72 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -176.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.88 176.53 10.07 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.789 1.236 . . . . 0.0 107.786 166.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.4 m -85.17 156.7 20.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 166.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 p -69.68 155.57 40.31 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 175.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -141.11 159.26 42.58 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 165.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -85.68 165.83 16.65 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.494 -0.754 . . . . 0.0 110.267 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.51 142.31 14.27 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 163.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -118.11 93.2 4.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.572 1.186 . . . . 0.0 109.034 -160.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.7 t -87.21 147.51 25.55 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.976 0.893 . . . . 0.0 110.198 -173.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.12 144.24 51.25 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 128.398 2.679 . . . . 0.0 106.479 173.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.69 -170.13 14.56 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 -165.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.6 ' HB2' HG22 ' A' ' 82' ' ' VAL . . . -166.97 -65.53 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 118.413 1.107 . . . . 0.0 109.203 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 155.11 174.35 24.91 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -167.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.521 HD23 HG22 ' A' ' 79' ' ' ILE . 4.2 mp -145.17 143.84 30.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -104.24 149.51 25.24 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -173.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.8 171.17 8.82 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -58.75 142.16 84.21 Favored Pre-proline 0 C--O 1.238 0.48 0 CA-C-O 119.165 -0.445 . . . . 0.0 109.865 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.43 152.55 78.62 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 120.931 1.087 . . . . 0.0 111.007 172.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -109.09 -174.19 2.45 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 130.955 3.702 . . . . 0.0 105.503 162.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -110.93 -11.8 14.3 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.309 1.844 . . . . 0.0 109.294 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -142.01 17.22 2.11 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.176 1.39 . . . . 0.0 111.6 174.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.3 t -142.82 156.04 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 172.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.41 156.71 42.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.777 0.717 . . . . 0.0 109.166 157.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -136.89 122.36 19.54 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.991 2.117 . . . . 0.0 108.403 -176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -124.61 160.52 28.28 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.773 2.429 . . . . 0.0 107.64 163.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -140.87 116.69 10.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.23 144.16 51.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.418 0.554 . . . . 0.0 109.939 -168.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -137.29 156.62 48.05 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -129.79 147.61 51.59 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 155.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -132.84 112.2 11.72 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.8 t -139.56 160.3 40.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.624 1.57 . . . . 0.0 108.228 -157.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.65 145.83 37.11 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.45 110.35 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 171.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 50.17 40.91 23.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.302 1.041 . . . . 0.0 111.97 -173.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.7 m 47.76 36.84 6.19 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.6 t -81.48 112.79 19.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 102.256 -3.239 . . . . 0.0 102.256 143.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.16 137.2 58.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 170.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.5 t -139.26 97.35 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.88 152.4 34.98 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 164.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.8 m -141.0 130.88 24.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 120.775 -1.427 . . . . 0.0 108.047 166.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -121.23 143.19 49.28 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.8 mt -144.75 132.31 16.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.805 1.242 . . . . 0.0 107.873 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.61 165.88 14.51 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -154.26 87.36 0.13 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -172.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.66 162.61 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 152.81 -119.37 0.95 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -150.59 176.38 11.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.119 1.368 . . . . 0.0 109.564 -158.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 137.9 23.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 117.65 -1.167 . . . . 0.0 109.039 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 12.0 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-N 119.34 0.973 . . . . 0.0 108.655 167.288 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 p -141.08 136.95 32.49 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 t -127.9 106.81 9.36 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 m -117.24 118.8 33.3 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.281 5.9 p -110.56 119.41 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 122.006 0.908 . . . . 0.0 111.093 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.32 137.77 23.36 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.728 1.211 . . . . 0.0 108.943 -167.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.5 170.07 40.08 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.59 -152.01 10.02 Favored Glycine 0 C--N 1.319 -0.375 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -172.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -91.87 157.7 16.71 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.47 113.29 11.68 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 169.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -107.32 148.04 29.52 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.8 t -138.88 115.57 10.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.982 2.113 . . . . 0.0 107.206 -171.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -131.38 160.69 34.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.068 0.947 . . . . 0.0 109.163 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.72 148.47 52.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 123.727 0.811 . . . . 0.0 110.986 -167.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 54.65 -70.15 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 128.323 2.649 . . . . 0.0 112.067 -175.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.75 -42.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.7 0 CA-C-N 119.975 1.261 . . . . 0.0 111.04 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -145.21 119.49 9.55 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 124.438 1.095 . . . . 0.0 108.461 164.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.2 ttm -157.18 -51.75 0.07 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.212 1.005 . . . . 0.0 109.324 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -142.19 158.22 43.98 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.232 1.813 . . . . 0.0 107.733 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -135.76 77.33 1.66 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 170.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -56.06 138.62 49.06 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 166.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.84 157.22 27.34 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 175.61 -166.68 38.17 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -170.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -99.89 154.74 18.12 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 117.326 0.563 . . . . 0.0 110.402 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -102.43 144.06 31.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.939 1.296 . . . . 0.0 108.271 161.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.0 mt -127.13 150.86 49.3 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 149.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -147.45 161.09 41.77 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 165.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -144.16 140.41 29.35 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -120.08 114.48 22.05 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.246 0.93 . . . . 0.0 109.357 169.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -99.32 151.92 20.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 163.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -134.69 130.57 36.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -172.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -76.71 163.11 27.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.352 1.072 . . . . 0.0 112.11 -161.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -86.71 27.47 0.98 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.616 1.566 . . . . 0.0 110.885 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -143.1 -65.05 0.39 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.156 1.782 . . . . 0.0 108.983 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.5 p -92.96 127.8 46.03 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.872 1.669 . . . . 0.0 108.921 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -76.92 54.81 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 124.088 3.192 . . . . 0.0 110.252 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.27 106.65 5.81 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.631 2.373 . . . . 0.0 106.73 -159.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.18 178.72 22.07 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.984 1.278 . . . . 0.0 111.082 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -130.85 144.68 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 124.266 1.026 . . . . 0.0 109.555 -156.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.7 mt -126.54 109.8 21.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.94 1.296 . . . . 0.0 108.083 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.01 148.04 18.35 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 105.862 -2.895 . . . . 0.0 105.862 151.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 p -108.89 144.17 37.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.255 1.027 . . . . 0.0 109.196 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -91.9 145.79 24.27 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 162.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 t -128.91 152.44 48.55 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.061 1.744 . . . . 0.0 108.084 176.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -136.98 156.65 48.17 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 175.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.4 m -98.35 121.96 40.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 165.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.56 53.45 1.05 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.474 2.31 . . . . 0.0 107.108 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -158.93 146.63 17.75 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 128.524 2.729 . . . . 0.0 108.464 169.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 p -127.7 156.66 42.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.929 2.491 . . . . 0.0 107.599 163.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 -133.74 146.19 50.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 175.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -145.75 147.73 32.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 54.81 52.8 11.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.555 1.542 . . . . 0.0 111.935 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t -142.34 -49.59 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.213 1.405 . . . . 0.0 107.879 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.1 m -136.68 -43.4 0.6 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.649 -173.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.02 8.15 15.78 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 118.977 0.808 . . . . 0.0 112.684 -170.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -72.02 91.01 1.2 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.833 1.653 . . . . 0.0 106.963 170.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -71.75 96.62 1.64 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.847 2.059 . . . . 0.0 107.861 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -66.06 107.08 1.78 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.581 -0.723 . . . . 0.0 110.396 -171.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' HZ2' HG21 ' A' ' 93' ' ' THR . 86.4 mttt -135.8 146.25 47.37 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 118.739 0.699 . . . . 0.0 110.213 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 51.2 -161.69 0.08 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.352 1.861 . . . . 0.0 110.745 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.67 176.13 7.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.154 1.381 . . . . 0.0 111.527 -171.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -89.3 130.87 35.62 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 160.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.63 120.04 41.12 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 165.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.31 88.67 0.19 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.47 141.07 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.4 p -126.36 155.79 41.52 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.737 1.615 . . . . 0.0 107.782 171.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -139.62 150.58 45.14 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.74 0.7 . . . . 0.0 110.284 170.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 173.53 137.35 2.39 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 174.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.22 164.83 34.4 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 CA-C-N 120.405 2.102 . . . . 0.0 110.706 167.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.14 103.98 13.07 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.236 1.414 . . . . 0.0 107.879 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.71 112.24 21.47 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.336 0.516 . . . . 0.0 109.713 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -67.96 136.67 54.3 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 168.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.483 HD12 ' HB3' ' A' ' 77' ' ' ALA . 1.9 pp -144.84 178.67 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 126.91 2.084 . . . . 0.0 105.88 172.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.8 t30 38.39 -121.37 0.26 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.435 1.494 . . . . 0.0 109.077 -162.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -110.19 104.14 12.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.202 1.801 . . . . 0.0 108.631 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 65.8 m95 60.84 19.46 9.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.381 2.272 . . . . 0.0 114.73 167.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' HB3' HD12 ' A' ' 73' ' ' ILE . . . -74.57 -169.85 0.92 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.293 0.951 . . . . 0.0 110.468 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.1 m -140.95 169.16 18.14 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.148 1.379 . . . . 0.0 107.726 167.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.8 mm -133.83 158.61 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 122.804 1.288 . . . . 0.0 109.235 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -105.43 175.48 5.48 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 130.048 3.339 . . . . 0.0 109.627 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 54.05 0.88 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.58 173.22 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 105.744 -1.946 . . . . 0.0 105.744 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.35 160.41 10.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 O-C-N 120.525 -1.359 . . . . 0.0 108.26 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -156.42 165.45 32.91 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-O 122.182 0.879 . . . . 0.0 112.936 162.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -115.26 150.51 17.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 127.055 2.142 . . . . 0.0 106.065 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.89 149.78 18.41 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 165.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -150.77 145.47 25.77 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.042 1.337 . . . . 0.0 108.944 172.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.62 -133.87 12.07 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.3 tttp 32.6 82.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.586 2.754 . . . . 0.0 114.709 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.52 -45.71 0.82 Allowed 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.594 -0.691 . . . . 0.0 112.603 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 56.84 27.51 13.04 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 p -94.39 97.49 10.23 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.09 1.356 . . . . 0.0 109.201 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.406 HG21 ' HZ2' ' A' ' 59' ' ' LYS . 52.1 m -138.61 -65.38 0.5 Allowed 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 105.896 -1.891 . . . . 0.0 105.896 171.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . 0.294 7.7 tt0 26.32 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.933 2.493 . . . . 0.0 111.666 -150.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -138.51 -69.06 0.02 OUTLIER Pre-proline 0 C--O 1.235 0.294 0 CA-C-O 117.342 -1.313 . . . . 0.0 111.369 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.26 -34.12 36.93 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.198 1.464 . . . . 0.0 112.837 -170.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.7 m -65.79 -55.09 19.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.299 0.954 . . . . 0.0 109.588 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.5 t80 43.92 34.76 0.97 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.774 1.63 . . . . 0.0 113.176 -174.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -64.36 -45.16 88.96 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 120.612 -1.305 . . . . 0.0 108.692 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 72.07 -74.17 0.09 Allowed 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 127.315 2.246 . . . . 0.0 108.876 167.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -133.82 146.38 50.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.394 1.877 . . . . 0.0 108.853 170.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 t -139.09 148.21 43.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.69 1.596 . . . . 0.0 106.94 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 t -79.34 24.67 0.34 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.747 1.619 . . . . 0.0 111.353 -175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.64 128.74 36.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 -171.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -114.68 142.83 45.96 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -102.35 168.5 18.79 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -138.43 151.72 47.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 164.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.1 m -169.4 -164.47 0.45 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.775 0.83 . . . . 0.0 110.56 166.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -134.5 160.3 38.44 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.51 1.924 . . . . 0.0 108.446 -176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -153.25 -158.19 8.43 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.771 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -139.83 168.76 19.06 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -167.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.24 86.42 0.1 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mt -130.15 149.85 51.67 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.6 1.16 . . . . 0.0 107.939 -173.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -135.25 158.88 43.24 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.199 0.454 . . . . 0.0 111.602 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -101.01 171.14 7.82 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.711 1.204 . . . . 0.0 107.77 166.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -56.77 107.01 0.76 Allowed Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 123.619 0.768 . . . . 0.0 110.653 -170.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.89 158.06 34.81 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.963 2.442 . . . . 0.0 109.59 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 49.4 ttm -135.95 159.82 40.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.127 1.371 . . . . 0.0 109.189 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -69.88 25.18 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 130.873 3.669 . . . . 0.0 110.75 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.14 -32.16 0.1 Allowed 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 120.885 -1.135 . . . . 0.0 113.015 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.5 m -145.78 135.77 18.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -174.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -103.19 155.32 18.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 119.098 0.863 . . . . 0.0 109.427 168.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -130.44 114.08 15.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 155.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -138.01 148.99 45.68 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.415 2.286 . . . . 0.0 105.607 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -149.83 138.98 21.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 120.644 -1.285 . . . . 0.0 109.471 -162.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.7 m -134.45 166.37 23.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 166.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -145.98 137.89 25.14 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -134.4 163.6 29.3 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -122.02 169.81 10.46 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 127.018 2.127 . . . . 0.0 106.48 170.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.7 t -131.82 159.9 37.19 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 163.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 ttm-85 -123.82 97.08 5.2 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.3 mt -86.88 81.95 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 65.94 -78.92 0.03 OUTLIER 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.248 2.219 . . . . 0.0 111.11 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -146.15 61.06 1.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.167 1.787 . . . . 0.0 107.102 166.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 72.9 t -125.08 145.61 32.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 162.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -101.25 137.17 39.95 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.864 1.666 . . . . 0.0 107.423 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.4 t -138.45 151.52 24.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 126.649 1.98 . . . . 0.0 106.937 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -137.05 143.86 15.27 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -140.48 135.99 32.5 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -123.83 131.18 53.54 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pp -135.5 115.93 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.499 . . . . 0.0 107.504 -166.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.85 152.3 21.34 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.143 0.577 . . . . 0.0 110.055 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -134.26 82.56 0.29 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.818 1.675 . . . . 0.0 109.719 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.8 t -104.19 158.41 5.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 126.516 1.926 . . . . 0.0 106.704 178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.33 -107.25 0.28 Allowed Glycine 0 C--O 1.221 -0.677 0 C-N-CA 118.657 -1.735 . . . . 0.0 112.799 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.5 165.85 23.27 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.046 1.738 . . . . 0.0 106.858 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -148.99 136.24 20.09 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 119.835 -1.79 . . . . 0.0 111.555 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 128.805 2.842 . . . . 0.0 111.252 168.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.6 m -141.2 125.01 16.98 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -98.86 132.63 44.06 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.496 1.119 . . . . 0.0 109.159 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -143.58 118.78 10.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.453 HG23 ' H ' ' A' ' 146' ' ' TYR . 2.4 m -92.38 143.82 10.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.4 m -158.35 139.57 13.29 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.971 1.708 . . . . 0.0 107.989 -175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.48 172.59 31.15 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.81 -160.68 29.0 Favored Glycine 0 N--CA 1.462 0.384 0 CA-C-N 120.33 2.065 . . . . 0.0 110.903 -172.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -91.71 157.34 16.99 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.405 1.102 . . . . 0.0 109.845 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.704 ' HB2' HD21 ' A' ' 25' ' ' ASN . . . -119.93 155.07 33.48 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.517 1.527 . . . . 0.0 110.035 -175.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -148.09 118.35 7.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 162.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -83.79 139.63 32.57 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 167.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -116.68 153.86 31.59 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 157.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.1 106.57 3.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.547 1.939 . . . . 0.0 108.524 -171.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 71.38 -54.1 0.67 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.762 2.025 . . . . 0.0 112.63 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.81 -81.38 0.05 OUTLIER Glycine 0 C--N 1.337 0.638 0 CA-C-N 119.469 1.031 . . . . 0.0 114.257 -172.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -152.57 95.87 2.07 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.279 1.539 . . . . 0.0 108.913 166.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.8 mtt -144.71 -48.87 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.654 0.782 . . . . 0.0 110.314 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -128.37 109.73 11.7 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -169.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -131.41 77.84 1.8 Allowed 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.717 1.207 . . . . 0.0 107.89 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.81 145.23 47.15 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 169.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . -159.36 -179.93 34.52 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 128.678 3.037 . . . . 0.0 106.747 167.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.81 -90.95 0.08 OUTLIER Glycine 0 CA--C 1.523 0.545 0 CA-C-N 118.998 1.399 . . . . 0.0 110.646 173.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -164.71 143.09 6.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 168.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.704 HD21 ' HB2' ' A' ' 10' ' ' ALA . 38.9 m-80 -125.32 163.26 22.93 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.133 0.973 . . . . 0.0 110.233 -166.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 mt -142.79 163.1 33.72 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.148 0.979 . . . . 0.0 110.516 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -140.03 161.06 38.51 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.477 2.311 . . . . 0.0 106.538 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -147.81 112.19 5.26 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -105.3 159.42 15.9 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 121.163 -0.96 . . . . 0.0 108.945 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -142.77 155.84 44.89 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.942 0.897 . . . . 0.0 108.86 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.41 113.06 19.78 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.335 0.654 . . . . 0.0 109.781 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.85 159.2 26.54 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.304 0.574 . . . . 0.0 109.674 167.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -128.83 39.54 3.78 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.66 -16.32 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.995 1.318 . . . . 0.0 112.15 -173.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.6 t -155.07 133.48 7.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.854 1.662 . . . . 0.0 108.193 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.84 -5.0 16.39 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.312 3.342 . . . . 0.0 113.867 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.3 tp -77.5 123.97 27.29 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.105 -0.997 . . . . 0.0 109.025 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.36 -167.39 36.91 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.7 t -127.08 147.78 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.344 1.458 . . . . 0.0 108.675 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.0 mm -122.48 127.85 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 166.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.17 108.71 0.39 Allowed Glycine 0 CA--C 1.523 0.564 0 N-CA-C 107.226 -2.35 . . . . 0.0 107.226 163.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.6 t -88.23 150.72 23.12 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.849 1.66 . . . . 0.0 108.293 167.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -127.72 131.13 49.75 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.394 1.878 . . . . 0.0 107.976 172.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.3 p -127.32 117.0 21.39 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.978 1.711 . . . . 0.0 109.073 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -113.52 133.91 54.97 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.284 1.434 . . . . 0.0 107.827 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.9 p -126.6 130.06 49.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.318 0.58 . . . . 0.0 110.878 -168.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -140.17 93.21 2.61 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.363 1.465 . . . . 0.0 108.155 -170.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -162.75 147.46 11.81 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.879 0.872 . . . . 0.0 109.11 -174.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.1 p -121.63 153.93 37.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.07 100.4 6.95 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 t -159.21 99.88 1.51 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -166.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.98 81.45 1.27 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.2 t 58.2 67.53 0.94 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 122.702 1.239 . . . . 0.0 107.697 -174.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.38 -32.01 0.39 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.533 173.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.96 47.02 68.0 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.36 104.62 10.18 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.959 2.103 . . . . 0.0 105.73 -175.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -90.8 98.27 11.68 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 120.475 -1.39 . . . . 0.0 110.446 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.21 122.34 6.72 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.758 -0.589 . . . . 0.0 109.843 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -115.26 171.64 7.57 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.892 1.677 . . . . 0.0 108.516 170.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.89 -176.01 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.379 1.072 . . . . 0.0 110.202 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 pm0 -137.1 162.15 34.16 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 160.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -83.87 143.09 30.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.61 117.71 21.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.844 2.057 . . . . 0.0 106.455 -178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.87 92.98 1.05 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.3 mm -79.71 146.43 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 p -133.66 155.42 49.74 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.02 139.21 21.22 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.22 175.33 34.96 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 123.176 0.417 . . . . 0.0 112.249 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -79.02 176.04 10.26 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.886 2.391 . . . . 0.0 110.351 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.01 150.48 38.54 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.631 1.173 . . . . 0.0 108.841 162.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.2 124.2 41.93 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.099 0.96 . . . . 0.0 108.571 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -71.8 133.27 45.42 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.012 0.369 . . . . 0.0 110.049 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.8 mt -77.95 -76.56 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 165.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -83.09 -76.07 0.29 Allowed 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 170.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -148.09 -62.01 0.26 Allowed 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -104.48 105.95 16.27 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.279 1.037 . . . . 0.0 109.56 172.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.42 -169.02 3.24 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.389 1.876 . . . . 0.0 108.754 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.97 169.67 17.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 157.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mm -143.06 147.3 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.628 ' HA ' ' HB3' ' A' ' 111' ' ' ALA . 21.9 p90 -105.4 141.59 36.65 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.425 2.29 . . . . 0.0 107.972 177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.82 50.42 0.21 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -161.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.526 HG22 ' HB2' ' A' ' 111' ' ' ALA . 3.6 m -123.04 176.4 4.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 163.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.55 130.22 54.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.55 158.41 15.13 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 172.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.01 118.36 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 170.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.63 122.69 7.62 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 107.372 -2.291 . . . . 0.0 107.372 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -132.63 116.93 17.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -169.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.23 101.55 0.22 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -56.67 161.5 2.74 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.666 0.733 . . . . 0.0 109.654 165.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -129.78 171.44 12.68 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 126.182 1.793 . . . . 0.0 106.493 167.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -143.52 135.32 26.5 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 120.92 -1.113 . . . . 0.0 108.592 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.3 p -105.84 108.11 19.46 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -170.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.4 m 50.64 -87.01 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.888 1.675 . . . . 0.0 109.62 -158.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -158.41 11.21 0.16 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.233 1.013 . . . . 0.0 110.831 -176.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -140.69 155.79 69.28 Favored Pre-proline 0 C--O 1.236 0.358 0 O-C-N 120.415 -1.428 . . . . 0.0 110.795 -173.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.9 -34.71 47.55 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.51 1.473 . . . . 0.0 109.85 170.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.4 m -52.38 -37.31 56.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 128.447 2.699 . . . . 0.0 112.953 -173.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -62.48 -53.54 53.25 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.618 0.644 . . . . 0.0 111.742 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.48 -60.45 0.11 Allowed 'General case' 0 C--O 1.226 -0.174 0 CA-C-O 117.158 -1.401 . . . . 0.0 109.078 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 32.97 89.57 0.01 OUTLIER 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.644 2.378 . . . . 0.0 110.979 -165.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -66.21 164.07 16.5 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 120.992 -1.068 . . . . 0.0 109.489 160.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.7 p -67.76 150.26 48.88 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.53 -0.731 . . . . 0.0 110.11 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 p -71.75 177.48 4.16 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 161.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.67 165.13 35.11 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.997 -1.065 . . . . 0.0 110.894 170.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.17 109.48 18.92 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 166.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.86 93.42 1.89 Allowed Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -74.52 111.65 9.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.64 1.176 . . . . 0.0 109.704 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.3 p -105.79 151.06 24.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.33 1.052 . . . . 0.0 111.211 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -136.85 80.84 1.84 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.468 1.907 . . . . 0.0 107.972 -170.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.08 -161.48 11.0 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 126.512 2.005 . . . . 0.0 108.144 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 80' ' ' TYR . . . -164.28 -82.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 153.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.449 ' C ' HD22 ' A' ' 113' ' ' LEU . . . 164.71 170.83 30.19 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -171.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 112' ' ' GLY . 3.7 mm? -133.29 150.83 51.88 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.58 1.952 . . . . 0.0 106.836 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -132.64 154.2 50.33 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 122.139 0.971 . . . . 0.0 110.023 -171.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -104.64 174.44 5.88 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 128.044 2.537 . . . . 0.0 109.107 173.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -55.62 114.09 6.75 Favored Pre-proline 0 C--O 1.234 0.269 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.28 103.56 1.7 Allowed 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.044 -1.56 . . . . 0.0 108.044 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 19.1 ttt -74.64 155.55 37.67 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -54.64 -33.25 60.33 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 126.787 2.035 . . . . 0.0 110.991 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -104.45 -25.95 12.6 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 117.271 -1.347 . . . . 0.0 113.602 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.93 109.47 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.308 0.958 . . . . 0.0 108.885 -174.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.97 154.17 42.04 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 162.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -132.26 116.35 16.81 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 168.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.84 146.58 37.74 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.913 2.085 . . . . 0.0 107.301 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -129.68 135.61 48.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.3 m -124.23 148.24 47.47 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 171.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -149.86 132.92 16.24 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -136.63 145.22 44.61 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.62 1.568 . . . . 0.0 107.693 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -116.75 129.07 55.89 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 171.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 t -111.11 159.57 17.7 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.188 0.995 . . . . 0.0 108.934 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -136.45 97.4 3.56 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -172.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.57 94.34 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 167.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 47.3 ttm-85 63.93 58.53 1.21 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.618 1.167 . . . . 0.0 111.741 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m 53.72 27.89 7.47 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.342 1.057 . . . . 0.0 113.073 171.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.8 p -82.45 149.0 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.392 1.477 . . . . 0.0 108.094 172.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.72 102.4 13.6 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 169.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.3 t -131.85 103.68 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.87 133.17 7.49 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.4 t -125.48 139.89 53.24 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.479 1.512 . . . . 0.0 107.457 -175.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -129.7 151.18 50.57 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 171.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.8 pt -136.23 145.16 31.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.13 158.04 18.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.25 101.95 0.36 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 106.664 -2.574 . . . . 0.0 106.664 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.87 160.44 20.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.06 -149.84 9.45 Favored Glycine 0 C--O 1.221 -0.718 0 C-N-CA 118.688 -1.72 . . . . 0.0 109.799 -172.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.453 ' H ' HG23 ' A' ' 5' ' ' VAL . 42.4 p90 -162.66 175.32 11.49 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.937 1.695 . . . . 0.0 106.988 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -102.98 147.67 26.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 C--O 1.249 1.064 0 C-N-CA 126.174 1.789 . . . . 0.0 108.049 170.79 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 p -131.82 137.58 48.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -132.21 106.89 8.23 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.8 t -135.96 127.21 28.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.496 HG11 ' CD1' ' A' ' 146' ' ' TYR 0.259 9.7 p -101.93 153.4 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.735 0.779 . . . . 0.0 109.512 -173.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.9 124.08 4.24 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 174.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.39 -172.7 45.67 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 118.594 0.634 . . . . 0.0 113.235 -166.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.31 -116.44 1.54 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.602 1.572 . . . . 0.0 110.818 169.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.35 146.26 45.47 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.617 1.209 . . . . 0.0 108.307 -163.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.39 120.84 24.88 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -169.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -99.65 148.15 24.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 168.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -130.93 131.34 44.4 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 165.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -119.25 111.17 17.87 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.4 143.04 27.03 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.324 1.049 . . . . 0.0 108.286 -170.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 60.89 -75.48 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.243 1.817 . . . . 0.0 109.537 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -159.46 -73.35 0.02 OUTLIER Glycine 0 CA--C 1.52 0.405 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -126.12 105.91 9.2 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.5 ttt -148.21 -54.63 0.2 Allowed 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.206 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -144.62 133.05 21.94 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -167.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -121.15 77.82 1.35 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -170.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -58.08 157.73 7.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.294 1.437 . . . . 0.0 110.31 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -148.69 155.16 26.25 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 163.07 -175.4 39.4 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 118.386 1.093 . . . . 0.0 111.688 -173.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.11 146.43 43.15 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.771 0.785 . . . . 0.0 111.604 -164.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.62 HD21 ' HA ' ' A' ' 44' ' ' THR . 1.0 OUTLIER -139.36 152.52 47.22 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.536 1.935 . . . . 0.0 109.531 176.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.441 HD21 ' CG2' ' A' ' 5' ' ' VAL . 1.3 tm? -156.28 116.11 3.59 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.667 0.787 . . . . 0.0 108.883 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 128.6 38.82 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.513 1.125 . . . . 0.0 109.58 175.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -95.74 141.5 29.14 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.778 2.431 . . . . 0.0 108.095 169.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 69.7 mtm-85 -128.37 162.85 26.13 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.958 1.254 . . . . 0.0 109.74 166.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -142.21 138.52 31.53 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -88.09 135.16 33.55 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 171.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -136.48 162.22 33.69 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.768 0.827 . . . . 0.0 110.639 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.68 47.09 2.18 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.247 1.419 . . . . 0.0 108.411 -166.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.51 -48.18 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.708 1.203 . . . . 0.0 109.455 171.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.97 115.07 45.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.602 1.161 . . . . 0.0 108.375 175.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.99 -43.81 6.1 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.809 1.673 . . . . 0.0 109.901 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.481 HD12 ' CB ' ' A' ' 69' ' ' PRO . 1.9 pt? -73.09 148.33 44.11 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.125 2.17 . . . . 0.0 110.597 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.72 -178.21 36.61 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.677 1.132 . . . . 0.0 110.613 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 73.5 t -117.95 139.57 44.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.353 1.861 . . . . 0.0 108.519 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 12.9 mm -134.04 127.36 51.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 124.502 1.121 . . . . 0.0 108.301 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.02 108.86 0.37 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 172.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 t -126.71 155.01 43.36 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.704 -0.88 . . . . 0.0 108.666 161.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -114.91 147.78 39.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.62 ' HA ' HD21 ' A' ' 25' ' ' ASN . 1.2 p -116.24 115.22 25.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -169.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -142.8 123.76 14.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.3 p -140.83 124.7 17.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -165.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -137.09 90.58 2.54 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -125.79 120.96 31.96 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.6 p -65.55 155.82 34.54 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.706 2.002 . . . . 0.0 110.457 -170.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -128.22 154.12 46.18 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 122.242 1.02 . . . . 0.0 108.694 166.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -162.71 103.51 1.04 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 101.35 -3.574 . . . . 0.0 101.35 163.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.0 -98.37 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 166.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -153.74 73.95 0.97 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 172.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.0 t -166.7 -62.34 0.03 OUTLIER 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.01 2.124 . . . . 0.0 105.898 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.96 60.31 0.34 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -85.4 91.38 8.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -75.81 88.88 2.85 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.122 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -70.89 62.49 0.28 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.566 1.947 . . . . 0.0 111.551 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -86.28 167.43 14.83 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.643 1.577 . . . . 0.0 110.589 -171.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.6 m120 50.41 -163.1 0.05 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.076 1.35 . . . . 0.0 110.032 -165.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -147.15 169.02 20.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.69 1.196 . . . . 0.0 109.599 -164.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -78.42 158.58 28.67 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.224 1.01 . . . . 0.0 108.686 159.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -135.87 117.74 15.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 161.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.49 154.1 16.63 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 170.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 tt -142.16 112.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.1 p -128.58 126.85 41.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.38 155.67 43.3 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.12 165.45 38.77 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.719 -1.753 . . . . 0.0 108.719 171.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CB ' HD12 ' A' ' 37' ' ' LEU . 3.6 Cg_endo -66.98 168.58 16.88 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 CA-C-N 119.622 1.711 . . . . 0.0 109.572 156.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.01 154.9 19.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 159.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -93.02 154.81 17.91 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 152.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -140.42 96.71 3.08 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.89 -55.5 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 118.039 0.381 . . . . 0.0 110.294 -170.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -79.17 178.53 7.99 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.983 1.313 . . . . 0.0 108.67 173.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.91 47.48 1.26 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.29 1.036 . . . . 0.0 110.333 172.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 22.2 p-90 -156.16 -57.93 0.09 Allowed 'General case' 0 CA--C 1.529 0.152 0 O-C-N 120.975 -1.078 . . . . 0.0 110.15 173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.43 154.02 44.23 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.999 0.92 . . . . 0.0 108.674 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.4 m -147.67 168.35 22.27 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.911 0.884 . . . . 0.0 110.609 -176.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -128.15 146.33 33.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -175.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -150.44 158.96 44.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.367 0.667 . . . . 0.0 109.773 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -124.3 129.87 7.32 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 108.201 -1.96 . . . . 0.0 108.201 174.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.45 151.89 6.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.6 m -145.17 159.79 13.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 123.843 0.857 . . . . 0.0 109.396 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 157.52 -136.39 4.84 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.55 151.06 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -166.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.89 158.38 22.25 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 161.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -149.45 160.34 43.53 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.122 1.769 . . . . 0.0 107.777 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.58 172.91 33.55 Favored Glycine 0 C--N 1.331 0.282 0 O-C-N 120.861 -1.149 . . . . 0.0 111.562 175.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -148.33 98.37 2.9 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 171.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -142.6 100.71 3.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -161.98 -78.93 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -132.04 128.97 39.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.8 m -154.6 84.1 1.11 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 -175.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -151.44 -70.93 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 175.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.1 -67.19 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 116.671 -1.633 . . . . 0.0 109.885 169.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -62.34 149.41 90.85 Favored 'Trans proline' 0 C--N 1.352 0.726 0 CA-C-N 121.877 1.706 . . . . 0.0 111.082 -173.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m 66.86 -14.28 0.17 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.777 2.031 . . . . 0.0 113.303 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 46.98 -143.76 0.33 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.428 1.891 . . . . 0.0 111.551 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -69.83 98.4 1.23 Allowed 'General case' 0 C--O 1.234 0.249 0 O-C-N 119.877 -1.764 . . . . 0.0 106.657 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -69.79 -73.35 0.16 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.863 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.21 124.28 20.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.678 1.191 . . . . 0.0 109.932 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.0 m -82.89 160.22 22.18 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.32 1.448 . . . . 0.0 110.335 -176.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.32 117.05 9.61 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.964 1.706 . . . . 0.0 108.946 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -151.52 171.64 17.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.77 0.714 . . . . 0.0 110.918 166.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -102.94 94.87 5.79 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -83.89 130.95 10.06 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -74.13 150.58 40.4 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 118.084 0.942 . . . . 0.0 109.162 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.0 m -131.35 135.98 47.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -155.42 95.72 1.72 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 -172.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.01 169.57 13.59 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 125.06 1.314 . . . . 0.0 111.293 -169.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.02 156.76 32.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.817 1.247 . . . . 0.0 108.747 -176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.487 ' C ' HD22 ' A' ' 113' ' ' LEU . . . -159.4 150.34 20.71 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 173.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.487 HD22 ' C ' ' A' ' 112' ' ' GLY . 3.8 mm? -138.26 139.75 39.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 -169.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -136.66 139.55 42.1 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.954 0.797 . . . . 0.0 110.199 -169.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -118.94 171.19 8.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.334 1.454 . . . . 0.0 108.208 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -59.89 114.6 10.1 Favored Pre-proline 0 N--CA 1.456 -0.152 0 C-N-CA 125.546 1.539 . . . . 0.0 107.912 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -81.48 122.81 4.15 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.468 1.446 . . . . 0.0 109.323 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.1 ttm -170.53 149.68 3.3 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.143 2.177 . . . . 0.0 107.051 174.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 117.3 12.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 131.23 3.812 . . . . 0.0 109.409 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 62.03 28.81 17.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.098 1.759 . . . . 0.0 111.196 -160.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 m -137.09 145.99 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.696 1.198 . . . . 0.0 108.4 156.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.38 163.13 23.06 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 120.183 -1.573 . . . . 0.0 109.927 149.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -118.99 113.56 21.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 158.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -148.36 149.54 31.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -129.45 151.71 49.78 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.31 0.959 . . . . 0.0 109.997 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.9 m -136.31 145.92 46.03 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.903 0.881 . . . . 0.0 110.729 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -138.76 148.38 43.8 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.671 1.988 . . . . 0.0 107.473 162.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -137.25 147.94 46.09 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 165.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -132.0 129.15 39.75 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 169.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.6 m -140.36 154.34 46.71 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.536 1.134 . . . . 0.0 108.098 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.5 mtp85 -121.6 98.13 5.82 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 121.449 -0.782 . . . . 0.0 109.388 -171.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 9.1 mm -66.0 91.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 67.27 -79.67 0.04 OUTLIER 'General case' 0 C--O 1.232 0.146 0 C-N-CA 127.924 2.49 . . . . 0.0 109.144 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.2 p -134.4 -2.16 2.8 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.12 1.368 . . . . 0.0 111.92 -170.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.17 149.31 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.366 1.066 . . . . 0.0 108.222 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.62 156.52 25.09 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.6 t -142.61 143.45 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 163.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -140.86 128.18 3.67 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.5 t -126.08 142.72 51.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -169.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -134.26 119.18 18.41 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.821 -2.288 . . . . 0.0 104.821 -165.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.1 mp -128.67 136.64 59.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.18 157.95 18.08 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -127.37 65.27 0.57 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.7 m -124.76 -176.35 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.519 1.527 . . . . 0.0 110.652 -164.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 149.27 -84.14 0.17 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 117.001 1.56 . . . . 0.0 117.001 174.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.496 ' CD1' HG11 ' A' ' 5' ' ' VAL . 19.6 p90 -163.32 177.41 8.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 128.699 2.799 . . . . 0.0 107.976 177.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -132.61 140.53 48.27 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 119.33 -2.106 . . . . 0.0 110.092 161.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 C--O 1.251 1.165 0 C-N-CA 128.509 2.723 . . . . 0.0 113.367 169.05 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 t -142.1 165.75 26.59 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 121.32 -0.863 . . . . 0.0 108.816 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 m -134.06 140.86 46.93 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.3 t -157.75 161.1 38.46 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 120.424 -1.422 . . . . 0.0 107.545 -171.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.75 119.77 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -160.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 p -135.49 155.36 50.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.469 1.128 . . . . 0.0 110.456 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.14 -159.2 30.9 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -164.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.03 -127.06 7.48 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -164.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -134.72 149.15 50.43 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.682 0.793 . . . . 0.0 109.061 -171.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.28 113.83 21.46 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 105.474 -2.046 . . . . 0.0 105.474 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -124.96 123.52 40.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -162.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.3 t -139.29 140.5 37.63 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.936 1.295 . . . . 0.0 107.75 -163.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -138.96 157.94 45.11 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.378 1.071 . . . . 0.0 110.746 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' A' ' 137' ' ' VAL . . . -94.17 165.05 12.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.406 1.082 . . . . 0.0 111.73 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -73.59 61.08 0.7 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.463 1.105 . . . . 0.0 110.318 168.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.65 104.02 0.28 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -53.74 96.32 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.326 2.251 . . . . 0.0 111.357 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 96.7 mtp -149.35 -56.4 0.19 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.906 2.082 . . . . 0.0 107.834 173.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -118.15 111.94 19.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.148 1.379 . . . . 0.0 109.231 -170.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.57 150.33 41.04 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 45.6 mtt -115.42 143.41 45.34 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 126.096 1.759 . . . . 0.0 107.01 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.26 168.05 40.62 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 126.601 2.048 . . . . 0.0 108.055 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 166.83 -85.03 0.1 OUTLIER Glycine 0 C--O 1.225 -0.41 0 N-CA-C 107.916 -2.073 . . . . 0.0 107.916 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.46 ' H ' ' HB3' ' A' ' 45' ' ' TYR . 7.0 m-85 -146.36 172.07 14.05 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.635 1.974 . . . . 0.0 108.633 173.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -125.35 152.76 44.32 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 160.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 tp -145.74 140.26 27.07 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.675 0.671 . . . . 0.0 109.358 161.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -138.98 163.21 32.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.167 1.387 . . . . 0.0 107.523 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -143.39 140.24 30.37 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -132.78 144.04 49.98 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -117.27 147.16 42.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 161.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.87 136.69 32.58 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 156.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -86.73 179.13 6.83 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.28 2.232 . . . . 0.0 111.232 -166.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.81 -22.67 14.32 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.442 -0.786 . . . . 0.0 112.071 165.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.62 5.25 33.54 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.106 1.362 . . . . 0.0 113.209 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -153.44 104.02 2.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.94 1.696 . . . . 0.0 106.81 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.05 78.29 3.22 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.993 2.462 . . . . 0.0 109.463 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.6 tp -149.78 131.71 15.2 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.084 0.954 . . . . 0.0 109.748 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.16 176.75 18.74 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 168.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 m -137.11 160.48 36.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 125.938 1.695 . . . . 0.0 108.988 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.5 mm -140.17 109.74 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.387 1.475 . . . . 0.0 107.729 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.69 167.06 33.27 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 153.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 p -125.5 151.54 46.16 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 118.685 1.242 . . . . 0.0 108.804 146.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.61 148.89 27.77 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.905 1.23 . . . . 0.0 109.206 156.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -94.11 148.97 21.66 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 162.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.46 ' HB3' ' H ' ' A' ' 24' ' ' PHE . 3.8 t80 -143.08 110.08 5.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.289 1.404 . . . . 0.0 108.161 176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.8 p -101.97 120.57 40.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 121.191 1.814 . . . . 0.0 111.224 -166.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -162.61 76.75 0.45 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.057 1.343 . . . . 0.0 108.289 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -162.42 114.15 1.61 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 164.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 155.57 39.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.845 1.202 . . . . 0.0 110.225 174.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.35 102.45 5.55 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 175.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.9 m -148.17 76.24 1.36 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -169.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.15 19.36 1.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.893 1.677 . . . . 0.0 110.763 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -145.58 -105.98 0.1 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.5 -46.51 59.52 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 121.144 1.793 . . . . 0.0 110.169 167.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.89 74.28 0.27 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.66 90.42 1.81 Allowed 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.0 77.88 10.03 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 123.235 1.493 . . . . 0.0 107.961 -176.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -67.26 105.11 1.64 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.645 175.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -143.85 114.67 7.73 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.598 1.09 . . . . 0.0 108.669 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 151.56 -170.02 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.024 2.93 . . . . 0.0 106.482 -164.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.8 170.46 8.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 125.704 1.602 . . . . 0.0 107.69 -162.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -76.81 143.05 40.04 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.9 -1.125 . . . . 0.0 109.719 166.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -141.63 118.35 11.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.735 1.614 . . . . 0.0 107.018 161.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.89 158.09 28.8 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 108.454 -1.859 . . . . 0.0 108.454 162.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 mp -133.39 143.77 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 169.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 84' ' ' GLY . 89.5 m -139.67 148.05 41.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 161.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.96 150.03 28.82 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.386 0.674 . . . . 0.0 110.897 -164.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.02 163.52 12.85 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.94 1.733 . . . . 0.0 110.861 166.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.68 172.46 15.73 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.736 2.291 . . . . 0.0 110.526 168.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.62 153.89 47.44 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.484 1.114 . . . . 0.0 109.81 163.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -151.17 151.54 32.06 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -164.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -82.07 149.91 27.8 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.127 0.571 . . . . 0.0 109.634 177.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 73' ' ' ILE . 3.2 mp -78.55 -103.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 162.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.02 0.73 1.4 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.218 1.372 . . . . 0.0 112.881 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -113.77 -118.99 0.31 Allowed 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -129.87 -9.31 4.43 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -165.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.53 159.7 30.12 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 121.606 2.003 . . . . 0.0 109.578 164.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.6 m -135.86 125.06 24.56 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -136.84 147.09 27.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.49 174.74 12.17 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.385 1.474 . . . . 0.0 109.413 171.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.16 138.8 14.12 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 168.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.9 m -131.4 159.42 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 118.214 1.007 . . . . 0.0 110.222 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.28 135.42 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 C-N-CA 125.136 1.374 . . . . 0.0 109.495 -168.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 66' ' ' THR . . . -128.3 168.05 20.31 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 123.922 0.763 . . . . 0.0 113.137 -169.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.88 150.79 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 127.386 2.274 . . . . 0.0 106.894 170.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.49 158.69 22.23 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 161.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.4 116.86 21.12 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.612 0.765 . . . . 0.0 109.978 173.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.06 112.52 3.6 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 167.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -54.12 -59.15 5.03 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.749 1.275 . . . . 0.0 112.093 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -147.32 -63.55 0.28 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.503 1.521 . . . . 0.0 107.053 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 73.13 -56.2 0.66 Allowed 'General case' 0 C--N 1.346 0.449 0 C-N-CA 124.706 1.202 . . . . 0.0 109.29 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.483 HG21 ' H ' ' A' ' 100' ' ' ASN . 8.8 t -67.08 113.54 5.13 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 165.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.3 p -119.8 74.44 1.02 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 167.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 55.1 19.2 2.68 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.373 1.869 . . . . 0.0 114.592 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.427 ' H ' ' HD2' ' A' ' 96' ' ' PRO . 9.7 m-85 -120.93 -56.68 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 126.791 2.036 . . . . 0.0 111.399 177.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.427 ' HD2' ' H ' ' A' ' 95' ' ' TYR . 42.0 Cg_endo -82.64 52.76 4.18 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 CA-C-N 121.962 1.737 . . . . 0.0 112.744 -172.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.8 p 47.14 69.55 0.49 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.101 2.16 . . . . 0.0 112.108 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 30.52 61.8 0.2 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.903 2.481 . . . . 0.0 113.045 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -77.55 -47.15 20.19 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 118.649 -0.691 . . . . 0.0 112.761 -159.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.483 ' H ' HG21 ' A' ' 92' ' ' THR . 11.0 t-20 -152.25 65.8 0.83 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.94 0.896 . . . . 0.0 110.731 -171.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -68.23 -59.99 2.8 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.049 1.34 . . . . 0.0 109.804 -171.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -68.12 97.03 0.67 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.345 1.858 . . . . 0.0 108.889 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.4 p -66.39 155.98 35.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.83 0.824 . . . . 0.0 111.165 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -155.83 166.67 32.79 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.489 1.116 . . . . 0.0 108.885 -171.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -78.87 131.35 36.41 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.546 0.738 . . . . 0.0 110.152 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.05 82.52 0.4 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -73.14 151.17 41.67 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 118.585 1.192 . . . . 0.0 108.323 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.9 p -146.44 162.64 37.83 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.962 0.905 . . . . 0.0 110.827 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -141.27 155.11 46.03 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.68 -146.84 7.05 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.47 158.93 43.32 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.853 0.861 . . . . 0.0 110.317 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -136.35 133.68 6.72 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.64 143.47 14.63 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.992 0.396 . . . . 0.0 110.019 -170.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -142.91 145.15 32.79 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.944 0.878 . . . . 0.0 111.572 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -139.73 111.63 7.41 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 166.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 117.3 61.2 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.64 -33.78 2.19 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.336 1.358 . . . . 0.0 110.868 172.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.5 mtt -157.89 159.27 36.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.975 0.91 . . . . 0.0 111.124 -165.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -91.65 42.61 1.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 126.09 1.756 . . . . 0.0 109.658 -174.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.538 ' HA ' ' CD2' ' A' ' 146' ' ' TYR . 0.7 OUTLIER -160.7 -14.21 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.623 1.969 . . . . 0.0 111.269 -174.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 120' ' ' ASN . 20.3 m -144.93 117.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 165.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.81 163.85 18.52 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 160.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.6 114.74 10.85 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 161.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.35 149.66 47.91 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 127.887 2.475 . . . . 0.0 107.06 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -129.66 151.44 50.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.2 m -145.52 166.32 26.04 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 145.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -143.41 145.75 32.89 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 160.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -138.13 159.86 40.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 119.734 1.152 . . . . 0.0 110.056 160.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -122.83 114.9 21.13 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.758 1.223 . . . . 0.0 109.596 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.5 p -100.88 130.57 46.91 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.779 2.032 . . . . 0.0 112.538 -171.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.81 111.89 24.31 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.44 81.55 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 171.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 53.8 -102.32 0.14 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.956 1.702 . . . . 0.0 108.508 -164.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m -105.29 3.52 30.03 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.27 1.028 . . . . 0.0 112.221 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 52.2 t -82.66 110.96 18.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 173.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -92.89 126.85 38.17 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 14' ' ' ALA . 4.5 t -133.78 146.75 31.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 171.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.69 150.53 18.7 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 169.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 t -122.87 146.5 47.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -135.84 123.67 22.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 167.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.8 pt -116.93 139.79 42.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -168.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.22 134.94 33.84 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -120.27 74.55 0.32 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 176.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.43 168.03 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 124.708 1.203 . . . . 0.0 108.747 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.56 -105.07 0.25 Allowed Glycine 0 C--O 1.227 -0.344 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.538 ' CD2' ' HA ' ' A' ' 120' ' ' ASN . 0.3 OUTLIER -161.39 167.62 25.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.063 2.545 . . . . 0.0 107.624 -170.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -138.78 158.29 44.49 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.362 -1.461 . . . . 0.0 108.853 166.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 . . . . . 0 C--O 1.251 1.169 0 C-N-CA 126.408 1.883 . . . . 0.0 109.766 -175.337 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.431 HG23 HH21 ' A' ' 147' ' ' ARG . 52.6 m -145.89 157.8 43.89 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 168.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 m -127.16 140.13 52.47 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 167.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.4 m -148.22 129.72 14.89 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 120.244 -1.535 . . . . 0.0 107.35 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.583 HG23 ' H ' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -108.93 138.41 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.165 1.386 . . . . 0.0 108.505 173.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 p -157.2 117.72 3.55 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.8 2.04 . . . . 0.0 105.581 -169.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -173.18 165.64 37.88 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.39 -127.14 1.39 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -147.7 158.39 43.99 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.335 1.068 . . . . 0.0 110.698 -169.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.15 154.66 48.12 Favored 'General case' 0 C--N 1.335 -0.051 0 C-N-CA 125.129 1.372 . . . . 0.0 110.133 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -113.0 104.84 12.8 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 162.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 t -85.05 124.54 31.86 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 166.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.97 163.72 12.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 125.533 1.533 . . . . 0.0 107.412 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.57 161.96 37.81 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -55.6 81.37 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.911 1.684 . . . . 0.0 113.089 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.67 -15.23 5.21 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.593 1.568 . . . . 0.0 112.458 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -132.95 93.66 3.23 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 122.68 1.229 . . . . 0.0 108.48 172.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -90.27 60.02 4.6 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 129.437 3.095 . . . . 0.0 109.585 173.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -137.03 -178.47 5.21 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.887 1.275 . . . . 0.0 110.662 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -89.22 84.32 6.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.526 1.93 . . . . 0.0 107.116 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.5 ttm -92.52 147.83 22.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 153.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.9 -160.83 30.31 Favored Glycine 0 C--O 1.228 -0.252 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.21 -155.44 7.57 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 105.646 -2.982 . . . . 0.0 105.646 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.73 145.28 25.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.442 ' ND2' HD13 ' A' ' 141' ' ' ILE . 1.2 t30 -95.01 135.87 36.02 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 103.671 -2.714 . . . . 0.0 103.671 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.2 tp -145.97 116.71 7.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 173.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.16 140.96 48.76 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -137.56 121.41 17.6 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.96 143.08 45.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -118.53 158.14 25.95 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.462 1.905 . . . . 0.0 108.263 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -125.56 143.04 51.19 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.531 -1.356 . . . . 0.0 107.787 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -114.65 159.3 20.65 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.051 0.94 . . . . 0.0 108.78 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -95.19 15.26 19.63 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.123 -0.986 . . . . 0.0 111.701 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.41 0.73 2.56 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.698 1.199 . . . . 0.0 113.865 -172.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.4 125.3 3.02 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 117.77 -1.11 . . . . 0.0 108.124 168.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -72.46 79.91 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.547 3.498 . . . . 0.0 109.027 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.1 tp -150.42 155.81 40.27 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.589 1.556 . . . . 0.0 107.39 -160.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.24 -175.84 14.03 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 161.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.15 162.41 39.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 127.749 2.42 . . . . 0.0 106.218 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.8 mm -114.82 120.29 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.33 108.8 1.05 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 105.308 -3.117 . . . . 0.0 105.308 155.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -122.36 153.36 39.11 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 158.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -144.16 122.86 12.57 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.409 1.883 . . . . 0.0 107.098 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.9 m -127.59 125.18 39.78 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 172.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -91.49 158.41 16.49 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.653 1.981 . . . . 0.0 106.928 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -105.22 130.93 53.26 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -144.6 141.23 29.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.133 2.173 . . . . 0.0 107.152 166.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -175.54 147.92 0.88 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.601 2.36 . . . . 0.0 105.791 163.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.0 t -66.54 105.2 1.44 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.7 ttt85 -91.22 115.62 28.17 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 166.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.1 p -129.37 115.39 17.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.23 -170.25 2.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 164.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.1 m -80.44 -57.4 3.61 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 170.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.3 m -63.65 -66.96 0.47 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.345 0.658 . . . . 0.0 110.655 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.97 19.21 0.03 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 119.505 -1.331 . . . . 0.0 115.435 -157.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -90.47 91.5 8.48 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.105 1.953 . . . . 0.0 107.796 169.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -96.19 158.07 15.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.045 1.338 . . . . 0.0 108.068 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -84.02 124.33 30.96 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.298 -0.876 . . . . 0.0 110.335 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -132.51 168.71 17.73 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.024 0.529 . . . . 0.0 109.776 166.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 m120 49.79 172.14 0.01 OUTLIER 'General case' 0 C--O 1.239 0.532 0 C-N-CA 128.49 2.716 . . . . 0.0 111.75 -155.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -123.5 147.58 47.08 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 120.968 -1.083 . . . . 0.0 110.284 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -76.11 128.37 34.84 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -109.81 117.83 34.88 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.7 89.41 0.29 Allowed Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -161.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.2 pp -109.47 141.55 24.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.762 0.791 . . . . 0.0 110.455 -166.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.7 m -111.38 148.45 33.01 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 170.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.95 159.02 43.83 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.359 0.6 . . . . 0.0 109.55 163.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.13 164.99 10.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.045 1.307 . . . . 0.0 110.626 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.88 144.47 53.51 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.962 2.442 . . . . 0.0 111.553 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.03 122.59 33.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 160.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -79.44 126.99 31.56 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 167.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -69.78 128.77 37.56 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 74' ' ' ASN . 6.7 tt -76.42 -178.85 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.709 0.766 . . . . 0.0 109.954 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.417 ' H ' HG12 ' A' ' 73' ' ' ILE . 7.9 t30 -60.9 -0.04 0.26 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.279 2.232 . . . . 0.0 115.963 -170.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -136.21 -87.52 0.33 Allowed 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 120.2 1.364 . . . . 0.0 110.056 168.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.78 70.21 0.63 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 120.091 1.314 . . . . 0.0 109.958 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.16 -169.04 3.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.477 1.911 . . . . 0.0 107.296 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 t -122.43 170.16 10.25 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.903 1.681 . . . . 0.0 110.496 -162.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.83 167.99 25.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 121.528 -0.733 . . . . 0.0 111.696 -176.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -104.27 123.98 48.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.903 2.081 . . . . 0.0 109.134 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.17 73.62 0.02 OUTLIER Glycine 0 C--N 1.334 0.46 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.71 171.89 13.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 117.863 0.831 . . . . 0.0 109.66 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -101.14 130.42 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.37 148.16 18.92 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 170.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.9 132.3 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 165.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.76 152.89 18.72 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 162.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.58 165.2 29.35 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.597 0.759 . . . . 0.0 109.094 163.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.26 -167.95 43.93 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.494 -0.321 . . . . 0.0 113.634 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? 51.7 70.35 0.56 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.837 1.303 . . . . 0.0 108.01 -163.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.53 78.56 1.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -131.77 145.68 51.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 163.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 94' ' ' GLU . 20.7 m -107.78 137.82 45.11 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 163.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.12 -4.13 52.84 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 124.201 1.0 . . . . 0.0 111.347 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.611 ' H ' HG22 ' A' ' 92' ' ' THR . 1.2 tp10 -115.84 -87.22 0.6 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -151.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -63.08 158.62 53.71 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.578 1.951 . . . . 0.0 110.821 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.85 1.37 1.12 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.708 3.605 . . . . 0.0 115.964 -175.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.1 m -66.97 -9.76 42.09 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 120.872 -1.143 . . . . 0.0 111.697 159.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -53.25 -16.59 1.33 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -160.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -90.24 76.39 6.83 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 157.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -63.98 -56.22 16.73 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.75 -55.11 0.54 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.081 2.552 . . . . 0.0 113.267 172.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.5 t -72.7 149.53 43.72 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.899 0.88 . . . . 0.0 108.996 169.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.2 m -120.2 161.78 20.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.687 1.195 . . . . 0.0 108.213 166.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.29 176.69 9.54 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.971 1.308 . . . . 0.0 108.999 159.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -115.9 166.91 11.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 150.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.17 122.39 1.45 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.259 -1.936 . . . . 0.0 108.259 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.5 m-30 -73.91 152.32 40.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.635 1.174 . . . . 0.0 109.754 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.5 t -134.44 143.65 47.67 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.891 0.876 . . . . 0.0 110.293 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -80.48 99.48 8.04 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -83.82 125.51 7.11 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 -175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.65 145.29 32.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.085 1.754 . . . . 0.0 107.439 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.32 148.63 8.58 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.521 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -139.43 142.63 37.43 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.555 2.342 . . . . 0.0 107.878 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -105.69 160.92 14.84 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.222 1.809 . . . . 0.0 109.82 169.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -91.65 171.69 8.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -57.1 111.43 3.36 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.491 1.116 . . . . 0.0 108.472 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -85.17 162.95 11.47 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.422 2.081 . . . . 0.0 111.971 -168.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 68.3 mtm -154.28 171.47 19.19 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 128.804 2.842 . . . . 0.0 108.649 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -44.12 -55.19 4.94 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 131.396 3.878 . . . . 0.0 109.77 -164.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.414 ' HB2' ' CD1' ' A' ' 146' ' ' TYR 0.3 0.2 OUTLIER -132.28 37.53 3.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.198 0.523 . . . . 0.0 110.224 171.739 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.46 110.22 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.81 157.53 40.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 161.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.674 HD13 HG12 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -133.7 132.25 40.41 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 102.752 -3.055 . . . . 0.0 102.752 176.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -140.32 128.97 22.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 119.54 1.064 . . . . 0.0 109.824 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -136.41 145.99 45.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.376 1.07 . . . . 0.0 108.135 -174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.75 166.74 25.0 Favored 'General case' 0 C--O 1.239 0.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.127 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.42 ' HB3' ' CE3' ' A' ' 140' ' ' TRP . 42.5 p90 -142.66 118.39 10.47 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 169.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.87 108.43 9.4 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -99.5 132.97 44.47 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.5 p -129.85 159.41 36.65 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.591 1.157 . . . . 0.0 109.951 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 47.8 mtt-85 -122.2 98.0 5.73 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.485 0.659 . . . . 0.0 109.466 -173.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 10.9 mm -82.41 81.12 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.384 1.073 . . . . 0.0 108.165 -175.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 64.14 -55.87 0.24 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.692 2.797 . . . . 0.0 114.08 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.3 t -149.85 -0.94 0.44 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.587 1.555 . . . . 0.0 110.546 169.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.18 135.66 24.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.9 137.17 32.57 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.0 t -139.33 108.0 3.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.039 1.336 . . . . 0.0 108.674 -174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.08 151.76 35.58 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 167.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.3 t -140.38 153.31 46.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 146.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.42 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 7.4 m95 -137.86 110.79 7.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 103.332 -2.84 . . . . 0.0 103.332 172.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.442 HD13 ' ND2' ' A' ' 25' ' ' ASN . 1.9 pp -81.72 154.57 4.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.0 166.41 22.47 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 163.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -176.57 167.46 38.96 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.674 HG12 HD13 ' A' ' 123' ' ' LEU . 1.5 m -144.35 148.7 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -163.16 -145.72 4.46 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.583 ' H ' HG23 ' A' ' 5' ' ' VAL . 8.1 m-85 -136.23 158.73 43.72 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.901 2.081 . . . . 0.0 108.395 -163.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.431 HH21 HG23 ' A' ' 2' ' ' THR . 0.8 OUTLIER -145.68 112.1 5.81 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 119.929 -0.708 . . . . 0.0 112.713 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 124.576 1.151 . . . . 0.0 108.367 178.362 . . . . . . . . 0 0 . 1 stop_ save_